[
  {
    "id": "Medical-73586ddc",
    "source": "Medical",
    "question": "What is the most common type of skin cancer?",
    "answer": "Basal cell carcinoma (BCC) is the most common type of skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Basal cell carcinoma (BCC) is the most common type of skin cancer"
  },
  {
    "id": "Medical-a8bad1cf",
    "source": "Medical",
    "question": "From which cell type does basal cell carcinoma arise?",
    "answer": "Basal cell carcinoma arises from basal cells in the lower part of the epidermis.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC arises from basal cells in the lower part of the epidermis"
  },
  {
    "id": "Medical-422500d5",
    "source": "Medical",
    "question": "Which anatomical locations are most commonly affected by basal cell carcinoma?",
    "answer": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck"
  },
  {
    "id": "Medical-6d2a190d",
    "source": "Medical",
    "question": "What is the primary risk factor for basal cell carcinoma?",
    "answer": "UV radiation exposure is a primary risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "UV radiation exposure is a primary risk factor for BCC"
  },
  {
    "id": "Medical-5ad931db",
    "source": "Medical",
    "question": "How does fair skin affect the risk of developing BCC?",
    "answer": "Fair skin increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-6b0f8bc4",
    "source": "Medical",
    "question": "Does older age influence the risk of basal cell carcinoma?",
    "answer": "Older age is associated with higher risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Older age is associated with higher risk of BCC"
  },
  {
    "id": "Medical-75c9949b",
    "source": "Medical",
    "question": "How does family history impact the risk of basal cell carcinoma?",
    "answer": "Family history of skin cancer increases risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "History of skin cancer or family history increases risk of BCC"
  },
  {
    "id": "Medical-ec091b24",
    "source": "Medical",
    "question": "Is immune suppression a risk factor for BCC?",
    "answer": "Immune suppression is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy and immune suppression are risk factors for BCC"
  },
  {
    "id": "Medical-8d39da2e",
    "source": "Medical",
    "question": "What are common symptoms of basal cell carcinoma?",
    "answer": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders"
  },
  {
    "id": "Medical-88c0b2ba",
    "source": "Medical",
    "question": "Which diagnostic methods are used for BCC?",
    "answer": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-a8ee8ba1",
    "source": "Medical",
    "question": "What is the most common treatment for basal cell carcinoma?",
    "answer": "Surgery is the most common treatment for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is the most common treatment for BCC"
  },
  {
    "id": "Medical-ec7d8801",
    "source": "Medical",
    "question": "When might radiation therapy be used in BCC?",
    "answer": "Radiation therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-9797af69",
    "source": "Medical",
    "question": "What is recurrence in the context of BCC?",
    "answer": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites.",
    "question_type": "Fact Retrieval",
    "evidence": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites"
  },
  {
    "id": "Medical-6884d3fa",
    "source": "Medical",
    "question": "What does follow-up for BCC typically include?",
    "answer": "Follow-up includes full skin exams with a doctor at least once a year.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-fc6d1c33",
    "source": "Medical",
    "question": "Which skin cancer subtype arises from basal cells?",
    "answer": "Basal cell carcinoma is the skin cancer subtype that arises from basal cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Basal cell carcinoma (BCC) is the most common type of skin cancer"
  },
  {
    "id": "Medical-97abee55",
    "source": "Medical",
    "question": "What anatomical layer do basal cells belong to?",
    "answer": "Basal cells are located in the lower part of the epidermis.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC arises from basal cells in the lower part of the epidermis"
  },
  {
    "id": "Medical-28d1e2d7",
    "source": "Medical",
    "question": "Is sun exposure a risk factor for BCC?",
    "answer": "Sun exposure is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Sun exposure"
  },
  {
    "id": "Medical-4cf524cb",
    "source": "Medical",
    "question": "Do tanning beds increase the risk of BCC?",
    "answer": "Tanning beds are a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Tanning beds are listed as a risk factor for BCC in the ontology"
  },
  {
    "id": "Medical-df1408f4",
    "source": "Medical",
    "question": "What hair and eye colors are associated with increased BCC risk?",
    "answer": "Red hair, blond hair, and light eye color increase the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-17ae12cd",
    "source": "Medical",
    "question": "Can a history of radiation therapy increase BCC risk?",
    "answer": "Radiation therapy is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy and immune suppression are risk factors for BCC"
  },
  {
    "id": "Medical-965ad8a8",
    "source": "Medical",
    "question": "What is a common presentation of BCC on the skin?",
    "answer": "BCC may present as a shiny bump.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders"
  },
  {
    "id": "Medical-5175a85e",
    "source": "Medical",
    "question": "What is the role of biopsy in BCC diagnosis?",
    "answer": "Biopsy is used as a diagnostic method for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-5f2cb8a5",
    "source": "Medical",
    "question": "Which systemic therapy may be considered for BCC?",
    "answer": "Systemic therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-0429f83c",
    "source": "Medical",
    "question": "What is included in the management of BCC recurrence?",
    "answer": "Management of recurrence involves treatment options based on risk and recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Management: Treatment options based on risk and recurrence"
  },
  {
    "id": "Medical-152bec6a",
    "source": "Medical",
    "question": "What is the recommended frequency for full skin exams in BCC follow-up?",
    "answer": "Full skin exams with a doctor are recommended at least once a year.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-e3923e5f",
    "source": "Medical",
    "question": "Can BCC spread to lymph nodes?",
    "answer": "BCC recurrence can involve spread to lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites"
  },
  {
    "id": "Medical-0c2f999d",
    "source": "Medical",
    "question": "What is a brown or glossy black bump with rolled border a symptom of?",
    "answer": "A brown or glossy black bump with rolled border is a symptom of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders"
  },
  {
    "id": "Medical-b6dc1118",
    "source": "Medical",
    "question": "What is the relationship between organ transplant and BCC risk?",
    "answer": "Organ transplant is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Organ transplant is listed as a risk factor for BCC in the ontology"
  },
  {
    "id": "Medical-ba2c8007",
    "source": "Medical",
    "question": "Is autoimmune disease associated with increased BCC risk?",
    "answer": "Autoimmune disease is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Autoimmune disease is listed as a risk factor for BCC in the ontology"
  },
  {
    "id": "Medical-5c30dd24",
    "source": "Medical",
    "question": "What is the role of imaging in BCC diagnosis?",
    "answer": "Imaging may be used in the diagnosis of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-8622e4cc",
    "source": "Medical",
    "question": "Can BCC occur anywhere on the body?",
    "answer": "BCC can occur anywhere on the body, but most commonly in sun-exposed areas.",
    "question_type": "Fact Retrieval",
    "evidence": "Anatomical Location: Anywhere on the body, most commonly face, head, and neck"
  },
  {
    "id": "Medical-b0b58bf2",
    "source": "Medical",
    "question": "What is the most common type of skin cancer?",
    "answer": "Basal cell carcinoma (BCC) is the most common type of skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Basal cell carcinoma (BCC) is the most common type of skin cancer"
  },
  {
    "id": "Medical-90704d0a",
    "source": "Medical",
    "question": "From which cells does basal cell carcinoma arise?",
    "answer": "BCC arises from basal cells in the lower part of the epidermis.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC arises from basal cells in the lower part of the epidermis"
  },
  {
    "id": "Medical-941c0004",
    "source": "Medical",
    "question": "Which anatomical locations are most commonly affected by BCC?",
    "answer": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck"
  },
  {
    "id": "Medical-4bb300c3",
    "source": "Medical",
    "question": "What is the primary risk factor for developing basal cell carcinoma?",
    "answer": "UV radiation exposure is a primary risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "UV radiation exposure is a primary risk factor for BCC"
  },
  {
    "id": "Medical-acec9fa2",
    "source": "Medical",
    "question": "How does fair skin affect the risk of basal cell carcinoma?",
    "answer": "Fair skin increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-7c81f966",
    "source": "Medical",
    "question": "Does older age influence the risk of BCC?",
    "answer": "Older age is associated with higher risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Older age is associated with higher risk of BCC"
  },
  {
    "id": "Medical-f6b5155a",
    "source": "Medical",
    "question": "Does a family history of skin cancer affect the risk of BCC?",
    "answer": "Family history of skin cancer increases risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "History of skin cancer or family history increases risk of BCC"
  },
  {
    "id": "Medical-4061f8c4",
    "source": "Medical",
    "question": "Is immune suppression a risk factor for basal cell carcinoma?",
    "answer": "Immune suppression is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy and immune suppression are risk factors for BCC"
  },
  {
    "id": "Medical-89de49a4",
    "source": "Medical",
    "question": "What are common symptoms of basal cell carcinoma?",
    "answer": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders.",
    "question_type": "Fact Retrieval",
    "evidence": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders"
  },
  {
    "id": "Medical-624c452d",
    "source": "Medical",
    "question": "What diagnostic methods are used for BCC?",
    "answer": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-4aab8ef7",
    "source": "Medical",
    "question": "What is the most common treatment for basal cell carcinoma?",
    "answer": "Surgery is the most common treatment for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is the most common treatment for BCC"
  },
  {
    "id": "Medical-bc412bb6",
    "source": "Medical",
    "question": "When might radiation therapy or systemic therapy be used for BCC?",
    "answer": "Radiation therapy or systemic therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-cb249d9b",
    "source": "Medical",
    "question": "What does recurrence mean in the context of BCC?",
    "answer": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites.",
    "question_type": "Fact Retrieval",
    "evidence": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites"
  },
  {
    "id": "Medical-e506aa4e",
    "source": "Medical",
    "question": "What is recommended for follow-up after BCC treatment?",
    "answer": "Follow-up includes full skin exams with a doctor at least once a year.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-14cee623",
    "source": "Medical",
    "question": "Which cell type is affected in basal cell carcinoma?",
    "answer": "Basal cells are the cell type affected in BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Basal cells"
  },
  {
    "id": "Medical-ae28e711",
    "source": "Medical",
    "question": "Is sun exposure a risk factor for BCC?",
    "answer": "Sun exposure is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Sun exposure"
  },
  {
    "id": "Medical-2bef6940",
    "source": "Medical",
    "question": "Are tanning beds considered a risk factor for BCC?",
    "answer": "Tanning beds are a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Tanning beds"
  },
  {
    "id": "Medical-0047c320",
    "source": "Medical",
    "question": "Does having red or blond hair increase the risk of BCC?",
    "answer": "Red hair and blond hair increase the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-ca377f8d",
    "source": "Medical",
    "question": "Is light eye color associated with increased risk of BCC?",
    "answer": "Light eye color increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-0b2a33fc",
    "source": "Medical",
    "question": "Can a history of radiation therapy increase BCC risk?",
    "answer": "Radiation therapy is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy and immune suppression are risk factors for BCC"
  },
  {
    "id": "Medical-de0b30b1",
    "source": "Medical",
    "question": "Are organ transplant recipients at higher risk for BCC?",
    "answer": "Organ transplant is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Organ transplant"
  },
  {
    "id": "Medical-4f1779a5",
    "source": "Medical",
    "question": "Is autoimmune disease a risk factor for BCC?",
    "answer": "Autoimmune disease is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Autoimmune disease"
  },
  {
    "id": "Medical-d675eecd",
    "source": "Medical",
    "question": "What is a flat, pale or yellow area on the skin indicative of in BCC?",
    "answer": "A flat, pale or yellow area is a symptom of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Flat pale or yellow area"
  },
  {
    "id": "Medical-7e4192af",
    "source": "Medical",
    "question": "What does a shiny bump on the skin suggest in the context of BCC?",
    "answer": "A shiny bump is a symptom of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Shiny bump"
  },
  {
    "id": "Medical-f8b6c41e",
    "source": "Medical",
    "question": "What is the significance of a brown or glossy black bump with rolled border?",
    "answer": "A brown or glossy black bump with rolled border is a symptom of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Brown or glossy black bump with rolled border"
  },
  {
    "id": "Medical-cef34fff",
    "source": "Medical",
    "question": "Which exams are essential for diagnosing BCC?",
    "answer": "Physical exam and skin exam are essential for diagnosing BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Physical exam, Skin exam"
  },
  {
    "id": "Medical-27280ca7",
    "source": "Medical",
    "question": "What role does biopsy play in BCC diagnosis?",
    "answer": "Biopsy is a diagnostic method for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy"
  },
  {
    "id": "Medical-04249246",
    "source": "Medical",
    "question": "Is imaging sometimes used in the diagnosis of BCC?",
    "answer": "Imaging may be used in the diagnosis of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-3e18a314",
    "source": "Medical",
    "question": "What treatments are available for BCC besides surgery?",
    "answer": "Radiation therapy and systemic therapy are treatments for BCC besides surgery.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-34ad11ec",
    "source": "Medical",
    "question": "How is recurrence of BCC managed?",
    "answer": "Recurrence is managed with treatment options based on risk and recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Management: Treatment options based on risk and recurrence"
  },
  {
    "id": "Medical-74440a6a",
    "source": "Medical",
    "question": "What is included in annual follow-up for BCC patients?",
    "answer": "Annual follow-up includes a full skin exam.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-a296a86b",
    "source": "Medical",
    "question": "What is the primary cancer type discussed in this context?",
    "answer": "Primary CNS lymphoma is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system"
  },
  {
    "id": "Medical-f907720b",
    "source": "Medical",
    "question": "Which cells does primary CNS lymphoma originate from?",
    "answer": "Primary CNS lymphoma originates from lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system"
  },
  {
    "id": "Medical-f80cbf85",
    "source": "Medical",
    "question": "What is the most common location affected by primary CNS lymphoma?",
    "answer": "The brain is most commonly affected by primary CNS lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes"
  },
  {
    "id": "Medical-b3c430ef",
    "source": "Medical",
    "question": "Name a cancer subtype of primary CNS lymphoma that affects the eyes.",
    "answer": "Vitreoretinal lymphoma is a subtype that affects the eyes.",
    "question_type": "Fact Retrieval",
    "evidence": "Vitreoretinal lymphoma is a cancer subtype of primary CNS lymphoma that affects the eyes, retina, and vitreous"
  },
  {
    "id": "Medical-304b0354",
    "source": "Medical",
    "question": "List three anatomical sites, other than the brain, that primary CNS lymphoma can involve.",
    "answer": "Primary CNS lymphoma can involve the spinal cord, cerebrospinal fluid, and eyes.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes"
  },
  {
    "id": "Medical-bc34a6a1",
    "source": "Medical",
    "question": "What is a major risk factor for developing primary CNS lymphoma?",
    "answer": "An impaired immune system is a major risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": "Impaired immune system is a risk factor for primary CNS lymphoma"
  },
  {
    "id": "Medical-b1a95144",
    "source": "Medical",
    "question": "Which viral infection is considered a risk factor for primary CNS lymphoma?",
    "answer": "HIV infection is a risk factor for primary CNS lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Immunodeficiency disorders, HIV infection, Epstein-Barr virus, autoimmune diseases, organ transplant, and older age are risk factors for primary CNS lymphoma"
  },
  {
    "id": "Medical-473eae59",
    "source": "Medical",
    "question": "Name two autoimmune conditions listed as risk factors for primary CNS lymphoma.",
    "answer": "Autoimmune disease and lupus are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor includes Autoimmune disease, Lupus"
  },
  {
    "id": "Medical-1b824083",
    "source": "Medical",
    "question": "Which diagnostic imaging technique is considered most useful for identifying primary CNS lymphoma?",
    "answer": "MRI with gadolinium contrast is the most useful imaging technique.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma"
  },
  {
    "id": "Medical-ba9d39eb",
    "source": "Medical",
    "question": "What is the standard biopsy procedure for diagnosing primary CNS lymphoma?",
    "answer": "Stereotactic biopsy is the standard diagnostic procedure.",
    "question_type": "Fact Retrieval",
    "evidence": "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma"
  },
  {
    "id": "Medical-e306413c",
    "source": "Medical",
    "question": "Which laboratory test is commonly used during the diagnosis of primary CNS lymphoma?",
    "answer": "Complete blood count (CBC) is commonly used.",
    "question_type": "Fact Retrieval",
    "evidence": "Laboratory Tests include Complete blood count (CBC)"
  },
  {
    "id": "Medical-64ef6350",
    "source": "Medical",
    "question": "What is a typical initial clinical assessment for suspected primary CNS lymphoma?",
    "answer": "A neurological exam is a typical initial clinical assessment.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture"
  },
  {
    "id": "Medical-e05d0922",
    "source": "Medical",
    "question": "Which procedure is performed if cancer cells are found in the cerebrospinal fluid?",
    "answer": "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid.",
    "question_type": "Fact Retrieval",
    "evidence": "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid"
  },
  {
    "id": "Medical-1c1492e7",
    "source": "Medical",
    "question": "What specialized treatment is given if the eyes are involved in primary CNS lymphoma?",
    "answer": "Intraocular chemotherapy or radiation may be used if the eyes are involved.",
    "question_type": "Fact Retrieval",
    "evidence": "Intraocular chemotherapy or radiation may be used if the eyes are involved"
  },
  {
    "id": "Medical-dba48e64",
    "source": "Medical",
    "question": "What is the main chemotherapy drug for primary CNS lymphoma?",
    "answer": "High-dose methotrexate is the main chemotherapy drug.",
    "question_type": "Fact Retrieval",
    "evidence": "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma"
  },
  {
    "id": "Medical-f5fc9016",
    "source": "Medical",
    "question": "Which immunotherapy drug is primarily used in the treatment of primary CNS lymphoma?",
    "answer": "Rituximab is the main immunotherapy drug used.",
    "question_type": "Fact Retrieval",
    "evidence": "Rituximab is the main immunotherapy drug used for primary CNS lymphoma"
  },
  {
    "id": "Medical-b80bf4c5",
    "source": "Medical",
    "question": "What is the most commonly used radiation technique for primary CNS lymphoma?",
    "answer": "Whole-brain radiation therapy (WBRT) is the most commonly used technique.",
    "question_type": "Fact Retrieval",
    "evidence": "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma"
  },
  {
    "id": "Medical-3978515f",
    "source": "Medical",
    "question": "What are the two main treatment phases for primary CNS lymphoma?",
    "answer": "Treatment is typically given in phases: induction and consolidation.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment is typically given in phases: induction and consolidation"
  },
  {
    "id": "Medical-afabde7f",
    "source": "Medical",
    "question": "What is the purpose of supportive care in primary CNS lymphoma management?",
    "answer": "Supportive care is provided to relieve symptoms and side effects at any stage of disease.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive care is provided to relieve symptoms and side effects at any stage of disease"
  },
  {
    "id": "Medical-a4081e18",
    "source": "Medical",
    "question": "Which performance measure is evaluated to guide treatment decisions in primary CNS lymphoma?",
    "answer": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials"
  },
  {
    "id": "Medical-79a788b8",
    "source": "Medical",
    "question": "What is recommended for all patients with primary CNS lymphoma regarding research participation?",
    "answer": "Clinical trial participation is recommended for all patients.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trial participation is recommended for all patients with primary CNS lymphoma"
  },
  {
    "id": "Medical-c99256ce",
    "source": "Medical",
    "question": "Name three neurological symptoms commonly caused by primary CNS lymphoma.",
    "answer": "Leg weakness, confusion, and seizures are common neurological symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma can cause neurological symptoms such as leg or arm weakness, coordination or movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes"
  },
  {
    "id": "Medical-7b5a8ac6",
    "source": "Medical",
    "question": "Which diagnostic method is used to assess eye involvement in primary CNS lymphoma?",
    "answer": "Eye exam is used to assess eye involvement.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture"
  },
  {
    "id": "Medical-26033837",
    "source": "Medical",
    "question": "What follow-up method is recommended for surveillance after treatment of primary CNS lymphoma?",
    "answer": "Repeat MRI is recommended for follow-up surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up/Surveillance includes Repeat MRI"
  },
  {
    "id": "Medical-9f3a0a90",
    "source": "Medical",
    "question": "Which age group is at higher risk for primary CNS lymphoma?",
    "answer": "Older adults are at higher risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Older age is a risk factor for primary CNS lymphoma"
  },
  {
    "id": "Medical-f619b6ea",
    "source": "Medical",
    "question": "What is the role of corticosteroids in the treatment of primary CNS lymphoma?",
    "answer": "Corticosteroids are one of the treatment options for primary CNS lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment options for primary CNS lymphoma include corticosteroids, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell rescue, and supportive care"
  },
  {
    "id": "Medical-9474c5bb",
    "source": "Medical",
    "question": "Which chemotherapy drugs, besides methotrexate, can be used in induction therapy for primary CNS lymphoma?",
    "answer": "Temozolomide, vincristine, procarbazine, cytarabine, pemetrexed, pomalidomide, lenalidomide, and ibrutinib can be used.",
    "question_type": "Fact Retrieval",
    "evidence": "Induction phase includes High-dose methotrexate, Rituximab, Temozolomide, Vincristine, Procarbazine, Cytarabine, Pemetrexed, Pomalidomide, Lenalidomide, Ibrutinib, Clinical trial"
  },
  {
    "id": "Medical-5825991f",
    "source": "Medical",
    "question": "Which procedure is included in laboratory tests for diagnosing primary CNS lymphoma?",
    "answer": "Lactate dehydrogenase (LDH) testing is included in laboratory tests.",
    "question_type": "Fact Retrieval",
    "evidence": "Laboratory Tests include Lactate dehydrogenase (LDH)"
  },
  {
    "id": "Medical-a4dcffa3",
    "source": "Medical",
    "question": "What is a potential site of relapse for primary CNS lymphoma?",
    "answer": "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes"
  },
  {
    "id": "Medical-3919018c",
    "source": "Medical",
    "question": "How often does primary CNS lymphoma spread outside the central nervous system?",
    "answer": "Primary CNS lymphoma rarely spreads outside the central nervous system.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary CNS lymphoma rarely spreads outside the central nervous system"
  },
  {
    "id": "Medical-d7180179",
    "source": "Medical",
    "question": "Which imaging technique uses gadolinium contrast for better visualization in primary CNS lymphoma?",
    "answer": "MRI uses gadolinium contrast for better visualization.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma"
  },
  {
    "id": "Medical-f05a2e9b",
    "source": "Medical",
    "question": "What supportive care interventions are recommended for patients with primary CNS lymphoma?",
    "answer": "Symptom management, palliative care, and quality of life interventions are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive Care includes Symptom management, Palliative care, Quality of life interventions"
  },
  {
    "id": "Medical-5b1265c0",
    "source": "Medical",
    "question": "What is the second most common type of skin cancer?",
    "answer": "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer"
  },
  {
    "id": "Medical-d1e50927",
    "source": "Medical",
    "question": "Which cancer subtype is classified as a type of nonmelanoma skin cancer?",
    "answer": "CSCC is a type of nonmelanoma skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "CSCC is a type of nonmelanoma skin cancer"
  },
  {
    "id": "Medical-9536f8e7",
    "source": "Medical",
    "question": "What are the main stages of cutaneous squamous cell carcinoma (CSCC)?",
    "answer": "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread).",
    "question_type": "Fact Retrieval",
    "evidence": "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread)"
  },
  {
    "id": "Medical-1f290988",
    "source": "Medical",
    "question": "What is a precancerous lesion that can progress to CSCC?",
    "answer": "Actinic keratosis is a precancerous lesion that can progress to CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Actinic keratosis is a precancerous lesion that can progress to CSCC"
  },
  {
    "id": "Medical-3d21bfb3",
    "source": "Medical",
    "question": "Which risk factors are major contributors to CSCC development?",
    "answer": "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars.",
    "question_type": "Fact Retrieval",
    "evidence": "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars"
  },
  {
    "id": "Medical-a2555661",
    "source": "Medical",
    "question": "Which genetic syndromes increase the risk for CSCC?",
    "answer": "Xeroderma pigmentosum and RDEB increase risk for CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC"
  },
  {
    "id": "Medical-8866282b",
    "source": "Medical",
    "question": "What are common symptoms of CSCC?",
    "answer": "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage"
  },
  {
    "id": "Medical-77287c53",
    "source": "Medical",
    "question": "Which methods are used to diagnose CSCC?",
    "answer": "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected"
  },
  {
    "id": "Medical-d9522675",
    "source": "Medical",
    "question": "What biopsy types are used in the diagnosis of CSCC?",
    "answer": "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy"
  },
  {
    "id": "Medical-8fe8663f",
    "source": "Medical",
    "question": "What are the preferred treatments for low-risk local CSCC?",
    "answer": "Low-risk local CSCC is primarily treated with surgery (C&E, standard excision, Mohs surgery/PDEMA).",
    "question_type": "Fact Retrieval",
    "evidence": "Low-risk local CSCC is primarily treated with surgery (C&E, standard excision, Mohs surgery/PDEMA)"
  },
  {
    "id": "Medical-c421a232",
    "source": "Medical",
    "question": "Which treatment options are considered for high-risk or very high-risk local CSCC?",
    "answer": "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible.",
    "question_type": "Fact Retrieval",
    "evidence": "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
  },
  {
    "id": "Medical-203a2d6b",
    "source": "Medical",
    "question": "How is regional CSCC with lymph node involvement treated?",
    "answer": "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy"
  },
  {
    "id": "Medical-dc52ffce",
    "source": "Medical",
    "question": "What is the preferred treatment for metastatic CSCC?",
    "answer": "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible"
  },
  {
    "id": "Medical-0d21d2d6",
    "source": "Medical",
    "question": "Which systemic therapies are used for advanced CSCC?",
    "answer": "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab).",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)"
  },
  {
    "id": "Medical-bfa9a27b",
    "source": "Medical",
    "question": "What therapies are used for actinic keratoses and superficial CSCC?",
    "answer": "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC"
  },
  {
    "id": "Medical-8d545fa4",
    "source": "Medical",
    "question": "What is the recommended follow-up strategy after CSCC treatment?",
    "answer": "Follow-up after treatment includes regular skin and lymph node exams, with frequency based on risk and stage.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up after treatment includes regular skin and lymph node exams, with frequency based on risk and stage"
  },
  {
    "id": "Medical-6a38af6d",
    "source": "Medical",
    "question": "What is a key biomarker used in risk assessment for CSCC?",
    "answer": "Perineural invasion is a key biomarker for CSCC risk assessment.",
    "question_type": "Fact Retrieval",
    "evidence": "Perineural invasion is listed as a biomarker in the ontology for CSCC"
  },
  {
    "id": "Medical-eac1c791",
    "source": "Medical",
    "question": "Which environmental toxins are risk factors for CSCC?",
    "answer": "Environmental toxins such as arsenic and tobacco smoke are risk factors for CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Environmental toxins (arsenic, tobacco smoke) are listed as risk factors for CSCC"
  },
  {
    "id": "Medical-8bf3a99b",
    "source": "Medical",
    "question": "How is risk assessment for CSCC performed?",
    "answer": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status"
  },
  {
    "id": "Medical-c8c9c0ee",
    "source": "Medical",
    "question": "Which imaging modalities are used for staging and surveillance in CSCC?",
    "answer": "Imaging (CT, MRI, PET/CT) is used for staging and surveillance in regional and high-risk cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging is used for staging and surveillance in regional and high-risk cases"
  },
  {
    "id": "Medical-b1ab4938",
    "source": "Medical",
    "question": "What follow-up schedule is recommended for high-risk local CSCC after treatment?",
    "answer": "Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months"
  },
  {
    "id": "Medical-1edadd2a",
    "source": "Medical",
    "question": "What are the main symptoms of CSCC in areas of chronic damage?",
    "answer": "Lesions in areas of chronic wounds or scars are a main symptom of CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of CSCC include lesions in areas of chronic damage"
  },
  {
    "id": "Medical-59292b3b",
    "source": "Medical",
    "question": "Which topical therapies are used for actinic keratosis?",
    "answer": "Topical therapies for actinic keratosis include 5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, and diclofenac.",
    "question_type": "Fact Retrieval",
    "evidence": "Topical therapy (5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, diclofenac) is listed for actinic keratosis"
  },
  {
    "id": "Medical-909f9360",
    "source": "Medical",
    "question": "What is the preferred surgical method for high-risk local CSCC?",
    "answer": "Mohs surgery/PDEMA is the preferred surgical method for high-risk local CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Mohs surgery/PDEMA (preferred) is listed for high-risk local CSCC"
  },
  {
    "id": "Medical-9a719269",
    "source": "Medical",
    "question": "Which patients are recommended to consider clinical trials in CSCC management?",
    "answer": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC"
  },
  {
    "id": "Medical-f10f3bc4",
    "source": "Medical",
    "question": "What is the role of sentinel lymph node biopsy (SLNB) in CSCC?",
    "answer": "Sentinel lymph node biopsy (SLNB) is used as a diagnostic method in regional CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Lymph node biopsy (FNA, core needle biopsy) is listed as a diagnostic method for regional CSCC in the ontology"
  },
  {
    "id": "Medical-d8a3772b",
    "source": "Medical",
    "question": "Which immunotherapy agents are used for metastatic CSCC?",
    "answer": "PD-1 inhibitors such as cemiplimab and pembrolizumab are used for metastatic CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "PD-1 inhibitors (cemiplimab, pembrolizumab) are listed as systemic therapy options for metastatic CSCC"
  },
  {
    "id": "Medical-2a0d5063",
    "source": "Medical",
    "question": "How often should skin and lymph node exams be performed for low-risk local CSCC during the first 2 years after treatment?",
    "answer": "Skin and lymph node exams every 3-12 months for 2 years are recommended for low-risk local CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Skin and lymph node exams every 3-12 months for 2 years for low-risk local CSCC"
  },
  {
    "id": "Medical-ff41533a",
    "source": "Medical",
    "question": "What is the preferred systemic therapy for metastatic CSCC?",
    "answer": "PD-1 inhibitor is the preferred systemic therapy for metastatic CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy (PD-1 inhibitor preferred) is listed for metastatic CSCC"
  },
  {
    "id": "Medical-c87c6baf",
    "source": "Medical",
    "question": "Which factors are included in clinical management risk assessment for CSCC?",
    "answer": "Risk assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, and immunosuppression.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, immunosuppression"
  },
  {
    "id": "Medical-3e2b82f5",
    "source": "Medical",
    "question": "Which clinical management strategy is used for surveillance in high-risk or regional CSCC?",
    "answer": "Surveillance involves regular skin and lymph node exams and imaging for high-risk or regional disease.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance: Regular skin and lymph node exams, imaging for high-risk or regional disease"
  },
  {
    "id": "Medical-0c8340a1",
    "source": "Medical",
    "question": "What type of cancer is chronic myeloid leukemia (CML)?",
    "answer": "CML is a type of blood cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Chronic myeloid leukemia (CML) is a type of blood cancer"
  },
  {
    "id": "Medical-9b293f2c",
    "source": "Medical",
    "question": "What genetic alteration causes chronic myeloid leukemia?",
    "answer": "CML is caused by the BCR::ABL1 fusion gene.",
    "question_type": "Fact Retrieval",
    "evidence": "CML is caused by the BCR::ABL1 fusion gene"
  },
  {
    "id": "Medical-e49be454",
    "source": "Medical",
    "question": "Which chromosomal translocation results in the BCR::ABL1 gene?",
    "answer": "A translocation between chromosome 9 and chromosome 22 creates the BCR::ABL1 gene.",
    "question_type": "Fact Retrieval",
    "evidence": "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22"
  },
  {
    "id": "Medical-c97b2e2b",
    "source": "Medical",
    "question": "What is the Philadelphia chromosome?",
    "answer": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from the translocation.",
    "question_type": "Fact Retrieval",
    "evidence": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation"
  },
  {
    "id": "Medical-e5676a79",
    "source": "Medical",
    "question": "What is required for a diagnosis of CML?",
    "answer": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
  },
  {
    "id": "Medical-fad73295",
    "source": "Medical",
    "question": "From which cells does CML arise?",
    "answer": "CML arises from blood stem cells producing increased myeloid progenitor cells.",
    "question_type": "Fact Retrieval",
    "evidence": "CML arises from blood stem cells producing increased myeloid progenitor cells"
  },
  {
    "id": "Medical-77457615",
    "source": "Medical",
    "question": "What are the two main diagnostic methods for CML?",
    "answer": "Blood tests and bone marrow tests are used to diagnose CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests and bone marrow tests are used to diagnose CML"
  },
  {
    "id": "Medical-9fb94929",
    "source": "Medical",
    "question": "Which biomarker is associated with CML?",
    "answer": "The BCR::ABL1 fusion gene is a biomarker for CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker: BCR::ABL1 fusion gene"
  },
  {
    "id": "Medical-b3eac8b2",
    "source": "Medical",
    "question": "What is the abnormal chromosome found in most CML cases?",
    "answer": "The Philadelphia chromosome (Ph) is the abnormal chromosome found in CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker: Philadelphia chromosome (Ph)"
  },
  {
    "id": "Medical-72a77731",
    "source": "Medical",
    "question": "What is the primary treatment goal for CML?",
    "answer": "Treatment for CML aims to inhibit BCR::ABL1 protein activity.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
  },
  {
    "id": "Medical-5fe38d4e",
    "source": "Medical",
    "question": "Which blood cell types are increased in CML?",
    "answer": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts.",
    "question_type": "Fact Retrieval",
    "evidence": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts"
  },
  {
    "id": "Medical-69537d43",
    "source": "Medical",
    "question": "What is blast phase CML?",
    "answer": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts.",
    "question_type": "Fact Retrieval",
    "evidence": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts"
  },
  {
    "id": "Medical-6d738949",
    "source": "Medical",
    "question": "Which chromosomes are involved in the translocation that creates the BCR::ABL1 fusion gene?",
    "answer": "Chromosome 9 and chromosome 22 are involved in the translocation.",
    "question_type": "Fact Retrieval",
    "evidence": "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22"
  },
  {
    "id": "Medical-7da67d67",
    "source": "Medical",
    "question": "What is the abnormality found on chromosome 22 in CML?",
    "answer": "The Philadelphia chromosome (Ph) is the abnormality found on chromosome 22.",
    "question_type": "Fact Retrieval",
    "evidence": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation"
  },
  {
    "id": "Medical-3170a5f2",
    "source": "Medical",
    "question": "Which fusion gene is necessary for the diagnosis of CML?",
    "answer": "The BCR::ABL1 fusion gene is necessary for the diagnosis of CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
  },
  {
    "id": "Medical-dc60c354",
    "source": "Medical",
    "question": "Which phase of CML is considered advanced?",
    "answer": "Blast phase CML (BP-CML) is considered advanced.",
    "question_type": "Fact Retrieval",
    "evidence": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts"
  },
  {
    "id": "Medical-62a9b979",
    "source": "Medical",
    "question": "Which blood cell type is produced in increased numbers in CML?",
    "answer": "Myeloid progenitor cells are produced in increased numbers in CML.",
    "question_type": "Fact Retrieval",
    "evidence": "CML arises from blood stem cells producing increased myeloid progenitor cells"
  },
  {
    "id": "Medical-57375967",
    "source": "Medical",
    "question": "What are the main white blood cell subtypes involved in CML?",
    "answer": "Granulocytes, including neutrophils, eosinophils, and basophils, are involved in CML.",
    "question_type": "Fact Retrieval",
    "evidence": "White blood cells (WBCs): granulocytes, neutrophils, eosinophils, basophils"
  },
  {
    "id": "Medical-7044a5ef",
    "source": "Medical",
    "question": "Which diagnostic tests are used to detect the BCR::ABL1 fusion gene?",
    "answer": "Blood test and bone marrow test are used to detect the BCR::ABL1 fusion gene.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: blood test, bone marrow test"
  },
  {
    "id": "Medical-c2ab6e9a",
    "source": "Medical",
    "question": "What chromosomal abnormality is characteristic of CML?",
    "answer": "The Philadelphia chromosome (Ph) is characteristic of CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Chromosomal Abnormality: Philadelphia chromosome (Ph)"
  },
  {
    "id": "Medical-61ec9250",
    "source": "Medical",
    "question": "Which treatment strategy targets the abnormal protein in CML?",
    "answer": "BCR::ABL1 protein inhibition is the treatment strategy.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment: BCR::ABL1 protein inhibition"
  },
  {
    "id": "Medical-cbbc0e25",
    "source": "Medical",
    "question": "What is the result of the translocation between chromosome 9 and 22?",
    "answer": "The result is the formation of the Philadelphia chromosome (Ph) and the BCR::ABL1 fusion gene.",
    "question_type": "Fact Retrieval",
    "evidence": "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22"
  },
  {
    "id": "Medical-5c8f25b0",
    "source": "Medical",
    "question": "Which phase of CML is associated with increased blasts in the blood or bone marrow?",
    "answer": "Blast phase CML (BP-CML) is associated with increased blasts.",
    "question_type": "Fact Retrieval",
    "evidence": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts"
  },
  {
    "id": "Medical-9b7aadb2",
    "source": "Medical",
    "question": "Which two main laboratory methods are used for CML diagnosis?",
    "answer": "Blood test and bone marrow test are the main methods.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests and bone marrow tests are used to diagnose CML"
  },
  {
    "id": "Medical-f18cea43",
    "source": "Medical",
    "question": "What is the relationship between the Philadelphia chromosome and the BCR::ABL1 fusion gene?",
    "answer": "The Philadelphia chromosome contains the BCR::ABL1 fusion gene.",
    "question_type": "Fact Retrieval",
    "evidence": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation"
  },
  {
    "id": "Medical-e2848d7f",
    "source": "Medical",
    "question": "Which blood cell types may show abnormal counts in CML?",
    "answer": "White blood cells (granulocytes) and platelets (PLTs) may show abnormal counts.",
    "question_type": "Fact Retrieval",
    "evidence": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts"
  },
  {
    "id": "Medical-e1b6447e",
    "source": "Medical",
    "question": "What is the role of blood stem cells in CML?",
    "answer": "Blood stem cells give rise to increased myeloid progenitor cells in CML.",
    "question_type": "Fact Retrieval",
    "evidence": "CML arises from blood stem cells producing increased myeloid progenitor cells"
  },
  {
    "id": "Medical-7db5b20d",
    "source": "Medical",
    "question": "Which progenitor cells are increased in blast phase CML?",
    "answer": "Myeloid progenitor cells, lymphoid progenitor cells, and blasts are increased in blast phase CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Blast phase CML (BP-CML): Blood Cell Type: myeloid progenitor cells, lymphoid progenitor cells, blasts"
  },
  {
    "id": "Medical-ea3d4859",
    "source": "Medical",
    "question": "Which chromosomes are specifically mentioned as being involved in CML pathogenesis?",
    "answer": "Chromosome 9 and chromosome 22 are involved.",
    "question_type": "Fact Retrieval",
    "evidence": "Chromosomal Abnormality: chromosome 9, chromosome 22"
  },
  {
    "id": "Medical-8109c3aa",
    "source": "Medical",
    "question": "What is the function of BCR::ABL1 protein inhibition in CML treatment?",
    "answer": "It is the primary treatment approach for CML.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
  },
  {
    "id": "Medical-ba894e2c",
    "source": "Medical",
    "question": "Which two biomarkers are most relevant for CML diagnosis?",
    "answer": "The BCR::ABL1 fusion gene and the Philadelphia chromosome (Ph) are most relevant.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker: BCR::ABL1 fusion gene, Philadelphia chromosome (Ph)"
  },
  {
    "id": "Medical-622cb4e3",
    "source": "Medical",
    "question": "What is the most common type of lung cancer?",
    "answer": "NSCLC is the most common type of lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "NSCLC is the most common type of lung cancer"
  },
  {
    "id": "Medical-42f1975a",
    "source": "Medical",
    "question": "Which cancer subtypes are included under NSCLC?",
    "answer": "Adenocarcinoma, squamous cell carcinoma, and large cell carcinoma are subtypes of NSCLC.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenocarcinoma, squamous cell carcinoma, and large cell carcinoma are subtypes of NSCLC"
  },
  {
    "id": "Medical-419cadfe",
    "source": "Medical",
    "question": "What type of cells does adenocarcinoma often form from?",
    "answer": "Adenocarcinoma often forms from cells that line the alveoli and make mucus.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenocarcinoma often forms from cells that line the alveoli and make mucus"
  },
  {
    "id": "Medical-8be16d47",
    "source": "Medical",
    "question": "Which cells do squamous cell carcinoma originate from?",
    "answer": "Squamous cell carcinoma forms from cells that line the bronchi.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell carcinoma forms from cells that line the bronchi"
  },
  {
    "id": "Medical-9e7500a0",
    "source": "Medical",
    "question": "What is the origin of large cell carcinoma in NSCLC?",
    "answer": "Large cell carcinoma forms from large cells found throughout the airways.",
    "question_type": "Fact Retrieval",
    "evidence": "Large cell carcinoma forms from large cells found throughout the airways"
  },
  {
    "id": "Medical-a61abd42",
    "source": "Medical",
    "question": "How is Stage 1 NSCLC classified?",
    "answer": "Stage 1 NSCLC is considered early stage.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 1 NSCLC is considered early stage"
  },
  {
    "id": "Medical-74016ca7",
    "source": "Medical",
    "question": "What stages of NSCLC are considered locally advanced?",
    "answer": "Stage 2 and Stage 3 NSCLC are considered locally advanced.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 2 and Stage 3 NSCLC are considered locally advanced"
  },
  {
    "id": "Medical-bffd01c2",
    "source": "Medical",
    "question": "What is the classification of Stage 4 NSCLC at diagnosis?",
    "answer": "Stage 4 NSCLC is metastatic at diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 4 NSCLC is metastatic at diagnosis"
  },
  {
    "id": "Medical-ef451592",
    "source": "Medical",
    "question": "Has early and locally advanced NSCLC spread to other organs at diagnosis?",
    "answer": "Early and locally advanced NSCLC have not spread to the tissue lining around the lung or to other organs at diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Early and locally advanced NSCLC have not spread to the tissue lining around the lung or to other organs at diagnosis"
  },
  {
    "id": "Medical-e1aa3f36",
    "source": "Medical",
    "question": "What is the primary treatment for early or locally advanced NSCLC when possible?",
    "answer": "Surgery is a primary treatment for early or locally advanced NSCLC when possible.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is a primary treatment for early or locally advanced NSCLC when possible"
  },
  {
    "id": "Medical-83b8a631",
    "source": "Medical",
    "question": "Which treatment is used for some early NSCLC cases?",
    "answer": "Radiation therapy is used for some early NSCLC cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy is used for some early NSCLC cases"
  },
  {
    "id": "Medical-2c702150",
    "source": "Medical",
    "question": "What treatment is used for some locally advanced NSCLC cases?",
    "answer": "Chemoradiation is used for some locally advanced NSCLC cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemoradiation is used for some locally advanced NSCLC cases"
  },
  {
    "id": "Medical-5bae1c96",
    "source": "Medical",
    "question": "What type of care extends and enhances life for people with lung cancer?",
    "answer": "Supportive care extends and enhances life for people with lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive care extends and enhances life for people with lung cancer"
  },
  {
    "id": "Medical-a5c06d63",
    "source": "Medical",
    "question": "How may lung nodules be detected?",
    "answer": "Lung nodules may be detected by imaging.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung nodules may be detected by imaging and require further assessment to determine malignancy"
  },
  {
    "id": "Medical-4de99f79",
    "source": "Medical",
    "question": "What diagnostic method is used to confirm lung cancer diagnosis?",
    "answer": "Biopsy is used to confirm lung cancer diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is used to confirm lung cancer diagnosis"
  },
  {
    "id": "Medical-ebb0af4d",
    "source": "Medical",
    "question": "Who is recommended to undergo lung cancer screening?",
    "answer": "Lung cancer screening is recommended for people at high risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung cancer screening is recommended for people at high risk"
  },
  {
    "id": "Medical-8217a825",
    "source": "Medical",
    "question": "What is the biggest risk factor for lung cancer?",
    "answer": "Tobacco smoking is the biggest risk factor for lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Tobacco smoking is the biggest risk factor for lung cancer"
  },
  {
    "id": "Medical-0cb322e0",
    "source": "Medical",
    "question": "Does exposure to second-hand smoke affect lung cancer risk?",
    "answer": "Exposure to second-hand smoke increases lung cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Exposure to second-hand smoke increases lung cancer risk"
  },
  {
    "id": "Medical-64042235",
    "source": "Medical",
    "question": "List environmental risk factors for lung cancer besides tobacco.",
    "answer": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer"
  },
  {
    "id": "Medical-b4100b78",
    "source": "Medical",
    "question": "What is the aim of lung cancer screening?",
    "answer": "Lung cancer screening aims to detect cancer at an early, more treatable stage.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung cancer screening aims to detect cancer at an early, more treatable stage"
  },
  {
    "id": "Medical-d2bac092",
    "source": "Medical",
    "question": "What are common symptoms of lung cancer?",
    "answer": "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms"
  },
  {
    "id": "Medical-eab59fae",
    "source": "Medical",
    "question": "Are clinical trials available for lung cancer treatment and prevention?",
    "answer": "Clinical trials are available for lung cancer treatment and prevention.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are available for lung cancer treatment and prevention"
  },
  {
    "id": "Medical-61cf41ee",
    "source": "Medical",
    "question": "What does follow-up care after lung cancer treatment include?",
    "answer": "Follow-up care is planned after treatment and includes surveillance for recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up care is planned after treatment and includes surveillance for recurrence"
  },
  {
    "id": "Medical-09d21113",
    "source": "Medical",
    "question": "Which imaging method is used to detect lung nodules?",
    "answer": "Imaging is used to detect lung nodules.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung nodules may be detected by imaging"
  },
  {
    "id": "Medical-1b7a0e02",
    "source": "Medical",
    "question": "How are lung nodules assessed for malignancy?",
    "answer": "Lung nodules are assessed by biopsy and lung cancer screening.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung nodules may be detected by imaging and require further assessment to determine malignancy"
  },
  {
    "id": "Medical-b77be62e",
    "source": "Medical",
    "question": "What is the indication for lung cancer screening?",
    "answer": "Lung cancer screening is indicated for high risk individuals.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung cancer screening is recommended for people at high risk"
  },
  {
    "id": "Medical-752ca0c2",
    "source": "Medical",
    "question": "What is the purpose of lung cancer screening?",
    "answer": "The purpose of lung cancer screening is early detection.",
    "question_type": "Fact Retrieval",
    "evidence": "Lung cancer screening aims to detect cancer at an early, more treatable stage"
  },
  {
    "id": "Medical-4ae5ec38",
    "source": "Medical",
    "question": "What are the main treatments for NSCLC?",
    "answer": "The main treatments for NSCLC are surgery, radiation therapy, chemoradiation, supportive care, and clinical trial.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for NSCLC includes surgery, radiation therapy, chemoradiation, supportive care, and clinical trial"
  },
  {
    "id": "Medical-2f2b791e",
    "source": "Medical",
    "question": "Which symptoms are specifically associated with NSCLC?",
    "answer": "Cough and chest pain are symptoms associated with NSCLC.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of NSCLC include cough and chest pain"
  },
  {
    "id": "Medical-563587c2",
    "source": "Medical",
    "question": "What are the follow-up strategies for NSCLC after treatment?",
    "answer": "Follow-up strategies for NSCLC include follow-up care and surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up Strategy for NSCLC includes follow-up care and surveillance"
  },
  {
    "id": "Medical-6aaabde4",
    "source": "Medical",
    "question": "What is the relationship between NSCLC and lung carcinoma?",
    "answer": "NSCLC is a type of lung carcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": "NSCLC is a type of lung carcinoma"
  },
  {
    "id": "Medical-2e9466a9",
    "source": "Medical",
    "question": "What type of cancer is nasopharyngeal carcinoma (NPC)?",
    "answer": "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx.",
    "question_type": "Fact Retrieval",
    "evidence": "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx"
  },
  {
    "id": "Medical-d2746bf8",
    "source": "Medical",
    "question": "What is the most common subtype of nasopharyngeal cancer?",
    "answer": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer"
  },
  {
    "id": "Medical-75f181e8",
    "source": "Medical",
    "question": "Which anatomical site is affected by nasopharyngeal carcinoma?",
    "answer": "Nasopharyngeal carcinoma affects the nasopharynx.",
    "question_type": "Fact Retrieval",
    "evidence": "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx"
  },
  {
    "id": "Medical-de0767ce",
    "source": "Medical",
    "question": "What system is used to stage nasopharyngeal carcinoma?",
    "answer": "NPC is staged using the AJCC TNM system.",
    "question_type": "Fact Retrieval",
    "evidence": "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M)"
  },
  {
    "id": "Medical-d5c10dcf",
    "source": "Medical",
    "question": "Name the main numbered stages used for nasopharyngeal carcinoma.",
    "answer": "The main numbered stages are Stage 0, Stage I, Stage II, Stage III, and Stage IV.",
    "question_type": "Fact Retrieval",
    "evidence": "Numbered Stages: [\"Stage 0\", \"Stage I\", \"Stage II\", \"Stage III\", \"Stage IV\"]"
  },
  {
    "id": "Medical-bb9550cb",
    "source": "Medical",
    "question": "Which virus is most commonly associated with nasopharyngeal carcinoma?",
    "answer": "Epstein-Barr virus (EBV) is most commonly associated with NPC.",
    "question_type": "Fact Retrieval",
    "evidence": "Most NPCs are related to Epstein-Barr virus (EBV) infection"
  },
  {
    "id": "Medical-85c57bc9",
    "source": "Medical",
    "question": "List two risk factors for nasopharyngeal carcinoma.",
    "answer": "Epstein-Barr virus (EBV) infection and tobacco use are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor: [\"Epstein-Barr virus (EBV)\", \"Tobacco use\", \"Alcohol use\", \"Geographic origin (Asia, Native America, North Africa)\"]"
  },
  {
    "id": "Medical-4196794d",
    "source": "Medical",
    "question": "Which geographic regions have higher rates of nasopharyngeal carcinoma?",
    "answer": "NPC most often occurs in people from parts of Asia, Native America, and North Africa.",
    "question_type": "Fact Retrieval",
    "evidence": "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
  },
  {
    "id": "Medical-c5bc82ff",
    "source": "Medical",
    "question": "What are two common symptoms of nasopharyngeal carcinoma?",
    "answer": "Enlarged lymph nodes and hearing loss are common symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom: [\"Enlarged lymph nodes\", \"Hearing loss\", \"Symptoms may be absent until advanced stage\"]"
  },
  {
    "id": "Medical-51e5f06f",
    "source": "Medical",
    "question": "Which imaging methods are used for diagnosis of NPC?",
    "answer": "CT scan, MRI, PET/CT, and ultrasound are used for diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy"
  },
  {
    "id": "Medical-28f101b7",
    "source": "Medical",
    "question": "What is the role of biopsy in diagnosing nasopharyngeal carcinoma?",
    "answer": "Biopsy confirms diagnosis and determines cancer subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy confirms diagnosis and determines cancer subtype"
  },
  {
    "id": "Medical-8f64cf43",
    "source": "Medical",
    "question": "Which biomarker tests are recommended for nasopharyngeal carcinoma?",
    "answer": "EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden are recommended biomarker tests.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden"
  },
  {
    "id": "Medical-49ff508e",
    "source": "Medical",
    "question": "Which performance measure is considered in NPC treatment planning?",
    "answer": "Performance status is considered in NPC treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status is considered in NPC treatment planning"
  },
  {
    "id": "Medical-debec9f1",
    "source": "Medical",
    "question": "What are the possible classifications of nasopharyngeal carcinoma based on extent of disease?",
    "answer": "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic.",
    "question_type": "Fact Retrieval",
    "evidence": "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic based on extent of disease"
  },
  {
    "id": "Medical-2f8ada62",
    "source": "Medical",
    "question": "Which organs are common sites for metastasis from nasopharyngeal carcinoma?",
    "answer": "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs.",
    "question_type": "Fact Retrieval",
    "evidence": "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs"
  },
  {
    "id": "Medical-b696a6b5",
    "source": "Medical",
    "question": "What is the purpose of EBV DNA testing in NPC?",
    "answer": "EBV DNA testing is performed before and after treatment for NPC.",
    "question_type": "Fact Retrieval",
    "evidence": "EBV DNA testing is performed before and after treatment for NPC"
  },
  {
    "id": "Medical-fea8a757",
    "source": "Medical",
    "question": "Which diagnostic methods are included in the initial evaluation of NPC?",
    "answer": "Medical history, physical exam, imaging, and biopsy are included in the initial evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy"
  },
  {
    "id": "Medical-41723902",
    "source": "Medical",
    "question": "How is the cancer subtype determined in NPC?",
    "answer": "Biopsy determines cancer subtype in NPC.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy confirms diagnosis and determines cancer subtype"
  },
  {
    "id": "Medical-558d306b",
    "source": "Medical",
    "question": "Which imaging tests are used for surveillance of NPC?",
    "answer": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance"
  },
  {
    "id": "Medical-806207e1",
    "source": "Medical",
    "question": "What are the different types of biopsy used for NPC diagnosis?",
    "answer": "Fine-needle aspiration (FNA), fine-needle biopsy (FNB), and core needle biopsy (CNB) are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: [\"Biopsy\", [\"Fine-needle aspiration (FNA)\", \"Fine-needle biopsy (FNB)\", \"Core needle biopsy (CNB)\"]]"
  },
  {
    "id": "Medical-0155c059",
    "source": "Medical",
    "question": "Which factors are considered prognostic in NPC?",
    "answer": "EBV DNA level and performance status are prognostic factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Prognostic Factor: [\"EBV DNA level\", \"Performance status\"]"
  },
  {
    "id": "Medical-d964c7f3",
    "source": "Medical",
    "question": "What fertility consideration should be discussed before NPC therapy?",
    "answer": "Fertility may be affected by NPC treatment and should be discussed before therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility may be affected by NPC treatment and should be discussed before therapy"
  },
  {
    "id": "Medical-4482bd32",
    "source": "Medical",
    "question": "Which assessments are recommended before starting NPC treatment?",
    "answer": "Dental exam, nutrition assessment, and speech and swallowing assessment are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: [\"Dental exam\", \"Nutrition assessment\", \"Speech and swallowing assessment\"]"
  },
  {
    "id": "Medical-ecfaba9c",
    "source": "Medical",
    "question": "What is the impact of head and neck cancer treatment on dental health?",
    "answer": "Dental health can be affected by head and neck cancer and its treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Dental health can be affected by head and neck cancer and its treatment"
  },
  {
    "id": "Medical-adb77b8f",
    "source": "Medical",
    "question": "What is the role of imaging in NPC management?",
    "answer": "Imaging is used for staging and surveillance of NPC.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance"
  },
  {
    "id": "Medical-7409b4bb",
    "source": "Medical",
    "question": "What are the main components of the AJCC TNM system for NPC staging?",
    "answer": "The AJCC TNM system includes tumor size (T), lymph node involvement (N), and distant metastasis (M).",
    "question_type": "Fact Retrieval",
    "evidence": "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M)"
  },
  {
    "id": "Medical-6b0b36c7",
    "source": "Medical",
    "question": "Which populations are at increased risk for NPC due to geographic origin?",
    "answer": "People from Asia, Native America, and North Africa are at increased risk.",
    "question_type": "Fact Retrieval",
    "evidence": "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
  },
  {
    "id": "Medical-5d011928",
    "source": "Medical",
    "question": "What is the significance of symptoms being absent until advanced stage in NPC?",
    "answer": "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions"
  },
  {
    "id": "Medical-07e567d4",
    "source": "Medical",
    "question": "Which biomarker is tested both before and after NPC treatment?",
    "answer": "EBV DNA is tested both before and after NPC treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "EBV DNA testing is performed before and after treatment for NPC"
  },
  {
    "id": "Medical-554369df",
    "source": "Medical",
    "question": "Which additional counseling is recommended for patients concerned about fertility before NPC treatment?",
    "answer": "Fertility counseling is recommended before NPC treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility counseling"
  },
  {
    "id": "Medical-cb2502ae",
    "source": "Medical",
    "question": "What is the primary cancer subtype found in the nasopharynx?",
    "answer": "Nasopharyngeal carcinoma (NPC) is the primary cancer subtype found in the nasopharynx.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer Subtype: {\"Nasopharyngeal carcinoma (NPC)\"}"
  },
  {
    "id": "Medical-06ecaea9",
    "source": "Medical",
    "question": "Which two lifestyle factors increase the risk of head and neck cancer?",
    "answer": "Tobacco and alcohol use are risk factors for head and neck cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Tobacco and alcohol use are risk factors for head and neck cancer"
  },
  {
    "id": "Medical-138aaa42",
    "source": "Medical",
    "question": "What type of cancer is colon cancer classified as?",
    "answer": "Colon cancer is a type of colorectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Colon cancer is a type of colorectal cancer"
  },
  {
    "id": "Medical-77578361",
    "source": "Medical",
    "question": "What is the most common subtype of colon cancer?",
    "answer": "Adenocarcinoma is the most common subtype of colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenocarcinoma is the most common subtype of colon cancer"
  },
  {
    "id": "Medical-35f3815e",
    "source": "Medical",
    "question": "From which type of polyp do most colon cancers originate?",
    "answer": "Most colon cancers start in polyps, especially adenomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Most colon cancers start in polyps, especially adenomas"
  },
  {
    "id": "Medical-252d49cb",
    "source": "Medical",
    "question": "How does adenocarcinoma of the colon typically arise?",
    "answer": "Adenocarcinoma arises from adenomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenocarcinoma arises from adenomas"
  },
  {
    "id": "Medical-04a90969",
    "source": "Medical",
    "question": "Which types of polyps rarely become cancerous in the colon?",
    "answer": "Hyperplastic and inflammatory polyps rarely become cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Hyperplastic and inflammatory polyps rarely become cancer"
  },
  {
    "id": "Medical-d3fcc0fe",
    "source": "Medical",
    "question": "What procedure is used to remove polyps during colonoscopy?",
    "answer": "Polypectomy removes polyps during colonoscopy.",
    "question_type": "Fact Retrieval",
    "evidence": "Polypectomy removes polyps during colonoscopy"
  },
  {
    "id": "Medical-640ee9ee",
    "source": "Medical",
    "question": "What surgery removes the cancerous part of the colon?",
    "answer": "Colectomy is surgery to remove the cancerous part of the colon.",
    "question_type": "Fact Retrieval",
    "evidence": "Colectomy is surgery to remove the cancerous part of the colon"
  },
  {
    "id": "Medical-d0839ef2",
    "source": "Medical",
    "question": "What is the purpose of a colostomy in colon cancer treatment?",
    "answer": "Colostomy diverts stool through an abdominal stoma if reconnection is not possible.",
    "question_type": "Fact Retrieval",
    "evidence": "Colostomy diverts stool through an abdominal stoma if reconnection is not possible"
  },
  {
    "id": "Medical-5b005bba",
    "source": "Medical",
    "question": "Which system is used to stage colon cancer?",
    "answer": "AJCC TNM system is used to stage colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "AJCC TNM system is used to stage colon cancer"
  },
  {
    "id": "Medical-2360f9dd",
    "source": "Medical",
    "question": "What defines Stage 0 colon cancer?",
    "answer": "Stage 0 colon cancer is carcinoma in situ.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 0 colon cancer is carcinoma in situ"
  },
  {
    "id": "Medical-25302adf",
    "source": "Medical",
    "question": "What characterizes Stage 1 colon cancer?",
    "answer": "Stage 1 colon cancer invades second or third layer of colon wall, no lymph node involvement.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 1 colon cancer invades second or third layer of colon wall, no lymph node involvement"
  },
  {
    "id": "Medical-c8d26f3e",
    "source": "Medical",
    "question": "How is Stage 2 colon cancer described?",
    "answer": "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement"
  },
  {
    "id": "Medical-c9408d83",
    "source": "Medical",
    "question": "What is the defining feature of Stage 3 colon cancer?",
    "answer": "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits"
  },
  {
    "id": "Medical-e9340ec8",
    "source": "Medical",
    "question": "What is characteristic of Stage 4 colon cancer?",
    "answer": "Stage 4 colon cancer has spread to distant organs (commonly liver or lungs).",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 4 colon cancer has spread to distant organs (commonly liver or lungs)"
  },
  {
    "id": "Medical-879889ee",
    "source": "Medical",
    "question": "Which biomarker testing is recommended for all colon cancers?",
    "answer": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
    "question_type": "Fact Retrieval",
    "evidence": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)"
  },
  {
    "id": "Medical-a77dafa9",
    "source": "Medical",
    "question": "Which biomarker guides immunotherapy in colon cancer?",
    "answer": "dMMR/MSI-H is a biomarker guiding immunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "dMMR/MSI-H is a biomarker guiding immunotherapy"
  },
  {
    "id": "Medical-973bc3d0",
    "source": "Medical",
    "question": "How are pMMR/MSS colon cancers generally treated?",
    "answer": "pMMR/MSS cancers are treated with chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "pMMR/MSS cancers are treated with chemotherapy"
  },
  {
    "id": "Medical-0b514b7c",
    "source": "Medical",
    "question": "Which inherited syndromes increase the risk of colon cancer?",
    "answer": "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk"
  },
  {
    "id": "Medical-a43ea44f",
    "source": "Medical",
    "question": "Is family history a risk factor for colon cancer?",
    "answer": "Family history of colorectal cancer is a risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": "Family history of colorectal cancer is a risk factor"
  },
  {
    "id": "Medical-13fbbea3",
    "source": "Medical",
    "question": "What blood tests are recommended for initial evaluation of colon cancer?",
    "answer": "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing"
  },
  {
    "id": "Medical-1b8745a9",
    "source": "Medical",
    "question": "Which biomarker is used for monitoring colon cancer?",
    "answer": "CEA is a biomarker for monitoring colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "CEA is a biomarker for monitoring colon cancer"
  },
  {
    "id": "Medical-637bb2bd",
    "source": "Medical",
    "question": "What is the main imaging test for staging and surveillance of colon cancer?",
    "answer": "CT with contrast is the main imaging test for staging and surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "CT with contrast is the main imaging test for staging and surveillance"
  },
  {
    "id": "Medical-6f2d6386",
    "source": "Medical",
    "question": "When is MRI used in the evaluation of colon cancer?",
    "answer": "MRI may be used for further evaluation of liver or rectum.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI may be used for further evaluation of liver or rectum"
  },
  {
    "id": "Medical-80328029",
    "source": "Medical",
    "question": "What is the current role of ctDNA testing in colon cancer?",
    "answer": "ctDNA testing is investigational and recommended only in clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": "ctDNA testing is investigational and recommended only in clinical trials"
  },
  {
    "id": "Medical-6ff7589c",
    "source": "Medical",
    "question": "What adjuvant therapy is recommended after colectomy for stage 3 colon cancer?",
    "answer": "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers"
  },
  {
    "id": "Medical-5f9dfcb6",
    "source": "Medical",
    "question": "What is the preferred treatment for dMMR/MSI-H colon cancers?",
    "answer": "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers"
  },
  {
    "id": "Medical-d4f3ad82",
    "source": "Medical",
    "question": "What are the components of surveillance after colon cancer treatment?",
    "answer": "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans"
  },
  {
    "id": "Medical-a116a662",
    "source": "Medical",
    "question": "What fertility preservation options should be discussed with young adults before colon cancer treatment?",
    "answer": "Young adults should be counseled about fertility risks and preservation options before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Young adults should be counseled about fertility risks and preservation options before treatment"
  },
  {
    "id": "Medical-a438f1ad",
    "source": "Medical",
    "question": "Which surgical procedures are included in colon cancer treatment?",
    "answer": "Polypectomy, colectomy, and colostomy are surgical procedures used in colon cancer treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Polypectomy, colectomy, and colostomy are surgical procedures used in colon cancer treatment"
  },
  {
    "id": "Medical-babf4510",
    "source": "Medical",
    "question": "What chemotherapy regimens are commonly used for colon cancer?",
    "answer": "Capecitabine, 5-fluorouracil (5-FU), leucovorin, FOLFOX, and CAPEOX are chemotherapy regimens used.",
    "question_type": "Fact Retrieval",
    "evidence": "Capecitabine, 5-fluorouracil (5-FU), Leucovorin, FOLFOX, CAPEOX"
  },
  {
    "id": "Medical-1e78dd0f",
    "source": "Medical",
    "question": "Which checkpoint inhibitors are used in immunotherapy for colon cancer?",
    "answer": "Pembrolizumab (Keytruda), Nivolumab (Opdivo), and Ipilimumab (Yervoy) are checkpoint inhibitors used.",
    "question_type": "Fact Retrieval",
    "evidence": "Pembrolizumab (Keytruda), Nivolumab (Opdivo), Ipilimumab (Yervoy)"
  },
  {
    "id": "Medical-6c255c33",
    "source": "Medical",
    "question": "What is the primary cancer type affecting the esophagus?",
    "answer": "Esophageal cancer is the primary type.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal cancer starts in the inner lining of the esophagus"
  },
  {
    "id": "Medical-84c55f8a",
    "source": "Medical",
    "question": "Which cancer subtype originates in the squamous cells of the esophagus?",
    "answer": "Esophageal squamous cell carcinoma originates in squamous cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus"
  },
  {
    "id": "Medical-34c3dd3d",
    "source": "Medical",
    "question": "Which cancer subtype arises from mucus-secreting cells in the esophagus?",
    "answer": "Esophageal adenocarcinoma arises from mucus-secreting cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus"
  },
  {
    "id": "Medical-611ac003",
    "source": "Medical",
    "question": "What anatomical locations are associated with esophageal squamous cell carcinoma?",
    "answer": "Upper, middle, and lower esophagus are associated locations.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus"
  },
  {
    "id": "Medical-bc1a34dd",
    "source": "Medical",
    "question": "Where in the esophagus does esophageal adenocarcinoma commonly occur?",
    "answer": "It commonly occurs in the lower and middle esophagus.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus"
  },
  {
    "id": "Medical-04e27815",
    "source": "Medical",
    "question": "Which anatomical sites are included for esophageal cancer in general?",
    "answer": "Esophagus and esophagogastric junction are included.",
    "question_type": "Fact Retrieval",
    "evidence": "Anatomical Location: Esophagus, Esophagogastric junction"
  },
  {
    "id": "Medical-21a6662e",
    "source": "Medical",
    "question": "What is the definition of early-stage esophageal cancer?",
    "answer": "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes"
  },
  {
    "id": "Medical-552983d2",
    "source": "Medical",
    "question": "How is locoregional esophageal cancer defined?",
    "answer": "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs"
  },
  {
    "id": "Medical-5179c591",
    "source": "Medical",
    "question": "What characterizes metastatic esophageal cancer?",
    "answer": "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain"
  },
  {
    "id": "Medical-4bb6d825",
    "source": "Medical",
    "question": "What are the common metastatic sites for esophageal cancer?",
    "answer": "Liver, lung, bone, brain, and distant lymph nodes are common sites.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic: Metastatic Site: Liver, Lung, Bone, Brain, Distant lymph nodes"
  },
  {
    "id": "Medical-bb0fe530",
    "source": "Medical",
    "question": "What is a precancerous condition for esophageal adenocarcinoma?",
    "answer": "Barrett esophagus is a precancerous condition.",
    "question_type": "Fact Retrieval",
    "evidence": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-08144fc9",
    "source": "Medical",
    "question": "Which risk factor increases the likelihood of developing esophageal adenocarcinoma?",
    "answer": "Barrett esophagus increases the risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-deee1f4b",
    "source": "Medical",
    "question": "What are Siewert types used for in esophageal cancer?",
    "answer": "Siewert types are used to stage tumors at the esophagogastric junction.",
    "question_type": "Fact Retrieval",
    "evidence": "Siewert types are used to stage tumors at the esophagogastric junction"
  },
  {
    "id": "Medical-fdfcf977",
    "source": "Medical",
    "question": "Which diagnostic methods are involved in esophageal cancer diagnosis?",
    "answer": "Blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-c06a99a5",
    "source": "Medical",
    "question": "What additional assessments are included in esophageal cancer diagnosis beyond imaging and biopsy?",
    "answer": "Nutritional assessment and performance status are included.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: Nutritional assessment, Performance status"
  },
  {
    "id": "Medical-f3a5a8a3",
    "source": "Medical",
    "question": "Which cancer subtypes are recognized for esophageal cancer?",
    "answer": "Esophageal squamous cell carcinoma and esophageal adenocarcinoma are recognized subtypes.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer Subtype: Esophageal squamous cell carcinoma, Esophageal adenocarcinoma"
  },
  {
    "id": "Medical-db30377a",
    "source": "Medical",
    "question": "What anatomical layers can esophageal cancer invade?",
    "answer": "Mucosa, submucosa, muscularis propria, and tunica adventitia can be invaded.",
    "question_type": "Fact Retrieval",
    "evidence": "Entities: Mucosa, Submucosa, Muscularis propria, Tunica adventitia"
  },
  {
    "id": "Medical-5c1a382a",
    "source": "Medical",
    "question": "What factors are considered in treatment planning for esophageal cancer?",
    "answer": "Cancer type, location, stage, and Siewert types (for EGJ tumors) are considered.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment planning is based on cancer type, location, and stage"
  },
  {
    "id": "Medical-0f576b9d",
    "source": "Medical",
    "question": "Which genetic assessments are part of esophageal cancer diagnosis?",
    "answer": "Biomarker testing and genetic risk testing are part of the diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-7d90c178",
    "source": "Medical",
    "question": "What is Barrett esophagus classified as in relation to esophageal cancer?",
    "answer": "It is classified as a precancerous condition.",
    "question_type": "Fact Retrieval",
    "evidence": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-d2b6f3bf",
    "source": "Medical",
    "question": "Which organs are potential metastatic sites for esophageal cancer?",
    "answer": "Liver, lung, bone, brain, and distant lymph nodes are potential metastatic sites.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic: Metastatic Site: Liver, Lung, Bone, Brain, Distant lymph nodes"
  },
  {
    "id": "Medical-58a3acce",
    "source": "Medical",
    "question": "Which part of the esophagus is most commonly affected by esophageal adenocarcinoma?",
    "answer": "The lower esophagus is most commonly affected.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus"
  },
  {
    "id": "Medical-5953d9c0",
    "source": "Medical",
    "question": "What is the anatomical location of the esophagogastric junction in esophageal cancer?",
    "answer": "The esophagogastric junction is an anatomical location considered in esophageal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Anatomical Location: Esophagus, Esophagogastric junction"
  },
  {
    "id": "Medical-6b811802",
    "source": "Medical",
    "question": "What are the main stages of esophageal cancer described in the ontology?",
    "answer": "Early-stage, locoregional, and metastatic are the main stages.",
    "question_type": "Fact Retrieval",
    "evidence": "Disease Stage: Early-stage, Locoregional, Metastatic"
  },
  {
    "id": "Medical-70bd4605",
    "source": "Medical",
    "question": "Which subtype of esophageal cancer is associated with Barrett esophagus as a risk factor?",
    "answer": "Esophageal adenocarcinoma is associated with Barrett esophagus.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal adenocarcinoma: Risk Factor: Barrett esophagus"
  },
  {
    "id": "Medical-430e59ee",
    "source": "Medical",
    "question": "What methods are used for biomarker and genetic risk assessment in esophageal cancer?",
    "answer": "Biomarker testing and genetic risk testing are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-2114ae1d",
    "source": "Medical",
    "question": "What is the initial site of origin for esophageal cancer?",
    "answer": "It starts in the inner lining of the esophagus.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal cancer starts in the inner lining of the esophagus"
  },
  {
    "id": "Medical-21c7cd3c",
    "source": "Medical",
    "question": "How are tumors at the esophagogastric junction staged?",
    "answer": "They are staged using Siewert types.",
    "question_type": "Fact Retrieval",
    "evidence": "Siewert types are used to stage tumors at the esophagogastric junction"
  },
  {
    "id": "Medical-9ba19145",
    "source": "Medical",
    "question": "Which assessments help determine performance status in esophageal cancer patients?",
    "answer": "Performance status assessment is used.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: Performance status"
  },
  {
    "id": "Medical-465ca672",
    "source": "Medical",
    "question": "What is a key factor in planning treatment for esophageal cancer located at the esophagogastric junction?",
    "answer": "Siewert types are a key factor for EGJ tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment Planning: Based on: Siewert types (for EGJ tumors)"
  },
  {
    "id": "Medical-3d1b49a8",
    "source": "Medical",
    "question": "What type of carcinoma starts in the mucus-secreting cells of the esophagus?",
    "answer": "Esophageal adenocarcinoma starts in mucus-secreting cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus"
  },
  {
    "id": "Medical-ad0123e9",
    "source": "Medical",
    "question": "What is the main cancer type discussed in this dataset?",
    "answer": "Gray zone lymphoma is the main cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "Gray zone lymphoma is listed as a Cancer Type in the ontology."
  },
  {
    "id": "Medical-48502550",
    "source": "Medical",
    "question": "Which subtype of gray zone lymphoma is characterized by a large mediastinal mass?",
    "answer": "Mediastinal gray zone lymphoma (MGZL) is characterized by a large mediastinal mass.",
    "question_type": "Fact Retrieval",
    "evidence": "MGZL is characterized by a large mediastinal mass"
  },
  {
    "id": "Medical-87d7f30f",
    "source": "Medical",
    "question": "What are the overlapping features of gray zone lymphomas?",
    "answer": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL).",
    "question_type": "Fact Retrieval",
    "evidence": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-cf8b52e2",
    "source": "Medical",
    "question": "Which histopathological feature is characteristic of MGZL?",
    "answer": "Reed-Sternberg cells are characteristic histopathological features in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Reed-Sternberg cells are characteristic histopathological features in MGZL"
  },
  {
    "id": "Medical-e875d9cd",
    "source": "Medical",
    "question": "What is the recommended initial treatment for MGZL?",
    "answer": "MGZL is usually treated with chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "MGZL is usually treated with chemotherapy"
  },
  {
    "id": "Medical-c0ac21ce",
    "source": "Medical",
    "question": "Which immunotherapy agent may be added to chemotherapy for MGZL?",
    "answer": "Rituximab may be added to chemotherapy for chemoimmunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Rituximab may be added to chemotherapy for chemoimmunotherapy"
  },
  {
    "id": "Medical-afb11f97",
    "source": "Medical",
    "question": "What type of radiation therapy may be used in localized MGZL?",
    "answer": "Involved-site radiation therapy (ISRT) may be added in localized MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Involved-site radiation therapy (ISRT) may be added in localized MGZL"
  },
  {
    "id": "Medical-0cbbd549",
    "source": "Medical",
    "question": "What diagnostic method is required for MGZL?",
    "answer": "Diagnosis of MGZL requires expert hematopathologist review.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of MGZL requires expert hematopathologist review"
  },
  {
    "id": "Medical-aed3f61c",
    "source": "Medical",
    "question": "Which age group is most commonly affected by MGZL?",
    "answer": "MGZL commonly affects individuals aged 20 to 40 years.",
    "question_type": "Fact Retrieval",
    "evidence": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
  },
  {
    "id": "Medical-3c1265b5",
    "source": "Medical",
    "question": "Which sex assigned at birth is more commonly affected by MGZL?",
    "answer": "MGZL commonly affects individuals assigned male at birth.",
    "question_type": "Fact Retrieval",
    "evidence": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
  },
  {
    "id": "Medical-368307ba",
    "source": "Medical",
    "question": "Which sites are typically involved in mediastinal gray zone lymphoma?",
    "answer": "The mediastinum and lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Sites of involvement for MGZL include Mediastinum and Lymph nodes above the collar bone (supraclavicular)"
  },
  {
    "id": "Medical-30e1cf9c",
    "source": "Medical",
    "question": "What is a common presenting symptom of MGZL?",
    "answer": "A large mediastinal mass is a common presenting symptom of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "MGZL is characterized by a large mediastinal mass"
  },
  {
    "id": "Medical-5dd8e62d",
    "source": "Medical",
    "question": "What is the relationship between gray zone lymphoma and primary mediastinal B-cell lymphoma?",
    "answer": "Gray zone lymphomas have overlapping features with primary mediastinal B-cell lymphoma (PMBL).",
    "question_type": "Fact Retrieval",
    "evidence": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-9086efa3",
    "source": "Medical",
    "question": "What is the relationship between gray zone lymphoma and Hodgkin lymphoma?",
    "answer": "Gray zone lymphomas have overlapping features with Hodgkin lymphoma (HL).",
    "question_type": "Fact Retrieval",
    "evidence": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-f6793331",
    "source": "Medical",
    "question": "Which lymphoma subtype is diagnosed as DLBCL-NOS if extra-mediastinal disease is present?",
    "answer": "Non-mediastinal gray zone lymphoma is diagnosed as DLBCL-NOS if extra-mediastinal disease is present.",
    "question_type": "Fact Retrieval",
    "evidence": "If extra-mediastinal disease: Diagnose as DLBCL-NOS"
  },
  {
    "id": "Medical-8a80ec5c",
    "source": "Medical",
    "question": "What is a distinguishing feature of non-mediastinal gray zone lymphomas compared to MGZL?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
  },
  {
    "id": "Medical-e9a8741e",
    "source": "Medical",
    "question": "Which sites are more commonly involved in non-mediastinal gray zone lymphomas?",
    "answer": "Bone marrow and extranodal disease are more commonly involved in non-mediastinal gray zone lymphomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Sites of involvement for non-mediastinal gray zone lymphoma include Bone marrow involvement and Extranodal disease"
  },
  {
    "id": "Medical-c5412c78",
    "source": "Medical",
    "question": "What is the typical stage at diagnosis for non-mediastinal gray zone lymphomas?",
    "answer": "Non-mediastinal gray zone lymphomas are typically diagnosed at an advanced stage.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage for non-mediastinal gray zone lymphoma: Advanced-stage disease"
  },
  {
    "id": "Medical-24928f80",
    "source": "Medical",
    "question": "What is the role of rituximab in the treatment of MGZL?",
    "answer": "Rituximab may be added to chemotherapy for chemoimmunotherapy in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Rituximab may be added to chemotherapy for chemoimmunotherapy"
  },
  {
    "id": "Medical-60151004",
    "source": "Medical",
    "question": "Which professional is required for the diagnosis of MGZL?",
    "answer": "Expert hematopathologist review is required for diagnosis of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of MGZL requires expert hematopathologist review"
  },
  {
    "id": "Medical-1b949b50",
    "source": "Medical",
    "question": "Name two related entities to gray zone lymphoma.",
    "answer": "Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) are related entities.",
    "question_type": "Fact Retrieval",
    "evidence": "Related Entities: Primary mediastinal B-cell lymphoma (PMBL), Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-f83e84a2",
    "source": "Medical",
    "question": "What kind of therapy may be considered for MGZL in addition to chemotherapy?",
    "answer": "Chemoimmunotherapy and radiation therapy may be considered for MGZL in addition to chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for MGZL includes Chemotherapy, Chemoimmunotherapy (Rituximab), and Radiation Therapy (ISRT)"
  },
  {
    "id": "Medical-e84ba674",
    "source": "Medical",
    "question": "Which cells are a histopathological hallmark of MGZL?",
    "answer": "Reed-Sternberg cells are a histopathological hallmark of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Reed-Sternberg cells are characteristic histopathological features in MGZL"
  },
  {
    "id": "Medical-e7b5ec54",
    "source": "Medical",
    "question": "Which lymphoma is a subtype of gray zone lymphomas?",
    "answer": "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas"
  },
  {
    "id": "Medical-47995a35",
    "source": "Medical",
    "question": "What is the epidemiological profile of non-mediastinal gray zone lymphomas?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-mediastinal gray zone lymphomas occur in older persons"
  },
  {
    "id": "Medical-4dcf4539",
    "source": "Medical",
    "question": "Which lymphoma is diagnosed if gray zone lymphoma presents with extra-mediastinal disease?",
    "answer": "DLBCL, not otherwise specified (DLBCL-NOS) is diagnosed if there is extra-mediastinal disease.",
    "question_type": "Fact Retrieval",
    "evidence": "If extra-mediastinal disease: Diagnose as DLBCL-NOS"
  },
  {
    "id": "Medical-efc035f3",
    "source": "Medical",
    "question": "What is the purpose of involved-site radiation therapy (ISRT) in MGZL?",
    "answer": "ISRT may be added in localized MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Involved-site radiation therapy (ISRT) may be added in localized MGZL"
  },
  {
    "id": "Medical-b6d5f2ae",
    "source": "Medical",
    "question": "Which lymph nodes are typically involved in MGZL?",
    "answer": "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "Sites of involvement for MGZL include Lymph nodes above the collar bone (supraclavicular)"
  },
  {
    "id": "Medical-5f5a35d2",
    "source": "Medical",
    "question": "What is the main diagnostic method for gray zone lymphoma?",
    "answer": "Expert hematopathologist review is the main diagnostic method.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method for MGZL: Expert hematopathologist review"
  },
  {
    "id": "Medical-5a4056c3",
    "source": "Medical",
    "question": "Name two cancer types related to gray zone lymphoma.",
    "answer": "Classical Hodgkin lymphoma (CHL) and Non-Hodgkin lymphoma are related to gray zone lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Related Entities: Classical Hodgkin lymphoma (CHL), Non-Hodgkin lymphoma"
  },
  {
    "id": "Medical-b4916c72",
    "source": "Medical",
    "question": "What is the standard chemotherapy regimen for MGZL?",
    "answer": "Chemotherapy is the standard treatment for MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": "MGZL is usually treated with chemotherapy"
  },
  {
    "id": "Medical-22a8c202",
    "source": "Medical",
    "question": "What is the most common subtype of cervical cancer?",
    "answer": "Squamous cell carcinoma is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell carcinoma is the most common subtype of cervical cancer"
  },
  {
    "id": "Medical-a52a80e6",
    "source": "Medical",
    "question": "Which virus is most commonly associated with cervical cancer?",
    "answer": "Human papillomavirus (HPV) is most commonly associated.",
    "question_type": "Fact Retrieval",
    "evidence": "Most cervical cancers are caused by long-term infection with human papillomavirus (HPV)"
  },
  {
    "id": "Medical-5610453b",
    "source": "Medical",
    "question": "Which HPV types are considered high-risk for cervical cancer?",
    "answer": "HPV16 and HPV18 are high-risk types.",
    "question_type": "Fact Retrieval",
    "evidence": "HPV16 and HPV18 are high-risk HPV types associated with cervical cancer"
  },
  {
    "id": "Medical-038b92bd",
    "source": "Medical",
    "question": "What screening method is used for cervical cancer?",
    "answer": "Pap smear is used for cervical cancer screening.",
    "question_type": "Fact Retrieval",
    "evidence": "Pap smear is used for cervical cancer screening"
  },
  {
    "id": "Medical-14497bbd",
    "source": "Medical",
    "question": "What is the primary diagnostic method for cervical cancer?",
    "answer": "Cervical biopsy is the primary diagnostic method.",
    "question_type": "Fact Retrieval",
    "evidence": "Cervical biopsy is the primary diagnostic method for cervical cancer"
  },
  {
    "id": "Medical-adfde050",
    "source": "Medical",
    "question": "Which imaging modalities are used for staging cervical cancer?",
    "answer": "CT scan, MRI, PET/CT, and transvaginal ultrasound are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment"
  },
  {
    "id": "Medical-29a726a3",
    "source": "Medical",
    "question": "What system is used to stage cervical cancer?",
    "answer": "The FIGO system is used to stage cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages)"
  },
  {
    "id": "Medical-8a456673",
    "source": "Medical",
    "question": "What is the main treatment for early-stage cervical cancer?",
    "answer": "Surgery is the main treatment for early-stage cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is the main treatment for early-stage cervical cancer"
  },
  {
    "id": "Medical-4262873a",
    "source": "Medical",
    "question": "Which surgical procedure can be both diagnostic and therapeutic for early-stage cervical cancer?",
    "answer": "Cone biopsy can be both diagnostic and therapeutic.",
    "question_type": "Fact Retrieval",
    "evidence": "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer"
  },
  {
    "id": "Medical-bb870733",
    "source": "Medical",
    "question": "Which fertility-sparing surgical option is available for selected early-stage cervical cancer cases?",
    "answer": "Trachelectomy is an option for selected early-stage cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases"
  },
  {
    "id": "Medical-a4c519cd",
    "source": "Medical",
    "question": "What is the recommended treatment for locally advanced cervical cancer?",
    "answer": "Chemoradiation is recommended for locally advanced cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer"
  },
  {
    "id": "Medical-e8a07389",
    "source": "Medical",
    "question": "Which radiation therapies are used for local control in cervical cancer?",
    "answer": "External beam radiation therapy (EBRT) and brachytherapy are used.",
    "question_type": "Fact Retrieval",
    "evidence": "External beam radiation therapy (EBRT) and brachytherapy are used for local control"
  },
  {
    "id": "Medical-a41f7cdf",
    "source": "Medical",
    "question": "Which systemic therapy options are available for cervical cancer?",
    "answer": "Platinum-based chemotherapy, targeted therapy, and immunotherapy are options.",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy"
  },
  {
    "id": "Medical-e3419109",
    "source": "Medical",
    "question": "Which biomarker testing is recommended for recurrent or metastatic cervical cancer?",
    "answer": "Biomarker testing for PD-L1, MSI, TMB, MMR, HER2, RET, and NTRK is recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer"
  },
  {
    "id": "Medical-bc97fb7b",
    "source": "Medical",
    "question": "What biomarker guides the use of pembrolizumab in cervical cancer?",
    "answer": "PD-L1 positivity guides the use of pembrolizumab.",
    "question_type": "Fact Retrieval",
    "evidence": "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)"
  },
  {
    "id": "Medical-5c0cc4b2",
    "source": "Medical",
    "question": "Which drug may be added to chemotherapy for metastatic cervical cancer?",
    "answer": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer"
  },
  {
    "id": "Medical-5fb3b9ac",
    "source": "Medical",
    "question": "What are common symptoms of cervical cancer?",
    "answer": "Common symptoms include watery vaginal discharge, pelvic pain, abnormal vaginal bleeding, and fatigue.",
    "question_type": "Fact Retrieval",
    "evidence": "Cervical cancer causes symptoms such as watery vaginal discharge, pelvic pain, abnormal vaginal bleeding, and fatigue"
  },
  {
    "id": "Medical-2bbad791",
    "source": "Medical",
    "question": "Which factors increase the risk of cervical cancer?",
    "answer": "HPV infection, smoking, immunosuppression, and HIV increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors include HPV infection, smoking, immunosuppression (e.g., HIV infection)"
  },
  {
    "id": "Medical-15dda38d",
    "source": "Medical",
    "question": "How does smoking affect cervical cancer risk?",
    "answer": "Smoking increases the risk of cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Smoking increases the risk of cervical cancer"
  },
  {
    "id": "Medical-788a228f",
    "source": "Medical",
    "question": "How does immunosuppression, such as HIV infection, affect cervical cancer risk?",
    "answer": "Immunosuppression increases the risk of cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer"
  },
  {
    "id": "Medical-bfa6e03a",
    "source": "Medical",
    "question": "What corresponds to a low-grade squamous intraepithelial lesion (LSIL) in cervical pathology?",
    "answer": "LSIL corresponds to CIN 1.",
    "question_type": "Fact Retrieval",
    "evidence": "Low-grade squamous intraepithelial lesion (LSIL) corresponds to CIN 1"
  },
  {
    "id": "Medical-c4c487bc",
    "source": "Medical",
    "question": "What is considered a high-grade squamous intraepithelial lesion (HSIL)?",
    "answer": "HSIL corresponds to CIN 2 and 3 and is considered pre-cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "High-grade squamous intraepithelial lesion (HSIL) corresponds to CIN 2 and 3 and is considered pre-cancer"
  },
  {
    "id": "Medical-c6f1ea93",
    "source": "Medical",
    "question": "What is the main purpose of surveillance after cervical cancer treatment?",
    "answer": "Surveillance includes regular physical exams and imaging as indicated.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance after treatment includes regular physical exams and imaging as indicated"
  },
  {
    "id": "Medical-e6bc0ffc",
    "source": "Medical",
    "question": "What supportive care options are recommended for advanced or metastatic cervical cancer?",
    "answer": "Supportive care and palliative care are integral for advanced or metastatic disease.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive care and palliative care are integral for advanced or metastatic disease"
  },
  {
    "id": "Medical-d6b9a73e",
    "source": "Medical",
    "question": "What effect does smoking cessation have on treatment outcomes in cervical cancer?",
    "answer": "Smoking cessation improves treatment outcomes.",
    "question_type": "Fact Retrieval",
    "evidence": "Smoking cessation improves treatment outcomes"
  },
  {
    "id": "Medical-6397e7b3",
    "source": "Medical",
    "question": "Are clinical trials an option for cervical cancer patients?",
    "answer": "Clinical trials are an option for all stages of cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are an option for all stages of cervical cancer"
  },
  {
    "id": "Medical-4a5f5e62",
    "source": "Medical",
    "question": "Which rare and aggressive subtype of cervical cancer is noted in the ontology?",
    "answer": "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype"
  },
  {
    "id": "Medical-38ee28b6",
    "source": "Medical",
    "question": "What is the relationship between cervical dysplasia and cervical cancer?",
    "answer": "Cervical dysplasia (CIN) can progress to cervical cancer if untreated.",
    "question_type": "Fact Retrieval",
    "evidence": "Cervical dysplasia (CIN) can progress to cervical cancer if untreated"
  },
  {
    "id": "Medical-5eeca870",
    "source": "Medical",
    "question": "Which physical examination methods are included in the diagnostic process for cervical cancer?",
    "answer": "Physical exam, cystoscopy, and proctoscopy are included.",
    "question_type": "Fact Retrieval",
    "evidence": "Other diagnostic methods include cystoscopy, proctoscopy, and physical exam"
  },
  {
    "id": "Medical-7eb90c51",
    "source": "Medical",
    "question": "What fertility preservation options are available for cervical cancer patients?",
    "answer": "Options include fertility-sparing surgery, ovarian transposition, egg freezing, and surrogacy.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility preservation options include fertility-sparing surgery, ovarian transposition, egg freezing, and surrogacy"
  },
  {
    "id": "Medical-c6e9519c",
    "source": "Medical",
    "question": "Which genetic alterations are relevant in cervical cancer for biomarker testing?",
    "answer": "Relevant genetic alterations include PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, and NTRK fusion.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic alterations include PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, NTRK fusion"
  },
  {
    "id": "Medical-6c42674a",
    "source": "Medical",
    "question": "What type of cancer is Hodgkin lymphoma?",
    "answer": "Hodgkin lymphoma is a type of lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Hodgkin lymphoma is a type of lymphoma"
  },
  {
    "id": "Medical-155549b0",
    "source": "Medical",
    "question": "What is the most common subtype of Hodgkin lymphoma?",
    "answer": "Classic Hodgkin lymphoma (CHL) is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma"
  },
  {
    "id": "Medical-56084fb4",
    "source": "Medical",
    "question": "Which cell type characterizes Classic Hodgkin lymphoma (CHL)?",
    "answer": "CHL is characterized by Reed-Sternberg cells.",
    "question_type": "Fact Retrieval",
    "evidence": "CHL is characterized by Reed-Sternberg cells"
  },
  {
    "id": "Medical-bc603db5",
    "source": "Medical",
    "question": "What is a rare subtype of Hodgkin lymphoma?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma"
  },
  {
    "id": "Medical-d81ad4db",
    "source": "Medical",
    "question": "Which cell type is characteristic of NLPHL?",
    "answer": "NLPHL is characterized by popcorn-shaped cells.",
    "question_type": "Fact Retrieval",
    "evidence": "NLPHL is characterized by popcorn-shaped cells"
  },
  {
    "id": "Medical-41eb01ac",
    "source": "Medical",
    "question": "Into which disease can NLPHL transform?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-620a1582",
    "source": "Medical",
    "question": "What is the primary diagnostic method for Hodgkin lymphoma?",
    "answer": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy"
  },
  {
    "id": "Medical-45b14e2d",
    "source": "Medical",
    "question": "Which biopsy method may be used for Hodgkin lymphoma diagnosis in some cases?",
    "answer": "Core needle biopsy may be used for diagnosis in some cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Core needle biopsy may be used for diagnosis in some cases"
  },
  {
    "id": "Medical-d3a58aef",
    "source": "Medical",
    "question": "Which diagnostic procedures are part of the initial workup for Hodgkin lymphoma?",
    "answer": "Health history and physical exam are part of the diagnostic process.",
    "question_type": "Fact Retrieval",
    "evidence": "Health history and physical exam are part of the diagnostic process"
  },
  {
    "id": "Medical-49e5ee6e",
    "source": "Medical",
    "question": "What laboratory and imaging tests are used in the diagnostic workup for Hodgkin lymphoma?",
    "answer": "Blood tests and imaging tests are used in the diagnostic workup.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-2b8c042d",
    "source": "Medical",
    "question": "Where does Hodgkin lymphoma usually start?",
    "answer": "Hodgkin lymphoma usually starts in lymph nodes in the upper body.",
    "question_type": "Fact Retrieval",
    "evidence": "Hodgkin lymphoma usually starts in lymph nodes in the upper body"
  },
  {
    "id": "Medical-3b688fe1",
    "source": "Medical",
    "question": "Which age groups are most commonly diagnosed with Hodgkin lymphoma?",
    "answer": "Most people are diagnosed between ages 15 to 30 or after age 55.",
    "question_type": "Fact Retrieval",
    "evidence": "Most people are diagnosed between ages 15 to 30 or after age 55"
  },
  {
    "id": "Medical-140a1830",
    "source": "Medical",
    "question": "What are the common sites involved in Hodgkin lymphoma?",
    "answer": "Common sites include lymph nodes in the upper body.",
    "question_type": "Fact Retrieval",
    "evidence": "Common Sites: lymph nodes in upper body"
  },
  {
    "id": "Medical-c76d84e2",
    "source": "Medical",
    "question": "What are the risk factors for Hodgkin lymphoma based on age?",
    "answer": "Risk factors include being between ages 15 to 30 or age 55.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor: ages 15 to 30, age 55"
  },
  {
    "id": "Medical-9b5a2b0a",
    "source": "Medical",
    "question": "Which two biopsy methods are listed for diagnosing CHL?",
    "answer": "Excisional lymph node biopsy and core needle biopsy are listed for CHL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: excisional lymph node biopsy, core needle biopsy"
  },
  {
    "id": "Medical-e39fe71c",
    "source": "Medical",
    "question": "What cell type is associated with Classic Hodgkin lymphoma according to the ontology?",
    "answer": "Reed-Sternberg cells are associated with Classic Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Cell Type: Reed-Sternberg cells"
  },
  {
    "id": "Medical-8f34d47a",
    "source": "Medical",
    "question": "What cell type is associated with NLPHL according to the ontology?",
    "answer": "Popcorn-shaped cells are associated with NLPHL.",
    "question_type": "Fact Retrieval",
    "evidence": "Cell Type: popcorn-shaped cells"
  },
  {
    "id": "Medical-54f18ca7",
    "source": "Medical",
    "question": "Which diagnostic methods are common to both CHL and NLPHL?",
    "answer": "Excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests are common to both.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, imaging tests"
  },
  {
    "id": "Medical-e9c535e5",
    "source": "Medical",
    "question": "What disease transformation is noted for NLPHL?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": "Disease Transformation: diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-653c0da3",
    "source": "Medical",
    "question": "Which lymphoma subtype is most frequently associated with Reed-Sternberg cells?",
    "answer": "Classic Hodgkin lymphoma (CHL) is most frequently associated with Reed-Sternberg cells.",
    "question_type": "Fact Retrieval",
    "evidence": "CHL is characterized by Reed-Sternberg cells"
  },
  {
    "id": "Medical-9d5ac399",
    "source": "Medical",
    "question": "What is the main cell type that distinguishes NLPHL from CHL?",
    "answer": "Popcorn-shaped cells distinguish NLPHL from CHL.",
    "question_type": "Fact Retrieval",
    "evidence": "NLPHL is characterized by popcorn-shaped cells"
  },
  {
    "id": "Medical-cfc34fd6",
    "source": "Medical",
    "question": "Which cancer type does Hodgkin lymphoma belong to?",
    "answer": "Hodgkin lymphoma belongs to the lymphoma cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "Hodgkin lymphoma is a type of lymphoma"
  },
  {
    "id": "Medical-6e415b34",
    "source": "Medical",
    "question": "What physical examination is included in the diagnostic process for Hodgkin lymphoma?",
    "answer": "Physical exam is part of the diagnostic process.",
    "question_type": "Fact Retrieval",
    "evidence": "Health history and physical exam are part of the diagnostic process"
  },
  {
    "id": "Medical-d9c6b363",
    "source": "Medical",
    "question": "Which lymphoma subtype can transform into another lymphoma, and what is the resulting disease?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-df4834b4",
    "source": "Medical",
    "question": "What is the significance of Reed-Sternberg cells in Hodgkin lymphoma?",
    "answer": "Reed-Sternberg cells characterize Classic Hodgkin lymphoma (CHL).",
    "question_type": "Fact Retrieval",
    "evidence": "CHL is characterized by Reed-Sternberg cells"
  },
  {
    "id": "Medical-a208f169",
    "source": "Medical",
    "question": "What is the typical anatomical location where Hodgkin lymphoma begins?",
    "answer": "Hodgkin lymphoma usually starts in lymph nodes in the upper body.",
    "question_type": "Fact Retrieval",
    "evidence": "Hodgkin lymphoma usually starts in lymph nodes in the upper body"
  },
  {
    "id": "Medical-6602e33d",
    "source": "Medical",
    "question": "What is the diagnostic significance of excisional lymph node biopsy in Hodgkin lymphoma?",
    "answer": "Excisional lymph node biopsy is the primary diagnostic method for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy"
  },
  {
    "id": "Medical-59a9ad6d",
    "source": "Medical",
    "question": "What are two age-related risk factors for Hodgkin lymphoma?",
    "answer": "Ages 15 to 30 and age 55 are risk factors for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor: ages 15 to 30, age 55"
  },
  {
    "id": "Medical-1b774745",
    "source": "Medical",
    "question": "Which subtype of Hodgkin lymphoma is rare according to the relations?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is rare.",
    "question_type": "Fact Retrieval",
    "evidence": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma"
  },
  {
    "id": "Medical-3306e2b6",
    "source": "Medical",
    "question": "What is the role of blood tests in Hodgkin lymphoma diagnosis?",
    "answer": "Blood tests are used in the diagnostic workup for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-15c48832",
    "source": "Medical",
    "question": "Which imaging techniques are part of the diagnostic methods for Hodgkin lymphoma?",
    "answer": "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-c8e42c69",
    "source": "Medical",
    "question": "What are the main cancer types associated with the gallbladder and bile ducts?",
    "answer": "Intrahepatic bile duct cancer is a main cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "intrahepatic bile duct cancer"
  },
  {
    "id": "Medical-0e5e7e44",
    "source": "Medical",
    "question": "Which anatomical structures are covered by a thin, moist epithelial layer?",
    "answer": "The gallbladder and bile ducts are covered by a thin, moist epithelial layer.",
    "question_type": "Fact Retrieval",
    "evidence": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer"
  },
  {
    "id": "Medical-a0ee92b3",
    "source": "Medical",
    "question": "What is the outermost membrane covering the gallbladder and bile ducts?",
    "answer": "Serosa is the outer membrane covering the gallbladder and bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-aa283616",
    "source": "Medical",
    "question": "What histological layers are found in the bile duct wall?",
    "answer": "The bile duct wall contains epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
    "question_type": "Fact Retrieval",
    "evidence": "bile duct has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-5136f646",
    "source": "Medical",
    "question": "Which connective tissue is located under the epithelium in the gallbladder and bile duct?",
    "answer": "Lamina propria is the connective tissue found under the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Lamina propria is a connective tissue found under the epithelium"
  },
  {
    "id": "Medical-7d67a49f",
    "source": "Medical",
    "question": "What is the function of the muscularis layer in the bile duct wall?",
    "answer": "Muscularis is a soft tissue layer in the bile duct wall.",
    "question_type": "Fact Retrieval",
    "evidence": "Muscularis is a soft tissue layer in the bile duct wall"
  },
  {
    "id": "Medical-0535a6b1",
    "source": "Medical",
    "question": "What tissue surrounds the muscle layer in the bile duct and gallbladder?",
    "answer": "Perimuscular fibrous tissue surrounds the muscle layer.",
    "question_type": "Fact Retrieval",
    "evidence": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-14c841bc",
    "source": "Medical",
    "question": "On what basis is bile duct cancer staging determined?",
    "answer": "Bile duct cancer staging is based on tumor size and extent of spread.",
    "question_type": "Fact Retrieval",
    "evidence": "Bile duct cancer staging is based on tumor size and extent of spread"
  },
  {
    "id": "Medical-2adbc240",
    "source": "Medical",
    "question": "What does the stage Tis indicate in intrahepatic bile duct cancer?",
    "answer": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
  },
  {
    "id": "Medical-fca41ac7",
    "source": "Medical",
    "question": "What are the tumor characteristics of Tis stage in intrahepatic bile duct cancer?",
    "answer": "Tis is characterized by carcinoma in situ, intraductal tumor, and confinement to the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis: Tumor Characteristic: carcinoma in situ, intraductal tumor, confined to epithelium"
  },
  {
    "id": "Medical-ebc2ff97",
    "source": "Medical",
    "question": "Which structures can bile duct cancer invade as it progresses?",
    "answer": "Cancer can invade nearby blood vessels, liver, or structures outside the liver.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-da181948",
    "source": "Medical",
    "question": "What are the histological layers present in the gallbladder?",
    "answer": "The gallbladder contains epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
    "question_type": "Fact Retrieval",
    "evidence": "gallbladder has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-1060f44f",
    "source": "Medical",
    "question": "Which cancer type is classified under the anatomical structure of the bile duct?",
    "answer": "Intrahepatic bile duct cancer is classified under the bile duct.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer Type: intrahepatic bile duct cancer under bile duct"
  },
  {
    "id": "Medical-e3492f40",
    "source": "Medical",
    "question": "What is carcinoma in situ in the context of intrahepatic bile duct cancer?",
    "answer": "Carcinoma in situ is an intraductal tumor confined to the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
  },
  {
    "id": "Medical-5c7974c9",
    "source": "Medical",
    "question": "Which layer directly covers the muscularis in the gallbladder and bile duct?",
    "answer": "Perimuscular fibrous tissue directly covers the muscularis.",
    "question_type": "Fact Retrieval",
    "evidence": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-d8aa135d",
    "source": "Medical",
    "question": "What is the primary tumor characteristic used for staging bile duct cancer?",
    "answer": "Primary tumor size and extent of spread are used for staging.",
    "question_type": "Fact Retrieval",
    "evidence": "Bile duct cancer staging is based on tumor size and extent of spread"
  },
  {
    "id": "Medical-d465de28",
    "source": "Medical",
    "question": "Which layer is the innermost lining of the gallbladder and bile ducts?",
    "answer": "The epithelium is the innermost lining.",
    "question_type": "Fact Retrieval",
    "evidence": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer"
  },
  {
    "id": "Medical-651ea4b6",
    "source": "Medical",
    "question": "What is the relationship between lamina propria and the epithelium in these cancers?",
    "answer": "Lamina propria is a connective tissue found under the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Lamina propria is a connective tissue found under the epithelium"
  },
  {
    "id": "Medical-340cdb40",
    "source": "Medical",
    "question": "What are examples of tumor spread in intrahepatic bile duct cancer?",
    "answer": "Tumor can spread to blood vessels, liver, or structures outside the liver.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-306b4531",
    "source": "Medical",
    "question": "What is an intraductal tumor in the context of cancer staging?",
    "answer": "An intraductal tumor is a carcinoma in situ confined to the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
  },
  {
    "id": "Medical-d70b14a4",
    "source": "Medical",
    "question": "Which anatomical structures are included in the ontology for intrahepatic bile duct cancer?",
    "answer": "Bile duct and gallbladder are included as anatomical structures.",
    "question_type": "Fact Retrieval",
    "evidence": "Anatomical Structure: bile duct, gallbladder"
  },
  {
    "id": "Medical-47be866b",
    "source": "Medical",
    "question": "What is the role of the serosa in gallbladder and bile duct anatomy?",
    "answer": "Serosa is the outer membrane covering these organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-2ebac5e5",
    "source": "Medical",
    "question": "Which tumor characteristic involves the measurement in centimeters or millimeters?",
    "answer": "Primary tumor size (cm or mm) is a tumor characteristic.",
    "question_type": "Fact Retrieval",
    "evidence": "Tumor Characteristic: primary tumor size (cm or mm)"
  },
  {
    "id": "Medical-edc4f2c6",
    "source": "Medical",
    "question": "What is the relationship between the muscularis and perimuscular fibrous tissue?",
    "answer": "Perimuscular fibrous tissue surrounds the muscularis layer.",
    "question_type": "Fact Retrieval",
    "evidence": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-177b0129",
    "source": "Medical",
    "question": "What does the term 'confined to epithelium' indicate in tumor staging?",
    "answer": "It indicates that the tumor is limited to the epithelial layer without invasion.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
  },
  {
    "id": "Medical-c663d954",
    "source": "Medical",
    "question": "Which histological layer provides structural support under the epithelium?",
    "answer": "Lamina propria provides structural support under the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Lamina propria is a connective tissue found under the epithelium"
  },
  {
    "id": "Medical-defb6aef",
    "source": "Medical",
    "question": "What is the significance of the muscularis in the context of bile duct cancer?",
    "answer": "The muscularis is a soft tissue layer that may be invaded as cancer progresses.",
    "question_type": "Fact Retrieval",
    "evidence": "Muscularis is a soft tissue layer in the bile duct wall"
  },
  {
    "id": "Medical-16bc9e87",
    "source": "Medical",
    "question": "Which cancer stage is defined by a tumor that is only within the epithelial layer?",
    "answer": "Tis (carcinoma in situ) is defined by a tumor confined to the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
  },
  {
    "id": "Medical-af5dbcb0",
    "source": "Medical",
    "question": "What anatomical layers must a tumor penetrate to reach the serosa in the bile duct?",
    "answer": "A tumor must penetrate the epithelium, lamina propria, muscularis, and perimuscular fibrous tissue to reach the serosa.",
    "question_type": "Fact Retrieval",
    "evidence": "bile duct has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-3539e146",
    "source": "Medical",
    "question": "What does spread to structures outside the liver signify in bile duct cancer?",
    "answer": "It signifies advanced tumor invasion beyond the liver.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-e79c55d4",
    "source": "Medical",
    "question": "Which layer is described as a membrane in the anatomical structure of the gallbladder and bile ducts?",
    "answer": "Serosa is described as a membrane covering the gallbladder and bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-e4d47909",
    "source": "Medical",
    "question": "What type of lymphoma is follicular lymphoma (FL)?",
    "answer": "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma"
  },
  {
    "id": "Medical-78788ae0",
    "source": "Medical",
    "question": "From which cell type does follicular lymphoma (FL) develop?",
    "answer": "FL develops from abnormal B lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues"
  },
  {
    "id": "Medical-c2568161",
    "source": "Medical",
    "question": "What are the main disease sites for follicular lymphoma (FL)?",
    "answer": "FL affects lymph nodes, bone marrow, spleen, and extranodal sites.",
    "question_type": "Fact Retrieval",
    "evidence": "Disease sites for FL include lymph node, bone marrow, spleen, and extranodal sites"
  },
  {
    "id": "Medical-49d93af8",
    "source": "Medical",
    "question": "How is follicular lymphoma (FL) graded?",
    "answer": "FL is graded based on the proportion of centrocytes and centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": "FL is graded based on the proportion of centrocytes and centroblasts"
  },
  {
    "id": "Medical-aacc81ea",
    "source": "Medical",
    "question": "Which grades of FL are classified as classic FL (cFL) according to ICC?",
    "answer": "Grades 1 and 2 FL are classified as classic FL (cFL).",
    "question_type": "Fact Retrieval",
    "evidence": "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC"
  },
  {
    "id": "Medical-7ed82690",
    "source": "Medical",
    "question": "How is grade 3B follicular lymphoma treated?",
    "answer": "Grade 3B FL is treated as diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": "Grade 3B FL is treated as DLBCL"
  },
  {
    "id": "Medical-13fe78ff",
    "source": "Medical",
    "question": "What is the typical genetic alteration found in almost all FL cases?",
    "answer": "Almost all FL cases have a chromosome translocation or excess BCL2 protein.",
    "question_type": "Fact Retrieval",
    "evidence": "Almost all FL cases have a chromosome translocation or excess BCL2 protein"
  },
  {
    "id": "Medical-4be4d916",
    "source": "Medical",
    "question": "What is the characteristic genetic alteration in uncommon FL (uFL)?",
    "answer": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features.",
    "question_type": "Fact Retrieval",
    "evidence": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features"
  },
  {
    "id": "Medical-2e05b3f3",
    "source": "Medical",
    "question": "How is uncommon FL (uFL) treated?",
    "answer": "Uncommon FL (uFL) is treated as classic FL.",
    "question_type": "Fact Retrieval",
    "evidence": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL"
  },
  {
    "id": "Medical-f3e4ed65",
    "source": "Medical",
    "question": "What is the typical presentation of pediatric-type follicular lymphoma (PTFL)?",
    "answer": "PTFL usually presents with a single enlarged lymph node in the head and neck and minimal symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-26ce4d1c",
    "source": "Medical",
    "question": "What can follicular lymphoma (FL) transform into?",
    "answer": "FL can transform into diffuse large B-cell lymphoma (DLBCL), a more aggressive lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "FL can transform into DLBCL, a more aggressive lymphoma"
  },
  {
    "id": "Medical-0ab293c2",
    "source": "Medical",
    "question": "Which diagnostic methods are used for follicular lymphoma (FL)?",
    "answer": "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping"
  },
  {
    "id": "Medical-2d90241b",
    "source": "Medical",
    "question": "What are common symptoms of follicular lymphoma (FL)?",
    "answer": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms).",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-5730fce1",
    "source": "Medical",
    "question": "Do all patients with follicular lymphoma require immediate treatment?",
    "answer": "Not all patients with FL require immediate treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Not all patients with FL require immediate treatment"
  },
  {
    "id": "Medical-44af5ecf",
    "source": "Medical",
    "question": "What guides treatment decisions in follicular lymphoma (FL)?",
    "answer": "The type of cells in FL determines the grade, which guides treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": "The type of cells in FL determines the grade, which guides treatment decisions"
  },
  {
    "id": "Medical-9b28edf9",
    "source": "Medical",
    "question": "What are the main cell types found in follicular lymphoma (FL)?",
    "answer": "The main cell types in FL are centrocytes and centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": "FL is graded based on the proportion of centrocytes and centroblasts"
  },
  {
    "id": "Medical-8a166224",
    "source": "Medical",
    "question": "Which biomarker is commonly associated with follicular lymphoma (FL)?",
    "answer": "BCL2 protein is a biomarker commonly associated with FL.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker: BCL2 protein"
  },
  {
    "id": "Medical-bf9805af",
    "source": "Medical",
    "question": "What genetic alteration is associated with FL besides t(14;18)?",
    "answer": "Chromosome translocation is associated with FL.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic Alteration: chromosome translocation"
  },
  {
    "id": "Medical-9410dd14",
    "source": "Medical",
    "question": "Which FL subtype is defined by t(14;18)-negativity?",
    "answer": "Uncommon FL (uFL) is defined by t(14;18)-negativity.",
    "question_type": "Fact Retrieval",
    "evidence": "Uncommon FL (uFL) is t(14;18)-negative"
  },
  {
    "id": "Medical-2876eea3",
    "source": "Medical",
    "question": "What is the classification of grade 3A FL?",
    "answer": "Grade 3A FL may be classified as classic FL or as DLBCL.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-43e5c06b",
    "source": "Medical",
    "question": "Which FL subtype is associated with minimal symptoms?",
    "answer": "Pediatric-type FL (PTFL) is associated with minimal symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-6a4086f1",
    "source": "Medical",
    "question": "What is the typical site of presentation for pediatric-type FL (PTFL)?",
    "answer": "PTFL usually presents with a single enlarged lymph node in the head and neck region.",
    "question_type": "Fact Retrieval",
    "evidence": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-c79a2c52",
    "source": "Medical",
    "question": "What is the cell type origin of follicular lymphoma?",
    "answer": "Follicular lymphoma originates from B lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Cell Type: B lymphocyte"
  },
  {
    "id": "Medical-cf21d241",
    "source": "Medical",
    "question": "What symptoms are collectively referred to as B symptoms in FL?",
    "answer": "B symptoms in FL include fever, night sweats, and weight loss.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-4392ee71",
    "source": "Medical",
    "question": "Which diagnostic method is used to assess bone marrow involvement in FL?",
    "answer": "Bone marrow aspirate and biopsy are used to assess bone marrow involvement in FL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping"
  },
  {
    "id": "Medical-1e353d15",
    "source": "Medical",
    "question": "Which grades of FL are characterized by both centrocytes and centroblasts?",
    "answer": "Grades 1, 2, and 3A FL are characterized by both centrocytes and centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade 1, grade 2, and grade 3A have Cell Type: centrocyte, centroblast"
  },
  {
    "id": "Medical-fb8d613d",
    "source": "Medical",
    "question": "Which grade of FL is characterized only by centroblasts?",
    "answer": "Grade 3B FL is characterized only by centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade 3B: Cell Type: centroblast"
  },
  {
    "id": "Medical-08098847",
    "source": "Medical",
    "question": "What is the main clinical management consideration for FL?",
    "answer": "Not all patients with FL require immediate treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Not all patients with FL require immediate treatment"
  },
  {
    "id": "Medical-3fb59b05",
    "source": "Medical",
    "question": "What is the disease site for extranodal FL?",
    "answer": "Extranodal FL occurs in tissues outside the lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "FL can present as nodal or extranodal disease"
  },
  {
    "id": "Medical-cd57cf13",
    "source": "Medical",
    "question": "Which lymphoma subtype can FL transform into?",
    "answer": "FL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": "FL can transform into DLBCL, a more aggressive lymphoma"
  },
  {
    "id": "Medical-d33f62e1",
    "source": "Medical",
    "question": "What is the role of immunophenotyping in FL diagnosis?",
    "answer": "Immunophenotyping is used as a diagnostic method for FL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: immunophenotyping"
  },
  {
    "id": "Medical-ffc96616",
    "source": "Medical",
    "question": "Which organ is commonly enlarged in FL patients?",
    "answer": "The spleen is commonly enlarged in FL patients.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-665744e5",
    "source": "Medical",
    "question": "What is the most common type of primary liver cancer?",
    "answer": "Hepatocellular carcinoma (HCC) is the most common type.",
    "question_type": "Fact Retrieval",
    "evidence": "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer"
  },
  {
    "id": "Medical-cc93885e",
    "source": "Medical",
    "question": "Which subtype of hepatocellular carcinoma occurs at a younger age?",
    "answer": "Fibrolamellar hepatocellular carcinoma (FLHC) occurs at a younger age.",
    "question_type": "Fact Retrieval",
    "evidence": "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age"
  },
  {
    "id": "Medical-682c2e93",
    "source": "Medical",
    "question": "What is intrahepatic cholangiocarcinoma?",
    "answer": "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts"
  },
  {
    "id": "Medical-fcc037cd",
    "source": "Medical",
    "question": "What defines a mixed-type liver tumor?",
    "answer": "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components.",
    "question_type": "Fact Retrieval",
    "evidence": "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components"
  },
  {
    "id": "Medical-3d95a5f2",
    "source": "Medical",
    "question": "Where does primary liver cancer originate?",
    "answer": "Primary liver cancer originates in the liver.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary liver cancer originates in the liver"
  },
  {
    "id": "Medical-0dfddbfc",
    "source": "Medical",
    "question": "What is secondary liver cancer?",
    "answer": "Secondary liver cancer is cancer that has spread to the liver from another organ.",
    "question_type": "Fact Retrieval",
    "evidence": "Secondary liver cancer is cancer that has spread to the liver from another organ"
  },
  {
    "id": "Medical-4664e4cf",
    "source": "Medical",
    "question": "What is a major risk factor for developing liver cancer?",
    "answer": "Cirrhosis is a major risk factor for developing liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Cirrhosis is a major risk factor for developing liver cancer"
  },
  {
    "id": "Medical-135a7719",
    "source": "Medical",
    "question": "How does chronic hepatitis B infection affect liver cancer risk?",
    "answer": "Chronic hepatitis B infection increases the risk of liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Chronic hepatitis B infection increases the risk of liver cancer"
  },
  {
    "id": "Medical-33eeb504",
    "source": "Medical",
    "question": "How does chronic hepatitis C infection affect liver cancer risk?",
    "answer": "Chronic hepatitis C infection increases the risk of liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Chronic hepatitis C infection increases the risk of liver cancer"
  },
  {
    "id": "Medical-72938445",
    "source": "Medical",
    "question": "Is alcohol use a risk factor for liver cancer?",
    "answer": "Alcohol use is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Alcohol use is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-ad9d77bd",
    "source": "Medical",
    "question": "Does non-alcoholic fatty liver disease increase the risk of liver cancer?",
    "answer": "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-2c05b904",
    "source": "Medical",
    "question": "Is genetic hemochromatosis associated with liver cancer risk?",
    "answer": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-87c96cae",
    "source": "Medical",
    "question": "Does alpha-1-antitrypsin deficiency increase liver cancer risk?",
    "answer": "Alpha-1-antitrypsin deficiency is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Alpha-1-antitrypsin deficiency is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-d7f052f4",
    "source": "Medical",
    "question": "Is stage 4 primary biliary cholangitis a risk factor for liver cancer?",
    "answer": "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-b73b866c",
    "source": "Medical",
    "question": "Who should undergo screening for liver cancer?",
    "answer": "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B.",
    "question_type": "Fact Retrieval",
    "evidence": "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B"
  },
  {
    "id": "Medical-0c921721",
    "source": "Medical",
    "question": "What screening methods are used for liver cancer?",
    "answer": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months.",
    "question_type": "Fact Retrieval",
    "evidence": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
  },
  {
    "id": "Medical-7e444f04",
    "source": "Medical",
    "question": "Which biomarker may indicate primary liver cancer?",
    "answer": "Elevated alpha-fetoprotein (AFP) may indicate primary liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Elevated AFP may indicate primary liver cancer"
  },
  {
    "id": "Medical-4329a9ca",
    "source": "Medical",
    "question": "What tests are usually used to confirm the diagnosis of liver cancer?",
    "answer": "Diagnosis of liver cancer is usually confirmed with imaging tests.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of liver cancer is usually confirmed with imaging tests"
  },
  {
    "id": "Medical-36b41c81",
    "source": "Medical",
    "question": "When may a biopsy be needed in liver cancer diagnosis?",
    "answer": "Biopsy may be needed to confirm liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy may be needed to confirm liver cancer"
  },
  {
    "id": "Medical-73945218",
    "source": "Medical",
    "question": "How can liver cancer spread within the body?",
    "answer": "Liver cancer can spread directly through the liver or to distant sites such as lung or bone.",
    "question_type": "Fact Retrieval",
    "evidence": "Liver cancer can spread directly through the liver or to distant sites such as lung or bone"
  },
  {
    "id": "Medical-f4ba3ee9",
    "source": "Medical",
    "question": "What are common sites of liver cancer metastasis?",
    "answer": "Liver cancer most often metastasizes to the lung or bone.",
    "question_type": "Fact Retrieval",
    "evidence": "Liver cancer most often metastasizes to the lung or bone"
  },
  {
    "id": "Medical-ff8f3b0c",
    "source": "Medical",
    "question": "What anatomical structure is the origin of primary liver cancer?",
    "answer": "The liver is the origin of primary liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary liver cancer originates in the liver"
  },
  {
    "id": "Medical-10ad8346",
    "source": "Medical",
    "question": "Which anatomical structure is affected in intrahepatic cholangiocarcinoma?",
    "answer": "The bile ducts are affected in intrahepatic cholangiocarcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts"
  },
  {
    "id": "Medical-67178f3b",
    "source": "Medical",
    "question": "What is the relationship between cirrhosis and liver cancer?",
    "answer": "Cirrhosis is a major risk factor for developing liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Cirrhosis is a major risk factor for developing liver cancer"
  },
  {
    "id": "Medical-4eb4395b",
    "source": "Medical",
    "question": "What is the role of ultrasound in liver cancer?",
    "answer": "Ultrasound is used as a screening method for liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
  },
  {
    "id": "Medical-ce8ad4ae",
    "source": "Medical",
    "question": "What is the function of the alpha-fetoprotein (AFP) test in liver cancer?",
    "answer": "The alpha-fetoprotein (AFP) test is used as a screening method and elevated levels may indicate primary liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months; Elevated AFP may indicate primary liver cancer"
  },
  {
    "id": "Medical-aece5feb",
    "source": "Medical",
    "question": "Which genetic alteration is a risk factor for liver cancer?",
    "answer": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-8c555476",
    "source": "Medical",
    "question": "What is the origin of secondary liver cancer?",
    "answer": "Secondary liver cancer originates from other primary cancers such as colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Secondary liver cancer is cancer that has spread to the liver from another organ; Other primary cancers (e.g., colon cancer) are the origin"
  },
  {
    "id": "Medical-3c025533",
    "source": "Medical",
    "question": "Which diagnostic methods are listed for liver cancer in the ontology?",
    "answer": "Imaging tests and biopsy are diagnostic methods for liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of liver cancer is usually confirmed with imaging tests; Biopsy may be needed to confirm liver cancer"
  },
  {
    "id": "Medical-44eed7f9",
    "source": "Medical",
    "question": "Which liver cancer subtype is listed under hepatocellular carcinoma in the ontology?",
    "answer": "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of hepatocellular carcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age"
  },
  {
    "id": "Medical-f4b744e6",
    "source": "Medical",
    "question": "What are the main subtypes of thyroid cancer?",
    "answer": "Thyroid cancer is classified into papillary, follicular, oncocytic, medullary, and anaplastic subtypes.",
    "question_type": "Fact Retrieval",
    "evidence": "Thyroid cancer is classified into papillary, follicular, oncocytic, medullary, and anaplastic subtypes"
  },
  {
    "id": "Medical-1517e1c3",
    "source": "Medical",
    "question": "Which thyroid cancer subtype is the most common?",
    "answer": "Papillary thyroid carcinoma is the most common thyroid cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Papillary thyroid carcinoma is the most common thyroid cancer"
  },
  {
    "id": "Medical-9671d373",
    "source": "Medical",
    "question": "What is another name for oncocytic carcinoma?",
    "answer": "Oncocytic carcinoma is also known as Hrthle cell carcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Oncocytic carcinoma is also known as Hrthle cell carcinoma"
  },
  {
    "id": "Medical-63709f72",
    "source": "Medical",
    "question": "Which thyroid cancer subtype is the rarest and most aggressive?",
    "answer": "Anaplastic thyroid cancer is the most aggressive and rarest subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Anaplastic thyroid cancer is the most aggressive and rarest subtype"
  },
  {
    "id": "Medical-11483e85",
    "source": "Medical",
    "question": "What genetic alteration is associated with medullary thyroid cancer?",
    "answer": "Medullary thyroid cancer is associated with RET gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": "Medullary thyroid cancer can be inherited and is associated with RET gene fusion"
  },
  {
    "id": "Medical-43cdd405",
    "source": "Medical",
    "question": "What are the main risk factors for thyroid cancer?",
    "answer": "Radiation exposure to the head or neck, family history, and inherited syndromes increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation exposure to the head or neck increases risk of thyroid cancer; Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk"
  },
  {
    "id": "Medical-1068c5b7",
    "source": "Medical",
    "question": "Which inherited syndromes are linked to increased thyroid cancer risk?",
    "answer": "FAP, Carney complex, Cowden syndrome, and MEN are inherited syndromes linked to increased thyroid cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk"
  },
  {
    "id": "Medical-e21aceef",
    "source": "Medical",
    "question": "What symptoms can large thyroid nodules cause?",
    "answer": "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems"
  },
  {
    "id": "Medical-3226c376",
    "source": "Medical",
    "question": "Which tests are recommended for evaluating thyroid nodules?",
    "answer": "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules.",
    "question_type": "Fact Retrieval",
    "evidence": "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules"
  },
  {
    "id": "Medical-420f3886",
    "source": "Medical",
    "question": "What procedure is used to sample suspicious thyroid nodules?",
    "answer": "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules.",
    "question_type": "Fact Retrieval",
    "evidence": "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules"
  },
  {
    "id": "Medical-bedfa4d0",
    "source": "Medical",
    "question": "What is the main treatment for most thyroid cancers?",
    "answer": "Surgery is the main treatment for most thyroid cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is the main treatment for most thyroid cancers"
  },
  {
    "id": "Medical-06892ea0",
    "source": "Medical",
    "question": "When is lobectomy considered for thyroid cancer?",
    "answer": "Lobectomy is an option for small, low-risk differentiated thyroid cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Lobectomy is an option for small, low-risk differentiated thyroid cancers"
  },
  {
    "id": "Medical-219d2cb0",
    "source": "Medical",
    "question": "What is the recommended surgery for larger or invasive thyroid cancers?",
    "answer": "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers"
  },
  {
    "id": "Medical-d5a2a39b",
    "source": "Medical",
    "question": "What additional surgical procedure is performed if lymph nodes are involved in thyroid cancer?",
    "answer": "Neck dissection is performed if lymph nodes are involved.",
    "question_type": "Fact Retrieval",
    "evidence": "Neck dissection is performed if lymph nodes are involved"
  },
  {
    "id": "Medical-5a111bc2",
    "source": "Medical",
    "question": "What therapy is required after total thyroidectomy?",
    "answer": "Thyroid hormone replacement therapy is required after total thyroidectomy.",
    "question_type": "Fact Retrieval",
    "evidence": "Thyroid hormone replacement therapy is required after total thyroidectomy"
  },
  {
    "id": "Medical-2e96fdbb",
    "source": "Medical",
    "question": "What is the standard medication for thyroid hormone replacement?",
    "answer": "Levothyroxine is the standard thyroid hormone replacement.",
    "question_type": "Fact Retrieval",
    "evidence": "Levothyroxine is the standard thyroid hormone replacement"
  },
  {
    "id": "Medical-74ed1afe",
    "source": "Medical",
    "question": "For which thyroid cancer subtypes is RAI therapy not effective?",
    "answer": "RAI therapy is not effective for medullary or anaplastic thyroid cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "RAI therapy is not effective for medullary or anaplastic thyroid cancer"
  },
  {
    "id": "Medical-dffcdcf8",
    "source": "Medical",
    "question": "What treatment is used for anaplastic, recurrent, or metastatic thyroid cancers not amenable to surgery or RAI?",
    "answer": "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI.",
    "question_type": "Fact Retrieval",
    "evidence": "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI"
  },
  {
    "id": "Medical-130e07e9",
    "source": "Medical",
    "question": "When is targeted therapy indicated in thyroid cancer?",
    "answer": "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis"
  },
  {
    "id": "Medical-7e564d1e",
    "source": "Medical",
    "question": "Which targeted therapies are used for progressive, unresectable, or metastatic thyroid cancer?",
    "answer": "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer"
  },
  {
    "id": "Medical-dc537cd7",
    "source": "Medical",
    "question": "What is the role of chemotherapy in thyroid cancer?",
    "answer": "Chemotherapy is rarely effective and mainly used for anaplastic thyroid cancer with radiation.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy is rarely effective, mainly used for anaplastic thyroid cancer with radiation"
  },
  {
    "id": "Medical-af243069",
    "source": "Medical",
    "question": "What biomarkers are recommended for testing in recurrent, advanced, or metastatic thyroid cancers not treatable with RAI?",
    "answer": "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, and TMB-H.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, TMB-H"
  },
  {
    "id": "Medical-8a22c205",
    "source": "Medical",
    "question": "What follow-up is recommended after total thyroidectomy?",
    "answer": "Follow-up after total thyroidectomy includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound"
  },
  {
    "id": "Medical-0ad1bc85",
    "source": "Medical",
    "question": "What may rising thyroglobulin after thyroidectomy indicate?",
    "answer": "Rising thyroglobulin after thyroidectomy may indicate recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Rising thyroglobulin after thyroidectomy may indicate recurrence"
  },
  {
    "id": "Medical-cdd407be",
    "source": "Medical",
    "question": "To which organs does metastatic thyroid cancer most commonly spread?",
    "answer": "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord"
  },
  {
    "id": "Medical-ccfe8840",
    "source": "Medical",
    "question": "What is an option for very-low-risk papillary thyroid cancers?",
    "answer": "Active surveillance is an option for very-low-risk papillary thyroid cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Active surveillance is an option for very-low-risk papillary thyroid cancers"
  },
  {
    "id": "Medical-880faffb",
    "source": "Medical",
    "question": "What laboratory tests are included in the follow-up of thyroid cancer?",
    "answer": "Laboratory tests include TSH, thyroglobulin (Tg), and anti-thyroglobulin antibodies (Tg ab).",
    "question_type": "Fact Retrieval",
    "evidence": "Laboratory: [\"TSH test\", \"Thyroglobulin (Tg)\", \"Anti-thyroglobulin antibodies (Tg ab)\"]"
  },
  {
    "id": "Medical-f944ae15",
    "source": "Medical",
    "question": "Which imaging methods are used for thyroid cancer diagnosis?",
    "answer": "Imaging methods include ultrasound, neck ultrasound, CT scan, MRI, and whole-body RAI scan.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging: [\"Ultrasound\", \"Neck ultrasound\", \"CT scan\", \"MRI\", \"Whole-body RAI scan\"]"
  },
  {
    "id": "Medical-666afa8e",
    "source": "Medical",
    "question": "What is the purpose of molecular tests in thyroid cancer diagnosis?",
    "answer": "Molecular tests can help determine malignancy and need for surgery.",
    "question_type": "Fact Retrieval",
    "evidence": "Molecular tests can help determine malignancy and need for surgery"
  },
  {
    "id": "Medical-db48e1e1",
    "source": "Medical",
    "question": "What is the recommended treatment for localized thyroid cancer?",
    "answer": "Treatment for localized thyroid cancer includes surgery (lobectomy or total thyroidectomy) and RAI therapy if indicated.",
    "question_type": "Fact Retrieval",
    "evidence": "Localized: {\"Treatment\": [\"Surgery (lobectomy or total thyroidectomy)\", \"RAI therapy (if indicated)\"]}"
  },
  {
    "id": "Medical-d184bb36",
    "source": "Medical",
    "question": "What is the recommended treatment for regional thyroid cancer with lymph node involvement?",
    "answer": "Treatment includes surgery with neck dissection and RAI therapy if indicated.",
    "question_type": "Fact Retrieval",
    "evidence": "Regional (lymph node involvement): {\"Treatment\": [\"Surgery with neck dissection\", \"RAI therapy (if indicated)\"]}"
  },
  {
    "id": "Medical-4e0348b9",
    "source": "Medical",
    "question": "What are the treatment options for thyroid cancer with distant metastasis?",
    "answer": "Treatment options for distant metastasis include RAI therapy (if iodine-avid), targeted therapy, external beam radiation therapy, chemotherapy (for anaplastic), and clinical trial.",
    "question_type": "Fact Retrieval",
    "evidence": "Distant metastasis: {\"Treatment\": [\"RAI therapy (if iodine-avid)\", \"Targeted therapy\", \"External beam radiation therapy\", \"Chemotherapy (for anaplastic)\", \"Clinical trial\"]}"
  },
  {
    "id": "Medical-35f5fbd3",
    "source": "Medical",
    "question": "Which gene mutations are considered actionable biomarkers in thyroid cancer?",
    "answer": "Actionable biomarkers include BRAF gene mutation, RET gene fusion, ALK gene fusion, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker: [\"BRAF gene mutation\", \"RET gene fusion\", \"ALK gene fusion\", \"NTRK gene fusion\"]"
  },
  {
    "id": "Medical-f8d40959",
    "source": "Medical",
    "question": "What is the primary method for detecting recurrence in thyroid cancer?",
    "answer": "Detection of recurrence is primarily by rising thyroglobulin, neck ultrasound, and imaging (CT, MRI).",
    "question_type": "Fact Retrieval",
    "evidence": "Recurrence: {\"Detection\": [\"Rising thyroglobulin\", \"Neck ultrasound\", \"Imaging (CT, MRI)\"]}"
  },
  {
    "id": "Medical-edb040bb",
    "source": "Medical",
    "question": "What is the origin of primary bone cancer?",
    "answer": "Primary bone cancer originates in bone or cartilage.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary bone cancer originates in bone or cartilage"
  },
  {
    "id": "Medical-84c13f69",
    "source": "Medical",
    "question": "What are secondary bone malignancies?",
    "answer": "Secondary bone malignancies are cancers that have metastasized to bone from other organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Secondary bone malignancies are cancers that have metastasized to bone from other organs"
  },
  {
    "id": "Medical-2bd43819",
    "source": "Medical",
    "question": "Which cancers commonly metastasize to bone?",
    "answer": "Breast cancer, lung cancer, and kidney cancer can metastasize to bone.",
    "question_type": "Fact Retrieval",
    "evidence": "Secondary bone malignancy: Origin: [Breast cancer, Lung cancer, Kidney cancer]"
  },
  {
    "id": "Medical-6580dc7a",
    "source": "Medical",
    "question": "What are the main subtypes of bone sarcoma?",
    "answer": "Bone sarcomas include osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma, and giant cell tumor of bone.",
    "question_type": "Fact Retrieval",
    "evidence": "Bone sarcomas include osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma, and giant cell tumor of bone"
  },
  {
    "id": "Medical-9a0c1ed4",
    "source": "Medical",
    "question": "Where does osteosarcoma most commonly arise?",
    "answer": "Osteosarcoma commonly arises in the metaphysis near growth plates.",
    "question_type": "Fact Retrieval",
    "evidence": "Osteosarcoma commonly arises in the metaphysis near growth plates"
  },
  {
    "id": "Medical-0cac50ed",
    "source": "Medical",
    "question": "What is the characteristic genetic alteration in Ewing sarcoma?",
    "answer": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1.",
    "question_type": "Fact Retrieval",
    "evidence": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1"
  },
  {
    "id": "Medical-122b1d5d",
    "source": "Medical",
    "question": "Which bone cancer subtype starts in cartilage-forming cells?",
    "answer": "Chondrosarcoma starts in cartilage-forming cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Chondrosarcoma starts in cartilage-forming cells"
  },
  {
    "id": "Medical-54f08470",
    "source": "Medical",
    "question": "From which cells does chordoma arise?",
    "answer": "Chordoma arises from notochordal cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Chordoma arises from notochordal cells, typically in the sacrum or base of skull"
  },
  {
    "id": "Medical-eefdc433",
    "source": "Medical",
    "question": "What anatomic locations are typical for chordoma?",
    "answer": "Chordoma typically arises in the sacrum or base of skull.",
    "question_type": "Fact Retrieval",
    "evidence": "Chordoma arises from notochordal cells, typically in the sacrum or base of skull"
  },
  {
    "id": "Medical-6ded047c",
    "source": "Medical",
    "question": "Where does giant cell tumor of bone often occur?",
    "answer": "Giant cell tumor of bone often occurs in the metaphysis and epiphysis.",
    "question_type": "Fact Retrieval",
    "evidence": "Giant cell tumor of bone often occurs in the metaphysis and epiphysis"
  },
  {
    "id": "Medical-dc9df053",
    "source": "Medical",
    "question": "Which imaging tests are used for bone cancer diagnosis?",
    "answer": "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan"
  },
  {
    "id": "Medical-c39b1031",
    "source": "Medical",
    "question": "How is the diagnosis of bone cancer confirmed?",
    "answer": "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy"
  },
  {
    "id": "Medical-38953b85",
    "source": "Medical",
    "question": "What blood tests are used in the evaluation of bone cancer?",
    "answer": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation"
  },
  {
    "id": "Medical-0fcdee63",
    "source": "Medical",
    "question": "What is the purpose of genetic cancer risk testing in bone cancer?",
    "answer": "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk"
  },
  {
    "id": "Medical-856e9c5c",
    "source": "Medical",
    "question": "What does biomarker testing in bone cancer include?",
    "answer": "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden"
  },
  {
    "id": "Medical-4dc9127d",
    "source": "Medical",
    "question": "Which mutation in chondrosarcoma can be targeted with ivosidenib?",
    "answer": "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib.",
    "question_type": "Fact Retrieval",
    "evidence": "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib"
  },
  {
    "id": "Medical-54b3e97f",
    "source": "Medical",
    "question": "Which status may be treated with pembrolizumab in bone cancer?",
    "answer": "MSI-H/dMMR status may be treated with pembrolizumab.",
    "question_type": "Fact Retrieval",
    "evidence": "MSI-H/dMMR status may be treated with pembrolizumab"
  },
  {
    "id": "Medical-7dd6e939",
    "source": "Medical",
    "question": "What treatments are available for tumor mutational burden-high (TMB-H) bone cancers?",
    "answer": "TMB-H may be treated with pembrolizumab, nivolumab, or ipilimumab.",
    "question_type": "Fact Retrieval",
    "evidence": "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab"
  },
  {
    "id": "Medical-142025a5",
    "source": "Medical",
    "question": "What system is used for staging bone cancer?",
    "answer": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
    "question_type": "Fact Retrieval",
    "evidence": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)"
  },
  {
    "id": "Medical-0b0c4cf9",
    "source": "Medical",
    "question": "How is tumor grade described in bone cancer?",
    "answer": "Tumor grade describes histologic differentiation.",
    "question_type": "Fact Retrieval",
    "evidence": "Tumor grade (G) describes histologic differentiation"
  },
  {
    "id": "Medical-8f43b36b",
    "source": "Medical",
    "question": "How is the stage of bone cancer determined?",
    "answer": "Stage is determined by combining T, N, M, and G scores.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage is determined by combining T, N, M, and G scores"
  },
  {
    "id": "Medical-712b02a6",
    "source": "Medical",
    "question": "Which performance status scales are used in bone cancer treatment planning?",
    "answer": "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status (ECOG or KPS) is considered in treatment planning"
  },
  {
    "id": "Medical-5a2979a1",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed before bone cancer treatment?",
    "answer": "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment"
  },
  {
    "id": "Medical-7ced180c",
    "source": "Medical",
    "question": "What metabolic complication can bone cancer cause?",
    "answer": "Bone cancer can cause hypercalcemia due to bone destruction.",
    "question_type": "Fact Retrieval",
    "evidence": "Bone cancer can cause hypercalcemia due to bone destruction"
  },
  {
    "id": "Medical-45b7e7da",
    "source": "Medical",
    "question": "Where can bone cancer spread?",
    "answer": "Bone cancer can spread to lungs, other bones, or distant organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Bone cancer can spread to lungs, other bones, or distant organs"
  },
  {
    "id": "Medical-4a90fe75",
    "source": "Medical",
    "question": "Which gene fusions are biomarkers for Ewing sarcoma?",
    "answer": "EWSR1-FLI1 fusion and EWSR1-ERG fusion are biomarkers for Ewing sarcoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1"
  },
  {
    "id": "Medical-a07284fb",
    "source": "Medical",
    "question": "What is the role of alkaline phosphatase in bone cancer evaluation?",
    "answer": "Alkaline phosphatase is used as a blood test in the evaluation of bone cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation"
  },
  {
    "id": "Medical-9418792b",
    "source": "Medical",
    "question": "Which diagnostic methods are used for bone sarcomas?",
    "answer": "Diagnostic methods for bone sarcomas include X-ray, bone scan, CT scan, MRI, PET scan, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Osteosarcoma: Diagnostic Method: [X-ray, Bone scan, CT scan, MRI, PET scan, Biopsy]"
  },
  {
    "id": "Medical-6b20ca96",
    "source": "Medical",
    "question": "Which genetic alteration is associated with Ewing sarcoma?",
    "answer": "Ewing sarcoma is associated with the t(11;22) translocation.",
    "question_type": "Fact Retrieval",
    "evidence": "Ewing sarcoma: Genetic Alteration: [t(11;22) translocation]"
  },
  {
    "id": "Medical-7a495600",
    "source": "Medical",
    "question": "What are the main risk factors for bone cancer?",
    "answer": "Family history of cancer and germline mutations are risk factors for bone cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor: [Family history of cancer, Germline mutations]"
  },
  {
    "id": "Medical-a9564c89",
    "source": "Medical",
    "question": "What are common symptoms of bone cancer?",
    "answer": "Bone pain and hypercalcemia are symptoms of bone cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom: [Bone pain, Hypercalcemia]"
  },
  {
    "id": "Medical-dee2271e",
    "source": "Medical",
    "question": "What is the most common subtype of mouth cancer?",
    "answer": "Squamous cell carcinoma (SCC) is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer"
  },
  {
    "id": "Medical-f0c44705",
    "source": "Medical",
    "question": "Which cancer type does mouth cancer belong to?",
    "answer": "Mouth cancer is a type of head and neck cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Mouth cancer is a type of head and neck cancer"
  },
  {
    "id": "Medical-836b4146",
    "source": "Medical",
    "question": "What are alternative names for mouth cancer?",
    "answer": "Mouth cancer is also known as oral cavity cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Mouth cancer: Also known as Oral cavity cancer"
  },
  {
    "id": "Medical-bb448a1f",
    "source": "Medical",
    "question": "Which anatomic sites can be affected by mouth cancer?",
    "answer": "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone.",
    "question_type": "Fact Retrieval",
    "evidence": "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone"
  },
  {
    "id": "Medical-92eb2c34",
    "source": "Medical",
    "question": "What is the basis for cancer staging in mouth cancer?",
    "answer": "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M).",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)"
  },
  {
    "id": "Medical-9a2bd385",
    "source": "Medical",
    "question": "What does Tis represent in the TNM classification for mouth cancer?",
    "answer": "Tis represents carcinoma in situ.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis: Carcinoma in situ"
  },
  {
    "id": "Medical-5492a510",
    "source": "Medical",
    "question": "What is the definition of T1 in mouth cancer TNM classification?",
    "answer": "T1 is a tumor 2 cm with depth of invasion (DOI) 5 mm.",
    "question_type": "Fact Retrieval",
    "evidence": "T1: Tumor 2 cm with DOI 5 mm"
  },
  {
    "id": "Medical-dbfb3406",
    "source": "Medical",
    "question": "How is T2 defined in mouth cancer TNM classification?",
    "answer": "T2 is a tumor 2 cm with DOI >5 mm or 24 cm with DOI 10 mm.",
    "question_type": "Fact Retrieval",
    "evidence": "T2: Tumor 2 cm with DOI >5 mm or 24 cm with DOI 10 mm"
  },
  {
    "id": "Medical-97502e67",
    "source": "Medical",
    "question": "What characterizes a T3 tumor in mouth cancer?",
    "answer": "T3 is a 24 cm tumor with DOI >10 mm or >4 cm tumor with DOI 10 mm.",
    "question_type": "Fact Retrieval",
    "evidence": "T3: 24 cm with DOI >10 mm or >4 cm with DOI 10 mm"
  },
  {
    "id": "Medical-4cb0599c",
    "source": "Medical",
    "question": "What does T4a indicate in mouth cancer staging?",
    "answer": "T4a indicates moderately advanced local disease.",
    "question_type": "Fact Retrieval",
    "evidence": "T4a: Moderately advanced local disease"
  },
  {
    "id": "Medical-2c20babc",
    "source": "Medical",
    "question": "What does T4b represent in the TNM classification for mouth cancer?",
    "answer": "T4b represents very advanced local disease.",
    "question_type": "Fact Retrieval",
    "evidence": "T4b: Very advanced local disease"
  },
  {
    "id": "Medical-0e684fa6",
    "source": "Medical",
    "question": "What is extranodal extension in the context of regional lymph nodes?",
    "answer": "Extranodal extension is cancer spread outside the lymph node.",
    "question_type": "Fact Retrieval",
    "evidence": "Extranodal extension: Cancer spread outside lymph node"
  },
  {
    "id": "Medical-acda3403",
    "source": "Medical",
    "question": "Which imaging tests are used for diagnosis and staging of mouth cancer?",
    "answer": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
  },
  {
    "id": "Medical-264200b9",
    "source": "Medical",
    "question": "What procedure is required to confirm the diagnosis of mouth cancer?",
    "answer": "Biopsy is required to confirm diagnosis and determine histology.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is required to confirm diagnosis and determine histology"
  },
  {
    "id": "Medical-4eefc14f",
    "source": "Medical",
    "question": "Which diagnostic methods may be used for mouth cancer besides imaging?",
    "answer": "Diagnostic methods include panoramic dental x-ray (Panorex), fine-needle aspiration (FNA), core needle biopsy (CNB), dental exam, speech and swallowing assessment, and nutrition assessment.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: [CT scan, MRI, PET/CT, Ultrasound, Panoramic dental x-ray (Panorex), Biopsy, Fine-needle aspiration (FNA), Core needle biopsy (CNB), Dental exam, Speech and swallowing assessment, Nutrition assessment]"
  },
  {
    "id": "Medical-6f5dcba9",
    "source": "Medical",
    "question": "What biomarkers may be tested in mouth cancer?",
    "answer": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)"
  },
  {
    "id": "Medical-dde9c1e8",
    "source": "Medical",
    "question": "Which risk factors are associated with mouth cancer?",
    "answer": "Tobacco use and alcohol use are risk factors for mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Tobacco and alcohol use are risk factors for mouth cancer"
  },
  {
    "id": "Medical-5ec05134",
    "source": "Medical",
    "question": "How does smoking or vaping affect mouth cancer treatment?",
    "answer": "Smoking or vaping negatively affects treatment outcomes and increases toxicity.",
    "question_type": "Fact Retrieval",
    "evidence": "Smoking or vaping negatively affects treatment outcomes and increases toxicity"
  },
  {
    "id": "Medical-6452b539",
    "source": "Medical",
    "question": "What is the role of depth of invasion (DOI) in mouth cancer?",
    "answer": "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer"
  },
  {
    "id": "Medical-bb899a92",
    "source": "Medical",
    "question": "What factors are considered in treatment planning for mouth cancer?",
    "answer": "Treatment planning is based on tumor location and stage.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment planning is based on tumor location and stage"
  },
  {
    "id": "Medical-9e29cae8",
    "source": "Medical",
    "question": "Which clinical assessment is important for treatment selection in mouth cancer?",
    "answer": "Performance status (ECOG) is considered in treatment selection.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status (ECOG) is considered in treatment selection"
  },
  {
    "id": "Medical-015910ee",
    "source": "Medical",
    "question": "How can cancer and its treatment impact fertility in mouth cancer patients?",
    "answer": "Cancer and its treatment can affect fertility.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer and its treatment can affect fertility"
  },
  {
    "id": "Medical-ab04c717",
    "source": "Medical",
    "question": "What symptoms may indicate mouth cancer?",
    "answer": "Symptoms may include changes in the mouth, tongue, or neck area.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms may include changes in the mouth, tongue, or neck area"
  },
  {
    "id": "Medical-69907f97",
    "source": "Medical",
    "question": "How is dental health affected by mouth cancer and its treatment?",
    "answer": "Dental health is affected by head and neck cancer and its treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Dental health is affected by head and neck cancer and its treatment"
  },
  {
    "id": "Medical-9c46dbea",
    "source": "Medical",
    "question": "What are the numbered stages used in mouth cancer staging?",
    "answer": "Numbered stages used are Stage 0, Stage I, Stage II, Stage III, and Stage IV.",
    "question_type": "Fact Retrieval",
    "evidence": "Numbered Stages: [Stage 0, Stage I, Stage II, Stage III, Stage IV]"
  },
  {
    "id": "Medical-f41a6eed",
    "source": "Medical",
    "question": "What is the purpose of a dental exam in mouth cancer management?",
    "answer": "Dental exam is a diagnostic method used in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: [Dental exam]"
  },
  {
    "id": "Medical-7f529715",
    "source": "Medical",
    "question": "Which assessments are included in the clinical evaluation of mouth cancer patients?",
    "answer": "Speech and swallowing assessment and nutrition assessment are included in clinical evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: [Speech and swallowing assessment, Nutrition assessment]"
  },
  {
    "id": "Medical-25024e4e",
    "source": "Medical",
    "question": "What is the significance of performance status (ECOG) in mouth cancer?",
    "answer": "Performance status (ECOG) is used as a clinical assessment in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical Assessment: [Performance status (ECOG)]"
  },
  {
    "id": "Medical-f598e40d",
    "source": "Medical",
    "question": "What fertility consideration should be addressed in mouth cancer patients?",
    "answer": "Fertility preservation is a fertility consideration in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility Consideration: [Fertility preservation]"
  },
  {
    "id": "Medical-f2c54ca8",
    "source": "Medical",
    "question": "Which genetic alterations may be evaluated in mouth cancer biomarker testing?",
    "answer": "MSI-H/dMMR and tumor mutational burden (TMB) may be evaluated.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)"
  },
  {
    "id": "Medical-c608379f",
    "source": "Medical",
    "question": "What is the role of a core needle biopsy (CNB) in mouth cancer?",
    "answer": "Core needle biopsy (CNB) is a diagnostic method for mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method: [Core needle biopsy (CNB)]"
  },
  {
    "id": "Medical-01f113f7",
    "source": "Medical",
    "question": "What is stomach cancer?",
    "answer": "Stomach cancer is a type of cancer that arises in the stomach.",
    "question_type": "Fact Retrieval",
    "evidence": "Stomach cancer is a type of cancer that arises in the stomach"
  },
  {
    "id": "Medical-9dfd9d7f",
    "source": "Medical",
    "question": "What is the most common subtype of stomach cancer?",
    "answer": "Most stomach cancers are adenocarcinomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Most stomach cancers are adenocarcinomas"
  },
  {
    "id": "Medical-437a1cdc",
    "source": "Medical",
    "question": "From which cells do adenocarcinomas of the stomach originate?",
    "answer": "Adenocarcinomas originate from cells lining the inside of the stomach that secrete mucus.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenocarcinomas originate from cells lining the inside of the stomach that secrete mucus"
  },
  {
    "id": "Medical-056be573",
    "source": "Medical",
    "question": "What are the two major subtypes of stomach adenocarcinoma?",
    "answer": "The two major subtypes are intestinal type adenocarcinoma and diffuse type adenocarcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse"
  },
  {
    "id": "Medical-79a34cfc",
    "source": "Medical",
    "question": "Which stomach adenocarcinoma subtype forms tube- and gland-shaped structures?",
    "answer": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures.",
    "question_type": "Fact Retrieval",
    "evidence": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures"
  },
  {
    "id": "Medical-b0ebc350",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma is more likely to have mutations treatable with targeted therapy?",
    "answer": "Intestinal type adenocarcinoma is more likely to have mutations treatable with targeted therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy"
  },
  {
    "id": "Medical-50852ffa",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma consists of scattered cells and is less common?",
    "answer": "Diffuse type adenocarcinoma consists of scattered cells and is less common.",
    "question_type": "Fact Retrieval",
    "evidence": "Diffuse type adenocarcinoma consists of scattered cells and is less common"
  },
  {
    "id": "Medical-0591c484",
    "source": "Medical",
    "question": "What defines early-stage stomach cancer?",
    "answer": "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes"
  },
  {
    "id": "Medical-2cd3be1d",
    "source": "Medical",
    "question": "What characterizes locoregional or locally advanced stomach cancer?",
    "answer": "Locoregional stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs"
  },
  {
    "id": "Medical-5bf4dcc9",
    "source": "Medical",
    "question": "What is metastatic stomach cancer?",
    "answer": "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes"
  },
  {
    "id": "Medical-5dedb4ec",
    "source": "Medical",
    "question": "Through which layers does stomach cancer spread outward?",
    "answer": "Stomach cancer spreads outward through the layers of the stomach wall.",
    "question_type": "Fact Retrieval",
    "evidence": "Stomach cancer spreads outward through the layers of the stomach wall"
  },
  {
    "id": "Medical-60b88999",
    "source": "Medical",
    "question": "Where do precancerous changes often occur before stomach cancer develops?",
    "answer": "Precancerous changes often occur in the mucosa before cancer develops.",
    "question_type": "Fact Retrieval",
    "evidence": "Precancerous changes often occur in the mucosa before cancer develops"
  },
  {
    "id": "Medical-442b042c",
    "source": "Medical",
    "question": "To which organs can stomach cancer spread?",
    "answer": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen"
  },
  {
    "id": "Medical-b76a0ae4",
    "source": "Medical",
    "question": "What diagnostic methods are used for stomach cancer?",
    "answer": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-d8dd3085",
    "source": "Medical",
    "question": "What is a risk factor for stomach cancer related to infection?",
    "answer": "H. pylori infection is a risk factor for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "H. pylori infection is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-e77a80c7",
    "source": "Medical",
    "question": "Is family history a risk factor for stomach cancer?",
    "answer": "Family history is a risk factor for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Family history is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-5778d49d",
    "source": "Medical",
    "question": "What symptoms can stomach cancer cause?",
    "answer": "Symptoms can include ulcer or mass formation in the stomach.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms can include ulcer or mass formation in the stomach"
  },
  {
    "id": "Medical-b182ee0f",
    "source": "Medical",
    "question": "What are the anatomical locations within the stomach relevant to stomach cancer?",
    "answer": "The anatomical locations are cardia, fundus, body, antrum, pylorus, and esophagogastric junction.",
    "question_type": "Fact Retrieval",
    "evidence": "The anatomical locations are cardia, fundus, body, antrum, pylorus, and esophagogastric junction"
  },
  {
    "id": "Medical-33e91398",
    "source": "Medical",
    "question": "What are the main layers of the stomach wall?",
    "answer": "The stomach wall layers are mucosa, submucosa, muscle layer (muscularis propria), subserosa, and serosa.",
    "question_type": "Fact Retrieval",
    "evidence": "The stomach wall layers are mucosa, submucosa, muscle layer (muscularis propria), subserosa, and serosa"
  },
  {
    "id": "Medical-b59fdb33",
    "source": "Medical",
    "question": "Which diagnostic method is used to visually examine the stomach?",
    "answer": "Endoscopy is used to visually examine the stomach.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-75f97fc6",
    "source": "Medical",
    "question": "Which diagnostic method involves sampling tissue for analysis in stomach cancer?",
    "answer": "Biopsy is used to sample tissue for analysis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-4a56a9a5",
    "source": "Medical",
    "question": "What is the local spread pattern of stomach cancer?",
    "answer": "Local spread involves the stomach wall layers and regional lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Local spread involves the stomach wall layers and regional lymph nodes"
  },
  {
    "id": "Medical-77f07857",
    "source": "Medical",
    "question": "What is the distant spread pattern of stomach cancer?",
    "answer": "Distant spread involves the liver, peritoneum, distant lymph nodes, pancreas, and spleen.",
    "question_type": "Fact Retrieval",
    "evidence": "Distant spread involves the liver, peritoneum, distant lymph nodes, pancreas, and spleen"
  },
  {
    "id": "Medical-ed553dca",
    "source": "Medical",
    "question": "What is the role of biomarker testing in stomach cancer diagnosis?",
    "answer": "Biomarker testing is used as part of the diagnostic process for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-fc8c1f25",
    "source": "Medical",
    "question": "What genetic risk factor is listed for stomach cancer?",
    "answer": "Family history is listed as a genetic risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": "Family history is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-5470aded",
    "source": "Medical",
    "question": "Which stomach cancer subtype is less common?",
    "answer": "Diffuse type adenocarcinoma is less common.",
    "question_type": "Fact Retrieval",
    "evidence": "Diffuse type adenocarcinoma consists of scattered cells and is less common"
  },
  {
    "id": "Medical-4c68753b",
    "source": "Medical",
    "question": "Which stomach wall layer is the initial site for early-stage stomach cancer?",
    "answer": "The mucosa is the initial site for early-stage stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes"
  },
  {
    "id": "Medical-e18d2c7f",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma is more likely to benefit from targeted therapy?",
    "answer": "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy"
  },
  {
    "id": "Medical-cdf0477d",
    "source": "Medical",
    "question": "Which organs are commonly involved in metastatic stomach cancer?",
    "answer": "The liver, peritoneum, and distant lymph nodes are commonly involved.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes"
  },
  {
    "id": "Medical-e542c70c",
    "source": "Medical",
    "question": "What are two main symptoms of stomach cancer listed in the ontology?",
    "answer": "Ulcer and mass are two main symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms can include ulcer or mass formation in the stomach"
  },
  {
    "id": "Medical-d3bb30e3",
    "source": "Medical",
    "question": "What is the significance of the mucosa in stomach cancer development?",
    "answer": "Precancerous changes often occur in the mucosa before cancer develops.",
    "question_type": "Fact Retrieval",
    "evidence": "Precancerous changes often occur in the mucosa before cancer develops"
  },
  {
    "id": "Medical-56aa3e9e",
    "source": "Medical",
    "question": "What type of tumor is glioma?",
    "answer": "Glioma is a type of malignant brain tumor.",
    "question_type": "Fact Retrieval",
    "evidence": "Glioma is a type of malignant brain tumor"
  },
  {
    "id": "Medical-da451391",
    "source": "Medical",
    "question": "From which cells do gliomas develop?",
    "answer": "Gliomas develop from glial cells in the central nervous system.",
    "question_type": "Fact Retrieval",
    "evidence": "Gliomas develop from glial cells in the central nervous system"
  },
  {
    "id": "Medical-5724612b",
    "source": "Medical",
    "question": "What are the most common subtypes of glioma?",
    "answer": "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma.",
    "question_type": "Fact Retrieval",
    "evidence": "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma"
  },
  {
    "id": "Medical-e84e4ea0",
    "source": "Medical",
    "question": "Which glioma subtype is the most aggressive?",
    "answer": "Glioblastoma is the most aggressive subtype of glioma.",
    "question_type": "Fact Retrieval",
    "evidence": "Glioblastoma is the most aggressive subtype of glioma"
  },
  {
    "id": "Medical-9884a4b5",
    "source": "Medical",
    "question": "How are gliomas classified?",
    "answer": "Gliomas are classified by histology, grade, and biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": "Gliomas are classified by histology, grade, and biomarkers"
  },
  {
    "id": "Medical-8b6ad218",
    "source": "Medical",
    "question": "Which grades are considered low-grade gliomas?",
    "answer": "Grades 1 and 2 are low-grade gliomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas"
  },
  {
    "id": "Medical-a49f0182",
    "source": "Medical",
    "question": "Which grades are classified as high-grade gliomas?",
    "answer": "Grades 3 and 4 are high-grade gliomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas"
  },
  {
    "id": "Medical-0ae25b73",
    "source": "Medical",
    "question": "What is the most common grade of glioblastoma?",
    "answer": "Grade 4 gliomas are most commonly glioblastomas.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade 4 gliomas are most commonly glioblastomas"
  },
  {
    "id": "Medical-d272b033",
    "source": "Medical",
    "question": "What biomarker is used to classify gliomas?",
    "answer": "IDH mutation is a biomarker used to classify gliomas.",
    "question_type": "Fact Retrieval",
    "evidence": "IDH mutation is a biomarker used to classify gliomas"
  },
  {
    "id": "Medical-90f1b2e6",
    "source": "Medical",
    "question": "What is the most useful imaging test for identifying glioma?",
    "answer": "MRI is the most useful imaging test for identifying glioma.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI is the most useful imaging test for identifying glioma"
  },
  {
    "id": "Medical-fe7631ea",
    "source": "Medical",
    "question": "What procedures are required for the definitive diagnosis and molecular testing of glioma?",
    "answer": "Biopsy is required for definitive diagnosis and molecular testing.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is required for definitive diagnosis and molecular testing"
  },
  {
    "id": "Medical-e436ffd1",
    "source": "Medical",
    "question": "Which diagnostic methods are used for glioma diagnosis?",
    "answer": "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy"
  },
  {
    "id": "Medical-de960459",
    "source": "Medical",
    "question": "What are common symptoms of glioma?",
    "answer": "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems"
  },
  {
    "id": "Medical-b0d802db",
    "source": "Medical",
    "question": "What are the main treatment options for glioma?",
    "answer": "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials"
  },
  {
    "id": "Medical-30a29470",
    "source": "Medical",
    "question": "What surgical procedures may be performed for glioma?",
    "answer": "Surgery may involve resection or biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery may involve resection or biopsy"
  },
  {
    "id": "Medical-7959a3b5",
    "source": "Medical",
    "question": "What additional therapy is required for high-grade gliomas after surgery?",
    "answer": "High-grade gliomas require additional therapy after surgery.",
    "question_type": "Fact Retrieval",
    "evidence": "High-grade gliomas require additional therapy after surgery"
  },
  {
    "id": "Medical-1392e5d5",
    "source": "Medical",
    "question": "Are gliomas curable?",
    "answer": "Gliomas are rarely curable but are treatable.",
    "question_type": "Fact Retrieval",
    "evidence": "Gliomas are rarely curable but are treatable"
  },
  {
    "id": "Medical-981edc6b",
    "source": "Medical",
    "question": "What is recommended for follow-up after glioma treatment?",
    "answer": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence"
  },
  {
    "id": "Medical-28389677",
    "source": "Medical",
    "question": "What is assessed to determine treatment eligibility for glioma?",
    "answer": "Performance status is assessed to determine treatment eligibility.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status is assessed to determine treatment eligibility"
  },
  {
    "id": "Medical-7b37919a",
    "source": "Medical",
    "question": "In which age group are gliomas more common?",
    "answer": "Gliomas are more common in adults than children.",
    "question_type": "Fact Retrieval",
    "evidence": "Gliomas are more common in adults than children"
  },
  {
    "id": "Medical-ea8aac67",
    "source": "Medical",
    "question": "Are most gliomas hereditary?",
    "answer": "Most gliomas are not hereditary.",
    "question_type": "Fact Retrieval",
    "evidence": "Most gliomas are not hereditary"
  },
  {
    "id": "Medical-d6bbd4d7",
    "source": "Medical",
    "question": "Which grades are included in low-grade gliomas according to the ontology?",
    "answer": "Low-grade gliomas include Grade 1 and Grade 2.",
    "question_type": "Fact Retrieval",
    "evidence": "Low-grade gliomas include Grade 1 and Grade 2"
  },
  {
    "id": "Medical-885582ad",
    "source": "Medical",
    "question": "Which grades are included in high-grade gliomas according to the ontology?",
    "answer": "High-grade gliomas include Grade 3 and Grade 4.",
    "question_type": "Fact Retrieval",
    "evidence": "High-grade gliomas include Grade 3 and Grade 4"
  },
  {
    "id": "Medical-3c7e7363",
    "source": "Medical",
    "question": "What performance status assessment is used in glioma diagnosis?",
    "answer": "Performance status is assessed as part of the clinical evaluation for glioma.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical evaluation for glioma includes performance status assessment"
  },
  {
    "id": "Medical-bf9e60be",
    "source": "Medical",
    "question": "Which imaging methods are used for glioma diagnosis according to the ontology?",
    "answer": "MRI and CT scan are imaging methods used for glioma diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging for glioma diagnosis includes MRI and CT scan"
  },
  {
    "id": "Medical-aca25b7f",
    "source": "Medical",
    "question": "What tissue sampling methods are available for glioma diagnosis?",
    "answer": "Tissue sampling for glioma diagnosis includes biopsy, stereotactic biopsy, open biopsy, and resection.",
    "question_type": "Fact Retrieval",
    "evidence": "Tissue sampling methods for glioma diagnosis include biopsy, stereotactic biopsy, open biopsy, and resection"
  },
  {
    "id": "Medical-86e59474",
    "source": "Medical",
    "question": "What laboratory tests are conducted for glioma diagnosis?",
    "answer": "Laboratory testing for glioma includes molecular testing and histology.",
    "question_type": "Fact Retrieval",
    "evidence": "Laboratory testing for glioma includes molecular testing and histology"
  },
  {
    "id": "Medical-2db59cde",
    "source": "Medical",
    "question": "What are the risk factors for glioma?",
    "answer": "Risk factors for glioma include age (more common in adults) and non-hereditary mutation.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors for glioma include age (more common in adults) and non-hereditary mutation"
  },
  {
    "id": "Medical-20cc11c5",
    "source": "Medical",
    "question": "Which biomarker is used for both astrocytoma and oligodendroglioma classification?",
    "answer": "IDH mutation is used as a biomarker for both astrocytoma and oligodendroglioma.",
    "question_type": "Fact Retrieval",
    "evidence": "IDH mutation is a biomarker for astrocytoma and oligodendroglioma"
  },
  {
    "id": "Medical-228c6c0b",
    "source": "Medical",
    "question": "What is the prognosis for low-grade gliomas?",
    "answer": "Low-grade gliomas have better prognosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Low-grade gliomas have better prognosis"
  },
  {
    "id": "Medical-54ee540e",
    "source": "Medical",
    "question": "What is the prognosis for high-grade gliomas?",
    "answer": "High-grade gliomas have poorer prognosis.",
    "question_type": "Fact Retrieval",
    "evidence": "High-grade gliomas have poorer prognosis"
  },
  {
    "id": "Medical-198aa7f0",
    "source": "Medical",
    "question": "What is the purpose of follow-up MRI in glioma patients?",
    "answer": "Follow-up MRI is used to monitor for recurrence in glioma patients.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence"
  },
  {
    "id": "Medical-96567841",
    "source": "Medical",
    "question": "What type of cancer is AML?",
    "answer": "AML is a type of blood cancer that starts in the stem cells of bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": "AML is a type of blood cancer that starts in the stem cells of bone marrow"
  },
  {
    "id": "Medical-78c160d3",
    "source": "Medical",
    "question": "How is AML diagnosed?",
    "answer": "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
    "question_type": "Fact Retrieval",
    "evidence": "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood"
  },
  {
    "id": "Medical-42ab49a0",
    "source": "Medical",
    "question": "What defines AML subtypes?",
    "answer": "AML subtypes are defined by gene mutations or abnormal chromosomes.",
    "question_type": "Fact Retrieval",
    "evidence": "AML subtypes are defined by gene mutations or abnormal chromosomes"
  },
  {
    "id": "Medical-92941568",
    "source": "Medical",
    "question": "Which gene fusion characterizes Acute promyelocytic leukemia (APL)?",
    "answer": "The PML::RARA fusion gene characterizes APL.",
    "question_type": "Fact Retrieval",
    "evidence": "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene"
  },
  {
    "id": "Medical-44f40835",
    "source": "Medical",
    "question": "What is Blastic plasmacytoid dendritic cell neoplasm (BPDCN)?",
    "answer": "BPDCN is an aggressive subtype of AML.",
    "question_type": "Fact Retrieval",
    "evidence": "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of AML"
  },
  {
    "id": "Medical-4535e4eb",
    "source": "Medical",
    "question": "What are the main symptoms of AML?",
    "answer": "Symptoms of AML include fatigue, infections, bleeding, and bruising.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of AML include fatigue, infections, bleeding, and bruising"
  },
  {
    "id": "Medical-93bdac1d",
    "source": "Medical",
    "question": "What causes low counts of healthy blood cells in AML?",
    "answer": "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells.",
    "question_type": "Fact Retrieval",
    "evidence": "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells"
  },
  {
    "id": "Medical-98aa1f14",
    "source": "Medical",
    "question": "Which laboratory tests are used for AML diagnosis?",
    "answer": "Complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Laboratory tests used for AML diagnosis include complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests"
  },
  {
    "id": "Medical-6d25f354",
    "source": "Medical",
    "question": "What bone marrow evaluations are performed for AML diagnosis?",
    "answer": "Bone marrow aspirate, bone marrow biopsy, and histopathology are performed.",
    "question_type": "Fact Retrieval",
    "evidence": "Bone marrow evaluation for AML includes bone marrow aspirate, bone marrow biopsy, and histopathology"
  },
  {
    "id": "Medical-722f609c",
    "source": "Medical",
    "question": "What molecular and cytogenetic tests are used in AML workup?",
    "answer": "Karyotype, FISH, next-generation sequencing (NGS), and PCR are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Molecular and cytogenetic testing for AML includes karyotype, FISH, next-generation sequencing (NGS), and PCR"
  },
  {
    "id": "Medical-9a67636f",
    "source": "Medical",
    "question": "Which imaging modalities assess extramedullary disease in AML?",
    "answer": "CT scan, MRI, and PET/CT are used to assess extramedullary disease or complications.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging (CT, MRI, PET/CT) is used to assess extramedullary disease or complications"
  },
  {
    "id": "Medical-b429ff37",
    "source": "Medical",
    "question": "What is the standard of care for AML treatment?",
    "answer": "Chemotherapy is the standard of care for AML.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy is the standard of care for AML"
  },
  {
    "id": "Medical-1345f015",
    "source": "Medical",
    "question": "Which chemotherapy agents are commonly used in AML?",
    "answer": "Chemotherapy regimens may include cytarabine, daunorubicin, idarubicin, and hypomethylating agents such as azacitidine and decitabine.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin), and hypomethylating agents (e.g., azacitidine, decitabine)"
  },
  {
    "id": "Medical-972209d3",
    "source": "Medical",
    "question": "What is the role of targeted therapy in AML?",
    "answer": "Targeted therapies are used for AML with specific genetic alterations, such as FLT3 inhibitors for FLT3-mutated AML and gemtuzumab ozogamicin for CD33-positive AML.",
    "question_type": "Fact Retrieval",
    "evidence": "Targeted therapies are used for AML with specific genetic alterations, such as FLT3 inhibitors for FLT3-mutated AML and gemtuzumab ozogamicin for CD33-positive AML"
  },
  {
    "id": "Medical-5cd1d09f",
    "source": "Medical",
    "question": "What are common genetic alterations found in AML?",
    "answer": "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA.",
    "question_type": "Fact Retrieval",
    "evidence": "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA"
  },
  {
    "id": "Medical-be0f5119",
    "source": "Medical",
    "question": "Which biomarker is targeted by gemtuzumab ozogamicin in AML?",
    "answer": "CD33 is the biomarker targeted by gemtuzumab ozogamicin.",
    "question_type": "Fact Retrieval",
    "evidence": "Targeted therapies are used for AML with specific genetic alterations, such as gemtuzumab ozogamicin for CD33-positive AML"
  },
  {
    "id": "Medical-284507d2",
    "source": "Medical",
    "question": "What is the goal of AML treatment phases?",
    "answer": "The goal of AML treatment phases is achieving remission.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for AML is delivered in phases with the goal of achieving remission"
  },
  {
    "id": "Medical-514e9bd7",
    "source": "Medical",
    "question": "When is hematopoietic cell transplant considered in AML?",
    "answer": "Hematopoietic cell transplant is considered for eligible patients.",
    "question_type": "Fact Retrieval",
    "evidence": "Hematopoietic cell transplant is considered for eligible patients"
  },
  {
    "id": "Medical-8ee2e2c7",
    "source": "Medical",
    "question": "What factors influence AML treatment selection?",
    "answer": "Performance status and general health influence treatment selection.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status and general health influence treatment selection"
  },
  {
    "id": "Medical-459e0a03",
    "source": "Medical",
    "question": "What should be discussed before starting systemic therapy for AML regarding fertility?",
    "answer": "Fertility preservation should be discussed before starting systemic therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility preservation should be discussed before starting systemic therapy"
  },
  {
    "id": "Medical-393eabb5",
    "source": "Medical",
    "question": "What supportive care measures are provided in AML?",
    "answer": "Supportive care includes transfusions, infection prevention, and management of side effects.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive care includes transfusions, infection prevention, and management of side effects"
  },
  {
    "id": "Medical-70d75840",
    "source": "Medical",
    "question": "What are risk factors for developing AML?",
    "answer": "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML.",
    "question_type": "Fact Retrieval",
    "evidence": "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML"
  },
  {
    "id": "Medical-99a81ca9",
    "source": "Medical",
    "question": "Which performance status scales are used in AML?",
    "answer": "Eastern Cooperative Oncology Group (ECOG) score and Karnofsky Performance Status (KPS) are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status in AML is assessed using Eastern Cooperative Oncology Group (ECOG) score and Karnofsky Performance Status (KPS)"
  },
  {
    "id": "Medical-5d792183",
    "source": "Medical",
    "question": "What is the cell of origin for AML?",
    "answer": "AML originates from myeloid blasts and bone marrow stem cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Cell of Origin for AML includes myeloid blasts and bone marrow stem cells"
  },
  {
    "id": "Medical-4811934e",
    "source": "Medical",
    "question": "Which tests are used for immunophenotyping in AML diagnosis?",
    "answer": "Flow cytometry and immunophenotyping are used for immunophenotyping in AML diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Flow cytometry and immunophenotyping are used for immunophenotyping in AML diagnosis"
  },
  {
    "id": "Medical-81e86b6a",
    "source": "Medical",
    "question": "What genetic alteration is characteristic of APL?",
    "answer": "PML::RARA is the genetic alteration characteristic of APL.",
    "question_type": "Fact Retrieval",
    "evidence": "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene"
  },
  {
    "id": "Medical-bb057eb6",
    "source": "Medical",
    "question": "Which AML subtype commonly involves the skin?",
    "answer": "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) commonly involves the skin.",
    "question_type": "Fact Retrieval",
    "evidence": "BPDCN is a subtype of AML with sites of involvement including skin"
  },
  {
    "id": "Medical-8ec806c0",
    "source": "Medical",
    "question": "Which agents are classified as hypomethylating agents in AML treatment?",
    "answer": "Azacitidine (Vidaza) and decitabine (Dacogen) are hypomethylating agents used in AML.",
    "question_type": "Fact Retrieval",
    "evidence": "Hypomethylating Agents for AML include azacitidine (Vidaza) and decitabine (Dacogen)"
  },
  {
    "id": "Medical-ed54bccb",
    "source": "Medical",
    "question": "What are the main phases of AML treatment?",
    "answer": "The main treatment phases are induction, consolidation, and maintenance.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment Phase for AML includes induction, consolidation, and maintenance"
  },
  {
    "id": "Medical-5c36e1bb",
    "source": "Medical",
    "question": "What is the purpose of genetic and biomarker tests in AML?",
    "answer": "Genetic and biomarker tests are used to determine AML subtype and guide treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic and biomarker tests are used to determine AML subtype and guide treatment"
  },
  {
    "id": "Medical-2432d7b4",
    "source": "Medical",
    "question": "Which prognostic factors are important in AML?",
    "answer": "Important prognostic factors in AML are genetic alterations, performance status, age, and response to induction therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Prognostic Factor for AML includes genetic alterations, performance status, age, and response to induction therapy"
  },
  {
    "id": "Medical-67b8e0a9",
    "source": "Medical",
    "question": "What fertility preservation options are recommended in AML?",
    "answer": "Fertility preservation counseling and referral to a reproductive specialist are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility Preservation in AML includes fertility preservation counseling and referral to reproductive specialist"
  },
  {
    "id": "Medical-78cecf8c",
    "source": "Medical",
    "question": "What is the most common type of ovarian cancer?",
    "answer": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium"
  },
  {
    "id": "Medical-17badae3",
    "source": "Medical",
    "question": "Which subtypes are most common in epithelial ovarian cancer?",
    "answer": "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes.",
    "question_type": "Fact Retrieval",
    "evidence": "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes of epithelial ovarian cancer"
  },
  {
    "id": "Medical-1bb1f1db",
    "source": "Medical",
    "question": "What are some less common subtypes of ovarian cancer?",
    "answer": "Less common ovarian cancers include low-grade serous carcinoma, low-grade endometrioid carcinoma, carcinosarcoma, clear cell carcinoma, mucinous carcinoma, borderline epithelial tumor, malignant sex-cord stromal tumors, and malignant germ cell tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Less common ovarian cancers include low-grade serous carcinoma, low-grade endometrioid carcinoma, carcinosarcoma, clear cell carcinoma, mucinous carcinoma, borderline epithelial tumor, malignant sex-cord stromal tumors, and malignant germ cell tumors"
  },
  {
    "id": "Medical-ceb6a99b",
    "source": "Medical",
    "question": "Which cancers are managed similarly to ovarian cancer?",
    "answer": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer"
  },
  {
    "id": "Medical-c4b74b77",
    "source": "Medical",
    "question": "What imaging methods are used to diagnose ovarian cancer?",
    "answer": "Diagnosis of ovarian cancer involves imaging such as ultrasound, CT, MRI, and PET.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers"
  },
  {
    "id": "Medical-1a736b11",
    "source": "Medical",
    "question": "What are the common symptoms of ovarian cancer?",
    "answer": "Common symptoms include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex.",
    "question_type": "Fact Retrieval",
    "evidence": "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex"
  },
  {
    "id": "Medical-d8149b81",
    "source": "Medical",
    "question": "Which hereditary syndromes are major risk factors for ovarian cancer?",
    "answer": "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer"
  },
  {
    "id": "Medical-40918a31",
    "source": "Medical",
    "question": "Who should receive genetic testing for BRCA and other syndromes in ovarian cancer?",
    "answer": "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer"
  },
  {
    "id": "Medical-1043deff",
    "source": "Medical",
    "question": "What tumor biomarker tests are performed in ovarian cancer?",
    "answer": "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion"
  },
  {
    "id": "Medical-cd6393dc",
    "source": "Medical",
    "question": "What staging system is used for ovarian cancer?",
    "answer": "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging.",
    "question_type": "Fact Retrieval",
    "evidence": "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging"
  },
  {
    "id": "Medical-cf87aed7",
    "source": "Medical",
    "question": "What is the standard initial treatment for most ovarian cancers?",
    "answer": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers"
  },
  {
    "id": "Medical-767b1550",
    "source": "Medical",
    "question": "When may fertility-sparing surgery be considered in ovarian cancer?",
    "answer": "Fertility-sparing surgery may be considered for select early-stage cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility-sparing surgery may be considered for select early-stage cases"
  },
  {
    "id": "Medical-ae9a09e0",
    "source": "Medical",
    "question": "What chemotherapy regimen is typically recommended after surgery for ovarian cancer?",
    "answer": "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages"
  },
  {
    "id": "Medical-2ca3a0ac",
    "source": "Medical",
    "question": "Which drug may be added to chemotherapy in some ovarian cancer cases?",
    "answer": "Bevacizumab may be added to chemotherapy in some cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Bevacizumab may be added to chemotherapy in some cases"
  },
  {
    "id": "Medical-ba9612df",
    "source": "Medical",
    "question": "Which maintenance therapies are recommended for advanced or BRCA-mutated/HRD-positive ovarian cancers after initial treatment?",
    "answer": "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment"
  },
  {
    "id": "Medical-3e80d395",
    "source": "Medical",
    "question": "What does surveillance after ovarian cancer treatment include?",
    "answer": "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers"
  },
  {
    "id": "Medical-4160eed8",
    "source": "Medical",
    "question": "How is recurrence of ovarian cancer managed?",
    "answer": "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment.",
    "question_type": "Fact Retrieval",
    "evidence": "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment"
  },
  {
    "id": "Medical-0ce3e959",
    "source": "Medical",
    "question": "What are the treatment options for platinum-resistant ovarian cancer?",
    "answer": "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors"
  },
  {
    "id": "Medical-7caf80a1",
    "source": "Medical",
    "question": "How is platinum-sensitive recurrence of ovarian cancer treated?",
    "answer": "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery.",
    "question_type": "Fact Retrieval",
    "evidence": "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery"
  },
  {
    "id": "Medical-41491cb3",
    "source": "Medical",
    "question": "When are clinical trials recommended for ovarian cancer?",
    "answer": "Clinical trials are recommended for recurrent or persistent ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are recommended for recurrent or persistent ovarian cancer"
  },
  {
    "id": "Medical-fcbaf737",
    "source": "Medical",
    "question": "Which tumor markers are used in ovarian cancer diagnosis?",
    "answer": "Tumor markers include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, and HE4.",
    "question_type": "Fact Retrieval",
    "evidence": "Tumor marker tests include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, HE4"
  },
  {
    "id": "Medical-6b4b11a7",
    "source": "Medical",
    "question": "Which diagnostic procedures are available for ovarian cancer?",
    "answer": "Diagnostic methods include abdominal and pelvic exam, ultrasound, CT scan, MRI, PET scan, chest x-ray, diagnostic laparoscopy, biopsy, FNA, core biopsy, paracentesis, colonoscopy, upper endoscopy, CBC, blood chemistry profile, and liver function tests.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method includes abdominal and pelvic exam, ultrasound, CT scan, MRI, PET scan, chest x-ray, diagnostic laparoscopy, biopsy, fine-needle aspiration (FNA), core biopsy, paracentesis, colonoscopy, upper endoscopy, complete blood count (CBC), blood chemistry profile, liver function tests"
  },
  {
    "id": "Medical-476ca8b6",
    "source": "Medical",
    "question": "What surgical procedures are included in the treatment of ovarian cancer?",
    "answer": "Surgical procedures include hysterectomy, bilateral salpingo-oophorectomy, unilateral salpingo-oophorectomy, debulking surgery, cytoreductive surgery, interval cytoreductive surgery, laparotomy, laparoscopy, and peritoneal washing.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgical Procedure includes hysterectomy, bilateral salpingo-oophorectomy (BSO), unilateral salpingo-oophorectomy (USO), debulking surgery, cytoreductive surgery, interval cytoreductive surgery (ICS), laparotomy, laparoscopy, peritoneal washing"
  },
  {
    "id": "Medical-451efc66",
    "source": "Medical",
    "question": "Which chemotherapy drugs are commonly used in ovarian cancer?",
    "answer": "Common chemotherapy drugs include paclitaxel, carboplatin, cisplatin, oxaliplatin, docetaxel, and bevacizumab.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy Regimen includes paclitaxel, carboplatin, cisplatin, oxaliplatin, docetaxel, bevacizumab (Avastin)"
  },
  {
    "id": "Medical-365a0e76",
    "source": "Medical",
    "question": "Which maintenance therapies are available for ovarian cancer?",
    "answer": "Maintenance therapies include olaparib, niraparib, rucaparib, bevacizumab, and mirvetuximab soravtansine-gynx.",
    "question_type": "Fact Retrieval",
    "evidence": "Maintenance Therapy includes olaparib (Lynparza), niraparib (Zejula), rucaparib (Rubraca), bevacizumab (Avastin), mirvetuximab soravtansine-gynx (Elahere)"
  },
  {
    "id": "Medical-181dd442",
    "source": "Medical",
    "question": "What genetic alterations are tested for in ovarian cancer?",
    "answer": "Genetic alterations tested include BRCA1 mutation, BRCA2 mutation, HRD, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutation, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic Alteration includes BRCA1 mutation, BRCA2 mutation, homologous recombination deficiency (HRD), microsatellite instability (MSI), mismatch repair (MMR), HER2 expression, tumor mutational burden (TMB), BRAF V600E mutation, folate receptor alpha (FR), RET mutation, NTRK gene fusion"
  },
  {
    "id": "Medical-fbef0cd8",
    "source": "Medical",
    "question": "What are the main risk factors for ovarian cancer?",
    "answer": "Risk factors include BRCA1 mutation, BRCA2 mutation, Lynch syndrome, and family history.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor includes BRCA1 mutation, BRCA2 mutation, Lynch syndrome, Family history"
  },
  {
    "id": "Medical-070e0d62",
    "source": "Medical",
    "question": "What are the stages of ovarian cancer according to the FIGO system?",
    "answer": "The stages are Stage I (IA, IB, IC1, IC2, IC3), Stage II (IIA, IIB), Stage III (IIIA1(i), IIIA1(ii), IIIA2, IIIB, IIIC), and Stage IV (IVA, IVB).",
    "question_type": "Fact Retrieval",
    "evidence": "Stage includes Stage I (IA, IB, IC1, IC2, IC3), Stage II (IIA, IIB), Stage III (IIIA1(i), IIIA1(ii), IIIA2, IIIB, IIIC), Stage IV (IVA, IVB)"
  },
  {
    "id": "Medical-adf818a2",
    "source": "Medical",
    "question": "What are common symptoms of ovarian cancer listed in the ontology?",
    "answer": "Common symptoms include persistent bloating, pelvic pain, abdominal pain, trouble eating, feeling full quickly, urinary urgency, urinary frequency, pain during sex, fatigue, unexplained weight loss, and constipation.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom includes persistent bloating, pelvic pain, abdominal pain, trouble eating, feeling full quickly, urinary urgency, urinary frequency, pain during sex, fatigue, unexplained weight loss, constipation"
  },
  {
    "id": "Medical-218c665a",
    "source": "Medical",
    "question": "What is the role of CA-125 in ovarian cancer management?",
    "answer": "CA-125 is used for tumor marker monitoring in surveillance after treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers"
  },
  {
    "id": "Medical-0f6078ff",
    "source": "Medical",
    "question": "Which therapies are considered for recurrent ovarian cancer based on platinum sensitivity?",
    "answer": "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab and secondary cytoreductive surgery; platinum-resistant recurrence is treated with non-platinum chemotherapy, bevacizumab, mirvetuximab soravtansine-gynx, targeted therapy, or immunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment"
  },
  {
    "id": "Medical-e7671bff",
    "source": "Medical",
    "question": "What is the recommended management for recurrent or persistent ovarian cancer?",
    "answer": "Clinical trial enrollment is recommended for recurrent or persistent disease.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trial enrollment for recurrent or persistent disease"
  },
  {
    "id": "Medical-bff939bb",
    "source": "Medical",
    "question": "What type of cancer is chronic lymphocytic leukemia (CLL)?",
    "answer": "CLL is a type of blood cancer affecting B lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes"
  },
  {
    "id": "Medical-33f78c6c",
    "source": "Medical",
    "question": "What is the main difference between CLL and SLL?",
    "answer": "SLL is the same cancer as CLL but primarily found in lymph nodes and spleen.",
    "question_type": "Fact Retrieval",
    "evidence": "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen"
  },
  {
    "id": "Medical-7c7f4d0b",
    "source": "Medical",
    "question": "Which cells are affected in CLL?",
    "answer": "B lymphocytes are affected in CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes"
  },
  {
    "id": "Medical-bdb21d34",
    "source": "Medical",
    "question": "What is the primary site of SLL?",
    "answer": "The primary site of SLL is the lymph nodes and spleen.",
    "question_type": "Fact Retrieval",
    "evidence": "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen"
  },
  {
    "id": "Medical-150e36b6",
    "source": "Medical",
    "question": "How is CLL/SLL diagnosed?",
    "answer": "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter.",
    "question_type": "Fact Retrieval",
    "evidence": "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter"
  },
  {
    "id": "Medical-cdfc9ecd",
    "source": "Medical",
    "question": "What are common symptoms of CLL?",
    "answer": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss"
  },
  {
    "id": "Medical-2ea1a654",
    "source": "Medical",
    "question": "Can CLL be asymptomatic?",
    "answer": "CLL may be asymptomatic and discovered incidentally on routine blood testing.",
    "question_type": "Fact Retrieval",
    "evidence": "CLL may be asymptomatic and discovered incidentally on routine blood testing"
  },
  {
    "id": "Medical-4f070485",
    "source": "Medical",
    "question": "What are risk factors for developing CLL?",
    "answer": "Risk factors for CLL include older age and family history of CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors for CLL include older age and family history of CLL"
  },
  {
    "id": "Medical-ae21e753",
    "source": "Medical",
    "question": "Which diagnostic methods are used to confirm CLL?",
    "answer": "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy"
  },
  {
    "id": "Medical-e33e6d40",
    "source": "Medical",
    "question": "What surface proteins are identified in CLL cells by immunophenotyping?",
    "answer": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1.",
    "question_type": "Fact Retrieval",
    "evidence": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1"
  },
  {
    "id": "Medical-9f0ba939",
    "source": "Medical",
    "question": "Which biomarker tests are performed in CLL?",
    "answer": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-d115e18c",
    "source": "Medical",
    "question": "What is the significance of beta-2 microglobulin in CLL?",
    "answer": "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis"
  },
  {
    "id": "Medical-99f96fdf",
    "source": "Medical",
    "question": "When is treatment for CLL/SLL initiated?",
    "answer": "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression"
  },
  {
    "id": "Medical-e773a3cf",
    "source": "Medical",
    "question": "What are the treatment options for CLL/SLL?",
    "answer": "Treatment options include oral medications, IV infusions, and combination therapies.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment options include oral medications, IV infusions, and combination therapies"
  },
  {
    "id": "Medical-37aba842",
    "source": "Medical",
    "question": "What is Richter transformation in CLL?",
    "answer": "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma"
  },
  {
    "id": "Medical-7102e82d",
    "source": "Medical",
    "question": "What follow-up strategies are recommended for CLL?",
    "answer": "Follow-up strategies include watch and wait, regular monitoring, and supportive care.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up strategies include watch and wait, regular monitoring, and supportive care"
  },
  {
    "id": "Medical-3eec0277",
    "source": "Medical",
    "question": "What imaging method is used to assess lymph node involvement in CLL?",
    "answer": "Diagnostic CT scans may be used to assess lymph node involvement and disease extent.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic CT scans may be used to assess lymph node involvement and disease extent"
  },
  {
    "id": "Medical-b31acd9a",
    "source": "Medical",
    "question": "What factors are considered in CLL treatment planning?",
    "answer": "Performance status and comprehensive metabolic panel are used in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status and comprehensive metabolic panel are used in treatment planning"
  },
  {
    "id": "Medical-a43be732",
    "source": "Medical",
    "question": "How does family history affect CLL risk?",
    "answer": "Family history increases the risk of developing CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Family history increases the risk of developing CLL"
  },
  {
    "id": "Medical-3d64f92a",
    "source": "Medical",
    "question": "What is the treatment goal regarding minimal residual disease in CLL?",
    "answer": "Minimal residual disease is a treatment goal indicating mostly healthy blood cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Minimal residual disease is a treatment goal indicating mostly healthy blood cells"
  },
  {
    "id": "Medical-7bc6693e",
    "source": "Medical",
    "question": "What considerations are needed before starting CLL treatment in women of reproductive age?",
    "answer": "Pregnancy testing and fertility preservation are considered before starting treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Pregnancy testing and fertility preservation are considered before starting treatment"
  },
  {
    "id": "Medical-92b44036",
    "source": "Medical",
    "question": "Which genetic alterations are relevant in CLL biomarker testing?",
    "answer": "Relevant genetic alterations include 17p deletion, TP53 mutation, and IGHV mutation.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-c9a77eee",
    "source": "Medical",
    "question": "What is the role of flow cytometry in CLL diagnosis?",
    "answer": "Flow cytometry is used to confirm CLL by identifying characteristic immunophenotypes.",
    "question_type": "Fact Retrieval",
    "evidence": "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy"
  },
  {
    "id": "Medical-7197a18d",
    "source": "Medical",
    "question": "What is the primary site of CLL?",
    "answer": "The primary site of CLL is the blood and bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": "The primary site of CLL is the blood and bone marrow"
  },
  {
    "id": "Medical-7d4acc17",
    "source": "Medical",
    "question": "Which complication of CLL involves transformation to DLBCL?",
    "answer": "Richter transformation is a complication where CLL transforms into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma"
  },
  {
    "id": "Medical-9f87cac2",
    "source": "Medical",
    "question": "What is the purpose of a comprehensive metabolic panel in CLL management?",
    "answer": "A comprehensive metabolic panel is used in treatment planning for CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status and comprehensive metabolic panel are used in treatment planning"
  },
  {
    "id": "Medical-f7b0cf01",
    "source": "Medical",
    "question": "What is the function of supportive care in CLL follow-up?",
    "answer": "Supportive care is part of follow-up strategies for CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up strategies include watch and wait, regular monitoring, and supportive care"
  },
  {
    "id": "Medical-ccd3b472",
    "source": "Medical",
    "question": "What is the significance of complex karyotype in CLL?",
    "answer": "Complex karyotype is a biomarker assessed in CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-322e6d04",
    "source": "Medical",
    "question": "What is the role of oral medications in CLL treatment?",
    "answer": "Oral medications are a treatment option for CLL/SLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment options include oral medications, IV infusions, and combination therapies"
  },
  {
    "id": "Medical-2621de32",
    "source": "Medical",
    "question": "Which symptoms may indicate advanced CLL?",
    "answer": "Symptoms such as early satiety and unintentional weight loss may indicate advanced CLL.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss"
  },
  {
    "id": "Medical-1429a1d6",
    "source": "Medical",
    "question": "What is the most common type of throat cancer?",
    "answer": "Squamous cell carcinoma is the most common type of throat cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell carcinoma is the most common type of throat cancer"
  },
  {
    "id": "Medical-bff8d7f5",
    "source": "Medical",
    "question": "Which cancer type does throat cancer belong to?",
    "answer": "Throat cancer is a type of head and neck cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Throat cancer is a type of head and neck cancer"
  },
  {
    "id": "Medical-93c00cfb",
    "source": "Medical",
    "question": "What is a major risk factor for oropharyngeal squamous cell carcinoma?",
    "answer": "HPV infection, especially HPV16, is a major risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma"
  },
  {
    "id": "Medical-ee60087b",
    "source": "Medical",
    "question": "Which protein is a surrogate biomarker for HPV-mediated throat cancer?",
    "answer": "p16 protein overexpression is a surrogate biomarker.",
    "question_type": "Fact Retrieval",
    "evidence": "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer"
  },
  {
    "id": "Medical-a6860279",
    "source": "Medical",
    "question": "What diagnostic method is required for definitive diagnosis and biomarker testing in throat cancer?",
    "answer": "Biopsy is required for definitive diagnosis and biomarker testing.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is required for definitive diagnosis and biomarker testing"
  },
  {
    "id": "Medical-c5930c02",
    "source": "Medical",
    "question": "Which imaging studies are used for diagnosis and staging of throat cancer?",
    "answer": "CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
  },
  {
    "id": "Medical-aabc078c",
    "source": "Medical",
    "question": "Which areas are included in the oropharynx, a common site for throat cancer?",
    "answer": "The oropharynx includes the soft palate, tonsils, side and back walls of the throat, and base of the tongue.",
    "question_type": "Fact Retrieval",
    "evidence": "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue"
  },
  {
    "id": "Medical-ff5b71cc",
    "source": "Medical",
    "question": "What is the recommended biomarker test for all patients with oropharyngeal cancer?",
    "answer": "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer"
  },
  {
    "id": "Medical-20454e30",
    "source": "Medical",
    "question": "Which factors are considered risk factors for head and neck cancers?",
    "answer": "Tobacco and alcohol use are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Tobacco and alcohol use are risk factors for head and neck cancers"
  },
  {
    "id": "Medical-c99a29ae",
    "source": "Medical",
    "question": "Which symptoms may indicate throat cancer?",
    "answer": "Symptoms may include difficulty swallowing, sore throat, and changes in voice.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice"
  },
  {
    "id": "Medical-cea4d8ff",
    "source": "Medical",
    "question": "Which system is used for staging throat cancer?",
    "answer": "Cancer staging uses the AJCC TNM system.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)"
  },
  {
    "id": "Medical-335d5ab4",
    "source": "Medical",
    "question": "What are the components of the AJCC TNM staging system?",
    "answer": "The AJCC TNM system incorporates tumor size (T), lymph node involvement (N), and metastasis (M).",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)"
  },
  {
    "id": "Medical-bfc7447f",
    "source": "Medical",
    "question": "What are the numbered stages of throat cancer according to the ontology?",
    "answer": "The numbered stages are Stage 0, Stage I, Stage II, Stage III, and Stage IV.",
    "question_type": "Fact Retrieval",
    "evidence": "Numbered stages: [\"Stage 0\", \"Stage I\", \"Stage II\", \"Stage III\", \"Stage IV\"]"
  },
  {
    "id": "Medical-c490d37b",
    "source": "Medical",
    "question": "What is the definition of Tis in the AJCC TNM staging for throat cancer?",
    "answer": "Tis is carcinoma in situ.",
    "question_type": "Fact Retrieval",
    "evidence": "Tis: Carcinoma in situ"
  },
  {
    "id": "Medical-5bf6c470",
    "source": "Medical",
    "question": "What tumor size corresponds to T1 in the AJCC TNM staging?",
    "answer": "T1 is a tumor 2 cm or less.",
    "question_type": "Fact Retrieval",
    "evidence": "T1: Tumor 2 cm"
  },
  {
    "id": "Medical-844b00fe",
    "source": "Medical",
    "question": "What tumor size corresponds to T2 in the AJCC TNM staging?",
    "answer": "T2 is a tumor greater than 2 cm and 4 cm or less.",
    "question_type": "Fact Retrieval",
    "evidence": "T2: Tumor >2 cm and 4 cm"
  },
  {
    "id": "Medical-9cb7758b",
    "source": "Medical",
    "question": "What does T3 indicate in the AJCC TNM staging for throat cancer?",
    "answer": "T3 is a tumor greater than 4 cm or extension to epiglottis.",
    "question_type": "Fact Retrieval",
    "evidence": "T3: Tumor >4 cm or extension to epiglottis"
  },
  {
    "id": "Medical-c808d555",
    "source": "Medical",
    "question": "Which biomarker expressions may guide immunotherapy treatment decisions in throat cancer?",
    "answer": "PD-L1 expression may guide immunotherapy treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": "PD-L1 expression may guide immunotherapy treatment decisions"
  },
  {
    "id": "Medical-4ba7ca1f",
    "source": "Medical",
    "question": "Which methods are used for tissue sampling in throat cancer diagnosis?",
    "answer": "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling.",
    "question_type": "Fact Retrieval",
    "evidence": "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling"
  },
  {
    "id": "Medical-930c4439",
    "source": "Medical",
    "question": "Which biomarker tests are included in throat cancer biomarker testing?",
    "answer": "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden"
  },
  {
    "id": "Medical-49e7d093",
    "source": "Medical",
    "question": "What are the common sites of metastasis for throat cancer?",
    "answer": "Common sites of metastasis are the lungs, liver, or spine.",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine"
  },
  {
    "id": "Medical-43965a1c",
    "source": "Medical",
    "question": "What is used to determine clinical stage before treatment in throat cancer?",
    "answer": "Clinical stage is determined before treatment using physical exam, imaging, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical stage is determined before treatment using physical exam, imaging, and biopsy"
  },
  {
    "id": "Medical-c89d3c38",
    "source": "Medical",
    "question": "How is pathologic stage determined in throat cancer?",
    "answer": "Pathologic stage is determined after surgery based on tissue examination.",
    "question_type": "Fact Retrieval",
    "evidence": "Pathologic stage is determined after surgery based on tissue examination"
  },
  {
    "id": "Medical-d8127f85",
    "source": "Medical",
    "question": "Which assessment is important before treatment of throat cancer?",
    "answer": "Dental health assessment is important before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Dental health assessment is important before treatment"
  },
  {
    "id": "Medical-26d2ebbd",
    "source": "Medical",
    "question": "Which performance status is considered a prognostic factor in throat cancer treatment planning?",
    "answer": "ECOG performance status is a prognostic factor considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status (ECOG) is a prognostic factor considered in treatment planning"
  },
  {
    "id": "Medical-2268f7cf",
    "source": "Medical",
    "question": "What are the main anatomical sites in the oropharynx related to throat cancer?",
    "answer": "The main anatomical sites are the soft palate, tonsils, base of tongue, and side and back walls of the throat.",
    "question_type": "Fact Retrieval",
    "evidence": "The oropharynx includes the soft palate, tonsils, base of tongue, and side and back walls of the throat"
  },
  {
    "id": "Medical-5e15bf0c",
    "source": "Medical",
    "question": "Which scoping procedures are used as diagnostic methods for throat cancer?",
    "answer": "Endoscopy, laryngoscopy, nasolaryngoscopy, esophagoscopy, bronchoscopy, and panendoscopy are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Scoping procedures: [\"Endoscopy\", \"Laryngoscopy\", \"Nasolaryngoscopy\", \"Esophagoscopy\", \"Bronchoscopy\", \"Panendoscopy\"]"
  },
  {
    "id": "Medical-f5e27a80",
    "source": "Medical",
    "question": "Which genetic alterations are associated with squamous cell carcinoma of the throat?",
    "answer": "HPV-mediated, p16-positive, and p16-negative are associated genetic alterations.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic Alteration: [\"HPV-mediated\", \"p16-positive\", \"p16-negative\"]"
  },
  {
    "id": "Medical-75107d1d",
    "source": "Medical",
    "question": "What surveillance methods are used for patients after throat cancer treatment?",
    "answer": "Surveillance includes dental health assessment, imaging follow-up, and physical exam.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance: [\"Dental health assessment\", \"Imaging follow-up\", \"Physical exam\"]"
  },
  {
    "id": "Medical-dd68e8b3",
    "source": "Medical",
    "question": "What symptoms are commonly associated with throat cancer?",
    "answer": "Difficulty swallowing, sore throat, and voice changes are common symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice"
  },
  {
    "id": "Medical-60bccc6c",
    "source": "Medical",
    "question": "What is the role of panoramic dental x-ray (Panorex) in throat cancer management?",
    "answer": "Panoramic dental x-ray (Panorex) is used as an imaging method for dental assessment.",
    "question_type": "Fact Retrieval",
    "evidence": "Panoramic dental x-ray (Panorex) is listed under imaging for diagnostic methods and dental health assessment"
  },
  {
    "id": "Medical-fde1ce46",
    "source": "Medical",
    "question": "What are the main prognostic factors considered for squamous cell carcinoma of the throat?",
    "answer": "ECOG performance status, tumor grade, and HPV/p16 status are main prognostic factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Prognostic Factor: [\"ECOG performance status\", \"Tumor grade\", \"HPV/p16 status\"]"
  },
  {
    "id": "Medical-613046c3",
    "source": "Medical",
    "question": "What type of lymphoma is found primarily in the skin?",
    "answer": "Primary cutaneous lymphoma (PCL) is found in the skin.",
    "question_type": "Fact Retrieval",
    "evidence": "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin"
  },
  {
    "id": "Medical-e60081a8",
    "source": "Medical",
    "question": "Which cell type is the origin of cutaneous B-cell lymphoma (CBCL)?",
    "answer": "CBCL originates from B lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Cutaneous B-cell lymphoma (CBCL) starts in B cells"
  },
  {
    "id": "Medical-f8d0ca45",
    "source": "Medical",
    "question": "What are the main subtypes of cutaneous B-cell lymphoma?",
    "answer": "The main subtypes are primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type).",
    "question_type": "Fact Retrieval",
    "evidence": "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)"
  },
  {
    "id": "Medical-d1271e37",
    "source": "Medical",
    "question": "What are common symptoms of cutaneous B-cell lymphoma?",
    "answer": "Symptoms include skin nodules and papules.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of CBCL include skin nodules and papules"
  },
  {
    "id": "Medical-63e12d36",
    "source": "Medical",
    "question": "Which diagnostic methods are used for CBCL?",
    "answer": "Skin exam, blood test, imaging test, biopsy, and immunophenotyping are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-2dad02e4",
    "source": "Medical",
    "question": "What is the cell of origin for cutaneous T-cell lymphoma (CTCL)?",
    "answer": "CTCL develops from abnormal T lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
  },
  {
    "id": "Medical-fa689991",
    "source": "Medical",
    "question": "Which cancer type does primary cutaneous lymphoma (PCL) belong to?",
    "answer": "PCL is a type of non-Hodgkin lymphoma (NHL).",
    "question_type": "Fact Retrieval",
    "evidence": "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin"
  },
  {
    "id": "Medical-d6749661",
    "source": "Medical",
    "question": "What type of blood cell are lymphocytes?",
    "answer": "Lymphocytes are a type of white blood cell.",
    "question_type": "Fact Retrieval",
    "evidence": "Lymphocytes are a type of white blood cell that help fight infection"
  },
  {
    "id": "Medical-87c6269c",
    "source": "Medical",
    "question": "What can unregulated growth of lymphocytes lead to?",
    "answer": "Unregulated growth of lymphocytes can develop into lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Unregulated growth of lymphocytes can develop into lymphoma"
  },
  {
    "id": "Medical-4c260a72",
    "source": "Medical",
    "question": "Which test is used to assess biomarkers and genetic changes in CBCL?",
    "answer": "Testing for CBCL includes assessment of biomarkers and genetic changes.",
    "question_type": "Fact Retrieval",
    "evidence": "Testing for CBCL includes assessment of biomarkers and genetic changes"
  },
  {
    "id": "Medical-500d2672",
    "source": "Medical",
    "question": "What are the typical clinical appearances of CBCL on the skin?",
    "answer": "CBCL appears as nodules or papules under the skin.",
    "question_type": "Fact Retrieval",
    "evidence": "CBCL appears as nodules or papules under the skin"
  },
  {
    "id": "Medical-a40a55aa",
    "source": "Medical",
    "question": "Which subtypes are included under cutaneous B-cell lymphoma in the ontology?",
    "answer": "Primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type) are included.",
    "question_type": "Fact Retrieval",
    "evidence": "The ontology lists PCMZL, PCFCL, and PC-DLBCL, leg type as subtypes of CBCL"
  },
  {
    "id": "Medical-8251b4f5",
    "source": "Medical",
    "question": "What is the growth pattern of most primary cutaneous B-cell lymphomas?",
    "answer": "Most primary cutaneous B-cell lymphomas are indolent or slow-growing.",
    "question_type": "Fact Retrieval",
    "evidence": "Most primary cutaneous B-cell lymphomas are indolent or slow-growing"
  },
  {
    "id": "Medical-b80836d6",
    "source": "Medical",
    "question": "Which lymphocyte subtype gives rise to cutaneous T-cell lymphoma?",
    "answer": "T lymphocytes give rise to cutaneous T-cell lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
  },
  {
    "id": "Medical-5d17dd81",
    "source": "Medical",
    "question": "What is the role of lymphocytes in the body?",
    "answer": "Lymphocytes help fight infection.",
    "question_type": "Fact Retrieval",
    "evidence": "Lymphocytes are a type of white blood cell that help fight infection"
  },
  {
    "id": "Medical-e4acadd1",
    "source": "Medical",
    "question": "What diagnostic method involves microscopic examination of tissue for CBCL?",
    "answer": "Biopsy is used for microscopic examination of tissue in CBCL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-06384900",
    "source": "Medical",
    "question": "Which cancer subtype starts specifically in B cells?",
    "answer": "Cutaneous B-cell lymphoma (CBCL) starts in B cells.",
    "question_type": "Fact Retrieval",
    "evidence": "Cutaneous B-cell lymphoma (CBCL) starts in B cells"
  },
  {
    "id": "Medical-fa265328",
    "source": "Medical",
    "question": "What are the two main cell origins for primary cutaneous lymphoma?",
    "answer": "Primary cutaneous lymphoma develops from abnormal B or T lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "PCL develops from abnormal B or T lymphocytes"
  },
  {
    "id": "Medical-c7d5764f",
    "source": "Medical",
    "question": "What are examples of diagnostic imaging tests for CBCL?",
    "answer": "Imaging tests are used for diagnosis of CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-1295f7a6",
    "source": "Medical",
    "question": "Which test is used to analyze cell surface proteins in CBCL diagnosis?",
    "answer": "Immunophenotyping is used to analyze cell surface proteins.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-6c304dfe",
    "source": "Medical",
    "question": "What laboratory test is commonly performed for CBCL diagnosis?",
    "answer": "Blood test is commonly performed for CBCL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-9b559ea7",
    "source": "Medical",
    "question": "What type of lymphoma is cutaneous T-cell lymphoma (CTCL)?",
    "answer": "CTCL is a cancer subtype of primary cutaneous lymphoma derived from T lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
  },
  {
    "id": "Medical-145d27de",
    "source": "Medical",
    "question": "What are the characteristic skin lesions seen in CBCL?",
    "answer": "Nodules and papules are characteristic skin lesions in CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of CBCL include skin nodules and papules"
  },
  {
    "id": "Medical-ed3b3141",
    "source": "Medical",
    "question": "Which white blood cell type can develop into lymphoma when growth is unregulated?",
    "answer": "Lymphocytes can develop into lymphoma when growth is unregulated.",
    "question_type": "Fact Retrieval",
    "evidence": "Unregulated growth of lymphocytes can develop into lymphoma"
  },
  {
    "id": "Medical-6a57de34",
    "source": "Medical",
    "question": "Which diagnostic method involves examining the skin for CBCL?",
    "answer": "Skin exam is a diagnostic method for CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-8bfc6705",
    "source": "Medical",
    "question": "Which categories of biomarkers are assessed in CBCL testing?",
    "answer": "Assessment includes both biomarkers and genetic changes.",
    "question_type": "Fact Retrieval",
    "evidence": "Testing for CBCL includes assessment of biomarkers and genetic changes"
  },
  {
    "id": "Medical-496f67b8",
    "source": "Medical",
    "question": "What is the relationship between primary cutaneous lymphoma and non-Hodgkin lymphoma in the ontology?",
    "answer": "Primary cutaneous lymphoma is classified under non-Hodgkin lymphoma in the ontology.",
    "question_type": "Fact Retrieval",
    "evidence": "The ontology places PCL under non-Hodgkin lymphoma (NHL)"
  },
  {
    "id": "Medical-075d923c",
    "source": "Medical",
    "question": "Which subtype of cutaneous lymphoma is associated with B lymphocytes in the ontology?",
    "answer": "Cutaneous B-cell lymphoma (CBCL) is associated with B lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "The ontology lists CBCL under B lymphocyte as cell of origin"
  },
  {
    "id": "Medical-4c444d45",
    "source": "Medical",
    "question": "Which diagnostic method is used to identify genetic changes in CBCL?",
    "answer": "Immunophenotyping is used to identify genetic changes in CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-ca48819b",
    "source": "Medical",
    "question": "What are the three named subtypes of CBCL in the ontology?",
    "answer": "The three named subtypes are PCMZL, PCFCL, and PC-DLBCL, leg type.",
    "question_type": "Fact Retrieval",
    "evidence": "The ontology lists PCMZL, PCFCL, and PC-DLBCL, leg type as subtypes of CBCL"
  },
  {
    "id": "Medical-76a58bea",
    "source": "Medical",
    "question": "What is the most common cancer diagnosed in children?",
    "answer": "Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL is the most common cancer diagnosed in children"
  },
  {
    "id": "Medical-960eb812",
    "source": "Medical",
    "question": "Which cell type is the origin of acute lymphoblastic leukemia (ALL)?",
    "answer": "ALL starts in lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-1b7da7b8",
    "source": "Medical",
    "question": "What are the two main subtypes of ALL?",
    "answer": "The two main subtypes of ALL are B-cell ALL (B-ALL) and T-cell ALL (T-ALL).",
    "question_type": "Fact Retrieval",
    "evidence": "ALL has two main subtypes: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)"
  },
  {
    "id": "Medical-ea0a73d8",
    "source": "Medical",
    "question": "Which subtype of ALL is more common, B-ALL or T-ALL?",
    "answer": "B-ALL is more common than T-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL"
  },
  {
    "id": "Medical-fe91b005",
    "source": "Medical",
    "question": "What rare subtype of B-ALL is treated differently?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-a413ecf5",
    "source": "Medical",
    "question": "What is B-cell lymphoblastic lymphoma also called?",
    "answer": "B-cell lymphoblastic lymphoma is also called B-LL or B-LBL.",
    "question_type": "Fact Retrieval",
    "evidence": "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)"
  },
  {
    "id": "Medical-9ab2163c",
    "source": "Medical",
    "question": "What is T-cell lymphoblastic lymphoma also called?",
    "answer": "T-cell lymphoblastic lymphoma is also called T-LL or T-LBL.",
    "question_type": "Fact Retrieval",
    "evidence": "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)"
  },
  {
    "id": "Medical-a3a4e6db",
    "source": "Medical",
    "question": "Which diagnostic methods are used for ALL?",
    "answer": "Blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture are used for ALL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture"
  },
  {
    "id": "Medical-5a825e05",
    "source": "Medical",
    "question": "What is the minimum percentage of lymphoblasts in bone marrow required for ALL diagnosis?",
    "answer": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow"
  },
  {
    "id": "Medical-b3af6970",
    "source": "Medical",
    "question": "What are the possible disease sites for ALL?",
    "answer": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS).",
    "question_type": "Fact Retrieval",
    "evidence": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)"
  },
  {
    "id": "Medical-53b40877",
    "source": "Medical",
    "question": "Which subtype of ALL can cause an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) can cause an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-daac4d33",
    "source": "Medical",
    "question": "What symptom can T-ALL cause due to an enlarged thymus?",
    "answer": "T-ALL can cause breathing problems due to an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL can cause breathing problems due to an enlarged thymus"
  },
  {
    "id": "Medical-6852591b",
    "source": "Medical",
    "question": "What is the initial treatment for everyone with ALL?",
    "answer": "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-e31f34b7",
    "source": "Medical",
    "question": "What are the components of ALL treatment besides chemotherapy and steroids?",
    "answer": "Systemic therapy and supportive care are part of ALL treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy and supportive care are part of ALL treatment"
  },
  {
    "id": "Medical-bff01916",
    "source": "Medical",
    "question": "Which subtype of B-ALL requires intensive systemic therapies?",
    "answer": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies.",
    "question_type": "Fact Retrieval",
    "evidence": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies"
  },
  {
    "id": "Medical-b63d5b37",
    "source": "Medical",
    "question": "For which cases are clinical trials preferred in ALL?",
    "answer": "Clinical trials are preferred for certain B-ALL and T-ALL cases.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are preferred for certain B-ALL and T-ALL cases"
  },
  {
    "id": "Medical-85d1a489",
    "source": "Medical",
    "question": "How is infant ALL (under 12 months) treated compared to other age groups?",
    "answer": "Infant ALL (under 12 months) is treated differently than other age groups.",
    "question_type": "Fact Retrieval",
    "evidence": "Infant ALL (under 12 months) is treated differently than other age groups"
  },
  {
    "id": "Medical-84c4f293",
    "source": "Medical",
    "question": "What testing methods are used in ALL management for biomarkers and genetics?",
    "answer": "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management.",
    "question_type": "Fact Retrieval",
    "evidence": "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management"
  },
  {
    "id": "Medical-786c3df5",
    "source": "Medical",
    "question": "Which age groups are most often affected by ALL?",
    "answer": "ALL most often affects children, adolescents, and young adults (AYAs).",
    "question_type": "Fact Retrieval",
    "evidence": "ALL most often affects children, adolescents, and young adults (AYAs)"
  },
  {
    "id": "Medical-ac636dac",
    "source": "Medical",
    "question": "Which lymphocyte subtype is the cell of origin for B-ALL?",
    "answer": "B-ALL starts in B-cell lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL"
  },
  {
    "id": "Medical-5a7c7b88",
    "source": "Medical",
    "question": "Which lymphocyte subtype is the cell of origin for T-ALL?",
    "answer": "T-ALL starts in T-cell lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-1d62116d",
    "source": "Medical",
    "question": "What is the purpose of a lumbar puncture in ALL diagnosis?",
    "answer": "A lumbar puncture is used as a diagnostic method for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture"
  },
  {
    "id": "Medical-5e031204",
    "source": "Medical",
    "question": "Name two types of testing used to identify biomarkers in ALL.",
    "answer": "Biomarker testing and pharmacogenomic testing are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management"
  },
  {
    "id": "Medical-0c88cd2e",
    "source": "Medical",
    "question": "What is the standard supportive care for ALL?",
    "answer": "Supportive care is part of ALL treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy and supportive care are part of ALL treatment"
  },
  {
    "id": "Medical-4cb346cb",
    "source": "Medical",
    "question": "What is the main treatment protocol for both B-ALL and T-ALL?",
    "answer": "Steroids, multiagent chemotherapy, systemic therapy, and clinical trial are main treatments.",
    "question_type": "Fact Retrieval",
    "evidence": "B-cell ALL (B-ALL): Treatment: [steroids, multiagent chemotherapy, systemic therapy, clinical trial]; T-cell ALL (T-ALL): Treatment: [steroids, multiagent chemotherapy, systemic therapy, clinical trial]"
  },
  {
    "id": "Medical-411895da",
    "source": "Medical",
    "question": "Which genetic alteration is a biomarker for B-ALL?",
    "answer": "BCR::ABL1-positive is a biomarker for B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies"
  },
  {
    "id": "Medical-efdf2abc",
    "source": "Medical",
    "question": "What cancer type is characterized by fast growth and origin in lymphocytes?",
    "answer": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-8997f8d7",
    "source": "Medical",
    "question": "Which site is affected in B-cell lymphoblastic lymphoma?",
    "answer": "B-cell lymphoblastic lymphoma involves lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)"
  },
  {
    "id": "Medical-45dbe22b",
    "source": "Medical",
    "question": "Which site is affected in T-cell lymphoblastic lymphoma?",
    "answer": "T-cell lymphoblastic lymphoma involves the thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)"
  },
  {
    "id": "Medical-d579b469",
    "source": "Medical",
    "question": "What symptom may result from T-ALL affecting the thymus?",
    "answer": "Breathing problems may result from T-ALL affecting the thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL can cause breathing problems due to an enlarged thymus"
  },
  {
    "id": "Medical-a685f7fb",
    "source": "Medical",
    "question": "Which age group requires a different treatment approach for ALL?",
    "answer": "Infants (under 12 months) require a different treatment approach for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Infant ALL (under 12 months) is treated differently than other age groups"
  },
  {
    "id": "Medical-e0090b36",
    "source": "Medical",
    "question": "What type of cancer is rectal cancer classified as?",
    "answer": "Rectal cancer is a type of colorectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Rectal cancer is a type of colorectal cancer"
  },
  {
    "id": "Medical-2f6c215a",
    "source": "Medical",
    "question": "What is the most common subtype of rectal cancer?",
    "answer": "Adenocarcinoma is the most common subtype of rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenocarcinoma is the most common subtype of rectal cancer"
  },
  {
    "id": "Medical-1b6c4690",
    "source": "Medical",
    "question": "From which type of polyp do most rectal cancers originate?",
    "answer": "Most rectal cancers start in adenomatous polyps.",
    "question_type": "Fact Retrieval",
    "evidence": "Most rectal cancers start in adenomatous polyps"
  },
  {
    "id": "Medical-49bb5694",
    "source": "Medical",
    "question": "Which polyps rarely become cancerous in the rectum?",
    "answer": "Hyperplastic and inflammatory polyps rarely turn into cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Hyperplastic and inflammatory polyps rarely turn into cancer"
  },
  {
    "id": "Medical-e6a5a2c8",
    "source": "Medical",
    "question": "How can most polyps be removed to prevent rectal cancer?",
    "answer": "Polypectomy during colonoscopy can remove most polyps and prevent cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Polypectomy during colonoscopy can remove most polyps and prevent cancer"
  },
  {
    "id": "Medical-6b8d3af0",
    "source": "Medical",
    "question": "What are the recommended biomarkers to test in all rectal tumors?",
    "answer": "All rectal tumors should be tested for dMMR or MSI-H.",
    "question_type": "Fact Retrieval",
    "evidence": "All rectal tumors should be tested for dMMR or MSI-H"
  },
  {
    "id": "Medical-63846367",
    "source": "Medical",
    "question": "Which biomarkers are associated with rectal cancer?",
    "answer": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer"
  },
  {
    "id": "Medical-7bd39a07",
    "source": "Medical",
    "question": "What genetic syndrome is a risk factor for rectal cancer?",
    "answer": "Lynch syndrome is a genetic risk factor for rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Lynch syndrome is a genetic risk factor for rectal cancer"
  },
  {
    "id": "Medical-5025010a",
    "source": "Medical",
    "question": "Which genetic syndrome causes multiple polyps and increases rectal cancer risk?",
    "answer": "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
  },
  {
    "id": "Medical-ebc00ba5",
    "source": "Medical",
    "question": "What blood test is used for monitoring rectal cancer?",
    "answer": "Blood tests such as CEA are used for monitoring rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood tests such as CEA are used for monitoring rectal cancer"
  },
  {
    "id": "Medical-9a4b562a",
    "source": "Medical",
    "question": "Which imaging method is recommended for staging rectal cancer?",
    "answer": "MRI of the pelvis is recommended for staging rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI of the pelvis is recommended for staging rectal cancer"
  },
  {
    "id": "Medical-121175d0",
    "source": "Medical",
    "question": "What diagnostic tool can assess tumor extent and guide biopsy in rectal cancer?",
    "answer": "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy"
  },
  {
    "id": "Medical-4418f730",
    "source": "Medical",
    "question": "Which scan is used to detect metastasis in rectal cancer?",
    "answer": "CT scan of chest and abdomen is used to detect metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "CT scan of chest and abdomen is used to detect metastasis"
  },
  {
    "id": "Medical-b31188bc",
    "source": "Medical",
    "question": "What is the recommended treatment for T1 rectal tumors?",
    "answer": "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors"
  },
  {
    "id": "Medical-58b16818",
    "source": "Medical",
    "question": "Which surgical procedure is an option for T1 tumors at the end of the rectum?",
    "answer": "Transanal local excision is an option for T1 tumors at the end of the rectum.",
    "question_type": "Fact Retrieval",
    "evidence": "Transanal local excision is an option for T1 tumors at the end of the rectum"
  },
  {
    "id": "Medical-40a89900",
    "source": "Medical",
    "question": "What surgical treatment is recommended for T2 and some T1/T3 rectal tumors?",
    "answer": "Transabdominal surgery is recommended for T2 and some T1/T3 tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Transabdominal surgery is recommended for T2 and some T1/T3 tumors"
  },
  {
    "id": "Medical-9fffc3b8",
    "source": "Medical",
    "question": "Which surgical procedure is used for tumors in the mid to upper rectum?",
    "answer": "Low anterior resection (LAR) is used for tumors in the mid to upper rectum.",
    "question_type": "Fact Retrieval",
    "evidence": "Low anterior resection (LAR) is used for tumors in the mid to upper rectum"
  },
  {
    "id": "Medical-b73e21e2",
    "source": "Medical",
    "question": "What surgery is performed for tumors in the lower rectum?",
    "answer": "Abdominoperineal resection (APR) is used for tumors in the lower rectum.",
    "question_type": "Fact Retrieval",
    "evidence": "Abdominoperineal resection (APR) is used for tumors in the lower rectum"
  },
  {
    "id": "Medical-bd4e8d31",
    "source": "Medical",
    "question": "What treatment is used for locally advanced rectal cancer?",
    "answer": "Chemoradiation is used for locally advanced rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemoradiation is used for locally advanced rectal cancer"
  },
  {
    "id": "Medical-1537264f",
    "source": "Medical",
    "question": "Which chemotherapy drugs may be included in rectal cancer regimens?",
    "answer": "Chemotherapy regimens may include oxaliplatin or irinotecan.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy regimens may include oxaliplatin or irinotecan"
  },
  {
    "id": "Medical-64d6964d",
    "source": "Medical",
    "question": "What is the surveillance strategy after local excision or ESD for rectal cancer?",
    "answer": "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging.",
    "question_type": "Fact Retrieval",
    "evidence": "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging"
  },
  {
    "id": "Medical-c02f01c8",
    "source": "Medical",
    "question": "Which procedure is recommended after surgery for surveillance of rectal cancer?",
    "answer": "Colonoscopy is recommended after surgery for surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "Colonoscopy is recommended after surgery for surveillance"
  },
  {
    "id": "Medical-3677b386",
    "source": "Medical",
    "question": "What are the fertility preservation options for rectal cancer patients?",
    "answer": "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition"
  },
  {
    "id": "Medical-ce8744bd",
    "source": "Medical",
    "question": "What symptoms may indicate rectal cancer?",
    "answer": "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain"
  },
  {
    "id": "Medical-4aba43e4",
    "source": "Medical",
    "question": "What is the role of polypectomy in rectal cancer prevention?",
    "answer": "Polypectomy during colonoscopy can remove most polyps and prevent cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Polypectomy during colonoscopy can remove most polyps and prevent cancer"
  },
  {
    "id": "Medical-f7e69032",
    "source": "Medical",
    "question": "Which genetic alterations are risk factors for rectal cancer?",
    "answer": "Lynch syndrome and familial adenomatous polyposis (FAP) are risk factors for rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Lynch syndrome is a genetic risk factor for rectal cancer; Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
  },
  {
    "id": "Medical-4361d3ae",
    "source": "Medical",
    "question": "What surveillance methods are used after T1 rectal tumor resection?",
    "answer": "Flexible sigmoidoscopy every 6 months for 5 years and imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5 are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Flexible sigmoidoscopy every 6 months for 5 years; Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5"
  },
  {
    "id": "Medical-43c23661",
    "source": "Medical",
    "question": "Which diagnostic methods are listed for rectal cancer?",
    "answer": "Diagnostic methods include MRI, endorectal ultrasound (EUS), CT scan, flexible sigmoidoscopy, colonoscopy, and CEA blood test.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI, Endorectal ultrasound (EUS), CT scan, Flexible sigmoidoscopy, Colonoscopy, CEA blood test"
  },
  {
    "id": "Medical-15f8d40a",
    "source": "Medical",
    "question": "Which surgical procedures are included in rectal cancer treatment?",
    "answer": "Surgical procedures include polypectomy, transanal local excision, transabdominal surgery, low anterior resection (LAR), and abdominoperineal resection (APR).",
    "question_type": "Fact Retrieval",
    "evidence": "Surgical Procedure: Polypectomy, Transanal local excision, Transabdominal surgery, Low anterior resection (LAR), Abdominoperineal resection (APR)"
  },
  {
    "id": "Medical-3a64b795",
    "source": "Medical",
    "question": "What are the main symptoms of rectal cancer according to the ontology?",
    "answer": "The main symptoms are rectal bleeding, abdominal pain, and changes in bowel habits.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom: Rectal bleeding, Abdominal pain, Changes in bowel habits"
  },
  {
    "id": "Medical-c17e7134",
    "source": "Medical",
    "question": "Which biomarkers are used for monitoring rectal cancer?",
    "answer": "CEA blood test and ctDNA are used for monitoring rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker: CEA blood test, ctDNA"
  },
  {
    "id": "Medical-9a4565c5",
    "source": "Medical",
    "question": "What is the recommended imaging for surveillance after local excision of rectal cancer?",
    "answer": "Imaging with EUS or MRI is recommended for surveillance after local excision.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5"
  },
  {
    "id": "Medical-1118823b",
    "source": "Medical",
    "question": "What is the most common subtype of bladder cancer?",
    "answer": "Urothelial carcinoma is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Urothelial carcinoma is the most common subtype of bladder cancer"
  },
  {
    "id": "Medical-b7f57756",
    "source": "Medical",
    "question": "Which cancer subtypes are less common in bladder cancer?",
    "answer": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common.",
    "question_type": "Fact Retrieval",
    "evidence": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes of bladder cancer"
  },
  {
    "id": "Medical-535b6521",
    "source": "Medical",
    "question": "How is bladder cancer staged?",
    "answer": "Bladder cancer is staged from 0 to 4 based on depth of invasion and spread.",
    "question_type": "Fact Retrieval",
    "evidence": "Bladder cancer is staged from 0 to 4 based on depth of invasion and spread"
  },
  {
    "id": "Medical-8cd77727",
    "source": "Medical",
    "question": "Which stages of bladder cancer are considered nonmuscle-invasive?",
    "answer": "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive"
  },
  {
    "id": "Medical-cf95f911",
    "source": "Medical",
    "question": "Which stages of bladder cancer are muscle-invasive?",
    "answer": "Stages 2, 3, and 4 bladder cancers are muscle-invasive.",
    "question_type": "Fact Retrieval",
    "evidence": "Stages 2, 3, and 4 bladder cancers are muscle-invasive"
  },
  {
    "id": "Medical-0dbb19e7",
    "source": "Medical",
    "question": "What characterizes Stage 4 bladder cancer?",
    "answer": "Stage 4 bladder cancer is metastatic and may involve distant organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 4 bladder cancer is metastatic and may involve distant organs"
  },
  {
    "id": "Medical-0cfbdcf6",
    "source": "Medical",
    "question": "How is cancer grade classified in bladder cancer?",
    "answer": "Cancer grade is classified as low grade (LG) or high grade (HG).",
    "question_type": "Fact Retrieval",
    "evidence": "Cancer grade is classified as low grade (LG) or high grade (HG)"
  },
  {
    "id": "Medical-aeb19c82",
    "source": "Medical",
    "question": "What is the greatest risk factor for bladder cancer?",
    "answer": "Smoking is the greatest risk factor for bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Smoking is the greatest risk factor for bladder cancer"
  },
  {
    "id": "Medical-7171cb7e",
    "source": "Medical",
    "question": "List other risk factors for bladder cancer besides smoking.",
    "answer": "Other risk factors include age, family history, Lynch syndrome, and chemical exposure.",
    "question_type": "Fact Retrieval",
    "evidence": "Other risk factors include age, family history, Lynch syndrome, and chemical exposure"
  },
  {
    "id": "Medical-faa1be8b",
    "source": "Medical",
    "question": "What is the most common symptom of bladder cancer?",
    "answer": "Blood in urine (hematuria) is the most common symptom.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood in urine (hematuria) is the most common symptom of bladder cancer"
  },
  {
    "id": "Medical-03cb5164",
    "source": "Medical",
    "question": "Name additional symptoms of bladder cancer.",
    "answer": "Other symptoms include frequent urination, urgency, painful urination, and back pain.",
    "question_type": "Fact Retrieval",
    "evidence": "Other symptoms include frequent urination, urgency, painful urination, and back pain"
  },
  {
    "id": "Medical-5d4c9987",
    "source": "Medical",
    "question": "Which diagnostic methods are used for bladder cancer?",
    "answer": "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)"
  },
  {
    "id": "Medical-a14ecb5b",
    "source": "Medical",
    "question": "What is the role of biomarker tests in bladder cancer?",
    "answer": "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer"
  },
  {
    "id": "Medical-7c3827b8",
    "source": "Medical",
    "question": "Which genetic alterations are associated with bladder cancer?",
    "answer": "Mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic alterations such as mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer"
  },
  {
    "id": "Medical-98f70f90",
    "source": "Medical",
    "question": "What surgical procedures are used to treat bladder cancer?",
    "answer": "Surgery includes TURBT, radical cystectomy, and partial cystectomy.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is a primary treatment for bladder cancer and includes TURBT, radical cystectomy, and partial cystectomy"
  },
  {
    "id": "Medical-4d4136c1",
    "source": "Medical",
    "question": "What is TURBT used for in bladder cancer?",
    "answer": "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer"
  },
  {
    "id": "Medical-87a9ce2a",
    "source": "Medical",
    "question": "What is the standard surgery for muscle-invasive bladder cancer?",
    "answer": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer"
  },
  {
    "id": "Medical-390dfa49",
    "source": "Medical",
    "question": "List urinary diversion procedures after bladder surgery.",
    "answer": "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch.",
    "question_type": "Fact Retrieval",
    "evidence": "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch"
  },
  {
    "id": "Medical-4c7b454c",
    "source": "Medical",
    "question": "What intravesical therapies are used for nonmuscle-invasive bladder cancer?",
    "answer": "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer"
  },
  {
    "id": "Medical-2f2a6fa6",
    "source": "Medical",
    "question": "What does systemic therapy for bladder cancer include?",
    "answer": "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy"
  },
  {
    "id": "Medical-d587c0c2",
    "source": "Medical",
    "question": "Which chemotherapy regimens are used for bladder cancer?",
    "answer": "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC"
  },
  {
    "id": "Medical-a605930d",
    "source": "Medical",
    "question": "Name immunotherapy agents used in bladder cancer treatment.",
    "answer": "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab.",
    "question_type": "Fact Retrieval",
    "evidence": "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab"
  },
  {
    "id": "Medical-b0dbdd5a",
    "source": "Medical",
    "question": "Which targeted therapies are available for bladder cancer?",
    "answer": "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy).",
    "question_type": "Fact Retrieval",
    "evidence": "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)"
  },
  {
    "id": "Medical-2349616a",
    "source": "Medical",
    "question": "How is radiation therapy used in bladder cancer?",
    "answer": "Radiation therapy (EBRT) is used alone or in combination with chemotherapy (chemoradiation).",
    "question_type": "Fact Retrieval",
    "evidence": "Radiation therapy (EBRT) is used alone or in combination with chemotherapy (chemoradiation)"
  },
  {
    "id": "Medical-01f6cee9",
    "source": "Medical",
    "question": "What is trimodal therapy in bladder cancer?",
    "answer": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach.",
    "question_type": "Fact Retrieval",
    "evidence": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach"
  },
  {
    "id": "Medical-f14367b4",
    "source": "Medical",
    "question": "Are clinical trials available for bladder cancer patients?",
    "answer": "Clinical trials are available at all stages of bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are available at all stages of bladder cancer"
  },
  {
    "id": "Medical-41a35ea5",
    "source": "Medical",
    "question": "Why is follow-up and surveillance important in bladder cancer?",
    "answer": "Follow-up and surveillance are required due to high recurrence rates.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up and surveillance are required due to high recurrence rates"
  },
  {
    "id": "Medical-bf15b76c",
    "source": "Medical",
    "question": "What does supportive care address in bladder cancer management?",
    "answer": "Supportive care addresses symptoms and side effects of cancer and its treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive care addresses symptoms and side effects of cancer and its treatment"
  },
  {
    "id": "Medical-5c1d4e51",
    "source": "Medical",
    "question": "What are common side effects of bladder cancer treatment?",
    "answer": "Common side effects include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea.",
    "question_type": "Fact Retrieval",
    "evidence": "Common side effects of treatment include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea"
  },
  {
    "id": "Medical-75349f3e",
    "source": "Medical",
    "question": "Which imaging modalities are used in diagnosing bladder cancer?",
    "answer": "Imaging methods include CT scan, MRI, PET/CT, ultrasound, pyelogram, and urogram.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)"
  },
  {
    "id": "Medical-0a1eb649",
    "source": "Medical",
    "question": "Which procedures are included in follow-up and surveillance for bladder cancer?",
    "answer": "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are included in follow-up and surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up/Surveillance: [Regular cystoscopy, Urine cytology, Imaging, Biomarker surveillance]"
  },
  {
    "id": "Medical-185686b9",
    "source": "Medical",
    "question": "What is the most common type of kidney cancer?",
    "answer": "Renal cell carcinoma (RCC) is the most common type.",
    "question_type": "Fact Retrieval",
    "evidence": "Renal cell carcinoma (RCC) is the most common type of kidney cancer"
  },
  {
    "id": "Medical-5d6707ec",
    "source": "Medical",
    "question": "Which subtype is most common within renal cell carcinoma?",
    "answer": "Clear cell RCC is the most common subtype of RCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Clear cell RCC is the most common subtype of RCC"
  },
  {
    "id": "Medical-d44eb527",
    "source": "Medical",
    "question": "What are the main non-clear cell subtypes of RCC?",
    "answer": "Papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma are the main non-clear cell RCC subtypes.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma"
  },
  {
    "id": "Medical-7996c42e",
    "source": "Medical",
    "question": "Which RCC subtype is associated with more aggressive disease due to sarcomatoid features?",
    "answer": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease.",
    "question_type": "Fact Retrieval",
    "evidence": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease"
  },
  {
    "id": "Medical-a8f6fa76",
    "source": "Medical",
    "question": "Where does renal cell carcinoma originate in the kidney?",
    "answer": "RCC starts in the cells that line the renal tubules.",
    "question_type": "Fact Retrieval",
    "evidence": "RCC starts in the cells that line the renal tubules"
  },
  {
    "id": "Medical-37dbfdeb",
    "source": "Medical",
    "question": "Which kidney cancer type starts in the renal pelvis and ureter?",
    "answer": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter.",
    "question_type": "Fact Retrieval",
    "evidence": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter"
  },
  {
    "id": "Medical-d0e5bc04",
    "source": "Medical",
    "question": "Which kidney cancer type is most commonly seen in young children?",
    "answer": "Wilms tumor usually occurs in young children and is a distinct kidney cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "Wilms tumor usually occurs in young children and is a distinct kidney cancer type"
  },
  {
    "id": "Medical-490d56f2",
    "source": "Medical",
    "question": "What kidney cancer type arises from the blood vessels or connective tissue?",
    "answer": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Fact Retrieval",
    "evidence": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
  },
  {
    "id": "Medical-10f571cf",
    "source": "Medical",
    "question": "Name two anatomical structures in the kidney where cancer can spread locally.",
    "answer": "Kidney cancer can spread locally to surrounding fat and blood vessels.",
    "question_type": "Fact Retrieval",
    "evidence": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-ba155dc8",
    "source": "Medical",
    "question": "Which distant organs are common sites for kidney cancer metastasis?",
    "answer": "Lungs, lymph nodes, bones, liver, and brain are common sites for metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain"
  },
  {
    "id": "Medical-dee6ad31",
    "source": "Medical",
    "question": "What diagnostic methods are used for kidney cancer?",
    "answer": "Imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-b8dfd72f",
    "source": "Medical",
    "question": "Which factors determine the treatment approach for RCC?",
    "answer": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis"
  },
  {
    "id": "Medical-1e2c5da7",
    "source": "Medical",
    "question": "How are multiple tumors in one or both kidneys classified?",
    "answer": "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis"
  },
  {
    "id": "Medical-a11058f1",
    "source": "Medical",
    "question": "Which anatomical structure is the origin of RCC according to the ontology?",
    "answer": "RCC originates from the renal tubules.",
    "question_type": "Fact Retrieval",
    "evidence": "RCC starts in the cells that line the renal tubules"
  },
  {
    "id": "Medical-21443bc5",
    "source": "Medical",
    "question": "What is the anatomical location for urothelial carcinoma in the kidney?",
    "answer": "Urothelial carcinoma originates from the renal pelvis.",
    "question_type": "Fact Retrieval",
    "evidence": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter"
  },
  {
    "id": "Medical-e3a6570b",
    "source": "Medical",
    "question": "List three diagnostic tests for kidney cancer.",
    "answer": "Imaging tests, blood tests, and urine tests are diagnostic methods.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-5d85f130",
    "source": "Medical",
    "question": "Which subtype of RCC includes papillary and chromophobe RCC?",
    "answer": "Non-clear cell RCC includes papillary RCC and chromophobe RCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma"
  },
  {
    "id": "Medical-a7da5e0d",
    "source": "Medical",
    "question": "What is a histological subtype of non-clear cell RCC?",
    "answer": "Papillary RCC is a histological subtype of non-clear cell RCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma"
  },
  {
    "id": "Medical-823c7c4f",
    "source": "Medical",
    "question": "Which anatomical structure surrounds the kidney and can be invaded by cancer?",
    "answer": "Gerotas fascia surrounds the kidney and can be invaded by cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-794ec19c",
    "source": "Medical",
    "question": "What is a potential local spread site for kidney cancer besides fat and vessels?",
    "answer": "Adrenal glands are a potential local spread site for kidney cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-1fc1a85d",
    "source": "Medical",
    "question": "Which diagnostic method is used to test for genetic risk in kidney cancer?",
    "answer": "Genetic risk testing is used for diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-f0243613",
    "source": "Medical",
    "question": "Which RCC subtype can show sarcomatoid features?",
    "answer": "Sarcomatoid features can occur in any RCC subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease"
  },
  {
    "id": "Medical-d44fbd5d",
    "source": "Medical",
    "question": "Which kidney cancer subtype is described as fumarate hydratase-deficient?",
    "answer": "Fumarate hydratase-deficient RCC is a non-clear cell RCC subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Fumarate hydratase-deficient RCC is listed under non-clear cell RCC in the ontology"
  },
  {
    "id": "Medical-974e88ba",
    "source": "Medical",
    "question": "Which cancer subtype is called nephroblastoma?",
    "answer": "Wilms tumor is also known as nephroblastoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Wilms tumor (nephroblastoma) is listed in the ontology"
  },
  {
    "id": "Medical-10a38986",
    "source": "Medical",
    "question": "Which kidney cancer arises from the connective tissue?",
    "answer": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Fact Retrieval",
    "evidence": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
  },
  {
    "id": "Medical-c7f55e00",
    "source": "Medical",
    "question": "What is the main anatomical structure involved in the origin of RCC?",
    "answer": "The renal tubules are the main anatomical structure involved.",
    "question_type": "Fact Retrieval",
    "evidence": "RCC starts in the cells that line the renal tubules"
  },
  {
    "id": "Medical-07accd3e",
    "source": "Medical",
    "question": "Which diagnostic method provides tissue for histology in kidney cancer?",
    "answer": "Biopsy is the diagnostic method that provides tissue for histology.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-d1937844",
    "source": "Medical",
    "question": "Which anatomical structure is a common site of distant metastasis from kidney cancer?",
    "answer": "The lungs are a common site of distant metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain"
  },
  {
    "id": "Medical-b53a2a5a",
    "source": "Medical",
    "question": "Which subtypes are included in non-clear cell RCC according to the ontology?",
    "answer": "Papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC are included.",
    "question_type": "Fact Retrieval",
    "evidence": "Non-clear cell RCC (nccRCC) includes Papillary RCC (PRCC), Chromophobe RCC, Collecting duct RCC (cdRCC), Renal medullary carcinoma (RMC), Clear cell papillary renal cell tumor, Fumarate hydratase-deficient RCC, and ELOC-mutated RCC"
  },
  {
    "id": "Medical-ebc2f755",
    "source": "Medical",
    "question": "What is the relationship between tumor location and RCC treatment?",
    "answer": "Tumor location is a treatment factor for RCC.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis"
  },
  {
    "id": "Medical-1fabcd8c",
    "source": "Medical",
    "question": "Which anatomical structure is part of the kidney's blood supply and can be involved in local spread?",
    "answer": "The renal vein is part of the blood supply and can be involved in local spread.",
    "question_type": "Fact Retrieval",
    "evidence": "Local spread includes blood vessels such as the renal vein"
  },
  {
    "id": "Medical-b821991a",
    "source": "Medical",
    "question": "Which test is used to evaluate biomarkers in kidney cancer?",
    "answer": "Biomarker testing is used to evaluate biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-a653aa5d",
    "source": "Medical",
    "question": "What is the most common subtype of anal cancer?",
    "answer": "Anal squamous cell carcinoma is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Anal squamous cell carcinoma is the most common subtype of anal cancer"
  },
  {
    "id": "Medical-a0d64e65",
    "source": "Medical",
    "question": "Which virus is the strongest risk factor for anal cancer?",
    "answer": "HPV infection is the strongest risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": "HPV infection is the strongest risk factor for anal cancer"
  },
  {
    "id": "Medical-c87340df",
    "source": "Medical",
    "question": "Which high-risk HPV strain is associated with anal cancer?",
    "answer": "HPV16 is a high-risk strain associated with anal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "HPV16 is a high-risk strain associated with anal cancer"
  },
  {
    "id": "Medical-dd224a09",
    "source": "Medical",
    "question": "What is the primary treatment for most non-metastatic anal cancers (stages I-III)?",
    "answer": "Chemoradiation is the recommended primary treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)"
  },
  {
    "id": "Medical-97813815",
    "source": "Medical",
    "question": "What chemotherapy regimens are recommended with radiation for anal cancer?",
    "answer": "Mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin"
  },
  {
    "id": "Medical-4a5a56d2",
    "source": "Medical",
    "question": "Which diagnostic methods are used for the diagnosis and staging of anal cancer?",
    "answer": "Digital rectal exam (DRE), high-resolution anoscopy (HRA), and imaging (CT, MRI, PET) are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Digital rectal exam (DRE), high-resolution anoscopy (HRA), and imaging (CT, MRI, PET) are used for diagnosis and staging"
  },
  {
    "id": "Medical-63c03e9b",
    "source": "Medical",
    "question": "What is the AJCC TNM stage for distant metastasis in anal cancer?",
    "answer": "Stage IV is defined as distant metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage IV: distant metastasis"
  },
  {
    "id": "Medical-08e2b14a",
    "source": "Medical",
    "question": "Which surgical procedure results in a permanent colostomy for anal cancer patients?",
    "answer": "Abdominoperineal resection (APR) results in a permanent colostomy.",
    "question_type": "Fact Retrieval",
    "evidence": "APR results in a permanent colostomy"
  },
  {
    "id": "Medical-7dfa3ebe",
    "source": "Medical",
    "question": "What are common symptoms of anal cancer?",
    "answer": "Common symptoms include rectal bleeding, anal itching, pain, and a lump near the anus.",
    "question_type": "Fact Retrieval",
    "evidence": "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus"
  },
  {
    "id": "Medical-5a8f962a",
    "source": "Medical",
    "question": "Which imaging techniques are used in the diagnosis of anal cancer?",
    "answer": "CT scan, MRI, and PET scan are used for diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "CT scan, MRI, PET scan are used for diagnosis"
  },
  {
    "id": "Medical-bb548dea",
    "source": "Medical",
    "question": "What is the indication for local excision in anal cancer treatment?",
    "answer": "Local excision is an option for some early-stage, low-grade perianal cancers.",
    "question_type": "Fact Retrieval",
    "evidence": "Local excision is an option for some early-stage, low-grade perianal cancers"
  },
  {
    "id": "Medical-6b2c8ad5",
    "source": "Medical",
    "question": "Which immunotherapy drugs are recommended for metastatic anal cancer that progresses after chemotherapy?",
    "answer": "Nivolumab and pembrolizumab are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy"
  },
  {
    "id": "Medical-042aa09a",
    "source": "Medical",
    "question": "What is the preferred radiation technique for anal cancer?",
    "answer": "IMRT is the preferred radiation technique.",
    "question_type": "Fact Retrieval",
    "evidence": "IMRT is the preferred radiation technique for anal cancer"
  },
  {
    "id": "Medical-0c7cb4ef",
    "source": "Medical",
    "question": "Which risk factor is shared by patients with a history of cervical, vulvar, or vaginal cancer or precancer?",
    "answer": "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk"
  },
  {
    "id": "Medical-5fed2a2c",
    "source": "Medical",
    "question": "What is the recommended follow-up for complete remission after anal cancer treatment?",
    "answer": "Follow-up includes DRE and inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, and imaging yearly for 3 years (stage II/III).",
    "question_type": "Fact Retrieval",
    "evidence": "Complete remission: DRE every 3-6 months for 5 years, inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, imaging yearly for 3 years (stage II/III)"
  },
  {
    "id": "Medical-c68b6022",
    "source": "Medical",
    "question": "What is the most common site of origin for anal cancer?",
    "answer": "Anal cancer most often starts in squamous cells lining the anal canal.",
    "question_type": "Fact Retrieval",
    "evidence": "Anal cancer most often starts in squamous cells lining the anal canal"
  },
  {
    "id": "Medical-facc6239",
    "source": "Medical",
    "question": "Which population should be tested for HIV when diagnosed with anal cancer?",
    "answer": "HIV testing is recommended in patients with anal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "HIV testing is recommended in patients with anal cancer"
  },
  {
    "id": "Medical-506ba6ee",
    "source": "Medical",
    "question": "Which chemotherapy regimens are used for metastatic anal cancer?",
    "answer": "Carboplatin and paclitaxel, FOLFOX, FOLFCIS, modified DCF, and 5-FU and cisplatin are used.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin)"
  },
  {
    "id": "Medical-63d09604",
    "source": "Medical",
    "question": "What precancerous lesions are associated with anal squamous cell carcinoma?",
    "answer": "AIN, LSIL, HSIL, and Stage 0 are precancerous lesions.",
    "question_type": "Fact Retrieval",
    "evidence": "Anal squamous cell carcinoma: Precancerous Lesion: [AIN, LSIL, HSIL, Stage 0]"
  },
  {
    "id": "Medical-481c27a3",
    "source": "Medical",
    "question": "What are the consequences of abdominoperineal resection (APR)?",
    "answer": "APR results in a permanent colostomy.",
    "question_type": "Fact Retrieval",
    "evidence": "APR results in a permanent colostomy"
  },
  {
    "id": "Medical-beaf1678",
    "source": "Medical",
    "question": "What fertility preservation options should be discussed before chemoradiation for anal cancer?",
    "answer": "Options include sperm banking, egg freezing, ovarian tissue banking, and oophoropexy.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility preservation options should be discussed: sperm banking, egg freezing, ovarian tissue banking, oophoropexy"
  },
  {
    "id": "Medical-86f3ab3d",
    "source": "Medical",
    "question": "What is the definition of Stage I anal cancer according to the AJCC TNM system?",
    "answer": "Stage I: tumor 2 cm, no lymph node or distant spread.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage I: tumor 2 cm, no lymph node or distant spread"
  },
  {
    "id": "Medical-73b1e8c2",
    "source": "Medical",
    "question": "What is the indication for groin dissection in anal cancer?",
    "answer": "Groin dissection is indicated for lymph node recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Groin dissection: Indication: Lymph node recurrence"
  },
  {
    "id": "Medical-f61e2128",
    "source": "Medical",
    "question": "What is the recommended treatment for persistent, recurrent, or locally progressive anal cancer?",
    "answer": "Abdominoperineal resection (APR) is recommended.",
    "question_type": "Fact Retrieval",
    "evidence": "Abdominoperineal resection (APR) is recommended for persistent, recurrent, or locally progressive anal cancer"
  },
  {
    "id": "Medical-912613b8",
    "source": "Medical",
    "question": "Which supportive care measures are provided for anal cancer patients?",
    "answer": "Supportive care includes pelvic floor physical therapy, dietary counseling, vaginal dilator therapy, ostomy care, mental health support, and peer-to-peer support.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive Care: [Pelvic floor physical therapy, Dietary counseling, Vaginal dilator therapy, Ostomy care, Mental health support, Peer-to-peer support]"
  },
  {
    "id": "Medical-ea7aec7d",
    "source": "Medical",
    "question": "What are common side effects of anal cancer treatment?",
    "answer": "Common side effects include infertility, bowel dysfunction, urinary incontinence, sexual dysfunction, hand-foot syndrome, nausea, vomiting, diarrhea, fatigue, skin irritation, mucositis, low blood cell counts, hearing loss (cisplatin), and neuropathy (oxaliplatin).",
    "question_type": "Fact Retrieval",
    "evidence": "Side Effect: [Infertility, Bowel dysfunction, Urinary incontinence, Sexual dysfunction, Hand-foot syndrome, Nausea, Vomiting, Diarrhea, Fatigue, Skin irritation, Mucositis, Low blood cell counts, Hearing loss (cisplatin), Neuropathy (oxaliplatin)]"
  },
  {
    "id": "Medical-4c1f9dd4",
    "source": "Medical",
    "question": "Which patients are eligible for clinical trials in anal cancer?",
    "answer": "All patients are encouraged to consider enrollment in clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are recommended for all patients if available"
  },
  {
    "id": "Medical-f057bf07",
    "source": "Medical",
    "question": "What is the definition of Stage 0 anal cancer?",
    "answer": "Stage 0 is carcinoma in situ or anal dysplasia.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 0 is carcinoma in situ or anal dysplasia"
  },
  {
    "id": "Medical-8251ced4",
    "source": "Medical",
    "question": "What are the main anatomic locations where anal cancer can start?",
    "answer": "Anal cancer can start in the anal canal or perianal region.",
    "question_type": "Fact Retrieval",
    "evidence": "Anal cancer can start in the anal canal or perianal region"
  },
  {
    "id": "Medical-dff662c1",
    "source": "Medical",
    "question": "Which populations are at increased risk of anal cancer due to immunosuppression?",
    "answer": "HIV infection and immunosuppressant use increase the risk of anal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "HIV infection increases the risk of anal cancer; Immunosuppressant use increases the risk of anal cancer"
  },
  {
    "id": "Medical-f3817e3b",
    "source": "Medical",
    "question": "What is the standard method for diagnosing anal cancer after abnormal DRE or anoscopy?",
    "answer": "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy.",
    "question_type": "Fact Retrieval",
    "evidence": "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy"
  },
  {
    "id": "Medical-23f92b9b",
    "source": "Medical",
    "question": "Which AJCC TNM stage involves lymph node involvement and/or invasion of nearby organs in anal cancer?",
    "answer": "Stage III involves lymph node involvement and/or invasion of nearby organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage III: lymph node involvement and/or invasion of nearby organs"
  },
  {
    "id": "Medical-0eed4fb2",
    "source": "Medical",
    "question": "What is the primary cancer type described in this context?",
    "answer": "Acute lymphoblastic leukemia (ALL) is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-abe5fc71",
    "source": "Medical",
    "question": "Which cells are the origin of ALL?",
    "answer": "ALL arises from lymphoid progenitor cells.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL arises from lymphoid progenitor cells"
  },
  {
    "id": "Medical-7904dba7",
    "source": "Medical",
    "question": "What are the two main subtypes of acute lymphoblastic leukemia?",
    "answer": "The two main subtypes are B-cell ALL (B-ALL) and T-cell ALL (T-ALL).",
    "question_type": "Fact Retrieval",
    "evidence": "There are two main subtypes of ALL: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)"
  },
  {
    "id": "Medical-e87faed8",
    "source": "Medical",
    "question": "Which ALL subtype is more common?",
    "answer": "B-cell ALL (B-ALL) is more common than T-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL"
  },
  {
    "id": "Medical-378948e8",
    "source": "Medical",
    "question": "What is the cell of origin for T-cell ALL?",
    "answer": "T-cell ALL starts in T-cell lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-3eede906",
    "source": "Medical",
    "question": "What diagnostic threshold defines ALL based on bone marrow lymphoblasts?",
    "answer": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow"
  },
  {
    "id": "Medical-4b10d237",
    "source": "Medical",
    "question": "Which diagnostic methods are used for ALL?",
    "answer": "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture"
  },
  {
    "id": "Medical-b0580d86",
    "source": "Medical",
    "question": "What are the common sites where ALL can be found?",
    "answer": "ALL can be found in bone marrow, blood, testicles, and central nervous system.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL can be found in bone marrow, blood, testicles, and central nervous system"
  },
  {
    "id": "Medical-b2e840c7",
    "source": "Medical",
    "question": "Which ALL subtype can cause an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) can cause an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-ce4f84f0",
    "source": "Medical",
    "question": "What is mature B-cell ALL also called?",
    "answer": "Mature B-cell ALL is also called Burkitt leukemia.",
    "question_type": "Fact Retrieval",
    "evidence": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-ea9eb2d8",
    "source": "Medical",
    "question": "What is the main difference in treatment for mature B-cell ALL compared to B-ALL?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-b58d9012",
    "source": "Medical",
    "question": "What is B-cell lymphoblastic lymphoma (B-LL/B-LBL)?",
    "answer": "B-cell lymphoblastic lymphoma occurs when B-cell lymphoblasts grow mostly in lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes"
  },
  {
    "id": "Medical-925c6318",
    "source": "Medical",
    "question": "Where do T-cell lymphoblastic lymphomas (T-LL/T-LBL) primarily grow?",
    "answer": "T-cell lymphoblastic lymphomas grow mostly in the thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-cell lymphoblastic lymphoma (T-LL/T-LBL) occurs when T-cell lymphoblasts grow mostly in the thymus"
  },
  {
    "id": "Medical-1b8db6c8",
    "source": "Medical",
    "question": "What are the main treatment modalities for ALL?",
    "answer": "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-da8083a2",
    "source": "Medical",
    "question": "When may targeted therapy be used in ALL?",
    "answer": "Targeted therapy may be used based on genetic alterations.",
    "question_type": "Fact Retrieval",
    "evidence": "Targeted therapy may be used based on genetic alterations"
  },
  {
    "id": "Medical-99cee2d0",
    "source": "Medical",
    "question": "Which ALL subtype is treated with therapies targeting the BCR::ABL protein?",
    "answer": "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein.",
    "question_type": "Fact Retrieval",
    "evidence": "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
  },
  {
    "id": "Medical-dfc549c9",
    "source": "Medical",
    "question": "What is the preferred treatment approach for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL?",
    "answer": "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL"
  },
  {
    "id": "Medical-0b9d8142",
    "source": "Medical",
    "question": "What are the treatment options for T-ALL?",
    "answer": "T-ALL treatment options include chemotherapy and clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL treatment options include chemotherapy and clinical trials"
  },
  {
    "id": "Medical-3c195424",
    "source": "Medical",
    "question": "What are common symptoms of ALL?",
    "answer": "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement"
  },
  {
    "id": "Medical-06ecb1df",
    "source": "Medical",
    "question": "What are some risk factors for developing ALL?",
    "answer": "Risk factors for ALL include certain genetic syndromes and family history.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors for ALL include certain genetic syndromes and family history"
  },
  {
    "id": "Medical-fcfc4ee8",
    "source": "Medical",
    "question": "Which patient populations are most commonly affected by ALL?",
    "answer": "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults"
  },
  {
    "id": "Medical-ae39f048",
    "source": "Medical",
    "question": "Which biomarker is associated with B-cell ALL?",
    "answer": "BCR::ABL1 is a biomarker associated with B-cell ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "B-cell ALL (B-ALL): Biomarker: [BCR::ABL1, Other gene or chromosome changes]"
  },
  {
    "id": "Medical-612b302a",
    "source": "Medical",
    "question": "What supportive care should be considered before ALL treatment?",
    "answer": "Fertility preservation should be considered before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility preservation should be considered before treatment"
  },
  {
    "id": "Medical-5496bd62",
    "source": "Medical",
    "question": "What is included in follow-up for ALL patients?",
    "answer": "Follow-up includes regular blood tests and surveillance for relapse.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes regular blood tests and surveillance for relapse"
  },
  {
    "id": "Medical-c3fbbeb8",
    "source": "Medical",
    "question": "What laboratory method is essential for immunophenotyping in ALL diagnosis?",
    "answer": "Flow cytometry is essential for immunophenotyping in ALL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of ALL involves flow cytometry, immunophenotyping"
  },
  {
    "id": "Medical-58758b1e",
    "source": "Medical",
    "question": "What genetic alteration is targeted in BCR::ABL1-positive B-ALL?",
    "answer": "BCR::ABL1 fusion is the genetic alteration targeted in BCR::ABL1-positive B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic Alteration: [BCR::ABL1 fusion, Other gene or chromosome changes]"
  },
  {
    "id": "Medical-30093110",
    "source": "Medical",
    "question": "Which organs may show involvement in ALL besides bone marrow?",
    "answer": "ALL may involve blood, lymph nodes, thymus, testicles, and central nervous system.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL can be found in bone marrow, blood, testicles, and central nervous system"
  },
  {
    "id": "Medical-ad34fb71",
    "source": "Medical",
    "question": "What is the initial cell type affected in ALL?",
    "answer": "Lymphoblasts are the initial cell type affected in ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow"
  },
  {
    "id": "Medical-a06b41f4",
    "source": "Medical",
    "question": "Which subtype of ALL is associated with an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) is associated with an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-277e2774",
    "source": "Medical",
    "question": "What is the role of steroids in ALL treatment?",
    "answer": "Steroids are part of the standard multiagent chemotherapy for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-76a07999",
    "source": "Medical",
    "question": "Which diagnostic procedure is used to examine the central nervous system in ALL?",
    "answer": "Lumbar puncture is used to examine the central nervous system in ALL.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis of ALL involves lumbar puncture"
  },
  {
    "id": "Medical-4505fae9",
    "source": "Medical",
    "question": "What is the most common subtype of pancreatic cancer?",
    "answer": "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype of pancreatic cancer"
  },
  {
    "id": "Medical-146a909f",
    "source": "Medical",
    "question": "Which subtype of pancreatic cancer is less common?",
    "answer": "Pancreatic neuroendocrine tumor is a less common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": "Pancreatic neuroendocrine tumor is a less common subtype of pancreatic cancer"
  },
  {
    "id": "Medical-ce9c83a7",
    "source": "Medical",
    "question": "What is Stage 0 pancreatic cancer?",
    "answer": "Stage 0 pancreatic cancer is confined to the innermost layer of the duct wall.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 0 pancreatic cancer is confined to the innermost layer of the duct wall"
  },
  {
    "id": "Medical-f27ac6b8",
    "source": "Medical",
    "question": "What characterizes Stage I pancreatic cancer?",
    "answer": "Stage I pancreatic cancer is a tumor 4 cm or smaller and has not spread outside the pancreas.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage I pancreatic cancer is a tumor 4 cm or smaller and has not spread outside the pancreas"
  },
  {
    "id": "Medical-69adc0f1",
    "source": "Medical",
    "question": "How is Stage II pancreatic cancer defined?",
    "answer": "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes"
  },
  {
    "id": "Medical-edd74751",
    "source": "Medical",
    "question": "What defines Stage III pancreatic cancer?",
    "answer": "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes"
  },
  {
    "id": "Medical-484cdbd7",
    "source": "Medical",
    "question": "What is Stage IV pancreatic cancer?",
    "answer": "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining"
  },
  {
    "id": "Medical-12c14164",
    "source": "Medical",
    "question": "What is another name for Stage IV pancreatic cancer?",
    "answer": "Stage IV pancreatic cancer is also known as metastatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage IV pancreatic cancer is metastatic cancer"
  },
  {
    "id": "Medical-0c8447e4",
    "source": "Medical",
    "question": "List three risk factors for pancreatic cancer.",
    "answer": "Risk factors include smoking, heavy alcohol use, and unhealthy diet.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors for pancreatic cancer include smoking, heavy alcohol use, unhealthy diet, exposure to pesticides, diabetes, chronic pancreatitis, and family history of certain cancers"
  },
  {
    "id": "Medical-62915cf3",
    "source": "Medical",
    "question": "Which hereditary syndromes increase the risk of pancreatic cancer?",
    "answer": "HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer"
  },
  {
    "id": "Medical-5d1e33ba",
    "source": "Medical",
    "question": "What diagnostic methods are used for pancreatic cancer?",
    "answer": "Diagnostic methods include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests"
  },
  {
    "id": "Medical-bbe2b0d9",
    "source": "Medical",
    "question": "What is the role of imaging in pancreatic cancer diagnosis?",
    "answer": "Imaging is used for staging and determining surgical eligibility in pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging is used for staging and determining surgical eligibility in pancreatic cancer"
  },
  {
    "id": "Medical-294e8af8",
    "source": "Medical",
    "question": "Which test can detect inherited mutations linked to hereditary pancreatic cancer?",
    "answer": "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer"
  },
  {
    "id": "Medical-73631aaa",
    "source": "Medical",
    "question": "What symptom may indicate pancreatic cancer?",
    "answer": "Jaundice (yellowed skin or eyes) may indicate pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)"
  },
  {
    "id": "Medical-3785154c",
    "source": "Medical",
    "question": "What treatment is an option for some patients with stage I, II, or III pancreatic cancer?",
    "answer": "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer"
  },
  {
    "id": "Medical-f5dd3419",
    "source": "Medical",
    "question": "What is the main purpose of drug treatment in pancreatic cancer?",
    "answer": "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer"
  },
  {
    "id": "Medical-ba2d6fae",
    "source": "Medical",
    "question": "Are clinical trials available for pancreatic cancer patients?",
    "answer": "Yes, clinical trials are available for pancreatic cancer patients.",
    "question_type": "Fact Retrieval",
    "evidence": "Clinical trials are available for pancreatic cancer patients"
  },
  {
    "id": "Medical-227447b0",
    "source": "Medical",
    "question": "Why is a multidisciplinary care team important in pancreatic cancer?",
    "answer": "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer"
  },
  {
    "id": "Medical-e947f2af",
    "source": "Medical",
    "question": "What is the role of supportive care in pancreatic cancer management?",
    "answer": "Supportive care is an important part of pancreatic cancer management.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive care is an important part of pancreatic cancer management"
  },
  {
    "id": "Medical-83d2a1a9",
    "source": "Medical",
    "question": "Which cancer type starts in the pancreas?",
    "answer": "Pancreatic cancer is a type of cancer that starts in the pancreas.",
    "question_type": "Fact Retrieval",
    "evidence": "Pancreatic cancer is a type of cancer that starts in the pancreas"
  },
  {
    "id": "Medical-e354dbd2",
    "source": "Medical",
    "question": "Which care team member specializes in imaging for diagnosis?",
    "answer": "A diagnostic radiologist specializes in imaging for diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic radiologist is listed as a Care Team Role in the ontology"
  },
  {
    "id": "Medical-79a126e8",
    "source": "Medical",
    "question": "Who on the care team provides genetic counseling for pancreatic cancer?",
    "answer": "A genetic counselor provides genetic counseling for pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic counselor is listed as a Care Team Role in the ontology"
  },
  {
    "id": "Medical-c6d4a32e",
    "source": "Medical",
    "question": "Which care team member is responsible for performing biopsies?",
    "answer": "A pathologist is responsible for performing biopsies.",
    "question_type": "Fact Retrieval",
    "evidence": "Pathologist is listed as a Care Team Role in the ontology"
  },
  {
    "id": "Medical-a8dea23c",
    "source": "Medical",
    "question": "Which care team professional manages drug treatments for pancreatic cancer?",
    "answer": "A medical oncologist manages drug treatments for pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Medical oncologist is listed as a Care Team Role in the ontology"
  },
  {
    "id": "Medical-5a1326ab",
    "source": "Medical",
    "question": "What is a common genetic syndrome associated with increased pancreatic cancer risk?",
    "answer": "Hereditary breast-ovarian cancer syndrome (HBOC) is associated with increased pancreatic cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": "Hereditary breast-ovarian cancer syndrome, HBOC, is listed under Genetic Syndrome increasing risk of pancreatic cancer"
  },
  {
    "id": "Medical-dfabcfaf",
    "source": "Medical",
    "question": "What is the definition of metastatic pancreatic cancer?",
    "answer": "Metastatic pancreatic cancer is pancreatic cancer that has spread to distant organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining"
  },
  {
    "id": "Medical-a79c7070",
    "source": "Medical",
    "question": "Which diagnostic method is used to obtain tissue samples in pancreatic cancer?",
    "answer": "Biopsy is used to obtain tissue samples in pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is listed as a Diagnostic Method for pancreatic cancer"
  },
  {
    "id": "Medical-34cfff2d",
    "source": "Medical",
    "question": "Name a blood-based diagnostic method for pancreatic cancer.",
    "answer": "Blood test is a blood-based diagnostic method for pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood test is listed as a Diagnostic Method for pancreatic cancer"
  },
  {
    "id": "Medical-11267008",
    "source": "Medical",
    "question": "Which lifestyle factor is a risk factor for pancreatic cancer?",
    "answer": "Smoking is a lifestyle risk factor for pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors for pancreatic cancer include smoking"
  },
  {
    "id": "Medical-05ba3aaa",
    "source": "Medical",
    "question": "What is the role of a registered dietitian in pancreatic cancer care?",
    "answer": "A registered dietitian is part of the care team for pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Registered dietitian is listed as a Care Team Role in the ontology"
  },
  {
    "id": "Medical-33142c97",
    "source": "Medical",
    "question": "Which syndrome is characterized by increased risk of both melanoma and pancreatic cancer?",
    "answer": "Familial malignant melanoma syndrome (FAMMM syndrome) is associated with increased risk of both.",
    "question_type": "Fact Retrieval",
    "evidence": "Familial malignant melanoma syndrome, FAMMM syndrome, is listed under Genetic Syndrome increasing risk of pancreatic cancer"
  },
  {
    "id": "Medical-3b1e4517",
    "source": "Medical",
    "question": "What supportive care options are included in pancreatic cancer management?",
    "answer": "Supportive care options include symptom management and palliative care.",
    "question_type": "Fact Retrieval",
    "evidence": "Supportive Care includes symptom management and palliative care in the ontology"
  },
  {
    "id": "Medical-f7ffe25a",
    "source": "Medical",
    "question": "What is the primary cancer type discussed in this dataset?",
    "answer": "Prostate cancer is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": "Prostate cancer is a disease where cells in the prostate gland grow out of control"
  },
  {
    "id": "Medical-9fbd09c4",
    "source": "Medical",
    "question": "Which subtype of prostate cancer is confined to the prostate gland?",
    "answer": "Localized prostate cancer is confined to the prostate.",
    "question_type": "Fact Retrieval",
    "evidence": "Localized prostate cancer is early-stage and confined to the prostate"
  },
  {
    "id": "Medical-83e047ca",
    "source": "Medical",
    "question": "What stage is regional prostate cancer classified as?",
    "answer": "Regional prostate cancer is classified as advanced-stage.",
    "question_type": "Fact Retrieval",
    "evidence": "Regional prostate cancer has spread to nearby lymph nodes"
  },
  {
    "id": "Medical-e8796bdf",
    "source": "Medical",
    "question": "Which organs can metastatic prostate cancer spread to?",
    "answer": "Metastatic prostate cancer can spread to bones, liver, or lungs.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic prostate cancer has spread to distant organs such as bones, liver, or lungs"
  },
  {
    "id": "Medical-85da0dd2",
    "source": "Medical",
    "question": "What blood test is commonly used for prostate cancer screening?",
    "answer": "The PSA test is commonly used for screening.",
    "question_type": "Fact Retrieval",
    "evidence": "PSA test and digital rectal exam are used for screening and diagnosis"
  },
  {
    "id": "Medical-90da4658",
    "source": "Medical",
    "question": "What procedure is required to confirm a prostate cancer diagnosis?",
    "answer": "A biopsy is required to confirm the diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is required to confirm prostate cancer diagnosis"
  },
  {
    "id": "Medical-3c98e480",
    "source": "Medical",
    "question": "Which imaging modalities are used to assess the extent of prostate cancer?",
    "answer": "MRI, CT, PET, ultrasound, and bone scan are used to assess extent of disease.",
    "question_type": "Fact Retrieval",
    "evidence": "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease"
  },
  {
    "id": "Medical-53fae064",
    "source": "Medical",
    "question": "Which genetic mutation increases the risk of prostate cancer?",
    "answer": "BRCA2 mutation increases risk of prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "BRCA2 mutation increases risk of prostate cancer"
  },
  {
    "id": "Medical-c6d69844",
    "source": "Medical",
    "question": "For which patients is germline genetic testing recommended in prostate cancer?",
    "answer": "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer"
  },
  {
    "id": "Medical-78a954b5",
    "source": "Medical",
    "question": "What is the role of molecular biomarker testing in prostate cancer?",
    "answer": "Molecular biomarker testing helps assess risk and guide treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": "Molecular biomarker testing helps assess risk and guide treatment decisions"
  },
  {
    "id": "Medical-ae01850d",
    "source": "Medical",
    "question": "Which grading systems are used to estimate prostate cancer aggressiveness?",
    "answer": "Grade Group and Gleason score are used to estimate aggressiveness.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade Group and Gleason score are used to estimate cancer aggressiveness"
  },
  {
    "id": "Medical-7960f915",
    "source": "Medical",
    "question": "How are risk groups utilized in prostate cancer management?",
    "answer": "Risk groups guide prognosis and treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment"
  },
  {
    "id": "Medical-f2fb665d",
    "source": "Medical",
    "question": "What are the main treatment options for prostate cancer?",
    "answer": "Hormone therapy, surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and radiopharmaceuticals are treatment options.",
    "question_type": "Fact Retrieval",
    "evidence": "Hormone therapy, surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and radiopharmaceuticals are treatment options"
  },
  {
    "id": "Medical-c9348a2d",
    "source": "Medical",
    "question": "What is the mainstay of advanced prostate cancer treatment?",
    "answer": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment"
  },
  {
    "id": "Medical-b1056b54",
    "source": "Medical",
    "question": "Which management strategy is recommended for low-risk, early-stage prostate cancer?",
    "answer": "Active surveillance is a management option for low-risk, early-stage prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Active surveillance is a management option for low-risk, early-stage prostate cancer"
  },
  {
    "id": "Medical-261cef1d",
    "source": "Medical",
    "question": "What symptoms are associated with advanced prostate cancer?",
    "answer": "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms"
  },
  {
    "id": "Medical-4eaa05dd",
    "source": "Medical",
    "question": "What are the risk factors for developing prostate cancer?",
    "answer": "Age, family history, race, genetic mutations, diet, obesity, and smoking are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Age, family history, race, genetic mutations, diet, obesity, and smoking are risk factors for prostate cancer"
  },
  {
    "id": "Medical-e22e810e",
    "source": "Medical",
    "question": "What is included in follow-up for prostate cancer patients?",
    "answer": "Follow-up includes regular PSA testing, imaging, and biopsies as needed.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes regular PSA testing, imaging, and biopsies as needed"
  },
  {
    "id": "Medical-34a94dcc",
    "source": "Medical",
    "question": "Which diagnostic methods are used for localized prostate cancer?",
    "answer": "PSA test, digital rectal exam, biopsy, MRI, and ultrasound are used for localized prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Localized prostate cancer: Diagnostic Method: PSA test, Digital rectal exam, Biopsy, MRI, Ultrasound"
  },
  {
    "id": "Medical-ff590b8b",
    "source": "Medical",
    "question": "Which treatments are available for metastatic prostate cancer?",
    "answer": "Metastatic prostate cancer treatments include ADT, LHRH agonist/antagonist, chemotherapy, immunotherapy, targeted therapy, radiation therapy, and radiopharmaceuticals.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic prostate cancer: Treatment: Androgen deprivation therapy (ADT), LHRH agonist, LHRH antagonist, Leuprolide, Goserelin, Triptorelin, Degarelix, Relugolix, Bicalutamide, Flutamide, Nilutamide, Orchiectomy, Chemotherapy, Immunotherapy, Targeted therapy, Radiation therapy, Radiopharmaceuticals"
  },
  {
    "id": "Medical-f9135c63",
    "source": "Medical",
    "question": "Which genetic alterations are associated with metastatic prostate cancer?",
    "answer": "BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, and FANCA are associated with metastatic prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic prostate cancer: Genetic Alteration: BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, FANCA"
  },
  {
    "id": "Medical-1ad52a4e",
    "source": "Medical",
    "question": "What are common urinary symptoms of prostate cancer?",
    "answer": "Common urinary symptoms include frequent urination, weak urine stream, and trouble urinating.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom: Frequent urination, Weak urine stream, Trouble urinating"
  },
  {
    "id": "Medical-677867c1",
    "source": "Medical",
    "question": "Which blood and urine biomarker tests are used in prostate cancer diagnosis?",
    "answer": "4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, and SelectMDx are used for biomarker testing.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood and urine biomarker tests (4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, SelectMDx)"
  },
  {
    "id": "Medical-babba8f2",
    "source": "Medical",
    "question": "What is the recommended follow-up strategy for patients on active surveillance?",
    "answer": "Repeat biopsy and regular PSA testing are recommended for active surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up Strategy: Repeat biopsy for active surveillance, Regular PSA testing"
  },
  {
    "id": "Medical-a45d778d",
    "source": "Medical",
    "question": "Which risk group classification guides prognosis and treatment decisions?",
    "answer": "Very low, low, intermediate, high, and very high risk groups guide prognosis and treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment"
  },
  {
    "id": "Medical-da107a1e",
    "source": "Medical",
    "question": "Which imaging test is specifically used to detect bone metastases in prostate cancer?",
    "answer": "Bone scan is used to detect bone metastases.",
    "question_type": "Fact Retrieval",
    "evidence": "Bone scan are imaging methods used to assess extent of disease"
  },
  {
    "id": "Medical-a0e852ec",
    "source": "Medical",
    "question": "Which treatment is a surgical option for advanced prostate cancer?",
    "answer": "Orchiectomy is a surgical option for advanced prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic prostate cancer: Treatment: Orchiectomy"
  },
  {
    "id": "Medical-8a3d6beb",
    "source": "Medical",
    "question": "What is a common symptom of prostate cancer that affects sexual function?",
    "answer": "Erectile dysfunction is a common symptom affecting sexual function.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom: Erectile dysfunction"
  },
  {
    "id": "Medical-bbe1e6e4",
    "source": "Medical",
    "question": "Which demographic factor increases prostate cancer risk?",
    "answer": "Black race increases the risk of prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor: Black race"
  },
  {
    "id": "Medical-4ae3b829",
    "source": "Medical",
    "question": "What is the purpose of the Gleason score in prostate cancer?",
    "answer": "The Gleason score estimates cancer aggressiveness.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade Group and Gleason score are used to estimate cancer aggressiveness"
  },
  {
    "id": "Medical-fec61a48",
    "source": "Medical",
    "question": "Which dietary habits are considered risk factors for prostate cancer?",
    "answer": "High-fat diet and low fruit and vegetable intake are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor: High-fat diet, Low fruit and vegetable intake"
  },
  {
    "id": "Medical-2eb79e75",
    "source": "Medical",
    "question": "What is the main hormonal therapy for advanced prostate cancer?",
    "answer": "Androgen deprivation therapy (ADT) is the main hormonal therapy.",
    "question_type": "Fact Retrieval",
    "evidence": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment"
  },
  {
    "id": "Medical-338ef222",
    "source": "Medical",
    "question": "What is the most common type of adrenal gland tumor?",
    "answer": "Adenoma is the most common type of adrenal gland tumor.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning"
  },
  {
    "id": "Medical-29777a9b",
    "source": "Medical",
    "question": "Which adrenal tumor arises from the adrenal cortex and is malignant?",
    "answer": "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex.",
    "question_type": "Fact Retrieval",
    "evidence": "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex"
  },
  {
    "id": "Medical-bfb768d9",
    "source": "Medical",
    "question": "What hormone is produced in excess by aldosteronoma?",
    "answer": "Aldosteronoma produces excess aldosterone.",
    "question_type": "Fact Retrieval",
    "evidence": "Aldosteronoma produces excess aldosterone"
  },
  {
    "id": "Medical-d909a766",
    "source": "Medical",
    "question": "Which adrenal tumor is associated with Cushing syndrome?",
    "answer": "Adenoma producing excess cortisol causes Cushing syndrome.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenoma producing excess cortisol causes Cushing syndrome"
  },
  {
    "id": "Medical-f3697acd",
    "source": "Medical",
    "question": "What are the two main types of adrenal tumors based on malignancy?",
    "answer": "Adrenal tumors can be benign or malignant.",
    "question_type": "Fact Retrieval",
    "evidence": "Adrenal tumors can be benign or malignant"
  },
  {
    "id": "Medical-72b24739",
    "source": "Medical",
    "question": "Do benign adrenal tumors metastasize?",
    "answer": "Benign adrenal tumors do not metastasize.",
    "question_type": "Fact Retrieval",
    "evidence": "Benign adrenal tumors do not metastasize"
  },
  {
    "id": "Medical-7c516e03",
    "source": "Medical",
    "question": "What is the main population affected by neuroblastoma?",
    "answer": "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5.",
    "question_type": "Fact Retrieval",
    "evidence": "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5"
  },
  {
    "id": "Medical-a4b7873b",
    "source": "Medical",
    "question": "Which adrenal tumor is often associated with high blood pressure and headaches?",
    "answer": "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating.",
    "question_type": "Fact Retrieval",
    "evidence": "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating"
  },
  {
    "id": "Medical-1bae3e94",
    "source": "Medical",
    "question": "What are the common imaging tests used to diagnose adrenal tumors?",
    "answer": "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT.",
    "question_type": "Fact Retrieval",
    "evidence": "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT"
  },
  {
    "id": "Medical-133462dd",
    "source": "Medical",
    "question": "Which diagnostic methods are used to detect hormone secretion by adrenal tumors?",
    "answer": "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors"
  },
  {
    "id": "Medical-4cfb5a3a",
    "source": "Medical",
    "question": "Which genetic tests may be performed to identify hereditary risk factors for adrenal tumors?",
    "answer": "Genetic testing may be performed to identify hereditary risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic testing may be performed to identify hereditary risk factors"
  },
  {
    "id": "Medical-c76c4ce3",
    "source": "Medical",
    "question": "What is the function of functional adrenal tumors?",
    "answer": "Functional adrenal tumors may produce excess hormones.",
    "question_type": "Fact Retrieval",
    "evidence": "Functional adrenal tumors may produce excess hormones"
  },
  {
    "id": "Medical-10fa6b86",
    "source": "Medical",
    "question": "Which hereditary syndromes are risk factors for adrenocortical carcinoma?",
    "answer": "Risk factors for adrenocortical carcinoma include Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), and Von Hippel-Lindau syndrome (VHL).",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor for Adrenocortical Carcinoma (ACC) includes Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), Von Hippel-Lindau syndrome (VHL)"
  },
  {
    "id": "Medical-189210ec",
    "source": "Medical",
    "question": "Which adrenal tumor originates from the adrenal medulla?",
    "answer": "Pheochromocytoma originates from the adrenal medulla.",
    "question_type": "Fact Retrieval",
    "evidence": "Origin of Pheochromocytoma is Adrenal medulla"
  },
  {
    "id": "Medical-df3d2ccc",
    "source": "Medical",
    "question": "What are common symptoms of adrenocortical carcinoma?",
    "answer": "Symptoms of adrenocortical carcinoma include weight gain, muscle weakness, pink or purple stretch marks, excess facial hair, hair loss on the head, irregular periods, enlarged breast tissue, shrinking testicles, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom of Adrenocortical Carcinoma (ACC) includes weight gain, muscle weakness, pink or purple stretch marks, excess facial hair, hair loss on the head, irregular periods, enlarged breast tissue, shrinking testicles, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying"
  },
  {
    "id": "Medical-f14c7935",
    "source": "Medical",
    "question": "Which symptoms are commonly associated with pheochromocytoma?",
    "answer": "Symptoms of pheochromocytoma include high blood pressure, headache, rapid heartbeat, and sweating.",
    "question_type": "Fact Retrieval",
    "evidence": "Symptom of Pheochromocytoma includes high blood pressure, headache, rapid heartbeat, and sweating"
  },
  {
    "id": "Medical-32b97819",
    "source": "Medical",
    "question": "What is the main population at risk for adrenocortical carcinoma?",
    "answer": "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s.",
    "question_type": "Fact Retrieval",
    "evidence": "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s"
  },
  {
    "id": "Medical-c78a374e",
    "source": "Medical",
    "question": "Which adrenal tumor may metastasize to bones?",
    "answer": "Neuroblastoma may metastasize to bones.",
    "question_type": "Fact Retrieval",
    "evidence": "Spread of Neuroblastoma: May metastasize to bones"
  },
  {
    "id": "Medical-bfcfdc70",
    "source": "Medical",
    "question": "Which imaging methods are included in the diagnosis of adrenocortical carcinoma?",
    "answer": "Diagnostic methods for adrenocortical carcinoma include CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method of Adrenocortical Carcinoma (ACC) includes CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy"
  },
  {
    "id": "Medical-3b36f388",
    "source": "Medical",
    "question": "What is the role of biopsy in adrenal tumor diagnosis?",
    "answer": "Biopsy may be used for diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy may be used for diagnosis"
  },
  {
    "id": "Medical-dfca353c",
    "source": "Medical",
    "question": "What percentage of adrenal cancer patients have symptoms due to hormone excess?",
    "answer": "Half of adrenal cancer patients have symptoms due to hormone excess.",
    "question_type": "Fact Retrieval",
    "evidence": "Half of adrenal cancer patients have symptoms due to hormone excess"
  },
  {
    "id": "Medical-7f86e4c5",
    "source": "Medical",
    "question": "What are the two functional categories of adenoma in the adrenal gland?",
    "answer": "Adenoma can be functioning or nonfunctioning.",
    "question_type": "Fact Retrieval",
    "evidence": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning"
  },
  {
    "id": "Medical-539448fd",
    "source": "Medical",
    "question": "What is the biomarker for aldosteronoma?",
    "answer": "Aldosterone is the biomarker for aldosteronoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker of Aldosteronoma: Aldosterone"
  },
  {
    "id": "Medical-77bf9d25",
    "source": "Medical",
    "question": "What is the biomarker for cortisol-producing adenoma?",
    "answer": "Cortisol is the biomarker for cortisol-producing adenoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Biomarker of Cortisol-producing Adenoma: Cortisol"
  },
  {
    "id": "Medical-efe7f41a",
    "source": "Medical",
    "question": "Which syndrome is associated with excess cortisol production by adrenal adenoma?",
    "answer": "Cushing syndrome is associated with cortisol-producing adenoma.",
    "question_type": "Fact Retrieval",
    "evidence": "Associated Syndrome of Cortisol-producing Adenoma: Cushing syndrome"
  },
  {
    "id": "Medical-bc1d5800",
    "source": "Medical",
    "question": "Which tests are used to identify hereditary risk factors for adrenal tumors?",
    "answer": "Genetic test is used to identify hereditary risk factors for adrenal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Genetic testing may be performed to identify hereditary risk factors"
  },
  {
    "id": "Medical-b79e4ca7",
    "source": "Medical",
    "question": "How are adrenal tumors often discovered?",
    "answer": "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI.",
    "question_type": "Fact Retrieval",
    "evidence": "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI"
  },
  {
    "id": "Medical-e171b56c",
    "source": "Medical",
    "question": "Which diagnostic methods are used for pheochromocytoma?",
    "answer": "Diagnostic methods for pheochromocytoma include CT scan, MRI scan, and biochemical test.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method of Pheochromocytoma includes CT scan, MRI scan, Biochemical test"
  },
  {
    "id": "Medical-28728520",
    "source": "Medical",
    "question": "Which diagnostic methods are used for neuroblastoma?",
    "answer": "Diagnostic methods for neuroblastoma include imaging tests and biochemical test.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic Method of Neuroblastoma includes Imaging tests, Biochemical test"
  },
  {
    "id": "Medical-2085b009",
    "source": "Medical",
    "question": "What are some risk factors for adrenal tumors in general?",
    "answer": "Certain hereditary syndromes and family history increase the risk of adrenal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk Factor for Adrenal Tumor includes Hereditary syndromes, Family history"
  },
  {
    "id": "Medical-ccecf24d",
    "source": "Medical",
    "question": "What is the most common type of invasive breast cancer?",
    "answer": "Invasive ductal carcinoma is the most common type.",
    "question_type": "Fact Retrieval",
    "evidence": "Invasive ductal carcinoma is the most common type of invasive breast cancer"
  },
  {
    "id": "Medical-328ec8f3",
    "source": "Medical",
    "question": "Which breast cancer subtype is noninvasive and found in the ducts?",
    "answer": "Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer found in the ducts.",
    "question_type": "Fact Retrieval",
    "evidence": "Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer found in the ducts"
  },
  {
    "id": "Medical-57129a04",
    "source": "Medical",
    "question": "What subtype of breast cancer is characterized by cancer cells blocking lymph vessels in the skin?",
    "answer": "Inflammatory breast cancer (IBC) is characterized by cancer cells blocking lymph vessels in the skin.",
    "question_type": "Fact Retrieval",
    "evidence": "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin"
  },
  {
    "id": "Medical-bfc5a235",
    "source": "Medical",
    "question": "What is the definition of metastatic breast cancer (MBC)?",
    "answer": "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs"
  },
  {
    "id": "Medical-b7bc98cd",
    "source": "Medical",
    "question": "Which system is used for staging breast cancer?",
    "answer": "The TNM system (Tumor, Node, Metastasis) is used for breast cancer staging.",
    "question_type": "Fact Retrieval",
    "evidence": "Breast cancer staging uses the TNM system (Tumor, Node, Metastasis)"
  },
  {
    "id": "Medical-b8694972",
    "source": "Medical",
    "question": "What stage is assigned to noninvasive ductal carcinoma in situ (DCIS)?",
    "answer": "Stage 0 is assigned to noninvasive DCIS.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage 0 breast cancer is noninvasive (DCIS)"
  },
  {
    "id": "Medical-8df61619",
    "source": "Medical",
    "question": "Which stages of breast cancer are considered invasive?",
    "answer": "Stages I-III are invasive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Stages I-III are invasive breast cancer"
  },
  {
    "id": "Medical-30486792",
    "source": "Medical",
    "question": "What stage is metastatic breast cancer classified as?",
    "answer": "Stage IV is metastatic breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Stage IV is metastatic breast cancer"
  },
  {
    "id": "Medical-a3f601d8",
    "source": "Medical",
    "question": "What does tumor grade describe in breast cancer?",
    "answer": "Grade describes how abnormal the tumor cells look under a microscope.",
    "question_type": "Fact Retrieval",
    "evidence": "Grade describes how abnormal the tumor cells look under a microscope"
  },
  {
    "id": "Medical-d47d0c68",
    "source": "Medical",
    "question": "Which biomarkers are key for breast cancer?",
    "answer": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer"
  },
  {
    "id": "Medical-b71386f7",
    "source": "Medical",
    "question": "What genetic mutations increase the risk of breast cancer?",
    "answer": "BRCA1 and BRCA2 mutations increase the risk.",
    "question_type": "Fact Retrieval",
    "evidence": "BRCA1 and BRCA2 mutations increase the risk of breast cancer"
  },
  {
    "id": "Medical-3e184ed2",
    "source": "Medical",
    "question": "Which mutation can be targeted with specific therapies in breast cancer?",
    "answer": "PIK3CA mutation can be targeted with specific therapies.",
    "question_type": "Fact Retrieval",
    "evidence": "PIK3CA mutation can be targeted with specific therapies"
  },
  {
    "id": "Medical-dd137889",
    "source": "Medical",
    "question": "Which biomarker status may influence immunotherapy options in breast cancer?",
    "answer": "MSI-H/dMMR status may influence immunotherapy options.",
    "question_type": "Fact Retrieval",
    "evidence": "MSI-H/dMMR status may influence immunotherapy options"
  },
  {
    "id": "Medical-03388322",
    "source": "Medical",
    "question": "Which biomarker may guide immunotherapy use in breast cancer?",
    "answer": "PD-L1 expression may guide immunotherapy use.",
    "question_type": "Fact Retrieval",
    "evidence": "PD-L1 expression may guide immunotherapy use"
  },
  {
    "id": "Medical-c1a69780",
    "source": "Medical",
    "question": "What diagnostic methods are used to diagnose breast cancer?",
    "answer": "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests"
  },
  {
    "id": "Medical-08b4a3c0",
    "source": "Medical",
    "question": "What is the purpose of screening mammograms?",
    "answer": "Screening mammograms are used for early detection in asymptomatic individuals.",
    "question_type": "Fact Retrieval",
    "evidence": "Screening mammograms are used for early detection in asymptomatic individuals"
  },
  {
    "id": "Medical-4e8dec79",
    "source": "Medical",
    "question": "When are diagnostic mammograms used?",
    "answer": "Diagnostic mammograms are used for individuals with symptoms or abnormal screening results.",
    "question_type": "Fact Retrieval",
    "evidence": "Diagnostic mammograms are used for individuals with symptoms or abnormal screening results"
  },
  {
    "id": "Medical-bf6e0650",
    "source": "Medical",
    "question": "What procedure is required for definitive diagnosis and biomarker testing in breast cancer?",
    "answer": "Biopsy is required for definitive diagnosis and biomarker testing.",
    "question_type": "Fact Retrieval",
    "evidence": "Biopsy is required for definitive diagnosis and biomarker testing"
  },
  {
    "id": "Medical-1560f6ac",
    "source": "Medical",
    "question": "How is lymph node involvement assessed in breast cancer?",
    "answer": "Sentinel lymph node biopsy is used to assess lymph node involvement.",
    "question_type": "Fact Retrieval",
    "evidence": "Sentinel lymph node biopsy is used to assess lymph node involvement"
  },
  {
    "id": "Medical-eece107d",
    "source": "Medical",
    "question": "What are the main treatment options for breast cancer?",
    "answer": "Treatment options include surgery, radiation therapy, chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, and targeted inhibitors.",
    "question_type": "Fact Retrieval",
    "evidence": "Treatment options include surgery (mastectomy, lumpectomy), radiation therapy, chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, and targeted inhibitors"
  },
  {
    "id": "Medical-8280c389",
    "source": "Medical",
    "question": "For which types of breast cancer is systemic therapy used?",
    "answer": "Systemic therapy is used for invasive and metastatic breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Systemic therapy is used for invasive and metastatic breast cancer"
  },
  {
    "id": "Medical-6c8055a7",
    "source": "Medical",
    "question": "Which therapy is used for hormone receptor-positive breast cancer?",
    "answer": "Endocrine therapy is used for hormone receptor-positive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "Endocrine therapy is used for hormone receptor-positive breast cancer"
  },
  {
    "id": "Medical-6fa265bc",
    "source": "Medical",
    "question": "What therapy is used for HER2-positive breast cancer?",
    "answer": "HER2-targeted therapy is used for HER2-positive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "HER2-targeted therapy is used for HER2-positive breast cancer"
  },
  {
    "id": "Medical-6f086f1b",
    "source": "Medical",
    "question": "Which therapy is used for BRCA-mutated, HER2-negative breast cancer?",
    "answer": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer"
  },
  {
    "id": "Medical-85ed509e",
    "source": "Medical",
    "question": "Which inhibitors are used for hormone receptor-positive, HER2-negative breast cancer?",
    "answer": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer"
  },
  {
    "id": "Medical-ff5afce7",
    "source": "Medical",
    "question": "Which inhibitors are used for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer?",
    "answer": "PIK3CA inhibitors are used for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": "PIK3CA inhibitors are used for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer"
  },
  {
    "id": "Medical-869c8d57",
    "source": "Medical",
    "question": "What are common symptoms of breast cancer?",
    "answer": "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange.",
    "question_type": "Fact Retrieval",
    "evidence": "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange"
  },
  {
    "id": "Medical-69eae99e",
    "source": "Medical",
    "question": "What are risk factors for breast cancer?",
    "answer": "Risk factors include family history, BRCA mutations, and being assigned female at birth.",
    "question_type": "Fact Retrieval",
    "evidence": "Risk factors include family history, BRCA mutations, and being assigned female at birth"
  },
  {
    "id": "Medical-329de573",
    "source": "Medical",
    "question": "What should be discussed before starting breast cancer treatment regarding reproductive health?",
    "answer": "Fertility preservation should be discussed before starting treatment.",
    "question_type": "Fact Retrieval",
    "evidence": "Fertility preservation should be discussed before starting treatment"
  },
  {
    "id": "Medical-e79a7e61",
    "source": "Medical",
    "question": "What patient factor is considered in treatment planning for breast cancer?",
    "answer": "Performance status is considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": "Performance status is considered in treatment planning"
  },
  {
    "id": "Medical-883feb97",
    "source": "Medical",
    "question": "What does follow-up for breast cancer include?",
    "answer": "Follow-up includes imaging, physical exams, and monitoring for recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": "Follow-up includes imaging, physical exams, and monitoring for recurrence"
  },
  {
    "id": "Medical-53f6f364",
    "source": "Medical",
    "question": "Which breast cancer subtype commonly presents with redness, swelling, and peau dorange?",
    "answer": "Inflammatory breast cancer (IBC) commonly presents with redness, swelling, and peau dorange.",
    "question_type": "Fact Retrieval",
    "evidence": "Inflammatory breast cancer (IBC): Symptom: Redness, Swelling, Peau dorange"
  },
  {
    "id": "Medical-6598f21c",
    "source": "Medical",
    "question": "What is the main symptom of metastatic breast cancer involving bones?",
    "answer": "Bone pain is a main symptom of metastatic breast cancer involving bones.",
    "question_type": "Fact Retrieval",
    "evidence": "Metastatic breast cancer (MBC): Symptom: Bone pain"
  },
  {
    "id": "Medical-604c9d44",
    "source": "Medical",
    "question": "Why is a patient with fair skin and a history of organ transplant at particularly high risk for developing basal cell carcinoma?",
    "answer": "Because both fair skin and immune suppression from organ transplant are independent risk factors for BCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "Immune suppression is a risk factor for BCC",
      "Basal cell carcinoma risk factors include fair skin and organ transplant"
    ]
  },
  {
    "id": "Medical-df366063",
    "source": "Medical",
    "question": "If a patient presents with a shiny bump on the face and has a history of tanning bed use, what diagnostic steps should be taken to evaluate for basal cell carcinoma?",
    "answer": "A medical and family history, physical and skin exam, and biopsy should be performed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCC presents as shiny bumps",
      "BCC most commonly develops in sun-exposed areas such as the face",
      "Tanning beds are a risk factor for BCC",
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy"
    ]
  },
  {
    "id": "Medical-0a90f1f2",
    "source": "Medical",
    "question": "How does the management of recurrent basal cell carcinoma differ from initial treatment, and what factors influence this?",
    "answer": "Management of recurrence depends on risk and recurrence site, with treatment options tailored accordingly.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites",
      "Management of recurrence involves treatment options based on risk and recurrence",
      "Surgery is the most common treatment for BCC"
    ]
  },
  {
    "id": "Medical-831bb1e6",
    "source": "Medical",
    "question": "Which combination of risk factors should prompt earlier and more frequent skin exams for BCC?",
    "answer": "A combination of older age, fair skin, and family history of skin cancer should prompt more frequent skin exams.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Older age is associated with higher risk of BCC",
      "Fair skin and family history of skin cancer increase risk of BCC",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-01e3a9ea",
    "source": "Medical",
    "question": "Why might a patient with a shiny bump and a history of radiation therapy require both imaging and biopsy for diagnosis?",
    "answer": "Because radiation therapy is a risk factor for BCC and shiny bumps are a symptom, so both imaging and biopsy help confirm diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radiation therapy is a risk factor for BCC",
      "BCC presents as shiny bumps",
      "Diagnosis of BCC involves biopsy and sometimes imaging"
    ]
  },
  {
    "id": "Medical-c69c2732",
    "source": "Medical",
    "question": "What follow-up strategy is recommended for a patient treated for BCC on the neck, and why?",
    "answer": "Annual full skin exams are recommended to monitor for recurrence or new lesions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas such as the neck",
      "Recurrence refers to BCC returning to the original site",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-f034d77d",
    "source": "Medical",
    "question": "How does UV radiation contribute to both the development and recurrence of basal cell carcinoma?",
    "answer": "UV radiation is a primary risk factor for BCC and continued exposure increases recurrence risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "UV radiation exposure is a primary risk factor for BCC",
      "Recurrence refers to BCC returning to the original site or spreading",
      "Basal cell carcinoma risk factors include UV radiation"
    ]
  },
  {
    "id": "Medical-1eab8fa2",
    "source": "Medical",
    "question": "Why should a patient with a family history of skin cancer and light eye color be particularly vigilant about skin changes?",
    "answer": "Because both family history and light eye color are risk factors for BCC, increasing overall risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history increases risk of BCC",
      "Light eye color increases the risk of BCC",
      "Basal cell carcinoma risk factors include family history and light eye color"
    ]
  },
  {
    "id": "Medical-14016ce3",
    "source": "Medical",
    "question": "What is the rationale for recommending surgery as the most common treatment for BCC lesions on sun-exposed areas?",
    "answer": "Because BCC most commonly develops on sun-exposed areas and surgery is the most effective treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Surgery is the most common treatment for BCC"
    ]
  },
  {
    "id": "Medical-5e530443",
    "source": "Medical",
    "question": "Which symptoms and risk factors together would most strongly indicate the need for biopsy to rule out BCC?",
    "answer": "A flat pale area on sun-exposed skin in a fair-skinned patient with a history of sun exposure strongly indicates the need for biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCC presents as flat, pale or yellow areas",
      "BCC most commonly develops in sun-exposed areas",
      "Fair skin and sun exposure are risk factors for BCC",
      "Diagnosis of BCC involves biopsy"
    ]
  },
  {
    "id": "Medical-c8dd3e29",
    "source": "Medical",
    "question": "How do immune suppression and prior radiation therapy interact to affect BCC risk and management?",
    "answer": "Both are risk factors that increase BCC risk and may necessitate more aggressive management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radiation therapy and immune suppression are risk factors for BCC",
      "Management of recurrence involves treatment options based on risk and recurrence"
    ]
  },
  {
    "id": "Medical-a9a52704",
    "source": "Medical",
    "question": "What combination of anatomical location and cell type defines basal cell carcinoma?",
    "answer": "BCC arises from basal cells in the lower part of the epidermis, often in sun-exposed locations.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCC arises from basal cells in the lower part of the epidermis",
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Basal cell carcinoma cell type is basal cells"
    ]
  },
  {
    "id": "Medical-346b12e8",
    "source": "Medical",
    "question": "Why is annual follow-up with full skin exams critical for patients with a history of BCC?",
    "answer": "Because recurrence can occur at the original site or spread, so annual full skin exams help detect new or returning lesions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-8ff5dd5a",
    "source": "Medical",
    "question": "Why might systemic therapy be considered for a patient with BCC that has spread to distant sites?",
    "answer": "Because systemic therapy is a treatment option for BCC that has recurred or spread to distant sites.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Recurrence refers to BCC spreading to distant sites",
      "Systemic therapy may be used in some cases of BCC"
    ]
  },
  {
    "id": "Medical-322bb52d",
    "source": "Medical",
    "question": "How do medical and family history contribute to the diagnostic process for BCC in a patient with a suspicious skin lesion?",
    "answer": "Both are part of the diagnostic workup to assess risk and guide further testing like biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy",
      "History of skin cancer or family history increases risk of BCC"
    ]
  },
  {
    "id": "Medical-35fee661",
    "source": "Medical",
    "question": "Which diagnostic procedures would be prioritized for a patient with primary CNS lymphoma presenting with blurry vision and suspected eye involvement?",
    "answer": "Eye exam, slit lamp, and vitrectomy would be prioritized for suspected eye involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes",
      "Primary CNS lymphoma can cause neurological symptoms such as vision changes",
      "Diagnostic Method for Primary CNS lymphoma includes Eye exam, Slit lamp, and Vitrectomy"
    ]
  },
  {
    "id": "Medical-f473bcb0",
    "source": "Medical",
    "question": "What is the main chemotherapy agent used during the induction phase of primary CNS lymphoma treatment and which diagnostic procedure confirms the diagnosis?",
    "answer": "High-dose methotrexate is the main chemotherapy agent, and stereotactic biopsy is the standard diagnostic procedure.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma",
      "Treatment is typically given in phases: induction and consolidation"
    ]
  },
  {
    "id": "Medical-f3af6f24",
    "source": "Medical",
    "question": "For a patient with primary CNS lymphoma and cerebrospinal fluid involvement, which specialized treatment is indicated and how is the involvement detected?",
    "answer": "Intrathecal chemotherapy is indicated, with CSF involvement detected by lumbar puncture.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid",
      "Primary CNS lymphoma is diagnosed using lumbar puncture",
      "Disease Location for Primary CNS lymphoma includes Cerebrospinal fluid (CSF)"
    ]
  },
  {
    "id": "Medical-ade4b34a",
    "source": "Medical",
    "question": "If a patient with primary CNS lymphoma presents with memory problems and confusion, what imaging modality is most useful and why?",
    "answer": "MRI with gadolinium contrast is most useful because it best identifies CNS lesions causing these symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Primary CNS lymphoma can cause neurological symptoms such as memory problems and confusion",
      "Diagnostic Method for Primary CNS lymphoma includes MRI and Gadolinium contrast"
    ]
  },
  {
    "id": "Medical-ade95016",
    "source": "Medical",
    "question": "Which risk factors should be considered for an older adult with a history of organ transplant who develops primary CNS lymphoma?",
    "answer": "Older age and organ transplant are both risk factors for primary CNS lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunodeficiency disorders, organ transplant, and older age are risk factors for primary CNS lymphoma",
      "Risk Factor for Primary CNS lymphoma includes Older adult and Organ transplant"
    ]
  },
  {
    "id": "Medical-8435c9f6",
    "source": "Medical",
    "question": "How would the treatment approach change for a primary CNS lymphoma patient with both brain and eye involvement?",
    "answer": "The patient would receive standard CNS-directed therapy plus intraocular chemotherapy or radiation for eye involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary CNS lymphoma most commonly affects the brain, but can also involve the eyes",
      "Intraocular chemotherapy or radiation may be used if the eyes are involved",
      "Treatment options for primary CNS lymphoma include chemotherapy and radiation therapy"
    ]
  },
  {
    "id": "Medical-23e6b6df",
    "source": "Medical",
    "question": "What are the two main phases of primary CNS lymphoma treatment, and which therapies are typically administered in each?",
    "answer": "Induction phase uses high-dose methotrexate and rituximab, while consolidation phase uses whole-brain radiation therapy or stem cell rescue.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment is typically given in phases: induction and consolidation",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma",
      "Rituximab is the main immunotherapy drug used for primary CNS lymphoma",
      "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma",
      "Consolidation phase includes whole-brain radiation therapy (WBRT) and stem cell rescue"
    ]
  },
  {
    "id": "Medical-4744dfa7",
    "source": "Medical",
    "question": "Which performance evaluation is necessary before determining eligibility for clinical trials in primary CNS lymphoma patients and why?",
    "answer": "Performance status evaluation is necessary to guide treatment decisions and clinical trial eligibility.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials",
      "Diagnostic Method for Primary CNS lymphoma includes Performance status evaluation"
    ]
  },
  {
    "id": "Medical-59ea36ca",
    "source": "Medical",
    "question": "What follow-up procedures are recommended after achieving remission in primary CNS lymphoma?",
    "answer": "Repeat MRI, eye exam, blood tests, and performance status assessment are recommended for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up/Surveillance for Primary CNS lymphoma includes Repeat MRI, Eye exam, Blood tests, Performance status assessment",
      "Remission is a stage after treatment in primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-4124f00f",
    "source": "Medical",
    "question": "If a patient with primary CNS lymphoma relapses in the spinal cord, which diagnostic and treatment strategies should be considered?",
    "answer": "Imaging (MRI), lumbar puncture, and possible intrathecal chemotherapy should be considered for spinal cord relapse.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid",
      "Lumbar puncture is a diagnostic method for Primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-ed26b623",
    "source": "Medical",
    "question": "Which laboratory tests are essential for initial workup of primary CNS lymphoma, particularly in patients with suspected immunodeficiency?",
    "answer": "Blood tests including CBC, CMP, LDH, and HIV blood test are essential for initial workup.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary CNS lymphoma is diagnosed using blood tests",
      "Laboratory Tests for Primary CNS lymphoma include Complete blood count (CBC), Comprehensive metabolic panel (CMP), Lactate dehydrogenase (LDH), HIV blood test"
    ]
  },
  {
    "id": "Medical-fbc9e7ec",
    "source": "Medical",
    "question": "What supportive care measures are recommended at any stage for primary CNS lymphoma patients experiencing severe side effects from treatment?",
    "answer": "Symptom management, palliative care, and quality of life interventions are recommended at any disease stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care is provided to relieve symptoms and side effects at any stage of disease",
      "Supportive Care for Primary CNS lymphoma includes Symptom management, Palliative care, Quality of life interventions"
    ]
  },
  {
    "id": "Medical-9a34e14c",
    "source": "Medical",
    "question": "In a patient with primary CNS lymphoma and concurrent HIV infection, why is additional laboratory testing necessary?",
    "answer": "HIV blood test is needed because immunodeficiency is a risk factor for primary CNS lymphoma and may influence management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunodeficiency disorders, HIV infection, and Epstein-Barr virus are risk factors for primary CNS lymphoma",
      "Laboratory Tests for Primary CNS lymphoma include HIV blood test"
    ]
  },
  {
    "id": "Medical-bfe2b31f",
    "source": "Medical",
    "question": "Which imaging and biopsy methods are used together to confirm a diagnosis of primary CNS lymphoma localized to the brain?",
    "answer": "MRI with gadolinium contrast and stereotactic biopsy are used together for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma",
      "Disease Location for Primary CNS lymphoma includes Brain"
    ]
  },
  {
    "id": "Medical-b6fbf092",
    "source": "Medical",
    "question": "Why is clinical trial participation recommended for all primary CNS lymphoma patients regardless of treatment phase?",
    "answer": "Because clinical trial participation is recommended for all patients and can be part of both induction and consolidation phases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trial participation is recommended for all patients with primary CNS lymphoma",
      "Treatment is typically given in phases: induction and consolidation",
      "Clinical trial is listed as an option in both induction and consolidation phases"
    ]
  },
  {
    "id": "Medical-55898188",
    "source": "Medical",
    "question": "Which diagnostic procedures are necessary for a patient with suspected regional CSCC presenting with lymph node involvement?",
    "answer": "Lymph node exam, imaging (CT, PET/CT), and lymph node biopsy are required for regional CSCC with lymph node involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy",
      "Regional CSCC: Diagnostic Method: Lymph node exam, Imaging (CT, PET/CT), Lymph node biopsy (FNA, core needle biopsy)"
    ]
  },
  {
    "id": "Medical-8b99b755",
    "source": "Medical",
    "question": "How does the management of high-risk local CSCC differ from low-risk local CSCC in terms of treatment and follow-up?",
    "answer": "High-risk local CSCC is treated with Mohs surgery or standard excision and may require radiation or systemic therapy, with more frequent follow-up exams than low-risk cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible",
      "Low-risk local CSCC is primarily treated with surgery (C&E, standard excision, Mohs surgery/PDEMA)",
      "High-risk: Follow-up Strategy: Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months",
      "Low-risk: Follow-up Strategy: Skin and lymph node exams every 3-12 months for 2 years, then every 6-12 months for 3 years, then annually"
    ]
  },
  {
    "id": "Medical-e0f29bbd",
    "source": "Medical",
    "question": "What are the preferred systemic therapy options for metastatic CSCC, and when might surgery or radiation be considered?",
    "answer": "Preferred systemic therapies for metastatic CSCC are PD-1 inhibitors, with surgery or radiation considered if feasible.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
      "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)",
      "Metastatic CSCC: Treatment: Systemic therapy (PD-1 inhibitor preferred), Surgery or radiation if feasible"
    ]
  },
  {
    "id": "Medical-55f0c0e2",
    "source": "Medical",
    "question": "Why is actinic keratosis considered a risk factor for CSCC, and how is it managed to prevent progression?",
    "answer": "Actinic keratosis is a precancerous lesion that can progress to CSCC and is managed with photodynamic therapy, cryotherapy, or topical treatments.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC",
      "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC"
    ]
  },
  {
    "id": "Medical-8407a0ab",
    "source": "Medical",
    "question": "Which patient characteristics would prompt the use of imaging during the diagnostic workup of CSCC?",
    "answer": "Imaging is used if deeper invasion or spread is suspected, especially in high-risk, regional, or metastatic CSCC cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected",
      "Imaging is used for staging and surveillance in regional and high-risk cases"
    ]
  },
  {
    "id": "Medical-7b4429ac",
    "source": "Medical",
    "question": "What findings on risk assessment would classify a local CSCC as high-risk, and how does this affect treatment choices?",
    "answer": "Features such as perineural invasion, lymphovascular invasion, or high tumor grade classify local CSCC as high-risk, requiring Mohs surgery or systemic therapy if surgery/radiation is not possible.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
    ]
  },
  {
    "id": "Medical-6d12f4ff",
    "source": "Medical",
    "question": "How does immunosuppression influence both the risk and clinical management of CSCC?",
    "answer": "Immunosuppression increases CSCC risk and is a factor in risk assessment, requiring intensified surveillance and potentially altered treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Major risk factors for CSCC include weakened immune system",
      "Risk assessment for CSCC is based on patient immune status",
      "Clinical Management: Risk Assessment: Immunosuppression"
    ]
  },
  {
    "id": "Medical-baed6d13",
    "source": "Medical",
    "question": "For a patient with CSCC arising in a chronic wound, what two risk factors are present and how does this affect staging and management?",
    "answer": "Both chronic wounds and scars are risk factors, increasing the likelihood of high-risk CSCC, which may require advanced staging and aggressive treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Major risk factors for CSCC include chronic wounds or scars",
      "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread)",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
    ]
  },
  {
    "id": "Medical-eb7624ca",
    "source": "Medical",
    "question": "What is the recommended follow-up strategy after treatment for regional CSCC compared to local low-risk CSCC?",
    "answer": "Regional CSCC requires more frequent skin and lymph node exams than local low-risk CSCC, especially in the first two years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regional CSCC: Follow-up Strategy: Skin and lymph node exams every 2-3 months for 1 year, every 2-4 months for year 2, every 4-6 months for 3 years, then every 6-12 months",
      "Low-risk: Follow-up Strategy: Skin and lymph node exams every 3-12 months for 2 years, then every 6-12 months for 3 years, then annually"
    ]
  },
  {
    "id": "Medical-0a6379ff",
    "source": "Medical",
    "question": "Which genetic syndromes are associated with increased CSCC risk and what is their implication for surveillance?",
    "answer": "Xeroderma pigmentosum and RDEB increase CSCC risk, necessitating regular skin and lymph node exams for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC",
      "Clinical Management: Surveillance: Regular skin and lymph node exams"
    ]
  },
  {
    "id": "Medical-462ecc23",
    "source": "Medical",
    "question": "How are PD-1 inhibitors used in the treatment of CSCC and at which stage are they preferred?",
    "answer": "PD-1 inhibitors are systemic therapy options preferred for metastatic CSCC, but may also be used for high-risk or regional disease if other treatments are not possible.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)",
      "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
    ]
  },
  {
    "id": "Medical-2782702e",
    "source": "Medical",
    "question": "What symptoms would prompt a clinician to perform a skin biopsy for suspected CSCC?",
    "answer": "Scaly patches, solid or misshapen lesions, or lesions in areas of chronic damage would prompt a skin biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage",
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected"
    ]
  },
  {
    "id": "Medical-f978cb28",
    "source": "Medical",
    "question": "What is the role of clinical trials in the management of advanced or refractory CSCC?",
    "answer": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC",
      "Metastatic CSCC: Treatment: Clinical trial"
    ]
  },
  {
    "id": "Medical-4f5a8531",
    "source": "Medical",
    "question": "Why might a patient with actinic keratosis require ongoing dermatologic surveillance even after lesion treatment?",
    "answer": "Because actinic keratosis can progress to CSCC and regular skin exams are recommended for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC",
      "Clinical Management: Surveillance: Regular skin and lymph node exams"
    ]
  },
  {
    "id": "Medical-db5aa2e3",
    "source": "Medical",
    "question": "What distinguishes Mohs surgery from other surgical options in the treatment of high-risk local CSCC?",
    "answer": "Mohs surgery is preferred for high-risk local CSCC due to its tissue-sparing and margin-assessing technique.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible",
      "High-risk: Treatment: Mohs surgery/PDEMA (preferred)"
    ]
  },
  {
    "id": "Medical-193a4b7f",
    "source": "Medical",
    "question": "What chromosomal abnormality must be present for a diagnosis of chronic myeloid leukemia (CML)?",
    "answer": "The Philadelphia chromosome (Ph), resulting from a translocation between chromosome 9 and chromosome 22, must be present.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22"
    ]
  },
  {
    "id": "Medical-e9ac42f1",
    "source": "Medical",
    "question": "How does the BCR::ABL1 fusion gene relate to both the diagnosis and treatment of CML?",
    "answer": "The BCR::ABL1 fusion gene is required for diagnosis and is also the target of CML treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "CML is caused by the BCR::ABL1 fusion gene",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
    ]
  },
  {
    "id": "Medical-78897235",
    "source": "Medical",
    "question": "Which two diagnostic methods are used to confirm CML by detecting its key biomarkers?",
    "answer": "Blood tests and bone marrow tests are used to detect the BCR::ABL1 fusion gene or Philadelphia chromosome.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests and bone marrow tests are used to diagnose CML",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "Biomarker includes BCR::ABL1 fusion gene and Philadelphia chromosome (Ph)"
    ]
  },
  {
    "id": "Medical-33494794",
    "source": "Medical",
    "question": "What cellular changes would you expect to find in a patient with CML, and which test would confirm these findings?",
    "answer": "Increased white blood cells (granulocytes) and abnormal platelet counts, confirmed by blood tests.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "Blood tests and bone marrow tests are used to diagnose CML"
    ]
  },
  {
    "id": "Medical-a7826934",
    "source": "Medical",
    "question": "Explain the relationship between the Philadelphia chromosome, BCR::ABL1 fusion gene, and the origin of CML.",
    "answer": "The Philadelphia chromosome results from a translocation that creates the BCR::ABL1 fusion gene, which causes CML.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "CML is caused by the BCR::ABL1 fusion gene"
    ]
  },
  {
    "id": "Medical-50bafb57",
    "source": "Medical",
    "question": "Which blood cell types are abnormally increased in CML and what underlying cellular process causes this?",
    "answer": "Granulocytes (a type of white blood cell) are increased due to overproduction by myeloid progenitor cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes)",
      "CML arises from blood stem cells producing increased myeloid progenitor cells"
    ]
  },
  {
    "id": "Medical-24373ebe",
    "source": "Medical",
    "question": "How does the disease phase of CML affect the types of blood cells present?",
    "answer": "Blast phase CML is characterized by increased blasts and progenitor cells, while chronic phase has increased mature granulocytes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
      "Blast phase CML (BP-CML) includes myeloid progenitor cells, lymphoid progenitor cells, and blasts",
      "CML is characterized by increased white blood cells (granulocytes)"
    ]
  },
  {
    "id": "Medical-9528082d",
    "source": "Medical",
    "question": "Why is detecting either the Philadelphia chromosome or BCR::ABL1 gene sufficient for diagnosing CML?",
    "answer": "Because both result from the same chromosomal translocation specific to CML and serve as key biomarkers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation"
    ]
  },
  {
    "id": "Medical-8b16a7bd",
    "source": "Medical",
    "question": "What is the rationale for targeting BCR::ABL1 protein activity in CML treatment?",
    "answer": "Since CML is caused by the BCR::ABL1 fusion gene, inhibiting its protein product addresses the underlying cause.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
    ]
  },
  {
    "id": "Medical-4fe06961",
    "source": "Medical",
    "question": "What is the sequence of genetic and chromosomal events leading to CML?",
    "answer": "A translocation between chromosome 9 and 22 creates the Philadelphia chromosome, which produces the BCR::ABL1 fusion gene that causes CML.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "CML is caused by the BCR::ABL1 fusion gene"
    ]
  },
  {
    "id": "Medical-41b1601a",
    "source": "Medical",
    "question": "Which two main biomarkers are tested to confirm a diagnosis of CML, and how are they related?",
    "answer": "BCR::ABL1 fusion gene and Philadelphia chromosome are tested, both resulting from the same chromosomal translocation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "Biomarker includes BCR::ABL1 fusion gene and Philadelphia chromosome (Ph)"
    ]
  },
  {
    "id": "Medical-38fe5331",
    "source": "Medical",
    "question": "How does the detection of increased blasts in blood or bone marrow influence the classification of CML phase?",
    "answer": "Increased blasts indicate progression to blast phase CML (BP-CML), an advanced disease stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
      "Blast phase CML (BP-CML) includes myeloid progenitor cells, lymphoid progenitor cells, and blasts"
    ]
  },
  {
    "id": "Medical-4987de7f",
    "source": "Medical",
    "question": "What are the cellular and molecular hallmarks required to definitively diagnose CML?",
    "answer": "Increased granulocytes and presence of either the Philadelphia chromosome or BCR::ABL1 fusion gene are required.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes)",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
    ]
  },
  {
    "id": "Medical-c2ead218",
    "source": "Medical",
    "question": "Which abnormal blood counts and genetic findings together support a diagnosis of CML?",
    "answer": "Increased white blood cells and abnormal platelet counts, along with the Philadelphia chromosome or BCR::ABL1 gene, support CML diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
    ]
  },
  {
    "id": "Medical-4d01de98",
    "source": "Medical",
    "question": "How do blood stem cells contribute to the abnormal blood cell profile observed in CML?",
    "answer": "Blood stem cells in CML produce increased myeloid progenitor cells, leading to elevated granulocytes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML arises from blood stem cells producing increased myeloid progenitor cells",
      "CML is characterized by increased white blood cells (granulocytes)"
    ]
  },
  {
    "id": "Medical-34a9155d",
    "source": "Medical",
    "question": "Why is a lung nodule detected by imaging not sufficient for a lung cancer diagnosis?",
    "answer": "Because biopsy is required to confirm the malignancy of a lung nodule detected by imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-b7e4be0e",
    "source": "Medical",
    "question": "What combination of risk factors and diagnostic methods would justify recommending lung cancer screening?",
    "answer": "Individuals with high-risk factors such as tobacco smoking should undergo lung cancer screening using imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tobacco smoking is the biggest risk factor for lung cancer",
      "Lung cancer screening is recommended for people at high risk",
      "Screening: lung cancer screening is indicated for high risk individuals"
    ]
  },
  {
    "id": "Medical-96bb3762",
    "source": "Medical",
    "question": "How does the treatment approach differ between Stage 1 and Stage 2 NSCLC?",
    "answer": "Stage 1 NSCLC is treated with surgery and possibly radiation therapy, while Stage 2 NSCLC may require surgery and chemoradiation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 1 NSCLC is considered early stage",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Stage 2 and Stage 3 NSCLC are considered locally advanced",
      "Chemoradiation is used for some locally advanced NSCLC cases"
    ]
  },
  {
    "id": "Medical-7ea7ec68",
    "source": "Medical",
    "question": "Why would a patient with a history of exposure to asbestos and a persistent cough be prioritized for lung cancer screening?",
    "answer": "Because asbestos exposure is a risk factor and persistent cough is a symptom, both increasing the need for early detection via screening.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Exposure to asbestos is a risk factor for lung cancer",
      "Symptoms of lung cancer may include cough",
      "Lung cancer screening is recommended for people at high risk"
    ]
  },
  {
    "id": "Medical-e7d1cd1c",
    "source": "Medical",
    "question": "How does the subtype of NSCLC influence the origin of the cancer cells?",
    "answer": "Adenocarcinoma forms from alveolar mucus-producing cells, while squamous cell carcinoma originates from bronchial lining cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenocarcinoma often forms from cells that line the alveoli and make mucus",
      "Squamous cell carcinoma forms from cells that line the bronchi"
    ]
  },
  {
    "id": "Medical-c7c59020",
    "source": "Medical",
    "question": "What is the rationale for using both imaging and biopsy in the assessment of a lung nodule?",
    "answer": "Imaging detects the lung nodule, but biopsy is necessary to determine if it is cancerous.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-ee49f3e8",
    "source": "Medical",
    "question": "Why is surgery not typically a treatment option for Stage 4 NSCLC?",
    "answer": "Because Stage 4 NSCLC is metastatic at diagnosis, making local treatments like surgery ineffective.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 4 NSCLC is metastatic at diagnosis",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible"
    ]
  },
  {
    "id": "Medical-b77d8e3d",
    "source": "Medical",
    "question": "How do follow-up strategies change after initial treatment for NSCLC?",
    "answer": "After initial treatment, follow-up care and surveillance are implemented to monitor for recurrence.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up care is planned after treatment and includes surveillance for recurrence",
      "Follow-up Strategy for NSCLC includes follow-up care and surveillance"
    ]
  },
  {
    "id": "Medical-6fb8996b",
    "source": "Medical",
    "question": "What factors would lead to recommending a clinical trial for a lung cancer patient?",
    "answer": "Patients with lung cancer may be eligible for clinical trials as part of their treatment or prevention options.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are available for lung cancer treatment and prevention",
      "NSCLC treatment options include clinical trial"
    ]
  },
  {
    "id": "Medical-edc3c6eb",
    "source": "Medical",
    "question": "Why is lung cancer screening particularly important for individuals exposed to air pollution and diesel fumes?",
    "answer": "Because both air pollution and diesel fumes are established risk factors for lung cancer, necessitating early detection strategies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Exposure to diesel fumes and air pollution are risk factors for lung cancer",
      "Lung cancer screening is recommended for people at high risk"
    ]
  },
  {
    "id": "Medical-f3048835",
    "source": "Medical",
    "question": "What are the main differences in treatment between early and locally advanced NSCLC?",
    "answer": "Early NSCLC is mainly treated with surgery and sometimes radiation, while locally advanced NSCLC may also require chemoradiation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Chemoradiation is used for some locally advanced NSCLC cases"
    ]
  },
  {
    "id": "Medical-f79d978d",
    "source": "Medical",
    "question": "How does the presence of a lung nodule on imaging affect the diagnostic workflow for lung cancer?",
    "answer": "A lung nodule detected by imaging prompts further assessment, including biopsy, to confirm or exclude cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-47504b64",
    "source": "Medical",
    "question": "Why is supportive care considered a treatment option for all stages of lung cancer?",
    "answer": "Supportive care improves quality of life for people with lung cancer regardless of stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care extends and enhances life for people with lung cancer",
      "NSCLC treatment options include supportive care"
    ]
  },
  {
    "id": "Medical-328006b7",
    "source": "Medical",
    "question": "What combination of exposure and symptom would most strongly suggest the need for diagnostic evaluation for lung cancer?",
    "answer": "A history of tobacco smoking combined with chest pain should prompt diagnostic evaluation for lung cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tobacco smoking is the biggest risk factor for lung cancer",
      "Symptoms of lung cancer may include chest pain",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-659d7c0a",
    "source": "Medical",
    "question": "How do the purposes of lung cancer screening and follow-up care differ?",
    "answer": "Screening aims for early detection in high-risk individuals, while follow-up care monitors for recurrence after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lung cancer screening aims to detect cancer at an early, more treatable stage",
      "Follow-up care is planned after treatment and includes surveillance for recurrence"
    ]
  },
  {
    "id": "Medical-689b17ad",
    "source": "Medical",
    "question": "Which biomarker should be tested both before and after treatment in nasopharyngeal carcinoma patients, and why is this monitoring important?",
    "answer": "EBV DNA should be tested before and after treatment because its level serves as a prognostic factor and is used for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "EBV DNA testing is performed before and after treatment for NPC",
      "Biomarker testing for NPC includes EBV DNA",
      "EBV DNA level is a prognostic factor",
      "Surveillance for NPC includes EBV DNA testing"
    ]
  },
  {
    "id": "Medical-a7e62dce",
    "source": "Medical",
    "question": "What combination of diagnostic methods is necessary to both confirm nasopharyngeal carcinoma and determine its subtype?",
    "answer": "Biopsy is required to confirm NPC and to determine its cancer subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biopsy confirms diagnosis and determines cancer subtype",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy"
    ]
  },
  {
    "id": "Medical-80912696",
    "source": "Medical",
    "question": "Why should fertility counseling be considered for patients undergoing treatment for nasopharyngeal carcinoma?",
    "answer": "Fertility counseling should be considered because NPC treatment can affect fertility.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility may be affected by NPC treatment and should be discussed before therapy",
      "Fertility counseling is part of the diagnostic and planning process for NPC",
      "Fertility counseling and impact of treatment on fertility are listed under Fertility Consideration in the ontology"
    ]
  },
  {
    "id": "Medical-aa1b8dbb",
    "source": "Medical",
    "question": "How does a patient's performance status influence nasopharyngeal carcinoma treatment planning?",
    "answer": "Performance status is assessed and considered in NPC treatment planning as a prognostic factor.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is considered in NPC treatment planning",
      "Performance status evaluation is a diagnostic method for NPC",
      "Performance status is a prognostic factor for NPC"
    ]
  },
  {
    "id": "Medical-d256aef2",
    "source": "Medical",
    "question": "If a patient with nasopharyngeal carcinoma presents with enlarged lymph nodes, what does this indicate about possible disease spread and staging?",
    "answer": "Enlarged lymph nodes suggest lymph node metastasis, which is included in the TNM staging system for NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of NPC include enlarged lymph nodes",
      "NPC commonly spreads to lymph nodes in the neck",
      "NPC is staged using the AJCC TNM system, which includes lymph node involvement (N)"
    ]
  },
  {
    "id": "Medical-c09d2bcb",
    "source": "Medical",
    "question": "Which populations are at increased risk for nasopharyngeal carcinoma and what risk factors contribute to this increased incidence?",
    "answer": "People from Asia, Native America, and North Africa are at increased risk due to geographic origin and EBV infection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa",
      "Most NPCs are related to Epstein-Barr virus (EBV) infection",
      "Geographic origin and EBV are risk factors for NPC"
    ]
  },
  {
    "id": "Medical-5fdb115b",
    "source": "Medical",
    "question": "What imaging modalities are used for both staging and surveillance of nasopharyngeal carcinoma?",
    "answer": "CT scan, MRI, PET/CT, and ultrasound are used for both staging and surveillance of NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance",
      "Diagnosis of NPC involves imaging (CT, MRI, PET/CT, ultrasound)"
    ]
  },
  {
    "id": "Medical-9231a873",
    "source": "Medical",
    "question": "Which cancer subtype is most commonly found in the nasopharynx and how is it classified within the cancer ontology?",
    "answer": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer, classified under nasopharyngeal carcinoma (NPC) in the ontology.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer",
      "Squamous cell carcinoma (SCC) is a subtype of NPC in the ontology"
    ]
  },
  {
    "id": "Medical-ad0cc053",
    "source": "Medical",
    "question": "If a nasopharyngeal carcinoma patient has both high EBV DNA levels and poor performance status, what does this indicate about their prognosis?",
    "answer": "High EBV DNA levels and poor performance status are both poor prognostic factors in NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "EBV DNA level is a prognostic factor",
      "Performance status is a prognostic factor",
      "Biomarker testing for NPC includes EBV DNA"
    ]
  },
  {
    "id": "Medical-5a6b98a7",
    "source": "Medical",
    "question": "Why might symptoms of nasopharyngeal carcinoma be absent until advanced stages, and how does this affect the diagnostic process?",
    "answer": "Symptoms may be absent until advanced stage, making imaging and biopsy essential for early diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions",
      "Diagnosis of NPC involves imaging (CT, MRI, PET/CT, ultrasound) and biopsy"
    ]
  },
  {
    "id": "Medical-1c53b384",
    "source": "Medical",
    "question": "What combination of risk factors should prompt clinicians to consider nasopharyngeal carcinoma in a differential diagnosis?",
    "answer": "Epstein-Barr virus infection, tobacco use, alcohol use, and geographic origin (Asia, Native America, North Africa) should prompt consideration of NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors for NPC include Epstein-Barr virus (EBV), tobacco use, alcohol use, and geographic origin (Asia, Native America, North Africa)",
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
    ]
  },
  {
    "id": "Medical-0e2be889",
    "source": "Medical",
    "question": "How does the AJCC TNM system contribute to the staging of nasopharyngeal carcinoma, and what aspects does it assess?",
    "answer": "The AJCC TNM system stages NPC by assessing tumor size (T), lymph node involvement (N), and distant metastasis (M).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M)",
      "Stage in the ontology includes AJCC TNM system"
    ]
  },
  {
    "id": "Medical-ff2105ab",
    "source": "Medical",
    "question": "Why is dental health assessment important in the management of nasopharyngeal carcinoma?",
    "answer": "Dental health can be affected by head and neck cancer and its treatment, so dental exams are part of NPC management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Dental health can be affected by head and neck cancer and its treatment",
      "Dental exam is a diagnostic method for NPC"
    ]
  },
  {
    "id": "Medical-6a90b47e",
    "source": "Medical",
    "question": "What methods are used to assess both nutritional status and speech/swallowing function in nasopharyngeal carcinoma patients?",
    "answer": "Nutrition assessment and speech and swallowing assessment are used in NPC patients.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Nutrition assessment and speech and swallowing assessment are diagnostic methods for NPC",
      "Diagnostic Method in the ontology includes nutrition assessment and speech and swallowing assessment"
    ]
  },
  {
    "id": "Medical-0d237b40",
    "source": "Medical",
    "question": "Which metastatic sites are most common in nasopharyngeal carcinoma and how is this reflected in the ontology?",
    "answer": "Lymph node and lung are the most common metastatic sites for NPC, as indicated in the ontology.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs",
      "Metastasis in the ontology for NPC includes lymph node and lung"
    ]
  },
  {
    "id": "Medical-cfab4b2d",
    "source": "Medical",
    "question": "Why is immunotherapy with checkpoint inhibitors recommended for some colon cancer patients but not others?",
    "answer": "Immunotherapy with checkpoint inhibitors is recommended for dMMR/MSI-H colon cancers but not for pMMR/MSS cancers, which are treated with chemotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "dMMR/MSI-H is a biomarker guiding immunotherapy",
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers",
      "pMMR/MSS cancers are treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-b2da7aee",
    "source": "Medical",
    "question": "What are the recommended surveillance strategies after treatment for colon cancer and which biomarkers are involved?",
    "answer": "Surveillance includes colonoscopy, CEA testing, and CT scans, with CEA serving as a biomarker for monitoring.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans",
      "CEA is a biomarker for monitoring colon cancer"
    ]
  },
  {
    "id": "Medical-7b422282",
    "source": "Medical",
    "question": "How does the presence of Lynch syndrome affect colon cancer risk and management?",
    "answer": "Lynch syndrome increases colon cancer risk and requires testing for mismatch repair deficiency (dMMR) or MSI-H, which guides immunotherapy decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
      "dMMR/MSI-H is a biomarker guiding immunotherapy"
    ]
  },
  {
    "id": "Medical-fc13ecfe",
    "source": "Medical",
    "question": "What is the rationale for recommending chemotherapy after colectomy in stage 3 colon cancer but not always in stage 2?",
    "answer": "Chemotherapy is recommended after colectomy for all stage 3 colon cancers due to lymph node involvement, while only some stage 2 cases receive it as they lack lymph node spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits",
      "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers"
    ]
  },
  {
    "id": "Medical-3447851a",
    "source": "Medical",
    "question": "Why should young adults with colon cancer be counseled about fertility preservation before treatment?",
    "answer": "Young adults should be counseled because treatments like chemotherapy and surgery can impair fertility, and options such as sperm banking, egg freezing, or ovarian tissue banking are available.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Young adults should be counseled about fertility risks and preservation options before treatment",
      "Fertility Preservation includes sperm banking, egg freezing, and ovarian tissue banking"
    ]
  },
  {
    "id": "Medical-97022167",
    "source": "Medical",
    "question": "How does the origin of colon cancer from adenomas influence early detection and prevention strategies?",
    "answer": "Since most colon cancers start in adenomas, early detection and removal of polyps via colonoscopy and polypectomy are crucial for prevention.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most colon cancers start in polyps, especially adenomas",
      "Polypectomy removes polyps during colonoscopy"
    ]
  },
  {
    "id": "Medical-781a9787",
    "source": "Medical",
    "question": "What diagnostic tests are used for both initial evaluation and staging of colon cancer, and what unique information does each provide?",
    "answer": "Blood tests (CBC, chemistry profile, CEA) are used for initial evaluation, while CT with contrast is the main imaging test for staging and surveillance; CEA is also a biomarker for monitoring.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing",
      "CT with contrast is the main imaging test for staging and surveillance",
      "CEA is a biomarker for monitoring colon cancer"
    ]
  },
  {
    "id": "Medical-104b2f70",
    "source": "Medical",
    "question": "For a patient with a first-degree relative with colorectal cancer, what risk factors and inherited syndromes should be considered?",
    "answer": "A first-degree relative is a risk factor, and inherited syndromes like Lynch syndrome and FAP should be evaluated for increased colon cancer risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history of colorectal cancer is a risk factor",
      "Risk Factor includes inherited syndromes such as Lynch syndrome and FAP"
    ]
  },
  {
    "id": "Medical-e1ede6d6",
    "source": "Medical",
    "question": "What distinguishes stage 4 colon cancer from earlier stages in terms of spread and treatment approach?",
    "answer": "Stage 4 colon cancer has spread to distant organs like the liver or lungs, requiring different treatment strategies compared to localized or regional disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 4 colon cancer has spread to distant organs (commonly liver or lungs)",
      "AJCC TNM system is used to stage colon cancer"
    ]
  },
  {
    "id": "Medical-e8957bed",
    "source": "Medical",
    "question": "Why is ctDNA testing not routinely used in colon cancer management outside clinical trials?",
    "answer": "ctDNA testing is considered investigational and recommended only in clinical trials, not in standard management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ctDNA testing is investigational and recommended only in clinical trials",
      "ctDNA is listed as a biomarker but not part of routine diagnostic or surveillance methods"
    ]
  },
  {
    "id": "Medical-38fc968c",
    "source": "Medical",
    "question": "Which surgical procedures may be required for colon cancer patients and under what circumstances is a colostomy necessary?",
    "answer": "Colectomy removes the cancerous colon segment, and colostomy is needed if bowel reconnection is not possible, diverting stool through a stoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Colectomy is surgery to remove the cancerous part of the colon",
      "Colostomy diverts stool through an abdominal stoma if reconnection is not possible"
    ]
  },
  {
    "id": "Medical-00ef7b5d",
    "source": "Medical",
    "question": "How are dMMR/MSI-H and pMMR/MSS statuses determined and how do they influence therapy choices?",
    "answer": "All colon cancers should be tested for dMMR/MSI-H or pMMR/MSS, with dMMR/MSI-H guiding immunotherapy and pMMR/MSS leading to chemotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
      "dMMR/MSI-H is a biomarker guiding immunotherapy",
      "pMMR/MSS cancers are treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-ebfc4679",
    "source": "Medical",
    "question": "What is the relationship between adenocarcinoma, adenomas, and the development of colon cancer?",
    "answer": "Adenocarcinoma, the most common colon cancer subtype, arises from adenomas that can become invasive cancer over many years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenocarcinoma is the most common subtype of colon cancer",
      "Adenocarcinoma arises from adenomas",
      "Adenomas can become invasive colon cancer over many years"
    ]
  },
  {
    "id": "Medical-f27c64c0",
    "source": "Medical",
    "question": "What steps are involved in the diagnostic workup for a patient suspected of colon cancer based on symptoms?",
    "answer": "Diagnostic workup includes colonoscopy (with possible polypectomy), blood tests (CBC, chemistry profile, CEA), and CT with contrast for staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Colonoscopy and polypectomy are diagnostic methods",
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing",
      "CT with contrast is the main imaging test for staging and surveillance"
    ]
  },
  {
    "id": "Medical-5b17d14f",
    "source": "Medical",
    "question": "Why are hyperplastic and inflammatory polyps less concerning than adenomas in colon cancer prevention?",
    "answer": "Hyperplastic and inflammatory polyps rarely become cancer, while adenomas can develop into invasive colon cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hyperplastic and inflammatory polyps rarely become cancer",
      "Adenomas can become invasive colon cancer over many years"
    ]
  },
  {
    "id": "Medical-bea3adf4",
    "source": "Medical",
    "question": "How does the presence of Barrett esophagus influence both risk and diagnostic approach for esophageal adenocarcinoma?",
    "answer": "Barrett esophagus increases risk for esophageal adenocarcinoma and necessitates biomarker and genetic risk testing during diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Esophageal adenocarcinoma has risk factor Barrett esophagus"
    ]
  },
  {
    "id": "Medical-99dd217e",
    "source": "Medical",
    "question": "What distinguishes early-stage esophageal cancer from locoregional and metastatic disease in terms of anatomical spread and diagnostic requirements?",
    "answer": "Early-stage is limited to the esophagus without lymph node involvement, while locoregional and metastatic involve spread to nodes or distant organs, requiring imaging and biopsy for staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
    ]
  },
  {
    "id": "Medical-166bcaa7",
    "source": "Medical",
    "question": "Why is Siewert type classification particularly important in the staging and treatment planning of tumors at the esophagogastric junction?",
    "answer": "Siewert types determine staging and guide treatment planning for esophagogastric junction tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Siewert types are used to stage tumors at the esophagogastric junction",
      "Treatment planning is based on cancer type, location, and stage",
      "Siewert types (for EGJ tumors) are included in treatment planning"
    ]
  },
  {
    "id": "Medical-48cb097c",
    "source": "Medical",
    "question": "Which anatomical locations are most associated with esophageal squamous cell carcinoma and esophageal adenocarcinoma, and how does this affect treatment planning?",
    "answer": "Squamous cell carcinoma often occurs in the upper/middle esophagus, adenocarcinoma in the lower/middle, and treatment planning considers these locations.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus",
      "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus",
      "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
      "Treatment planning is based on cancer type, location, and stage"
    ]
  },
  {
    "id": "Medical-a88065af",
    "source": "Medical",
    "question": "If a patient with esophageal cancer presents with liver and bone metastases, what is their disease stage and which diagnostic methods are necessary?",
    "answer": "The patient has metastatic disease and requires imaging tests and biopsy for confirmation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Metastatic: Spread to distant organs, including liver and bone"
    ]
  },
  {
    "id": "Medical-c41cab28",
    "source": "Medical",
    "question": "How does the identification of Barrett esophagus change the risk profile and surveillance strategy for esophageal cancer?",
    "answer": "Barrett esophagus increases adenocarcinoma risk, so surveillance includes biomarker and genetic risk testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Barrett esophagus is a risk factor for esophageal adenocarcinoma"
    ]
  },
  {
    "id": "Medical-f00f6356",
    "source": "Medical",
    "question": "What combination of factors must be considered in treatment planning for a locoregional esophageal adenocarcinoma at the lower esophagus?",
    "answer": "Treatment planning requires cancer type (adenocarcinoma), location (lower esophagus), and stage (locoregional).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment planning is based on cancer type, location, and stage",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs"
    ]
  },
  {
    "id": "Medical-c22fc609",
    "source": "Medical",
    "question": "Why must both performance status and nutritional assessment be included in the diagnostic workup for esophageal cancer?",
    "answer": "Both are required to assess patient suitability for treatment and are listed as diagnostic methods.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Nutritional assessment and performance status are diagnostic methods for esophageal cancer"
    ]
  },
  {
    "id": "Medical-e7ebb96c",
    "source": "Medical",
    "question": "Which diagnostic methods are necessary for confirming both the subtype and stage of esophageal cancer?",
    "answer": "Imaging tests, endoscopy, and biopsy are required to determine both subtype and stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Treatment planning is based on cancer type, location, and stage"
    ]
  },
  {
    "id": "Medical-c7bf38df",
    "source": "Medical",
    "question": "If a tumor is located at the esophagogastric junction, which classification system and factors are used for staging and treatment planning?",
    "answer": "The Siewert classification and factors such as cancer type, location, and stage are used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Siewert types are used to stage tumors at the esophagogastric junction",
      "Treatment planning is based on cancer type, location, and stage",
      "Siewert types (for EGJ tumors) are included in treatment planning"
    ]
  },
  {
    "id": "Medical-833304f8",
    "source": "Medical",
    "question": "How does the anatomical location of a tumor help distinguish between esophageal squamous cell carcinoma and adenocarcinoma?",
    "answer": "Squamous cell carcinoma is more common in the upper/middle esophagus, while adenocarcinoma is more common in the lower/middle esophagus.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus"
    ]
  },
  {
    "id": "Medical-efd5b238",
    "source": "Medical",
    "question": "What is the significance of identifying the disease stage in esophageal cancer for determining metastatic sites?",
    "answer": "Disease stage determines if metastasis to organs like liver, lung, bone, and brain has occurred.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Disease Stage: Metastatic: Spread to distant organs, including liver, lung, bone, brain, and distant lymph nodes",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain"
    ]
  },
  {
    "id": "Medical-52ca0ffb",
    "source": "Medical",
    "question": "Why are both biomarker testing and genetic risk testing included in the diagnostic process for esophageal cancer?",
    "answer": "Both are needed to identify molecular and inherited factors influencing cancer risk and treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Biomarker testing and genetic risk testing are diagnostic methods for esophageal cancer"
    ]
  },
  {
    "id": "Medical-16a39fa8",
    "source": "Medical",
    "question": "What role do anatomical layers of the esophagus play in distinguishing early-stage from locoregional esophageal cancer?",
    "answer": "Early-stage is confined to the esophagus, while locoregional involves invasion through esophageal layers and nearby structures.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs"
    ]
  },
  {
    "id": "Medical-a5d38351",
    "source": "Medical",
    "question": "How does the presence of distant metastasis affect treatment planning for esophageal cancer?",
    "answer": "Distant metastasis classifies the cancer as metastatic, which alters treatment planning based on stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Treatment planning is based on cancer type, location, and stage"
    ]
  },
  {
    "id": "Medical-f57e3ab2",
    "source": "Medical",
    "question": "What combination of clinical and pathological features would support a diagnosis of mediastinal gray zone lymphoma (MGZL) in a young male patient?",
    "answer": "A large mediastinal mass, Reed-Sternberg cells, and an age of 20-40 years assigned male at birth support MGZL diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
    ]
  },
  {
    "id": "Medical-7b682af7",
    "source": "Medical",
    "question": "Which additional therapy may be used alongside chemotherapy for localized MGZL, and under what circumstance?",
    "answer": "Involved-site radiation therapy (ISRT) may be added to chemotherapy in localized MGZL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL",
      "MGZL is usually treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-def9b488",
    "source": "Medical",
    "question": "Why is expert hematopathologist review crucial in diagnosing MGZL?",
    "answer": "Because diagnosis of MGZL requires expert hematopathologist review due to its overlapping features with PMBL and HL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of MGZL requires expert hematopathologist review",
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-950b879f",
    "source": "Medical",
    "question": "How does the typical site of involvement differ between mediastinal and non-mediastinal gray zone lymphomas?",
    "answer": "Mediastinal gray zone lymphomas involve the mediastinum and supraclavicular lymph nodes, while non-mediastinal types involve bone marrow and extranodal sites.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sites of involvement for MGZL include mediastinum and lymph nodes above the collar bone (supraclavicular)",
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
    ]
  },
  {
    "id": "Medical-35afeb4b",
    "source": "Medical",
    "question": "What treatment modification is made for MGZL patients to enhance chemoimmunotherapy?",
    "answer": "Rituximab may be added to chemotherapy for chemoimmunotherapy in MGZL patients.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Rituximab may be added to chemotherapy for chemoimmunotherapy",
      "MGZL is usually treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-b9f39886",
    "source": "Medical",
    "question": "What factors distinguish non-mediastinal gray zone lymphomas from mediastinal gray zone lymphomas?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons and have more bone marrow and extranodal involvement, unlike mediastinal types seen in younger males.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
    ]
  },
  {
    "id": "Medical-6d56985a",
    "source": "Medical",
    "question": "How does the diagnosis of gray zone lymphoma change if there is extra-mediastinal disease?",
    "answer": "If extra-mediastinal disease is present, the diagnosis changes to DLBCL, not otherwise specified (DLBCL-NOS).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "If extra-mediastinal disease: Diagnose as DLBCL-NOS",
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
    ]
  },
  {
    "id": "Medical-f9e22272",
    "source": "Medical",
    "question": "Which two related lymphomas share overlapping features with gray zone lymphomas, complicating diagnosis?",
    "answer": "Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) share overlapping features with gray zone lymphomas.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)",
      "Related Entities for gray zone lymphoma include Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-efd1af00",
    "source": "Medical",
    "question": "What evidence supports the use of chemoimmunotherapy instead of chemotherapy alone in MGZL?",
    "answer": "Chemoimmunotherapy is supported because rituximab may be added to chemotherapy for MGZL treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Rituximab may be added to chemotherapy for chemoimmunotherapy",
      "MGZL is usually treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-dc695a12",
    "source": "Medical",
    "question": "What histopathological finding is essential for diagnosing MGZL, and how is it confirmed?",
    "answer": "Reed-Sternberg cells are essential and diagnosis is confirmed by expert hematopathologist review.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Reed-Sternberg cells are characteristic histopathological features in MGZL",
      "Diagnosis of MGZL requires expert hematopathologist review"
    ]
  },
  {
    "id": "Medical-34a70628",
    "source": "Medical",
    "question": "Which population is most at risk for developing mediastinal gray zone lymphoma based on epidemiology?",
    "answer": "Individuals aged 20 to 40 years assigned male at birth are most at risk for MGZL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
      "Epidemiology of MGZL includes Age 20-40 years and Assigned male at birth"
    ]
  },
  {
    "id": "Medical-5e3016f9",
    "source": "Medical",
    "question": "What combination of features would indicate a diagnosis of non-mediastinal gray zone lymphoma rather than MGZL?",
    "answer": "Older age, bone marrow or extranodal involvement, and absence of mediastinal mass indicate non-mediastinal gray zone lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement",
      "MGZL is characterized by a large mediastinal mass"
    ]
  },
  {
    "id": "Medical-e0c754c6",
    "source": "Medical",
    "question": "How does the histopathology of MGZL relate to its clinical presentation?",
    "answer": "MGZL presents with a large mediastinal mass and Reed-Sternberg cells as histopathological features.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL"
    ]
  },
  {
    "id": "Medical-6ac9b753",
    "source": "Medical",
    "question": "What diagnostic methods are required for confirming MGZL and why?",
    "answer": "Expert hematopathologist review is required because of the overlapping features with other lymphomas.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of MGZL requires expert hematopathologist review",
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-23080670",
    "source": "Medical",
    "question": "If a patient presents with a large mediastinal mass and is assigned male at birth aged 25, what additional diagnostic step is necessary?",
    "answer": "Expert hematopathologist review is necessary to confirm MGZL diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
      "Diagnosis of MGZL requires expert hematopathologist review"
    ]
  },
  {
    "id": "Medical-bd7c7e1a",
    "source": "Medical",
    "question": "Which patients with recurrent or metastatic cervical cancer are eligible for immunotherapy, and what biomarker guides this decision?",
    "answer": "Patients with recurrent or metastatic cervical cancer who are PD-L1 positive are eligible for immunotherapy such as pembrolizumab.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer",
      "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)",
      "PD-L1 is a biomarker for cervical cancer according to the ontology"
    ]
  },
  {
    "id": "Medical-92ed141f",
    "source": "Medical",
    "question": "How does the approach to fertility preservation differ between early-stage cervical cancer patients and those with advanced disease?",
    "answer": "Early-stage patients may undergo fertility-sparing surgery or ovarian transposition, while these options are not available for advanced disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
      "Ovarian transposition is listed under fertility preservation in the ontology",
      "Surgery is the main treatment for early-stage cervical cancer",
      "Fertility preservation is not mentioned as an option for advanced stages in the ontology"
    ]
  },
  {
    "id": "Medical-6428d1f1",
    "source": "Medical",
    "question": "Why is chemoradiation the standard of care for locally advanced cervical cancer rather than surgery?",
    "answer": "Because chemoradiation is recommended for locally advanced cervical cancer, while surgery is the main treatment for early-stage disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer",
      "Surgery is the main treatment for early-stage cervical cancer",
      "Chemoradiation is included under systemic therapy and radiation therapy in the ontology"
    ]
  },
  {
    "id": "Medical-04e9f25b",
    "source": "Medical",
    "question": "Which imaging modalities are used both for staging and surveillance in cervical cancer management?",
    "answer": "CT scan, MRI, PET/CT, and transvaginal ultrasound are used for staging and can be used for surveillance imaging as indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment",
      "Surveillance after treatment includes regular physical exams and imaging as indicated",
      "CT scan, MRI, PET/CT, and transvaginal ultrasound are listed as imaging diagnostic methods in the ontology"
    ]
  },
  {
    "id": "Medical-213bbcca",
    "source": "Medical",
    "question": "What are the main histological subtypes of cervical cancer and how do their frequencies compare?",
    "answer": "Squamous cell carcinoma is the most common, while adenocarcinoma, adenosquamous carcinoma, and NECC are less common or rare.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Squamous cell carcinoma is the most common subtype of cervical cancer",
      "Adenocarcinoma and adenosquamous carcinoma are less common subtypes",
      "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype",
      "The ontology lists these as subtypes under cervical cancer"
    ]
  },
  {
    "id": "Medical-e0a5fcc5",
    "source": "Medical",
    "question": "How is high-grade squamous intraepithelial lesion (HSIL) related to cervical cancer progression and diagnosis?",
    "answer": "HSIL corresponds to CIN 2 and 3, is considered pre-cancer, and may be identified by biopsy as part of cervical cancer diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-grade squamous intraepithelial lesion (HSIL) corresponds to CIN 2 and 3 and is considered pre-cancer",
      "Cervical biopsy is the primary diagnostic method for cervical cancer",
      "Biopsy is listed as a diagnostic method for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-423d4257",
    "source": "Medical",
    "question": "Which risk factors are shared by cervical cancer and its precursor lesions, and how do they contribute to disease development?",
    "answer": "HPV infection, smoking, and immunosuppression are risk factors for both cervical cancer and cervical dysplasia, contributing to disease progression.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most cervical cancers are caused by long-term infection with human papillomavirus (HPV)",
      "Smoking increases the risk of cervical cancer",
      "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer",
      "Cervical dysplasia (CIN) can progress to cervical cancer if untreated",
      "HPV infection, smoking, and immunosuppression are listed as risk factors for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-68ea8206",
    "source": "Medical",
    "question": "What is the relationship between Pap smear screening and the detection of cervical dysplasia and cancer?",
    "answer": "Pap smear is used for cervical cancer screening and can detect cervical dysplasia, which may progress to cancer if untreated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pap smear is used for cervical cancer screening",
      "Cervical dysplasia (CIN) can progress to cervical cancer if untreated",
      "Pap smear is listed as a screening diagnostic method for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-e2ac8ec4",
    "source": "Medical",
    "question": "How does the addition of bevacizumab to chemotherapy alter the management of metastatic cervical cancer?",
    "answer": "Bevacizumab may be added to chemotherapy to improve outcomes in metastatic cervical cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bevacizumab may be added to chemotherapy for metastatic cervical cancer",
      "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy",
      "Bevacizumab is listed as a systemic therapy for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-413d4c7e",
    "source": "Medical",
    "question": "What are the main symptoms prompting diagnostic evaluation for cervical cancer, and which diagnostic methods confirm the diagnosis?",
    "answer": "Symptoms like watery vaginal discharge, pelvic pain, and abnormal vaginal bleeding prompt evaluation, confirmed by cervical biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Watery vaginal discharge, pelvic pain, and abnormal vaginal bleeding are symptoms of cervical cancer",
      "Cervical biopsy is the primary diagnostic method for cervical cancer",
      "These symptoms and diagnostic methods are listed for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-f63520dd",
    "source": "Medical",
    "question": "What is the role of supportive and palliative care in advanced or metastatic cervical cancer management?",
    "answer": "Supportive and palliative care are integral for advanced or metastatic cervical cancer to manage symptoms and improve quality of life.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care and palliative care are integral for advanced or metastatic disease",
      "Supportive care and palliative care are listed as treatments for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-8307a348",
    "source": "Medical",
    "question": "Which surgical procedures are available for early-stage cervical cancer, and how do they relate to fertility preservation?",
    "answer": "Cone biopsy and trachelectomy are surgical options for early-stage disease, with trachelectomy serving as a fertility-sparing procedure.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer",
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
      "Cone biopsy and trachelectomy are listed as surgical procedures for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-86e095c3",
    "source": "Medical",
    "question": "How does smoking status influence both the risk and treatment outcomes of cervical cancer?",
    "answer": "Smoking increases the risk of cervical cancer, and smoking cessation improves treatment outcomes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Smoking increases the risk of cervical cancer",
      "Smoking cessation improves treatment outcomes",
      "Smoking is listed as a risk factor for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-02d254bc",
    "source": "Medical",
    "question": "For which stages of cervical cancer is surgery the primary treatment, and when is chemoradiation preferred?",
    "answer": "Surgery is primary for early-stage cervical cancer, while chemoradiation is preferred for locally advanced stages.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surgery is the main treatment for early-stage cervical cancer",
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer",
      "The ontology lists surgical procedures and chemoradiation as treatments for cervical cancer by stage"
    ]
  },
  {
    "id": "Medical-83eb6b6b",
    "source": "Medical",
    "question": "What follow-up methods are recommended after cervical cancer treatment, and how do they help in surveillance?",
    "answer": "Regular physical exams, imaging as indicated, Pap testing, and blood tests are recommended for surveillance after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance after treatment includes regular physical exams and imaging as indicated",
      "Follow-up in the ontology includes physical exam, imaging, Pap testing, and blood tests"
    ]
  },
  {
    "id": "Medical-df78005a",
    "source": "Medical",
    "question": "How can you distinguish between classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma based on cell morphology?",
    "answer": "Classic Hodgkin lymphoma has Reed-Sternberg cells, while nodular lymphocyte-predominant Hodgkin lymphoma has popcorn-shaped cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells"
    ]
  },
  {
    "id": "Medical-f8e45373",
    "source": "Medical",
    "question": "Which subtype of Hodgkin lymphoma is most likely to transform into diffuse large B-cell lymphoma, and how is this subtype identified?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma and is identified by popcorn-shaped cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "NLPHL is characterized by popcorn-shaped cells",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-b503f3f3",
    "source": "Medical",
    "question": "What combination of diagnostic methods is typically used to confirm Hodgkin lymphoma and assess its extent?",
    "answer": "Excisional lymph node biopsy, blood tests, and imaging tests are used together for diagnosis and staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
      "Blood tests and imaging tests are used in the diagnostic workup"
    ]
  },
  {
    "id": "Medical-705f9e89",
    "source": "Medical",
    "question": "If a patient aged 25 presents with swollen lymph nodes in the upper body, what cancer type should be highly suspected and why?",
    "answer": "Hodgkin lymphoma should be suspected because it usually starts in upper body lymph nodes and is common between ages 15 to 30.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body",
      "Most people are diagnosed between ages 15 to 30 or after age 55"
    ]
  },
  {
    "id": "Medical-8779d729",
    "source": "Medical",
    "question": "What are the main differences in cell type and disease progression risk between classic Hodgkin lymphoma and NLPHL?",
    "answer": "Classic Hodgkin lymphoma has Reed-Sternberg cells and is the most common subtype, while NLPHL has popcorn-shaped cells and can transform into DLBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-f7300f3c",
    "source": "Medical",
    "question": "Which diagnostic methods are shared between classic Hodgkin lymphoma and NLPHL, and what does this suggest about their diagnostic process?",
    "answer": "Both use excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests, indicating a similar diagnostic process.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Classic Hodgkin lymphoma (CHL): Diagnostic Method: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, imaging tests",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): Diagnostic Method: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, imaging tests"
    ]
  },
  {
    "id": "Medical-c31057de",
    "source": "Medical",
    "question": "What evidence supports the use of both health history and physical exam in the diagnostic workup for Hodgkin lymphoma?",
    "answer": "Health history and physical exam are part of the diagnostic process for Hodgkin lymphoma and are included in the diagnostic methods for both CHL and NLPHL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Health history and physical exam are part of the diagnostic process",
      "Classic Hodgkin lymphoma (CHL): Diagnostic Method: health history, physical exam",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): Diagnostic Method: health history, physical exam"
    ]
  },
  {
    "id": "Medical-45173331",
    "source": "Medical",
    "question": "How does the age of onset relate to the risk factors for Hodgkin lymphoma according to the ontology?",
    "answer": "Ages 15 to 30 and after age 55 are risk factors for Hodgkin lymphoma, matching the typical age of diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most people are diagnosed between ages 15 to 30 or after age 55",
      "Risk Factor: ages 15 to 30, age 55"
    ]
  },
  {
    "id": "Medical-1930c305",
    "source": "Medical",
    "question": "What features distinguish Hodgkin lymphoma from other lymphomas based on the ontology and relations provided?",
    "answer": "Hodgkin lymphoma is defined by its subtypes (CHL and NLPHL), characteristic cell types (Reed-Sternberg or popcorn-shaped cells), and typical onset in upper body lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hodgkin lymphoma is a type of lymphoma",
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "NLPHL is a rare subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells",
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body"
    ]
  },
  {
    "id": "Medical-9d34bcac",
    "source": "Medical",
    "question": "Which subtype of Hodgkin lymphoma is less common, and what unique risk does it carry compared to the common subtype?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma is less common and can transform into diffuse large B-cell lymphoma, unlike the classic subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-68694b91",
    "source": "Medical",
    "question": "Why might a core needle biopsy be chosen over an excisional lymph node biopsy in Hodgkin lymphoma diagnosis?",
    "answer": "Core needle biopsy may be used in some cases as an alternative to excisional lymph node biopsy for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
      "Core needle biopsy may be used for diagnosis in some cases"
    ]
  },
  {
    "id": "Medical-9bc8aaa1",
    "source": "Medical",
    "question": "What findings from both the patient's age and the location of lymph node involvement would increase suspicion for Hodgkin lymphoma?",
    "answer": "A patient aged 15-30 or over 55 with lymph node involvement in the upper body increases suspicion for Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most people are diagnosed between ages 15 to 30 or after age 55",
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body"
    ]
  },
  {
    "id": "Medical-b2a64d4a",
    "source": "Medical",
    "question": "Which cell type is diagnostic for the most common subtype of Hodgkin lymphoma, and how is this subtype classified in the ontology?",
    "answer": "Reed-Sternberg cells are diagnostic for classic Hodgkin lymphoma, which is the most common subtype of Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells"
    ]
  },
  {
    "id": "Medical-4b359d87",
    "source": "Medical",
    "question": "If a patient's lymph node biopsy reveals popcorn-shaped cells, what is the diagnosis and what is a potential complication?",
    "answer": "The diagnosis is nodular lymphocyte-predominant Hodgkin lymphoma, which can transform into diffuse large B-cell lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "NLPHL is characterized by popcorn-shaped cells",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-5459ea22",
    "source": "Medical",
    "question": "Why is a tumor classified as Tis (carcinoma in situ) in intrahepatic bile duct cancer only found in the epithelium and not in deeper layers?",
    "answer": "Because Tis tumors are intraductal and confined to the epithelium, not invading lamina propria or deeper layers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
      "Intrahepatic bile duct cancer Tis tumors are described as carcinoma in situ and confined to epithelium"
    ]
  },
  {
    "id": "Medical-f25adcc2",
    "source": "Medical",
    "question": "If a primary tumor in intrahepatic bile duct cancer is found in the perimuscular fibrous tissue, why can it not be staged as Tis?",
    "answer": "Because Tis is defined as a tumor confined to the epithelium, and perimuscular fibrous tissue is a deeper layer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Perimuscular fibrous tissue surrounds the muscle layer",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-904e0a11",
    "source": "Medical",
    "question": "How does the anatomical structure of the bile duct relate to the spread of cancer to the liver?",
    "answer": "The bile duct is composed of several layers, and cancer can invade through these layers into the liver.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-3c536762",
    "source": "Medical",
    "question": "Why is tumor size and extent of spread important in staging bile duct cancer?",
    "answer": "Because bile duct cancer staging is based on tumor size and how far it has spread beyond the original location.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bile duct cancer staging is based on tumor size and extent of spread",
      "Tumor Characteristic includes primary tumor size (cm or mm) and spread to blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-aacc98ed",
    "source": "Medical",
    "question": "What histological layers must a tumor penetrate to reach the serosa from the epithelium in the bile duct?",
    "answer": "A tumor must penetrate the lamina propria, muscularis, and perimuscular fibrous tissue to reach the serosa from the epithelium.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa",
      "Lamina propria is a connective tissue found under the epithelium",
      "Muscularis is a soft tissue layer in the bile duct wall",
      "Perimuscular fibrous tissue surrounds the muscle layer"
    ]
  },
  {
    "id": "Medical-7bf81d77",
    "source": "Medical",
    "question": "Why does carcinoma in situ not involve spread to blood vessels or the liver?",
    "answer": "Because carcinoma in situ is by definition confined to the epithelium and does not invade deeper tissues or structures.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Tumor Characteristic includes spread to blood vessels and liver for advanced stages"
    ]
  },
  {
    "id": "Medical-6e39cbe0",
    "source": "Medical",
    "question": "Which anatomical layer acts as a barrier before cancer reaches the outer membrane (serosa) of the gallbladder?",
    "answer": "The perimuscular fibrous tissue acts as a barrier before the serosa.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Perimuscular fibrous tissue surrounds the muscle layer",
      "Serosa is the outer membrane covering the gallbladder and bile ducts",
      "The gallbladder wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-41284331",
    "source": "Medical",
    "question": "If a tumor is described as intraductal and confined to the epithelium, what stage and tumor characteristic does it correspond to in intrahepatic bile duct cancer?",
    "answer": "It corresponds to Tis stage and carcinoma in situ tumor characteristic.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Intrahepatic bile duct cancer Tis tumors are described as carcinoma in situ and confined to epithelium"
    ]
  },
  {
    "id": "Medical-f078c897",
    "source": "Medical",
    "question": "Why is the lamina propria not included in the definition of carcinoma in situ for intrahepatic bile duct cancer?",
    "answer": "Because carcinoma in situ is restricted to the epithelium, and the lamina propria is a connective tissue beneath it.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Lamina propria is a connective tissue found under the epithelium"
    ]
  },
  {
    "id": "Medical-7c1c087a",
    "source": "Medical",
    "question": "How does the presence of serosa impact the potential for cancer to spread outside the gallbladder or bile duct?",
    "answer": "The serosa acts as the last anatomical barrier before cancer can spread to structures outside the organ.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Serosa is the outer membrane covering the gallbladder and bile ducts",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-787b9c0b",
    "source": "Medical",
    "question": "If a tumor in the bile duct is only found in the muscularis layer, how does this affect its staging compared to a tumor confined to the epithelium?",
    "answer": "A tumor in the muscularis is a more advanced stage than one confined to the epithelium (Tis).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Muscularis is a soft tissue layer in the bile duct wall",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-a0c1c9cd",
    "source": "Medical",
    "question": "Why is the anatomical knowledge of layers like lamina propria and muscularis important for understanding tumor invasion in bile duct cancer?",
    "answer": "Because the depth of tumor invasion into these layers determines the cancer stage and treatment approach.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bile duct cancer staging is based on tumor size and extent of spread",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-c5b8734d",
    "source": "Medical",
    "question": "What distinguishes carcinoma in situ from invasive bile duct cancer based on histological layers?",
    "answer": "Carcinoma in situ is confined to the epithelium, while invasive cancer penetrates deeper layers such as lamina propria and beyond.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-56f4cb0b",
    "source": "Medical",
    "question": "How does the involvement of blood vessels or liver affect the classification of bile duct cancer compared to a tumor confined to the epithelium?",
    "answer": "Involvement of blood vessels or liver indicates a higher stage than a tumor confined to the epithelium (Tis).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tumor Characteristic includes spread to blood vessels and liver",
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
    ]
  },
  {
    "id": "Medical-7f3beb74",
    "source": "Medical",
    "question": "If a tumor spreads through all histological layers of the bile duct, which anatomical structures could it potentially invade next?",
    "answer": "It could invade nearby blood vessels, the liver, or structures outside the liver.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-2d14639d",
    "source": "Medical",
    "question": "How does the grade of follicular lymphoma influence its classification and treatment approach?",
    "answer": "Grades 1 and 2 are classified as classic FL and treated accordingly, while grade 3B is classified and treated as DLBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC",
      "Grade 3B FL is treated as DLBCL",
      "The type of cells in FL determines the grade, which guides treatment decisions"
    ]
  },
  {
    "id": "Medical-1e1b5f1d",
    "source": "Medical",
    "question": "What diagnostic procedures are necessary to confirm follicular lymphoma and why are multiple methods required?",
    "answer": "Diagnosis requires blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping to fully characterize the disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues"
    ]
  },
  {
    "id": "Medical-a660735d",
    "source": "Medical",
    "question": "Why might a patient with pediatric-type follicular lymphoma present differently from an adult with classic FL?",
    "answer": "PTFL usually presents with a single enlarged lymph node and minimal symptoms, unlike classic FL which may have widespread lymphadenopathy and B symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
      "classic FL (cFL) is the classification for most adult FL"
    ]
  },
  {
    "id": "Medical-4a4eaab8",
    "source": "Medical",
    "question": "How does the presence or absence of the t(14;18) translocation affect the classification of follicular lymphoma?",
    "answer": "FL cases lacking t(14;18) or with uncommon pathologic features are classified as uncommon FL (uFL) but are treated as classic FL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL",
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein",
      "Genetic Alteration of uncommon FL (uFL) is t(14;18)-negative"
    ]
  },
  {
    "id": "Medical-37f18801",
    "source": "Medical",
    "question": "What features distinguish grade 3A from grade 3B follicular lymphoma in terms of treatment?",
    "answer": "Grade 3A FL may be treated as classic FL or as DLBCL, while grade 3B FL is always treated as DLBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)",
      "Grade 3B FL is treated as DLBCL",
      "Grade 3A and 3B differ in classification and management"
    ]
  },
  {
    "id": "Medical-d7e8bc97",
    "source": "Medical",
    "question": "Which symptoms would raise suspicion for advanced follicular lymphoma involving multiple disease sites?",
    "answer": "Swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss suggest advanced FL involving lymph nodes, spleen, and possibly bone marrow.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
      "FL can present as nodal or extranodal disease",
      "Disease Site of FL includes lymph node, bone marrow, spleen, extranodal sites"
    ]
  },
  {
    "id": "Medical-6a5c89f3",
    "source": "Medical",
    "question": "Why do not all patients with follicular lymphoma require immediate treatment upon diagnosis?",
    "answer": "Because clinical management guidelines state not all patients require immediate treatment and treatment decisions are guided by grade and cell type.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Not all patients with FL require immediate treatment",
      "Treatment decisions are guided by grade and cell type",
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma"
    ]
  },
  {
    "id": "Medical-c76b58b2",
    "source": "Medical",
    "question": "How is the transformation of follicular lymphoma into a more aggressive disease identified and classified?",
    "answer": "Transformation is identified by the development of DLBCL from FL, which is classified as transformed FL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "FL can transform into DLBCL, a more aggressive lymphoma",
      "transformed FL: Transformation is to diffuse large B-cell lymphoma (DLBCL)",
      "DLBCL is a distinct classification in the ontology"
    ]
  },
  {
    "id": "Medical-fb234ffb",
    "source": "Medical",
    "question": "What is the significance of BCL2 protein in the diagnosis or classification of follicular lymphoma?",
    "answer": "BCL2 protein is a biomarker found in almost all FL cases, often due to chromosome translocation, and helps confirm the diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein",
      "Biomarker of FL is BCL2 protein",
      "Genetic Alteration of FL includes chromosome translocation, t(14;18)"
    ]
  },
  {
    "id": "Medical-0030eab4",
    "source": "Medical",
    "question": "What combination of cell types is used to determine the grade of follicular lymphoma and how does this affect management?",
    "answer": "The proportion of centrocytes and centroblasts determines the grade, which guides treatment decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "FL is graded based on the proportion of centrocytes and centroblasts",
      "The type of cells in FL determines the grade, which guides treatment decisions",
      "Grade 1 and 2 FL have both centrocytes and centroblasts, while grade 3B has only centroblasts"
    ]
  },
  {
    "id": "Medical-f9bc1472",
    "source": "Medical",
    "question": "If a patient presents with a single enlarged lymph node in the head and neck and minimal symptoms, which FL subtype is most likely, and what is its typical genetic status?",
    "answer": "Pediatric-type FL (PTFL) is most likely, typically lacking the t(14;18) translocation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms",
      "Genetic Alteration of uncommon FL (uFL) is t(14;18)-negative",
      "PTFL is a distinct cancer subtype in the ontology"
    ]
  },
  {
    "id": "Medical-3aa8a2c6",
    "source": "Medical",
    "question": "How does the site of disease involvement influence the presentation of follicular lymphoma symptoms?",
    "answer": "Involvement of lymph nodes, spleen, and bone marrow leads to symptoms such as swollen lymph nodes, enlarged spleen, and B symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Disease Site of FL includes lymph node, bone marrow, spleen, extranodal sites",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
    ]
  },
  {
    "id": "Medical-96508468",
    "source": "Medical",
    "question": "Why are both immunophenotyping and biopsy necessary in the diagnostic workup of follicular lymphoma?",
    "answer": "Both are required to identify cell type and confirm the diagnosis, as FL arises from abnormal B lymphocytes and is graded based on cell proportions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues",
      "FL is graded based on the proportion of centrocytes and centroblasts"
    ]
  },
  {
    "id": "Medical-98bb0bbc",
    "source": "Medical",
    "question": "How does the classification of uncommon FL (uFL) differ from classic FL (cFL), and how does this affect treatment?",
    "answer": "Uncommon FL is t(14;18)-negative or has unusual features, but is treated as classic FL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL",
      "classic FL (cFL) is the standard classification for most FL"
    ]
  },
  {
    "id": "Medical-5581adb2",
    "source": "Medical",
    "question": "What combination of symptoms and diagnostic findings would suggest follicular lymphoma with bone marrow involvement?",
    "answer": "Symptoms like fatigue and weight loss, combined with abnormal findings on bone marrow aspirate and biopsy, suggest FL with bone marrow involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "Symptoms of FL include fatigue and weight loss (B symptoms)",
      "Disease Site of FL includes bone marrow"
    ]
  },
  {
    "id": "Medical-31580ac0",
    "source": "Medical",
    "question": "Which liver cancer subtype is most likely to be found in younger patients, and what are the main risk factors for its parent cancer type?",
    "answer": "Fibrolamellar hepatocellular carcinoma (FLHC) is found in younger patients, and its parent type, HCC, is mainly associated with cirrhosis, hepatitis B, and hepatitis C.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age",
      "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer",
      "Chronic hepatitis B infection increases the risk of liver cancer",
      "Chronic hepatitis C infection increases the risk of liver cancer"
    ]
  },
  {
    "id": "Medical-cfc21569",
    "source": "Medical",
    "question": "Why is liver cancer screening with ultrasound and AFP test recommended every 6 months for some individuals?",
    "answer": "Because individuals with cirrhosis or chronic hepatitis B are at increased risk for liver cancer, and regular screening with ultrasound and AFP can detect cancer early.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
    ]
  },
  {
    "id": "Medical-443e3d36",
    "source": "Medical",
    "question": "If a patient with chronic hepatitis C and cirrhosis develops elevated AFP, which cancer type and diagnostic methods should be considered?",
    "answer": "Primary liver cancer should be considered, and diagnosis should be confirmed with imaging tests and possibly biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chronic hepatitis C infection increases the risk of liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer",
      "Elevated AFP may indicate primary liver cancer",
      "Diagnosis of liver cancer is usually confirmed with imaging tests",
      "Biopsy may be needed to confirm liver cancer"
    ]
  },
  {
    "id": "Medical-e9ef7d6f",
    "source": "Medical",
    "question": "What distinguishes secondary liver cancer from primary liver cancer in terms of origin and anatomical structure involved?",
    "answer": "Primary liver cancer originates in the liver, while secondary liver cancer spreads to the liver from other organs.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary liver cancer originates in the liver",
      "Secondary liver cancer is cancer that has spread to the liver from another organ",
      "Secondary liver cancer: Origin: Other primary cancers (e.g., colon cancer)"
    ]
  },
  {
    "id": "Medical-c2af5dd7",
    "source": "Medical",
    "question": "Which two risk factors for liver cancer are also major causes of cirrhosis, further increasing cancer risk?",
    "answer": "Alcohol use and non-alcoholic fatty liver disease (NAFLD) are both risk factors for cirrhosis and liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Alcohol use is a risk factor for cirrhosis and liver cancer",
      "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer"
    ]
  },
  {
    "id": "Medical-83ff7511",
    "source": "Medical",
    "question": "If liver cancer is found to have both hepatocellular and cholangiocarcinoma components, what is the tumor called and what does this imply about its classification?",
    "answer": "Such a tumor is called a mixed-type tumor, implying it contains both HCC and cholangiocarcinoma features.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components",
      "Cancer Subtype: Mixed-type tumor contains both HCC and cholangiocarcinoma"
    ]
  },
  {
    "id": "Medical-5a2c0504",
    "source": "Medical",
    "question": "Which anatomical sites are most commonly affected by metastasis from primary liver cancer, and how is this supported by the ontology?",
    "answer": "The lung and bone are the most common metastasis sites for primary liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Liver cancer most often metastasizes to the lung or bone",
      "Metastasis Site: Primary liver cancer commonly spreads to lung and bone"
    ]
  },
  {
    "id": "Medical-38a8b852",
    "source": "Medical",
    "question": "Why might a patient with genetic hemochromatosis require regular liver cancer screening, and which methods are used?",
    "answer": "Because genetic hemochromatosis is a risk factor for cirrhosis and liver cancer, screening with ultrasound and AFP test is recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer",
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
    ]
  },
  {
    "id": "Medical-0b5acb42",
    "source": "Medical",
    "question": "What is the relationship between alpha-1-antitrypsin deficiency, cirrhosis, and liver cancer risk?",
    "answer": "Alpha-1-antitrypsin deficiency increases the risk of cirrhosis, which in turn increases the risk of liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Alpha-1-antitrypsin deficiency is a risk factor for cirrhosis and liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer"
    ]
  },
  {
    "id": "Medical-535c413f",
    "source": "Medical",
    "question": "Which diagnostic steps should be taken if a screening ultrasound and AFP test suggest liver cancer in a patient with hepatitis B?",
    "answer": "Imaging tests should be performed to confirm diagnosis, and a biopsy may be needed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months",
      "Diagnosis of liver cancer is usually confirmed with imaging tests",
      "Biopsy may be needed to confirm liver cancer"
    ]
  },
  {
    "id": "Medical-c6a7964c",
    "source": "Medical",
    "question": "How do risk factors for primary liver cancer differ from those for secondary liver cancer according to the ontology?",
    "answer": "Primary liver cancer risk factors include cirrhosis, hepatitis B, hepatitis C, and others, while secondary liver cancer originates from cancers in other organs.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk Factor: Primary liver cancer is associated with cirrhosis, hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, non-alcoholic fatty liver disease (NAFLD), genetic hemochromatosis, alpha-1-antitrypsin deficiency, and stage 4 primary biliary cholangitis",
      "Secondary liver cancer: Origin: Other primary cancers (e.g., colon cancer)"
    ]
  },
  {
    "id": "Medical-803f66d8",
    "source": "Medical",
    "question": "Why is elevated alpha-fetoprotein (AFP) particularly significant in the context of primary liver cancer screening and diagnosis?",
    "answer": "Because elevated AFP may indicate primary liver cancer and is used as a biomarker in screening and diagnostic protocols.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Elevated AFP may indicate primary liver cancer",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months",
      "Biomarker: Alpha-fetoprotein (AFP) is used for primary liver cancer"
    ]
  },
  {
    "id": "Medical-819d9c6c",
    "source": "Medical",
    "question": "What distinguishes intrahepatic cholangiocarcinoma from other primary liver cancer subtypes in terms of anatomical origin?",
    "answer": "Intrahepatic cholangiocarcinoma arises from the bile ducts within the liver, unlike HCC or mixed-type tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts",
      "Anatomical Structure: Bile ducts are a part of the liver"
    ]
  },
  {
    "id": "Medical-ac781c3a",
    "source": "Medical",
    "question": "If a patient with stage 4 primary biliary cholangitis develops liver cancer, what is the likely sequence of risk events?",
    "answer": "Stage 4 primary biliary cholangitis increases risk of cirrhosis, which then raises the risk for liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer"
    ]
  },
  {
    "id": "Medical-0955a900",
    "source": "Medical",
    "question": "How does the presence of both hepatitis B and alcohol use affect liver cancer risk, and what does the ontology indicate about their combined effect?",
    "answer": "Both hepatitis B and alcohol use independently increase the risk of liver cancer, and their presence together further elevates the risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chronic hepatitis B infection increases the risk of liver cancer",
      "Alcohol use is a risk factor for cirrhosis and liver cancer",
      "Risk Factor: Primary liver cancer is associated with hepatitis B virus (HBV) and alcohol use"
    ]
  },
  {
    "id": "Medical-18be1c24",
    "source": "Medical",
    "question": "Which diagnostic and biomarker tests are indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma?",
    "answer": "TSH test, neck ultrasound, fine-needle aspiration, pathology review, molecular tests, and biomarker analysis for BRAF, NTRK, and ALK gene mutations are indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of large thyroid nodules include visible neck lump",
      "Papillary thyroid carcinoma Diagnostic Method: TSH test, Ultrasound, Fine-needle aspiration, Pathology review, Molecular tests",
      "Papillary thyroid carcinoma Biomarker: BRAF gene mutation, NTRK gene fusion, ALK gene fusion"
    ]
  },
  {
    "id": "Medical-09eac393",
    "source": "Medical",
    "question": "Why is radioactive iodine therapy not used for medullary thyroid cancer after total thyroidectomy, and what alternative therapies are recommended?",
    "answer": "RAI therapy is ineffective for medullary thyroid cancer, so targeted therapy and thyroid hormone replacement are recommended alternatives.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RAI therapy is not effective for medullary or anaplastic thyroid cancer",
      "Medullary thyroid cancer Treatment: Total thyroidectomy, Neck dissection, Targeted therapy (if advanced/metastatic), Thyroid hormone replacement therapy"
    ]
  },
  {
    "id": "Medical-3f8a738d",
    "source": "Medical",
    "question": "If a patient with a history of head and neck radiation presents with a neck lump and trouble swallowing, what diagnostic steps should be taken to evaluate for thyroid cancer?",
    "answer": "TSH test, neck ultrasound, and fine-needle aspiration biopsy should be performed to evaluate for thyroid cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radiation exposure to the head or neck increases risk of thyroid cancer",
      "Symptoms of large thyroid nodules include visible neck lump, problems swallowing",
      "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules"
    ]
  },
  {
    "id": "Medical-03451b65",
    "source": "Medical",
    "question": "What is the recommended management for a small, noninvasive papillary thyroid carcinoma found to be less than 1 cm with no lymph node involvement?",
    "answer": "Active surveillance or lobectomy are recommended management options.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Active surveillance is an option for very-low-risk papillary thyroid cancers",
      "Lobectomy is an option for small, low-risk differentiated thyroid cancers",
      "Papillary thyroid carcinoma Treatment: Active surveillance (for very-low-risk, small tumors), Lobectomy (for small, noninvasive tumors 1-4 cm, no spread)"
    ]
  },
  {
    "id": "Medical-f4972c91",
    "source": "Medical",
    "question": "Which treatments are used for metastatic differentiated thyroid cancer that is iodine-avid and which are considered if the disease is not iodine-avid?",
    "answer": "RAI therapy is used for iodine-avid disease, while targeted therapy and external beam radiation therapy are used if the disease is not iodine-avid.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RAI therapy is used after total thyroidectomy for differentiated thyroid cancers that take up iodine",
      "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis",
      "Stage Distant metastasis Treatment: RAI therapy (if iodine-avid), Targeted therapy, External beam radiation therapy"
    ]
  },
  {
    "id": "Medical-a0cd1d28",
    "source": "Medical",
    "question": "Which genetic alteration is most associated with inherited medullary thyroid cancer and what implication does this have for family members?",
    "answer": "RET gene fusion is most associated, indicating the need for family genetic screening for inherited syndromes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Medullary thyroid cancer can be inherited and is associated with RET gene fusion",
      "Medullary thyroid cancer Risk Factor: Inherited syndromes (MEN, RET mutation)"
    ]
  },
  {
    "id": "Medical-2f70ddcb",
    "source": "Medical",
    "question": "What follow-up tests are recommended after total thyroidectomy for thyroid cancer, and how can recurrence be detected?",
    "answer": "Physical exam, TSH, thyroglobulin, anti-thyroglobulin antibodies blood tests, and neck ultrasound are recommended; recurrence may be detected by rising thyroglobulin or imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound",
      "Rising thyroglobulin after thyroidectomy may indicate recurrence",
      "Recurrence Detection: Rising thyroglobulin, Neck ultrasound, Imaging (CT, MRI)"
    ]
  },
  {
    "id": "Medical-6e99ce81",
    "source": "Medical",
    "question": "For a patient with anaplastic thyroid cancer and distant metastasis, which combination of therapies is most likely to be recommended?",
    "answer": "External beam radiation therapy, chemotherapy, and possibly targeted therapy are most likely recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Anaplastic thyroid cancer is the most aggressive and rarest subtype",
      "Anaplastic thyroid cancer Treatment: External beam radiation therapy, Chemotherapy (with radiation), Surgery (if possible), Targeted therapy (if indicated)",
      "Stage Distant metastasis Treatment: External beam radiation therapy, Chemotherapy (for anaplastic), Targeted therapy"
    ]
  },
  {
    "id": "Medical-b94e5d8e",
    "source": "Medical",
    "question": "If a thyroid cancer patient develops brain and bone metastases, which treatment options should be considered?",
    "answer": "External beam radiation therapy, targeted therapy, and clinical trial participation should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord",
      "Metastasis Treatment: External beam radiation therapy, Targeted therapy, Clinical trial"
    ]
  },
  {
    "id": "Medical-32fce5f0",
    "source": "Medical",
    "question": "What are the standard hormone replacement options after total thyroidectomy and why are they necessary?",
    "answer": "Levothyroxine, Levoxyl, or Synthroid are necessary to replace lost thyroid hormone after total thyroidectomy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Thyroid hormone replacement therapy is required after total thyroidectomy",
      "Thyroid hormone replacement therapy: Levothyroxine, Levoxyl, Synthroid"
    ]
  },
  {
    "id": "Medical-e1deaedc",
    "source": "Medical",
    "question": "Which molecular biomarkers should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy, and why?",
    "answer": "ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, and TMB-H should be tested to guide targeted therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biomarker testing is recommended for recurrent, advanced, or metastatic cancers not treatable with RAI",
      "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, TMB-H"
    ]
  },
  {
    "id": "Medical-ee644399",
    "source": "Medical",
    "question": "Why is lobectomy preferred over total thyroidectomy for some small, low-risk differentiated thyroid cancers?",
    "answer": "Lobectomy is preferred because it is sufficient for small, noninvasive tumors and avoids the need for lifelong thyroid hormone replacement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lobectomy is an option for small, low-risk differentiated thyroid cancers",
      "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers",
      "Thyroid hormone replacement therapy is required after total thyroidectomy"
    ]
  },
  {
    "id": "Medical-072545c5",
    "source": "Medical",
    "question": "What is the role of molecular tests in the management of thyroid nodules and how do they impact surgical decisions?",
    "answer": "Molecular tests help determine malignancy and the need for surgery in patients with suspicious thyroid nodules.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Molecular tests can help determine malignancy and need for surgery",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules"
    ]
  },
  {
    "id": "Medical-0e57f27f",
    "source": "Medical",
    "question": "When should a clinical trial be considered for a thyroid cancer patient, and what disease characteristics warrant this recommendation?",
    "answer": "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer, especially when standard treatments are ineffective.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer",
      "Metastasis Treatment: Clinical trial"
    ]
  },
  {
    "id": "Medical-c58fae3b",
    "source": "Medical",
    "question": "Which targeted therapies are approved for progressive, unresectable, or metastatic thyroid cancer, and what is their main indication?",
    "answer": "Lenvatinib, sorafenib, and cabozantinib are approved for progressive, unresectable, or metastatic thyroid cancer not responsive to surgery or RAI.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer",
      "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis"
    ]
  },
  {
    "id": "Medical-66e7fe35",
    "source": "Medical",
    "question": "Which diagnostic methods are necessary to confirm a case of Ewing sarcoma, and which biomarker supports the diagnosis?",
    "answer": "Diagnosis of Ewing sarcoma requires imaging tests and biopsy, with EWSR1-FLI1 fusion serving as a supporting biomarker.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy",
      "Ewing sarcoma: Diagnostic Method: [\"X-ray\", \"Bone scan\", \"CT scan\", \"MRI\", \"PET scan\", \"Biopsy\"]"
    ]
  },
  {
    "id": "Medical-47b62614",
    "source": "Medical",
    "question": "What is the appropriate targeted therapy for a patient with chondrosarcoma harboring an IDH1 mutation, and how is this mutation identified?",
    "answer": "Ivosidenib is the targeted therapy for chondrosarcoma with IDH1 mutation, which is identified through biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1)",
      "Chondrosarcoma: Treatment: [\"Ivosidenib (for IDH1 mutation)\"]"
    ]
  },
  {
    "id": "Medical-06055fa9",
    "source": "Medical",
    "question": "How does the TNM system integrate with tumor grade to determine the stage of primary bone cancer?",
    "answer": "The stage of primary bone cancer is determined by combining TNM scores and tumor grade.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)",
      "Tumor grade (G) describes histologic differentiation",
      "Stage is determined by combining T, N, M, and G scores"
    ]
  },
  {
    "id": "Medical-81c95a46",
    "source": "Medical",
    "question": "Which anatomic locations are most commonly associated with osteosarcoma and giant cell tumor of bone, and what do these locations have in common?",
    "answer": "Osteosarcoma commonly arises in the metaphysis near growth plates, and giant cell tumor of bone often occurs in the metaphysis and epiphysis; both involve the metaphysis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Osteosarcoma commonly arises in the metaphysis near growth plates",
      "Giant cell tumor of bone often occurs in the metaphysis and epiphysis",
      "Osteosarcoma: Anatomic Location: [\"Metaphysis\", \"Near growth plates\"]",
      "Giant cell tumor of bone (GCTB): Anatomic Location: [\"Metaphysis\", \"Epiphysis\"]"
    ]
  },
  {
    "id": "Medical-fe7f2575",
    "source": "Medical",
    "question": "What two performance status scales are considered when planning treatment for primary bone cancer?",
    "answer": "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status (ECOG or KPS) is considered in treatment planning",
      "Performance Status: [\"ECOG performance status\", \"Karnofsky Performance Status (KPS)\"]"
    ]
  },
  {
    "id": "Medical-ce635798",
    "source": "Medical",
    "question": "Which genetic alterations are characteristic of Ewing sarcoma, and by which diagnostic methods can these be detected?",
    "answer": "Ewing sarcoma is characterized by EWSR1-FLI1 and EWSR1-ERG fusions, detectable via biomarker testing such as PCR or next-generation sequencing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden",
      "Next-generation sequencing (NGS)",
      "Polymerase chain reaction (PCR)",
      "Ewing sarcoma: Biomarker: [\"EWSR1-FLI1 fusion\", \"EWSR1-ERG fusion\"]"
    ]
  },
  {
    "id": "Medical-b2b43c1e",
    "source": "Medical",
    "question": "Which bone sarcoma subtype is most likely to originate from cartilage-forming cells, and what biomarker is relevant for its targeted therapy?",
    "answer": "Chondrosarcoma originates from cartilage-forming cells and the IDH1 mutation is relevant for targeted therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chondrosarcoma starts in cartilage-forming cells",
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
      "Chondrosarcoma: Biomarker: [\"IDH1 mutation\"]"
    ]
  },
  {
    "id": "Medical-e6db1c4b",
    "source": "Medical",
    "question": "Which imaging modalities and biopsy types are recommended for the diagnosis of osteosarcoma?",
    "answer": "Diagnosis of osteosarcoma involves X-ray, bone scan, CT scan, MRI, PET scan, and either core needle or surgical biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Osteosarcoma: Diagnostic Method: [\"X-ray\", \"Bone scan\", \"CT scan\", \"MRI\", \"PET scan\", \"Biopsy\"]",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy"
    ]
  },
  {
    "id": "Medical-14d39f0c",
    "source": "Medical",
    "question": "What are the common symptoms and metabolic complications associated with bone cancer, and what causes the metabolic complication?",
    "answer": "Bone pain and hypercalcemia are common symptoms, with hypercalcemia caused by bone destruction.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bone cancer can cause hypercalcemia due to bone destruction",
      "Symptom: [\"Bone pain\", \"Hypercalcemia\"]"
    ]
  },
  {
    "id": "Medical-bce86fcf",
    "source": "Medical",
    "question": "How are germline mutations relevant to bone cancer risk, and what testing modality is used to identify them?",
    "answer": "Germline mutations are risk factors for bone cancer and can be identified by genetic cancer risk testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk",
      "Risk Factor: [\"Family history of cancer\", \"Germline mutations\"]"
    ]
  },
  {
    "id": "Medical-a6155d9a",
    "source": "Medical",
    "question": "Which systemic therapies may be considered for bone sarcoma patients with MSI-H, dMMR, or TMB-H, and what is the biomarker testing relevance?",
    "answer": "Pembrolizumab, nivolumab, or ipilimumab may be used for bone sarcoma patients with MSI-H, dMMR, or TMB-H identified by biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MSI-H/dMMR status may be treated with pembrolizumab",
      "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden"
    ]
  },
  {
    "id": "Medical-9b3c8ac0",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed before starting treatment for bone cancer in young patients?",
    "answer": "Some treatments for bone cancer can affect fertility, so fertility preservation should be discussed prior to treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment",
      "Fertility Consideration: [\"Fertility preservation\"]"
    ]
  },
  {
    "id": "Medical-4aed3e10",
    "source": "Medical",
    "question": "Which blood tests are included in the evaluation of bone cancer, and what is their collective purpose?",
    "answer": "Alkaline phosphatase, CBC, CMP, and LDH are used to evaluate bone cancer as part of blood tests.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation",
      "Blood tests: [\"Alkaline phosphatase\", \"CBC\", \"Comprehensive metabolic panel (CMP)\", \"Lactate dehydrogenase (LDH)\"]"
    ]
  },
  {
    "id": "Medical-641dcaf5",
    "source": "Medical",
    "question": "What distinguishes primary bone cancer from secondary bone malignancy in terms of origin and common cancer types?",
    "answer": "Primary bone cancer originates in bone or cartilage and includes sarcomas, while secondary bone malignancies are metastases from other organs such as breast, lung, or kidney.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary bone cancer originates in bone or cartilage",
      "Most primary bone cancers are sarcomas",
      "Secondary bone malignancies are cancers that have metastasized to bone from other organs",
      "Secondary bone malignancy: Origin: [\"Breast cancer\", \"Lung cancer\", \"Kidney cancer\"]"
    ]
  },
  {
    "id": "Medical-333a4a3b",
    "source": "Medical",
    "question": "Which bone sarcoma subtype is most likely to arise in the diaphysis or flat bones, and what genetic alteration is characteristic of this subtype?",
    "answer": "Ewing sarcoma most commonly arises in the diaphysis or flat bones and is characterized by the t(11;22) translocation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ewing sarcoma: Anatomic Location: [\"Diaphysis\", \"Flat bones (pelvis, scapula)\"]",
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Ewing sarcoma: Genetic Alteration: [\"t(11;22) translocation\"]"
    ]
  },
  {
    "id": "Medical-54cc91bf",
    "source": "Medical",
    "question": "Which diagnostic methods are needed to both confirm squamous cell carcinoma (SCC) in the mouth and assess its anatomical extent?",
    "answer": "Biopsy is required to confirm SCC diagnosis and imaging tests like CT, MRI, PET/CT, and ultrasound are used to assess anatomical extent.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biopsy is required to confirm diagnosis and determine histology",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
    ]
  },
  {
    "id": "Medical-ee09c8e9",
    "source": "Medical",
    "question": "Why is performance status (ECOG) considered in treatment selection for mouth cancer?",
    "answer": "Performance status (ECOG) is used to guide treatment selection based on the patient's ability to tolerate therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status (ECOG) is considered in treatment selection",
      "Clinical Assessment includes Performance status (ECOG) in the ontology for squamous cell carcinoma (SCC) of the mouth"
    ]
  },
  {
    "id": "Medical-27c72004",
    "source": "Medical",
    "question": "How do tobacco and alcohol use impact both the risk and outcomes of mouth cancer treatment?",
    "answer": "Tobacco and alcohol use increase the risk of mouth cancer and negatively affect treatment outcomes by increasing toxicity.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tobacco and alcohol use are risk factors for mouth cancer",
      "Smoking or vaping negatively affects treatment outcomes and increases toxicity"
    ]
  },
  {
    "id": "Medical-fe83d01e",
    "source": "Medical",
    "question": "What two assessments are necessary for comprehensive care due to the effects of mouth cancer and its treatment on dental health and swallowing?",
    "answer": "Dental exam and speech and swallowing assessment are necessary for comprehensive care.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Dental health is affected by head and neck cancer and its treatment",
      "Dental exam and speech and swallowing assessment are listed as diagnostic methods in the ontology"
    ]
  },
  {
    "id": "Medical-69bd1f37",
    "source": "Medical",
    "question": "Which biomarkers should be tested in a patient with SCC of the tongue to inform treatment options?",
    "answer": "PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB) should be tested.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)",
      "Biomarker includes PD-L1, MSI-H/dMMR, and TMB for SCC in the ontology"
    ]
  },
  {
    "id": "Medical-70db1204",
    "source": "Medical",
    "question": "How is the stage of mouth cancer determined using both tumor characteristics and lymph node involvement?",
    "answer": "Stage is determined by the TNM system, which includes tumor size and depth, lymph node involvement, and distant metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)",
      "TNM Classification includes T, N, and M parameters in the ontology for mouth cancer"
    ]
  },
  {
    "id": "Medical-b016ff7a",
    "source": "Medical",
    "question": "Why is depth of invasion (DOI) important in the TNM staging of mouth cancer?",
    "answer": "DOI is used to assess tumor extension and is a criterion in T classification for staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer",
      "TNM Classification uses DOI in the definitions for T1, T2, and T3 in the ontology"
    ]
  },
  {
    "id": "Medical-7dd235f1",
    "source": "Medical",
    "question": "What is the significance of extranodal extension in regional lymph nodes for mouth cancer staging?",
    "answer": "Extranodal extension indicates cancer spread outside the lymph node and affects staging and prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regional lymph node involvement includes extranodal extension",
      "Extranodal extension is defined as cancer spread outside lymph node in the ontology"
    ]
  },
  {
    "id": "Medical-5adcec8a",
    "source": "Medical",
    "question": "How do symptoms guide the use of imaging and biopsy in the diagnostic process for mouth cancer?",
    "answer": "Symptoms such as changes in the mouth, tongue, or neck area prompt the use of imaging and biopsy for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms may include changes in the mouth, tongue, or neck area",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Biopsy is required to confirm diagnosis and determine histology"
    ]
  },
  {
    "id": "Medical-25d1d605",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed with certain mouth cancer patients before treatment?",
    "answer": "Cancer and its treatment can affect fertility, so fertility preservation should be considered before therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cancer and its treatment can affect fertility",
      "Fertility preservation is included under Fertility Consideration in the ontology for SCC"
    ]
  },
  {
    "id": "Medical-2cc4ff58",
    "source": "Medical",
    "question": "For a patient with a tumor in the retromolar trigone, which cancer subtype and anatomic site categories are relevant for diagnosis and staging?",
    "answer": "The relevant cancer subtype is squamous cell carcinoma (SCC) and the anatomic site is the retromolar trigone.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer",
      "Mouth cancer can develop in the retromolar trigone",
      "Anatomic Site includes retromolar trigone for SCC in the ontology"
    ]
  },
  {
    "id": "Medical-48843076",
    "source": "Medical",
    "question": "How does the location and stage of a mouth tumor influence treatment planning?",
    "answer": "Treatment planning is based on both tumor location and stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment planning is based on tumor location and stage",
      "Stage and anatomic site are both specified under SCC in the ontology"
    ]
  },
  {
    "id": "Medical-aa9a54c8",
    "source": "Medical",
    "question": "Which diagnostic methods would be used to assess both lymph node involvement and distant metastasis in mouth cancer?",
    "answer": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used to assess lymph node involvement and distant metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Cancer staging is based on the TNM system, which includes lymph node involvement and distant metastasis"
    ]
  },
  {
    "id": "Medical-ec4712e3",
    "source": "Medical",
    "question": "Why is a panoramic dental x-ray (Panorex) included in diagnostic evaluation for mouth cancer?",
    "answer": "A Panorex is used to assess dental health, which is affected by mouth cancer and its treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Dental health is affected by head and neck cancer and its treatment",
      "Panoramic dental x-ray (Panorex) is listed as a diagnostic method in the ontology for SCC"
    ]
  },
  {
    "id": "Medical-299b8b83",
    "source": "Medical",
    "question": "How do risk factors and performance status together influence mouth cancer management?",
    "answer": "Risk factors like tobacco and alcohol use increase risk and affect outcomes, while performance status helps guide treatment selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tobacco and alcohol use are risk factors for mouth cancer",
      "Performance status (ECOG) is considered in treatment selection"
    ]
  },
  {
    "id": "Medical-2350fb33",
    "source": "Medical",
    "question": "What diagnostic methods should be employed to confirm a suspected case of metastatic stomach cancer with a family history of the disease?",
    "answer": "Imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing should be used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes",
      "Family history is a risk factor for stomach cancer"
    ]
  },
  {
    "id": "Medical-984c0f56",
    "source": "Medical",
    "question": "How does the spread of early-stage versus locoregional stomach cancer differ in terms of stomach wall invasion and lymph node involvement?",
    "answer": "Early-stage is confined to mucosa without lymph node involvement, while locoregional invades deeper layers and/or regional lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Early-stage stomach cancer: Confined to mucosa, not in lymph nodes (ontology rewritten)",
      "Locoregional stomach cancer: Invades other layers and/or regional lymph nodes or nearby organs (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-01abc791",
    "source": "Medical",
    "question": "Why is intestinal type adenocarcinoma more likely to benefit from targeted therapy compared to diffuse type?",
    "answer": "Because intestinal type more often has mutations treatable with targeted therapy, while diffuse type is less common and lacks these features.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy",
      "Diffuse type adenocarcinoma consists of scattered cells and is less common",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse"
    ]
  },
  {
    "id": "Medical-7faeddee",
    "source": "Medical",
    "question": "If a patient presents with an ulcer and mass in the stomach, what cancer subtype is most likely and what is the cell of origin?",
    "answer": "Adenocarcinoma, originating from mucus-secreting cells lining the stomach.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most stomach cancers are adenocarcinomas",
      "Adenocarcinomas originate from cells lining the inside of the stomach that secrete mucus",
      "Symptoms can include ulcer or mass formation in the stomach"
    ]
  },
  {
    "id": "Medical-ef429fbb",
    "source": "Medical",
    "question": "Which risk factors should be investigated in a patient with a suspected stomach mass and a positive genetic risk test?",
    "answer": "H. pylori infection and family history should be investigated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "H. pylori infection is a risk factor for stomach cancer",
      "Family history is a risk factor for stomach cancer",
      "Genetic risk testing is a diagnostic method for stomach cancer (ontology rewritten)",
      "Symptoms can include ulcer or mass formation in the stomach"
    ]
  },
  {
    "id": "Medical-370cff35",
    "source": "Medical",
    "question": "How does stomach cancer typically progress from a precancerous state to metastatic disease?",
    "answer": "It begins with mucosal changes, spreads outward through stomach wall layers, and eventually reaches distant organs like the liver.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Precancerous changes often occur in the mucosa before cancer develops",
      "Stomach cancer spreads outward through the layers of the stomach wall",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes"
    ]
  },
  {
    "id": "Medical-3e87c7a1",
    "source": "Medical",
    "question": "What anatomical locations are at risk for distant metastasis from stomach cancer and what is the typical spread pattern?",
    "answer": "The liver, peritoneum, distant lymph nodes, pancreas, and spleen are at risk due to distant spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes",
      "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen",
      "Distant spread pattern includes liver, peritoneum, distant lymph nodes, pancreas, and spleen (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-84ec68f0",
    "source": "Medical",
    "question": "Why is it important to perform both biomarker and genetic risk testing in the diagnosis of stomach cancer?",
    "answer": "Because diagnosis requires comprehensive assessment, including identification of treatable mutations and genetic risk factors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Intestinal type adenocarcinoma is more likely to have mutations treatable with targeted therapy",
      "Family history is a risk factor for stomach cancer"
    ]
  },
  {
    "id": "Medical-2157ec85",
    "source": "Medical",
    "question": "What features distinguish diffuse type adenocarcinoma from intestinal type in stomach cancer pathology?",
    "answer": "Diffuse type consists of scattered cells and is less common, while intestinal type forms tube- and gland-shaped structures.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy",
      "Diffuse type adenocarcinoma consists of scattered cells and is less common",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse"
    ]
  },
  {
    "id": "Medical-56e2a338",
    "source": "Medical",
    "question": "If a stomach cancer is found to be confined to the mucosa and there is no lymph node involvement, what is the stage and which stomach wall layer is affected?",
    "answer": "It is early-stage stomach cancer, affecting only the mucosa.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Early-stage stomach cancer: Confined to mucosa, not in lymph nodes (ontology rewritten)",
      "Mucosa is the innermost layer of the stomach wall (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-33af9785",
    "source": "Medical",
    "question": "What is the relationship between H. pylori infection, precancerous mucosal changes, and stomach cancer development?",
    "answer": "H. pylori infection is a risk factor that can lead to precancerous mucosal changes, which may progress to stomach cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "H. pylori infection is a risk factor for stomach cancer",
      "Precancerous changes often occur in the mucosa before cancer develops",
      "Stomach cancer is a type of cancer that arises in the stomach"
    ]
  },
  {
    "id": "Medical-7fba506d",
    "source": "Medical",
    "question": "How does the anatomical location within the stomach influence the potential spread of cancer to nearby organs?",
    "answer": "Tumors in any stomach region can invade adjacent organs such as the pancreas and spleen through local and distant spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Anatomical Location includes cardia, fundus, body, antrum, pylorus, and esophagogastric junction (ontology rewritten)",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen"
    ]
  },
  {
    "id": "Medical-032223d5",
    "source": "Medical",
    "question": "Why might a patient with a stomach mass and positive family history undergo genetic risk testing in addition to biopsy?",
    "answer": "Because family history is a genetic risk factor and diagnosis requires both tissue confirmation and risk assessment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history is a risk factor for stomach cancer",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Genetic risk testing is a diagnostic method for stomach cancer (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-d42f24b5",
    "source": "Medical",
    "question": "What is the sequence of diagnostic steps for a patient presenting with symptoms of ulcer or mass suspected to be stomach cancer?",
    "answer": "Imaging tests, endoscopy, and biopsy are performed, followed by biomarker and genetic risk testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms can include ulcer or mass formation in the stomach",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Biopsy is a diagnostic method for stomach cancer (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-c4772f49",
    "source": "Medical",
    "question": "How do the submucosa and muscle layer relate to the progression from early-stage to locoregional stomach cancer?",
    "answer": "Progression from early-stage to locoregional involves invasion beyond the mucosa into the submucosa and muscle layer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Stomach Wall Layer includes mucosa, submucosa, muscle layer, subserosa, and serosa (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-cb781b83",
    "source": "Medical",
    "question": "What sequence of diagnostic steps is required to confirm a glioma diagnosis and classify its grade and biomarker status?",
    "answer": "A neurological exam, imaging with MRI, and a biopsy for histology and molecular testing are required.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy",
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing",
      "Gliomas are classified by histology, grade, and biomarkers"
    ]
  },
  {
    "id": "Medical-6cb18929",
    "source": "Medical",
    "question": "Which glioma subtype is always considered high-grade and what diagnostic and treatment steps are typically involved?",
    "answer": "Glioblastoma is always high-grade (Grade 4) and requires MRI, biopsy, and additional therapy after surgery.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Glioblastoma is the most aggressive subtype of glioma",
      "Grade 4 gliomas are most commonly glioblastomas",
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing",
      "High-grade gliomas require additional therapy after surgery"
    ]
  },
  {
    "id": "Medical-569780c4",
    "source": "Medical",
    "question": "How is IDH mutation status relevant for classifying both astrocytoma and oligodendroglioma, and what procedure is necessary to determine this status?",
    "answer": "IDH mutation is a biomarker used to classify both astrocytoma and oligodendroglioma, and biopsy is necessary to determine this status.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "IDH mutation is a biomarker used to classify gliomas",
      "Astrocytoma and oligodendroglioma have IDH mutation as a biomarker",
      "Biopsy is required for definitive diagnosis and molecular testing"
    ]
  },
  {
    "id": "Medical-32b9ef93",
    "source": "Medical",
    "question": "If a patient presents with seizures and cognitive changes, what diagnostic methods should be prioritized and why?",
    "answer": "A neurological exam and MRI should be prioritized because these symptoms are common in glioma and MRI is the best imaging test.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy",
      "MRI is the most useful imaging test for identifying glioma"
    ]
  },
  {
    "id": "Medical-6f0e62e5",
    "source": "Medical",
    "question": "Why is follow-up with periodic MRI imaging recommended after treatment for glioma?",
    "answer": "Follow-up MRI is recommended to monitor for recurrence after glioma treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence",
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials"
    ]
  },
  {
    "id": "Medical-732c4e13",
    "source": "Medical",
    "question": "How does performance status influence treatment eligibility for glioma patients, and how is it assessed?",
    "answer": "Performance status is assessed clinically and determines eligibility for glioma treatments.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is assessed to determine treatment eligibility",
      "Clinical Evaluation includes performance status and neurological exam"
    ]
  },
  {
    "id": "Medical-889e2c6a",
    "source": "Medical",
    "question": "What factors contribute to a poorer prognosis in glioma patients, and how are these factors determined?",
    "answer": "High-grade glioma and glioblastoma contribute to poorer prognosis, determined by histology and grade from biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-grade gliomas have poorer prognosis",
      "Glioblastoma is the most aggressive subtype of glioma",
      "Gliomas are classified by histology, grade, and biomarkers",
      "Biopsy is required for definitive diagnosis and molecular testing"
    ]
  },
  {
    "id": "Medical-68c30458",
    "source": "Medical",
    "question": "What is the rationale for recommending molecular testing after a biopsy in glioma diagnosis?",
    "answer": "Molecular testing after biopsy is recommended to determine biomarker status and guide classification and treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biopsy is required for definitive diagnosis and molecular testing",
      "Gliomas are classified by histology, grade, and biomarkers",
      "IDH mutation is a biomarker used to classify gliomas"
    ]
  },
  {
    "id": "Medical-3a5fb7b0",
    "source": "Medical",
    "question": "Why are high-grade gliomas treated differently than low-grade gliomas following surgery?",
    "answer": "High-grade gliomas require additional therapy after surgery due to their aggressive nature, unlike low-grade gliomas.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-grade gliomas require additional therapy after surgery",
      "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas",
      "Glioblastoma is the most aggressive subtype of glioma"
    ]
  },
  {
    "id": "Medical-4191d4b2",
    "source": "Medical",
    "question": "Which two diagnostic methods are essential for both initial detection and definitive classification of glioma?",
    "answer": "MRI is essential for initial detection and biopsy for definitive classification of glioma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing"
    ]
  },
  {
    "id": "Medical-43a4d872",
    "source": "Medical",
    "question": "What symptoms in an adult patient should prompt evaluation for glioma using imaging and neurological examination?",
    "answer": "Symptoms like headache, seizures, and cognitive changes in adults should prompt MRI and neurological exam for glioma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Gliomas are more common in adults than children",
      "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy"
    ]
  },
  {
    "id": "Medical-9386f24f",
    "source": "Medical",
    "question": "How do grade and biomarker status together affect the classification of astrocytoma and oligodendroglioma?",
    "answer": "Grade and IDH mutation status are both required to classify astrocytoma and oligodendroglioma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Astrocytoma and oligodendroglioma have IDH mutation as a biomarker",
      "Gliomas are classified by histology, grade, and biomarkers",
      "Astrocytoma: Grade 1, 2, 3, 4; Oligodendroglioma: Grade 2, 3"
    ]
  },
  {
    "id": "Medical-91742d51",
    "source": "Medical",
    "question": "Why is glioblastoma associated with the worst prognosis among glioma subtypes?",
    "answer": "Glioblastoma is the most aggressive subtype and is always high-grade, leading to a poor prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Glioblastoma is the most aggressive subtype of glioma",
      "Grade 4 gliomas are most commonly glioblastomas",
      "High-grade gliomas have poorer prognosis"
    ]
  },
  {
    "id": "Medical-c6b862bd",
    "source": "Medical",
    "question": "What are the key risk factors for developing glioma, and how are these determined from the ontology?",
    "answer": "Key risk factors are age (more common in adults) and non-hereditary mutation, as indicated by the ontology.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Gliomas are more common in adults than children",
      "Most gliomas are not hereditary",
      "Risk Factor includes age (more common in adults) and non-hereditary mutation"
    ]
  },
  {
    "id": "Medical-39012a36",
    "source": "Medical",
    "question": "Which treatments may be considered for a glioma patient after surgical resection and how is this decision guided?",
    "answer": "Radiation therapy, chemotherapy, or clinical trials may be considered after surgery, guided by grade and performance status.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials",
      "High-grade gliomas require additional therapy after surgery",
      "Performance status is assessed to determine treatment eligibility"
    ]
  },
  {
    "id": "Medical-ca3e2437",
    "source": "Medical",
    "question": "Which diagnostic procedures are necessary to both confirm an AML diagnosis and determine the specific subtype?",
    "answer": "Bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, and molecular/cytogenetic testing are required.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment"
    ]
  },
  {
    "id": "Medical-ec84ae56",
    "source": "Medical",
    "question": "Why would a patient with FLT3-ITD mutated AML receive a targeted therapy in addition to chemotherapy?",
    "answer": "FLT3 inhibitors are used as targeted therapy for FLT3-mutated AML, which is treated alongside standard chemotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Targeted therapies are used for AML with specific genetic alterations, such as FLT3 inhibitors for FLT3-mutated AML",
      "Chemotherapy is the standard of care for AML",
      "Common genetic alterations in AML include FLT3-ITD"
    ]
  },
  {
    "id": "Medical-890965f6",
    "source": "Medical",
    "question": "What laboratory findings and symptoms together would strongly suggest a diagnosis of AML?",
    "answer": "The presence of 20% myeloblasts in bone marrow or blood along with symptoms such as fatigue, infections, bleeding, and bruising suggest AML.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood",
      "Symptoms of AML include fatigue, infections, bleeding, and bruising"
    ]
  },
  {
    "id": "Medical-2a61ebd2",
    "source": "Medical",
    "question": "How does the identification of the PML::RARA fusion gene influence both the classification and treatment of AML?",
    "answer": "Detection of PML::RARA classifies the AML as acute promyelocytic leukemia (APL), which is treated with chemotherapy and targeted therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
      "AML subtypes are defined by gene mutations or abnormal chromosomes",
      "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
      "Acute promyelocytic leukemia (APL) is treated with chemotherapy and targeted therapy"
    ]
  },
  {
    "id": "Medical-0a8d750c",
    "source": "Medical",
    "question": "What are the key factors influencing the selection of treatment in AML patients?",
    "answer": "Genetic alterations, performance status, and general health are key factors influencing treatment selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment",
      "Performance status and general health influence treatment selection",
      "Prognostic Factor includes genetic alterations and performance status"
    ]
  },
  {
    "id": "Medical-f6a94128",
    "source": "Medical",
    "question": "Which tests are essential to perform before starting systemic therapy in a young AML patient concerned about fertility?",
    "answer": "Fertility preservation counseling and referral to a reproductive specialist should be done before therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility preservation should be discussed before starting systemic therapy",
      "Fertility Preservation includes fertility preservation counseling and referral to reproductive specialist"
    ]
  },
  {
    "id": "Medical-4e39d9d5",
    "source": "Medical",
    "question": "What steps are necessary to diagnose and fully characterize an AML case with suspected extramedullary involvement?",
    "answer": "Diagnosis requires blood tests, bone marrow evaluation, flow cytometry, molecular/cytogenetic testing, and imaging (CT, MRI, PET/CT) for extramedullary disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Imaging (CT, MRI, PET/CT) is used to assess extramedullary disease or complications",
      "Diagnostic Method includes Imaging: CT scan, MRI, PET/CT"
    ]
  },
  {
    "id": "Medical-57f0c93d",
    "source": "Medical",
    "question": "Which combination of therapies may be considered for an AML patient with CD33-positive blasts and why?",
    "answer": "Chemotherapy plus gemtuzumab ozogamicin (GO), a targeted therapy for CD33-positive AML, may be used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Targeted therapies are used for AML with specific genetic alterations, such as gemtuzumab ozogamicin for CD33-positive AML",
      "Chemotherapy is the standard of care for AML",
      "Biomarker includes CD33"
    ]
  },
  {
    "id": "Medical-ddde0e24",
    "source": "Medical",
    "question": "For which AML patients is hematopoietic cell transplant considered and what factors influence this decision?",
    "answer": "Hematopoietic cell transplant is considered for eligible patients based on performance status, genetic alterations, and response to induction therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hematopoietic cell transplant is considered for eligible patients",
      "Prognostic Factor includes genetic alterations, performance status, and response to induction therapy"
    ]
  },
  {
    "id": "Medical-c57bf64d",
    "source": "Medical",
    "question": "How does family history affect AML risk assessment, and what additional steps should be taken in such cases?",
    "answer": "Family history increases AML risk due to hereditary predisposition, so genetic counseling and testing may be indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML",
      "Risk Factor includes family history of leukemia and leukemia predisposition syndrome"
    ]
  },
  {
    "id": "Medical-640a315c",
    "source": "Medical",
    "question": "Which supportive care interventions are necessary for an AML patient presenting with severe anemia and infection risk?",
    "answer": "Transfusions and infection prevention measures are necessary supportive care interventions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care includes transfusions, infection prevention, and management of side effects",
      "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells"
    ]
  },
  {
    "id": "Medical-669af50b",
    "source": "Medical",
    "question": "How does performance status impact the treatment plan for an AML patient?",
    "answer": "Performance status influences the selection and intensity of AML treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status and general health influence treatment selection",
      "Performance Status includes Eastern Cooperative Oncology Group (ECOG) score and Karnofsky Performance Status (KPS)"
    ]
  },
  {
    "id": "Medical-1ab31cd8",
    "source": "Medical",
    "question": "What combination of findings would support a diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN)?",
    "answer": "BPDCN diagnosis is supported by its aggressive nature, involvement of blood, bone marrow, lymph nodes, and skin, and its classification as an AML subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of AML",
      "Sites of Involvement for BPDCN include blood, bone marrow, lymph nodes, skin",
      "AML subtypes are defined by gene mutations or abnormal chromosomes"
    ]
  },
  {
    "id": "Medical-575e6d7f",
    "source": "Medical",
    "question": "Which phases make up the standard treatment course for AML and what is their primary goal?",
    "answer": "Induction, consolidation, and maintenance phases make up AML treatment, aiming for remission.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for AML is delivered in phases with the goal of achieving remission",
      "Treatment Phase includes induction, consolidation, and maintenance"
    ]
  },
  {
    "id": "Medical-ee302181",
    "source": "Medical",
    "question": "Why is it important to perform both flow cytometry and molecular testing in newly diagnosed AML?",
    "answer": "Both tests are essential to identify cell surface markers and genetic alterations for accurate classification and treatment guidance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment"
    ]
  },
  {
    "id": "Medical-54a3a465",
    "source": "Medical",
    "question": "Which maintenance therapies are recommended for a patient with advanced ovarian cancer who is BRCA-mutated after initial treatment?",
    "answer": "PARP inhibitors such as olaparib, niraparib, or rucaparib are recommended as maintenance therapy for advanced or BRCA-mutated ovarian cancer after initial treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment",
      "BRCA1 and BRCA2 mutations are major hereditary risk factors for ovarian cancer",
      "Olaparib (Lynparza), Niraparib (Zejula), and Rucaparib (Rubraca) are listed as maintenance therapy options in the ontology"
    ]
  },
  {
    "id": "Medical-8f1032c7",
    "source": "Medical",
    "question": "What diagnostic steps should be taken for a woman presenting with persistent bloating and pelvic pain suggestive of ovarian cancer?",
    "answer": "Imaging such as ultrasound or CT, abdominal and pelvic exam, biopsy, and tumor marker blood tests should be performed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers",
      "Common symptoms of ovarian cancer include bloating and pelvic or abdominal pain",
      "The ontology lists 'persistent bloating' and 'pelvic pain' as symptoms and includes diagnostic methods such as imaging, biopsy, and tumor marker tests"
    ]
  },
  {
    "id": "Medical-ffffe4b8",
    "source": "Medical",
    "question": "How is platinum-resistant ovarian cancer managed differently from platinum-sensitive recurrence?",
    "answer": "Platinum-resistant disease is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies, while platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab and secondary cytoreductive surgery.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors",
      "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery",
      "The ontology specifies different treatment regimens for platinum-sensitive and platinum-resistant recurrence"
    ]
  },
  {
    "id": "Medical-2521e4dd",
    "source": "Medical",
    "question": "Why is genetic testing for BRCA mutations recommended for all ovarian cancer patients?",
    "answer": "Because BRCA mutations are major hereditary risk factors and influence eligibility for targeted therapies such as PARP inhibitors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer",
      "BRCA1 and BRCA2 mutations are major hereditary risk factors for ovarian cancer",
      "Maintenance therapy with PARP inhibitors is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment"
    ]
  },
  {
    "id": "Medical-884a8392",
    "source": "Medical",
    "question": "Which cancers are managed similarly to ovarian cancer and why might their management overlap?",
    "answer": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer due to shared origin and treatment protocols.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer",
      "The ontology lists primary peritoneal cancer and fallopian tube cancer as related cancers under ovarian cancer"
    ]
  },
  {
    "id": "Medical-e851fe04",
    "source": "Medical",
    "question": "What factors determine the use of fertility-sparing surgery in ovarian cancer patients?",
    "answer": "Fertility-sparing surgery is considered for select early-stage cases, depending on stage and patient fertility desires.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility-sparing surgery may be considered for select early-stage cases",
      "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging",
      "The ontology lists surgical procedures and stages relevant to ovarian cancer"
    ]
  },
  {
    "id": "Medical-6e8f1b95",
    "source": "Medical",
    "question": "Which tumor markers should be monitored during surveillance after ovarian cancer treatment?",
    "answer": "CA-125 or other tumor markers such as HE4, CEA, and CA 19-9 should be monitored during surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers",
      "The ontology lists CA-125, HE4, CEA, and CA 19-9 as tumor markers for ovarian cancer"
    ]
  },
  {
    "id": "Medical-18fc35e5",
    "source": "Medical",
    "question": "What are the recommended initial treatments for most stages of epithelial ovarian cancer?",
    "answer": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) followed by chemotherapy (typically paclitaxel and carboplatin) is recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers",
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages",
      "Epithelial ovarian cancer is the most common type of ovarian cancer"
    ]
  },
  {
    "id": "Medical-eb042e58",
    "source": "Medical",
    "question": "Which biomarkers are tested to determine eligibility for targeted therapies in ovarian cancer?",
    "answer": "BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion are tested.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion",
      "The ontology lists these as genetic alterations or biomarkers for ovarian cancer"
    ]
  },
  {
    "id": "Medical-6bed629f",
    "source": "Medical",
    "question": "How does the management of recurrent ovarian cancer differ based on platinum sensitivity?",
    "answer": "Platinum-sensitive recurrence is managed with platinum-based chemotherapy and possibly surgery, while platinum-resistant recurrence uses non-platinum chemotherapy or targeted agents.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment",
      "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery",
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies"
    ]
  },
  {
    "id": "Medical-0be2176d",
    "source": "Medical",
    "question": "Why might a patient with FR-positive platinum-resistant ovarian cancer be treated with mirvetuximab soravtansine-gynx?",
    "answer": "Mirvetuximab soravtansine-gynx is a targeted therapy specifically indicated for FR-positive platinum-resistant ovarian cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors",
      "Folate receptor alpha (FR) is listed as a genetic alteration/biomarker in the ontology"
    ]
  },
  {
    "id": "Medical-45847608",
    "source": "Medical",
    "question": "Which hereditary syndromes increase the risk for ovarian cancer and how does this affect patient management?",
    "answer": "BRCA1, BRCA2 mutations, and Lynch syndrome increase risk and prompt genetic testing and consideration of targeted therapies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer",
      "Maintenance therapy with PARP inhibitors is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment"
    ]
  },
  {
    "id": "Medical-4e5d3831",
    "source": "Medical",
    "question": "What role does imaging play in the diagnosis and surveillance of ovarian cancer?",
    "answer": "Imaging is used for initial diagnosis (ultrasound, CT, MRI, PET) and for surveillance as indicated after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET)",
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers, and imaging as indicated",
      "The ontology lists imaging modalities under diagnostic methods and surveillance"
    ]
  },
  {
    "id": "Medical-d7765001",
    "source": "Medical",
    "question": "Which symptoms should prompt evaluation for possible ovarian cancer using tumor markers and imaging?",
    "answer": "Symptoms such as persistent bloating, pelvic pain, trouble eating, and urinary urgency should prompt evaluation with tumor markers and imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex",
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers"
    ]
  },
  {
    "id": "Medical-e2bcebf4",
    "source": "Medical",
    "question": "When is enrollment in a clinical trial particularly recommended for ovarian cancer patients?",
    "answer": "Clinical trial enrollment is recommended for recurrent or persistent ovarian cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are recommended for recurrent or persistent ovarian cancer",
      "The ontology lists clinical trial enrollment for recurrent or persistent disease"
    ]
  },
  {
    "id": "Medical-22b8a5ee",
    "source": "Medical",
    "question": "How is small lymphocytic lymphoma (SLL) differentiated from chronic lymphocytic leukemia (CLL) in terms of primary site and diagnostic approach?",
    "answer": "SLL primarily affects lymph nodes and spleen, while CLL affects blood and bone marrow, and both require blood tests and biopsies for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen",
      "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes",
      "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "In the ontology, SLL is listed under CLL as a subtype with primary sites of lymph nodes and spleen, while CLL's primary sites are blood and bone marrow"
    ]
  },
  {
    "id": "Medical-eab49131",
    "source": "Medical",
    "question": "Which diagnostic tests are necessary to confirm CLL and detect prognostic biomarkers, and why are multiple methods needed?",
    "answer": "Blood test, flow cytometry, FISH, DNA sequencing, and karyotype are all needed to confirm CLL and identify prognostic biomarkers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "In the ontology, diagnostic methods for CLL include blood test, flow cytometry, FISH, DNA sequencing, and karyotype"
    ]
  },
  {
    "id": "Medical-223def84",
    "source": "Medical",
    "question": "What factors determine whether a newly diagnosed CLL patient should begin treatment immediately or undergo watchful waiting?",
    "answer": "Treatment is based on symptoms, blood counts, and disease progression, so asymptomatic or stable patients may be managed with watch and wait.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression",
      "Follow-up strategies include watch and wait, regular monitoring, and supportive care",
      "CLL may be asymptomatic and discovered incidentally on routine blood testing"
    ]
  },
  {
    "id": "Medical-48e987ed",
    "source": "Medical",
    "question": "How do risk factors and symptoms together contribute to the early detection of CLL?",
    "answer": "Older age and family history increase risk, and the presence of symptoms like swollen glands or incidental findings on blood tests aid early detection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors for CLL include older age and family history of CLL",
      "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss",
      "CLL may be asymptomatic and discovered incidentally on routine blood testing"
    ]
  },
  {
    "id": "Medical-c92bbd26",
    "source": "Medical",
    "question": "Why is immunophenotyping by flow cytometry essential in the diagnosis of CLL?",
    "answer": "It identifies CLL cells by their surface proteins (CD20, CD200, LEF1), confirming the diagnosis after initial blood tests.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "In the ontology, flow cytometry with immunophenotype markers is a diagnostic method for CLL"
    ]
  },
  {
    "id": "Medical-2ebcf55d",
    "source": "Medical",
    "question": "What is the clinical significance of detecting a 17p deletion or TP53 mutation in CLL patients?",
    "answer": "Detection of 17p deletion or TP53 mutation indicates poorer prognosis and guides treatment selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "In the ontology, 17p deletion and TP53 mutation are listed as biomarkers for CLL"
    ]
  },
  {
    "id": "Medical-a7fb4f11",
    "source": "Medical",
    "question": "How does the management plan for CLL change if a patient develops Richter transformation?",
    "answer": "Richter transformation requires a shift to therapies targeting aggressive lymphomas such as DLBCL or Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma",
      "In the ontology, Richter transformation is a complication of CLL with subtypes DLBCL and Hodgkin lymphoma"
    ]
  },
  {
    "id": "Medical-ce7076ea",
    "source": "Medical",
    "question": "Why is a comprehensive metabolic panel and assessment of performance status important before starting CLL treatment?",
    "answer": "These assessments help guide treatment planning and ensure patient suitability for specific therapies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status and comprehensive metabolic panel are used in treatment planning",
      "In the ontology, performance status and comprehensive metabolic panel are listed under clinical management and diagnostic methods for CLL"
    ]
  },
  {
    "id": "Medical-6108fa72",
    "source": "Medical",
    "question": "What follow-up strategies are recommended for CLL patients not requiring immediate therapy, and what is their purpose?",
    "answer": "Watch and wait, regular monitoring, and supportive care are used to track disease progression and manage symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up strategies include watch and wait, regular monitoring, and supportive care",
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression"
    ]
  },
  {
    "id": "Medical-56131016",
    "source": "Medical",
    "question": "How do family history and older age together influence the risk and screening approach for CLL?",
    "answer": "Both increase CLL risk, so older individuals with a family history may warrant closer monitoring for early detection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors for CLL include older age and family history of CLL",
      "Family history increases the risk of developing CLL"
    ]
  },
  {
    "id": "Medical-1e7500e4",
    "source": "Medical",
    "question": "What combination of tests would be used to assess both disease burden and prognosis in CLL?",
    "answer": "CBC, beta-2 microglobulin, biomarker testing (FISH, DNA sequencing, karyotype), and diagnostic CT scan assess disease burden and prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "Diagnostic CT scans may be used to assess lymph node involvement and disease extent"
    ]
  },
  {
    "id": "Medical-29a8ae2e",
    "source": "Medical",
    "question": "Why might a pregnancy test and fertility preservation be considered in the management of CLL?",
    "answer": "They are considered before starting treatment to address potential impacts of therapy on fertility and pregnancy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pregnancy testing and fertility preservation are considered before starting treatment",
      "In the ontology, pregnancy test and fertility preservation are listed under clinical management for CLL"
    ]
  },
  {
    "id": "Medical-3776fc3d",
    "source": "Medical",
    "question": "How does achieving minimal residual disease status affect the prognosis and management of CLL?",
    "answer": "Minimal residual disease indicates mostly healthy blood cells and is a treatment goal associated with better prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Minimal residual disease is a treatment goal indicating mostly healthy blood cells",
      "In the ontology, minimal residual disease is listed as a disease stage for CLL"
    ]
  },
  {
    "id": "Medical-836e7db0",
    "source": "Medical",
    "question": "Which symptoms, when present together, would most strongly suggest CLL as a diagnosis requiring further blood and immunophenotyping tests?",
    "answer": "Swollen glands, fatigue, and recurrent infections together should prompt CLL workup with blood test and flow cytometry.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy"
    ]
  },
  {
    "id": "Medical-1852bc75",
    "source": "Medical",
    "question": "What is the rationale for using both oral medications and IV infusions in the treatment of CLL?",
    "answer": "Combination therapy using oral and IV drugs may be required for optimal disease control based on disease progression and patient factors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment options include oral medications, IV infusions, and combination therapies",
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression"
    ]
  },
  {
    "id": "Medical-8ac49b5b",
    "source": "Medical",
    "question": "Which biomarker must be tested in all patients diagnosed with oropharyngeal cancer, and what is its clinical significance?",
    "answer": "p16 (HPV) testing must be performed in all oropharyngeal cancer patients as it serves as a surrogate biomarker for HPV-mediated disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer"
    ]
  },
  {
    "id": "Medical-cf2fbd21",
    "source": "Medical",
    "question": "How do risk factors for oropharyngeal squamous cell carcinoma differ from those for head and neck cancers in general?",
    "answer": "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma, while tobacco and alcohol use are risk factors for head and neck cancers in general.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma",
      "Tobacco and alcohol use are risk factors for head and neck cancers"
    ]
  },
  {
    "id": "Medical-30e7caf0",
    "source": "Medical",
    "question": "Which diagnostic methods are required to confirm throat cancer and determine its biomarkers?",
    "answer": "Imaging studies and biopsy are required for diagnosis, and biopsy enables biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Biopsy is required for definitive diagnosis and biomarker testing"
    ]
  },
  {
    "id": "Medical-ab708cf8",
    "source": "Medical",
    "question": "What anatomical sites are included under oropharyngeal cancer, and how does this relate to the diagnosis of throat cancer?",
    "answer": "Oropharyngeal cancer includes the soft palate, tonsils, base of tongue, and side and back walls of the throat, which are common sites where throat cancer arises.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Oropharyngeal cancer is a subtype of throat cancer",
      "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue"
    ]
  },
  {
    "id": "Medical-321f2f6d",
    "source": "Medical",
    "question": "What staging system is used for throat cancer, and which parameters does it incorporate?",
    "answer": "The AJCC TNM system is used, incorporating tumor size (T), lymph node involvement (N), and metastasis (M).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)",
      "AJCC TNM staging includes Tis, T1, T2, T3, T4a, and T4b for tumor classification"
    ]
  },
  {
    "id": "Medical-95bdfdba",
    "source": "Medical",
    "question": "Which symptoms should prompt consideration of throat cancer and subsequent diagnostic evaluation?",
    "answer": "Difficulty swallowing, sore throat, and voice changes should prompt evaluation for throat cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
    ]
  },
  {
    "id": "Medical-1892185a",
    "source": "Medical",
    "question": "What is the role of p16 protein in distinguishing subtypes of squamous cell carcinoma in the oropharynx?",
    "answer": "p16 protein overexpression identifies HPV-mediated squamous cell carcinoma in the oropharynx.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer",
      "Squamous cell carcinoma is the most common type of throat cancer"
    ]
  },
  {
    "id": "Medical-ade34649",
    "source": "Medical",
    "question": "Which diagnostic procedures are used for tissue sampling in throat cancer, and why are they important?",
    "answer": "Fine-needle aspiration, core needle biopsy, and endoscopic biopsies are used to obtain tissue for definitive diagnosis and biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling",
      "Biopsy is required for definitive diagnosis and biomarker testing"
    ]
  },
  {
    "id": "Medical-cd4d3dd1",
    "source": "Medical",
    "question": "What factors are considered prognostic in treatment planning for throat cancer?",
    "answer": "ECOG performance status and HPV/p16 status are prognostic factors in treatment planning.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status (ECOG) is a prognostic factor considered in treatment planning",
      "HPV/p16 status is a prognostic factor for throat cancer"
    ]
  },
  {
    "id": "Medical-6624a28a",
    "source": "Medical",
    "question": "How is clinical stage of throat cancer determined prior to treatment?",
    "answer": "Clinical stage is determined by physical exam, imaging, and biopsy before treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical stage is determined before treatment using physical exam, imaging, and biopsy",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
    ]
  },
  {
    "id": "Medical-60acb9ee",
    "source": "Medical",
    "question": "Which patients with throat cancer should undergo dental health assessment and why?",
    "answer": "All patients should have dental health assessment before treatment as dental health impacts treatment planning and outcomes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Dental health assessment is important before treatment",
      "Surveillance includes dental health assessment"
    ]
  },
  {
    "id": "Medical-ac502742",
    "source": "Medical",
    "question": "How can PD-L1 expression influence the treatment of throat cancer?",
    "answer": "PD-L1 expression may guide immunotherapy treatment decisions in throat cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PD-L1 expression may guide immunotherapy treatment decisions",
      "Biomarker testing includes PD-L1"
    ]
  },
  {
    "id": "Medical-6e4da4de",
    "source": "Medical",
    "question": "What are the main routes of metastasis in throat cancer and which distant sites are commonly involved?",
    "answer": "Throat cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine",
      "Metastasis includes lungs, liver, and spine"
    ]
  },
  {
    "id": "Medical-b6f1658b",
    "source": "Medical",
    "question": "What is the relationship between HPV status and the recommended biomarker testing in oropharyngeal cancer?",
    "answer": "HPV status is assessed by p16 (HPV) testing, which is recommended for all oropharyngeal cancer patients.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer"
    ]
  },
  {
    "id": "Medical-a0a1a141",
    "source": "Medical",
    "question": "Which imaging modalities are used for both diagnosis and staging of throat cancer, and what is their role?",
    "answer": "CT scan, MRI, PET/CT, and ultrasound are used for both diagnosis and staging to assess tumor extent and spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)"
    ]
  },
  {
    "id": "Medical-6e3e48fa",
    "source": "Medical",
    "question": "Which diagnostic procedures are essential for confirming a case of cutaneous B-cell lymphoma presenting with skin nodules?",
    "answer": "Skin exam, blood tests, imaging tests, biopsy, and immunophenotyping are essential for confirming CBCL with nodules.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Symptoms of CBCL include skin nodules and papules"
    ]
  },
  {
    "id": "Medical-2529e505",
    "source": "Medical",
    "question": "What distinguishes cutaneous B-cell lymphoma from cutaneous T-cell lymphoma in terms of cell of origin and cancer subtype?",
    "answer": "CBCL originates from B lymphocytes and includes subtypes like PCMZL, PCFCL, and PC-DLBCL leg type, while CTCL originates from T lymphocytes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
    ]
  },
  {
    "id": "Medical-68e55e0e",
    "source": "Medical",
    "question": "If a patient has papules under the skin and is diagnosed with a lymphoma subtype originating from B lymphocytes, which subtypes should be considered?",
    "answer": "Primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "CBCL appears as nodules or papules under the skin",
      "CBCL starts in B cells"
    ]
  },
  {
    "id": "Medical-8d55a40b",
    "source": "Medical",
    "question": "Which cancer type is characterized by the development of abnormal lymphocytes in the skin and can originate from either B or T cells?",
    "answer": "Primary cutaneous lymphoma (PCL) is characterized by abnormal lymphocytes in the skin and can originate from B or T cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "PCL develops from abnormal B or T lymphocytes"
    ]
  },
  {
    "id": "Medical-8233f77f",
    "source": "Medical",
    "question": "What laboratory and tissue-based tests are required to assess both biomarkers and genetic alterations in cutaneous B-cell lymphoma?",
    "answer": "Biopsy and immunophenotyping are required to assess biomarkers and genetic changes in CBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes"
    ]
  },
  {
    "id": "Medical-bc622c63",
    "source": "Medical",
    "question": "How does the unregulated growth of lymphocytes relate to the development of cutaneous B-cell lymphoma?",
    "answer": "Unregulated growth of B lymphocytes can develop into CBCL, a subtype of primary cutaneous lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Unregulated growth of lymphocytes can develop into lymphoma",
      "CBCL starts in B cells",
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin"
    ]
  },
  {
    "id": "Medical-de3d6946",
    "source": "Medical",
    "question": "Which diagnostic methods would be most informative for differentiating between cutaneous B-cell and T-cell lymphomas?",
    "answer": "Immunophenotyping and biopsy are most informative for differentiating CBCL from CTCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
    ]
  },
  {
    "id": "Medical-5f54bb84",
    "source": "Medical",
    "question": "What symptoms and diagnostic findings would prompt a clinician to test for biomarkers and genetic changes in a suspected case of CBCL?",
    "answer": "The presence of skin nodules or papules and findings from biopsy or immunophenotyping would prompt biomarker and genetic testing in suspected CBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CBCL appears as nodules or papules under the skin",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes"
    ]
  },
  {
    "id": "Medical-618ab93c",
    "source": "Medical",
    "question": "If a patient is diagnosed with a slow-growing primary cutaneous lymphoma of B-cell origin, which subtypes are likely?",
    "answer": "Primary cutaneous marginal zone lymphoma and primary cutaneous follicle center lymphoma are likely, as most CBCLs are indolent.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most primary cutaneous B-cell lymphomas are indolent or slow-growing",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "CBCL starts in B cells"
    ]
  },
  {
    "id": "Medical-bb678310",
    "source": "Medical",
    "question": "What is the hierarchical relationship between non-Hodgkin lymphoma, primary cutaneous lymphoma, and cutaneous B-cell lymphoma?",
    "answer": "Cutaneous B-cell lymphoma is a subtype of primary cutaneous lymphoma, which is a form of non-Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "CBCL is a subtype of primary cutaneous lymphoma according to the ontology"
    ]
  },
  {
    "id": "Medical-58981bbb",
    "source": "Medical",
    "question": "What combination of cell type and clinical presentation would suggest a diagnosis of cutaneous B-cell lymphoma rather than T-cell lymphoma?",
    "answer": "A neoplasm originating from B lymphocytes presenting as nodules or papules under the skin suggests cutaneous B-cell lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CBCL starts in B cells",
      "CBCL appears as nodules or papules under the skin",
      "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
    ]
  },
  {
    "id": "Medical-63b4b70c",
    "source": "Medical",
    "question": "Which subtypes of cutaneous B-cell lymphoma should be considered when a biopsy confirms B-cell origin in a patient with skin papules?",
    "answer": "Primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "CBCL starts in B cells",
      "CBCL appears as nodules or papules under the skin"
    ]
  },
  {
    "id": "Medical-d163acf5",
    "source": "Medical",
    "question": "How does the function of lymphocytes as white blood cells relate to the pathogenesis of cutaneous B-cell lymphoma?",
    "answer": "Lymphocytes are white blood cells that help fight infection, and their unregulated growth can lead to cutaneous B-cell lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lymphocytes are a type of white blood cell that help fight infection",
      "Unregulated growth of lymphocytes can develop into lymphoma",
      "CBCL starts in B cells"
    ]
  },
  {
    "id": "Medical-2a24f6a2",
    "source": "Medical",
    "question": "Which methods are used to confirm both the presence and subtype of cutaneous B-cell lymphoma in a patient with skin lesions?",
    "answer": "Biopsy and immunophenotyping are used to confirm both the presence and subtype of CBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)"
    ]
  },
  {
    "id": "Medical-417cbcfd",
    "source": "Medical",
    "question": "What is the connection between the assessment of biomarkers/genetic changes and the selection of diagnostic methods in CBCL?",
    "answer": "Assessment of biomarkers and genetic changes in CBCL requires diagnostic methods like biopsy and immunophenotyping.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
    ]
  },
  {
    "id": "Medical-6a1c421a",
    "source": "Medical",
    "question": "What diagnostic procedures are essential for confirming ALL in children and why are multiple tests necessary?",
    "answer": "Blood tests, bone marrow tests, imaging tests, heart tests, lumbar puncture, biomarker testing, and pharmacogenomic testing are all necessary because diagnosis requires both identifying lymphoblasts and assessing disease extent and subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-4777cfbb",
    "source": "Medical",
    "question": "Why would a child with an enlarged thymus and breathing problems be evaluated for T-cell ALL rather than B-cell ALL?",
    "answer": "Because T-cell ALL can cause an enlarged thymus leading to breathing problems, whereas these symptoms are not associated with B-cell ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL"
    ]
  },
  {
    "id": "Medical-88e1fb4a",
    "source": "Medical",
    "question": "How does the treatment approach differ for mature B-cell ALL (Burkitt leukemia) compared to other B-cell ALL subtypes in children?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL, requiring a distinct therapeutic protocol.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL",
      "B-cell ALL (B-ALL) starts in B-cell lymphocytes and is more common than T-ALL",
      "B-cell ALL (B-ALL) has a variant called Mature B-cell ALL (Burkitt leukemia)"
    ]
  },
  {
    "id": "Medical-2ca88e8f",
    "source": "Medical",
    "question": "What factors determine the specific treatment regimen for a pediatric ALL patient?",
    "answer": "Treatment for ALL depends on subtype, age at diagnosis, and other factors such as biomarkers and genetic alterations.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies"
    ]
  },
  {
    "id": "Medical-213847bd",
    "source": "Medical",
    "question": "Why is clinical trial enrollment especially considered for certain B-ALL and T-ALL cases in children?",
    "answer": "Clinical trials are preferred for certain B-ALL and T-ALL cases to provide access to novel therapies and tailored treatment approaches.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are preferred for certain B-ALL and T-ALL cases",
      "B-cell ALL (B-ALL) and T-cell ALL (T-ALL) are subtypes of ALL",
      "ALL treatment includes clinical trial as an option"
    ]
  },
  {
    "id": "Medical-1a56336a",
    "source": "Medical",
    "question": "What distinguishes B-cell lymphoblastic lymphoma (B-LL, B-LBL) from B-cell ALL in terms of disease site?",
    "answer": "B-cell lymphoblastic lymphoma is characterized by B-cell lymphoblasts growing in lymph nodes, whereas B-cell ALL primarily involves bone marrow and blood.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)",
      "Acute lymphoblastic leukemia (ALL) can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "B-cell ALL (B-ALL) starts in B-cell lymphocytes"
    ]
  },
  {
    "id": "Medical-a4ac550d",
    "source": "Medical",
    "question": "What is the rationale for using both steroids and multiagent chemotherapy in the treatment of all pediatric ALL patients?",
    "answer": "All patients receive steroids and multiagent chemotherapy to target lymphoblasts and maximize treatment efficacy regardless of subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
      "B-cell ALL (B-ALL) and T-cell ALL (T-ALL) both list steroids and multiagent chemotherapy as treatment"
    ]
  },
  {
    "id": "Medical-4d6219bc",
    "source": "Medical",
    "question": "Why is pharmacogenomic and biomarker testing important in the management of pediatric ALL?",
    "answer": "Pharmacogenomic and biomarker testing guide treatment decisions and help tailor therapies for optimal outcomes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
      "Diagnostic Method for ALL includes biomarker testing and pharmacogenomic testing"
    ]
  },
  {
    "id": "Medical-ef073c61",
    "source": "Medical",
    "question": "What age group is most commonly affected by ALL and how does this influence diagnostic and treatment strategies?",
    "answer": "Children, adolescents, and young adults are most often affected, requiring age-specific diagnostic and treatment approaches.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALL is the most common cancer diagnosed in children",
      "ALL most often affects children, adolescents, and young adults (AYAs)",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-99964376",
    "source": "Medical",
    "question": "Why would a lumbar puncture be performed in the diagnostic workup of a child with ALL?",
    "answer": "A lumbar puncture is performed to assess central nervous system (CNS) involvement, a potential disease site in ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "Lumbar puncture is listed as a diagnostic method for ALL"
    ]
  },
  {
    "id": "Medical-cdce534a",
    "source": "Medical",
    "question": "In what situation would a pediatric ALL patient receive supportive care in addition to systemic therapy?",
    "answer": "Supportive care is given alongside systemic therapy to manage side effects and complications during ALL treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Systemic therapy and supportive care are part of ALL treatment",
      "Treatment for ALL includes systemic therapy and supportive care",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy"
    ]
  },
  {
    "id": "Medical-1f7241a3",
    "source": "Medical",
    "question": "How does the presence of BCR::ABL1-positive status in B-ALL affect treatment choice in children?",
    "answer": "BCR::ABL1-positive B-ALL requires intensive systemic therapies compared to other B-ALL cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
      "B-cell ALL (B-ALL) has a biomarker called BCR::ABL1-positive",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-d186c439",
    "source": "Medical",
    "question": "What distinguishes T-cell lymphoblastic lymphoma (T-LL, T-LBL) from T-cell ALL in terms of disease location?",
    "answer": "T-cell lymphoblastic lymphoma involves T-cell lymphoblasts growing in the thymus, while T-cell ALL primarily involves bone marrow and blood.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)",
      "Acute lymphoblastic leukemia (ALL) can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "T-cell ALL (T-ALL) starts in T-cell lymphocytes"
    ]
  },
  {
    "id": "Medical-222ee61b",
    "source": "Medical",
    "question": "Why is the diagnostic threshold of 20 percent or more lymphoblasts in bone marrow important for ALL diagnosis?",
    "answer": "It ensures that the diagnosis of ALL is based on a significant proportion of malignant lymphoblasts in the bone marrow.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
      "Bone marrow test is a diagnostic method for ALL"
    ]
  },
  {
    "id": "Medical-c650bba8",
    "source": "Medical",
    "question": "How does the treatment of infant ALL differ from that of older children or adolescents?",
    "answer": "Infant ALL (under 12 months) is treated differently than other age groups, with specialized protocols.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Infant ALL (under 12 months) is treated differently than other age groups",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Age Group for ALL includes infant, child, adolescent, and young adult (AYA)"
    ]
  },
  {
    "id": "Medical-50fe4cfa",
    "source": "Medical",
    "question": "Why should all rectal tumors be tested for mismatch repair deficiency or microsatellite instability-high, especially in patients with Lynch syndrome?",
    "answer": "Because dMMR/MSI-H are biomarkers for rectal cancer and Lynch syndrome is a genetic risk factor, making testing essential for management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All rectal tumors should be tested for dMMR or MSI-H",
      "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer",
      "Lynch syndrome is a genetic risk factor for rectal cancer"
    ]
  },
  {
    "id": "Medical-ac73c113",
    "source": "Medical",
    "question": "What combination of diagnostic tools is recommended for staging and detecting metastasis in rectal cancer?",
    "answer": "MRI of the pelvis and CT scan of chest and abdomen are recommended for staging and detecting metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI of the pelvis is recommended for staging rectal cancer",
      "CT scan of chest and abdomen is used to detect metastasis",
      "Rectal cancer diagnostic methods include MRI and CT scan"
    ]
  },
  {
    "id": "Medical-f7ce6257",
    "source": "Medical",
    "question": "How does the treatment approach differ between T1 and T2 rectal tumors according to surgical recommendations?",
    "answer": "T1 tumors are treated with local excision or endoscopic methods, while T2 tumors require transabdominal surgery.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors",
      "Transanal local excision is an option for T1 tumors at the end of the rectum",
      "Transabdominal surgery is recommended for T2 and some T1/T3 tumors"
    ]
  },
  {
    "id": "Medical-136a5739",
    "source": "Medical",
    "question": "Which two polyp types are unlikely to progress to rectal cancer, and how does this contrast with adenomas?",
    "answer": "Hyperplastic and inflammatory polyps rarely turn into cancer, while adenomas can become invasive rectal cancer over many years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hyperplastic and inflammatory polyps rarely turn into cancer",
      "Adenomas can become invasive rectal cancer over many years"
    ]
  },
  {
    "id": "Medical-aaefb0f2",
    "source": "Medical",
    "question": "What surveillance strategies are recommended after local excision or ESD for T1 rectal cancer?",
    "answer": "Regular flexible sigmoidoscopy every 6 months and imaging (EUS or MRI) every 3-6 months are recommended for up to 5 years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging",
      "Flexible sigmoidoscopy every 6 months for 5 years is recommended for T1 rectal tumors",
      "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5 is part of surveillance for T1 tumors"
    ]
  },
  {
    "id": "Medical-a5435dbc",
    "source": "Medical",
    "question": "Why is colonoscopy recommended after rectal cancer surgery, and what risk factor may increase its importance?",
    "answer": "Colonoscopy is recommended for surveillance after surgery, especially important in patients with familial adenomatous polyposis (FAP) due to high polyp risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Colonoscopy is recommended after surgery for surveillance",
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
    ]
  },
  {
    "id": "Medical-e8163237",
    "source": "Medical",
    "question": "Which surgical procedures are specifically used for tumors in different parts of the rectum?",
    "answer": "Low anterior resection (LAR) is used for mid to upper rectum tumors, while abdominoperineal resection (APR) is used for lower rectum tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Low anterior resection (LAR) is used for tumors in the mid to upper rectum",
      "Abdominoperineal resection (APR) is used for tumors in the lower rectum"
    ]
  },
  {
    "id": "Medical-af6105a0",
    "source": "Medical",
    "question": "What are the recommended fertility preservation options for rectal cancer patients, and why might these be important?",
    "answer": "Sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition are recommended, important due to risks of premature ovarian insufficiency from treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition",
      "Premature ovarian insufficiency (POI) is a risk after some cancer treatments"
    ]
  },
  {
    "id": "Medical-c58dca0f",
    "source": "Medical",
    "question": "Which chemotherapy agents may be included in rectal cancer treatment regimens and for what stage are they typically used?",
    "answer": "Oxaliplatin and irinotecan may be included in chemotherapy regimens, typically used for locally advanced rectal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemotherapy regimens may include oxaliplatin or irinotecan",
      "Chemoradiation is used for locally advanced rectal cancer"
    ]
  },
  {
    "id": "Medical-f5089b0a",
    "source": "Medical",
    "question": "What symptoms, if present together, should prompt diagnostic testing for rectal cancer using imaging and endoscopic methods?",
    "answer": "Changes in bowel habits, rectal bleeding, and abdominal pain should prompt MRI, EUS, and colonoscopy for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain",
      "MRI of the pelvis is recommended for staging rectal cancer",
      "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy",
      "Colonoscopy is a diagnostic method for rectal cancer"
    ]
  },
  {
    "id": "Medical-a73aa030",
    "source": "Medical",
    "question": "Why is polypectomy during colonoscopy considered a preventive strategy for rectal cancer?",
    "answer": "Because most rectal cancers start in adenomatous polyps and polypectomy can remove these polyps to prevent cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most rectal cancers start in adenomatous polyps",
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer"
    ]
  },
  {
    "id": "Medical-fad3190e",
    "source": "Medical",
    "question": "For a patient with a history of FAP, what combination of surveillance and diagnostic methods is most critical?",
    "answer": "Regular colonoscopy and polypectomy are critical due to the high risk of multiple polyps and rectal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
      "Colonoscopy is recommended after surgery for surveillance",
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer"
    ]
  },
  {
    "id": "Medical-2e2c9c8e",
    "source": "Medical",
    "question": "If a rectal cancer patient has dMMR or MSI-H, what does this indicate regarding their tumor, and what testing is required?",
    "answer": "It indicates a biomarker status relevant for management, and all rectal tumors should be tested for dMMR or MSI-H.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer",
      "All rectal tumors should be tested for dMMR or MSI-H"
    ]
  },
  {
    "id": "Medical-9675683c",
    "source": "Medical",
    "question": "What methods are used to monitor rectal cancer after initial treatment and what biomarker is involved?",
    "answer": "Blood tests such as CEA and imaging are used for monitoring after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests such as CEA are used for monitoring rectal cancer",
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging"
    ]
  },
  {
    "id": "Medical-26ced7a1",
    "source": "Medical",
    "question": "How are endoscopic and surgical options distinguished for early-stage rectal tumors?",
    "answer": "Endoscopic methods like ESD and EMR are used for T1 tumors, while transabdominal surgery is used for T2 and some T1/T3 tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors",
      "Transabdominal surgery is recommended for T2 and some T1/T3 tumors"
    ]
  },
  {
    "id": "Medical-a6968a78",
    "source": "Medical",
    "question": "Which diagnostic methods are recommended for a patient presenting with hematuria and frequent urination suspected of having bladder cancer?",
    "answer": "Cystoscopy, urine cytology, biopsy, and imaging such as CT scan or MRI are recommended diagnostic methods.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer",
      "Other symptoms include frequent urination",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)"
    ]
  },
  {
    "id": "Medical-91c35427",
    "source": "Medical",
    "question": "What is the standard surgical procedure for muscle-invasive bladder cancer, and what urinary diversion options may follow?",
    "answer": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer, followed by urinary diversion procedures such as ileal conduit, neobladder, or continent cutaneous pouch.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch",
      "Stages 2, 3, and 4 bladder cancers are muscle-invasive"
    ]
  },
  {
    "id": "Medical-da2b7d6f",
    "source": "Medical",
    "question": "Which treatments are used for nonmuscle-invasive bladder cancer and what surgical procedure is typically involved?",
    "answer": "TURBT and intravesical therapy (BCG or chemotherapy) are used for nonmuscle-invasive bladder cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer",
      "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer"
    ]
  },
  {
    "id": "Medical-27edd702",
    "source": "Medical",
    "question": "What systemic therapies are available for bladder cancer patients with advanced or metastatic disease?",
    "answer": "Systemic therapies include chemotherapy (cisplatin-based regimens), immunotherapy (checkpoint inhibitors), and targeted therapies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC",
      "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab",
      "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)",
      "Stage 4 bladder cancer is metastatic and may involve distant organs"
    ]
  },
  {
    "id": "Medical-ac86bfad",
    "source": "Medical",
    "question": "How does the treatment approach differ between muscle-invasive and nonmuscle-invasive bladder cancer?",
    "answer": "Muscle-invasive bladder cancer is treated with radical cystectomy and may require urinary diversion, while nonmuscle-invasive bladder cancer is treated with TURBT and intravesical therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stages 2, 3, and 4 bladder cancers are muscle-invasive",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer",
      "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer"
    ]
  },
  {
    "id": "Medical-d1c9cdcd",
    "source": "Medical",
    "question": "What are the common genetic alterations associated with bladder cancer, and how might these influence targeted therapy options?",
    "answer": "Genetic alterations such as FGFR3, CDKN2A, PIK3CA, and ERBB mutations are associated with bladder cancer and may be targeted by therapies like erdafitinib and enfortumab vedotin-ejfv.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic alterations such as mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer",
      "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)",
      "FGFR3 mutation is a genetic alteration linked to bladder cancer"
    ]
  },
  {
    "id": "Medical-0bd26353",
    "source": "Medical",
    "question": "What are the main components of trimodal therapy for bladder cancer and in which clinical context is it used?",
    "answer": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach for muscle-invasive bladder cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Trimodal therapy is an alternative to radical cystectomy for bladder preservation"
    ]
  },
  {
    "id": "Medical-025c325c",
    "source": "Medical",
    "question": "Which symptoms and risk factors would prompt early diagnostic evaluation for bladder cancer?",
    "answer": "Blood in urine, frequent urination, and risk factors like smoking and chemical exposure should prompt early diagnostic evaluation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer",
      "Other symptoms include frequent urination",
      "Smoking is the greatest risk factor for bladder cancer",
      "Other risk factors include chemical exposure"
    ]
  },
  {
    "id": "Medical-79d13dd8",
    "source": "Medical",
    "question": "What follow-up and surveillance methods are recommended after initial treatment of nonmuscle-invasive bladder cancer?",
    "answer": "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are recommended for follow-up after nonmuscle-invasive bladder cancer treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up and surveillance are required due to high recurrence rates",
      "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer",
      "Follow-up/Surveillance includes regular cystoscopy, urine cytology, imaging, and biomarker surveillance"
    ]
  },
  {
    "id": "Medical-a0699e9e",
    "source": "Medical",
    "question": "Which side effects might a patient experience after radical cystectomy and urinary diversion for bladder cancer?",
    "answer": "Patients may experience urinary incontinence, sexual dysfunction, infection, and fatigue after radical cystectomy and urinary diversion.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch",
      "Common side effects of treatment include urinary incontinence, sexual dysfunction, infection, and fatigue"
    ]
  },
  {
    "id": "Medical-a7a91e43",
    "source": "Medical",
    "question": "For a patient with high-grade, muscle-invasive urothelial carcinoma, what are the standard treatment options?",
    "answer": "Radical cystectomy, systemic chemotherapy, and possibly chemoradiation or trimodal therapy are standard options.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cancer grade is classified as low grade (LG) or high grade (HG)",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Systemic therapy includes chemotherapy",
      "Radiation therapy (EBRT) is used alone or in combination with chemotherapy (chemoradiation)",
      "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach"
    ]
  },
  {
    "id": "Medical-b200a90c",
    "source": "Medical",
    "question": "Which bladder cancer subtypes are less common and how does this affect the overall classification of the disease?",
    "answer": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes, with urothelial carcinoma being the most common.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Urothelial carcinoma is the most common subtype of bladder cancer",
      "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes of bladder cancer"
    ]
  },
  {
    "id": "Medical-2a5688d0",
    "source": "Medical",
    "question": "What are the main imaging modalities used in the diagnosis and surveillance of bladder cancer?",
    "answer": "CT scan, MRI, PET/CT, ultrasound, pyelogram, and urogram are main imaging modalities used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of bladder cancer involves imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)",
      "Follow-up/Surveillance includes imaging"
    ]
  },
  {
    "id": "Medical-e54f3250",
    "source": "Medical",
    "question": "What are the roles of immunotherapy agents in systemic therapy for advanced bladder cancer?",
    "answer": "Immunotherapy agents like pembrolizumab, nivolumab, avelumab, and atezolizumab are used as systemic therapy for advanced bladder cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Systemic therapy includes immunotherapy (checkpoint inhibitors)",
      "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab",
      "Stage 4 bladder cancer is metastatic and may involve distant organs"
    ]
  },
  {
    "id": "Medical-18263083",
    "source": "Medical",
    "question": "Which risk factors should be considered when assessing a patient's likelihood of developing bladder cancer?",
    "answer": "Smoking, secondhand smoke, age, family history, Lynch syndrome, and chemical exposure should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Smoking is the greatest risk factor for bladder cancer",
      "Other risk factors include age, family history, Lynch syndrome, and chemical exposure"
    ]
  },
  {
    "id": "Medical-648df362",
    "source": "Medical",
    "question": "What distinguishes Wilms tumor from other kidney cancer subtypes in terms of patient population and classification?",
    "answer": "Wilms tumor is a distinct kidney cancer type that usually occurs in young children, unlike other subtypes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Wilms tumor usually occurs in young children and is a distinct kidney cancer type",
      "Wilms tumor (nephroblastoma) is listed as a separate subtype under Cancer Type: Kidney cancer in the ontology"
    ]
  },
  {
    "id": "Medical-97e7a1d0",
    "source": "Medical",
    "question": "If a kidney tumor is found to have sarcomatoid features, what does this indicate regarding its subtype and disease aggressiveness?",
    "answer": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease",
      "Sarcomatoid RCC (sRCC) is included under Histology for RCC in the ontology"
    ]
  },
  {
    "id": "Medical-a56d528c",
    "source": "Medical",
    "question": "How does the origin of RCC differ from that of urothelial carcinoma within the kidney?",
    "answer": "RCC starts in the cells lining the renal tubules, while urothelial carcinoma starts in the cells lining the renal pelvis and ureter.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RCC starts in the cells that line the renal tubules",
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter"
    ]
  },
  {
    "id": "Medical-99713759",
    "source": "Medical",
    "question": "Which diagnostic methods are recommended for confirming a diagnosis of kidney cancer, and what is their basis in the classification system?",
    "answer": "Imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing are all recommended diagnostic methods for kidney cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
      "Diagnostic Method includes imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing for Kidney cancer in the ontology"
    ]
  },
  {
    "id": "Medical-daeae948",
    "source": "Medical",
    "question": "What are the most common and less common subtypes of RCC, and how are they organized?",
    "answer": "Clear cell RCC is the most common subtype, while non-clear cell RCC includes papillary, chromophobe, collecting duct RCC, and renal medullary carcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Clear cell RCC (ccRCC) and Non-clear cell RCC (nccRCC) with its subtypes are listed under Histology for RCC in the ontology"
    ]
  },
  {
    "id": "Medical-d2458aa7",
    "source": "Medical",
    "question": "If a patient has multiple tumors in both kidneys, how should these be classified and why?",
    "answer": "They should be treated as separate primary tumors, not metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis",
      "The ontology distinguishes between local spread/metastasis and primary tumors in classification"
    ]
  },
  {
    "id": "Medical-ed5085d7",
    "source": "Medical",
    "question": "Which anatomical structures are at risk for local spread of kidney cancer, and how are they categorized?",
    "answer": "Surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia are at risk for local spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia",
      "Stage in the ontology lists local spread to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
    ]
  },
  {
    "id": "Medical-74b73ed7",
    "source": "Medical",
    "question": "What distant organs are common sites of kidney cancer metastasis, and how is this reflected in the classification?",
    "answer": "Lungs, lymph nodes, bones, liver, and brain are common distant metastatic sites.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain",
      "Stage in the ontology includes metastasis to lungs, lymph nodes, bones, liver, and brain"
    ]
  },
  {
    "id": "Medical-bb361e83",
    "source": "Medical",
    "question": "How does the presence of sarcomatoid features influence treatment considerations for RCC?",
    "answer": "Sarcomatoid features indicate more aggressive disease, which is a treatment factor for RCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease",
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis",
      "Histology, including sarcomatoid RCC, is listed as a treatment factor in the ontology"
    ]
  },
  {
    "id": "Medical-6b3f89bd",
    "source": "Medical",
    "question": "Which RCC subtypes are considered non-clear cell RCC, and how are they grouped in the classification?",
    "answer": "Papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC are all non-clear cell RCC subtypes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Non-clear cell RCC (nccRCC) in the ontology includes Papillary RCC, Chromophobe RCC, Collecting duct RCC, Renal medullary carcinoma, Clear cell papillary renal cell tumor, Fumarate hydratase-deficient RCC, and ELOC-mutated RCC"
    ]
  },
  {
    "id": "Medical-a5f2e7a9",
    "source": "Medical",
    "question": "What are the key factors that determine the treatment approach for RCC according to the classification system?",
    "answer": "Histology, tumor size, tumor location, and presence of metastasis are key treatment factors for RCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis",
      "Treatment Factor in the ontology lists histology, tumor size, tumor location, and presence of metastasis"
    ]
  },
  {
    "id": "Medical-4ff142d9",
    "source": "Medical",
    "question": "How does the starting location of renal cell carcinoma compare to that of renal sarcoma within the kidney?",
    "answer": "RCC starts in the renal tubules, while renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RCC starts in the cells that line the renal tubules",
      "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
    ]
  },
  {
    "id": "Medical-5504201a",
    "source": "Medical",
    "question": "If a kidney tumor is found in the renal pelvis, which cancer subtype is most likely and why?",
    "answer": "Urothelial carcinoma is most likely since it starts in the cells lining the renal pelvis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter",
      "Renal pelvis is listed under Anatomical Structure for Kidney cancer in the ontology"
    ]
  },
  {
    "id": "Medical-6d335c18",
    "source": "Medical",
    "question": "What histological subtypes are found under RCC and how are they organized in the classification?",
    "answer": "Clear cell RCC, non-clear cell RCC (with papillary, chromophobe, collecting duct, renal medullary carcinoma, clear cell papillary, fumarate hydratase-deficient, ELOC-mutated), and sarcomatoid RCC are all histological subtypes under RCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Histology for RCC in the ontology lists clear cell RCC, non-clear cell RCC (with its subtypes), and sarcomatoid RCC"
    ]
  },
  {
    "id": "Medical-b272ce63",
    "source": "Medical",
    "question": "Which anatomical structures are directly involved in the spread of kidney cancer and how are these structures classified?",
    "answer": "Renal vein, renal artery, Gerotas fascia, adrenal gland, and lymph nodes are anatomical structures involved in local spread or metastasis of kidney cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia",
      "Anatomical Structure in the ontology includes renal vein, renal artery, Gerotas fascia, adrenal gland, and lymph nodes"
    ]
  },
  {
    "id": "Medical-32861246",
    "source": "Medical",
    "question": "Which combination of diagnostic methods is necessary to confirm and stage anal cancer after a patient presents with rectal bleeding and an anal lump?",
    "answer": "Digital rectal exam (DRE), anoscopy or high-resolution anoscopy (HRA), biopsy, and imaging (CT, MRI, PET) are necessary to confirm and stage anal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy",
      "Digital rectal exam (DRE), high-resolution anoscopy (HRA), and imaging (CT, MRI, PET) are used for diagnosis and staging",
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus"
    ]
  },
  {
    "id": "Medical-219da1ba",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed before chemoradiation in a young patient with Stage II anal cancer?",
    "answer": "Because chemoradiation can cause infertility and Stage II anal cancer is treated with chemoradiation, so fertility preservation options should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "Radiation and chemotherapy can cause infertility; fertility preservation options should be discussed",
      "Fertility Preservation includes sperm banking, egg freezing, ovarian tissue banking, and oophoropexy"
    ]
  },
  {
    "id": "Medical-ec0be6f4",
    "source": "Medical",
    "question": "How is the treatment approach different for a patient with Stage III anal cancer compared to one with Stage IV disease?",
    "answer": "Stage III is treated with chemoradiation while Stage IV requires systemic chemotherapy and possibly immunotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin)",
      "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy"
    ]
  },
  {
    "id": "Medical-3964e4de",
    "source": "Medical",
    "question": "What factors would indicate that a patient with anal cancer should undergo HIV testing as part of their diagnostic workup?",
    "answer": "Because HIV infection increases anal cancer risk and HIV testing is recommended in patients with anal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HIV infection increases the risk of anal cancer",
      "HIV testing is recommended in patients with anal cancer"
    ]
  },
  {
    "id": "Medical-441c763b",
    "source": "Medical",
    "question": "Which treatment is indicated for a patient with persistent or recurrent anal cancer after initial chemoradiation, and what is a major consequence of this intervention?",
    "answer": "Abdominoperineal resection (APR) is indicated, resulting in a permanent colostomy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Abdominoperineal resection (APR) is recommended for persistent, recurrent, or locally progressive anal cancer",
      "APR results in a permanent colostomy"
    ]
  },
  {
    "id": "Medical-9626892c",
    "source": "Medical",
    "question": "If a patient with a history of cervical cancer presents with anal pain and is found to have HSIL on biopsy, what does this indicate about their risk and disease status?",
    "answer": "They have an increased risk for anal cancer and HSIL represents a precancerous lesion (Stage 0).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk",
      "HSIL (high-grade squamous intraepithelial lesion) is a precancerous lesion for anal cancer",
      "Stage 0 is carcinoma in situ or anal dysplasia"
    ]
  },
  {
    "id": "Medical-402f416c",
    "source": "Medical",
    "question": "Which chemotherapy regimens are recommended as part of chemoradiation for a patient with Stage II anal squamous cell carcinoma?",
    "answer": "Mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin are recommended regimens.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin",
      "Anal squamous cell carcinoma is the most common subtype of anal cancer"
    ]
  },
  {
    "id": "Medical-59890a0c",
    "source": "Medical",
    "question": "What is the preferred radiation technique for treating non-metastatic anal cancer and which stages does this include?",
    "answer": "IMRT is the preferred technique for stages I-III anal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "IMRT is the preferred radiation technique for anal cancer",
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)"
    ]
  },
  {
    "id": "Medical-fd4cca6e",
    "source": "Medical",
    "question": "When is local excision considered as a treatment option in anal cancer, and what are the tumor characteristics that support this choice?",
    "answer": "Local excision is considered for early-stage, low-grade perianal cancers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Local excision is an option for some early-stage, low-grade perianal cancers",
      "Anal cancer can start in the anal canal or perianal region"
    ]
  },
  {
    "id": "Medical-9499de40",
    "source": "Medical",
    "question": "Which biomarkers are most closely associated with the development of anal squamous cell carcinoma, and what is the most common risk factor?",
    "answer": "HPV and HPV16 are closely associated biomarkers, with HPV infection being the strongest risk factor.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HPV infection is the strongest risk factor for anal cancer",
      "HPV16 is a high-risk strain associated with anal cancer",
      "Anal squamous cell carcinoma is the most common subtype of anal cancer",
      "HPV and HPV16 are listed as biomarkers for anal cancer"
    ]
  },
  {
    "id": "Medical-bcfc4592",
    "source": "Medical",
    "question": "What surveillance methods are recommended after complete remission of Stage III anal cancer, and how does the frequency of these methods vary?",
    "answer": "DRE and inguinal lymph node exams every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, and imaging yearly for 3 years are recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance after treatment includes DRE, lymph node exams, anoscopy, and imaging",
      "Complete remission: DRE every 3-6 months for 5 years, inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, imaging yearly for 3 years (stage II/III)"
    ]
  },
  {
    "id": "Medical-fd151825",
    "source": "Medical",
    "question": "Which patients with anal cancer should be encouraged to enroll in clinical trials, and what phases might these trials include?",
    "answer": "All patients with anal cancer should be encouraged to consider clinical trial enrollment, which may include phases I-IV.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are recommended for all patients if available",
      "Clinical Trial: Eligibility: All patients encouraged to consider enrollment",
      "Clinical Trial: Phases: Phase I, Phase II, Phase III, Phase IV"
    ]
  },
  {
    "id": "Medical-27281f31",
    "source": "Medical",
    "question": "If a patient develops lymph node recurrence after initial treatment for anal cancer, what are the recommended interventions?",
    "answer": "Groin dissection, chemotherapy, and radiation (if not previously given) are recommended for lymph node recurrence.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lymph node recurrence: Groin dissection, chemotherapy, radiation (if not previously given)",
      "Groin dissection: Indication: Lymph node recurrence"
    ]
  },
  {
    "id": "Medical-95283550",
    "source": "Medical",
    "question": "Which metastatic anal cancer patients are eligible for immunotherapy, and which drugs are recommended in this setting?",
    "answer": "Patients with metastatic anal cancer that progresses after chemotherapy are eligible for immunotherapy with nivolumab or pembrolizumab.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy",
      "Metastatic (Stage IV): Immunotherapy: Nivolumab, Pembrolizumab"
    ]
  },
  {
    "id": "Medical-fdd40f83",
    "source": "Medical",
    "question": "What symptoms would most likely prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer?",
    "answer": "Rectal bleeding, anal itching, anal pain, and an anal lump would prompt these exams.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus",
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy"
    ]
  },
  {
    "id": "Medical-3d54d9e7",
    "source": "Medical",
    "question": "Which diagnostic methods are necessary to confirm a diagnosis of ALL and why must both bone marrow and blood tests be used?",
    "answer": "Both bone marrow and blood tests are necessary because ALL is diagnosed when lymphoblasts are present in the bone marrow and can also be detected in the blood.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture"
    ]
  },
  {
    "id": "Medical-a3c6c911",
    "source": "Medical",
    "question": "How does the presence of BCR::ABL1 in B-ALL influence both the prognosis and the treatment approach?",
    "answer": "BCR::ABL1 in B-ALL defines a prognostic subgroup and requires therapies targeting the BCR::ABL protein.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein",
      "B-cell ALL (B-ALL) has prognostic groups including BCR::ABL1-positive B-ALL",
      "B-cell ALL (B-ALL) has biomarkers such as BCR::ABL1"
    ]
  },
  {
    "id": "Medical-64f219fe",
    "source": "Medical",
    "question": "Why is fertility preservation considered before ALL treatment, and which treatment modalities make this necessary?",
    "answer": "Fertility preservation is considered before ALL treatment because steroids and multiagent chemotherapy may affect fertility.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Fertility preservation should be considered before treatment",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-99cbd976",
    "source": "Medical",
    "question": "What distinguishes mature B-cell ALL (Burkitt leukemia) from typical B-ALL in terms of classification and treatment?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype of B-ALL and is treated differently than typical B-ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL",
      "B-cell ALL (B-ALL) has subtypes including Mature B-cell ALL (Burkitt leukemia)"
    ]
  },
  {
    "id": "Medical-e1ef9e9b",
    "source": "Medical",
    "question": "If a patient presents with enlarged lymph nodes and the diagnosis is B-cell lymphoblastic lymphoma, what does this indicate about the disease site and cell of origin?",
    "answer": "It indicates that B-cell lymphoblasts are primarily growing in lymph nodes and originate from lymphoid progenitor cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
      "ALL arises from lymphoid progenitor cells"
    ]
  },
  {
    "id": "Medical-1024ca84",
    "source": "Medical",
    "question": "How does the treatment strategy for T-ALL differ from BCR::ABL1-positive B-ALL, and what evidence supports this distinction?",
    "answer": "T-ALL is treated with chemotherapy and clinical trials, while BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "T-ALL treatment options include chemotherapy and clinical trials",
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
    ]
  },
  {
    "id": "Medical-40446029",
    "source": "Medical",
    "question": "Why are clinical trials particularly preferred for BCR::ABL1-negative or BCR::ABL1-like B-ALL subtypes?",
    "answer": "Because these subtypes may have poorer prognosis or lack targeted therapies, making clinical trials a preferred option.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL",
      "B-cell ALL (B-ALL) has prognostic groups including BCR::ABL1-negative and BCR::ABL1-like B-ALL"
    ]
  },
  {
    "id": "Medical-2b2dd1fb",
    "source": "Medical",
    "question": "What combination of symptoms and diagnostic methods would most likely lead to an ALL diagnosis involving the central nervous system?",
    "answer": "Symptoms like organ involvement combined with lumbar puncture and imaging tests would indicate CNS involvement in ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALL can be found in bone marrow, blood, testicles, and central nervous system",
      "Symptoms of ALL may include organ involvement",
      "Diagnosis of ALL involves imaging tests and lumbar puncture"
    ]
  },
  {
    "id": "Medical-04fc1c61",
    "source": "Medical",
    "question": "How does the age of a patient influence the management of ALL, and which patient populations are most commonly affected?",
    "answer": "Age influences treatment choices, and ALL is most common in children but also affects adolescents, young adults, and adults.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults"
    ]
  },
  {
    "id": "Medical-594504cc",
    "source": "Medical",
    "question": "What genetic and biomarker testing is necessary for ALL patients and how does it impact therapy selection?",
    "answer": "ALL patients require genetic and biomarker testing to identify alterations like BCR::ABL1, which guide targeted therapy selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of ALL involves genetic and biomarker testing",
      "Targeted therapy may be used based on genetic alterations",
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
    ]
  },
  {
    "id": "Medical-3d9e3424",
    "source": "Medical",
    "question": "In what situations is a lumbar puncture indicated during the diagnosis of ALL, and what does its use suggest about disease spread?",
    "answer": "A lumbar puncture is indicated to assess CNS involvement, suggesting possible spread of ALL to the central nervous system.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of ALL involves lumbar puncture",
      "ALL can be found in bone marrow, blood, testicles, and central nervous system"
    ]
  },
  {
    "id": "Medical-141fd876",
    "source": "Medical",
    "question": "Why are both flow cytometry and immunophenotyping required in the diagnostic process for ALL?",
    "answer": "Both are required to accurately identify the lineage and subtype of ALL cells by analyzing their surface markers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of ALL involves flow cytometry and immunophenotyping",
      "There are two main subtypes of ALL: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)"
    ]
  },
  {
    "id": "Medical-5422875d",
    "source": "Medical",
    "question": "What risk factors should be evaluated in a patient suspected of having ALL and why are these important?",
    "answer": "Genetic syndromes and family history should be evaluated as they increase the risk of developing ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors for ALL include certain genetic syndromes and family history",
      "ALL is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-82f4c628",
    "source": "Medical",
    "question": "How does the disease site differ between B-cell lymphoblastic lymphoma and T-cell lymphoblastic lymphoma, and what does this imply for clinical presentation?",
    "answer": "B-cell lymphoblastic lymphoma mainly affects lymph nodes, while T-cell lymphoblastic lymphoma primarily involves the thymus, affecting clinical symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
      "T-cell lymphoblastic lymphoma (T-LL/T-LBL) occurs when T-cell lymphoblasts grow mostly in the thymus"
    ]
  },
  {
    "id": "Medical-2148e062",
    "source": "Medical",
    "question": "What is the purpose of surveillance for relapse in ALL patients and which follow-up methods are used?",
    "answer": "Surveillance for relapse aims to detect disease return using regular blood tests and clinical monitoring.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up includes regular blood tests and surveillance for relapse",
      "ALL is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-2be4d7f3",
    "source": "Medical",
    "question": "Which stages of pancreatic ductal adenocarcinoma are eligible for surgery, and what is the criterion for eligibility at Stage III?",
    "answer": "Stages I, II, and selected cases of Stage III pancreatic ductal adenocarcinoma are eligible for surgery, with eligibility at Stage III depending on tumor spread to major arteries or lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer",
      "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes",
      "Surgery: Stage I, Stage II, Stage III (selected cases) (ontology, rewritten: Surgery is a treatment for Stage I, Stage II, and selected Stage III pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-3a5671fc",
    "source": "Medical",
    "question": "What diagnostic methods are used to detect hereditary pancreatic cancer risk, and which genetic syndromes are relevant?",
    "answer": "Genetic tests are used to detect hereditary pancreatic cancer risk, especially in patients with syndromes like HBOC, Peutz-Jeghers, Lynch, Li-Fraumeni, FAMMM, and hereditary pancreatitis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer",
      "Genetic test is a diagnostic method for pancreatic ductal adenocarcinoma (ontology, rewritten: Genetic tests are among the diagnostic methods for pancreatic ductal adenocarcinoma)",
      "Genetic Syndrome: Hereditary breast-ovarian cancer syndrome, HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, Familial malignant melanoma syndrome, FAMMM syndrome, Hereditary pancreatitis (ontology, rewritten: These genetic syndromes are risk factors for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-42d7ac7c",
    "source": "Medical",
    "question": "If a patient presents with jaundice and has a family history of breast cancer, which diagnostic tests and risk factors should be considered?",
    "answer": "Imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests should be considered, and family history of breast cancer is a risk factor for pancreatic ductal adenocarcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Family history of breast cancer is a risk factor for pancreatic cancer",
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests",
      "Risk Factor: Family history of breast cancer (ontology, rewritten: Family history of breast cancer is a risk factor for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-4f7fc60b",
    "source": "Medical",
    "question": "How is Stage IV pancreatic cancer defined, and what is its alternative name?",
    "answer": "Stage IV pancreatic cancer is defined by distant metastasis to organs like liver, lungs, or abdominal lining, and is also known as metastatic pancreatic cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining",
      "Stage IV pancreatic cancer is metastatic cancer",
      "Stage IV: Distant metastasis (liver, lungs, abdominal lining), Also known as: Metastatic pancreatic cancer (ontology, rewritten: Stage IV pancreatic ductal adenocarcinoma is also called metastatic pancreatic cancer and involves distant metastasis)"
    ]
  },
  {
    "id": "Medical-f2800f11",
    "source": "Medical",
    "question": "Which care team roles are necessary for comprehensive diagnosis and treatment planning in pancreatic cancer?",
    "answer": "A multidisciplinary care team including diagnostic radiologist, interventional radiologist, pathologist, gastroenterologist, medical oncologist, surgical oncologist, radiation oncologist, geriatrician, registered dietitian, genetic counselor, palliative care provider, and mental health provider is necessary.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer",
      "Care Team Role: Diagnostic radiologist, Interventional radiologist, Pathologist, Gastroenterologist, Medical oncologist, Surgical oncologist, Radiation oncologist, Geriatrician, Registered dietitian, Genetic counselor, Palliative care provider, Mental health provider (ontology, rewritten: These roles are part of the multidisciplinary care team for pancreatic cancer)"
    ]
  },
  {
    "id": "Medical-833eac1d",
    "source": "Medical",
    "question": "Which risk factors and genetic syndromes should prompt genetic testing in a patient with pancreatic cancer?",
    "answer": "Risk factors like family history of pancreatic, breast, ovarian, colorectal cancer, or melanoma, and genetic syndromes such as HBOC, Peutz-Jeghers, Lynch, Li-Fraumeni, FAMMM, and hereditary pancreatitis should prompt genetic testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors for pancreatic cancer include family history of certain cancers",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer",
      "Genetic test is a diagnostic method for pancreatic ductal adenocarcinoma (ontology, rewritten: Genetic testing is used to diagnose hereditary pancreatic cancer risk)"
    ]
  },
  {
    "id": "Medical-25c17c3d",
    "source": "Medical",
    "question": "What treatments are recommended for advanced or metastatic pancreatic ductal adenocarcinoma?",
    "answer": "Drug treatment, clinical trials, and supportive care are recommended for advanced or metastatic pancreatic ductal adenocarcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer",
      "Stage IV pancreatic cancer is metastatic cancer",
      "Drug treatment: All stages, especially advanced; Clinical trial: All stages; Supportive care: All stages (ontology, rewritten: Drug treatment, clinical trials, and supportive care are recommended for all stages, especially advanced pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-17015c75",
    "source": "Medical",
    "question": "Which subtypes of pancreatic cancer are described, and which is most common?",
    "answer": "Pancreatic ductal adenocarcinoma is the most common subtype, while pancreatic neuroendocrine tumor is less common.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype of pancreatic cancer",
      "Pancreatic neuroendocrine tumor is a less common subtype of pancreatic cancer",
      "Cancer Subtype: Pancreatic ductal adenocarcinoma, Pancreatic neuroendocrine tumor (ontology, rewritten: The main subtypes of pancreatic cancer are pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumor)"
    ]
  },
  {
    "id": "Medical-fa092b30",
    "source": "Medical",
    "question": "What is the significance of imaging in the management of pancreatic cancer, and for which purposes is it used?",
    "answer": "Imaging is used for staging, determining surgical eligibility, and as a diagnostic method in pancreatic cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging is used for staging and determining surgical eligibility in pancreatic cancer",
      "Diagnostic methods for pancreatic cancer include imaging",
      "Imaging is a diagnostic method for pancreatic ductal adenocarcinoma (ontology, rewritten: Imaging is used to diagnose and stage pancreatic ductal adenocarcinoma and assess surgical eligibility)"
    ]
  },
  {
    "id": "Medical-c218fffa",
    "source": "Medical",
    "question": "Which supportive care approaches are important for pancreatic cancer management, and what symptoms might require them?",
    "answer": "Supportive care including symptom management and palliative care is important, particularly for symptoms like jaundice.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care is an important part of pancreatic cancer management",
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Supportive Care: Symptom management, Palliative care (ontology, rewritten: Symptom management and palliative care are supportive care approaches for pancreatic cancer)"
    ]
  },
  {
    "id": "Medical-056e1e60",
    "source": "Medical",
    "question": "If a patient with pancreatic ductal adenocarcinoma has chronic pancreatitis and a family history of melanoma, what are their risk factors and what additional testing should be considered?",
    "answer": "Chronic pancreatitis and family history of melanoma are risk factors, and genetic testing should be considered to assess for hereditary syndromes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors for pancreatic cancer include chronic pancreatitis and family history of melanoma",
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer",
      "Risk Factor: Chronic pancreatitis, Family history of melanoma (ontology, rewritten: Chronic pancreatitis and family history of melanoma are risk factors for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-bb794987",
    "source": "Medical",
    "question": "What are the primary symptoms and diagnostic methods associated with pancreatic ductal adenocarcinoma?",
    "answer": "Jaundice is a primary symptom, and diagnostic methods include imaging, endoscopic test, biopsy, blood test, genetic test, and biomarker test.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests",
      "Symptom: Jaundice; Diagnostic Method: Imaging, Endoscopic test, Biopsy, Blood test, Genetic test, Biomarker test (ontology, rewritten: Jaundice is a symptom and these are the diagnostic methods for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-aba4e30c",
    "source": "Medical",
    "question": "Which stages of pancreatic ductal adenocarcinoma may involve lymph node spread, and how does this affect staging?",
    "answer": "Stage II involves spread to 1-3 lymph nodes, while Stage III involves spread to 4 or more lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes",
      "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes",
      "Stage: Stage II: Tumor >4 cm or spread to 1-3 lymph nodes; Stage III: Spread to major arteries or 4 lymph nodes (ontology, rewritten: Stage II involves 1-3 lymph nodes; Stage III involves 4 or more lymph nodes)"
    ]
  },
  {
    "id": "Medical-0103d518",
    "source": "Medical",
    "question": "How are hereditary breast-ovarian cancer syndrome and HBOC related to pancreatic ductal adenocarcinoma risk?",
    "answer": "Both hereditary breast-ovarian cancer syndrome and HBOC are genetic syndromes that increase the risk of pancreatic ductal adenocarcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hereditary syndromes such as HBOC and hereditary breast-ovarian cancer syndrome increase risk of pancreatic cancer",
      "Genetic Syndrome: Hereditary breast-ovarian cancer syndrome, HBOC (ontology, rewritten: Both hereditary breast-ovarian cancer syndrome and HBOC are risk factors for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-ad078f77",
    "source": "Medical",
    "question": "Which treatments are available to all patients with pancreatic ductal adenocarcinoma, regardless of stage?",
    "answer": "Drug treatment, clinical trials, and supportive care are available to all patients with pancreatic ductal adenocarcinoma, regardless of stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer",
      "Clinical trials are available for pancreatic cancer patients",
      "Drug treatment: All stages, especially advanced; Clinical trial: All stages; Supportive care: All stages (ontology, rewritten: Drug treatment, clinical trials, and supportive care are available to all stages of pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-b914d234",
    "source": "Medical",
    "question": "Which diagnostic procedures and biomarkers are required to confirm and assess the aggressiveness of localized prostate cancer?",
    "answer": "PSA test, digital rectal exam, and biopsy are used for diagnosis, while Gleason score and Grade Group estimate aggressiveness.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PSA test and digital rectal exam are used for screening and diagnosis",
      "Biopsy is required to confirm prostate cancer diagnosis",
      "Gleason score and Grade Group are used to estimate cancer aggressiveness",
      "Localized prostate cancer uses PSA test, digital rectal exam, biopsy, MRI, and ultrasound as diagnostic methods and PSA, Gleason score, and Grade Group as biomarkers"
    ]
  },
  {
    "id": "Medical-b3fece20",
    "source": "Medical",
    "question": "Why should germline genetic testing be considered for a patient with metastatic prostate cancer?",
    "answer": "Because metastatic prostate cancer is high-risk and may involve genetic mutations like BRCA2, which increase risk and influence treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer",
      "BRCA2 mutation increases risk of prostate cancer",
      "Metastatic prostate cancer includes genetic alterations such as BRCA2"
    ]
  },
  {
    "id": "Medical-0093e2ec",
    "source": "Medical",
    "question": "What combination of symptoms and imaging findings would indicate metastatic prostate cancer?",
    "answer": "Bone pain and unexplained weight loss with positive findings on bone scan or PET scan indicate metastatic prostate cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of advanced prostate cancer include bone pain, weight loss",
      "Metastatic prostate cancer has spread to distant organs such as bones",
      "Bone scan and PET scan are imaging methods used to assess extent of disease"
    ]
  },
  {
    "id": "Medical-65f00413",
    "source": "Medical",
    "question": "How does the treatment strategy differ between localized low-risk and metastatic prostate cancer?",
    "answer": "Localized low-risk prostate cancer may be managed with active surveillance, while metastatic disease requires androgen deprivation therapy and other systemic treatments.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Active surveillance is a management option for low-risk, early-stage prostate cancer",
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment",
      "Metastatic prostate cancer treatment includes ADT, chemotherapy, immunotherapy, and more"
    ]
  },
  {
    "id": "Medical-cfdb85ba",
    "source": "Medical",
    "question": "Which risk factors and genetic alterations should be evaluated in a patient with a family history of prostate cancer?",
    "answer": "Age, family history, and genetic mutations such as BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, and PMS2 should be evaluated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Age, family history, and genetic mutations are risk factors for prostate cancer",
      "BRCA2 mutation increases risk of prostate cancer",
      "Genetic Alteration category includes BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2"
    ]
  },
  {
    "id": "Medical-727f425f",
    "source": "Medical",
    "question": "What follow-up strategies are recommended for a patient on active surveillance for localized prostate cancer?",
    "answer": "Regular PSA testing, repeat biopsy, and imaging as indicated are recommended for active surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed",
      "Localized prostate cancer follow-up strategy includes regular PSA testing, repeat biopsy, and imaging as indicated",
      "Active surveillance is a management option for low-risk, early-stage prostate cancer"
    ]
  },
  {
    "id": "Medical-9b9b7f4a",
    "source": "Medical",
    "question": "Which diagnostic and molecular tests are used to guide treatment decisions in high-risk localized prostate cancer?",
    "answer": "PSA test, biopsy, MRI, and molecular biomarker testing are used to guide treatment decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Localized prostate cancer diagnostic methods include PSA test, biopsy, and MRI",
      "High-risk group guides prognosis and treatment"
    ]
  },
  {
    "id": "Medical-72cfd9c6",
    "source": "Medical",
    "question": "What symptoms and risk factors would prompt early screening for prostate cancer?",
    "answer": "Urinary symptoms and risk factors such as age, family history, and Black race would prompt early screening.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of prostate cancer include urinary symptoms",
      "Age, family history, and Black race are risk factors for prostate cancer",
      "PSA test and digital rectal exam are used for screening"
    ]
  },
  {
    "id": "Medical-e9900b5c",
    "source": "Medical",
    "question": "Why is androgen deprivation therapy a key component in the management of metastatic prostate cancer?",
    "answer": "Because ADT is a mainstay for advanced disease and is included among treatments for metastatic prostate cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment",
      "Metastatic prostate cancer treatment includes ADT"
    ]
  },
  {
    "id": "Medical-3bea99a2",
    "source": "Medical",
    "question": "Which imaging modalities are necessary to fully stage a patient with suspected regional prostate cancer spread?",
    "answer": "MRI, CT scan, and PSMA-PET are necessary to assess regional spread in prostate cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regional prostate cancer has spread to nearby lymph nodes",
      "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease",
      "Regional prostate cancer diagnostic methods include MRI, CT scan, and PSMA-PET"
    ]
  },
  {
    "id": "Medical-0125ebb1",
    "source": "Medical",
    "question": "How do Gleason score and Grade Group contribute to the management of prostate cancer?",
    "answer": "They estimate cancer aggressiveness and help assign risk groups that guide prognosis and treatment decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Gleason score and Grade Group are used to estimate cancer aggressiveness",
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment",
      "Biomarkers for prostate cancer include Gleason score and Grade Group"
    ]
  },
  {
    "id": "Medical-33e5776d",
    "source": "Medical",
    "question": "Which patients with prostate cancer should receive molecular biomarker testing as part of their follow-up?",
    "answer": "Patients with high-risk, very-high-risk, regional, or metastatic prostate cancer should receive molecular biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer",
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Follow-up strategy includes molecular biomarker testing"
    ]
  },
  {
    "id": "Medical-b0ec1abf",
    "source": "Medical",
    "question": "What is the rationale for using both PSA testing and imaging in the follow-up of advanced prostate cancer?",
    "answer": "Because PSA monitoring detects biochemical recurrence, while imaging assesses disease progression or metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed",
      "Advanced prostate cancer follow-up strategy includes PSA monitoring and imaging",
      "Imaging methods include MRI, CT, PET, bone scan, and PSMA-PET"
    ]
  },
  {
    "id": "Medical-5c6a1008",
    "source": "Medical",
    "question": "Which combination of therapies might be considered for a patient with metastatic prostate cancer and a BRCA2 mutation?",
    "answer": "Androgen deprivation therapy, chemotherapy, and targeted therapy may be considered for metastatic prostate cancer with BRCA2 mutation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic prostate cancer treatment includes ADT, chemotherapy, targeted therapy",
      "BRCA2 mutation increases risk of prostate cancer",
      "Metastatic prostate cancer includes BRCA2 as a genetic alteration"
    ]
  },
  {
    "id": "Medical-2e171c34",
    "source": "Medical",
    "question": "How do risk group classification and molecular biomarker testing together influence treatment selection in prostate cancer?",
    "answer": "Risk group classification guides prognosis and initial management, while molecular biomarker testing refines risk assessment and guides therapy choices.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment",
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Biomarkers include molecular biomarker tests and are linked to risk group assignment"
    ]
  },
  {
    "id": "Medical-a9db9ed9",
    "source": "Medical",
    "question": "If a child under 5 presents with an adrenal mass and bone metastases, what is the most likely diagnosis and which diagnostic methods should be prioritized?",
    "answer": "Neuroblastoma is most likely, and imaging tests plus biochemical tests should be prioritized.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
      "Neuroblastoma may metastasize to bones",
      "Neuroblastoma diagnostic methods include imaging tests and biochemical test"
    ]
  },
  {
    "id": "Medical-015f2cf7",
    "source": "Medical",
    "question": "How would you distinguish between a functional adenoma and a pheochromocytoma in a patient with an adrenal mass and high blood pressure?",
    "answer": "A pheochromocytoma arises from the adrenal medulla and causes high blood pressure, while functional adenoma does not typically present with high blood pressure.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure",
      "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
      "Functional adenoma subtypes are aldosteronoma and cortisol-producing adenoma"
    ]
  },
  {
    "id": "Medical-1a7ab06f",
    "source": "Medical",
    "question": "What combination of symptoms and test results would suggest an aldosteronoma rather than a cortisol-producing adenoma?",
    "answer": "Excess aldosterone on biochemical testing without Cushing syndrome symptoms suggests aldosteronoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Aldosteronoma produces excess aldosterone",
      "Adenoma producing excess cortisol causes Cushing syndrome",
      "Cortisol-producing adenoma is associated with Cushing syndrome"
    ]
  },
  {
    "id": "Medical-5456c556",
    "source": "Medical",
    "question": "Which hereditary syndromes should be considered risk factors if a patient is diagnosed with adrenocortical carcinoma (ACC)?",
    "answer": "Beckwith-Wiedemann syndrome, Carney complex, FAP, PGL/PCC syndrome, Li-Fraumeni syndrome, Lynch syndrome, MEN 1, MEN 2, NF1, and VHL should be considered as risk factors for ACC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Certain hereditary syndromes increase the risk of adrenal tumors",
      "Adrenocortical carcinoma (ACC) risk factors include Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), and Von Hippel-Lindau syndrome (VHL)"
    ]
  },
  {
    "id": "Medical-d3dfaf75",
    "source": "Medical",
    "question": "If a patient presents with rapid heartbeat, headache, and sweating, which adrenal tumor is most likely and what is its origin?",
    "answer": "Pheochromocytoma is most likely, and it originates from the adrenal medulla.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating",
      "Pheochromocytoma origin is adrenal medulla"
    ]
  },
  {
    "id": "Medical-e3da3cd7",
    "source": "Medical",
    "question": "Which diagnostic methods are common to both adrenocortical carcinoma (ACC) and pheochromocytoma, and which are unique to ACC?",
    "answer": "CT scan, MRI scan, and biochemical test are common to both; PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, genetic test, and biopsy are unique to ACC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adrenocortical carcinoma (ACC) diagnostic methods include CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy",
      "Pheochromocytoma diagnostic methods include CT scan, MRI scan, and biochemical test"
    ]
  },
  {
    "id": "Medical-9db4f113",
    "source": "Medical",
    "question": "What evidence would indicate that an adrenal tumor is benign and unlikely to metastasize?",
    "answer": "If the tumor is a benign adrenal tumor, such as an adenoma, it does not metastasize.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adrenal tumors can be benign or malignant",
      "Benign adrenal tumors do not metastasize",
      "Adenoma is the most common type of adrenal gland tumor"
    ]
  },
  {
    "id": "Medical-395b9708",
    "source": "Medical",
    "question": "Which symptoms and hormone findings would suggest a cortisol-producing adenoma causing Cushing syndrome?",
    "answer": "Symptoms such as weight gain, muscle weakness, and pink or purple stretch marks with excess cortisol on testing suggest a cortisol-producing adenoma causing Cushing syndrome.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenoma producing excess cortisol causes Cushing syndrome",
      "Cortisol-producing adenoma is associated with Cushing syndrome",
      "Adrenocortical carcinoma (ACC) symptoms include weight gain, muscle weakness, and pink or purple stretch marks"
    ]
  },
  {
    "id": "Medical-7718481e",
    "source": "Medical",
    "question": "If imaging and biochemical tests reveal an adrenal mass with excess aldosterone, what is the most probable diagnosis?",
    "answer": "Aldosteronoma is the most probable diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Aldosteronoma produces excess aldosterone",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors"
    ]
  },
  {
    "id": "Medical-8e0c15db",
    "source": "Medical",
    "question": "What combination of findings would indicate the need for genetic testing in a patient with an adrenal tumor?",
    "answer": "If there is a family history or features of hereditary syndromes in a patient with an adrenal tumor, genetic testing should be performed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Certain hereditary syndromes increase the risk of adrenal tumors",
      "Genetic testing may be performed to identify hereditary risk factors",
      "Risk factors for adrenal tumor include hereditary syndromes and family history"
    ]
  },
  {
    "id": "Medical-6e464eb2",
    "source": "Medical",
    "question": "In a patient with symptoms of hormone excess and an adrenal mass found incidentally on CT, what further tests are indicated to determine tumor type?",
    "answer": "Biochemical tests to assess hormone secretion and further imaging such as MRI or PET scan are indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Half of adrenal cancer patients have symptoms due to hormone excess",
      "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT"
    ]
  },
  {
    "id": "Medical-15b033b6",
    "source": "Medical",
    "question": "How does the origin of ACC differ from that of pheochromocytoma, and how does this affect their typical symptoms?",
    "answer": "ACC arises from the adrenal cortex and can cause a range of hormone-related symptoms, while pheochromocytoma arises from the adrenal medulla and typically causes high blood pressure, headache, rapid heartbeat, and sweating.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex",
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating"
    ]
  },
  {
    "id": "Medical-5e710a7f",
    "source": "Medical",
    "question": "Which adrenal tumor is most commonly associated with children under 5, and what is a key difference in its spread compared to benign tumors?",
    "answer": "Neuroblastoma is most common in children under 5 and may metastasize to bones, unlike benign tumors which do not metastasize.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
      "Neuroblastoma may metastasize to bones",
      "Benign adrenal tumors do not metastasize"
    ]
  },
  {
    "id": "Medical-c0103315",
    "source": "Medical",
    "question": "What differentiates a functional from a nonfunctioning adrenal adenoma, and how does this impact patient symptoms?",
    "answer": "Functional adenomas secrete excess hormones and cause symptoms, while nonfunctioning adenomas do not secrete hormones and are usually asymptomatic.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
      "Functional adrenal tumors may produce excess hormones"
    ]
  },
  {
    "id": "Medical-2045d4e4",
    "source": "Medical",
    "question": "Which diagnostic approach is shared among all adrenal tumor types and why is it important?",
    "answer": "CT scan and MRI scan are shared diagnostic methods among all adrenal tumor types because they are essential for detecting and characterizing adrenal masses.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT",
      "Adrenocortical carcinoma (ACC) diagnostic methods include CT scan and MRI scan",
      "Pheochromocytoma diagnostic methods include CT scan and MRI scan"
    ]
  },
  {
    "id": "Medical-ef8fe744",
    "source": "Medical",
    "question": "Which diagnostic tests are necessary to confirm and further characterize invasive ductal carcinoma presenting with a breast lump?",
    "answer": "Mammogram, ultrasound, MRI, biopsy, and blood tests are necessary to confirm and characterize invasive ductal carcinoma with a breast lump.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Invasive ductal carcinoma is the most common type of invasive breast cancer",
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests",
      "Invasive ductal carcinoma uses mammogram, ultrasound, MRI, biopsy, and blood tests as diagnostic methods"
    ]
  },
  {
    "id": "Medical-8ff4d088",
    "source": "Medical",
    "question": "What treatment options are specifically recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer?",
    "answer": "Endocrine therapy, CDK4/6 inhibitors, and PIK3CA inhibitors are recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer",
      "PIK3CA inhibitors are used for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs"
    ]
  },
  {
    "id": "Medical-020cc551",
    "source": "Medical",
    "question": "How does the presence of a BRCA1 mutation influence both risk assessment and treatment in HER2-negative breast cancer?",
    "answer": "BRCA1 mutation increases breast cancer risk and enables the use of PARP inhibitors for HER2-negative disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BRCA1 and BRCA2 mutations increase the risk of breast cancer",
      "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer"
    ]
  },
  {
    "id": "Medical-1c34ae24",
    "source": "Medical",
    "question": "What is the clinical significance of PD-L1 expression in the management of metastatic breast cancer?",
    "answer": "PD-L1 expression may guide immunotherapy use in metastatic breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PD-L1 expression may guide immunotherapy use",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "Immunotherapy is a treatment option for metastatic breast cancer"
    ]
  },
  {
    "id": "Medical-e99acf57",
    "source": "Medical",
    "question": "For a patient presenting with redness, swelling, and peau dorange of the breast, what subtype and stage of breast cancer should be suspected and which diagnostic methods are indicated?",
    "answer": "Inflammatory breast cancer (IBC), typically stage III or IV, should be suspected and diagnosis should include physical exam, medical photographs, imaging, and biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin",
      "IBC symptoms include redness, swelling, and peau dorange",
      "IBC is diagnosed with physical exam, medical photographs, mammogram, ultrasound, MRI, CT scan, PET scan, biopsy, skin biopsy, and sentinel lymph node biopsy"
    ]
  },
  {
    "id": "Medical-a13a1285",
    "source": "Medical",
    "question": "What are the distinguishing features between Stage 0 and Stage IV breast cancer in terms of pathology and clinical management?",
    "answer": "Stage 0 is noninvasive (DCIS) and managed with surgery and radiation, while Stage IV is metastatic and managed with systemic therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 0 breast cancer is noninvasive (DCIS)",
      "Stages I-III are invasive breast cancer",
      "Stage IV is metastatic breast cancer",
      "Treatment options include surgery and radiation for DCIS, and systemic therapy for metastatic breast cancer"
    ]
  },
  {
    "id": "Medical-647b438f",
    "source": "Medical",
    "question": "Which biomarkers must be tested to guide targeted therapy decisions in invasive ductal carcinoma, and why?",
    "answer": "Estrogen receptor, progesterone receptor, HER2, BRCA1/2, PIK3CA, MSI-H/dMMR, and PD-L1 must be tested to guide targeted therapy in invasive ductal carcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer",
      "PIK3CA mutation can be targeted with specific therapies",
      "MSI-H/dMMR status may influence immunotherapy options",
      "PD-L1 expression may guide immunotherapy use",
      "Invasive ductal carcinoma biomarkers include ER, PR, HER2, BRCA1 mutation, BRCA2 mutation, PIK3CA mutation, MSI-H, dMMR, and PD-L1"
    ]
  },
  {
    "id": "Medical-6bd5b75d",
    "source": "Medical",
    "question": "What is the rationale for performing a sentinel lymph node biopsy in invasive breast cancer and not in DCIS?",
    "answer": "Sentinel lymph node biopsy is performed in invasive breast cancer to assess lymph node involvement, which is not required in noninvasive DCIS.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sentinel lymph node biopsy is used to assess lymph node involvement",
      "Invasive ductal carcinoma diagnostic methods include sentinel lymph node biopsy",
      "DCIS is noninvasive and does not require sentinel lymph node biopsy"
    ]
  },
  {
    "id": "Medical-8488f954",
    "source": "Medical",
    "question": "How does performance status influence the treatment plan for a patient with metastatic breast cancer?",
    "answer": "Performance status is considered in treatment planning for metastatic breast cancer to tailor therapy to the patient's functional capacity.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is considered in treatment planning",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "Clinical management includes performance status assessment"
    ]
  },
  {
    "id": "Medical-f5688b0c",
    "source": "Medical",
    "question": "What are the necessary follow-up procedures after completing primary treatment for breast cancer to monitor for recurrence?",
    "answer": "Follow-up includes imaging, physical exams, and monitoring for recurrence after primary breast cancer treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up includes imaging, physical exams, and monitoring for recurrence",
      "Follow-up/Surveillance for breast cancer includes these components"
    ]
  },
  {
    "id": "Medical-1eda4787",
    "source": "Medical",
    "question": "Which patients with breast cancer should receive fertility preservation counseling before treatment, and why?",
    "answer": "All patients of reproductive potential should receive fertility preservation counseling before starting breast cancer treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility preservation should be discussed before starting treatment",
      "Clinical management includes fertility preservation counseling"
    ]
  },
  {
    "id": "Medical-24f2e8ea",
    "source": "Medical",
    "question": "How does the presence of HER2 positivity alter the systemic therapy options for invasive breast cancer?",
    "answer": "HER2 positivity adds HER2-targeted therapy to the systemic treatment options for invasive breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HER2-targeted therapy is used for HER2-positive breast cancer",
      "Treatment options for invasive ductal carcinoma include HER2-targeted therapy"
    ]
  },
  {
    "id": "Medical-d1a87cb4",
    "source": "Medical",
    "question": "What combination of clinical findings and diagnostic results would indicate metastatic breast cancer (Stage IV)?",
    "answer": "Symptoms like bone pain or neurological symptoms plus imaging or biopsy showing distant spread indicate metastatic breast cancer (Stage IV).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "MBC symptoms include bone pain, shortness of breath, liver dysfunction, neurological symptoms",
      "MBC diagnostic methods include imaging tests and biopsy"
    ]
  },
  {
    "id": "Medical-311d66d6",
    "source": "Medical",
    "question": "Which risk factors should be evaluated in a patient with a new breast lump to assess their likelihood of breast cancer?",
    "answer": "Family history, BRCA1/2 mutations, and assigned female at birth should be evaluated as risk factors for breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors include family history, BRCA mutations, and being assigned female at birth",
      "Breast lump is a common symptom of breast cancer"
    ]
  },
  {
    "id": "Medical-ac117ebf",
    "source": "Medical",
    "question": "Why is a biopsy essential in both the diagnosis and management planning for breast cancer?",
    "answer": "Biopsy is essential for definitive diagnosis and biomarker testing, which guides treatment planning in breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biopsy is required for definitive diagnosis and biomarker testing",
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests"
    ]
  },
  {
    "id": "Medical-5fd3c02d",
    "source": "Medical",
    "question": "What are the main risk factors associated with the development of basal cell carcinoma?",
    "answer": "Basal cell carcinoma risk is increased by UV radiation, sun exposure, tanning beds, fair skin, light hair and eye color, older age, prior or family history of skin cancer, radiation therapy, immune suppression, organ transplant, and autoimmune disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "UV radiation exposure is a primary risk factor for BCC",
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "Older age is associated with higher risk of BCC",
      "History of skin cancer or family history increases risk of BCC",
      "Radiation therapy and immune suppression are risk factors for BCC",
      "Basal cell carcinoma has risk factors including tanning beds, organ transplant, and autoimmune disease",
      "Risk factors listed in the ontology for BCC include UV radiation, sun exposure, tanning beds, fair skin, red hair, blond hair, light eye color, older age, history of skin cancer, family history of skin cancer, radiation therapy, immune suppression, organ transplant, and autoimmune disease"
    ]
  },
  {
    "id": "Medical-b8b22d33",
    "source": "Medical",
    "question": "Which anatomical locations and cell types are most commonly involved in basal cell carcinoma?",
    "answer": "Basal cell carcinoma arises from basal cells in the lower part of the epidermis and most commonly develops in sun-exposed areas such as the face, head, and neck, but can occur anywhere on the body.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "BCC arises from basal cells in the lower part of the epidermis",
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Basal cell carcinoma is a subtype of skin cancer affecting basal cells",
      "Anatomical locations for BCC include face, head, neck, arms, legs, trunk, and anywhere on the body",
      "Cell type for BCC is basal cells as listed in the ontology"
    ]
  },
  {
    "id": "Medical-9c85110b",
    "source": "Medical",
    "question": "What are the typical symptoms and presentations of basal cell carcinoma?",
    "answer": "Basal cell carcinoma typically presents as flat pale or yellow areas, red patches, shiny bumps, open sores, or brown or glossy black bumps with rolled borders, often appearing as skin lesions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders",
      "Basal cell carcinoma symptoms include flat pale or yellow area",
      "Symptoms also include red patch, shiny bump, open sore, and brown or glossy black bump with rolled border",
      "Skin lesion is a symptom of BCC",
      "The ontology lists these symptoms under BCC: flat pale or yellow area, red patch, shiny bump, open sore, brown or glossy black bump with rolled border, and skin lesion"
    ]
  },
  {
    "id": "Medical-fcf87025",
    "source": "Medical",
    "question": "Which diagnostic methods are used to confirm basal cell carcinoma and what does the process involve?",
    "answer": "Diagnosis of basal cell carcinoma involves a combination of medical and family history, physical and skin exams, biopsy, and sometimes imaging to confirm the presence and extent of disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging",
      "Diagnostic methods for BCC include medical history, family history, physical exam, skin exam, biopsy, and imaging",
      "Biopsy is a diagnostic method used in BCC",
      "Imaging may be used in the diagnostic process for BCC",
      "The ontology lists all of these diagnostic methods under BCC"
    ]
  },
  {
    "id": "Medical-6baf8bff",
    "source": "Medical",
    "question": "What are the standard treatment options for basal cell carcinoma?",
    "answer": "Surgery is the most common treatment for basal cell carcinoma, with radiation therapy or systemic therapy used in selected cases.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surgery is the most common treatment for BCC",
      "Radiation therapy or systemic therapy may be used in some cases of BCC",
      "Treatment options for BCC include surgery, radiation therapy, and systemic therapy",
      "The ontology lists treatment for BCC as surgery, radiation therapy, and systemic therapy",
      "Radiation therapy (as treatment) and systemic therapy are included as entities for BCC"
    ]
  },
  {
    "id": "Medical-643b2b9d",
    "source": "Medical",
    "question": "What constitutes recurrence in basal cell carcinoma and how is it managed?",
    "answer": "Recurrence in basal cell carcinoma refers to the cancer returning to the original site or spreading to lymph nodes or distant sites, with management involving treatment options based on risk and recurrence.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites",
      "Recurrence in BCC can include spread to lymph nodes",
      "Recurrence in BCC can include spread to distant sites",
      "Recurrence management involves treatment options based on risk and recurrence",
      "The ontology defines recurrence for BCC as return to original site, spread to lymph nodes, or distant sites, and management by treatment options based on risk"
    ]
  },
  {
    "id": "Medical-25f8ca5e",
    "source": "Medical",
    "question": "What follow-up practices are recommended after treatment for basal cell carcinoma?",
    "answer": "Follow-up after basal cell carcinoma includes a full skin exam with a doctor at least once a year to monitor for recurrence or new lesions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up includes full skin exams with a doctor at least once a year",
      "Full skin exam is a follow-up method for BCC",
      "Annual follow-up is recommended for BCC",
      "The ontology lists follow-up for BCC as full skin exam and annual follow-up",
      "Follow-up is important to detect recurrence or new skin cancers"
    ]
  },
  {
    "id": "Medical-d961b796",
    "source": "Medical",
    "question": "How does a patients medical and family history contribute to the diagnosis and risk assessment of basal cell carcinoma?",
    "answer": "A patient's medical and family history are used both to assess risk for basal cell carcinoma and as part of the diagnostic process to identify individuals at higher risk.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of BCC involves medical and family history",
      "History of skin cancer or family history increases risk of BCC",
      "Medical history is a diagnostic method for BCC",
      "Family history is a diagnostic method for BCC",
      "The ontology lists medical history and family history as both risk factors and diagnostic methods for BCC"
    ]
  },
  {
    "id": "Medical-915df475",
    "source": "Medical",
    "question": "What are the connections between risk factors, symptoms, and anatomical location in basal cell carcinoma?",
    "answer": "Basal cell carcinoma most often affects sun-exposed areas such as the face, head, and neck, with risk factors including UV radiation and fair skin, and typically presents with symptoms like flat pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "UV radiation exposure is a primary risk factor for BCC",
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders",
      "Anatomical locations for BCC include face, head, neck, arms, legs, trunk, and anywhere on the body"
    ]
  },
  {
    "id": "Medical-e0e8fd6d",
    "source": "Medical",
    "question": "What are the major risk factors and disease locations associated with primary CNS lymphoma?",
    "answer": "Primary CNS lymphoma most commonly affects the brain, spinal cord, cerebrospinal fluid, and eyes, with risk factors including immunodeficiency disorders, HIV infection, Epstein-Barr virus, autoimmune diseases such as lupus, organ transplant, and older age.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes",
      "Impaired immune system is a risk factor for primary CNS lymphoma",
      "Immunodeficiency disorders, HIV infection, Epstein-Barr virus, autoimmune diseases, organ transplant, and older age are risk factors for primary CNS lymphoma",
      "Disease Location for Primary CNS lymphoma includes: Brain, Spinal cord, Cerebrospinal fluid (CSF), Eyes",
      "Risk Factor for Primary CNS lymphoma includes: Immunodeficiency disorder, HIV, Epstein-Barr virus, Autoimmune disease, Lupus, Organ transplant, Older adult"
    ]
  },
  {
    "id": "Medical-d7012112",
    "source": "Medical",
    "question": "Which diagnostic methods are used to identify primary CNS lymphoma and what are their specific roles?",
    "answer": "Diagnosis of primary CNS lymphoma involves neurological exam, imaging with MRI (especially with gadolinium contrast) or CT, stereotactic biopsy, blood tests, eye exam, and lumbar puncture, with MRI with gadolinium being the most useful imaging and stereotactic biopsy as the standard procedure.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Diagnostic Method for Primary CNS lymphoma includes: Neurological exam, Performance status evaluation, MRI, Gadolinium contrast, CT scan, PET scan, Stereotactic biopsy, Vitrectomy, Blood tests, Eye exam, Lumbar puncture",
      "Imaging (MRI or CT) and biopsy are key diagnostic methods for primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-6bb8a85b",
    "source": "Medical",
    "question": "What are the common neurological and systemic symptoms observed in patients with primary CNS lymphoma?",
    "answer": "Patients with primary CNS lymphoma may experience neurological symptoms such as leg or arm weakness, coordination and movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary CNS lymphoma can cause neurological symptoms such as leg or arm weakness, coordination or movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes",
      "Symptom for Primary CNS lymphoma includes: Leg weakness, Arm weakness, Coordination difficulties, Movement difficulties, Personality changes, Behavior changes, Depression, Confusion, Memory problems, Incontinence, Difficulty speaking, Difficulty swallowing, Headaches, Nausea, Vomiting, Seizures, Blurry vision, Double vision",
      "Blurry vision and double vision are among the symptoms listed for Primary CNS lymphoma",
      "Primary CNS lymphoma presents with both neurological and systemic symptoms",
      "Symptoms such as headaches, seizures, and memory problems are associated with Primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-0a87d395",
    "source": "Medical",
    "question": "What are the main treatment modalities and phases for primary CNS lymphoma, and which drugs are commonly used?",
    "answer": "Treatment for primary CNS lymphoma includes corticosteroids, chemotherapy (notably high-dose methotrexate), radiation therapy (particularly whole-brain radiation therapy), targeted therapy, immunotherapy (mainly rituximab), stem cell rescue, and supportive care, typically administered in induction and consolidation phases.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment options for primary CNS lymphoma include corticosteroids, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell rescue, and supportive care",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma",
      "Rituximab is the main immunotherapy drug used for primary CNS lymphoma",
      "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma",
      "Treatment is typically given in phases: induction and consolidation"
    ]
  },
  {
    "id": "Medical-23285edf",
    "source": "Medical",
    "question": "How is treatment tailored for primary CNS lymphoma involving the cerebrospinal fluid or eyes?",
    "answer": "For primary CNS lymphoma with cerebrospinal fluid involvement, intrathecal chemotherapy may be used, while intraocular chemotherapy or radiation therapy is considered if the eyes are affected.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid",
      "Intraocular chemotherapy or radiation may be used if the eyes are involved",
      "Specialized Treatments for Primary CNS lymphoma include: Intrathecal chemotherapy for CSF involvement, Intraocular chemotherapy for eye involvement, Radiation therapy for ocular involvement",
      "Disease Location for Primary CNS lymphoma includes: Cerebrospinal fluid (CSF), Eyes",
      "Treatment for Primary CNS lymphoma is adapted based on disease location, including CSF and ocular involvement"
    ]
  },
  {
    "id": "Medical-a1adaecd",
    "source": "Medical",
    "question": "What is the role of supportive care and follow-up in the management of primary CNS lymphoma?",
    "answer": "Supportive care in primary CNS lymphoma focuses on symptom management and quality of life at any disease stage, while follow-up involves repeat MRI, eye exams, blood tests, and performance status assessment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Supportive care is provided to relieve symptoms and side effects at any stage of disease",
      "Supportive Care for Primary CNS lymphoma includes: Symptom management, Palliative care, Quality of life interventions",
      "Follow-up/Surveillance for Primary CNS lymphoma includes: Repeat MRI, Eye exam, Blood tests, Performance status assessment",
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials",
      "Follow-up procedures include imaging, laboratory tests, and clinical assessments"
    ]
  },
  {
    "id": "Medical-ead123bc",
    "source": "Medical",
    "question": "What are the recommendations regarding clinical trial participation and how does performance status influence treatment for primary CNS lymphoma?",
    "answer": "Clinical trial participation is recommended for all patients with primary CNS lymphoma, and performance status is assessed to guide treatment decisions and determine eligibility for trials.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Clinical trial participation is recommended for all patients with primary CNS lymphoma",
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials",
      "Clinical trial is listed as a treatment modality and in both induction and consolidation phases",
      "Performance status evaluation is included as a diagnostic method and part of follow-up/surveillance",
      "Performance status assessment is a key component in the management of primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-ce5815bf",
    "source": "Medical",
    "question": "How does primary CNS lymphoma typically progress and where is relapse most likely to occur?",
    "answer": "Primary CNS lymphoma rarely spreads outside the central nervous system and can relapse in the brain, spinal cord, or eyes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary CNS lymphoma rarely spreads outside the central nervous system",
      "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes",
      "Disease Location for Primary CNS lymphoma includes: Brain, Spinal cord, Eyes",
      "Relapse is noted to occur in central nervous system compartments",
      "Follow-up/Surveillance includes monitoring for relapse in brain, spinal cord, or eyes"
    ]
  },
  {
    "id": "Medical-17444c2c",
    "source": "Medical",
    "question": "What are the major risk factors and genetic syndromes associated with cutaneous squamous cell carcinoma (CSCC)?",
    "answer": "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes such as xeroderma pigmentosum and RDEB, immunosuppression, and chronic wounds or scars.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars",
      "CSCC most commonly arises in sun-exposed areas, especially in fair-skinned individuals",
      "Actinic keratosis is a precancerous lesion that can progress to CSCC",
      "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC",
      "Risk Factor in CSCC ontology includes chronic sun exposure, indoor tanning, actinic keratosis, genetic syndromes (xeroderma pigmentosum, RDEB), immunosuppression, chronic wounds or scars, and environmental toxins (arsenic, tobacco smoke)"
    ]
  },
  {
    "id": "Medical-9e04431e",
    "source": "Medical",
    "question": "Which diagnostic methods are used for CSCC at different stages, and how do they differ between local, regional, and metastatic disease?",
    "answer": "CSCC diagnosis involves clinical examination and skin biopsy for local disease, with imaging (CT, MRI, PET/CT) used when deeper invasion or spread is suspected; regional CSCC requires lymph node exams and biopsies, while metastatic CSCC relies on advanced imaging techniques.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected",
      "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy",
      "Imaging is used for staging and surveillance in regional and high-risk cases",
      "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy",
      "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
      "Regional CSCC Diagnostic Method: Lymph node exam, Imaging (CT, PET/CT), Lymph node biopsy (FNA, core needle biopsy)",
      "Metastatic CSCC Diagnostic Method: Imaging (CT, PET/CT, MRI)"
    ]
  },
  {
    "id": "Medical-0170eecb",
    "source": "Medical",
    "question": "What are the main symptoms and typical clinical presentations of cutaneous squamous cell carcinoma?",
    "answer": "CSCC typically presents as scaly patches, solid or misshapen skin lesions, and lesions that develop in areas of chronic wounds or scars.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage",
      "CSCC most commonly arises in sun-exposed areas, especially in fair-skinned individuals",
      "Lesions in chronic wounds or scars are a symptom of CSCC",
      "Symptom in CSCC ontology includes scaly patches, solid or misshapen lesions, and lesions in chronic wounds or scars",
      "Actinic keratosis is a precancerous lesion that can progress to CSCC"
    ]
  },
  {
    "id": "Medical-79b30aaa",
    "source": "Medical",
    "question": "How is risk assessment performed for CSCC, and what factors are considered in determining risk level?",
    "answer": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth of invasion, perineural and lymphovascular invasion, tumor grade, and patient immune status.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status",
      "Clinical Management Risk Assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, immunosuppression",
      "Perineural invasion, lymphovascular invasion, and tumor grade are considered biomarkers in CSCC",
      "Risk Factor in CSCC ontology includes immunosuppression",
      "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread)"
    ]
  },
  {
    "id": "Medical-76e69cd5",
    "source": "Medical",
    "question": "What are the recommended treatment strategies for local CSCC based on risk stratification?",
    "answer": "Low-risk local CSCC is mainly treated with surgical methods such as C&E, standard excision, or Mohs surgery/PDEMA, while high-risk and very high-risk cases may require Mohs surgery/PDEMA (preferred), standard excision, radiation if surgery is not possible, or systemic therapy if neither surgery nor radiation is feasible.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Low-risk local CSCC is primarily treated with surgery (C&E, standard excision, Mohs surgery/PDEMA)",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible",
      "Local CSCC Risk Assessment: Low-risk, High-risk, Very high-risk",
      "Low-risk Treatment: Curettage and electrodesiccation (C&E), Shave excision, Standard surgical excision, Mohs surgery/PDEMA, Radiation therapy (if not surgical candidate)",
      "High-risk/Very high-risk Treatment: Mohs surgery/PDEMA (preferred), Standard surgical excision, Radiation therapy (if not surgical candidate), Systemic therapy (if surgery/radiation not possible)"
    ]
  },
  {
    "id": "Medical-ff793656",
    "source": "Medical",
    "question": "How are regional and metastatic CSCC managed, and what systemic therapies are available?",
    "answer": "Regional CSCC is managed with surgery, often followed by radiation and sometimes systemic therapy, while metastatic CSCC is primarily treated with systemic therapypreferably PD-1 inhibitorswith surgery or radiation considered if feasible; available systemic therapies include platinum-based chemotherapy, EGFR inhibitors, and PD-1 inhibitors.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy",
      "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
      "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)",
      "Regional CSCC Treatment: Surgery (tumor and lymph node excision), Radiation therapy (adjuvant), Systemic therapy (platinum-based chemotherapy, EGFR inhibitor, PD-1 inhibitor), Clinical trial",
      "Metastatic CSCC Treatment: Systemic therapy (PD-1 inhibitor preferred), Surgery or radiation if feasible, Clinical trial, Platinum-based chemotherapy, EGFR inhibitor"
    ]
  },
  {
    "id": "Medical-62d1fdf9",
    "source": "Medical",
    "question": "What are the follow-up strategies after CSCC treatment, and how are they tailored by risk and stage?",
    "answer": "Follow-up after CSCC treatment consists of regular skin and lymph node exams, with frequency determined by risk and stage: low-risk local cases require less frequent monitoring, while high-risk, regional, and metastatic cases undergo more intensive surveillance schedules.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up after treatment includes regular skin and lymph node exams, with frequency based on risk and stage",
      "Low-risk local CSCC follow-up: Skin and lymph node exams every 3-12 months for 2 years, then every 6-12 months for 3 years, then annually",
      "High-risk/Very high-risk local CSCC follow-up: Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months",
      "Regional CSCC follow-up: Skin and lymph node exams every 2-3 months for 1 year, every 2-4 months for year 2, every 4-6 months for 3 years, then every 6-12 months",
      "Metastatic CSCC follow-up: Individualized based on disease extent and response"
    ]
  },
  {
    "id": "Medical-fd3d70cc",
    "source": "Medical",
    "question": "Which therapies are used to treat actinic keratosis and superficial CSCC, and what are their main types?",
    "answer": "Actinic keratosis and superficial CSCC are treated with photodynamic therapy, cryotherapy, and topical therapies such as 5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, and diclofenac.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC",
      "Precancerous Lesion: Actinic keratosis Treatment: Photodynamic therapy, Cryotherapy, Topical therapy (5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, diclofenac)",
      "Actinic keratosis is a precancerous lesion that can progress to CSCC",
      "Topical therapy includes 5-fluorouracil, imiquimod, calcipotriene, tirbanibulin, diclofenac",
      "Cryotherapy and photodynamic therapy are local treatment options for actinic keratosis and superficial CSCC"
    ]
  },
  {
    "id": "Medical-1b9a995e",
    "source": "Medical",
    "question": "What is the hierarchical classification of CSCC within the broader context of skin cancers?",
    "answer": "CSCC, also known as cutaneous squamous cell carcinoma, is a subtype of nonmelanoma skin cancer and is the second most common type of skin cancer after basal cell carcinoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer",
      "CSCC is a type of nonmelanoma skin cancer",
      "Nonmelanoma skin cancer includes subtypes such as cutaneous squamous cell carcinoma (CSCC)",
      "Basal cell carcinoma and melanoma are other types of skin cancer",
      "Cancer Type ontology: Nonmelanoma skin cancer > Cutaneous squamous cell carcinoma (CSCC)"
    ]
  },
  {
    "id": "Medical-7544e6ca",
    "source": "Medical",
    "question": "Which biomarkers are considered in CSCC, and how do they relate to prognosis and risk assessment?",
    "answer": "Perineural invasion, lymphovascular invasion, and tumor grade are key biomarkers in CSCC, and their presence is associated with higher risk and worse prognosis, influencing risk assessment and management decisions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status",
      "Biomarker in CSCC ontology includes perineural invasion, lymphovascular invasion, tumor grade",
      "Perineural invasion, lymphovascular invasion, and tumor grade are considered biomarkers in CSCC",
      "High-risk features in CSCC include perineural invasion and lymphovascular invasion",
      "Tumor grade is a factor in risk assessment and prognosis for CSCC"
    ]
  },
  {
    "id": "Medical-aae429f4",
    "source": "Medical",
    "question": "What are the key genetic and chromosomal abnormalities involved in the diagnosis of chronic myeloid leukemia (CML)?",
    "answer": "CML diagnosis relies on the presence of the BCR::ABL1 fusion gene and the Philadelphia chromosome, which results from a translocation between chromosome 9 and chromosome 22.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "CML includes biomarkers: BCR::ABL1 fusion gene, Philadelphia chromosome (Ph)"
    ]
  },
  {
    "id": "Medical-d21811b0",
    "source": "Medical",
    "question": "Which diagnostic methods and biomarkers are essential for identifying CML, and what blood cell abnormalities are commonly observed?",
    "answer": "CML is diagnosed using blood tests and bone marrow tests, with the detection of BCR::ABL1 fusion gene or Philadelphia chromosome as key biomarkers, and it is characterized by increased white blood cells and abnormal platelet counts.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Blood tests and bone marrow tests are used to diagnose CML",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "CML includes biomarkers: BCR::ABL1 fusion gene, Philadelphia chromosome (Ph)",
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "CML arises from blood stem cells producing increased myeloid progenitor cells"
    ]
  },
  {
    "id": "Medical-61d081d5",
    "source": "Medical",
    "question": "How does the BCR::ABL1 fusion gene contribute to the pathogenesis and treatment strategy of CML?",
    "answer": "The BCR::ABL1 fusion gene drives CML development through abnormal chromosomal translocation, and treatment is focused on inhibiting the BCR::ABL1 protein activity.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity",
      "CML includes treatment: BCR::ABL1 protein inhibition",
      "CML includes genetic alteration: BCR::ABL1 fusion gene"
    ]
  },
  {
    "id": "Medical-2952a7a6",
    "source": "Medical",
    "question": "What are the main phases of CML and how do they differ in terms of blood cell involvement?",
    "answer": "CML includes a chronic phase and a blast phase, with the blast phase (BP-CML) marked by increased blasts and involvement of myeloid and lymphoid progenitor cells.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
      "CML arises from blood stem cells producing increased myeloid progenitor cells",
      "CML includes disease phases: Chronic phase, Blast phase CML (BP-CML)",
      "Blast phase CML (BP-CML) includes blood cell types: myeloid progenitor cells, lymphoid progenitor cells, blasts",
      "CML includes blood cell types: White blood cells (WBCs), Red blood cells (RBCs), Platelets (PLTs)"
    ]
  },
  {
    "id": "Medical-0a7d95fc",
    "source": "Medical",
    "question": "Which blood cell types are affected in CML, and what lineage changes are observed in the disease?",
    "answer": "CML primarily affects white blood cells, especially granulocytes, and can also involve abnormal counts of red blood cells and platelets due to increased myeloid progenitor cell production.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "CML arises from blood stem cells producing increased myeloid progenitor cells",
      "CML includes blood cell types: White blood cells (WBCs), Red blood cells (RBCs), Platelets (PLTs)",
      "White blood cells (WBCs) include granulocytes, neutrophils, eosinophils, basophils",
      "CML includes blood cell type: myeloid progenitor cells"
    ]
  },
  {
    "id": "Medical-f8dc595c",
    "source": "Medical",
    "question": "What is the relationship between chromosomal abnormalities and biomarkers in the diagnosis of CML?",
    "answer": "The Philadelphia chromosome, resulting from a translocation between chromosomes 9 and 22, and the BCR::ABL1 fusion gene are interrelated chromosomal abnormalities and biomarkers essential for CML diagnosis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "CML includes biomarkers: BCR::ABL1 fusion gene, Philadelphia chromosome (Ph)",
      "CML includes chromosomal abnormality: Philadelphia chromosome (Ph), chromosome 9, chromosome 22"
    ]
  },
  {
    "id": "Medical-48edb564",
    "source": "Medical",
    "question": "How are blood and bone marrow tests utilized in the context of CML diagnosis and monitoring?",
    "answer": "Blood and bone marrow tests are essential for diagnosing CML by detecting the BCR::ABL1 fusion gene or Philadelphia chromosome, and for assessing blood cell abnormalities such as increased granulocytes and abnormal platelet counts.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Blood tests and bone marrow tests are used to diagnose CML",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "CML includes diagnostic method: blood test, bone marrow test",
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "CML includes biomarkers: BCR::ABL1 fusion gene, Philadelphia chromosome (Ph)"
    ]
  },
  {
    "id": "Medical-b55db5c0",
    "source": "Medical",
    "question": "Which molecular and cytogenetic features are central to the classification and targeted treatment of CML?",
    "answer": "CML classification and targeted treatment are based on the detection of the BCR::ABL1 fusion gene and Philadelphia chromosome, with therapy aimed at inhibiting BCR::ABL1 protein activity.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity",
      "CML includes biomarkers: BCR::ABL1 fusion gene, Philadelphia chromosome (Ph)",
      "CML includes treatment: BCR::ABL1 protein inhibition"
    ]
  },
  {
    "id": "Medical-024ef7a1",
    "source": "Medical",
    "question": "What are the main subtypes of NSCLC and how do their cellular origins differ?",
    "answer": "The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, each arising from different lung cell types including mucus-producing alveolar cells, bronchial lining cells, and large cells throughout the airways.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Adenocarcinoma, squamous cell carcinoma, and large cell carcinoma are subtypes of NSCLC",
      "Adenocarcinoma often forms from cells that line the alveoli and make mucus",
      "Squamous cell carcinoma forms from cells that line the bronchi",
      "Large cell carcinoma forms from large cells found throughout the airways",
      "NSCLC is a type of lung carcinoma",
      "NSCLC includes subtypes: adenocarcinoma, squamous cell carcinoma, large cell carcinoma",
      "Adenocarcinoma, squamous cell carcinoma, and large cell carcinoma are classified under NSCLC in the ontology"
    ]
  },
  {
    "id": "Medical-c0c6b4fb",
    "source": "Medical",
    "question": "What are the stages of NSCLC and how do their characteristics and treatments differ?",
    "answer": "NSCLC is staged from 1 to 4, with Stage 1 being early disease treated primarily with surgery or radiation, Stages 2 and 3 being locally advanced and treated with surgery and chemoradiation, and Stage 4 representing metastatic disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Stage 1 NSCLC is considered early stage",
      "Stage 2 and Stage 3 NSCLC are considered locally advanced",
      "Stage 4 NSCLC is metastatic at diagnosis",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Chemoradiation is used for some locally advanced NSCLC cases",
      "Stage 1: Treatment includes surgery and radiation therapy",
      "Stage 2 and 3: Treatment includes surgery and chemoradiation",
      "Stage 4: Described as metastatic NSCLC in the ontology"
    ]
  },
  {
    "id": "Medical-3cd90d08",
    "source": "Medical",
    "question": "Which diagnostic methods are used to detect and confirm NSCLC, and how are lung nodules evaluated?",
    "answer": "NSCLC diagnosis involves imaging, biopsy, lung nodule assessment, and lung cancer screening, with lung nodules detected by imaging and further assessed by biopsy or screening to determine malignancy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Imaging and biopsy are used as diagnostic methods for NSCLC",
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis",
      "Lung cancer screening is recommended for people at high risk",
      "Lung nodule: Detected by imaging, assessed by biopsy and lung cancer screening",
      "NSCLC: Diagnostic Method includes imaging, biopsy, lung nodule assessment, and lung cancer screening"
    ]
  },
  {
    "id": "Medical-024819a8",
    "source": "Medical",
    "question": "What are the most significant risk factors for NSCLC according to current biomedical knowledge?",
    "answer": "Major risk factors for NSCLC include tobacco smoking, exposure to second-hand smoke, radon, asbestos, arsenic, various metals, coal smoke, soot, silica, diesel fumes, and air pollution.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Tobacco smoking is the biggest risk factor for lung cancer",
      "Exposure to second-hand smoke increases lung cancer risk",
      "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer",
      "NSCLC: Risk Factor includes tobacco smoking, second-hand smoke, radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, air pollution",
      "Lung cancer risk factors are explicitly listed in the ontology under NSCLC"
    ]
  },
  {
    "id": "Medical-3cc76c04",
    "source": "Medical",
    "question": "What symptoms are commonly associated with NSCLC and how are they described?",
    "answer": "NSCLC commonly presents with respiratory symptoms such as cough and chest pain, and may include other related symptoms as part of lung cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms",
      "NSCLC: Symptom includes cough and chest pain",
      "Cough and chest pain are listed as symptoms in the ontology for NSCLC",
      "NSCLC is the most common type of lung cancer",
      "Lung cancer symptoms are described as respiratory in nature"
    ]
  },
  {
    "id": "Medical-df2fbbd7",
    "source": "Medical",
    "question": "What are the primary treatment options for NSCLC at various stages, including supportive and investigational approaches?",
    "answer": "Treatment options for NSCLC include surgery, radiation therapy, chemoradiation depending on stage, as well as supportive care and participation in clinical trials.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Chemoradiation is used for some locally advanced NSCLC cases",
      "Supportive care extends and enhances life for people with lung cancer",
      "Clinical trials are available for lung cancer treatment and prevention",
      "NSCLC: Treatment includes surgery, radiation therapy, chemoradiation, supportive care, clinical trial"
    ]
  },
  {
    "id": "Medical-2fcaf5ff",
    "source": "Medical",
    "question": "How is lung cancer screening utilized for NSCLC, and who is recommended to undergo screening?",
    "answer": "Lung cancer screening is recommended for high-risk individuals to detect NSCLC at an early, more treatable stage using imaging and assessment of lung nodules.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Lung cancer screening is recommended for people at high risk",
      "Lung cancer screening aims to detect cancer at an early, more treatable stage",
      "Lung nodule: Detected by imaging, assessed by lung cancer screening",
      "Screening: Indication is high risk individuals, purpose is early detection",
      "NSCLC: Diagnostic Method includes lung cancer screening"
    ]
  },
  {
    "id": "Medical-bbb1e0c6",
    "source": "Medical",
    "question": "What strategies are recommended for follow-up and surveillance after NSCLC treatment?",
    "answer": "Follow-up care and surveillance are planned after NSCLC treatment to monitor for recurrence and manage ongoing health needs.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up care is planned after treatment and includes surveillance for recurrence",
      "NSCLC: Follow-up Strategy includes follow-up care and surveillance",
      "Follow-up care is included in the ontology under NSCLC",
      "Surveillance is part of post-treatment strategy for NSCLC",
      "Clinical trials may also be available in the follow-up phase"
    ]
  },
  {
    "id": "Medical-31427bc6",
    "source": "Medical",
    "question": "How does the progression from early to advanced stages of NSCLC affect treatment approaches?",
    "answer": "Early and locally advanced NSCLC, which have not spread beyond the lung, are often treated with surgery and radiation or chemoradiation, while metastatic (Stage 4) NSCLC has different management strategies.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Early and locally advanced NSCLC have not spread to the tissue lining around the lung or to other organs at diagnosis",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Chemoradiation is used for some locally advanced NSCLC cases",
      "Stage 4 NSCLC is metastatic at diagnosis",
      "Stage 1: Treatment includes surgery and radiation therapy",
      "Stage 2 and 3: Treatment includes surgery and chemoradiation"
    ]
  },
  {
    "id": "Medical-0c1ef334",
    "source": "Medical",
    "question": "What is the role of lung nodules in the detection and diagnosis of NSCLC?",
    "answer": "Lung nodules, detected by imaging, are assessed by biopsy and lung cancer screening to determine if they are malignant and indicative of NSCLC.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Lung nodule: Detected by imaging",
      "Lung nodule: Assessed by biopsy and lung cancer screening",
      "Biopsy is used to confirm lung cancer diagnosis",
      "Imaging is a diagnostic method for NSCLC"
    ]
  },
  {
    "id": "Medical-611836a0",
    "source": "Medical",
    "question": "What are the major diagnostic methods and biomarkers used in nasopharyngeal carcinoma (NPC)?",
    "answer": "Diagnosis of NPC involves medical history, physical exam, imaging modalities such as CT, MRI, PET/CT, and ultrasound, as well as biopsy, with biomarker testing including EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy",
      "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance",
      "Biopsy confirms diagnosis and determines cancer subtype",
      "EBV DNA testing is performed before and after treatment for NPC",
      "NPC Diagnostic Method includes: Medical history, Physical exam, Imaging, Biopsy",
      "NPC Biomarker includes: EBV DNA, MSI-H/dMMR, PD-L1, HPV, Tumor mutational burden (TMB)"
    ]
  },
  {
    "id": "Medical-e168b4d3",
    "source": "Medical",
    "question": "Which risk factors and geographic regions are most associated with nasopharyngeal carcinoma (NPC)?",
    "answer": "NPC is most often associated with Epstein-Barr virus infection, tobacco and alcohol use, and occurs more frequently in people from Asia, Native America, and North Africa.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Most NPCs are related to Epstein-Barr virus (EBV) infection",
      "Tobacco and alcohol use are risk factors for head and neck cancer",
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa",
      "Risk Factor includes: Epstein-Barr virus (EBV), Tobacco use, Alcohol use, Geographic origin (Asia, Native America, North Africa)",
      "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx"
    ]
  },
  {
    "id": "Medical-9f34bb0a",
    "source": "Medical",
    "question": "How is nasopharyngeal carcinoma (NPC) staged and what are the key classification systems used?",
    "answer": "NPC is staged using the AJCC TNM system, which evaluates tumor size, lymph node involvement, and distant metastasis, and is also classified into numbered stages (0IV) and categories such as resectable, unresectable, locoregional, locally advanced, or metastatic.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M)",
      "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic based on extent of disease",
      "AJCC TNM system includes T0, Tis, T1, T2",
      "Numbered Stages include: Stage 0, Stage I, Stage II, Stage III, Stage IV",
      "Classification includes: Resectable, Unresectable, Locoregional, Locally advanced, Metastatic"
    ]
  },
  {
    "id": "Medical-69e0dbc6",
    "source": "Medical",
    "question": "What are the most common symptoms and metastatic sites of nasopharyngeal carcinoma (NPC)?",
    "answer": "NPC often presents with symptoms such as enlarged lymph nodes and hearing loss, though symptoms may be absent until advanced stages, and commonly metastasizes to neck lymph nodes and less frequently to the lungs.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions",
      "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs",
      "Symptom includes: Enlarged lymph nodes, Hearing loss, Symptoms may be absent until advanced stage",
      "Metastasis includes: Lymph node, Lung",
      "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx"
    ]
  },
  {
    "id": "Medical-6c6ace8b",
    "source": "Medical",
    "question": "How is treatment for nasopharyngeal carcinoma (NPC) planned and what factors are considered?",
    "answer": "NPC treatment planning is based on results from imaging, biopsy, and biomarker testing, with consideration of performance status and potential impact on fertility.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment planning for NPC is based on test results including imaging, biopsy, and biomarker testing",
      "Performance status is considered in NPC treatment planning",
      "Fertility may be affected by NPC treatment and should be discussed before therapy",
      "Diagnostic Method includes: Imaging, Biopsy, Biomarker testing",
      "Fertility counseling is part of diagnostic and treatment considerations"
    ]
  },
  {
    "id": "Medical-7b4b0aa6",
    "source": "Medical",
    "question": "Which biomarkers are used for surveillance and prognosis in nasopharyngeal carcinoma (NPC)?",
    "answer": "EBV DNA levels are used both for surveillance and as a prognostic factor in NPC, with additional biomarker testing for MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "EBV DNA testing is performed before and after treatment for NPC",
      "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden",
      "Surveillance includes: Imaging tests, EBV DNA testing",
      "Prognostic Factor includes: EBV DNA level",
      "NPC Biomarker includes: EBV DNA, MSI-H/dMMR, PD-L1, HPV, Tumor mutational burden (TMB)"
    ]
  },
  {
    "id": "Medical-9712745d",
    "source": "Medical",
    "question": "What are the main cancer subtypes and anatomical sites involved in nasopharyngeal carcinoma (NPC)?",
    "answer": "NPC is a subtype of head and neck cancer that arises in the nasopharynx, with squamous cell carcinoma being the most common histological subtype.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx",
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer",
      "Anatomical Site includes: Pharynx, Nasopharynx",
      "Cancer Subtype includes: Nasopharyngeal carcinoma (NPC), Squamous cell carcinoma (SCC)",
      "Head and neck cancer includes anatomical sites such as the nasopharynx"
    ]
  },
  {
    "id": "Medical-0ae62420",
    "source": "Medical",
    "question": "What assessments and counseling are recommended for patients with nasopharyngeal carcinoma (NPC) prior to treatment?",
    "answer": "Patients with NPC should undergo dental, nutrition, and speech and swallowing assessments, as well as fertility counseling and performance status evaluation before starting treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Dental health can be affected by head and neck cancer and its treatment",
      "Nutrition assessment and speech and swallowing assessment are part of diagnostic methods",
      "Performance status evaluation is included in diagnostic methods",
      "Fertility counseling is recommended before therapy",
      "Diagnostic Method includes: Dental exam, Nutrition assessment, Speech and swallowing assessment, Performance status evaluation, Fertility counseling"
    ]
  },
  {
    "id": "Medical-35e77a1a",
    "source": "Medical",
    "question": "How does performance status influence the management and prognosis of nasopharyngeal carcinoma (NPC)?",
    "answer": "Performance status is a key consideration in NPC treatment planning and also serves as a prognostic factor, influencing both management decisions and expected outcomes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Performance status is considered in NPC treatment planning",
      "Prognostic Factor includes: Performance status",
      "Performance status evaluation is part of diagnostic methods",
      "Treatment planning for NPC is based on test results including imaging, biopsy, and biomarker testing, and performance status",
      "NPC Prognostic Factor includes: EBV DNA level, Performance status"
    ]
  },
  {
    "id": "Medical-97ddb491",
    "source": "Medical",
    "question": "What are the main diagnostic methods and surveillance strategies for colon cancer?",
    "answer": "Colon cancer diagnosis relies on colonoscopy with polypectomy, blood tests including CBC, CMP, and CEA, as well as imaging with CT scan and MRI, while post-treatment surveillance includes colonoscopy, CEA testing, CT scans, and physical exams.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Colonoscopy with polypectomy is a diagnostic method for colon cancer",
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing",
      "CT with contrast is the main imaging test for staging and surveillance",
      "MRI may be used for further evaluation of liver or rectum",
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans",
      "Physical exam is included in surveillance strategies",
      "ctDNA testing is investigational and recommended only in clinical trials"
    ]
  },
  {
    "id": "Medical-fe85502c",
    "source": "Medical",
    "question": "How do genetic alterations and inherited syndromes influence colon cancer risk and management?",
    "answer": "Genetic alterations such as MMR gene mutations and inherited syndromes like Lynch syndrome and FAP increase colon cancer risk and necessitate biomarker testing for dMMR/MSI-H to guide immunotherapy decisions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk",
      "First-degree relative with colorectal cancer is a risk factor",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
      "MMR gene mutations are a genetic alteration in colon cancer",
      "dMMR/MSI-H is a biomarker guiding immunotherapy",
      "Inherited syndromes include Lynch syndrome and FAP",
      "Attenuated FAP is a subtype of FAP"
    ]
  },
  {
    "id": "Medical-8644244f",
    "source": "Medical",
    "question": "What are the stages of colon cancer and their key characteristics according to the AJCC TNM system?",
    "answer": "Colon cancer stages progress from carcinoma in situ (Stage 0), to invasion of the colon wall without lymph node involvement (Stages 1 and 2), to spread to nearby lymph nodes or tumor deposits (Stage 3), and finally to distant organ metastasis, commonly liver or lungs (Stage 4).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "AJCC TNM system is used to stage colon cancer",
      "Stage 0 colon cancer is carcinoma in situ",
      "Stage 1 colon cancer invades second or third layer of colon wall, no lymph node involvement",
      "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement",
      "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits",
      "Stage 4 colon cancer has spread to distant organs (commonly liver or lungs)",
      "Stage descriptions are provided in the ontology"
    ]
  },
  {
    "id": "Medical-c2a36052",
    "source": "Medical",
    "question": "How do biomarkers influence treatment selection in colon cancer?",
    "answer": "Biomarker testing for dMMR/MSI-H guides the use of immunotherapy with checkpoint inhibitors, while pMMR/MSS cancers are treated with chemotherapy and CEA is used for disease monitoring.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
      "dMMR/MSI-H is a biomarker guiding immunotherapy",
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers",
      "pMMR/MSS cancers are treated with chemotherapy",
      "CEA is a biomarker for monitoring colon cancer",
      "Biomarker ontology includes dMMR, MSI-H, pMMR, MSS, CEA, and ctDNA"
    ]
  },
  {
    "id": "Medical-8cb461ed",
    "source": "Medical",
    "question": "What are the main types of surgical and non-surgical treatments available for colon cancer?",
    "answer": "Colon cancer treatments include surgical procedures such as polypectomy, colectomy, and colostomy, as well as chemotherapy regimens and immunotherapy with checkpoint inhibitors for biomarker-selected patients.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Polypectomy removes polyps during colonoscopy",
      "Colectomy is surgery to remove the cancerous part of the colon",
      "Colostomy diverts stool through an abdominal stoma if reconnection is not possible",
      "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers",
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers",
      "Treatment ontology includes surgical procedures, chemotherapy, and immunotherapy"
    ]
  },
  {
    "id": "Medical-60b3092a",
    "source": "Medical",
    "question": "What are the origins and most common subtypes of colon cancer?",
    "answer": "Most colon cancers originate from adenomas, with adenocarcinoma being the most common subtype, while hyperplastic and inflammatory polyps rarely progress to cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Most colon cancers start in polyps, especially adenomas",
      "Adenocarcinoma is the most common subtype of colon cancer",
      "Adenomas can become invasive colon cancer over many years",
      "Adenocarcinoma arises from adenomas",
      "Hyperplastic and inflammatory polyps rarely become cancer",
      "Origin ontology lists adenoma, hyperplastic polyp, and inflammatory polyp"
    ]
  },
  {
    "id": "Medical-83b86188",
    "source": "Medical",
    "question": "What risk factors and inherited conditions are associated with increased colon cancer risk?",
    "answer": "Risk factors for colon cancer include a first-degree relative with colorectal cancer and inherited syndromes such as Lynch syndrome and FAP, including its attenuated form.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Family history of colorectal cancer is a risk factor",
      "First-degree relative with colorectal cancer is a risk factor",
      "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk",
      "Inherited syndromes include Lynch syndrome, FAP, and attenuated FAP",
      "Risk factor ontology includes first-degree relative and inherited syndromes"
    ]
  },
  {
    "id": "Medical-01f95b27",
    "source": "Medical",
    "question": "What are the recommended fertility preservation options for young adults undergoing colon cancer treatment?",
    "answer": "Young adults should be counseled about fertility risks and offered options such as sperm banking, egg freezing, and ovarian tissue banking before colon cancer treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Young adults should be counseled about fertility risks and preservation options before treatment",
      "Fertility Preservation ontology includes sperm banking, egg freezing, and ovarian tissue banking",
      "Fertility preservation is recommended prior to treatment",
      "Ovarian tissue banking is listed as a method for fertility preservation",
      "Sperm banking and egg freezing are available options"
    ]
  },
  {
    "id": "Medical-67b7cadd",
    "source": "Medical",
    "question": "How is chemotherapy utilized in the management of colon cancer across different stages?",
    "answer": "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers, with regimens including capecitabine, 5-fluorouracil, leucovorin, FOLFOX, and CAPEOX.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers",
      "Chemotherapy regimens include capecitabine, 5-fluorouracil (5-FU), leucovorin, FOLFOX, and CAPEOX",
      "Colectomy is surgery to remove the cancerous part of the colon",
      "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits",
      "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement",
      "Chemotherapy is a treatment modality listed in the ontology"
    ]
  },
  {
    "id": "Medical-18b6cbc6",
    "source": "Medical",
    "question": "What are the main cancer subtypes of esophageal cancer and their typical anatomical locations?",
    "answer": "The primary subtypes of esophageal cancer are esophageal squamous cell carcinoma, which occurs in the upper, middle, and lower esophagus, and esophageal adenocarcinoma, which typically arises in the lower and middle esophagus.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus",
      "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus",
      "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
      "Cancer Subtype: Esophageal squamous cell carcinoma and Esophageal adenocarcinoma are both subtypes of esophageal cancer"
    ]
  },
  {
    "id": "Medical-296c7595",
    "source": "Medical",
    "question": "How are the stages of esophageal cancer defined and what are their distinguishing features?",
    "answer": "Esophageal cancer stages include early-stage (confined to the esophagus and not in lymph nodes), locoregional (invading the esophagus wall and/or nearby lymph nodes or organs), and metastatic (spread to distant organs such as liver, lung, bone, and brain).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Disease Stage: Early-stage: Definition: Contained within esophagus, not in lymph nodes",
      "Disease Stage: Metastatic: Definition: Spread to distant organs, Metastatic Site: Liver, Lung, Bone, Brain, Distant lymph nodes"
    ]
  },
  {
    "id": "Medical-e8019816",
    "source": "Medical",
    "question": "What diagnostic methods are commonly used for esophageal cancer and what aspects of the disease do they assess?",
    "answer": "Diagnosis of esophageal cancer involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, genetic risk testing, nutritional assessment, and evaluation of performance status, each contributing to the assessment of disease presence, subtype, risk, and patient condition.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Diagnostic Method: Blood tests, Imaging tests, Endoscopy, Biopsy, Biomarker testing, Genetic risk testing, Nutritional assessment, Performance status",
      "Biopsy is a diagnostic method for esophageal cancer",
      "Endoscopy is a diagnostic method for esophageal cancer",
      "Nutritional assessment and performance status are included as diagnostic methods in the ontology"
    ]
  },
  {
    "id": "Medical-733f63f7",
    "source": "Medical",
    "question": "How does Barrett esophagus relate to esophageal adenocarcinoma in terms of risk and classification?",
    "answer": "Barrett esophagus is classified as a precancerous condition and is a recognized risk factor that increases the likelihood of developing esophageal adenocarcinoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
      "Precancerous Condition: Barrett esophagus",
      "Esophageal adenocarcinoma: Risk Factor: Barrett esophagus",
      "Barrett esophagus is included as a risk factor in the ontology for esophageal adenocarcinoma",
      "Barrett esophagus is listed as a precancerous condition in the ontology for esophageal cancer"
    ]
  },
  {
    "id": "Medical-2ab4a26d",
    "source": "Medical",
    "question": "What factors are considered in treatment planning for esophageal cancer according to the knowledge base?",
    "answer": "Treatment planning for esophageal cancer is based on cancer type, anatomical location, disease stage, and Siewert types for tumors at the esophagogastric junction.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment planning is based on cancer type, location, and stage",
      "Siewert types are used to stage tumors at the esophagogastric junction",
      "Treatment Planning: Based on: Cancer type, Location, Stage, Siewert types (for EGJ tumors)",
      "Anatomical Location: Esophagus, Esophagogastric junction",
      "The ontology lists Siewert types as relevant for tumors at the esophagogastric junction in treatment planning"
    ]
  },
  {
    "id": "Medical-78a99b6b",
    "source": "Medical",
    "question": "Which metastatic sites are commonly involved in advanced esophageal cancer?",
    "answer": "Metastatic esophageal cancer commonly spreads to distant organs including the liver, lung, bone, brain, and distant lymph nodes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Disease Stage: Metastatic: Metastatic Site: Liver, Lung, Bone, Brain, Distant lymph nodes",
      "Metastatic sites listed in the ontology include liver, lung, bone, brain, and distant lymph nodes",
      "Metastatic esophageal cancer involves distant organs",
      "The ontology specifies metastatic sites for esophageal cancer"
    ]
  },
  {
    "id": "Medical-d6d07c2c",
    "source": "Medical",
    "question": "What is the significance of Siewert types in the management of esophageal cancer?",
    "answer": "Siewert types are used to stage tumors at the esophagogastric junction and are an important factor in treatment planning for esophageal cancer involving this region.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Siewert types are used to stage tumors at the esophagogastric junction",
      "Treatment Planning: Based on: Siewert types (for EGJ tumors)",
      "Anatomical Location: Esophagogastric junction",
      "Siewert types are referenced in the ontology for staging and treatment planning",
      "Siewert types are specifically mentioned for tumors at the esophagogastric junction"
    ]
  },
  {
    "id": "Medical-d90aa96f",
    "source": "Medical",
    "question": "How do anatomical locations differ between esophageal squamous cell carcinoma and esophageal adenocarcinoma?",
    "answer": "Esophageal squamous cell carcinoma can occur in the upper, middle, and lower esophagus, whereas esophageal adenocarcinoma is primarily found in the lower and middle esophagus.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
      "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus",
      "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus",
      "Ontology distinguishes anatomical locations for both subtypes"
    ]
  },
  {
    "id": "Medical-b7a4ed28",
    "source": "Medical",
    "question": "What are the key clinical, pathological, and epidemiological features of mediastinal gray zone lymphoma (MGZL)?",
    "answer": "MGZL is characterized by a large mediastinal mass, the presence of Reed-Sternberg cells, predominantly affects individuals aged 20 to 40 years assigned male at birth, and requires expert hematopathologist review for diagnosis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
      "Diagnosis of MGZL requires expert hematopathologist review",
      "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas",
      "MGZL involves the mediastinum and lymph nodes above the collar bone (supraclavicular)",
      "MGZL has overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-b5a3c96e",
    "source": "Medical",
    "question": "How do the sites of involvement and epidemiology differ between mediastinal and non-mediastinal gray zone lymphomas?",
    "answer": "Mediastinal gray zone lymphoma primarily involves the mediastinum and supraclavicular lymph nodes in younger males, while non-mediastinal gray zone lymphomas occur in older persons and are associated with bone marrow and extranodal involvement.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
      "MGZL is characterized by a large mediastinal mass",
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement",
      "Sites of involvement for MGZL include mediastinum and lymph nodes above the collar bone (supraclavicular)",
      "Sites of involvement for non-mediastinal gray zone lymphoma include bone marrow involvement and extranodal disease",
      "Non-mediastinal gray zone lymphoma is associated with advanced-stage disease"
    ]
  },
  {
    "id": "Medical-bcf1ff5a",
    "source": "Medical",
    "question": "What are the main treatment options for mediastinal gray zone lymphoma (MGZL) and their indications?",
    "answer": "MGZL is usually treated with chemotherapy, with rituximab added for chemoimmunotherapy, and involved-site radiation therapy (ISRT) may be used in localized disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "MGZL is usually treated with chemotherapy",
      "Rituximab may be added to chemotherapy for chemoimmunotherapy",
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL",
      "Treatment options for MGZL include chemotherapy, chemoimmunotherapy (with rituximab), and radiation therapy (ISRT)",
      "Radiation therapy is specifically indicated for localized MGZL"
    ]
  },
  {
    "id": "Medical-b1ec8b7e",
    "source": "Medical",
    "question": "What diagnostic methods and histopathological features are essential for identifying mediastinal gray zone lymphoma (MGZL)?",
    "answer": "Diagnosis of MGZL requires expert hematopathologist review and is based on identifying a large mediastinal mass and Reed-Sternberg cells as key histopathological features.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of MGZL requires expert hematopathologist review",
      "MGZL is characterized by a large mediastinal mass",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL",
      "Diagnostic Method for MGZL includes expert hematopathologist review",
      "Histopathology of MGZL includes large mediastinal mass and Reed-Sternberg cells"
    ]
  },
  {
    "id": "Medical-f24f442f",
    "source": "Medical",
    "question": "How are gray zone lymphomas related to other lymphoma subtypes, and what are their overlapping features?",
    "answer": "Gray zone lymphomas, including MGZL, have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL), and may also share characteristics with classical Hodgkin lymphoma (CHL) and non-Hodgkin lymphoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)",
      "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas",
      "Gray zone lymphoma is related to primary mediastinal B-cell lymphoma (PMBL), Hodgkin lymphoma (HL), classical Hodgkin lymphoma (CHL), and non-Hodgkin lymphoma",
      "MGZL has overlapping pathological features with PMBL and HL",
      "Related entities for gray zone lymphoma include PMBL, HL, CHL, and non-Hodgkin lymphoma"
    ]
  },
  {
    "id": "Medical-e14162c2",
    "source": "Medical",
    "question": "What criteria distinguish extra-mediastinal gray zone lymphoma from DLBCL, not otherwise specified (DLBCL-NOS)?",
    "answer": "Extra-mediastinal gray zone lymphoma, when presenting with disease outside the mediastinum, is diagnosed as DLBCL-NOS, particularly in cases with bone marrow or extranodal involvement and advanced-stage disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement",
      "Sites of involvement for non-mediastinal gray zone lymphoma include bone marrow involvement and extranodal disease",
      "Non-mediastinal gray zone lymphoma is associated with advanced-stage disease",
      "If extra-mediastinal disease: Diagnose as DLBCL-NOS",
      "Extra-mediastinal disease in gray zone lymphoma leads to diagnosis of DLBCL-NOS"
    ]
  },
  {
    "id": "Medical-46ec9d7b",
    "source": "Medical",
    "question": "What are the major risk factors and high-risk HPV types associated with cervical cancer?",
    "answer": "Cervical cancer is strongly linked to persistent infection with high-risk HPV types such as HPV16 and HPV18, with additional risk factors including smoking, immunosuppression (e.g., HIV), high parity, oral contraceptive use, early sexual activity, multiple sexual partners, a history of sexually transmitted infection, and autoimmune diseases.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Most cervical cancers are caused by long-term infection with human papillomavirus (HPV)",
      "HPV16 and HPV18 are high-risk HPV types associated with cervical cancer",
      "Smoking increases the risk of cervical cancer",
      "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer",
      "Risk Factor includes: HPV infection, HPV16, HPV18, Smoking, Immunosuppression, HIV, High parity, Oral contraceptive use, Early sexual activity, Multiple sexual partners, History of sexually transmitted infection, Autoimmune diseases"
    ]
  },
  {
    "id": "Medical-1565017b",
    "source": "Medical",
    "question": "What are the primary screening and diagnostic methods used for cervical cancer detection and staging?",
    "answer": "Cervical cancer screening is performed with Pap smear, diagnosis is confirmed by cervical biopsy or cone biopsy, and staging and assessment utilize imaging modalities such as CT scan, MRI, PET/CT, and transvaginal ultrasound.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Pap smear is used for cervical cancer screening",
      "Cervical biopsy is the primary diagnostic method for cervical cancer",
      "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer",
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment",
      "Diagnostic Method includes: Screening (Pap smear), Biopsy (Cervical biopsy, Cone biopsy), Imaging (CT scan, MRI, PET/CT, Transvaginal ultrasound)"
    ]
  },
  {
    "id": "Medical-51a4d6d2",
    "source": "Medical",
    "question": "What are the main histological subtypes of cervical cancer and their relative prevalence?",
    "answer": "The main histological subtypes of cervical cancer are squamous cell carcinoma (the most common), adenocarcinoma, adenosquamous carcinoma, and the rare and aggressive neuroendocrine carcinoma of the cervix (NECC).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Squamous cell carcinoma is the most common subtype of cervical cancer",
      "Adenocarcinoma and adenosquamous carcinoma are less common subtypes",
      "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype",
      "Cancer Subtype includes: Squamous cell carcinoma, Adenocarcinoma, Adenosquamous carcinoma, Neuroendocrine carcinoma of the cervix (NECC)",
      "Cervical cancer is a common cancer of the female reproductive system"
    ]
  },
  {
    "id": "Medical-f9a73f1e",
    "source": "Medical",
    "question": "How is cervical cancer staged and what are the main treatment modalities at different stages?",
    "answer": "Cervical cancer is staged using the FIGO system (Stages I-IV with sub-stages); early-stage disease is mainly treated with surgery (including fertility-sparing options), while locally advanced stages are managed with chemoradiation, and metastatic or recurrent disease may require systemic therapy including chemotherapy, targeted therapy, or immunotherapy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages)",
      "Surgery is the main treatment for early-stage cervical cancer",
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer",
      "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy"
    ]
  },
  {
    "id": "Medical-b08051d8",
    "source": "Medical",
    "question": "Which biomarkers and genetic alterations are relevant for guiding therapy in recurrent or metastatic cervical cancer?",
    "answer": "In recurrent or metastatic cervical cancer, biomarker testing for PD-L1, MSI, MMR, TMB, HER2, RET, and NTRK is recommended, with PD-L1 positivity guiding immunotherapy and other alterations potentially informing targeted therapy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer",
      "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)",
      "Biomarker includes: PD-L1, MSI, MMR, TMB, HER2, RET, NTRK",
      "Genetic Alteration includes: PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, NTRK fusion",
      "Pembrolizumab is used as immunotherapy guided by PD-L1 status"
    ]
  },
  {
    "id": "Medical-5df1a831",
    "source": "Medical",
    "question": "What are the key symptoms of cervical cancer and how do they inform clinical suspicion?",
    "answer": "Cervical cancer commonly presents with symptoms such as watery vaginal discharge, pelvic pain, abnormal vaginal bleeding, and fatigue, which should prompt clinical suspicion and further diagnostic evaluation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cervical cancer is a common cancer of the female reproductive system",
      "Symptom includes: Watery vaginal discharge, Pelvic pain, Abnormal vaginal bleeding, Fatigue",
      "Cervical cancer presents with watery vaginal discharge",
      "Cervical cancer presents with pelvic pain and abnormal vaginal bleeding",
      "Fatigue is a symptom of cervical cancer"
    ]
  },
  {
    "id": "Medical-5779b132",
    "source": "Medical",
    "question": "What fertility preservation options are available for patients with early-stage cervical cancer?",
    "answer": "For selected patients with early-stage cervical cancer, fertility preservation can include fertility-sparing surgery such as trachelectomy, as well as ovarian transposition, egg freezing, and surrogacy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
      "Fertility Preservation includes: Fertility-sparing surgery, Ovarian transposition, Egg freezing, Surrogacy",
      "Trachelectomy is a fertility-sparing surgical procedure",
      "Ovarian transposition and egg freezing are fertility preservation options",
      "Surrogacy is included among fertility preservation strategies for cervical cancer patients"
    ]
  },
  {
    "id": "Medical-dfb56ae9",
    "source": "Medical",
    "question": "How is surveillance and follow-up managed after cervical cancer treatment?",
    "answer": "Surveillance after cervical cancer treatment involves regular physical exams, imaging as indicated, Pap testing, and blood tests to monitor for recurrence or complications.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surveillance after treatment includes regular physical exams and imaging as indicated",
      "Follow-up includes: Physical exam, Imaging as indicated, Pap testing, Blood tests",
      "Pap testing is part of post-treatment surveillance",
      "Physical exam and blood tests are used in follow-up",
      "Imaging as indicated is recommended for surveillance"
    ]
  },
  {
    "id": "Medical-37ade7a5",
    "source": "Medical",
    "question": "What are the main components of supportive and palliative care in advanced or metastatic cervical cancer?",
    "answer": "Supportive care and palliative care are integral for patients with advanced or metastatic cervical cancer, aiming to manage symptoms, improve quality of life, and provide comprehensive support alongside or in place of disease-directed therapies.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Supportive care and palliative care are integral for advanced or metastatic disease",
      "Supportive Care includes: Supportive care, Palliative care",
      "Palliative care is recommended for advanced cervical cancer",
      "Supportive care is part of the treatment options in cervical cancer",
      "Supportive and palliative care focus on symptom management and quality of life"
    ]
  },
  {
    "id": "Medical-0a9237ce",
    "source": "Medical",
    "question": "Which therapeutic options are available for metastatic cervical cancer, including the role of clinical trials?",
    "answer": "Metastatic cervical cancer may be treated with systemic therapies such as platinum-based chemotherapy, targeted therapy, immunotherapy (guided by biomarkers), and bevacizumab, with clinical trials being an option at all stages.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy",
      "Bevacizumab may be added to chemotherapy for metastatic cervical cancer",
      "Clinical trials are an option for all stages of cervical cancer",
      "Systemic Therapy includes: Chemoradiation, Cisplatin, Carboplatin, Paclitaxel, Topotecan, Bevacizumab, Pembrolizumab, Tisotumab vedotin-tftv, Cemiplimab",
      "Biomarker testing (e.g., PD-L1) guides the use of immunotherapy (e.g., pembrolizumab)"
    ]
  },
  {
    "id": "Medical-50c09918",
    "source": "Medical",
    "question": "What are the main diagnostic methods used for Hodgkin lymphoma and its subtypes?",
    "answer": "Hodgkin lymphoma and its subtypes are diagnosed through excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
      "Core needle biopsy may be used for diagnosis in some cases",
      "Health history and physical exam are part of the diagnostic process",
      "Blood tests and imaging tests are used in the diagnostic workup",
      "Classic Hodgkin lymphoma (CHL) and Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) both use excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests as diagnostic methods"
    ]
  },
  {
    "id": "Medical-62476085",
    "source": "Medical",
    "question": "How are the subtypes of Hodgkin lymphoma characterized in terms of cell type?",
    "answer": "Classic Hodgkin lymphoma (CHL) is characterized by Reed-Sternberg cells, while nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is characterized by popcorn-shaped cells.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
      "NLPHL is characterized by popcorn-shaped cells",
      "CHL and NLPHL are both subtypes of Hodgkin lymphoma, each defined by distinct cell types: Reed-Sternberg cells for CHL and popcorn-shaped cells for NLPHL"
    ]
  },
  {
    "id": "Medical-5cb17774",
    "source": "Medical",
    "question": "What are the common sites and age-related risk factors associated with Hodgkin lymphoma?",
    "answer": "Hodgkin lymphoma commonly starts in lymph nodes in the upper body and is most often diagnosed in people aged 15 to 30 or after age 55.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body",
      "Most people are diagnosed between ages 15 to 30 or after age 55",
      "Common Sites for Hodgkin lymphoma include lymph nodes in upper body",
      "Risk Factor for Hodgkin lymphoma includes ages 15 to 30",
      "Risk Factor for Hodgkin lymphoma includes age 55"
    ]
  },
  {
    "id": "Medical-1d7e42b7",
    "source": "Medical",
    "question": "How does nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) differ from classic Hodgkin lymphoma (CHL) in terms of rarity and disease transformation?",
    "answer": "NLPHL is a rare subtype of Hodgkin lymphoma that can transform into diffuse large B-cell lymphoma (DLBCL), whereas CHL is the most common subtype and is not associated with such transformation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)",
      "Disease Transformation for NLPHL includes diffuse large B-cell lymphoma (DLBCL)",
      "CHL is not noted to undergo disease transformation in the provided data"
    ]
  },
  {
    "id": "Medical-0b161de9",
    "source": "Medical",
    "question": "What are the hierarchical relationships among lymphoma, Hodgkin lymphoma, and its subtypes according to the ontology?",
    "answer": "Hodgkin lymphoma is a type of lymphoma, which includes classic Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) as subtypes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Hodgkin lymphoma is a type of lymphoma",
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
      "Lymphoma includes Hodgkin lymphoma as a cancer type in the ontology",
      "Hodgkin lymphoma includes subtypes: Classic Hodgkin lymphoma (CHL) and Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)"
    ]
  },
  {
    "id": "Medical-0dd275c6",
    "source": "Medical",
    "question": "Which diagnostic steps are shared between classic Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL)?",
    "answer": "Both CHL and NLPHL utilize excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests in their diagnostic process.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
      "Core needle biopsy may be used for diagnosis in some cases",
      "Health history and physical exam are part of the diagnostic process",
      "Blood tests and imaging tests are used in the diagnostic workup",
      "CHL and NLPHL share the same diagnostic methods according to the ontology: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests"
    ]
  },
  {
    "id": "Medical-3c38602c",
    "source": "Medical",
    "question": "What is the significance of cell type identification in diagnosing Hodgkin lymphoma subtypes?",
    "answer": "Identifying Reed-Sternberg cells indicates CHL, while finding popcorn-shaped cells points to NLPHL, helping distinguish between these Hodgkin lymphoma subtypes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells",
      "Classic Hodgkin lymphoma (CHL) and Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) are defined by unique cell types",
      "Cell Type for CHL: Reed-Sternberg cells",
      "Cell Type for NLPHL: popcorn-shaped cells"
    ]
  },
  {
    "id": "Medical-5ba676fd",
    "source": "Medical",
    "question": "What are the main histological layers of the gallbladder and bile ducts, and how are they organized anatomically?",
    "answer": "The gallbladder and bile ducts are composed of five main histological layers arranged from inner to outer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
      "Lamina propria is a connective tissue found under the epithelium",
      "Muscularis is a soft tissue layer in the bile duct wall",
      "Perimuscular fibrous tissue surrounds the muscle layer",
      "Serosa is the outer membrane covering the gallbladder and bile ducts",
      "bile duct: Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa",
      "gallbladder: Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
    ]
  },
  {
    "id": "Medical-20eb3bc8",
    "source": "Medical",
    "question": "How is bile duct cancer staging determined and what tumor characteristics are considered?",
    "answer": "Bile duct cancer staging is determined by assessing the primary tumor size and the extent of its spread, including invasion into blood vessels, the liver, or structures outside the liver.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Bile duct cancer staging is based on tumor size and extent of spread",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver",
      "primary tumor size (cm or mm) is a tumor characteristic",
      "spread to blood vessels is a tumor characteristic",
      "spread to liver is a tumor characteristic",
      "spread to structures outside the liver is a tumor characteristic"
    ]
  },
  {
    "id": "Medical-3b99f5cd",
    "source": "Medical",
    "question": "What defines the Tis (carcinoma in situ) stage in intrahepatic bile duct cancer?",
    "answer": "Tis (carcinoma in situ) in intrahepatic bile duct cancer is defined as an intraductal tumor that is confined to the epithelial layer and has not invaded deeper tissues.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "intrahepatic bile duct cancer: Stage: Tis: Tumor Characteristic: carcinoma in situ",
      "intrahepatic bile duct cancer: Stage: Tis: Tumor Characteristic: intraductal tumor",
      "intrahepatic bile duct cancer: Stage: Tis: Tumor Characteristic: confined to epithelium",
      "epithelium is the innermost histological layer of the bile duct and gallbladder"
    ]
  },
  {
    "id": "Medical-ec4330ad",
    "source": "Medical",
    "question": "Which anatomical structures are at risk of invasion by bile duct cancer, and how does this affect staging?",
    "answer": "Bile duct cancer can invade nearby blood vessels, the liver, and structures outside the liver, and such invasions are key factors in determining the stage of the disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver",
      "Bile duct cancer staging is based on tumor size and extent of spread",
      "spread to blood vessels is a tumor characteristic",
      "spread to liver is a tumor characteristic",
      "spread to structures outside the liver is a tumor characteristic"
    ]
  },
  {
    "id": "Medical-a8a154f8",
    "source": "Medical",
    "question": "What are the shared histological layers between the gallbladder and bile duct, and what is their functional significance?",
    "answer": "Both the gallbladder and bile duct share the histological layers of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa, which together provide structural integrity and compartmentalization.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "bile duct: Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa",
      "gallbladder: Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa",
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
      "Lamina propria is a connective tissue found under the epithelium",
      "Serosa is the outer membrane covering the gallbladder and bile ducts"
    ]
  },
  {
    "id": "Medical-f04a4100",
    "source": "Medical",
    "question": "How does the anatomical layering of the bile duct relate to the progression of cancer invasion?",
    "answer": "Cancer progression in the bile duct is influenced by its anatomical layers, with tumors starting in the epithelium and potentially invading through the lamina propria, muscularis, perimuscular fibrous tissue, and reaching the serosa.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
      "Lamina propria is a connective tissue found under the epithelium",
      "Muscularis is a soft tissue layer in the bile duct wall",
      "Perimuscular fibrous tissue surrounds the muscle layer",
      "Serosa is the outer membrane covering the gallbladder and bile ducts",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-f38ec745",
    "source": "Medical",
    "question": "What are the key diagnostic methods and common symptoms associated with follicular lymphoma (FL)?",
    "answer": "Follicular lymphoma is diagnosed using blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping, and it commonly presents with symptoms such as swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
      "FL can present as nodal or extranodal disease",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues",
      "Symptom ontology for FL includes swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, weight loss, and B symptoms"
    ]
  },
  {
    "id": "Medical-0bc96001",
    "source": "Medical",
    "question": "How is follicular lymphoma (FL) classified by grade and what are the clinical implications of each grade?",
    "answer": "FL is graded based on the proportion of centrocytes and centroblasts: grades 1 and 2 are classic FL, grade 3A may be treated as classic FL or DLBCL, and grade 3B is treated as DLBCL, with grade guiding treatment decisions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "FL is graded based on the proportion of centrocytes and centroblasts",
      "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC",
      "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)",
      "Grade 3B FL is treated as DLBCL",
      "The type of cells in FL determines the grade, which guides treatment decisions"
    ]
  },
  {
    "id": "Medical-d1ead1ea",
    "source": "Medical",
    "question": "What are the main genetic alterations and biomarkers found in follicular lymphoma (FL), and how do they differ in uncommon FL (uFL)?",
    "answer": "Most FL cases have a chromosome translocation or excess BCL2 protein, while uncommon FL is t(14;18)-negative or has uncommon pathologic features but is still treated as classic FL.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein",
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL",
      "FL includes biomarkers: BCL2 protein",
      "FL includes genetic alterations: chromosome translocation, t(14;18)",
      "Uncommon FL (uFL) has the genetic alteration t(14;18)-negative"
    ]
  },
  {
    "id": "Medical-cd32265c",
    "source": "Medical",
    "question": "How does the presentation and clinical course of pediatric-type follicular lymphoma (PTFL) differ from classic FL?",
    "answer": "Pediatric-type FL usually presents with a single enlarged lymph node in the head and neck and minimal symptoms, whereas classic FL can involve multiple sites and more systemic symptoms.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms",
      "FL can present as nodal or extranodal disease",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
      "PTFL is a cancer subtype under FL with unique presentation"
    ]
  },
  {
    "id": "Medical-363f6824",
    "source": "Medical",
    "question": "In what ways can follicular lymphoma (FL) progress or transform, and what are the implications for disease management?",
    "answer": "FL can transform into diffuse large B-cell lymphoma (DLBCL), a more aggressive lymphoma, and grade 3B FL is treated as DLBCL, which affects treatment strategies and prognosis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "FL can transform into DLBCL, a more aggressive lymphoma",
      "Grade 3B FL is treated as DLBCL",
      "Grade 3A FL may be treated as classic FL or as DLBCL",
      "Transformed FL is a cancer subtype with transformation to DLBCL",
      "The type of cells in FL determines the grade, which guides treatment decisions"
    ]
  },
  {
    "id": "Medical-da6253bc",
    "source": "Medical",
    "question": "What are the typical disease sites and cell types involved in follicular lymphoma (FL)?",
    "answer": "FL typically involves B lymphocytes and affects lymph nodes, bone marrow, spleen, and sometimes extranodal sites, with the cell types centrocytes and centroblasts determining the grade.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues",
      "Disease site ontology for FL includes lymph node, bone marrow, spleen, and extranodal sites",
      "Cell type ontology for FL includes B lymphocyte, centrocyte, and centroblast",
      "FL is graded based on the proportion of centrocytes and centroblasts",
      "FL can present as nodal or extranodal disease"
    ]
  },
  {
    "id": "Medical-61c0e9bc",
    "source": "Medical",
    "question": "How are treatment decisions and clinical management determined for follicular lymphoma (FL)?",
    "answer": "Treatment decisions in FL are guided by grade and cell type, and not all patients require immediate treatment, with some subtypes like uncommon FL treated as classic FL.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment decisions are guided by grade and cell type",
      "Not all patients with FL require immediate treatment",
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL",
      "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)",
      "Grade 3B FL is treated as DLBCL"
    ]
  },
  {
    "id": "Medical-bc92c071",
    "source": "Medical",
    "question": "What are the major subtypes of primary liver cancer and their distinguishing features?",
    "answer": "Primary liver cancer includes hepatocellular carcinoma (HCC), fibrolamellar hepatocellular carcinoma (a subtype of HCC occurring at a younger age), intrahepatic cholangiocarcinoma (arising from bile ducts), and mixed-type tumors containing both HCC and cholangiocarcinoma components.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary liver cancer originates in the liver",
      "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer",
      "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age",
      "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts",
      "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components"
    ]
  },
  {
    "id": "Medical-8897e674",
    "source": "Medical",
    "question": "Which risk factors are associated with the development of primary liver cancer?",
    "answer": "Cirrhosis, chronic hepatitis B and C infections, alcohol use, non-alcoholic fatty liver disease, genetic hemochromatosis, alpha-1-antitrypsin deficiency, and stage 4 primary biliary cholangitis are all significant risk factors for primary liver cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cirrhosis is a major risk factor for developing liver cancer",
      "Chronic hepatitis B infection increases the risk of liver cancer",
      "Chronic hepatitis C infection increases the risk of liver cancer",
      "Alcohol use is a risk factor for cirrhosis and liver cancer",
      "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer",
      "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer",
      "Alpha-1-antitrypsin deficiency is a risk factor for cirrhosis and liver cancer",
      "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer"
    ]
  },
  {
    "id": "Medical-6e7c77a8",
    "source": "Medical",
    "question": "What screening methods and criteria are recommended for liver cancer detection?",
    "answer": "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B and typically includes ultrasound and alpha-fetoprotein (AFP) tests every 6 months.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months",
      "Ultrasound is a screening method for primary liver cancer",
      "Alpha-fetoprotein (AFP) test is a screening method for primary liver cancer",
      "Cirrhosis and chronic hepatitis B are risk factors that determine screening eligibility"
    ]
  },
  {
    "id": "Medical-0fd3dcfd",
    "source": "Medical",
    "question": "Which diagnostic methods and biomarkers are used to confirm liver cancer?",
    "answer": "Diagnosis of liver cancer is usually confirmed with imaging tests and may require biopsy, while elevated alpha-fetoprotein (AFP) serves as a biomarker that may indicate primary liver cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of liver cancer is usually confirmed with imaging tests",
      "Biopsy may be needed to confirm liver cancer",
      "Elevated AFP may indicate primary liver cancer",
      "Imaging tests are a diagnostic method for primary liver cancer",
      "Alpha-fetoprotein (AFP) is a biomarker for primary liver cancer"
    ]
  },
  {
    "id": "Medical-c39fbc42",
    "source": "Medical",
    "question": "What are the common sites of metastasis for primary liver cancer and how does it spread?",
    "answer": "Primary liver cancer can spread directly through the liver and most often metastasizes to distant sites such as the lung or bone.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Liver cancer can spread directly through the liver or to distant sites such as lung or bone",
      "Liver cancer most often metastasizes to the lung or bone",
      "Primary liver cancer includes metastasis sites: lung and bone",
      "Lung and bone are anatomical structures listed as metastasis sites in the ontology",
      "Primary liver cancer originates in the liver but can spread to other organs"
    ]
  },
  {
    "id": "Medical-5161f780",
    "source": "Medical",
    "question": "What distinguishes primary from secondary liver cancer?",
    "answer": "Primary liver cancer originates in the liver, while secondary liver cancer is cancer that has spread to the liver from another organ.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary liver cancer originates in the liver",
      "Secondary liver cancer is cancer that has spread to the liver from another organ",
      "Primary liver cancer is listed as a cancer type in the ontology",
      "Secondary liver cancer has its origin in other primary cancers (e.g., colon cancer)",
      "The ontology distinguishes primary and secondary liver cancer based on origin"
    ]
  },
  {
    "id": "Medical-2a12c6b8",
    "source": "Medical",
    "question": "How are cirrhosis and its causes linked to liver cancer risk and screening?",
    "answer": "Cirrhosis, caused by factors such as hepatitis B, hepatitis C, alcohol use, NAFLD, genetic hemochromatosis, alpha-1-antitrypsin deficiency, and stage 4 primary biliary cholangitis, is a major risk factor for liver cancer and determines eligibility for liver cancer screening.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cirrhosis is a major risk factor for developing liver cancer",
      "Alcohol use is a risk factor for cirrhosis and liver cancer",
      "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer",
      "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer",
      "Alpha-1-antitrypsin deficiency is a risk factor for cirrhosis and liver cancer",
      "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer",
      "Screening for liver cancer is recommended for individuals with cirrhosis"
    ]
  },
  {
    "id": "Medical-4357e2e4",
    "source": "Medical",
    "question": "What are the main diagnostic methods used for evaluating thyroid nodules and confirming thyroid cancer?",
    "answer": "Evaluation of thyroid nodules and confirmation of thyroid cancer involves TSH blood tests, neck ultrasound, fine-needle aspiration biopsy, pathology review, and molecular tests.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules",
      "Pathology review determines cancer type and guides treatment",
      "Molecular tests can help determine malignancy and need for surgery",
      "Diagnostic Method includes TSH test, ultrasound, fine-needle aspiration, pathology review, and molecular tests"
    ]
  },
  {
    "id": "Medical-3dea6ece",
    "source": "Medical",
    "question": "Which risk factors are associated with the development of thyroid cancer?",
    "answer": "Risk factors for thyroid cancer include radiation exposure to the head or neck, family history, and inherited syndromes such as FAP, Carney complex, Cowden syndrome, and MEN.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Radiation exposure to the head or neck increases risk of thyroid cancer",
      "Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk",
      "Risk Factor includes radiation exposure, family history of thyroid cancer, and inherited syndromes (FAP, Carney complex, Cowden syndrome/PTEN hamartoma tumor syndrome, MEN)",
      "Medullary thyroid cancer can be inherited and is associated with RET gene fusion",
      "Risk Factor for papillary, follicular, and oncocytic carcinomas includes radiation exposure, family history, and inherited syndromes"
    ]
  },
  {
    "id": "Medical-06ba718a",
    "source": "Medical",
    "question": "What are the typical symptoms and signs of thyroid cancer, especially when nodules are large?",
    "answer": "Typical symptoms of thyroid cancer, especially with large nodules, include a visible neck lump, neck pain, voice changes, trouble breathing, and problems swallowing.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems",
      "Symptom includes visible neck lump, neck pain, voice changes, trouble breathing, and problems swallowing",
      "Papillary thyroid carcinoma symptom list includes visible neck lump, neck pain, voice changes, trouble breathing, and problems swallowing",
      "Thyroid nodules are often benign but can be the origin of thyroid cancer",
      "Symptom is a core concept associated with thyroid cancer"
    ]
  },
  {
    "id": "Medical-c01491e4",
    "source": "Medical",
    "question": "How are differentiated thyroid cancers (papillary, follicular, oncocytic) treated based on tumor size and spread?",
    "answer": "Differentiated thyroid cancers are treated with lobectomy for small, confined tumors, total thyroidectomy for larger or invasive tumors, neck dissection if lymph nodes are involved, and radioactive iodine therapy post-thyroidectomy if indicated.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Papillary, follicular, and oncocytic carcinomas are differentiated thyroid cancers",
      "Lobectomy is an option for small, low-risk differentiated thyroid cancers",
      "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers",
      "Neck dissection is performed if lymph nodes are involved",
      "RAI therapy is used after total thyroidectomy for differentiated thyroid cancers that take up iodine"
    ]
  },
  {
    "id": "Medical-64c2bdbe",
    "source": "Medical",
    "question": "Which biomarkers and genetic alterations are relevant for thyroid cancer diagnosis and therapy selection?",
    "answer": "Relevant biomarkers and genetic alterations in thyroid cancer include BRAF gene mutation, RET gene fusion, ALK gene fusion, NTRK gene fusion, mismatch repair deficiency (dMMR), microsatellite instability-high (MSI-H), and tumor mutational burden-high (TMB-H).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biomarker testing is recommended for recurrent, advanced, or metastatic cancers not treatable with RAI",
      "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, TMB-H",
      "Papillary thyroid carcinoma biomarkers include BRAF gene mutation, NTRK gene fusion, ALK gene fusion",
      "Medullary thyroid cancer is associated with RET gene fusion",
      "Anaplastic thyroid cancer biomarkers include BRAF gene mutation and other actionable mutations"
    ]
  },
  {
    "id": "Medical-d76e4df9",
    "source": "Medical",
    "question": "What are the main treatment modalities for advanced, metastatic, or RAI-refractory thyroid cancer?",
    "answer": "Advanced, metastatic, or RAI-refractory thyroid cancer is treated with targeted therapy (kinase inhibitors such as lenvatinib, sorafenib, cabozantinib), external beam radiation therapy, chemotherapy (mainly for anaplastic subtype), and participation in clinical trials.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis",
      "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer",
      "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI",
      "Chemotherapy is rarely effective, mainly used for anaplastic thyroid cancer with radiation",
      "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer"
    ]
  },
  {
    "id": "Medical-0fe6af86",
    "source": "Medical",
    "question": "What follow-up and surveillance strategies are recommended after thyroid cancer treatment?",
    "answer": "Post-treatment follow-up for thyroid cancer includes periodic physical exams, blood tests (TSH, thyroglobulin, anti-thyroglobulin antibodies), neck ultrasound, and whole-body RAI scan if indicated, with surveillance continuing long-term.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound",
      "After total thyroidectomy: physical exam, TSH, Tg, Tg ab blood tests, neck ultrasound (6-12 months post-op), whole-body RAI scan (if RAI given)",
      "After lobectomy: physical exam, TSH blood test, neck ultrasound (6-12 months post-op)",
      "Surveillance: Long-term: periodic physical exams, blood tests, neck ultrasound",
      "Rising thyroglobulin after thyroidectomy may indicate recurrence"
    ]
  },
  {
    "id": "Medical-6c832349",
    "source": "Medical",
    "question": "How is recurrence of thyroid cancer detected and managed?",
    "answer": "Recurrence of thyroid cancer is detected by rising thyroglobulin levels, neck ultrasound, and imaging, and is managed with surgery, radioactive iodine therapy (if iodine-avid), external beam radiation therapy, targeted therapy, or clinical trial enrollment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Rising thyroglobulin after thyroidectomy may indicate recurrence",
      "Neck ultrasound is used in follow-up and recurrence detection",
      "Imaging (CT, MRI) is used for recurrence detection",
      "Recurrence treatment includes surgery (if resectable), RAI therapy (if iodine-avid), external beam radiation therapy, targeted therapy, and clinical trial",
      "Detection of recurrence includes rising thyroglobulin, neck ultrasound, and imaging (CT, MRI)"
    ]
  },
  {
    "id": "Medical-0dc6b940",
    "source": "Medical",
    "question": "What are the common sites of metastasis for thyroid cancer and the available treatment options?",
    "answer": "Thyroid cancer most commonly metastasizes to the lungs, liver, bones, brain, and spinal cord, and treatment options include radioactive iodine therapy (if iodine-avid), targeted therapy, external beam radiation therapy, and clinical trials.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord",
      "Metastasis: Sites include lungs, liver, bones, brain, spinal cord",
      "Metastasis treatment includes RAI therapy (if iodine-avid), targeted therapy, external beam radiation therapy, and clinical trial",
      "Targeted therapy (kinase inhibitors) is used for cancers with metastasis",
      "External beam radiation therapy is used for metastatic cancers not amenable to surgery or RAI"
    ]
  },
  {
    "id": "Medical-31dd8ffb",
    "source": "Medical",
    "question": "What are the main diagnostic methods used for primary bone cancer and what types of tests are included in the diagnostic process?",
    "answer": "Primary bone cancer is diagnosed using imaging tests such as X-ray, bone scan, CT scan, MRI, and PET scan, along with biopsy, blood tests, bone marrow tests, genetic cancer risk testing, and biomarker testing.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan",
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation",
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden",
      "Biopsy includes core needle biopsy and surgical biopsy",
      "Bone marrow tests include bone marrow aspirate and bone marrow biopsy"
    ]
  },
  {
    "id": "Medical-8d17a0a2",
    "source": "Medical",
    "question": "Which subtypes of bone sarcoma are recognized and what are their characteristic anatomic locations?",
    "answer": "Recognized bone sarcoma subtypes include osteosarcoma (metaphysis near growth plates), Ewing sarcoma (diaphysis and flat bones), chondrosarcoma (cartilage-forming cells), chordoma (sacrum or base of skull), and giant cell tumor of bone (metaphysis and epiphysis).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Bone sarcomas include osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma, and giant cell tumor of bone",
      "Osteosarcoma commonly arises in the metaphysis near growth plates",
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Chondrosarcoma starts in cartilage-forming cells",
      "Chordoma arises from notochordal cells, typically in the sacrum or base of skull",
      "Giant cell tumor of bone often occurs in the metaphysis and epiphysis",
      "Ewing sarcoma anatomic location: diaphysis, flat bones (pelvis, scapula)"
    ]
  },
  {
    "id": "Medical-0002d2de",
    "source": "Medical",
    "question": "How are bone cancers staged and what factors are considered in determining the stage?",
    "answer": "Bone cancers are staged using the TNM system, which considers tumor size/location (T), lymph node involvement (N), metastasis (M), and tumor grade (G), with the final stage determined by combining these scores.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)",
      "Tumor grade (G) describes histologic differentiation",
      "Stage is determined by combining T, N, M, and G scores",
      "Numbered stages include Stage I, Stage II, Stage III, and Stage IV",
      "TNM staging includes T1-T4, N0-N1, M0-M1",
      "Tumor grade includes G1, G2, G3, GX"
    ]
  },
  {
    "id": "Medical-6da13b57",
    "source": "Medical",
    "question": "What are the key biomarkers and genetic alterations in bone cancer, and how do they inform targeted therapy?",
    "answer": "Key biomarkers and genetic alterations in bone cancer include EWSR1-FLI1 and EWSR1-ERG fusions in Ewing sarcoma, IDH1 mutation in chondrosarcoma (targeted by ivosidenib), and MSI-H/dMMR or TMB-H status (treated with pembrolizumab, nivolumab, or ipilimumab).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
      "MSI-H/dMMR status may be treated with pembrolizumab",
      "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden",
      "Genetic Alteration includes EWSR1-FLI1 fusion, EWSR1-ERG fusion, IDH1 mutation, MSI-H, dMMR, TMB-H"
    ]
  },
  {
    "id": "Medical-3e66af03",
    "source": "Medical",
    "question": "What are the main risk factors and symptoms associated with primary bone cancer?",
    "answer": "Primary bone cancer risk factors include family history of cancer and germline mutations, while common symptoms are bone pain and hypercalcemia resulting from bone destruction.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Risk Factor includes Family history of cancer, Germline mutations",
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk",
      "Bone cancer can cause hypercalcemia due to bone destruction",
      "Symptom includes Bone pain, Hypercalcemia",
      "Primary bone cancer originates in bone or cartilage"
    ]
  },
  {
    "id": "Medical-5f6b723d",
    "source": "Medical",
    "question": "How does performance status influence treatment planning in bone cancer patients?",
    "answer": "Performance status, assessed by ECOG or Karnofsky Performance Status (KPS), is an important consideration in treatment planning for bone cancer patients.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Performance status (ECOG or KPS) is considered in treatment planning",
      "Performance Status includes ECOG performance status, Karnofsky Performance Status (KPS)",
      "ECOG and KPS are used to assess patient functional status",
      "Treatment planning for bone cancer incorporates performance status",
      "ECOG and KPS are performance status scales included in the ontology"
    ]
  },
  {
    "id": "Medical-d72543ef",
    "source": "Medical",
    "question": "What fertility considerations should be addressed prior to initiating bone cancer treatment?",
    "answer": "Because some treatments for bone cancer can affect fertility, fertility preservation should be discussed with patients before starting therapy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment",
      "Fertility Consideration includes Fertility preservation",
      "Fertility preservation is a consideration prior to therapy",
      "Certain treatments may impact reproductive potential",
      "Fertility preservation is included in the ontology as a consideration for bone cancer patients"
    ]
  },
  {
    "id": "Medical-ee0d07fe",
    "source": "Medical",
    "question": "How do primary and secondary bone cancers differ in origin and classification?",
    "answer": "Primary bone cancer arises from bone or cartilage, most commonly as sarcomas, whereas secondary bone malignancies are cancers that have metastasized to bone from other organs such as breast, lung, or kidney.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary bone cancer originates in bone or cartilage",
      "Most primary bone cancers are sarcomas",
      "Secondary bone malignancies are cancers that have metastasized to bone from other organs",
      "Secondary bone malignancy origin includes breast cancer, lung cancer, kidney cancer",
      "Bone sarcomas include osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma, and giant cell tumor of bone"
    ]
  },
  {
    "id": "Medical-880d8f25",
    "source": "Medical",
    "question": "What is the role of biomarker and genetic testing in the evaluation and management of bone cancer?",
    "answer": "Biomarker and genetic testing in bone cancer involve identifying gene mutations, protein expression, and tumor mutational burden, which aid in risk assessment and guide targeted therapy options.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden",
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk",
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
      "MSI-H/dMMR status may be treated with pembrolizumab",
      "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab"
    ]
  },
  {
    "id": "Medical-2a43b505",
    "source": "Medical",
    "question": "What are the main diagnostic methods and clinical assessments used for mouth cancer?",
    "answer": "Mouth cancer diagnosis relies on imaging tests such as CT, MRI, PET/CT, ultrasound, and Panorex, combined with biopsy and clinical assessments including dental exam, speech and swallowing assessment, nutrition assessment, and evaluation of performance status (ECOG).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Biopsy is required to confirm diagnosis and determine histology",
      "Panoramic dental x-ray (Panorex) is listed as a diagnostic method for mouth cancer",
      "Clinical assessments include dental exam, speech and swallowing assessment, and nutrition assessment",
      "Performance status (ECOG) is considered in treatment selection"
    ]
  },
  {
    "id": "Medical-181fe114",
    "source": "Medical",
    "question": "How is mouth cancer staged and what criteria are used in the TNM classification?",
    "answer": "Mouth cancer staging is based on the TNM system, which evaluates tumor size and depth (T), lymph node involvement (N), and distant metastasis (M), with depth of invasion (DOI) specifically used to assess tumor extension.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)",
      "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer",
      "TNM staging is listed as part of the ontology for mouth cancer",
      "The TNM classification includes Tis, T1, T2, T3, T4a, and T4b categories",
      "Regional lymph node and extranodal extension are specified in the TNM system"
    ]
  },
  {
    "id": "Medical-251615ea",
    "source": "Medical",
    "question": "Which anatomic sites are commonly affected by squamous cell carcinoma (SCC) of the mouth?",
    "answer": "Squamous cell carcinoma (SCC) of the mouth commonly affects the lips, gums, buccal mucosa, tongue (front two-thirds), hard palate, alveolar ridge, floor of mouth, and retromolar trigone.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer",
      "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone",
      "SCC's anatomic sites include: Lips (mucosal lip), Gums (gingiva), Buccal mucosa, Tongue (front two-thirds), Hard palate, Alveolar ridge, Floor of mouth, Retromolar trigone",
      "The ontology lists these sites under SCC of mouth cancer",
      "Oral cavity cancer is another term for mouth cancer, encompassing these sites"
    ]
  },
  {
    "id": "Medical-1e74344c",
    "source": "Medical",
    "question": "What biomarkers are tested in mouth cancer and how might they inform management?",
    "answer": "Biomarker testing in mouth cancer may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB), which can provide information relevant to prognosis and treatment planning.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)",
      "Biomarker is a core concept for mouth cancer in the ontology",
      "PD-L1, MSI-H/dMMR, and TMB are listed as biomarkers under SCC of mouth cancer",
      "Biomarker testing is included in the management of mouth cancer",
      "Biomarker results may influence treatment decisions"
    ]
  },
  {
    "id": "Medical-69c5e22f",
    "source": "Medical",
    "question": "What are the major risk factors for developing mouth cancer and their impact on outcomes?",
    "answer": "Tobacco use, alcohol use, smoking, and vaping are major risk factors for mouth cancer, and continued smoking or vaping negatively affects treatment outcomes and increases toxicity.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Tobacco and alcohol use are risk factors for mouth cancer",
      "Smoking or vaping negatively affects treatment outcomes and increases toxicity",
      "Risk factors for mouth cancer include tobacco use, alcohol use, smoking, and vaping",
      "These risk factors are listed in the ontology for SCC of mouth cancer",
      "Alcohol and tobacco are repeatedly cited as important contributors to mouth cancer risk"
    ]
  },
  {
    "id": "Medical-61a5ec94",
    "source": "Medical",
    "question": "How is treatment for mouth cancer determined and what factors are considered in planning?",
    "answer": "Treatment planning for mouth cancer is based on tumor location and stage, with performance status (ECOG) also considered to guide appropriate therapy selection.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment planning is based on tumor location and stage",
      "Performance status (ECOG) is considered in treatment selection",
      "Stage and anatomic site are included in the ontology as determinants for treatment",
      "Mouth cancer management includes assessment of performance status",
      "Tumor location is a key factor in the treatment decision process"
    ]
  },
  {
    "id": "Medical-088c7ad0",
    "source": "Medical",
    "question": "What are the common symptoms and additional health considerations for patients with mouth cancer?",
    "answer": "Symptoms of mouth cancer may include changes in the mouth, tongue, or neck area, and both the cancer and its treatment can impact dental health and fertility.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms may include changes in the mouth, tongue, or neck area",
      "Dental health is affected by head and neck cancer and its treatment",
      "Cancer and its treatment can affect fertility",
      "Fertility preservation is listed as a consideration in the ontology",
      "Dental exam is included in the clinical assessment for mouth cancer"
    ]
  },
  {
    "id": "Medical-b17a5c65",
    "source": "Medical",
    "question": "What fertility considerations are relevant for patients with mouth cancer?",
    "answer": "Cancer and its treatment can affect fertility, so fertility preservation is an important consideration in the management of mouth cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cancer and its treatment can affect fertility",
      "Fertility preservation is included as a consideration in the ontology",
      "Fertility Consideration is a core concept for mouth cancer",
      "Fertility preservation is listed as an option for patients",
      "Mouth cancer management includes assessment of fertility impact"
    ]
  },
  {
    "id": "Medical-c9e77dca",
    "source": "Medical",
    "question": "What is the relationship between mouth cancer, its subtypes, and head and neck cancer?",
    "answer": "Mouth cancer, also known as oral cavity cancer, is a subtype of head and neck cancer, with squamous cell carcinoma (SCC) being the most common form.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Mouth cancer is a type of head and neck cancer",
      "Oral cavity cancer is another term for mouth cancer",
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer",
      "The ontology lists mouth cancer under head and neck cancer",
      "Mouth cancer is further classified into subtypes such as SCC"
    ]
  },
  {
    "id": "Medical-eb6686a0",
    "source": "Medical",
    "question": "What are the main diagnostic methods and risk factors for stomach cancer?",
    "answer": "Stomach cancer is diagnosed using imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing, with risk factors including H. pylori infection and family history.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "H. pylori infection is a risk factor for stomach cancer",
      "Family history is a risk factor for stomach cancer",
      "Stomach cancer includes diagnostic methods: imaging tests, endoscopy, biopsy, biomarker testing, genetic risk testing",
      "Stomach cancer includes risk factors: H. pylori infection, family history"
    ]
  },
  {
    "id": "Medical-4641d74e",
    "source": "Medical",
    "question": "How are the stages of stomach cancer defined and what patterns of spread are associated with each stage?",
    "answer": "Early-stage stomach cancer is confined to the mucosa and not present in lymph nodes, locoregional stomach cancer invades other stomach wall layers and/or regional lymph nodes or nearby organs, while metastatic stomach cancer spreads to distant organs such as the liver, peritoneum, and distant lymph nodes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes",
      "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen",
      "Spread Pattern: Local includes stomach wall layers and regional lymph nodes; Distant includes liver, peritoneum, distant lymph nodes, pancreas, and spleen"
    ]
  },
  {
    "id": "Medical-9e6a8495",
    "source": "Medical",
    "question": "What are the major subtypes of stomach adenocarcinoma and how do they differ in cellular structure and clinical features?",
    "answer": "Stomach adenocarcinoma consists of intestinal and diffuse subtypes, with the intestinal type forming tube- and gland-shaped structures and being more likely to have mutations treatable with targeted therapy, while the diffuse type consists of scattered cells and is less common.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse",
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy",
      "Diffuse type adenocarcinoma consists of scattered cells and is less common",
      "Adenocarcinomas originate from cells lining the inside of the stomach that secrete mucus",
      "Adenocarcinoma has subtypes: Intestinal type adenocarcinoma, Diffuse type adenocarcinoma"
    ]
  },
  {
    "id": "Medical-6f917f07",
    "source": "Medical",
    "question": "What are the anatomical locations and wall layers relevant to stomach cancer development and progression?",
    "answer": "Stomach cancer can develop in anatomical locations such as the cardia, fundus, body, antrum, pylorus, and esophagogastric junction, and progresses outward through the stomach wall layers: mucosa, submucosa, muscle layer (muscularis propria), subserosa, and serosa.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Anatomical Location: Cardia, Fundus, Body, Antrum, Pylorus, Esophagogastric junction",
      "Stomach Wall Layer: Mucosa, Submucosa, Muscle layer (muscularis propria), Subserosa, Serosa",
      "Stomach cancer spreads outward through the layers of the stomach wall",
      "Precancerous changes often occur in the mucosa before cancer develops",
      "Stomach cancer develops in various anatomical locations and progresses through defined wall layers"
    ]
  },
  {
    "id": "Medical-6b047fee",
    "source": "Medical",
    "question": "What are the key symptoms and physical manifestations of stomach cancer?",
    "answer": "Stomach cancer can present with symptoms such as ulcer or mass formation in the stomach.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms can include ulcer or mass formation in the stomach",
      "Symptom: Ulcer, Mass",
      "Stomach cancer is associated with the formation of ulcers and masses",
      "Ulcer and mass are listed as symptoms of stomach cancer in the ontology",
      "Ulcer and mass are physical manifestations of stomach cancer"
    ]
  },
  {
    "id": "Medical-a9f73379",
    "source": "Medical",
    "question": "How does stomach cancer typically spread within and beyond the stomach?",
    "answer": "Stomach cancer spreads locally through the stomach wall layers and regional lymph nodes, and distantly to organs such as the liver, peritoneum, distant lymph nodes, pancreas, and spleen.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Stomach cancer spreads outward through the layers of the stomach wall",
      "Spread Pattern: Local includes stomach wall layers and regional lymph nodes",
      "Spread Pattern: Distant includes liver, peritoneum, distant lymph nodes, pancreas, and spleen",
      "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes"
    ]
  },
  {
    "id": "Medical-77d91ba8",
    "source": "Medical",
    "question": "Which risk factors and genetic predispositions are associated with stomach cancer development?",
    "answer": "Stomach cancer risk factors include H. pylori infection and family history, with genetic risk testing used to identify inherited predispositions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "H. pylori infection is a risk factor for stomach cancer",
      "Family history is a risk factor for stomach cancer",
      "Genetic Risk Factor: Family history",
      "Risk Factor: H. pylori infection, Family history",
      "Diagnosis involves genetic risk testing"
    ]
  },
  {
    "id": "Medical-e1db913e",
    "source": "Medical",
    "question": "What sequence of pathological changes leads to the development of stomach cancer?",
    "answer": "Stomach cancer often develops after precancerous changes occur in the mucosa, with adenocarcinomas originating from mucus-secreting cells lining the stomach.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Precancerous changes often occur in the mucosa before cancer develops",
      "Adenocarcinomas originate from cells lining the inside of the stomach that secrete mucus",
      "Early-stage stomach cancer is confined to the mucosa",
      "Stomach Wall Layer: Mucosa is the innermost layer",
      "Stomach cancer arises in the stomach"
    ]
  },
  {
    "id": "Medical-05f3bf13",
    "source": "Medical",
    "question": "What are the main subtypes of glioma and how are they classified by grade and biomarkers?",
    "answer": "The main subtypes of glioma are astrocytoma, oligodendroglioma, and glioblastoma, which are classified by histology, grade (with grades 1 and 2 as low-grade and grades 3 and 4 as high-grade), and biomarkers such as IDH mutation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma",
      "Gliomas are classified by histology, grade, and biomarkers",
      "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas",
      "IDH mutation is a biomarker used to classify gliomas",
      "Astrocytoma and oligodendroglioma both include IDH mutation as a biomarker in the ontology"
    ]
  },
  {
    "id": "Medical-2148aacc",
    "source": "Medical",
    "question": "What diagnostic methods are used to identify and classify gliomas?",
    "answer": "Glioma diagnosis involves neurological exam, imaging such as MRI and CT scan, and tissue sampling through biopsy, with MRI being the most useful imaging test and biopsy required for definitive diagnosis and molecular testing.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy",
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing",
      "Clinical Evaluation includes neurological exam and performance status",
      "Imaging includes MRI and CT scan; tissue sampling includes biopsy, stereotactic biopsy, open biopsy, and resection"
    ]
  },
  {
    "id": "Medical-5905da7e",
    "source": "Medical",
    "question": "What are the typical symptoms experienced by patients with glioma?",
    "answer": "Glioma commonly presents with symptoms such as headache, seizures, fatigue, nausea, vomiting, cognitive changes, memory loss, speech difficulties, muscle weakness, balance problems, personality changes, and vision problems.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems",
      "Symptom list in ontology includes memory loss, speech difficulties, muscle weakness, balance problems, personality changes, and vision problems",
      "Headache is a symptom of glioma",
      "Seizure is a symptom of glioma",
      "Cognitive changes and personality changes are symptoms of glioma"
    ]
  },
  {
    "id": "Medical-74be0fed",
    "source": "Medical",
    "question": "What are the standard treatment options for glioma and how does grade influence therapy?",
    "answer": "Standard treatment options for glioma include surgery (resection or biopsy), radiation therapy, chemotherapy, and clinical trials, with high-grade gliomas requiring additional therapy after surgery.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials",
      "Surgery may involve resection or biopsy",
      "High-grade gliomas require additional therapy after surgery",
      "Treatment ontology includes surgery, radiation therapy, chemotherapy, and clinical trial",
      "Gliomas are rarely curable but are treatable"
    ]
  },
  {
    "id": "Medical-1991db28",
    "source": "Medical",
    "question": "How is follow-up care managed in patients with glioma?",
    "answer": "Follow-up care for glioma patients involves periodic imaging, especially follow-up MRI, to monitor for recurrence after initial treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence",
      "Follow-up MRI is included in the follow-up ontology",
      "Periodic imaging is part of follow-up care for glioma",
      "MRI is the most useful imaging test for identifying glioma",
      "Gliomas are rarely curable but are treatable, necessitating ongoing monitoring"
    ]
  },
  {
    "id": "Medical-f3cb62dc",
    "source": "Medical",
    "question": "What are the key risk factors and demographic patterns associated with glioma?",
    "answer": "Gliomas are more common in adults than children and most are not hereditary, with non-hereditary mutations and age being notable risk factors.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Gliomas are more common in adults than children",
      "Most gliomas are not hereditary",
      "Risk Factor ontology includes age (more common in adults) and non-hereditary mutation",
      "Gliomas develop from glial cells in the central nervous system",
      "Gliomas are a type of malignant brain tumor"
    ]
  },
  {
    "id": "Medical-8171339b",
    "source": "Medical",
    "question": "How does performance status affect treatment decisions in glioma patients?",
    "answer": "Performance status is assessed in glioma patients to determine eligibility for specific treatments and is part of the clinical evaluation during diagnosis and management.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Performance status is assessed to determine treatment eligibility",
      "Clinical Evaluation in the ontology includes performance status",
      "Diagnosis of glioma involves neurological exam and performance status",
      "Performance status is an entity listed for glioma management",
      "Treatment options are influenced by the patient's performance status"
    ]
  },
  {
    "id": "Medical-c1c8e6d9",
    "source": "Medical",
    "question": "What is the relationship between glioma grade and prognosis?",
    "answer": "Low-grade gliomas (grades 1 and 2) have a better prognosis, while high-grade gliomas (grades 3 and 4), especially glioblastoma, are associated with poorer outcomes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas",
      "Low-grade gliomas have better prognosis",
      "High-grade gliomas have poorer prognosis",
      "Glioblastoma is the most aggressive subtype of glioma",
      "Grade 4 gliomas are most commonly glioblastomas"
    ]
  },
  {
    "id": "Medical-a7769409",
    "source": "Medical",
    "question": "Which genetic alterations and biomarkers are important in the classification and management of gliomas?",
    "answer": "IDH mutation is a key genetic alteration and biomarker used in the classification of astrocytoma and oligodendroglioma, influencing diagnosis and management strategies.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "IDH mutation is a biomarker used to classify gliomas",
      "Astrocytoma and oligodendroglioma both include IDH mutation as a biomarker in the ontology",
      "IDH mutation is listed as a genetic alteration in glioma ontology",
      "Biopsy is required for definitive diagnosis and molecular testing",
      "Laboratory Testing in the ontology includes molecular testing and histology"
    ]
  },
  {
    "id": "Medical-25f9adbb",
    "source": "Medical",
    "question": "What are the main diagnostic methods and laboratory tests used to diagnose AML?",
    "answer": "AML diagnosis involves laboratory tests such as CBC, CMP, LDH, and blood clotting tests, bone marrow aspirate and biopsy, flow cytometry and immunophenotyping, molecular and cytogenetic testing, and imaging studies like CT, MRI, and PET/CT.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Laboratory Tests include complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests",
      "Bone Marrow Evaluation includes bone marrow aspirate, bone marrow biopsy, and histopathology",
      "Imaging (CT, MRI, PET/CT) is used to assess extramedullary disease or complications",
      "Flow Cytometry: flow cytometry, immunophenotyping",
      "Molecular and Cytogenetic Testing: karyotype, FISH, next-generation sequencing (NGS), PCR"
    ]
  },
  {
    "id": "Medical-0d99173e",
    "source": "Medical",
    "question": "Which genetic alterations and biomarkers are commonly associated with AML and how do they influence treatment?",
    "answer": "Common genetic alterations and biomarkers in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), PML::RARA, and CD33; these guide the use of targeted therapies such as FLT3 inhibitors for FLT3-mutated AML and gemtuzumab ozogamicin for CD33-positive AML.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment",
      "Targeted therapies are used for AML with specific genetic alterations, such as FLT3 inhibitors for FLT3-mutated AML and gemtuzumab ozogamicin for CD33-positive AML",
      "Biomarker: CD33, PML::RARA, FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), RUNX1::RUNX1T1",
      "Genetic Alteration: FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), PML::RARA, RUNX1::RUNX1T1"
    ]
  },
  {
    "id": "Medical-18c0b2dd",
    "source": "Medical",
    "question": "What are the main treatment modalities and phases for AML, and how are they selected?",
    "answer": "AML treatment consists of chemotherapy, hypomethylating agents, targeted therapy, and hematopoietic cell transplant, delivered in induction, consolidation, and maintenance phases, with selection influenced by genetic alterations, performance status, and general health.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Chemotherapy is the standard of care for AML",
      "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin), and hypomethylating agents (e.g., azacitidine, decitabine)",
      "Treatment for AML is delivered in phases with the goal of achieving remission",
      "Hematopoietic cell transplant is considered for eligible patients",
      "Performance status and general health influence treatment selection",
      "Treatment Phase: induction, consolidation, maintenance",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment"
    ]
  },
  {
    "id": "Medical-27277239",
    "source": "Medical",
    "question": "How are AML subtypes defined and what are key features of notable subtypes?",
    "answer": "AML subtypes are defined by gene mutations or abnormal chromosomes, with notable subtypes such as APL characterized by the PML::RARA fusion gene and BPDCN involving blood, bone marrow, lymph nodes, and skin.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "AML subtypes are defined by gene mutations or abnormal chromosomes",
      "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of AML",
      "Acute promyelocytic leukemia (APL): Genetic Alteration: PML::RARA",
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN): Sites of Involvement: blood, bone marrow, lymph nodes, skin"
    ]
  },
  {
    "id": "Medical-192138ad",
    "source": "Medical",
    "question": "What are the typical symptoms and risk factors associated with AML?",
    "answer": "Typical symptoms of AML include fatigue, infections, bleeding, and bruising, while risk factors include family history of leukemia and hereditary predisposition syndromes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of AML include fatigue, infections, bleeding, and bruising",
      "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells",
      "Symptom: fatigue, infections, bleeding, bruising",
      "Risk Factor: family history of leukemia, leukemia predisposition syndrome",
      "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML"
    ]
  },
  {
    "id": "Medical-7099cc9f",
    "source": "Medical",
    "question": "What supportive care measures are important during AML treatment and why?",
    "answer": "Supportive care for AML includes transfusions, infection prevention, and side effect management, which are essential due to low blood cell counts and treatment-related complications.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Supportive care includes transfusions, infection prevention, and management of side effects",
      "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells",
      "Chemotherapy is the standard of care for AML",
      "Supportive Care: transfusions, infection prevention, side effect management",
      "Symptoms of AML include infections, bleeding, and bruising"
    ]
  },
  {
    "id": "Medical-dcbc35dd",
    "source": "Medical",
    "question": "Which factors are considered prognostic in AML and how do they impact treatment decisions?",
    "answer": "Prognostic factors in AML include genetic alterations, performance status, age, and response to induction therapy, all of which influence treatment selection and expected outcomes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Prognostic Factor: genetic alterations, performance status, age, response to induction therapy",
      "Performance status and general health influence treatment selection",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment",
      "Treatment for AML is delivered in phases with the goal of achieving remission",
      "Performance Status: Eastern Cooperative Oncology Group (ECOG) score, Karnofsky Performance Status (KPS)"
    ]
  },
  {
    "id": "Medical-7d2a19f6",
    "source": "Medical",
    "question": "What considerations are recommended regarding fertility for patients with AML before treatment?",
    "answer": "Fertility preservation should be discussed before starting systemic therapy for AML, with options including counseling and referral to a reproductive specialist.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Fertility preservation should be discussed before starting systemic therapy",
      "Fertility Preservation: fertility preservation counseling, referral to reproductive specialist",
      "Chemotherapy is the standard of care for AML",
      "Treatment for AML is delivered in phases with the goal of achieving remission",
      "General health and performance status influence treatment selection"
    ]
  },
  {
    "id": "Medical-3276a6de",
    "source": "Medical",
    "question": "How is performance status assessed in AML and why is it important?",
    "answer": "Performance status in AML is assessed using the ECOG score or Karnofsky Performance Status, and it is important because it guides treatment selection and prognosis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Performance status and general health influence treatment selection",
      "Performance Status: Eastern Cooperative Oncology Group (ECOG) score, Karnofsky Performance Status (KPS)",
      "Prognostic Factor: genetic alterations, performance status, age, response to induction therapy",
      "Treatment for AML is delivered in phases with the goal of achieving remission",
      "Chemotherapy is the standard of care for AML"
    ]
  },
  {
    "id": "Medical-03a82e56",
    "source": "Medical",
    "question": "What are the main subtypes of ovarian cancer and how are related cancers managed?",
    "answer": "Ovarian cancer consists primarily of epithelial and non-epithelial subtypes, with high-grade serous and high-grade endometrioid carcinomas being most common, and related cancers such as primary peritoneal and fallopian tube cancer are managed similarly to ovarian cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium",
      "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes of epithelial ovarian cancer",
      "Less common ovarian cancers include low-grade serous carcinoma, low-grade endometrioid carcinoma, carcinosarcoma, clear cell carcinoma, mucinous carcinoma, borderline epithelial tumor, malignant sex-cord stromal tumors, and malignant germ cell tumors",
      "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer",
      "Epithelial ovarian cancer includes common subtypes: High-grade serous carcinoma (HGSC), High-grade endometrioid carcinoma; and less common subtypes: Low-grade serous carcinoma, Low-grade endometrioid carcinoma, Carcinosarcoma, Clear cell carcinoma, Mucinous carcinoma, Borderline epithelial tumor"
    ]
  },
  {
    "id": "Medical-8e6563e6",
    "source": "Medical",
    "question": "What diagnostic methods and biomarkers are used in the evaluation of ovarian cancer?",
    "answer": "Diagnosis of ovarian cancer involves imaging modalities such as ultrasound, CT, MRI, and PET, as well as physical examination, biopsy, and blood tests for tumor markers including CA-125, HE4, and various genetic alterations like BRCA mutations and HRD status.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers",
      "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion",
      "Diagnostic Method includes: Abdominal and pelvic exam, Ultrasound, Transvaginal ultrasound, CT scan, MRI, PET scan, Chest x-ray, Diagnostic laparoscopy, Biopsy, Fine-needle aspiration (FNA), Core biopsy, Paracentesis, Colonoscopy, Upper endoscopy, Complete blood count (CBC), Blood chemistry profile, Liver function tests, Tumor marker tests",
      "Biomarker: Tumor Markers include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, HE4",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer"
    ]
  },
  {
    "id": "Medical-a3c885aa",
    "source": "Medical",
    "question": "Which hereditary and genetic risk factors are associated with ovarian cancer?",
    "answer": "Ovarian cancer risk is significantly increased by hereditary factors such as BRCA1 and BRCA2 mutations and Lynch syndrome, and genetic testing for these and other hereditary syndromes is recommended for all patients.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer",
      "Risk Factor includes: BRCA1 mutation, BRCA2 mutation, Lynch syndrome, Family history",
      "Biomarker: Genetic Alteration includes BRCA1 mutation, BRCA2 mutation, Homologous recombination deficiency (HRD), Microsatellite instability (MSI), Mismatch repair (MMR)",
      "Ovarian cancer includes risk factors such as family history and hereditary syndromes"
    ]
  },
  {
    "id": "Medical-14de13d0",
    "source": "Medical",
    "question": "What are the standard initial treatments and surgical procedures for ovarian cancer?",
    "answer": "The standard initial treatment for most ovarian cancers is surgery, typically hysterectomy with bilateral salpingo-oophorectomy, often followed by chemotherapy, and fertility-sparing surgery may be considered for select early-stage cases.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers",
      "Fertility-sparing surgery may be considered for select early-stage cases",
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages",
      "Surgical Procedure includes: Hysterectomy, Bilateral salpingo-oophorectomy (BSO), Unilateral salpingo-oophorectomy (USO), Debulking surgery, Cytoreductive surgery, Interval cytoreductive surgery (ICS), Laparotomy, Laparoscopy, Peritoneal washing",
      "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging"
    ]
  },
  {
    "id": "Medical-fb67edf6",
    "source": "Medical",
    "question": "What chemotherapy regimens and maintenance therapies are commonly used in ovarian cancer treatment?",
    "answer": "Ovarian cancer is commonly treated with chemotherapy regimens such as paclitaxel and carboplatin, with bevacizumab sometimes added, and maintenance therapy with PARP inhibitors like olaparib, niraparib, or rucaparib is recommended for advanced or BRCA-mutated/HRD-positive cases.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages",
      "Bevacizumab may be added to chemotherapy in some cases",
      "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment",
      "Chemotherapy Regimen includes: Paclitaxel, Carboplatin, Cisplatin, Oxaliplatin, Docetaxel, Bevacizumab (Avastin)",
      "Maintenance Therapy includes: Olaparib (Lynparza), Niraparib (Zejula), Rucaparib (Rubraca), Bevacizumab (Avastin), Mirvetuximab soravtansine-gynx (Elahere)"
    ]
  },
  {
    "id": "Medical-28687496",
    "source": "Medical",
    "question": "How is recurrence of ovarian cancer managed based on platinum sensitivity and biomarker status?",
    "answer": "Recurrence in ovarian cancer is managed by assessing platinum sensitivity and biomarker status, with platinum-sensitive cases receiving platinum-based chemotherapy and possibly surgery, while platinum-resistant cases are treated with non-platinum chemotherapy, bevacizumab, targeted therapies, or immunotherapy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment",
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors",
      "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery",
      "Recurrence: Platinum-sensitive includes: Platinum-based chemotherapy, Bevacizumab, Secondary cytoreductive surgery, Maintenance therapy with PARP inhibitor",
      "Recurrence: Platinum-resistant includes: Non-platinum chemotherapy, Bevacizumab, Mirvetuximab soravtansine-gynx (Elahere), Targeted therapy, Immunotherapy"
    ]
  },
  {
    "id": "Medical-9601f6f1",
    "source": "Medical",
    "question": "What symptoms are commonly associated with ovarian cancer and how are they categorized?",
    "answer": "Common symptoms of ovarian cancer include persistent bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, pain during sex, fatigue, unexplained weight loss, and constipation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex",
      "Symptom: Persistent bloating, Pelvic pain, Abdominal pain, Trouble eating, Feeling full quickly, Urinary urgency, Urinary frequency, Pain during sex, Fatigue, Unexplained weight loss, Constipation",
      "Ovarian cancer includes symptoms such as persistent bloating, pelvic pain, abdominal pain, and trouble eating",
      "Ovarian cancer symptoms include urinary urgency, urinary frequency, and pain during sex",
      "Fatigue, unexplained weight loss, and constipation are also symptoms of ovarian cancer"
    ]
  },
  {
    "id": "Medical-19aa2257",
    "source": "Medical",
    "question": "What surveillance strategies are recommended after initial treatment for ovarian cancer?",
    "answer": "Post-treatment surveillance for ovarian cancer includes regular physical and pelvic examinations, monitoring of CA-125 or other tumor markers, and imaging as indicated.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers",
      "Surveillance: Physical and pelvic exams, CA-125 or tumor marker monitoring, Imaging as indicated",
      "Tumor marker tests are part of surveillance after ovarian cancer treatment",
      "Imaging modalities such as ultrasound, CT, and MRI may be used during surveillance as indicated",
      "CA-125 is a commonly monitored tumor marker in ovarian cancer surveillance"
    ]
  },
  {
    "id": "Medical-ee34cda2",
    "source": "Medical",
    "question": "How are clinical trials integrated into the management of recurrent or persistent ovarian cancer?",
    "answer": "Clinical trial enrollment is recommended as a management option for patients with recurrent or persistent ovarian cancer, especially when standard therapies are insufficient.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment",
      "Clinical trials are recommended for recurrent or persistent ovarian cancer",
      "Clinical Trial: Clinical trial enrollment for recurrent or persistent disease",
      "Ovarian cancer management includes clinical trial participation for certain patients",
      "Clinical trial enrollment is considered for patients with recurrent or persistent ovarian cancer"
    ]
  },
  {
    "id": "Medical-fc7727b2",
    "source": "Medical",
    "question": "What are the main diagnostic methods and biomarkers used in the diagnosis and management of CLL?",
    "answer": "CLL is diagnosed and managed using blood tests including complete blood count and flow cytometry for immunophenotyping, biopsies, FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, karyotype analysis, and measurement of beta-2 microglobulin.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis"
    ]
  },
  {
    "id": "Medical-403bb394",
    "source": "Medical",
    "question": "What symptoms and risk factors are commonly associated with CLL?",
    "answer": "Common symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss, while risk factors include older age and a family history of CLL.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss",
      "CLL may be asymptomatic and discovered incidentally on routine blood testing",
      "Risk factors for CLL include older age and family history of CLL",
      "Family history increases the risk of developing CLL",
      "Older age is a risk factor for CLL"
    ]
  },
  {
    "id": "Medical-b9f1cbe3",
    "source": "Medical",
    "question": "How do clinical management and follow-up strategies guide the care of CLL patients?",
    "answer": "CLL management involves assessing performance status, conducting pregnancy testing and considering fertility preservation, with follow-up strategies that include watch and wait, regular monitoring, and supportive care.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Performance status and comprehensive metabolic panel are used in treatment planning",
      "Pregnancy testing and fertility preservation are considered before starting treatment",
      "Follow-up strategies include watch and wait, regular monitoring, and supportive care",
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression",
      "Supportive care is part of the follow-up strategy for CLL"
    ]
  },
  {
    "id": "Medical-0d661e08",
    "source": "Medical",
    "question": "What are the primary treatment options for CLL and when are they initiated?",
    "answer": "Treatment options for CLL include oral medications, IV infusions, combination therapies, watch and wait, and supportive care, with initiation based on symptoms, blood counts, and disease progression.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression",
      "Treatment options include oral medications, IV infusions, and combination therapies",
      "Watch and wait is a treatment approach for CLL",
      "Supportive care is included as a treatment for CLL",
      "Clinical management strategies inform when to initiate treatment"
    ]
  },
  {
    "id": "Medical-2c03807c",
    "source": "Medical",
    "question": "What complications can arise from CLL and what are their characteristics?",
    "answer": "A major complication of CLL is Richter transformation, where CLL transforms into a more aggressive lymphoma such as diffuse large B-cell lymphoma (DLBCL) or Hodgkin lymphoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma",
      "Complication: Richter transformation includes diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma",
      "CLL can progress to more aggressive lymphomas as a complication",
      "Richter transformation is a known risk during CLL disease course",
      "DLBCL and Hodgkin lymphoma are aggressive lymphomas associated with Richter transformation"
    ]
  },
  {
    "id": "Medical-d33066da",
    "source": "Medical",
    "question": "How are biomarkers and genetic alterations integrated into the prognosis and treatment planning for CLL?",
    "answer": "Biomarkers and genetic alterations such as 17p deletion, TP53 mutation, IGHV mutation, complex karyotype, and beta-2 microglobulin are assessed through FISH, DNA sequencing, and karyotype analysis to guide prognosis and inform treatment planning in CLL.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "Complex karyotype is a genetic alteration evaluated in CLL",
      "Performance status and comprehensive metabolic panel are used in treatment planning"
    ]
  },
  {
    "id": "Medical-0895dc9d",
    "source": "Medical",
    "question": "What distinguishes CLL from its subtype SLL in terms of primary site and presentation?",
    "answer": "CLL primarily affects the blood and bone marrow, while its subtype SLL involves the same cancer but is mainly found in lymph nodes and spleen.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes",
      "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen",
      "CLL: Primary Site includes blood and bone marrow",
      "SLL: Primary Site includes lymph nodes and spleen",
      "CLL and SLL are classified under the same disease spectrum"
    ]
  },
  {
    "id": "Medical-aa179e3f",
    "source": "Medical",
    "question": "What is the role of minimal residual disease in the management of CLL?",
    "answer": "Minimal residual disease in CLL represents a treatment goal indicating mostly healthy blood cells and is used to assess disease status after therapy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Minimal residual disease is a treatment goal indicating mostly healthy blood cells",
      "Disease Stage: Minimal residual disease is recognized in the CLL ontology",
      "Assessment of minimal residual disease is part of CLL management",
      "Minimal residual disease reflects response to treatment in CLL",
      "CLL clinical management includes monitoring for minimal residual disease"
    ]
  },
  {
    "id": "Medical-d94fa48e",
    "source": "Medical",
    "question": "Which laboratory and imaging studies are commonly employed to assess CLL at diagnosis and during follow-up?",
    "answer": "Common studies for CLL include complete blood count, flow cytometry, comprehensive metabolic panel, beta-2 microglobulin testing, and diagnostic CT scans to evaluate disease status and extent.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Comprehensive metabolic panel is used in treatment planning",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "Diagnostic CT scans may be used to assess lymph node involvement and disease extent"
    ]
  },
  {
    "id": "Medical-18e51427",
    "source": "Medical",
    "question": "What are the key risk factors and biomarkers associated with oropharyngeal squamous cell carcinoma?",
    "answer": "Oropharyngeal squamous cell carcinoma is strongly associated with HPV infection, especially HPV16, and tobacco and alcohol use are additional risk factors; key biomarkers include p16 protein overexpression, PD-L1, MSI-H/dMMR, and high tumor mutational burden.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma",
      "Tobacco and alcohol use are risk factors for head and neck cancers",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer",
      "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden",
      "Squamous cell carcinoma (SCC) includes biomarkers: p16 protein, HPV, HPV16, HPV18, PD-L1, MSI-H, dMMR, Tumor mutational burden-high (TMB-H)"
    ]
  },
  {
    "id": "Medical-bf479234",
    "source": "Medical",
    "question": "Which anatomic sites are most commonly involved in throat cancer and what are the main symptoms?",
    "answer": "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue, and typically presents with symptoms such as difficulty swallowing, sore throat, and changes in voice.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue",
      "Oropharynx includes soft palate, tonsils, base of tongue, side and back walls of throat",
      "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice",
      "Squamous cell carcinoma (SCC) includes symptoms: Difficulty swallowing, Sore throat, Voice changes",
      "Oropharyngeal cancer is a subtype of throat cancer"
    ]
  },
  {
    "id": "Medical-67d6c501",
    "source": "Medical",
    "question": "What diagnostic methods and procedures are used to evaluate and stage throat cancer?",
    "answer": "Evaluation and staging of throat cancer involve medical history, physical and dental exams, imaging studies such as CT scan, MRI, PET/CT, and ultrasound, scoping procedures like endoscopy and laryngoscopy, and tissue sampling via biopsy, including fine-needle aspiration and core needle biopsy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Biopsy is required for definitive diagnosis and biomarker testing",
      "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling",
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)",
      "Diagnostic Method includes: Medical history, Physical exam, Dental exam, Imaging (CT scan, MRI, PET/CT, Ultrasound, Panoramic dental x-ray), Scoping procedures (Endoscopy, Laryngoscopy, Nasolaryngoscopy, Esophagoscopy, Bronchoscopy, Panendoscopy), Biopsy (FNA, CNB, Endoscopic biopsy), Biomarker testing"
    ]
  },
  {
    "id": "Medical-aa279376",
    "source": "Medical",
    "question": "How is HPV status assessed and what is its clinical significance in oropharyngeal cancer?",
    "answer": "HPV status in oropharyngeal cancer is assessed using p16 (HPV) testing, which is recommended for all patients, and p16 protein overexpression serves as a surrogate biomarker for HPV-mediated disease, influencing prognosis and treatment planning.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer",
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
      "Biomarker testing includes p16 (HPV)",
      "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma",
      "Squamous cell carcinoma (SCC) includes genetic alterations: HPV-mediated, p16-positive, p16-negative"
    ]
  },
  {
    "id": "Medical-a3c71579",
    "source": "Medical",
    "question": "What staging systems and factors are used to determine the extent and prognosis of throat cancer?",
    "answer": "Throat cancer staging is based on the AJCC TNM system, which evaluates tumor size, lymph node involvement, and metastasis, and incorporates both clinical and pathologic stages; prognosis is further informed by factors such as ECOG performance status and HPV/p16 status.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)",
      "Clinical stage is determined before treatment using physical exam, imaging, and biopsy",
      "Pathologic stage is determined after surgery based on tissue examination",
      "Performance status (ECOG) is a prognostic factor considered in treatment planning",
      "Prognostic Factor includes: ECOG performance status, Tumor grade, HPV/p16 status"
    ]
  },
  {
    "id": "Medical-6809b810",
    "source": "Medical",
    "question": "What are the main types and subtypes of throat cancer and how are they classified within head and neck cancers?",
    "answer": "Throat cancer is classified as a subtype of head and neck cancer, with oropharyngeal cancer as a further subtype; squamous cell carcinoma is the most common type of throat cancer, often arising in the oropharynx.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Throat cancer is a type of head and neck cancer",
      "Oropharyngeal cancer is a subtype of throat cancer",
      "Squamous cell carcinoma is the most common type of throat cancer",
      "Oropharynx is a key anatomic site for throat cancer",
      "Head and neck cancer includes subtypes: Throat cancer, Oropharyngeal cancer, Squamous cell carcinoma (SCC)"
    ]
  },
  {
    "id": "Medical-3cf18099",
    "source": "Medical",
    "question": "Which biomarkers are tested in throat cancer and how do they influence treatment decisions?",
    "answer": "Biomarker testing in throat cancer includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden; PD-L1 expression may guide immunotherapy, while p16 status is particularly relevant for HPV-mediated disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden",
      "PD-L1 expression may guide immunotherapy treatment decisions",
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
      "Squamous cell carcinoma (SCC) includes biomarkers: p16 protein, HPV, HPV16, HPV18, PD-L1, MSI-H, dMMR, Tumor mutational burden-high (TMB-H)",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer"
    ]
  },
  {
    "id": "Medical-c2dcacec",
    "source": "Medical",
    "question": "How is tissue sampling performed for diagnosis and biomarker analysis in throat cancer?",
    "answer": "Tissue sampling for throat cancer diagnosis and biomarker analysis is performed using biopsy techniques such as fine-needle aspiration, core needle biopsy, and endoscopic biopsy, which provide material for definitive diagnosis and biomarker testing.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Biopsy is required for definitive diagnosis and biomarker testing",
      "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling",
      "Diagnostic Method includes: Biopsy, Fine-needle aspiration (FNA), Core needle biopsy (CNB), Endoscopic biopsy",
      "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden",
      "Squamous cell carcinoma (SCC) includes diagnostic methods: Biopsy, FNA, CNB, Endoscopic biopsy, Biomarker testing"
    ]
  },
  {
    "id": "Medical-f657d12f",
    "source": "Medical",
    "question": "What surveillance strategies are recommended for patients with throat cancer after initial treatment?",
    "answer": "Surveillance for throat cancer patients includes regular dental health assessment, imaging follow-up, and physical examinations to monitor for recurrence and manage complications.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Dental health assessment is important before treatment",
      "Surveillance includes: Dental health assessment, Imaging follow-up, Physical exam",
      "Squamous cell carcinoma (SCC) includes surveillance: Dental health assessment, Imaging follow-up, Physical exam",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Panoramic dental x-ray (Panorex) is included in diagnostic and surveillance imaging"
    ]
  },
  {
    "id": "Medical-ee0525ef",
    "source": "Medical",
    "question": "What are the main diagnostic methods and symptoms associated with cutaneous B-cell lymphoma (CBCL)?",
    "answer": "CBCL is primarily diagnosed using skin exam, blood tests, imaging tests, biopsy, and immunophenotyping, and it typically presents as nodules or papules under the skin.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Symptoms of CBCL include skin nodules and papules",
      "CBCL appears as nodules or papules under the skin",
      "Cutaneous B-cell lymphoma (CBCL) is a subtype of primary cutaneous lymphoma (PCL)",
      "CBCL includes symptoms: nodule, papule",
      "CBCL includes diagnostic methods: skin exam, blood test, imaging test, biopsy, immunophenotyping"
    ]
  },
  {
    "id": "Medical-2cb951c9",
    "source": "Medical",
    "question": "Which subtypes are classified under cutaneous B-cell lymphoma (CBCL), and what is their cell of origin?",
    "answer": "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type), all of which originate from B lymphocytes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "CBCL is a cancer subtype under B lymphocyte cell of origin",
      "Primary cutaneous lymphoma (PCL) develops from abnormal B or T lymphocytes",
      "CBCL includes subtypes: PCMZL, PCFCL, PC-DLBCL, leg type"
    ]
  },
  {
    "id": "Medical-84f32cc1",
    "source": "Medical",
    "question": "How does cutaneous B-cell lymphoma (CBCL) relate to non-Hodgkin lymphoma and primary cutaneous lymphoma in terms of classification and origin?",
    "answer": "CBCL is a subtype of primary cutaneous lymphoma, which itself is a type of non-Hodgkin lymphoma originating from abnormal B lymphocytes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "Cutaneous B-cell lymphoma (CBCL) is a subtype of primary cutaneous lymphoma (PCL)",
      "CBCL starts in B cells",
      "PCL develops from abnormal B or T lymphocytes",
      "CBCL is classified under B lymphocyte cell of origin in the ontology"
    ]
  },
  {
    "id": "Medical-1edecc97",
    "source": "Medical",
    "question": "What are the typical features and growth patterns of primary cutaneous B-cell lymphomas?",
    "answer": "Most primary cutaneous B-cell lymphomas are indolent or slow-growing and commonly present as skin nodules or papules.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Most primary cutaneous B-cell lymphomas are indolent or slow-growing",
      "Symptoms of CBCL include skin nodules and papules",
      "CBCL appears as nodules or papules under the skin",
      "CBCL is a subtype of primary cutaneous lymphoma (PCL)",
      "CBCL includes symptoms: nodule, papule"
    ]
  },
  {
    "id": "Medical-f23b49f6",
    "source": "Medical",
    "question": "What are the key components assessed during the diagnosis of cutaneous B-cell lymphoma (CBCL)?",
    "answer": "The diagnosis of CBCL involves clinical evaluation through skin exam, laboratory analysis with blood tests, imaging studies, tissue assessment by biopsy, and cellular characterization using immunophenotyping.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "CBCL includes diagnostic methods: skin exam, blood test, imaging test, biopsy, immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "CBCL is a subtype of primary cutaneous lymphoma (PCL)",
      "CBCL is classified under B lymphocyte cell of origin"
    ]
  },
  {
    "id": "Medical-29e992c3",
    "source": "Medical",
    "question": "Which biomarkers and genetic alterations are evaluated in cutaneous B-cell lymphoma (CBCL), and how are they assessed?",
    "answer": "CBCL diagnosis involves assessment of biomarkers and genetic changes, typically evaluated through immunophenotyping and related laboratory tests.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "Diagnosis of CBCL involves immunophenotyping",
      "CBCL includes biomarkers: biomarker, genetic change",
      "CBCL is a subtype of primary cutaneous lymphoma (PCL)",
      "Immunophenotyping is a diagnostic method used in CBCL"
    ]
  },
  {
    "id": "Medical-aec58243",
    "source": "Medical",
    "question": "What is the relationship between lymphocytes and the development of cutaneous B-cell lymphoma (CBCL)?",
    "answer": "CBCL develops from abnormal B lymphocytes, which are a type of white blood cell; unregulated growth of these lymphocytes can lead to lymphoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "PCL develops from abnormal B or T lymphocytes",
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "Lymphocytes are a type of white blood cell that help fight infection",
      "Unregulated growth of lymphocytes can develop into lymphoma",
      "CBCL is classified under B lymphocyte cell of origin"
    ]
  },
  {
    "id": "Medical-56575021",
    "source": "Medical",
    "question": "What are the main diagnostic methods and criteria for diagnosing acute lymphoblastic leukemia (ALL) in children?",
    "answer": "ALL in children is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture, with diagnosis generally requiring 20 percent or more lymphoblasts in the bone marrow.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Diagnostic Method for ALL includes blood test, bone marrow test, imaging test, heart test, lumbar puncture, biomarker testing, and pharmacogenomic testing",
      "ALL is a fast-growing blood cancer that starts in lymphocytes",
      "Bone marrow and blood are disease sites for ALL"
    ]
  },
  {
    "id": "Medical-209dcb5d",
    "source": "Medical",
    "question": "How are the main subtypes of ALL in children characterized and what are their distinguishing features?",
    "answer": "The main subtypes of ALL in children are B-cell ALL (B-ALL), which starts in B-cell lymphocytes and is more common, and T-cell ALL (T-ALL), which starts in T-cell lymphocytes and can cause an enlarged thymus and breathing problems.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "ALL has two main subtypes: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)",
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)"
    ]
  },
  {
    "id": "Medical-7a915f7f",
    "source": "Medical",
    "question": "What are the common treatment approaches for childhood ALL and how do they vary by subtype or special cases?",
    "answer": "Treatment for childhood ALL typically includes steroids, multiagent chemotherapy, systemic therapy, and supportive care, with clinical trials preferred for certain B-ALL and T-ALL cases, and different regimens used for mature B-cell ALL and infant ALL.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Systemic therapy and supportive care are part of ALL treatment",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases",
      "Infant ALL (under 12 months) is treated differently than other age groups"
    ]
  },
  {
    "id": "Medical-d7a42746",
    "source": "Medical",
    "question": "Which biomarkers and genetic alterations are important in the management of B-cell ALL in children?",
    "answer": "BCR::ABL1-positive, BCR::ABL1-negative, and BCR::ABL1-like are key biomarkers in B-cell ALL, with BCR::ABL1-positive cases receiving intensive systemic therapies and biomarker/genetic testing guiding management.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
      "Biomarker for B-cell ALL includes BCR::ABL1-positive, BCR::ABL1-negative, and BCR::ABL1-like",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "B-cell ALL (B-ALL) is a subtype of ALL",
      "Treatment for B-ALL includes systemic therapy and clinical trial"
    ]
  },
  {
    "id": "Medical-b2f0a4f3",
    "source": "Medical",
    "question": "What are the typical disease sites and symptoms associated with ALL in children?",
    "answer": "ALL in children can be found in the bone marrow, blood, testicles, and central nervous system, with T-cell ALL specifically causing an enlarged thymus and breathing problems.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "Disease Site for ALL includes bone marrow, blood, lymph nodes, thymus, testicles, and CNS",
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)"
    ]
  },
  {
    "id": "Medical-cbbe92d1",
    "source": "Medical",
    "question": "How does the age group at diagnosis influence the management and treatment of ALL in children?",
    "answer": "Management and treatment of ALL in children are influenced by age, with infants (under 12 months) receiving different treatments and ALL most commonly affecting children, adolescents, and young adults.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Infant ALL (under 12 months) is treated differently than other age groups",
      "ALL most often affects children, adolescents, and young adults (AYAs)",
      "Age Group for ALL includes infant, child, adolescent, and young adult (AYA)",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases"
    ]
  },
  {
    "id": "Medical-30f4f09d",
    "source": "Medical",
    "question": "What role do supportive care and systemic therapy play in the treatment of ALL in children?",
    "answer": "Supportive care and systemic therapy are integral to ALL treatment in children, provided alongside steroids and multiagent chemotherapy to address both disease and treatment-related needs.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Systemic therapy and supportive care are part of ALL treatment",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Treatment for ALL includes steroids, multiagent chemotherapy, systemic therapy, supportive care, and clinical trial",
      "Supportive care is listed as a treatment option in the ALL ontology",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases"
    ]
  },
  {
    "id": "Medical-3c58f2c2",
    "source": "Medical",
    "question": "What are the key differences in presentation and management between B-cell ALL and T-cell ALL in children?",
    "answer": "B-cell ALL is more common and defined by B-cell biomarkers, while T-cell ALL often presents with an enlarged thymus and breathing problems, with both subtypes managed using steroids, multiagent chemotherapy, systemic therapy, and clinical trials.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "Biomarker for B-cell ALL includes BCR::ABL1-positive, BCR::ABL1-negative, and BCR::ABL1-like",
      "Treatment for B-ALL and T-ALL includes steroids, multiagent chemotherapy, systemic therapy, and clinical trial"
    ]
  },
  {
    "id": "Medical-5ac7f21f",
    "source": "Medical",
    "question": "What are the main diagnostic methods and surveillance strategies used in rectal cancer management?",
    "answer": "Rectal cancer is diagnosed using MRI, endorectal ultrasound (EUS), CT scan, flexible sigmoidoscopy, colonoscopy, and CEA blood tests, while surveillance after treatment includes regular flexible sigmoidoscopy, imaging (EUS or MRI), and colonoscopy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "MRI of the pelvis is recommended for staging rectal cancer",
      "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy",
      "CT scan of chest and abdomen is used to detect metastasis",
      "Colonoscopy is recommended after surgery for surveillance",
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging",
      "Diagnostic Method includes: MRI, Endorectal ultrasound (EUS), CT scan, Flexible sigmoidoscopy, Colonoscopy, CEA blood test, ctDNA",
      "Surveillance Strategy includes: Flexible sigmoidoscopy, Imaging (EUS or MRI), Colonoscopy"
    ]
  },
  {
    "id": "Medical-b3d60550",
    "source": "Medical",
    "question": "Which polyp types are associated with rectal cancer, and how does polypectomy impact cancer prevention?",
    "answer": "Adenomas are the primary polyp type that can become invasive rectal cancer over many years, while hyperplastic and inflammatory polyps rarely turn into cancer; polypectomy during colonoscopy can remove most polyps and prevent cancer development.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Most rectal cancers start in adenomatous polyps",
      "Adenomas can become invasive rectal cancer over many years",
      "Hyperplastic and inflammatory polyps rarely turn into cancer",
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer",
      "Polyp Type includes: Adenoma, Hyperplastic polyp, Inflammatory polyp"
    ]
  },
  {
    "id": "Medical-0e7e9c94",
    "source": "Medical",
    "question": "What are the common genetic and biomarker features of rectal cancer and their implications for diagnosis?",
    "answer": "Rectal cancer is characterized by biomarkers such as mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H), with all tumors recommended for dMMR or MSI-H testing, and genetic risk factors including Lynch syndrome and familial adenomatous polyposis (FAP).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer",
      "All rectal tumors should be tested for dMMR or MSI-H",
      "Lynch syndrome is a genetic risk factor for rectal cancer",
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
      "Biomarker includes: Mismatch repair deficiency (dMMR), Microsatellite instability-high (MSI-H), Microsatellite stable (MSS), Mismatch repair proficient (pMMR), CEA blood test, ctDNA"
    ]
  },
  {
    "id": "Medical-09c3281f",
    "source": "Medical",
    "question": "How are treatment strategies for rectal cancer determined by tumor stage?",
    "answer": "Treatment for rectal cancer is stage-dependent: T1 tumors are managed with endoscopic and transanal procedures, T2 and T3 tumors require transabdominal surgery, and locally advanced cases are treated with chemoradiation and chemotherapy regimens including oxaliplatin or irinotecan.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors",
      "Transanal local excision is an option for T1 tumors at the end of the rectum",
      "Transabdominal surgery is recommended for T2 and some T1/T3 tumors",
      "Chemoradiation is used for locally advanced rectal cancer",
      "Chemotherapy regimens may include oxaliplatin or irinotecan"
    ]
  },
  {
    "id": "Medical-80578893",
    "source": "Medical",
    "question": "What are the primary surgical procedures used in rectal cancer, and how do they relate to tumor location and stage?",
    "answer": "Surgical procedures for rectal cancer include polypectomy, transanal local excision for early-stage or distal tumors, transabdominal surgery for more advanced stages, low anterior resection (LAR) for mid to upper rectal tumors, and abdominoperineal resection (APR) for lower rectal tumors.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer",
      "Transanal local excision is an option for T1 tumors at the end of the rectum",
      "Transabdominal surgery is recommended for T2 and some T1/T3 tumors",
      "Low anterior resection (LAR) is used for tumors in the mid to upper rectum",
      "Abdominoperineal resection (APR) is used for tumors in the lower rectum"
    ]
  },
  {
    "id": "Medical-dbdb19b5",
    "source": "Medical",
    "question": "Which risk factors and genetic syndromes are linked to rectal cancer, and what is their significance?",
    "answer": "Lynch syndrome and familial adenomatous polyposis (FAP) are significant genetic risk factors for rectal cancer, with FAP causing multiple polyps and increased cancer risk, highlighting the importance of genetic assessment in at-risk individuals.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Lynch syndrome is a genetic risk factor for rectal cancer",
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
      "Risk Factor includes: Lynch syndrome, Familial adenomatous polyposis (FAP)",
      "Genetic Alteration includes: Lynch syndrome, Familial adenomatous polyposis (FAP)",
      "Adenomas can become invasive rectal cancer over many years"
    ]
  },
  {
    "id": "Medical-89593bb0",
    "source": "Medical",
    "question": "What symptoms are commonly observed in patients with rectal cancer?",
    "answer": "Rectal cancer commonly presents with symptoms such as changes in bowel habits, rectal bleeding, and abdominal pain.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain",
      "Symptom includes: Rectal bleeding, Abdominal pain, Changes in bowel habits",
      "Rectal bleeding is a symptom of rectal cancer",
      "Abdominal pain is a symptom of rectal cancer",
      "Changes in bowel habits are a symptom of rectal cancer"
    ]
  },
  {
    "id": "Medical-904ab164",
    "source": "Medical",
    "question": "What fertility preservation options are available to patients undergoing rectal cancer treatment?",
    "answer": "Fertility preservation options for rectal cancer patients include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition, which can be considered prior to treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition",
      "Fertility Preservation includes: Sperm banking, Egg freezing, Ovarian tissue banking, Ovarian transposition",
      "Ovarian transposition is a fertility preservation option",
      "Egg freezing is a fertility preservation option",
      "Sperm banking is a fertility preservation option"
    ]
  },
  {
    "id": "Medical-ef0f9988",
    "source": "Medical",
    "question": "How is surveillance structured following local excision or endoscopic submucosal dissection in rectal cancer?",
    "answer": "Surveillance after local excision or ESD for rectal cancer involves regular flexible sigmoidoscopy every 6 months for 5 years and imaging with EUS or MRI every 3-6 months for 2 years, then every 6 months through year 5.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging",
      "Flexible sigmoidoscopy every 6 months for 5 years is part of the surveillance strategy for T1 tumors",
      "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5 is part of the surveillance strategy for T1 tumors",
      "Surveillance Strategy includes: Flexible sigmoidoscopy, Imaging (EUS or MRI), Colonoscopy",
      "Flexible sigmoidoscopy is recommended for surveillance"
    ]
  },
  {
    "id": "Medical-6b88dffb",
    "source": "Medical",
    "question": "What are the main subtypes, stages, and grades of bladder cancer, and how are they classified?",
    "answer": "Bladder cancer is classified into subtypes such as urothelial carcinoma (the most common), squamous cell carcinoma, adenocarcinoma, and small cell carcinoma; it is staged from 0 to 4 based on invasion and spread, with grades designated as low grade (LG) or high grade (HG).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Bladder cancer is a disease of the inner lining of the bladder",
      "Urothelial carcinoma is the most common subtype of bladder cancer",
      "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes of bladder cancer",
      "Bladder cancer is staged from 0 to 4 based on depth of invasion and spread",
      "Cancer grade is classified as low grade (LG) or high grade (HG)"
    ]
  },
  {
    "id": "Medical-a3a6eab2",
    "source": "Medical",
    "question": "What are the primary risk factors and genetic alterations associated with bladder cancer?",
    "answer": "Smoking is the greatest risk factor for bladder cancer, with additional risks including age, family history, Lynch syndrome, and chemical exposure; genetic alterations such as CDKN2A, FGFR3, PIK3CA, and ERBB mutations are also associated with the disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Smoking is the greatest risk factor for bladder cancer",
      "Other risk factors include age, family history, Lynch syndrome, and chemical exposure",
      "Genetic alterations such as mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer",
      "Risk Factor: [\"Smoking\", \"Secondhand smoke\", \"Age\", \"Family history\", \"Lynch syndrome\", \"Chemical exposure\"]",
      "Genetic Alteration: [\"CDKN2A mutation\", \"FGFR3 mutation\", \"PIK3CA mutation\", \"ERBB mutation\"]"
    ]
  },
  {
    "id": "Medical-5d754d6e",
    "source": "Medical",
    "question": "What symptoms and diagnostic methods are commonly associated with bladder cancer?",
    "answer": "Bladder cancer commonly presents with blood in urine (hematuria), frequent urination, urgency, painful urination, and back pain, and is diagnosed using cystoscopy, urine cytology, biopsy, and imaging techniques such as CT, MRI, PET/CT, ultrasound, pyelogram, and urogram.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer",
      "Other symptoms include frequent urination, urgency, painful urination, and back pain",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)",
      "Symptom: [\"Blood in urine\", \"Hematuria\", \"Frequent urination\", \"Urgency\", \"Painful urination\", \"Back pain\"]",
      "Diagnostic Method: {\"Cystoscopy\": {}, \"Urine cytology\": {}, \"Biopsy\": {}, \"Imaging\": {\"CT scan\": {}, \"MRI\": {}, \"PET/CT\": {}, \"Ultrasound\": {}, \"Pyelogram\": {}, \"Urogram\": {}}}"
    ]
  },
  {
    "id": "Medical-4937721e",
    "source": "Medical",
    "question": "How are nonmuscle-invasive and muscle-invasive bladder cancers defined and treated?",
    "answer": "Nonmuscle-invasive bladder cancers (Stage 0 and 1) are treated with TURBT and intravesical therapy, while muscle-invasive bladder cancers (Stages 2, 3, and 4) typically require radical cystectomy, with additional options such as systemic therapy and radiation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive",
      "Stages 2, 3, and 4 bladder cancers are muscle-invasive",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer"
    ]
  },
  {
    "id": "Medical-01692d91",
    "source": "Medical",
    "question": "What systemic therapies are available for bladder cancer and what agents are commonly used?",
    "answer": "Systemic therapy for bladder cancer includes chemotherapy (such as cisplatin-based regimens like ddMVAC), immunotherapy (checkpoint inhibitors like pembrolizumab, nivolumab, avelumab, and atezolizumab), and targeted therapies (enfortumab vedotin-ejfv, erdafitinib, and sacituzumab govitecan-hziy).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC",
      "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab",
      "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)",
      "Systemic Therapy: {\"Chemotherapy\": [\"Cisplatin\", \"Methotrexate\", \"Vinblastine\", \"Doxorubicin\", \"ddMVAC\"], \"Immunotherapy\": [\"Pembrolizumab (Keytruda)\", \"Nivolumab (Opdivo)\", \"Avelumab (Bavencio)\", \"Atezolizumab (Tecentriq)\"], \"Targeted Therapy\": [\"Enfortumab vedotin-ejfv (Padcev)\", \"Erdafitinib (Balversa)\", \"Sacituzumab govitecan-hziy (Trodelvy)\"]}"
    ]
  },
  {
    "id": "Medical-766a9a4c",
    "source": "Medical",
    "question": "What are the main surgical procedures and urinary diversion options used in bladder cancer treatment?",
    "answer": "Bladder cancer surgery includes TURBT, radical cystectomy, partial cystectomy, and urinary diversion procedures such as ileal conduit, neobladder, and continent cutaneous pouch (Indiana pouch).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surgery is a primary treatment for bladder cancer and includes TURBT, radical cystectomy, and partial cystectomy",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch",
      "Surgical Procedure: {\"TURBT\": {}, \"Radical cystectomy\": {}, \"Partial cystectomy\": {}, \"Urinary Diversion\": [\"Ileal conduit\", \"Neobladder\", \"Continent cutaneous pouch (Indiana pouch)\"]}"
    ]
  },
  {
    "id": "Medical-ab49732b",
    "source": "Medical",
    "question": "Which therapies are used as bladder-preserving approaches in bladder cancer, and what do they involve?",
    "answer": "Bladder-preserving approaches include trimodal therapy, which combines TURBT, chemotherapy, and radiation, as well as radiation therapy (EBRT) alone or with chemotherapy (chemoradiation).",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach",
      "Radiation therapy (EBRT) is used alone or in combination with chemotherapy (chemoradiation)",
      "Treatment: {\"Trimodal therapy\": {}, \"Radiation Therapy\": [\"External beam radiation therapy (EBRT)\", \"Chemoradiation\"]}",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC"
    ]
  },
  {
    "id": "Medical-f67e9cbf",
    "source": "Medical",
    "question": "How is follow-up and surveillance conducted in bladder cancer patients and why is it important?",
    "answer": "Follow-up and surveillance in bladder cancer involve regular cystoscopy, urine cytology, imaging, and biomarker tests, which are essential due to the high recurrence rates of the disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up and surveillance are required due to high recurrence rates",
      "Follow-up/Surveillance: [\"Regular cystoscopy\", \"Urine cytology\", \"Imaging\", \"Biomarker surveillance\"]",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)",
      "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer",
      "Bladder cancer has a high recurrence rate necessitating ongoing surveillance"
    ]
  },
  {
    "id": "Medical-5b662312",
    "source": "Medical",
    "question": "What are the most common side effects and symptoms experienced by bladder cancer patients, both from the disease and its treatments?",
    "answer": "Bladder cancer patients commonly experience symptoms such as hematuria, frequent urination, urgency, painful urination, and back pain, with treatments often causing side effects like bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer",
      "Other symptoms include frequent urination, urgency, painful urination, and back pain",
      "Common side effects of treatment include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea",
      "Symptom: [\"Blood in urine\", \"Hematuria\", \"Frequent urination\", \"Urgency\", \"Painful urination\", \"Back pain\"]",
      "Side Effect: [\"Bleeding\", \"Blood clots\", \"Kidney problems\", \"Infection\", \"Sexual dysfunction\", \"Urinary incontinence\", \"Fatigue\", \"Nausea\", \"Vomiting\", \"Diarrhea\", \"Constipation\", \"Fever\"]"
    ]
  },
  {
    "id": "Medical-8c9d1ae8",
    "source": "Medical",
    "question": "What roles do clinical trials and supportive care play in the management of bladder cancer?",
    "answer": "Clinical trials are available at all stages of bladder cancer, offering access to new treatments, while supportive care addresses symptoms and side effects from both the cancer and its treatments.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Clinical trials are available at all stages of bladder cancer",
      "Supportive care addresses symptoms and side effects of cancer and its treatment",
      "Treatment: {\"Clinical trial\": {}, \"Supportive care\": {}}",
      "Common side effects of treatment include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea",
      "Supportive care is included as a treatment modality in the ontology for bladder cancer"
    ]
  },
  {
    "id": "Medical-a4897c00",
    "source": "Medical",
    "question": "What are the major subtypes of kidney cancer and how are they histologically classified?",
    "answer": "Kidney cancer includes subtypes such as renal cell carcinoma (RCC), urothelial carcinoma, Wilms tumor, and renal sarcoma, with RCC further classified by histology into clear cell RCC, non-clear cell RCC (including papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC), and sarcomatoid RCC.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Wilms tumor usually occurs in young children and is a distinct kidney cancer type",
      "Renal sarcoma starts in the blood vessels or connective tissue of the kidney",
      "RCC starts in the cells that line the renal tubules",
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease"
    ]
  },
  {
    "id": "Medical-ad636be8",
    "source": "Medical",
    "question": "Which anatomical structures are involved in the origin and local spread of kidney cancer?",
    "answer": "Kidney cancer originates in structures such as the renal tubules and renal pelvis and can locally spread to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "RCC starts in the cells that line the renal tubules",
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter",
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia",
      "Anatomical Structure includes: Renal tubules, Renal pelvis, Renal vein, Renal artery, Gerotas fascia, Adrenal gland",
      "Stage: Local spread includes: Surrounding fat, Blood vessels, Lymph nodes, Adrenal glands, Gerotas fascia"
    ]
  },
  {
    "id": "Medical-1f8fc3b0",
    "source": "Medical",
    "question": "What diagnostic methods are used to identify kidney cancer and its subtypes?",
    "answer": "Diagnosis of kidney cancer and its subtypes involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
      "Diagnostic Method includes: Imaging tests, Blood tests, Urine tests, Biopsy, Biomarker testing, Genetic risk testing",
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer"
    ]
  },
  {
    "id": "Medical-b87987f5",
    "source": "Medical",
    "question": "How does kidney cancer metastasize and what are the common distant sites of spread?",
    "answer": "Kidney cancer can metastasize to distant sites including the lungs, lymph nodes, bones, liver, and brain.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain",
      "Stage: Metastasis includes: Lungs, Lymph nodes, Bones, Liver, Brain",
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
      "RCC starts in the cells that line the renal tubules"
    ]
  },
  {
    "id": "Medical-0ab278c6",
    "source": "Medical",
    "question": "What factors influence treatment decisions for renal cell carcinoma (RCC)?",
    "answer": "Treatment for RCC is determined by factors such as histology, tumor size, tumor location, and the presence of metastasis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis",
      "Treatment Factor includes: Histology, Tumor size, Tumor location, Presence of metastasis",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
      "Clear cell RCC is the most common subtype of RCC",
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease"
    ]
  },
  {
    "id": "Medical-4019aff7",
    "source": "Medical",
    "question": "What distinguishes Wilms tumor from other kidney cancer types?",
    "answer": "Wilms tumor is a distinct type of kidney cancer that usually occurs in young children, unlike other subtypes such as RCC, urothelial carcinoma, and renal sarcoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Wilms tumor usually occurs in young children and is a distinct kidney cancer type",
      "Wilms tumor (nephroblastoma) is listed as a Cancer Subtype under Kidney cancer",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter",
      "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
    ]
  },
  {
    "id": "Medical-fd2c6b79",
    "source": "Medical",
    "question": "How are multiple tumors in the kidneys classified in relation to metastasis?",
    "answer": "Multiple tumors in one or both kidneys are treated as separate primary tumors and not considered metastasis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis",
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain",
      "Stage: Metastasis includes: Lungs, Lymph nodes, Bones, Liver, Brain",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
      "Clear cell RCC is the most common subtype of RCC"
    ]
  },
  {
    "id": "Medical-8fc62c51",
    "source": "Medical",
    "question": "What are the key histological features and subtypes of non-clear cell RCC?",
    "answer": "Non-clear cell RCC comprises subtypes such as papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Non-clear cell RCC (nccRCC) includes: Papillary RCC (PRCC), Chromophobe RCC, Collecting duct RCC (cdRCC), Renal medullary carcinoma (RMC), Clear cell papillary renal cell tumor, Fumarate hydratase-deficient RCC, ELOC-mutated RCC",
      "Clear cell RCC is the most common subtype of RCC",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease"
    ]
  },
  {
    "id": "Medical-4a723f3f",
    "source": "Medical",
    "question": "What are the origins and histological diversity of renal cell carcinoma?",
    "answer": "Renal cell carcinoma originates from cells lining the renal tubules and displays histological diversity, including clear cell, non-clear cell, and sarcomatoid subtypes.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "RCC starts in the cells that line the renal tubules",
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease",
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer"
    ]
  },
  {
    "id": "Medical-84c1024b",
    "source": "Medical",
    "question": "What are the main risk factors and biomarkers associated with anal cancer?",
    "answer": "Anal cancer is strongly linked to risk factors such as HPV infection (especially HPV16), HIV infection, immunosuppressant use, smoking, and a history of gynecologic cancers or precancers, with HPV and HPV16 also serving as key biomarkers.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "HPV infection is the strongest risk factor for anal cancer",
      "HIV infection increases the risk of anal cancer",
      "Immunosuppressant use increases the risk of anal cancer",
      "Smoking is a risk factor for anal cancer",
      "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk",
      "HPV16 is a high-risk strain associated with anal cancer",
      "Biomarker: HPV, HPV16"
    ]
  },
  {
    "id": "Medical-6baff610",
    "source": "Medical",
    "question": "Which diagnostic methods are used for the detection and staging of anal cancer?",
    "answer": "Anal cancer diagnosis and staging utilize digital rectal exam (DRE), high-resolution anoscopy (HRA), anoscopy, biopsy, and imaging modalities such as CT, MRI, and PET scans, with HIV testing also recommended for patients.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy",
      "Digital rectal exam (DRE), high-resolution anoscopy (HRA), and imaging (CT, MRI, PET) are used for diagnosis and staging",
      "HIV testing is recommended in patients with anal cancer",
      "Diagnostic Method: Digital rectal exam (DRE), High-resolution anoscopy (HRA), Anoscopy, Biopsy, CT scan, MRI, PET scan, HIV testing",
      "Staging uses the AJCC TNM system"
    ]
  },
  {
    "id": "Medical-b6606867",
    "source": "Medical",
    "question": "What are the primary symptoms of anal cancer and its most common subtype?",
    "answer": "The main symptoms of anal cancer, particularly anal squamous cell carcinomathe most prevalent subtypeinclude rectal bleeding, anal itching, anal pain, and a lump near the anus.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Anal squamous cell carcinoma is the most common subtype of anal cancer",
      "Anal cancer most often starts in squamous cells lining the anal canal",
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus",
      "Symptom: Rectal bleeding, Anal itching, Anal pain, Anal lump",
      "Anal cancer can start in the anal canal or perianal region"
    ]
  },
  {
    "id": "Medical-420f5e71",
    "source": "Medical",
    "question": "How is anal cancer staged, and what do the different stages represent?",
    "answer": "Anal cancer is staged using the AJCC TNM system, with Stage 0 as carcinoma in situ or anal dysplasia, Stage I for tumors 2 cm without spread, Stage II for tumors >2 cm without spread, Stage III indicating lymph node involvement or local invasion, and Stage IV representing distant metastasis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Staging uses the AJCC TNM system",
      "Stage 0 is carcinoma in situ or anal dysplasia",
      "Stage I: tumor 2 cm, no lymph node or distant spread",
      "Stage II: tumor >2 cm, no lymph node or distant spread",
      "Stage III: lymph node involvement and/or invasion of nearby organs",
      "Stage IV: distant metastasis"
    ]
  },
  {
    "id": "Medical-2def53f0",
    "source": "Medical",
    "question": "What are the standard treatment approaches for non-metastatic and metastatic anal cancer?",
    "answer": "Non-metastatic anal cancers (Stages I-III) are primarily treated with chemoradiation using IMRT or EBRT and regimens such as mitomycin with capecitabine or 5-FU, while metastatic (Stage IV) disease is managed with systemic chemotherapy, immunotherapy, and palliative radiation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "IMRT is the preferred radiation technique for anal cancer",
      "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin",
      "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin)",
      "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy"
    ]
  },
  {
    "id": "Medical-6746d569",
    "source": "Medical",
    "question": "What surgical procedures are used in the management of anal cancer and under what circumstances are they indicated?",
    "answer": "Local excision is reserved for select early-stage, low-grade perianal cancers, while abdominoperineal resection (APR) is indicated for persistent, recurrent, or locally progressive anal cancer and results in a permanent colostomy; groin dissection is performed for lymph node recurrence.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Local excision is an option for some early-stage, low-grade perianal cancers",
      "Abdominoperineal resection (APR) is recommended for persistent, recurrent, or locally progressive anal cancer",
      "APR results in a permanent colostomy",
      "Groin dissection: Indication: Lymph node recurrence",
      "Surgical Procedure: Abdominoperineal resection (APR), Groin dissection"
    ]
  },
  {
    "id": "Medical-bc903265",
    "source": "Medical",
    "question": "What follow-up and surveillance strategies are recommended after treatment for anal cancer?",
    "answer": "Post-treatment surveillance for anal cancer includes regular digital rectal exams, inguinal lymph node exams, anoscopy, and imaging over several years, with more frequent intervals in the first five years and annual imaging for higher stages.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surveillance after treatment includes DRE, lymph node exams, anoscopy, and imaging",
      "Complete remission: DRE: Every 3-6 months for 5 years",
      "Complete remission: Inguinal lymph node exam: Every 3-6 months for 5 years",
      "Complete remission: Anoscopy: Every 6-12 months for 3 years",
      "Complete remission: Imaging: Yearly for 3 years (stage II/III)"
    ]
  },
  {
    "id": "Medical-172b14e6",
    "source": "Medical",
    "question": "What are the main side effects of anal cancer treatments and what fertility preservation options are available?",
    "answer": "Anal cancer treatments can cause side effects such as infertility, bowel and urinary dysfunction, sexual dysfunction, and various systemic symptoms, with fertility preservation options including sperm banking, egg freezing, ovarian tissue banking, and oophoropexy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Radiation and chemotherapy can cause infertility; fertility preservation options should be discussed",
      "Side Effect: Infertility, Bowel dysfunction, Urinary incontinence, Sexual dysfunction, Hand-foot syndrome, Nausea, Vomiting, Diarrhea, Fatigue, Skin irritation, Mucositis, Low blood cell counts, Hearing loss (cisplatin), Neuropathy (oxaliplatin)",
      "Fertility Preservation: Sperm banking, Egg freezing, Ovarian tissue banking, Oophoropexy",
      "Supportive Care: Pelvic floor physical therapy, Dietary counseling, Vaginal dilator therapy, Ostomy care, Mental health support, Peer-to-peer support",
      "Radiation and chemotherapy can cause infertility"
    ]
  },
  {
    "id": "Medical-ee24dc0c",
    "source": "Medical",
    "question": "How are recurrences of anal cancer managed depending on the site of recurrence?",
    "answer": "Local recurrence of anal cancer is typically managed with abdominoperineal resection (APR), lymph node recurrence with groin dissection, chemotherapy, or additional radiation, and distant recurrence with systemic chemotherapy or immunotherapy.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Recurrence: Local: APR",
      "Recurrence: Lymph node: Groin dissection, Chemotherapy, Radiation (if not previously given)",
      "Recurrence: Distant: Systemic chemotherapy, immunotherapy",
      "Abdominoperineal resection (APR) is recommended for persistent, recurrent, or locally progressive anal cancer",
      "Groin dissection: Indication: Lymph node recurrence"
    ]
  },
  {
    "id": "Medical-2a88c6c4",
    "source": "Medical",
    "question": "What are the main diagnostic methods and common sites of involvement for acute lymphoblastic leukemia (ALL)?",
    "answer": "ALL is diagnosed using blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture, and it commonly involves the bone marrow, blood, lymph nodes, thymus, testicles, and central nervous system.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture",
      "ALL can be found in bone marrow, blood, testicles, and central nervous system",
      "ALL includes Disease Site: bone marrow, blood, lymph nodes, thymus, testicles, central nervous system (CNS)",
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow",
      "Diagnostic Method for ALL includes blood tests, bone marrow aspirate, bone marrow biopsy, flow cytometry, immunophenotyping, genetic testing, biomarker testing, imaging tests, lumbar puncture"
    ]
  },
  {
    "id": "Medical-831734ba",
    "source": "Medical",
    "question": "How are the subtypes of ALL classified and what are their distinguishing features?",
    "answer": "ALL is classified into B-cell ALL and T-cell ALL, with B-ALL starting in B-cell lymphocytes and being more common, while T-ALL arises from T-cell lymphocytes and may cause an enlarged thymus; mature B-cell ALL (Burkitt leukemia) and lymphoblastic lymphomas are notable subtypes with specific sites of growth.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "There are two main subtypes of ALL: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)",
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL",
      "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
      "T-cell lymphoblastic lymphoma (T-LL/T-LBL) occurs when T-cell lymphoblasts grow mostly in the thymus"
    ]
  },
  {
    "id": "Medical-5c82be50",
    "source": "Medical",
    "question": "What are the standard treatment approaches for ALL and how do they vary by subtype or prognostic group?",
    "answer": "Treatment for ALL generally includes steroids and multiagent chemotherapy for all patients, with targeted therapy and clinical trials considered for specific subtypes such as BCR::ABL1-positive or BCR::ABL1-negative B-ALL, and T-ALL is treated with chemotherapy and may involve clinical trials.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Targeted therapy may be used based on genetic alterations",
      "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL",
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein",
      "T-ALL treatment options include chemotherapy and clinical trials",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-1b4960b5",
    "source": "Medical",
    "question": "Which biomarkers and genetic alterations are important in the management of B-cell ALL?",
    "answer": "B-cell ALL management is guided by biomarkers and genetic alterations such as BCR::ABL1 and other gene or chromosome changes, which influence prognosis and the use of targeted therapies.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein",
      "BCR::ABL1 is a biomarker for B-cell ALL",
      "Other gene or chromosome changes are biomarkers in B-cell ALL",
      "Genetic Alteration in ALL includes BCR::ABL1 fusion and other gene or chromosome changes",
      "Targeted therapy may be used based on genetic alterations"
    ]
  },
  {
    "id": "Medical-34be9c71",
    "source": "Medical",
    "question": "What are the common symptoms and risk factors associated with ALL?",
    "answer": "ALL commonly presents with symptoms such as anemia, infections, bleeding, enlarged lymph nodes, and organ involvement, and its risk factors include certain genetic syndromes and family history.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement",
      "Risk factors for ALL include certain genetic syndromes and family history",
      "Symptom ontology for ALL includes anemia, infections, bleeding, enlarged lymph nodes, organ involvement",
      "Risk Factor ontology for ALL includes genetic syndromes and family history",
      "ALL is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-1587857f",
    "source": "Medical",
    "question": "Which patient populations are most commonly affected by ALL and what supportive care considerations are important?",
    "answer": "ALL most often affects children but also occurs in adolescents, young adults, and adults, and supportive care such as fertility preservation should be considered before treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults",
      "Patient Population for ALL includes children, adolescents and young adults (AYAs), and adults",
      "Fertility preservation should be considered before treatment",
      "Supportive Care for ALL includes fertility preservation",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-1acacc3d",
    "source": "Medical",
    "question": "What are the key steps involved in the follow-up and surveillance of ALL patients after initial treatment?",
    "answer": "Follow-up for ALL patients includes regular blood tests and surveillance for relapse to monitor disease status after initial treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up includes regular blood tests and surveillance for relapse",
      "Follow-up/Surveillance ontology for ALL includes regular blood tests and surveillance for relapse",
      "Diagnosis of ALL involves blood tests",
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow",
      "ALL can be found in bone marrow, blood, testicles, and central nervous system"
    ]
  },
  {
    "id": "Medical-d2ff311e",
    "source": "Medical",
    "question": "How do the sites of disease involvement differ between B-cell and T-cell lymphoblastic lymphoma?",
    "answer": "B-cell lymphoblastic lymphoma primarily involves lymph nodes, while T-cell lymphoblastic lymphoma mainly affects the thymus.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
      "T-cell lymphoblastic lymphoma (T-LL/T-LBL) occurs when T-cell lymphoblasts grow mostly in the thymus",
      "Disease Site ontology for ALL includes lymph nodes and thymus",
      "B-cell ALL (B-ALL) includes the subtype B-cell lymphoblastic lymphoma (B-LL, B-LBL)",
      "T-cell ALL (T-ALL) includes the subtype T-cell lymphoblastic lymphoma (T-LL, T-LBL)"
    ]
  },
  {
    "id": "Medical-00bf955d",
    "source": "Medical",
    "question": "What is the role of clinical trials in the treatment of specific ALL subtypes?",
    "answer": "Clinical trials are preferred for certain ALL subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL and are also an option for T-ALL, providing access to novel therapies.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL",
      "T-ALL treatment options include chemotherapy and clinical trials",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "B-cell ALL (B-ALL) includes the prognostic groups BCR::ABL1-negative B-ALL, BCR::ABL1-like B-ALL, and BCR::ABL1-positive B-ALL",
      "Treatment Modality ontology for ALL includes clinical trial"
    ]
  },
  {
    "id": "Medical-4094ccc8",
    "source": "Medical",
    "question": "What are the main diagnostic methods and symptoms associated with pancreatic ductal adenocarcinoma (PDAC)?",
    "answer": "Pancreatic ductal adenocarcinoma is primarily diagnosed using imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests, with jaundice being a notable symptom.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests",
      "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype of pancreatic cancer",
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Imaging is used for staging and determining surgical eligibility in pancreatic cancer",
      "Pancreatic ductal adenocarcinoma includes diagnostic methods: Imaging, Endoscopic test, Biopsy, Blood test, Genetic test, Biomarker test",
      "Pancreatic ductal adenocarcinoma includes symptom: Jaundice"
    ]
  },
  {
    "id": "Medical-30340b89",
    "source": "Medical",
    "question": "Which risk factors and hereditary syndromes are associated with increased risk of pancreatic cancer?",
    "answer": "Risk factors for pancreatic cancer include smoking, heavy alcohol use, unhealthy diet, exposure to pesticides, diabetes, chronic pancreatitis, and a family history of certain cancers, while hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis also increase risk.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Risk factors for pancreatic cancer include smoking, heavy alcohol use, unhealthy diet, exposure to pesticides, diabetes, chronic pancreatitis, and family history of certain cancers",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer",
      "Pancreatic ductal adenocarcinoma includes risk factors: Smoking, Heavy alcohol use, Unhealthy diet, Pesticides, Diabetes, Chronic pancreatitis, Family history of pancreatic cancer, Family history of breast cancer, Family history of ovarian cancer, Family history of colorectal cancer, Family history of melanoma",
      "Pancreatic ductal adenocarcinoma includes genetic syndromes: Hereditary breast-ovarian cancer syndrome, HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, Familial malignant melanoma syndrome, FAMMM syndrome, Hereditary pancreatitis",
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer"
    ]
  },
  {
    "id": "Medical-adb2e872",
    "source": "Medical",
    "question": "How are the stages of pancreatic ductal adenocarcinoma defined and what is the significance of Stage IV disease?",
    "answer": "The stages of pancreatic ductal adenocarcinoma range from Stage 0, confined to the duct wall, to Stage IV, which is characterized by distant metastasis to organs such as the liver, lungs, or abdominal lining and is also known as metastatic pancreatic cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Stage 0 pancreatic cancer is confined to the innermost layer of the duct wall",
      "Stage I pancreatic cancer is a tumor 4 cm or smaller and has not spread outside the pancreas",
      "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes",
      "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes",
      "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining",
      "Stage IV pancreatic cancer is metastatic cancer",
      "Pancreatic ductal adenocarcinoma includes stages: Stage 0, Stage I, Stage II, Stage III, Stage IV"
    ]
  },
  {
    "id": "Medical-91bd2db8",
    "source": "Medical",
    "question": "What are the primary treatment options for pancreatic ductal adenocarcinoma at different stages?",
    "answer": "Treatment options for pancreatic ductal adenocarcinoma include surgery for select patients with Stage I, II, or III disease, drug treatment for all stages especially advanced cases, clinical trials, and supportive care across all stages.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer",
      "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer",
      "Clinical trials are available for pancreatic cancer patients",
      "Supportive care is an important part of pancreatic cancer management",
      "Pancreatic ductal adenocarcinoma includes treatments: Surgery (Stage I, II, III), Drug treatment (all stages), Clinical trial (all stages), Supportive care (all stages)"
    ]
  },
  {
    "id": "Medical-39074ccf",
    "source": "Medical",
    "question": "Who are the key members of the multidisciplinary care team involved in pancreatic cancer management?",
    "answer": "The multidisciplinary care team for pancreatic cancer includes diagnostic and interventional radiologists, pathologists, gastroenterologists, medical, surgical, and radiation oncologists, geriatricians, registered dietitians, genetic counselors, palliative care providers, and mental health providers.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer",
      "Care Team Role includes: Diagnostic radiologist, Interventional radiologist, Pathologist, Gastroenterologist, Medical oncologist, Surgical oncologist, Radiation oncologist, Geriatrician, Registered dietitian, Genetic counselor, Palliative care provider, Mental health provider",
      "Pancreatic cancer includes care team roles: Diagnostic radiologist, Interventional radiologist, Pathologist, Gastroenterologist, Medical oncologist, Surgical oncologist, Radiation oncologist, Geriatrician, Registered dietitian, Genetic counselor, Palliative care provider, Mental health provider",
      "Supportive care is an important part of pancreatic cancer management",
      "Supportive Care includes: Symptom management, Palliative care"
    ]
  },
  {
    "id": "Medical-3ad15fef",
    "source": "Medical",
    "question": "What is the role and scope of supportive care in pancreatic cancer management?",
    "answer": "Supportive care in pancreatic cancer focuses on symptom management and palliative care, and is considered an important component of management at all stages of the disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Supportive care is an important part of pancreatic cancer management",
      "Supportive Care includes: Symptom management, Palliative care",
      "Pancreatic ductal adenocarcinoma includes supportive care at all stages",
      "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer",
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer"
    ]
  },
  {
    "id": "Medical-9351c8ee",
    "source": "Medical",
    "question": "How do genetic testing and biomarker tests contribute to the diagnosis and risk assessment of pancreatic cancer?",
    "answer": "Genetic tests and biomarker tests are used in the diagnosis of pancreatic cancer to detect inherited mutations associated with hereditary risk and to identify disease-specific biomarkers.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer",
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests",
      "Pancreatic ductal adenocarcinoma includes diagnostic methods: Genetic test, Biomarker test",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer",
      "Risk factors for pancreatic cancer include family history of certain cancers"
    ]
  },
  {
    "id": "Medical-8f9d5dde",
    "source": "Medical",
    "question": "What are the main diagnostic methods and biomarkers used for prostate cancer across its stages?",
    "answer": "Prostate cancer diagnosis commonly involves PSA testing, digital rectal exam, biopsy, and imaging modalities such as MRI, CT, PET, bone scan, and ultrasound, with biomarkers including PSA, Gleason score, Grade Group, and molecular biomarker tests used throughout all stages.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "PSA test and digital rectal exam are used for screening and diagnosis",
      "Biopsy is required to confirm prostate cancer diagnosis",
      "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease",
      "Biomarker: PSA, Gleason score, Grade Group, Molecular biomarker tests",
      "Diagnostic Method: PSA test, Digital rectal exam, Biopsy, MRI, CT scan, PET scan, Bone scan, Ultrasound, PSMA-PET, Blood and urine biomarker tests (4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, SelectMDx)"
    ]
  },
  {
    "id": "Medical-e75b6871",
    "source": "Medical",
    "question": "How do risk groups and genetic alterations influence prognosis and management in prostate cancer?",
    "answer": "Risk groups (very low to very high) and genetic alterations such as BRCA1, BRCA2, and others inform prognosis and guide treatment and genetic testing decisions in prostate cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment",
      "BRCA2 mutation increases risk of prostate cancer",
      "Genetic Alteration: BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, FANCA",
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer",
      "Molecular biomarker testing helps assess risk and guide treatment decisions"
    ]
  },
  {
    "id": "Medical-46639f91",
    "source": "Medical",
    "question": "What are the primary treatment options for localized, regional, and metastatic prostate cancer?",
    "answer": "Treatment options for localized prostate cancer include active surveillance, surgery, radiation therapy, and hormone therapy, while regional and metastatic disease are managed with combinations of hormone therapy, surgery, radiation, chemotherapy, targeted therapy, immunotherapy, and radiopharmaceuticals.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Localized prostate cancer: Treatment: Active surveillance, Surgery, Radiation therapy, Hormone therapy",
      "Regional prostate cancer: Treatment: Hormone therapy, Radiation therapy, Surgery, Chemotherapy, Targeted therapy",
      "Metastatic prostate cancer: Treatment: Androgen deprivation therapy (ADT), LHRH agonist, LHRH antagonist, Leuprolide, Goserelin, Triptorelin, Degarelix, Relugolix, Bicalutamide, Flutamide, Nilutamide, Orchiectomy, Chemotherapy, Immunotherapy, Targeted therapy, Radiation therapy, Radiopharmaceuticals",
      "Hormone therapy, surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and radiopharmaceuticals are treatment options",
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment"
    ]
  },
  {
    "id": "Medical-436b2db6",
    "source": "Medical",
    "question": "Which symptoms are associated with advanced and metastatic prostate cancer?",
    "answer": "Advanced and metastatic prostate cancer commonly present with symptoms such as bone pain, blood in urine or semen, unexplained weight loss, hip and back pain, and various urinary symptoms.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms",
      "Metastatic prostate cancer: Symptom: Bone pain, Hip pain, Back pain, Unexplained weight loss, Blood in urine, Blood in semen, Urinary symptoms",
      "Bone pain, hip pain, and back pain are symptoms of metastatic prostate cancer",
      "Blood in urine and blood in semen are symptoms of advanced prostate cancer",
      "Unexplained weight loss and urinary symptoms occur in advanced stages"
    ]
  },
  {
    "id": "Medical-0fec5b62",
    "source": "Medical",
    "question": "What are the main risk factors for developing prostate cancer?",
    "answer": "The main risk factors for prostate cancer include age, family history, Black race, genetic mutations such as BRCA1/2 and others, obesity, smoking, and dietary habits like high-fat diet and low fruit and vegetable intake.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Age, family history, race, genetic mutations, diet, obesity, and smoking are risk factors for prostate cancer",
      "Risk Factor: Age, Family history, Black race, Genetic mutations (BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2), Obesity, Smoking, High-fat diet, Low fruit and vegetable intake",
      "BRCA2 mutation increases risk of prostate cancer",
      "Obesity and smoking are risk factors for prostate cancer",
      "High-fat diet and low fruit and vegetable intake are risk factors"
    ]
  },
  {
    "id": "Medical-7b29a89d",
    "source": "Medical",
    "question": "How is follow-up managed after prostate cancer diagnosis and treatment?",
    "answer": "Follow-up for prostate cancer includes regular PSA testing, imaging as indicated, and repeat biopsies or molecular biomarker testing, with strategies tailored to risk group and disease stage.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed",
      "Localized prostate cancer: Follow-up Strategy: Regular PSA testing, Repeat biopsy, Imaging as indicated",
      "Regional prostate cancer: Follow-up Strategy: PSA monitoring, Imaging, Biopsy as needed",
      "Metastatic prostate cancer: Follow-up Strategy: PSA monitoring, Imaging, Biopsy as indicated",
      "Follow-up Strategy: Regular PSA testing, Imaging as indicated, Repeat biopsy for active surveillance, Molecular biomarker testing, Nomogram-based risk assessment"
    ]
  },
  {
    "id": "Medical-502e8349",
    "source": "Medical",
    "question": "What is the role of molecular biomarker and genetic testing in prostate cancer management?",
    "answer": "Molecular biomarker and genetic testing are used to assess risk, guide treatment decisions, and are recommended especially for high-risk, regional, or metastatic prostate cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer",
      "Biomarker: Molecular biomarker tests",
      "Genetic Alteration: BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, FANCA",
      "Follow-up Strategy: Molecular biomarker testing"
    ]
  },
  {
    "id": "Medical-66093871",
    "source": "Medical",
    "question": "Which urinary and sexual symptoms can present in prostate cancer patients?",
    "answer": "Prostate cancer can cause urinary symptoms such as frequent urination, weak urine stream, trouble urinating, and sexual symptoms like erectile dysfunction and painful ejaculation.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptom: Blood in urine, Blood in semen, Burning or pain while urinating, Unexplained weight loss, Bone pain, Hip pain, Back pain, Frequent urination, Weak urine stream, Trouble urinating, Trouble holding in urine, Feeling of incomplete bladder emptying, Dull pain in groin or pelvis, Erectile dysfunction, Painful ejaculation",
      "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms",
      "Localized prostate cancer: Symptom: Often asymptomatic, Blood in urine, Blood in semen, Urinary symptoms, Erectile dysfunction",
      "Urinary symptoms are common in localized, regional, and metastatic prostate cancer",
      "Erectile dysfunction and painful ejaculation are sexual symptoms associated with prostate cancer"
    ]
  },
  {
    "id": "Medical-e4cfdc32",
    "source": "Medical",
    "question": "How does the staging of prostate cancer affect diagnostic and imaging strategies?",
    "answer": "Staging determines the extent of diagnostic and imaging evaluation, with localized disease using PSA, digital rectal exam, biopsy, MRI, and ultrasound, while regional and metastatic stages require additional imaging such as CT, PET, bone scan, and PSMA-PET.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Localized prostate cancer: Diagnostic Method: PSA test, Digital rectal exam, Biopsy, MRI, Ultrasound",
      "Regional prostate cancer: Diagnostic Method: PSA test, Digital rectal exam, Biopsy, MRI, CT scan, PSMA-PET",
      "Metastatic prostate cancer: Diagnostic Method: PSA test, Biopsy, MRI, CT scan, PET scan, Bone scan, PSMA-PET",
      "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease",
      "PSA test and digital rectal exam are used for screening and diagnosis"
    ]
  },
  {
    "id": "Medical-c84d2076",
    "source": "Medical",
    "question": "What are the main types of adrenal tumors and how do they differ in terms of malignancy and function?",
    "answer": "Adrenal tumors can be benign or malignant, with benign tumors like adenomas often being non-metastasizing and either functional or nonfunctioning, while malignant tumors include adrenocortical carcinoma, pheochromocytoma, and neuroblastoma, which may produce hormones and have potential for metastasis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Adrenal tumors can be benign or malignant",
      "Benign adrenal tumors do not metastasize",
      "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex",
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
      "Functional adrenal tumors may produce excess hormones",
      "Malignant adrenal tumors include Adrenocortical Carcinoma (ACC), Pheochromocytoma, and Neuroblastoma"
    ]
  },
  {
    "id": "Medical-eeadd54a",
    "source": "Medical",
    "question": "What are the key symptoms and hormone-related syndromes associated with adrenocortical carcinoma and functional adrenal tumors?",
    "answer": "Adrenocortical carcinoma may cause symptoms such as weight gain, muscle weakness, stretch marks, hormonal changes, and loss of appetite, while functional adrenal tumors can lead to hormone excess syndromes like Cushing syndrome from cortisol-producing adenomas and excess aldosterone from aldosteronoma.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of adrenal cancer include weight gain, muscle weakness, stretch marks, hormonal changes, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and unintentional weight loss",
      "Half of adrenal cancer patients have symptoms due to hormone excess",
      "Adenoma producing excess cortisol causes Cushing syndrome",
      "Aldosteronoma produces excess aldosterone",
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex",
      "Adrenocortical Carcinoma (ACC) symptoms include weight gain, muscle weakness, pink or purple stretch marks, and hormonal changes"
    ]
  },
  {
    "id": "Medical-081395a7",
    "source": "Medical",
    "question": "Which diagnostic methods are commonly used to evaluate adrenal tumors and what is their purpose?",
    "answer": "Adrenal tumors are commonly evaluated using imaging tests such as CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT, as well as blood and biochemical tests to detect hormone secretion, with genetic testing and biopsy also used for diagnosis.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors",
      "Genetic testing may be performed to identify hereditary risk factors",
      "Biopsy may be used for diagnosis",
      "Diagnostic methods for Adrenocortical Carcinoma (ACC) include CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy"
    ]
  },
  {
    "id": "Medical-af1875a1",
    "source": "Medical",
    "question": "What hereditary syndromes are recognized as risk factors for adrenocortical carcinoma?",
    "answer": "Adrenocortical carcinoma risk is increased by hereditary syndromes such as Beckwith-Wiedemann syndrome, Carney complex, FAP, PGL/PCC syndrome, Li-Fraumeni syndrome, Lynch syndrome, MEN 1, MEN 2, NF1, and Von Hippel-Lindau syndrome.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Certain hereditary syndromes increase the risk of adrenal tumors",
      "Risk factors for Adrenocortical Carcinoma (ACC) include Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), and Von Hippel-Lindau syndrome (VHL)",
      "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s",
      "Genetic testing may be performed to identify hereditary risk factors",
      "Risk factors for adrenal tumors include hereditary syndromes and family history"
    ]
  },
  {
    "id": "Medical-b2552c99",
    "source": "Medical",
    "question": "How do the symptoms and diagnostic approaches differ between pheochromocytoma and adrenocortical carcinoma?",
    "answer": "Pheochromocytoma typically presents with high blood pressure, headache, rapid heartbeat, and sweating, and is diagnosed using CT scan, MRI scan, and biochemical tests, whereas adrenocortical carcinoma presents with a broader range of symptoms including hormonal changes and is diagnosed with a wider array of imaging, blood, genetic, and biopsy tests.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating",
      "Pheochromocytoma diagnostic methods include CT scan, MRI scan, and biochemical test",
      "Symptoms of adrenocortical carcinoma include weight gain, muscle weakness, stretch marks, hormonal changes, and loss of appetite",
      "Diagnostic methods for Adrenocortical Carcinoma (ACC) include CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy",
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex"
    ]
  },
  {
    "id": "Medical-226ee2f8",
    "source": "Medical",
    "question": "What populations are most affected by neuroblastoma and what are its diagnostic features?",
    "answer": "Neuroblastoma primarily affects children under 5 years old, may metastasize to bones, and is diagnosed using imaging tests and biochemical tests.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
      "Neuroblastoma may metastasize to bones",
      "Neuroblastoma diagnostic methods include imaging tests and biochemical test",
      "Malignant adrenal tumors include neuroblastoma",
      "Imaging tests are used in the diagnosis of adrenal tumors"
    ]
  },
  {
    "id": "Medical-32153300",
    "source": "Medical",
    "question": "What are the functional categories of adrenal adenomas and their associated hormone excess syndromes or biomarkers?",
    "answer": "Adrenal adenomas can be functional, such as aldosteronoma producing excess aldosterone or cortisol-producing adenoma causing Cushing syndrome, or nonfunctioning, with their respective biomarkers being aldosterone and cortisol.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
      "Functional adrenal tumors may produce excess hormones",
      "Aldosteronoma produces excess aldosterone",
      "Adenoma producing excess cortisol causes Cushing syndrome",
      "Aldosteronoma biomarker is aldosterone; cortisol-producing adenoma biomarker is cortisol"
    ]
  },
  {
    "id": "Medical-704ecbec",
    "source": "Medical",
    "question": "Which symptoms are commonly observed in patients with adrenal cancer and what is their origin?",
    "answer": "Patients with adrenal cancer commonly experience symptoms such as weight gain, muscle weakness, stretch marks, hormonal changes, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and unintentional weight loss, originating from hormone excess or tumor growth.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Symptoms of adrenal cancer include weight gain, muscle weakness, stretch marks, hormonal changes, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and unintentional weight loss",
      "Half of adrenal cancer patients have symptoms due to hormone excess",
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex",
      "Adrenocortical Carcinoma (ACC) symptoms include weight gain, muscle weakness, pink or purple stretch marks, and hormonal changes",
      "Functional adrenal tumors may produce excess hormones"
    ]
  },
  {
    "id": "Medical-97625b74",
    "source": "Medical",
    "question": "What are the main diagnostic methods and common symptoms across major subtypes of breast cancer?",
    "answer": "Breast cancer diagnosis commonly involves mammogram, ultrasound, MRI, CT scan, PET scan, biopsy, sentinel lymph node biopsy, blood tests, and physical exam, while symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, peau dorange, and, in advanced cases, systemic symptoms such as bone pain or shortness of breath.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests",
      "Sentinel lymph node biopsy is used to assess lymph node involvement",
      "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange",
      "Metastatic breast cancer (MBC) symptoms include bone pain, shortness of breath, liver dysfunction, and neurological symptoms",
      "Inflammatory breast cancer (IBC) presents with redness, swelling, warmth, peau dorange, skin thickening, edema, and erythema",
      "Invasive ductal carcinoma symptoms include breast lump, breast pain, nipple discharge, skin thickening, redness, swelling, and peau dorange",
      "Diagnostic methods listed in the ontology include mammogram, ultrasound, MRI, CT scan, PET scan, biopsy, sentinel lymph node biopsy, blood tests, and physical exam"
    ]
  },
  {
    "id": "Medical-25d7185d",
    "source": "Medical",
    "question": "How are breast cancer subtypes defined and what are their distinguishing clinical and pathological features?",
    "answer": "Breast cancer subtypes include ductal carcinoma in situ (DCIS), invasive ductal carcinoma, lobular carcinoma, inflammatory breast cancer (IBC), and metastatic breast cancer (MBC), each defined by site of origin, invasiveness, stage, unique symptoms, and specific diagnostic or treatment considerations.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer found in the ducts",
      "Invasive ductal carcinoma is the most common type of invasive breast cancer",
      "Lobular carcinoma starts in the lobules of the breast",
      "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "Stage 0 breast cancer is noninvasive (DCIS)",
      "Stages I-III are invasive breast cancer",
      "Stage IV is metastatic breast cancer"
    ]
  },
  {
    "id": "Medical-47ffef04",
    "source": "Medical",
    "question": "What are the key biomarkers and genetic alterations relevant to breast cancer diagnosis and targeted therapy?",
    "answer": "Key biomarkers and genetic alterations in breast cancer include hormone receptor status (estrogen and progesterone receptors), HER2 status, BRCA1/2 mutations, PIK3CA mutation, MSI-H/dMMR status, and PD-L1 expression, which guide both diagnosis and the selection of targeted therapies.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer",
      "BRCA1 and BRCA2 mutations increase the risk of breast cancer",
      "PIK3CA mutation can be targeted with specific therapies",
      "MSI-H/dMMR status may influence immunotherapy options",
      "PD-L1 expression may guide immunotherapy use",
      "Biomarker ontology includes Estrogen receptor (ER), Progesterone receptor (PR), HER2, BRCA1 mutation, BRCA2 mutation, PIK3CA mutation, MSI-H, dMMR, and PD-L1",
      "Biopsy is required for definitive diagnosis and biomarker testing"
    ]
  },
  {
    "id": "Medical-edced729",
    "source": "Medical",
    "question": "How does the stage of breast cancer influence treatment options and management strategies?",
    "answer": "Breast cancer stage determines treatment approaches: Stage 0 (DCIS) is managed with surgery and radiation; Stages I-III (invasive) involve surgery, radiation, chemotherapy, endocrine, HER2-targeted, and immunotherapy; Stage IV (metastatic) emphasizes systemic therapies, targeted agents, and palliative interventions.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Stage 0 breast cancer is noninvasive (DCIS)",
      "Stages I-III are invasive breast cancer",
      "Stage IV is metastatic breast cancer",
      "Treatment options include surgery (mastectomy, lumpectomy), radiation therapy, chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, and targeted inhibitors",
      "Systemic therapy is used for invasive and metastatic breast cancer",
      "Endocrine therapy is used for hormone receptor-positive breast cancer",
      "HER2-targeted therapy is used for HER2-positive breast cancer"
    ]
  },
  {
    "id": "Medical-5562c2ca",
    "source": "Medical",
    "question": "Which treatments are matched to specific breast cancer biomarkers or genetic alterations?",
    "answer": "Endocrine therapy is used for hormone receptor-positive breast cancer, HER2-targeted therapy for HER2-positive cases, PARP inhibitors for BRCA-mutated, HER2-negative cancers, CDK4/6 inhibitors for hormone receptor-positive, HER2-negative tumors, and PIK3CA inhibitors for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Endocrine therapy is used for hormone receptor-positive breast cancer",
      "HER2-targeted therapy is used for HER2-positive breast cancer",
      "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer",
      "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer",
      "PIK3CA inhibitors are used for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer",
      "Biomarker ontology includes hormone receptor, HER2, BRCA1 mutation, BRCA2 mutation, PIK3CA mutation"
    ]
  },
  {
    "id": "Medical-0cba5d0a",
    "source": "Medical",
    "question": "What are the main risk factors and considerations for breast cancer prevention and patient counseling?",
    "answer": "Major risk factors for breast cancer include family history, BRCA1/2 mutations, and being assigned female at birth; fertility preservation and performance status are important considerations in patient counseling before treatment.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Risk factors include family history, BRCA mutations, and being assigned female at birth",
      "BRCA1 and BRCA2 mutations increase the risk of breast cancer",
      "Fertility preservation should be discussed before starting treatment",
      "Performance status is considered in treatment planning",
      "Risk Factor ontology includes family history, BRCA1 mutation, BRCA2 mutation, assigned female at birth"
    ]
  },
  {
    "id": "Medical-d72d7cb9",
    "source": "Medical",
    "question": "How is follow-up and surveillance conducted for breast cancer patients after initial treatment?",
    "answer": "Follow-up for breast cancer patients includes regular imaging, physical examinations, and monitoring for recurrence to ensure early detection of relapse or new disease.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Follow-up includes imaging, physical exams, and monitoring for recurrence",
      "Follow-up/Surveillance ontology includes imaging, physical exams, and monitoring for recurrence",
      "Imaging methods include mammogram, ultrasound, MRI, CT scan, and PET scan",
      "Physical exams are part of ongoing surveillance",
      "Monitoring for recurrence is a component of follow-up care"
    ]
  },
  {
    "id": "Medical-97d64c1f",
    "source": "Medical",
    "question": "What is the clinical significance of tumor grade in breast cancer, and how is it assessed?",
    "answer": "Tumor grade in breast cancer, described as GX, G1, G2, or G3, reflects how abnormal the tumor cells appear microscopically and helps predict disease aggressiveness and guide management.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Grade describes how abnormal the tumor cells look under a microscope",
      "Grade ontology includes GX, G1, G2, G3",
      "Tumor grade is used in breast cancer assessment",
      "Grade is distinct from stage and provides information about tumor differentiation",
      "Pathological assessment of grade informs prognosis and treatment planning"
    ]
  },
  {
    "id": "Medical-4dc06fbd",
    "source": "Medical",
    "question": "What are the most common therapies used in the systemic treatment of breast cancer, and when are they indicated?",
    "answer": "Systemic therapies for breast cancer include chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, and targeted inhibitors, which are indicated for invasive and metastatic disease based on biomarker status.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Systemic therapy is used for invasive and metastatic breast cancer",
      "Treatment options include chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, and targeted inhibitors",
      "Endocrine therapy is used for hormone receptor-positive breast cancer",
      "HER2-targeted therapy is used for HER2-positive breast cancer",
      "Immunotherapy is used based on PD-L1 expression and MSI-H/dMMR status"
    ]
  },
  {
    "id": "Medical-19f19b9b",
    "source": "Medical",
    "question": "How are imaging and biopsy utilized throughout the continuum of breast cancer care, from screening to diagnosis and surveillance?",
    "answer": "Imaging (mammogram, ultrasound, MRI, CT, PET) is used for screening, diagnosis, staging, and surveillance, while biopsy is required for definitive diagnosis and biomarker testing, and both are essential across all stages of breast cancer care.",
    "question_type": "Contextual Summarize",
    "evidence": [
      "Screening mammograms are used for early detection in asymptomatic individuals",
      "Diagnostic mammograms are used for individuals with symptoms or abnormal screening results",
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests",
      "Biopsy is required for definitive diagnosis and biomarker testing",
      "Follow-up includes imaging, physical exams, and monitoring for recurrence"
    ]
  },
  {
    "id": "Medical-fe3240a4",
    "source": "Medical",
    "question": "Imagine you are a dermatology attending receiving a new patient referral for a suspicious lesion on the face. Write a consult note summarizing the key risk factors, diagnostic steps, and initial management plan for suspected basal cell carcinoma, referencing current clinical practice guidelines.",
    "answer": "Consult Note: \n\nPatient presents with a suspicious lesion on the left cheek. Key risk factors include significant sun exposure, fair skin, and a personal history of skin cancer. On examination, the lesion appears as a shiny, pearly bump with rolled borders. The diagnostic plan includes a thorough skin exam, detailed medical and family history, and performing a skin biopsy to confirm the diagnosis of basal cell carcinoma (BCC). Imaging may be considered if there is suspicion of deep tissue involvement. If BCC is confirmed, surgical excision is proposed as the first-line treatment. The patient will be counseled on recurrence risk and the importance of annual full skin exams for follow-up.",
    "question_type": "Creative Generation",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "History of skin cancer or family history increases risk of BCC",
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging",
      "Surgery is the most common treatment for BCC",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-8f5233d5",
    "source": "Medical",
    "question": "You are a general practitioner drafting a discharge summary for a patient treated for basal cell carcinoma on the scalp. Transform the clinical facts into a formal discharge summary, ensuring inclusion of risk factors, clinical presentation, diagnostic workup, treatment, and follow-up recommendations.",
    "answer": "Discharge Summary:\n\nDiagnosis: Basal cell carcinoma (BCC) of the scalp\n\nSummary: The patient presented with a shiny bump with rolled borders on the scalp, a sun-exposed area. Risk factors include prolonged UV radiation exposure, fair skin, and older age. Diagnostic evaluation included a physical and skin exam, as well as a skin biopsy confirming BCC. The patient underwent surgical excision of the lesion. No evidence of recurrence or metastasis was found. The patient is advised to attend full skin exams at least annually for follow-up and to practice sun protection to reduce recurrence risk.",
    "question_type": "Creative Generation",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Older age is associated with higher risk of BCC",
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging",
      "Surgery is the most common treatment for BCC",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-c9c108e1",
    "source": "Medical",
    "question": "Assume the role of a patient who has just been diagnosed with basal cell carcinoma. Write a letter to your family explaining what the diagnosis means, the likely causes, the treatment you will receive, and what you will need to do to monitor your health going forward, using evidence from the clinical guideline.",
    "answer": "Dear Family,\n\nI wanted to let you know that I have been diagnosed with basal cell carcinoma, which is the most common type of skin cancer. It develops from basal cells in the lower part of the skins outer layer, usually in areas exposed to the sun like the face or scalp. My doctor told me that risk factors include things like fair skin, getting a lot of sun or UV exposure, and family history. The diagnosis was made after a skin exam and biopsy. The good news is that surgery is very effective and is the standard treatment. I will need to have regular full skin exams at least once a year to catch any possible recurrence early. Im also planning to be extra careful about sun protection from now on.",
    "question_type": "Creative Generation",
    "evidence": [
      "Basal cell carcinoma (BCC) is the most common type of skin cancer",
      "BCC arises from basal cells in the lower part of the epidermis",
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "UV radiation exposure is a primary risk factor for BCC",
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging",
      "Surgery is the most common treatment for BCC",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-bf68d23e",
    "source": "Medical",
    "question": "Rewrite the following scenario into a public health advisory: There has been an increase in basal cell carcinoma diagnoses in your community, particularly among older adults with fair skin. Use the clinical guideline to construct an evidence-based advisory focused on prevention, early detection, and high-risk groups.",
    "answer": "Public Health Advisory: Increased Basal Cell Carcinoma Cases in Our Community\n\nWe are observing a rise in basal cell carcinoma (BCC), the most common type of skin cancer, especially among older adults with fair skin and light-colored eyes or hair. BCC typically develops in sun-exposed areas such as the face, head, and neck, and risk increases with UV radiation exposure. Individuals with a personal or family history of skin cancer, those who have undergone radiation therapy, or those with immune suppression are at higher risk. We urge the community to practice sun protection, avoid tanning beds, and seek medical evaluation for new or changing skin lesions. Annual full skin exams with your healthcare provider are recommended for early detection and improved outcomes.",
    "question_type": "Creative Generation",
    "evidence": [
      "Basal cell carcinoma (BCC) is the most common type of skin cancer",
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "Older age is associated with higher risk of BCC",
      "History of skin cancer or family history increases risk of BCC",
      "Radiation therapy and immune suppression are risk factors for BCC",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-fd1b07be",
    "source": "Medical",
    "question": "You are a dermatology intern preparing a referral letter to oncology for a patient with recurrent basal cell carcinoma that has spread to lymph nodes. Summarize the clinical findings, risk factors, diagnostic confirmation, and rationale for referral, referencing the guideline.",
    "answer": "Referral Letter to Oncology:\n\nDear Colleague,\n\nI am referring a patient with a history of basal cell carcinoma (BCC) who now presents with recurrence at the original site and evidence of spread to regional lymph nodes. The patient has multiple risk factors, including fair skin, significant UV exposure, and a prior history of skin cancer. The current diagnosis was established via physical and skin examination, followed by a confirmatory biopsy and imaging studies. Given the recurrence and lymph node involvement, I am seeking your expertise regarding systemic therapy or radiation options beyond surgical management. Please advise on further staging and treatment recommendations.",
    "question_type": "Creative Generation",
    "evidence": [
      "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites",
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "History of skin cancer or family history increases risk of BCC",
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging",
      "Radiation therapy or systemic therapy may be used in some cases of BCC",
      "Treatment options based on risk and recurrence"
    ]
  },
  {
    "id": "Medical-ea29b9d8",
    "source": "Medical",
    "question": "Imagine you are a neuro-oncology fellow. Write a detailed initial diagnostic workup and staging plan for a 62-year-old patient presenting with progressive leg weakness, memory problems, and blurry vision, suspected of having primary CNS lymphoma. Your plan should outline all relevant assessments and justify their use.",
    "answer": "For a 62-year-old patient presenting with progressive leg weakness, memory problems, and blurry vision, the initial diagnostic workup for suspected primary CNS lymphoma should include:\n\n1. Neurological examination to assess the extent of neurological deficits and establish a clinical baseline.\n2. MRI of the brain with gadolinium contrast as the most sensitive imaging modality to identify CNS lesions characteristic of lymphoma.\n3. Eye examination using slit lamp and potentially vitrectomy if ocular involvement is suspected, given the blurry vision.\n4. Stereotactic biopsy of the brain lesion to obtain histopathologic confirmation, as this is the standard diagnostic procedure.\n5. Laboratory assessments including complete blood count, comprehensive metabolic panel, lactate dehydrogenase (LDH) levels, and HIV and hepatitis B testing to evaluate for risk factors and baseline organ function.\n6. Lumbar puncture to analyze cerebrospinal fluid for malignant cells, especially given the possibility of CSF involvement in primary CNS lymphoma.\n7. Performance status evaluation to guide further diagnostic and treatment decisions.\nThis comprehensive approach ensures accurate diagnosis, detection of disease extent (including possible eye and CSF involvement), and risk factor assessment to inform treatment planning.",
    "question_type": "Creative Generation",
    "evidence": [
      "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture.",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma.",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma.",
      "Eye exam and vitrectomy may be used if the eyes are involved.",
      "Laboratory tests include complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), HIV blood test, and hepatitis B testing.",
      "Lumbar puncture is used to assess for cerebrospinal fluid involvement.",
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials."
    ]
  },
  {
    "id": "Medical-c2658ea4",
    "source": "Medical",
    "question": "As a hematologist, develop a comprehensive induction and consolidation treatment plan for a newly diagnosed immunocompetent adult with primary CNS lymphoma confined to the brain. The plan should detail drug regimens, rationale, and supportive care measures.",
    "answer": "For an immunocompetent adult with newly diagnosed primary CNS lymphoma confined to the brain, the treatment plan consists of:\n\nInduction Phase: Initiate high-dose methotrexate-based chemotherapy, as this is the mainstay of induction for primary CNS lymphoma. Combine with rituximab, the primary immunotherapy agent, to enhance response. Consider adding agents such as temozolomide or vincristine as per protocol and patient tolerance. Supportive corticosteroids may be used to reduce cerebral edema and symptoms.\n\nConsolidation Phase: Upon achieving remission or maximal response, proceed to consolidation with whole-brain radiation therapy (WBRT), which is the most commonly used radiation technique in this context. Alternatively, high-dose chemotherapy followed by hematopoietic stem cell rescue may be considered based on patient performance status and institutional protocols.\n\nThroughout treatment, provide supportive care to manage symptoms and treatment side effects, involving a multidisciplinary team as needed. Monitor performance status regularly to adjust therapy and consider clinical trial participation if available.",
    "question_type": "Creative Generation",
    "evidence": [
      "Treatment options for primary CNS lymphoma include corticosteroids, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell rescue, and supportive care.",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma.",
      "Rituximab is the main immunotherapy drug used for primary CNS lymphoma.",
      "Treatment is typically given in phases: induction and consolidation.",
      "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma.",
      "Supportive care is provided to relieve symptoms and side effects at any stage of disease.",
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials."
    ]
  },
  {
    "id": "Medical-e6da7d3c",
    "source": "Medical",
    "question": "Rewrite the core recommendations for the diagnosis and management of primary CNS lymphoma into a formal referral letter from a general neurologist to a neuro-oncologist, ensuring all key clinical, diagnostic, and management considerations are included.",
    "answer": "Dear Neuro-Oncology Colleague,\n\nI am referring a 58-year-old patient with recent onset progressive arm weakness, confusion, and double vision. MRI with gadolinium contrast revealed a solitary enhancing lesion in the right frontal lobe. The patient has no known history of immunodeficiency but is an older adult. Given these findings, primary CNS lymphoma is strongly suspected.\n\nTo confirm the diagnosis, I recommend proceeding with stereotactic biopsy, as this is the standard diagnostic procedure. Additional workup should include comprehensive laboratory tests (CBC, CMP, LDH, HIV, and hepatitis B), lumbar puncture to assess for cerebrospinal fluid involvement, and detailed eye examination due to reported visual symptoms. Performance status assessment is essential to guide both treatment planning and clinical trial eligibility.\n\nFor management, high-dose methotrexate-based chemotherapy, with consideration for rituximab, should be initiated as induction therapy, followed by consolidation with whole-brain radiation therapy or high-dose chemotherapy with stem cell rescue as appropriate. Supportive care should be provided throughout. I recommend considering clinical trial enrollment if available.\n\nThank you for your expert evaluation and management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture.",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma.",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma.",
      "Laboratory tests include complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), HIV blood test, and hepatitis B testing.",
      "Lumbar puncture is used to assess for cerebrospinal fluid involvement.",
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials.",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma.",
      "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma.",
      "Clinical trial participation is recommended for all patients with primary CNS lymphoma."
    ]
  },
  {
    "id": "Medical-96352a3c",
    "source": "Medical",
    "question": "Transform the main points of the guideline into a discharge summary for a patient with primary CNS lymphoma who has completed induction chemotherapy and is entering the consolidation phase.",
    "answer": "Discharge Summary\n\nDiagnosis: Primary Central Nervous System Lymphoma (PCNSL)\n\nSummary of Hospital Course: The patient presented with headaches, nausea, and coordination difficulties. MRI with gadolinium contrast demonstrated multifocal enhancing lesions in the brain. Stereotactic biopsy confirmed PCNSL. Laboratory evaluation, including CBC, CMP, LDH, and HIV testing, was performed. Eye examination and lumbar puncture showed no evidence of ocular or CSF involvement. Performance status was assessed throughout.\n\nTreatment: The patient completed induction chemotherapy with high-dose methotrexate and rituximab, along with corticosteroids for symptom management. The patient tolerated therapy well, with improvement in neurological symptoms.\n\nPlan: The patient will transition to consolidation therapy with whole-brain radiation therapy (WBRT), as per guideline recommendations. Supportive care will continue to address any ongoing symptoms or treatment side effects. The patient is encouraged to consider clinical trial participation and will have regular follow-up with repeat MRI, blood tests, and performance status assessments.",
    "question_type": "Creative Generation",
    "evidence": [
      "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture.",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma.",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma.",
      "Treatment is typically given in phases: induction and consolidation.",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma.",
      "Rituximab is the main immunotherapy drug used for primary CNS lymphoma.",
      "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma.",
      "Supportive care is provided to relieve symptoms and side effects at any stage of disease.",
      "Follow-up/Surveillance: Repeat MRI, eye exam, blood tests, performance status assessment.",
      "Clinical trial participation is recommended for all patients with primary CNS lymphoma."
    ]
  },
  {
    "id": "Medical-3396b459",
    "source": "Medical",
    "question": "Write a public health advisory summarizing risk factors, key symptoms, and the importance of early specialist referral for primary CNS lymphoma, using evidence from the guideline.",
    "answer": "Public Health Advisory: Primary Central Nervous System Lymphoma (PCNSL)\n\nPrimary CNS lymphoma is a rare but aggressive cancer that originates from lymphocytes within the central nervous system, most commonly affecting the brain but also the spinal cord, cerebrospinal fluid, and eyes. Individuals at increased risk include those with impaired immune systems, such as patients with immunodeficiency disorders, HIV infection, Epstein-Barr virus, autoimmune diseases, organ transplants, and older adults.\n\nKey symptoms to watch for include leg or arm weakness, difficulties with coordination or movement, changes in personality or behavior, memory problems, headaches, nausea, vomiting, seizures, and vision changes such as blurry or double vision. Early and accurate diagnosis is critical for improving outcomes. Diagnostic evaluation includes neurological examination, MRI with gadolinium contrast, stereotactic biopsy, laboratory tests, eye examination, and lumbar puncture.\n\nPrompt referral to a neuro-oncology specialist is essential for timely diagnosis and initiation of evidence-based therapy, which typically involves high-dose methotrexate-based chemotherapy and possible whole-brain radiation therapy. Participation in clinical trials and supportive care are also recommended. Early detection and specialist management can significantly impact patient prognosis.",
    "question_type": "Creative Generation",
    "evidence": [
      "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system.",
      "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes.",
      "Impaired immune system is a risk factor for primary CNS lymphoma.",
      "Immunodeficiency disorders, HIV infection, Epstein-Barr virus, autoimmune diseases, organ transplant, and older age are risk factors for primary CNS lymphoma.",
      "Primary CNS lymphoma can cause neurological symptoms such as leg or arm weakness, coordination or movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes.",
      "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture.",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma.",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma.",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma.",
      "Clinical trial participation is recommended for all patients with primary CNS lymphoma."
    ]
  },
  {
    "id": "Medical-beb1f30e",
    "source": "Medical",
    "question": "Imagine you are a dermatology attending preparing a referral letter for a patient with a newly diagnosed high-risk cutaneous squamous cell carcinoma (CSCC) on the scalp. Summarize the case, risk assessment, diagnostic findings, and recommend next steps, incorporating relevant guideline recommendations.",
    "answer": "Dear Colleague,\n\nI am referring a 68-year-old fair-skinned male recently diagnosed with high-risk cutaneous squamous cell carcinoma (CSCC) of the scalp. The patient has a history of chronic sun exposure and presented with a 2.5 cm solid, irregular lesion on an area of chronic scarring. Clinical examination and excision biopsy confirmed invasive CSCC with perineural invasion and poorly defined borders. Imaging (CT) did not reveal nodal or distant metastasis. Risk assessment classified the tumor as high-risk due to its size, location (scalp), perineural invasion, and history of recurrence. \n\nGuidelines recommend Mohs surgery/PDEMA as the preferred treatment for high-risk local CSCC, with consideration of adjuvant radiation therapy if surgical margins are inadequate or perineural invasion is extensive. Regular skin and lymph node exams every 3-6 months for the first 2 years are advised for surveillance. Please see attached pathology and imaging reports for further details.\n\nSincerely,\nDermatology Attending",
    "question_type": "Creative Generation",
    "evidence": [
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible.",
      "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status.",
      "CSCC most commonly arises in sun-exposed areas, especially in fair-skinned individuals.",
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected.",
      "Follow-up after treatment includes regular skin and lymph node exams, with frequency based on risk and stage."
    ]
  },
  {
    "id": "Medical-9e9cc51b",
    "source": "Medical",
    "question": "You are an oncology nurse tasked with drafting a patient-friendly discharge summary for a person with regional CSCC (lymph node involvement) who has completed surgery and adjuvant radiation. Use the guideline to summarize their diagnosis, treatment, risk factors, and follow-up plan.",
    "answer": "Discharge Summary for Regional Cutaneous Squamous Cell Carcinoma (CSCC)\n\nDiagnosis: You were diagnosed with cutaneous squamous cell carcinoma (CSCC) that had spread to a nearby lymph node. Major risk factors included chronic sun exposure and a weakened immune system.\n\nTreatment: You underwent surgery to remove the skin tumor and the affected lymph node, followed by radiation therapy to reduce the risk of recurrence. No evidence of further spread was found on imaging.\n\nFollow-up Plan: Follow-up will include skin and lymph node checks every 23 months in the first year, then every 24 months in the second year, and less frequently after that. Imaging will be used for ongoing surveillance. Please continue sun protection and report any new skin changes promptly.\n\nThank you for your cooperation.",
    "question_type": "Creative Generation",
    "evidence": [
      "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy.",
      "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars.",
      "Follow-up after treatment includes regular skin and lymph node exams, with frequency based on risk and stage.",
      "Imaging is used for staging and surveillance in regional and high-risk cases.",
      "Skin and lymph node exams every 2-3 months for 1 year, every 2-4 months for year 2, every 4-6 months for 3 years, then every 6-12 months."
    ]
  },
  {
    "id": "Medical-970792d6",
    "source": "Medical",
    "question": "Assume the role of a medical intern on the dermatology service. You are asked to write a SOAP progress note for a patient with actinic keratosis and a history of immunosuppression, referencing both diagnosis and management per guidelines.",
    "answer": "SOAP Note\n\nSubjective: Patient reports several rough, scaly patches on sun-exposed areas of the face and forearms. No pain or bleeding. History significant for chronic immunosuppression due to organ transplant.\n\nObjective: Exam reveals multiple erythematous, scaly papules on the left cheek and dorsal hands. No palpable lymphadenopathy. Biopsy confirms actinic keratosis.\n\nAssessment: Actinic keratosis in an immunosuppressed patient, increasing risk for progression to cutaneous squamous cell carcinoma (CSCC).\n\nPlan: Initiate cryotherapy for visible lesions and topical 5-fluorouracil for field treatment. Educate on strict photoprotection. Schedule regular skin exams every 36 months due to increased risk. Monitor for any new or changing lesions.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC.",
      "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC.",
      "Major risk factors for CSCC include chronic sun exposure, actinic keratosis, genetic syndromes, weakened immune system, and chronic wounds or scars.",
      "Follow-up after treatment includes regular skin and lymph node exams, with frequency based on risk and stage.",
      "Immunosuppression is a risk factor for both actinic keratosis and progression to CSCC."
    ]
  },
  {
    "id": "Medical-5b2de94d",
    "source": "Medical",
    "question": "You are a public health official drafting an advisory for primary care providers about prevention, early detection, and high-risk populations for cutaneous squamous cell carcinoma (CSCC). Use guideline facts to inform your advisory.",
    "answer": "Public Health Advisory: Prevention and Early Detection of Cutaneous Squamous Cell Carcinoma (CSCC)\n\nPrimary care providers should be vigilant for CSCC, the second most common skin cancer, particularly in fair-skinned individuals and those with extensive sun exposure. High-risk populations include patients with chronic sun exposure, indoor tanning history, actinic keratosis, genetic syndromes (e.g., xeroderma pigmentosum, RDEB), immunosuppression, and chronic wounds or scars. \n\nEarly detection relies on clinical examination for scaly patches or misshapen skin lesions, especially in sun-exposed or chronically damaged areas. Biopsy is essential for suspicious lesions. Encourage sun protection and routine skin exams, especially for high-risk patients. Prompt referral for dermatologic evaluation is recommended for new, persistent, or changing lesions.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer.",
      "CSCC most commonly arises in sun-exposed areas, especially in fair-skinned individuals.",
      "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars.",
      "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage.",
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected."
    ]
  },
  {
    "id": "Medical-22918f14",
    "source": "Medical",
    "question": "Imagine you are a hematology fellow receiving a new referral for a patient with suspected chronic myeloid leukemia (CML). Draft a detailed diagnostic workup plan, including key laboratory and molecular studies, and explain how you would confirm the diagnosis and characterize the disease phase.",
    "answer": "As a hematology fellow, my diagnostic workup for suspected CML would begin with a complete blood count (CBC) to assess for increased white blood cell (WBC) counts, particularly granulocytes, and evaluate platelet (PLT) and red blood cell (RBC) levels. I would order a peripheral blood smear to further characterize granulocyte lineage and identify abnormal cells. Next, I would request a bone marrow aspiration and biopsy to assess myeloid progenitor cell proliferation and to look for any increase in blasts, which could indicate blast phase CML (BP-CML). Cytogenetic analysis would be performed to detect the presence of the Philadelphia chromosome (Ph), the abnormal chromosome 22 resulting from the translocation between chromosomes 9 and 22. Additionally, molecular testing for the BCR::ABL1 fusion gene would be conducted, as its presence is required for a definitive diagnosis of CML. The combination of clinical, morphologic, cytogenetic, and molecular findings would allow me to confirm CML, differentiate it from other myeloproliferative neoplasms, and determine if the disease is in chronic or blast phase.",
    "question_type": "Creative Generation",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts.",
      "Blood tests and bone marrow tests are used to diagnose CML.",
      "CML arises from blood stem cells producing increased myeloid progenitor cells.",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22.",
      "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts."
    ]
  },
  {
    "id": "Medical-c5176f5c",
    "source": "Medical",
    "question": "You are an oncologist preparing a treatment initiation summary for a patient newly diagnosed with chronic phase CML. Summarize the pathogenesis, diagnostic criteria, and first-line therapeutic strategy, referencing relevant biomarkers and molecular targets.",
    "answer": "Chronic myeloid leukemia (CML) is a blood cancer caused by the BCR::ABL1 fusion gene, which arises from a translocation between chromosomes 9 and 22, forming the Philadelphia chromosome (Ph). Diagnosis is established by detecting either the Ph chromosome or the BCR::ABL1 fusion gene, typically via cytogenetic and molecular testing of blood or bone marrow samples. The disease originates in blood stem cells, leading to excessive production of myeloid progenitor cells and increased granulocyte (white blood cell) counts, often accompanied by abnormal platelet levels. The primary therapeutic approach targets the BCR::ABL1 protein, whose abnormal tyrosine kinase activity drives disease progression. Initiation of treatment with a BCR::ABL1 protein inhibitor is recommended as first-line therapy for chronic phase CML, with ongoing monitoring of molecular response.",
    "question_type": "Creative Generation",
    "evidence": [
      "Chronic myeloid leukemia (CML) is a type of blood cancer.",
      "CML is caused by the BCR::ABL1 fusion gene.",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22.",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation.",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
      "CML arises from blood stem cells producing increased myeloid progenitor cells.",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity."
    ]
  },
  {
    "id": "Medical-3aed2370",
    "source": "Medical",
    "question": "Transform the core clinical facts about chronic myeloid leukemia (CML) into a structured discharge summary for a patient completing diagnostic evaluation and beginning therapy.",
    "answer": "**Discharge Summary**\n\nDiagnosis: Chronic Myeloid Leukemia (CML)\nSummary: The patient was evaluated for elevated white blood cell counts and abnormal platelets. Blood and bone marrow analyses revealed increased granulocytes and myeloid progenitor cells. Cytogenetic and molecular studies confirmed the presence of the Philadelphia chromosome (Ph) and BCR::ABL1 fusion gene, fulfilling diagnostic criteria for CML. The disease is currently in the chronic phase. Initiation of BCR::ABL1 protein inhibitor therapy is planned.\nKey Findings:\n- Increased WBC (granulocytes) and abnormal platelet counts\n- Bone marrow: proliferation of myeloid progenitor cells\n- Cytogenetics: Philadelphia chromosome (Ph) detected (translocation between chromosome 9 and 22)\n- Molecular: BCR::ABL1 fusion gene present\nPlan: Begin BCR::ABL1 protein inhibitor therapy with ongoing monitoring of blood counts and molecular response.",
    "question_type": "Creative Generation",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts.",
      "CML arises from blood stem cells producing increased myeloid progenitor cells.",
      "Blood tests and bone marrow tests are used to diagnose CML.",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22.",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity."
    ]
  },
  {
    "id": "Medical-fbacfb98",
    "source": "Medical",
    "question": "Reframe the guideline information into a referral note addressed to a specialist, clearly stating the clinical suspicion, supporting laboratory findings, and rationale for specialist input.",
    "answer": "Dear Hematology Specialist,\n\nI am referring a patient with clinical and laboratory findings suggestive of chronic myeloid leukemia (CML). The patient presents with persistent leukocytosis, notably increased granulocytes, and abnormal platelet counts identified on routine blood tests. Bone marrow evaluation demonstrated hypercellularity with expansion of myeloid progenitor cells. Cytogenetic analysis revealed the Philadelphia chromosome (Ph), resulting from a translocation between chromosomes 9 and 22. Molecular studies confirmed the presence of the BCR::ABL1 fusion gene. Given these findings, CML is strongly suspected and I am seeking your expertise for confirmation of diagnosis, disease phase classification, and initiation of targeted therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts.",
      "CML arises from blood stem cells producing increased myeloid progenitor cells.",
      "Blood tests and bone marrow tests are used to diagnose CML.",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22.",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation.",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis."
    ]
  },
  {
    "id": "Medical-70301a25",
    "source": "Medical",
    "question": "You are a public health officer tasked with writing an educational advisory on the importance of genetic and molecular testing in diagnosing chronic myeloid leukemia (CML). Summarize the key genetic mechanisms, diagnostic requirements, and implications for treatment.",
    "answer": "**Public Health Advisory: The Role of Genetic and Molecular Testing in CML Diagnosis**\n\nChronic myeloid leukemia (CML) is a blood cancer defined by a specific genetic alteration: the BCR::ABL1 fusion gene, formed by a translocation between chromosomes 9 and 22, leading to the formation of the Philadelphia chromosome (Ph). Accurate diagnosis requires laboratory confirmation of either the Ph chromosome or the BCR::ABL1 fusion gene through cytogenetic and molecular testing of blood or bone marrow samples. These tests distinguish CML from other blood disorders and are critical for selecting appropriate therapy. Targeted treatments that inhibit the BCR::ABL1 protein have dramatically improved outcomes. Public health initiatives should ensure access to advanced molecular diagnostics for all suspected CML patients.",
    "question_type": "Creative Generation",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene.",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22.",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation.",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
      "Blood tests and bone marrow tests are used to diagnose CML.",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity."
    ]
  },
  {
    "id": "Medical-0f84be73",
    "source": "Medical",
    "question": "As a pulmonologist, you are seeing a 62-year-old patient with a 40 pack-year smoking history who presents with a persistent cough. Imaging has revealed a solitary lung nodule. Using the clinical practice guidelines provided, draft a detailed diagnostic and initial management plan, including risk assessment, confirmatory steps, and early treatment considerations.",
    "answer": "Given the patient's significant tobacco smoking history, he is at high risk for lung cancer. The solitary lung nodule detected on imaging warrants further workup. I would recommend a biopsy to confirm malignancy, as this is essential for diagnosis. If the biopsy confirms non-small cell lung cancer (NSCLC), I would determine the subtype (likely adenocarcinoma, squamous cell carcinoma, or large cell carcinoma) and stage the disease. For early-stage (Stage 1) NSCLC, surgery is the primary treatment, with radiation therapy as an option in some cases. If the disease is locally advanced (Stage 2 or 3), chemoradiation and possibly surgery would be considered. Throughout, supportive care should be integrated to address symptoms such as cough and chest pain, and follow-up care with surveillance would be planned after initial treatment.",
    "question_type": "Creative Generation",
    "evidence": [
      "Tobacco smoking is the biggest risk factor for lung cancer.",
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy.",
      "Biopsy is used to confirm lung cancer diagnosis.",
      "NSCLC is the most common type of lung cancer.",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible.",
      "Radiation therapy is used for some early NSCLC cases.",
      "Chemoradiation is used for some locally advanced NSCLC cases.",
      "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms.",
      "Follow-up care is planned after treatment and includes surveillance for recurrence."
    ]
  },
  {
    "id": "Medical-6e3f025e",
    "source": "Medical",
    "question": "You are a medical intern tasked with writing a referral note for a patient with suspected Stage 2 NSCLC based on the guideline. Your note should summarize the diagnostic findings, risk factors, and recommend further specialist evaluation and treatment options.",
    "answer": "Referral Note:\n\nPatient is a 58-year-old with a 30 pack-year smoking history presenting with persistent cough and chest pain. Imaging revealed a lung nodule, and biopsy confirmed NSCLC, likely Stage 2 based on local extension without distant spread. Major risk factors include tobacco use and possible occupational exposure to asbestos. Recommend thoracic oncology evaluation for definitive staging and management. As per guidelines, treatment options include surgery and/or chemoradiation. Supportive care for symptom management and follow-up surveillance should be discussed.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage 2 and Stage 3 NSCLC are considered locally advanced.",
      "Biopsy is used to confirm lung cancer diagnosis.",
      "Imaging is used to detect lung nodules.",
      "Tobacco smoking is the biggest risk factor for lung cancer.",
      "Exposure to asbestos increases lung cancer risk.",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible.",
      "Chemoradiation is used for some locally advanced NSCLC cases.",
      "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms.",
      "Follow-up care is planned after treatment and includes surveillance for recurrence."
    ]
  },
  {
    "id": "Medical-8c4b4b2f",
    "source": "Medical",
    "question": "Rewrite the clinical practice guideline content into a patient-friendly discharge summary for a person who has undergone surgery for Stage 1 NSCLC. The summary should explain the diagnosis, risk factors, treatment performed, and follow-up plan.",
    "answer": "Discharge Summary:\n\nDiagnosis: Early-stage non-small cell lung cancer (NSCLC), specifically Stage 1, was confirmed after your recent surgery. This cancer type most often develops in people with risk factors like tobacco smoking and exposure to substances such as asbestos or air pollution. You underwent successful surgical removal of the tumor, which is the standard treatment for early NSCLC. No evidence of spread was found at this stage. Moving forward, you will have regular follow-up visits and imaging to monitor for recurrence. Please report any new symptoms such as cough or chest pain promptly.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage 1 NSCLC is considered early stage.",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible.",
      "NSCLC is the most common type of lung cancer.",
      "Tobacco smoking is the biggest risk factor for lung cancer.",
      "Exposure to asbestos and air pollution are risk factors for lung cancer.",
      "Follow-up care is planned after treatment and includes surveillance for recurrence.",
      "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms."
    ]
  },
  {
    "id": "Medical-d5964ccf",
    "source": "Medical",
    "question": "As a public health officer, draft a community health advisory on lung cancer prevention and early detection, integrating key guideline facts on risk factors, screening, and symptom awareness.",
    "answer": "Community Health Advisory: Preventing and Detecting Lung Cancer Early\n\nLung cancer is a leading cause of cancer-related deaths. The most common type, non-small cell lung cancer (NSCLC), is strongly linked to tobacco smoking and exposure to substances like radon, asbestos, and air pollution. Individuals with a history of heavy smoking or exposure to these risk factors should ask their healthcare provider about lung cancer screening, which can detect cancer at an early, more treatable stage. Watch for warning signs such as persistent cough or chest pain. Quitting smoking and reducing exposure to harmful substances significantly lowers your risk. Regular follow-up and participation in clinical trials may also improve outcomes.",
    "question_type": "Creative Generation",
    "evidence": [
      "NSCLC is the most common type of lung cancer.",
      "Tobacco smoking is the biggest risk factor for lung cancer.",
      "Exposure to radon, asbestos, and air pollution are risk factors for lung cancer.",
      "Lung cancer screening is recommended for people at high risk.",
      "Lung cancer screening aims to detect cancer at an early, more treatable stage.",
      "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms.",
      "Clinical trials are available for lung cancer treatment and prevention.",
      "Supportive care extends and enhances life for people with lung cancer."
    ]
  },
  {
    "id": "Medical-0ec610fa",
    "source": "Medical",
    "question": "Format the key elements of NSCLC diagnosis and management from the guideline into a SOAP (Subjective, Objective, Assessment, Plan) note for a new oncology consultation.",
    "answer": "SOAP Note:\n\nSubjective: Patient reports persistent cough and intermittent chest pain. History includes current tobacco smoking and prior exposure to diesel fumes.\n\nObjective: Imaging revealed a lung nodule; biopsy confirmed NSCLC. No evidence of distant spread on staging.\n\nAssessment: Newly diagnosed NSCLC, likely early or locally advanced stage. Significant risk factors include tobacco use and occupational exposure.\n\nPlan: Refer for surgical evaluation (if early stage), consider chemoradiation for locally advanced disease. Initiate supportive care for symptom management. Enroll in follow-up care and surveillance after primary treatment. Discuss potential clinical trial participation.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of lung cancer may include cough, chest pain, and other respiratory symptoms.",
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy.",
      "Biopsy is used to confirm lung cancer diagnosis.",
      "NSCLC is the most common type of lung cancer.",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible.",
      "Chemoradiation is used for some locally advanced NSCLC cases.",
      "Tobacco smoking and exposure to diesel fumes are risk factors for lung cancer.",
      "Follow-up care is planned after treatment and includes surveillance for recurrence.",
      "Clinical trials are available for lung cancer treatment and prevention.",
      "Supportive care extends and enhances life for people with lung cancer."
    ]
  },
  {
    "id": "Medical-65be7ca5",
    "source": "Medical",
    "question": "Imagine you are a head and neck cancer specialist preparing a referral letter for a 45-year-old male from Southeast Asia with suspected nasopharyngeal carcinoma (NPC). Summarize the relevant risk factors, preliminary findings, required diagnostic workup, and initial management considerations to the oncology team.",
    "answer": "Dear Oncology Team,\n\nI am referring a 45-year-old male of Southeast Asian origin with a clinical suspicion of nasopharyngeal carcinoma (NPC). The patient presents with a neck mass and intermittent hearing loss. Notably, he has a history of tobacco and alcohol use. NPC is more prevalent in individuals from Asia, and EBV infection is a major etiologic factor. On examination, there is an enlarged cervical lymph node. I recommend a thorough diagnostic workup including imaging (CT/MRI and PET/CT) to assess primary tumor extent and nodal involvement, as well as a biopsy of the nasopharyngeal lesion for histopathological confirmation. Biomarker testing for EBV DNA, PD-L1, and MSI-H/dMMR should also be performed. Please also evaluate performance status and discuss fertility preservation options prior to therapy. Dental and nutritional assessments are advised due to the potential impact of head and neck cancer treatment on oral health and nutrition.",
    "question_type": "Creative Generation",
    "evidence": [
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa.",
      "Most NPCs are related to Epstein-Barr virus (EBV) infection.",
      "Tobacco and alcohol use are risk factors for head and neck cancer.",
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions; common symptoms include enlarged lymph nodes and hearing loss.",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy.",
      "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden.",
      "Performance status is considered in NPC treatment planning.",
      "Fertility may be affected by NPC treatment and should be discussed before therapy.",
      "Dental health can be affected by head and neck cancer and its treatment."
    ]
  },
  {
    "id": "Medical-700264e4",
    "source": "Medical",
    "question": "Rewrite the key recommendations for NPC diagnosis and surveillance as a structured clinical protocol for a multidisciplinary tumor board. Include essential steps for staging, biomarker evaluation, and follow-up planning.",
    "answer": "**Nasopharyngeal Carcinoma (NPC): Multidisciplinary Clinical Protocol**\n\n1. Initial Assessment: Obtain comprehensive medical history, with attention to geographic origin (notably Asia, Native America, North Africa) and risk factors (tobacco, alcohol, EBV exposure).\n2. Symptom Evaluation: Assess for enlarged lymph nodes, hearing loss, and other head and neck symptoms, noting that early NPC may be asymptomatic.\n3. Diagnostic Workup: Perform physical examination and imaging studies (CT, MRI, PET/CT, ultrasound) to evaluate tumor extent and nodal involvement.\n4. Histopathologic Confirmation: Conduct biopsy of nasopharyngeal lesion and/or lymph node (FNA, FNB, or CNB) to confirm diagnosis and determine subtype (e.g., SCC).\n5. Biomarker Testing: Test for EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden at diagnosis.\n6. Staging: Utilize the AJCC TNM system to classify tumor size, nodal involvement, and distant metastasis; categorize as resectable, unresectable, locoregional, locally advanced, or metastatic.\n7. Multidisciplinary Review: Assess performance status, dental and nutritional health, and discuss fertility preservation when appropriate.\n8. Surveillance: Plan follow-up with periodic imaging (CT, MRI, PET/CT) and serial EBV DNA testing post-treatment.",
    "question_type": "Creative Generation",
    "evidence": [
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa.",
      "Tobacco and alcohol use are risk factors for head and neck cancer.",
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions.",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy.",
      "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden.",
      "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).",
      "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic based on extent of disease.",
      "Performance status is considered in NPC treatment planning.",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance.",
      "EBV DNA testing is performed before and after treatment for NPC."
    ]
  },
  {
    "id": "Medical-cc919ee4",
    "source": "Medical",
    "question": "As a patient education nurse, draft a public health announcement informing high-risk communities about nasopharyngeal carcinoma (NPC). Emphasize risk factors, warning signs, and the importance of early medical evaluation.",
    "answer": "**Public Health Announcement: Protect Yourself Against Nasopharyngeal Carcinoma (NPC)**\n\nNasopharyngeal carcinoma is a cancer that affects the area behind the nose and above the back of the throat. People from Asia, Native America, and North Africa are at higher risk, especially if exposed to the Epstein-Barr virus (EBV). Use of tobacco and alcohol can also increase risk. NPC may not cause symptoms until it is advanced, but watch for warning signs like lumps in the neck or hearing loss. Early detection is keyif you notice these symptoms or have risk factors, seek medical evaluation promptly. Diagnosis involves a physical exam, imaging tests, and a biopsy. Talk to your healthcare provider about ways to reduce your risk and the importance of regular checkups.",
    "question_type": "Creative Generation",
    "evidence": [
      "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx.",
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa.",
      "Most NPCs are related to Epstein-Barr virus (EBV) infection.",
      "Tobacco and alcohol use are risk factors for head and neck cancer.",
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions.",
      "Symptom: Enlarged lymph nodes, hearing loss.",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy."
    ]
  },
  {
    "id": "Medical-d96c57fa",
    "source": "Medical",
    "question": "You are a medical intern tasked with writing a SOAP (Subjective, Objective, Assessment, Plan) note for a patient newly diagnosed with Stage II nasopharyngeal carcinoma. Incorporate relevant history, exam findings, diagnostic results, and initial management steps.",
    "answer": "**S:** 38-year-old male of North African descent presents with a painless neck mass and occasional hearing loss. Reports no other significant symptoms. Past history notable for moderate tobacco and alcohol use.\n\n**O:** Physical exam reveals a 2-cm firm, non-tender lymph node in the left cervical chain. No oral or pharyngeal lesions visible. Imaging with CT and MRI shows a nasopharyngeal mass with ipsilateral lymphadenopathy. Biopsy confirms squamous cell carcinoma. EBV DNA detected in plasma. Performance status is ECOG 1. Dental and nutritional evaluations completed.\n\n**A:** Stage II nasopharyngeal carcinoma (NPC), squamous cell carcinoma subtype, EBV-associated, with cervical lymph node involvement. Risk factors include geographic origin and substance use. Good performance status.\n\n**P:** Multidisciplinary tumor board discussion. Begin definitive therapy per guidelines. Counsel patient regarding potential effects on fertility and oral health. Schedule baseline and surveillance EBV DNA testing. Continue nutritional and speech/swallowing support as indicated.",
    "question_type": "Creative Generation",
    "evidence": [
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa.",
      "Tobacco and alcohol use are risk factors for head and neck cancer.",
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions; common symptoms include enlarged lymph nodes and hearing loss.",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy.",
      "Biomarker testing for NPC includes EBV DNA.",
      "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).",
      "Performance status is considered in NPC treatment planning.",
      "Dental health can be affected by head and neck cancer and its treatment.",
      "Fertility may be affected by NPC treatment and should be discussed before therapy.",
      "Nutrition assessment and speech and swallowing assessment are recommended in diagnostic method."
    ]
  },
  {
    "id": "Medical-caab7a58",
    "source": "Medical",
    "question": "You are a radiation oncologist preparing an initial case summary for a patient with locally advanced, unresectable nasopharyngeal carcinoma (NPC). Summarize the diagnostic findings, relevant biomarkers, staging, and multidisciplinary considerations for the tumor board.",
    "answer": "Patient is a 52-year-old male presenting with a large nasopharyngeal mass and multiple enlarged cervical lymph nodes. Imaging (MRI and PET/CT) demonstrates extensive locoregional disease without distant metastasis. Biopsy confirms squamous cell carcinoma subtype of NPC. Biomarker analysis reveals elevated EBV DNA levels and positive PD-L1 expression. Staging per AJCC TNM system classifies the tumor as locally advanced and unresectable. Performance status is ECOG 2. Pre-treatment dental and nutritional assessments have been completed. The patient has been counseled about potential fertility impacts of therapy. Multidisciplinary input from medical oncology, speech/swallowing therapy, and supportive care is recommended for comprehensive management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer.",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy.",
      "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden.",
      "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M).",
      "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic based on extent of disease.",
      "Performance status is considered in NPC treatment planning.",
      "Dental health can be affected by head and neck cancer and its treatment.",
      "Fertility may be affected by NPC treatment and should be discussed before therapy.",
      "Nutrition assessment and speech and swallowing assessment are recommended in diagnostic method."
    ]
  },
  {
    "id": "Medical-048eef0e",
    "source": "Medical",
    "question": "You are a colorectal surgeon receiving a referral for a 45-year-old patient newly diagnosed with Stage 3 colon adenocarcinoma. Based on the clinical practice guideline, draft a surgical and perioperative management plan, including diagnostic confirmation, surgical intervention, adjuvant therapy, biomarker testing, and postoperative surveillance.",
    "answer": "Upon referral of the patient with Stage 3 colon adenocarcinoma, I would first confirm the diagnosis and staging with a colonoscopy and biopsy, supplemented by CT scan with contrast to assess for nodal involvement and distant metastases. Preoperative blood tests, including CBC, chemistry profile, and CEA, would be obtained for baseline assessment. All colon cancers should undergo testing for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) to guide postoperative therapy. The primary surgical approach would be a colectomy to remove the cancerous segment of the colon, with en bloc resection of adjacent lymph nodes. Intraoperatively, if primary anastomosis is not possible, a colostomy may be required. After recovery, adjuvant chemotherapytypically FOLFOX or CAPEOXshould be initiated. Postoperative surveillance will include regular colonoscopy, CEA testing, and CT scans. The patient should also be counseled on genetic risk factors and offered referral to genetic counseling if appropriate.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits.",
      "Colonoscopy is the recommended diagnostic method for colon cancer, with polypectomy performed for removal of polyps.",
      "CT with contrast is the main imaging test for staging and surveillance.",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
      "Colectomy is surgery to remove the cancerous part of the colon.",
      "Colostomy diverts stool through an abdominal stoma if reconnection is not possible.",
      "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers.",
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans.",
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing."
    ]
  },
  {
    "id": "Medical-80b6ffc1",
    "source": "Medical",
    "question": "Rewrite the clinical management of a young adult with newly diagnosed colon cancer into a formal discharge summary, ensuring inclusion of diagnostic workup, staging, biomarker assessment, surgical and adjuvant treatment, and fertility preservation counseling as per guidelines.",
    "answer": "Discharge Summary:\n\nPatient: [Name Redacted]\nAge: 32\nDiagnosis: Stage 2 colon adenocarcinoma\n\nHospital Course:\nThe patient presented with rectal bleeding and was diagnosed with colon adenocarcinoma following colonoscopy and biopsy. CT scan with contrast confirmed stage 2 disease with no lymph node or distant organ involvement. Baseline laboratory evaluation included CBC, chemistry profile, and CEA. Tumor tissue was tested for mismatch repair deficiency (dMMR) and found to be dMMR/MSI-H. The patient underwent segmental colectomy with primary anastomosis. Given dMMR/MSI-H status, adjuvant immunotherapy with a checkpoint inhibitor was recommended over standard chemotherapy. The patient received counseling regarding the risk of infertility associated with treatment and was offered sperm banking prior to therapy. Discharge instructions included scheduling for follow-up colonoscopy, CEA testing, and CT imaging as part of surveillance.",
    "question_type": "Creative Generation",
    "evidence": [
      "Colonoscopy is the recommended diagnostic method for colon cancer.",
      "Stage 2 colon cancer invades or passes fourth layer, no lymph node involvement.",
      "CT with contrast is the main imaging test for staging and surveillance.",
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing.",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers.",
      "Colectomy is surgery to remove the cancerous part of the colon.",
      "Young adults should be counseled about fertility risks and preservation options before treatment.",
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans."
    ]
  },
  {
    "id": "Medical-cf4e8f59",
    "source": "Medical",
    "question": "Imagine you are a genetic counselor receiving a patient with a new diagnosis of colon adenocarcinoma and a family history of colorectal cancer. Draft a counseling summary addressing inherited syndromes, genetic testing recommendations, implications for at-risk relatives, and surveillance strategies.",
    "answer": "As a genetic counselor, I would explain that a family history of colorectal cancer increases the risk of inherited cancer syndromes such as Lynch syndrome and familial adenomatous polyposis (FAP). I would recommend genetic testing for mismatch repair gene mutations associated with Lynch syndrome, and for APC gene mutations if FAP is suspected. Identification of an inherited syndrome has implications for both the patient and at-risk relatives, who should be offered predictive testing and appropriate surveillance. For patients with Lynch syndrome, regular colonoscopy at earlier and more frequent intervals is advised. I would provide information on the signs, risks, and management of both Lynch syndrome and FAP, and coordinate referrals for genetic testing and surveillance as per guidelines.",
    "question_type": "Creative Generation",
    "evidence": [
      "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk.",
      "Family history of colorectal cancer is a risk factor.",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
      "MMR gene mutations are genetic alterations associated with inherited syndromes.",
      "First-degree relative with colorectal cancer is a recognized risk factor.",
      "Surveillance after treatment includes colonoscopy.",
      "Inherited syndromes include Lynch syndrome and FAP."
    ]
  },
  {
    "id": "Medical-ec48f89d",
    "source": "Medical",
    "question": "Transform the following clinical recommendations into a public health advisory for primary care providers: Highlight the importance of early detection, risk stratification, and guideline-based management of colon cancer.",
    "answer": "Public Health Advisory for Primary Care Providers: Early Detection and Management of Colon Cancer\n\nColon cancer is a leading cause of cancer-related morbidity and mortality. Early detection through colonoscopy and removal of precancerous polyps (adenomas) significantly reduces cancer risk. Providers should identify individuals with risk factors, such as a family history of colorectal cancer or inherited syndromes (Lynch syndrome, FAP), and refer them for genetic counseling and earlier surveillance. All patients diagnosed with colon cancer should have their tumors tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H), as these biomarkers guide therapy. Post-treatment, ongoing surveillance with colonoscopy, CEA testing, and CT scans is essential to detect recurrence. Discuss fertility preservation options with young adults prior to initiating therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "Most colon cancers start in polyps, especially adenomas.",
      "Polypectomy removes polyps during colonoscopy.",
      "Family history of colorectal cancer is a risk factor.",
      "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk.",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans.",
      "Young adults should be counseled about fertility risks and preservation options before treatment."
    ]
  },
  {
    "id": "Medical-5b2ade97",
    "source": "Medical",
    "question": "You are a medical oncologist asked to summarize the evidence-based first-line treatment options for metastatic (Stage 4) colon cancer, including biomarker-driven therapy, surgical considerations, and palliative care integration.",
    "answer": "For Stage 4 (metastatic) colon cancer, initial management involves confirming distant metastases with contrast-enhanced CT imaging. All tumors must be tested for mismatch repair deficiency (dMMR)/microsatellite instability-high (MSI-H), as immunotherapy with checkpoint inhibitors (e.g., pembrolizumab, nivolumab) is preferred for dMMR/MSI-H cancers. For pMMR/MSS tumors, systemic chemotherapy regimens such as FOLFOX or CAPEOX are recommended. Surgical resection of the primary tumor or metastases may be considered for select patients with limited disease. Palliative care should be integrated early to address symptoms and improve quality of life. Surveillance with imaging and CEA testing is essential for monitoring treatment response.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage 4 colon cancer has spread to distant organs (commonly liver or lungs).",
      "CT with contrast is the main imaging test for staging and surveillance.",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers.",
      "pMMR/MSS cancers are treated with chemotherapy.",
      "FOLFOX and CAPEOX are recommended chemotherapy regimens.",
      "Colectomy is surgery to remove the cancerous part of the colon.",
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans."
    ]
  },
  {
    "id": "Medical-9d9b1ed1",
    "source": "Medical",
    "question": "Imagine you are a gastroenterologist evaluating a patient newly diagnosed with esophageal cancer. Write a comprehensive case summary that includes cancer subtype differentiation, staging considerations, diagnostic workup, and initial factors for treatment planning, referencing the relevant clinical practice guidelines.",
    "answer": "The patient presents with a new diagnosis of esophageal cancer. The first step is to determine the histological subtype, distinguishing between esophageal squamous cell carcinoma, which originates from the squamous cells of the upper and middle esophagus, and esophageal adenocarcinoma, arising from the mucus-secreting cells typically found in the lower esophagus, often associated with Barrett esophagus. Staging is crucial: early-stage disease remains confined to the esophagus without lymph node involvement, while locoregional disease involves invasion of the esophageal wall and/or spread to regional lymph nodes or adjacent organs. Metastatic disease is defined by distant spread, particularly to the liver, lung, bone, or brain. The diagnostic workup includes blood tests, imaging (such as CT or PET scans), endoscopic evaluation with biopsy for histopathological confirmation, biomarker testing, and assessment of genetic risk factors. For tumors at the esophagogastric junction, Siewert classification assists in accurate staging. Treatment planning will be based on cancer type, anatomical location, and stage, with additional consideration of the patient's nutritional status and performance.",
    "question_type": "Creative Generation",
    "evidence": [
      "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus.",
      "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus.",
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma.",
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes.",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Siewert types are used to stage tumors at the esophagogastric junction.",
      "Treatment planning is based on cancer type, location, and stage."
    ]
  },
  {
    "id": "Medical-09c35fc8",
    "source": "Medical",
    "question": "You are a medical oncologist preparing a multidisciplinary treatment plan for a patient diagnosed with locoregional esophageal adenocarcinoma at the esophagogastric junction. Detail your diagnostic confirmation steps, staging process, and key considerations for therapy selection, using the guideline.",
    "answer": "For this case of locoregional esophageal adenocarcinoma at the esophagogastric junction, I would initiate comprehensive diagnostic confirmation with endoscopic biopsy to determine histology, supported by blood tests and imaging studies to assess extent of disease. The Siewert classification will be applied for precise staging at the esophagogastric junction. The staging process distinguishes locoregional disease, where the tumor has invaded the esophageal wall and/or spread to regional lymph nodes or nearby organs, from early-stage or metastatic disease. Biomarker and genetic risk testing will be included to identify potential therapeutic targets. Nutritional assessment and evaluation of performance status are essential components of the pre-treatment workup. The treatment plan will be tailored based on cancer type (adenocarcinoma), anatomical location (esophagogastric junction), and locoregional stage, in accordance with current multidisciplinary guidelines.",
    "question_type": "Creative Generation",
    "evidence": [
      "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus.",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs.",
      "Siewert types are used to stage tumors at the esophagogastric junction.",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Treatment planning is based on cancer type, location, and stage.",
      "Nutritional assessment and performance status are part of the diagnostic method."
    ]
  },
  {
    "id": "Medical-bc7d17ab",
    "source": "Medical",
    "question": "Transform the clinical facts into a formal discharge summary for a patient with metastatic esophageal squamous cell carcinoma, referencing relevant staging, diagnostic, and treatment planning considerations from the guideline.",
    "answer": "**Discharge Summary**\n\nDiagnosis: Metastatic esophageal squamous cell carcinoma\n\nSummary: The patient was admitted for evaluation and management of esophageal cancer. Diagnostic workup included blood tests, imaging (CT and PET scans), endoscopic examination, and biopsy, confirming squamous cell carcinoma of the esophagus. Staging revealed metastatic disease with involvement of the liver and lung. Biomarker and genetic risk testing were performed. The tumor originated in the middle esophagus, consistent with the typical location for squamous cell carcinoma. Multidisciplinary discussions recommended palliative systemic therapy based on the metastatic stage, primary tumor type, and patient performance status. Nutritional assessment was conducted due to risk of dysphagia and weight loss. The patient was discharged with a follow-up plan for oncology and supportive care.",
    "question_type": "Creative Generation",
    "evidence": [
      "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus.",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain.",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Treatment planning is based on cancer type, location, and stage.",
      "Nutritional assessment and performance status are part of the diagnostic method.",
      "Anatomical location for squamous cell carcinoma includes the middle esophagus."
    ]
  },
  {
    "id": "Medical-9b2a1d38",
    "source": "Medical",
    "question": "As a primary care physician, draft a referral note to an oncology center for a patient with Barrett esophagus and new-onset dysphagia, incorporating risk stratification and diagnostic recommendations from the guidelines.",
    "answer": "**Referral Note**\n\nPatient: [Name Redacted]\nDOB: [Redacted]\n\nReason for Referral: Barrett esophagus with new-onset dysphagia\n\nSummary: The patient has a history of Barrett esophagus, a recognized precancerous condition for esophageal adenocarcinoma. He now presents with progressive dysphagia. Given the increased risk of malignant transformation, prompt evaluation for possible esophageal cancer is warranted. I recommend a comprehensive diagnostic workup including endoscopy with biopsy, imaging studies, blood tests, biomarker testing, and genetic risk assessment. Please consider staging and Siewert classification if a lesion is identified at the esophagogastric junction. Nutritional assessment should be performed due to risk of malnutrition. Thank you for your evaluation and management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma.",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Siewert types are used to stage tumors at the esophagogastric junction.",
      "Treatment planning is based on cancer type, location, and stage.",
      "Nutritional assessment is part of the diagnostic method."
    ]
  },
  {
    "id": "Medical-45390bd2",
    "source": "Medical",
    "question": "Rewrite the core clinical recommendations into a public health advisory aimed at increasing awareness of esophageal cancer risk factors, early detection, and diagnostic pathways.",
    "answer": "**Public Health Advisory: Esophageal Cancer Awareness and Early Detection**\n\nEsophageal cancer arises from the inner lining of the esophagus and may develop as either squamous cell carcinoma or adenocarcinoma. Risk factors include the presence of Barrett esophagus, a precancerous condition that increases the likelihood of adenocarcinoma. Early-stage esophageal cancer is often asymptomatic and confined to the esophagus, while advanced stages may involve spread to lymph nodes or distant organs such as the liver, lungs, bones, and brain. Early detection is critical and involves blood tests, imaging, endoscopy, biopsy, and assessment of biomarkers and genetic risk. If symptoms such as persistent difficulty swallowing occur, prompt medical evaluation is advised. Comprehensive treatment planning requires accurate cancer type, location, and stage determination. Public awareness and timely screening can improve outcomes for those at risk.",
    "question_type": "Creative Generation",
    "evidence": [
      "Esophageal cancer starts in the inner lining of the esophagus.",
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma.",
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes.",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain.",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Treatment planning is based on cancer type, location, and stage."
    ]
  },
  {
    "id": "Medical-dca8ac49",
    "source": "Medical",
    "question": "Imagine you are a hematopathologist receiving a referral for a 32-year-old male with a large mediastinal mass and supraclavicular lymphadenopathy. Based on the provided clinical practice guideline, write a diagnostic summary that outlines the differential diagnosis, key histopathological features, and the necessary steps to confirm mediastinal gray zone lymphoma (MGZL).",
    "answer": "Diagnostic Summary:\n\nThe patient is a 32-year-old male presenting with a large mediastinal mass and supraclavicular lymph node involvement. The differential diagnosis includes mediastinal gray zone lymphoma (MGZL), primary mediastinal B-cell lymphoma (PMBL), and classical Hodgkin lymphoma (CHL), given the overlapping clinical and histopathological features. Histological evaluation is essential, with particular attention to the presence of Reed-Sternberg cells and the overall morphology of the tumor. Diagnosis of MGZL requires an expert hematopathologist review to distinguish it from other mediastinal lymphomas. Immunophenotyping and a comprehensive panel of markers should be employed to assess for features characteristic of both PMBL and CHL. Final diagnosis will guide appropriate therapy, such as chemotherapy with or without rituximab and consideration of involved-site radiation therapy (ISRT) in localized cases.",
    "question_type": "Creative Generation",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass.",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth.",
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL).",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL.",
      "Diagnosis of MGZL requires expert hematopathologist review."
    ]
  },
  {
    "id": "Medical-e89fa155",
    "source": "Medical",
    "question": "You are an oncology fellow tasked with constructing an initial treatment plan for a patient newly diagnosed with localized mediastinal gray zone lymphoma (MGZL). Integrate the guidelines recommendations regarding therapeutic modalities and patient characteristics.",
    "answer": "Initial Treatment Plan:\n\nFor this patient with newly diagnosed, localized mediastinal gray zone lymphoma (MGZL), I recommend initiation of chemotherapy as the foundation of treatment. Rituximab may be added to create a chemoimmunotherapy regimen, in line with current evidence for improved outcomes. Given the localized nature of the disease, involved-site radiation therapy (ISRT) should also be considered as an adjunct to systemic therapy. The patient's age (within the typical 2040 year range) and mediastinal involvement support this treatment approach. Multidisciplinary collaboration with radiation oncology and regular assessment of treatment response will be crucial.",
    "question_type": "Creative Generation",
    "evidence": [
      "MGZL is usually treated with chemotherapy.",
      "Rituximab may be added to chemotherapy for chemoimmunotherapy.",
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL.",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth.",
      "MGZL is characterized by a large mediastinal mass."
    ]
  },
  {
    "id": "Medical-de2ed9e3",
    "source": "Medical",
    "question": "Transform the core clinical and pathological features of mediastinal gray zone lymphoma (MGZL) into a formal referral letter from a primary care physician to a hematology specialist.",
    "answer": "Referral Letter:\n\nDear Hematology Specialist,\n\nI am referring a 28-year-old male who presents with a rapidly enlarging mediastinal mass and supraclavicular lymphadenopathy. Imaging studies confirm a bulky mediastinal tumor. Histopathological examination has revealed the presence of Reed-Sternberg cells. Given the overlap of features between primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL), I am seeking your expert evaluation for possible mediastinal gray zone lymphoma (MGZL). I recommend expert hematopathologist review to establish a definitive diagnosis and guide management, including consideration of chemoimmunotherapy and potential involved-site radiation therapy.\n\nSincerely,\n[Referring Physician]",
    "question_type": "Creative Generation",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass.",
      "Lymph nodes above the collar bone (supraclavicular) may be involved.",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL.",
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL).",
      "Diagnosis of MGZL requires expert hematopathologist review."
    ]
  },
  {
    "id": "Medical-6956692c",
    "source": "Medical",
    "question": "Rewrite the main findings and recommendations regarding non-mediastinal gray zone lymphoma into a discharge summary for a 68-year-old patient diagnosed with this entity, highlighting clinical presentation, diagnostic process, and treatment considerations.",
    "answer": "Discharge Summary:\n\nPatient: [Name], 68-year-old\nDiagnosis: Non-mediastinal gray zone lymphoma\n\nClinical Presentation:\nThe patient presented with generalized lymphadenopathy and evidence of bone marrow and extranodal involvement. There was no mediastinal mass observed.\n\nDiagnostic Process:\nHistopathological and immunophenotypic studies demonstrated features consistent with gray zone lymphoma. The absence of mediastinal disease and presence of advanced-stage features led to the diagnosis of non-mediastinal gray zone lymphoma.\n\nTreatment Considerations:\nNon-mediastinal gray zone lymphomas are more common in older adults and tend to present at advanced stages with higher rates of bone marrow and extranodal involvement. Management typically follows protocols for diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS), especially in cases with extra-mediastinal disease.\n\nPlan:\nThe patient will be referred for systemic chemotherapy as per DLBCL-NOS protocols. Follow-up will include monitoring for marrow and extranodal disease response.",
    "question_type": "Creative Generation",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement.",
      "Sites of involvement include bone marrow involvement and extranodal disease.",
      "Non-mediastinal gray zone lymphomas often present as advanced-stage disease.",
      "If extra-mediastinal disease: Diagnose as DLBCL-NOS.",
      "Treatment protocols for advanced-stage or extra-mediastinal disease align with those for DLBCL-NOS."
    ]
  },
  {
    "id": "Medical-27b6e451",
    "source": "Medical",
    "question": "You are drafting a public health information sheet for primary care providers on the recognition and referral of patients with suspected mediastinal gray zone lymphoma (MGZL). Summarize the key clinical features, diagnostic approach, and referral recommendations using evidence from the guideline.",
    "answer": "Information Sheet: Recognizing and Referring Mediastinal Gray Zone Lymphoma (MGZL)\n\nKey Clinical Features:\n- MGZL typically presents as a large mediastinal mass, often with supraclavicular lymph node involvement.\n- Most affected individuals are aged 2040 years and assigned male at birth.\n\nDiagnostic Approach:\n- Histopathological assessment is critical, with Reed-Sternberg cells often observed.\n- MGZL shares overlapping features with both primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL), making diagnosis challenging.\n- An expert hematopathologist review is required for accurate classification.\n\nReferral Recommendations:\n- Refer patients with unexplained mediastinal masses, especially in young males, for specialist hematology evaluation.\n- Ensure tissue samples are reviewed by a hematopathology expert to guide appropriate therapy, including consideration of chemoimmunotherapy and involved-site radiation therapy in localized cases.",
    "question_type": "Creative Generation",
    "evidence": [
      "MGZL is characterized by a large mediastinal mass.",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth.",
      "Lymph nodes above the collar bone (supraclavicular) may be involved.",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL.",
      "Diagnosis of MGZL requires expert hematopathologist review."
    ]
  },
  {
    "id": "Medical-1bd20d18",
    "source": "Medical",
    "question": "Imagine you are a gynecologic oncologist receiving a referral for a 32-year-old woman with a recent diagnosis of stage IB1 squamous cell carcinoma of the cervix. The patient wishes to preserve fertility. Draft a detailed treatment plan, including diagnostic confirmation, staging, treatment options, and fertility preservation strategies, referencing the latest clinical practice guidelines.",
    "answer": "As a gynecologic oncologist, my initial step would be to confirm the diagnosis of stage IB1 squamous cell carcinoma with a cervical biopsy. I would ensure complete staging using the FIGO system, supplemented by pelvic MRI and/or CT scan to assess local and nodal involvement. Since the patient desires fertility preservation and has early-stage disease, I would discuss the option of fertility-sparing surgery, specifically radical trachelectomy with pelvic lymph node dissection or sentinel lymph node biopsy. Ovarian transposition may be considered to preserve ovarian function if adjuvant therapy is needed. Regular follow-up with physical exams and imaging as indicated will be essential for surveillance. Throughout the process, I would provide supportive care and discuss the option of clinical trial participation.",
    "question_type": "Creative Generation",
    "evidence": [
      "Cervical biopsy is the primary diagnostic method for cervical cancer.",
      "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages).",
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment.",
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases.",
      "Ovarian transposition is a fertility preservation strategy.",
      "Surveillance after treatment includes regular physical exams and imaging as indicated.",
      "Clinical trials are an option for all stages of cervical cancer."
    ]
  },
  {
    "id": "Medical-47ec9e64",
    "source": "Medical",
    "question": "As a medical intern in the oncology ward, write a referral letter to a radiation oncologist for a patient with newly diagnosed FIGO stage IIB cervical cancer. Your note should summarize the diagnostic findings, risk factors, and rationale for the recommended treatment approach.",
    "answer": "Dear Radiation Oncology Team,\n\nI am referring Ms. J, a 45-year-old woman recently diagnosed with FIGO stage IIB squamous cell carcinoma of the cervix. Her diagnosis was established via cervical biopsy following symptoms of abnormal vaginal bleeding and pelvic pain. Imaging with pelvic MRI and PET/CT confirmed parametrial invasion without distant metastasis. Notable risk factors include a history of smoking and chronic immunosuppression due to HIV infection. Given the locally advanced disease, concurrent chemoradiation with external beam radiation therapy (EBRT) and cisplatin-based chemotherapy is recommended as per current guidelines. Please assess for initiation of chemoradiation and consider brachytherapy for local control. Thank you for your expert evaluation.",
    "question_type": "Creative Generation",
    "evidence": [
      "Cervical biopsy is the primary diagnostic method for cervical cancer.",
      "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages).",
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment.",
      "Smoking increases the risk of cervical cancer.",
      "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer.",
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer.",
      "External beam radiation therapy (EBRT) and brachytherapy are used for local control."
    ]
  },
  {
    "id": "Medical-a4a83818",
    "source": "Medical",
    "question": "Transform the guideline information into a comprehensive discharge summary for a patient with stage IIIB adenocarcinoma of the cervix who has completed chemoradiation. Include the diagnosis, staging, treatments provided, biomarkers tested, and follow-up recommendations.",
    "answer": "Discharge Summary:\n\nDiagnosis: Stage IIIB adenocarcinoma of the cervix, confirmed by cervical biopsy.\n\nStaging: Pelvic MRI and PET/CT indicated parametrial extension and involvement of the pelvic sidewall, consistent with FIGO IIIB disease.\n\nTreatment: The patient completed concurrent chemoradiation, consisting of external beam radiation therapy (EBRT), brachytherapy, and weekly cisplatin. Biomarker testing for PD-L1, MSI, and TMB was performed to inform potential future systemic therapy options.\n\nFollow-up: The patient will undergo regular physical examinations and imaging as indicated for surveillance. Supportive care and palliative care resources have been discussed. Smoking cessation is strongly encouraged to improve long-term outcomes. Participation in clinical trials will be considered if recurrent or metastatic disease develops.",
    "question_type": "Creative Generation",
    "evidence": [
      "Adenocarcinoma and adenosquamous carcinoma are less common subtypes.",
      "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages).",
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment.",
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer.",
      "External beam radiation therapy (EBRT) and brachytherapy are used for local control.",
      "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer.",
      "Surveillance after treatment includes regular physical exams and imaging as indicated.",
      "Supportive care and palliative care are integral for advanced or metastatic disease.",
      "Smoking cessation improves treatment outcomes.",
      "Clinical trials are an option for all stages of cervical cancer."
    ]
  },
  {
    "id": "Medical-e0a374bb",
    "source": "Medical",
    "question": "You are a public health officer tasked with creating an evidence-based public health advisory to reduce cervical cancer incidence in your community. Incorporate screening, prevention, risk factor modification, and follow-up recommendations from the clinical practice guideline.",
    "answer": "**Public Health Advisory: Preventing Cervical Cancer in Our Community**\n\nCervical cancer remains a significant threat to women's health. Most cases are caused by persistent infection with high-risk human papillomavirus (HPV) types, particularly HPV16 and HPV18. Regular screening with Pap smears is essential for early detection and prevention of cervical cancer. Cervical dysplasia, if identified, can be treated to prevent progression to cancer. Risk factors such as smoking and immunosuppression (including HIV infection) increase the likelihood of developing cervical cancer. We urge all eligible individuals to participate in screening programs, avoid tobacco use, and seek regular medical care. Follow-up after abnormal screening or treatment should include physical exams and imaging as appropriate. Clinical trials are available and may offer additional options for prevention and care.",
    "question_type": "Creative Generation",
    "evidence": [
      "Most cervical cancers are caused by long-term infection with human papillomavirus (HPV).",
      "HPV16 and HPV18 are high-risk HPV types associated with cervical cancer.",
      "Pap smear is used for cervical cancer screening.",
      "Cervical dysplasia (CIN) can progress to cervical cancer if untreated.",
      "Smoking increases the risk of cervical cancer.",
      "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer.",
      "Surveillance after treatment includes regular physical exams and imaging as indicated.",
      "Clinical trials are an option for all stages of cervical cancer."
    ]
  },
  {
    "id": "Medical-11abd566",
    "source": "Medical",
    "question": "Reformat the following clinical scenario into a structured SOAP note: A 55-year-old woman presents with abnormal vaginal bleeding and fatigue. Imaging and biopsy confirm stage IVA neuroendocrine carcinoma of the cervix. She has a history of smoking and multiple sexual partners. Document the relevant findings, assessment, and plan based on guideline recommendations.",
    "answer": "SOAP Note:\n\nSubjective: 55-year-old female presents with abnormal vaginal bleeding and fatigue. Past medical history significant for chronic tobacco use and multiple sexual partners.\n\nObjective: On examination, watery vaginal discharge and pelvic pain noted. Imaging (CT and MRI) reveals local invasion into adjacent pelvic organs, consistent with FIGO stage IVA. Cervical biopsy confirms neuroendocrine carcinoma of the cervix.\n\nAssessment: Advanced (stage IVA) neuroendocrine carcinoma of the cervix with poor prognostic features (aggressive histology, high-risk behaviors).\n\nPlan:\n- Initiate systemic therapy, including platinum-based chemotherapy and consider targeted or immunotherapy based on biomarker testing (PD-L1, MSI, MMR, TMB, HER2, RET, NTRK).\n- Consider external beam radiation therapy (EBRT) and/or brachytherapy for local control as appropriate.\n- Engage palliative care for symptom management and supportive care.\n- Counsel on smoking cessation to improve treatment outcomes.\n- Offer clinical trial enrollment if eligible.",
    "question_type": "Creative Generation",
    "evidence": [
      "Abnormal vaginal bleeding and fatigue are symptoms associated with cervical cancer.",
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment.",
      "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype.",
      "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages).",
      "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy.",
      "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer.",
      "Supportive care and palliative care are integral for advanced or metastatic disease.",
      "Smoking increases the risk of cervical cancer.",
      "Smoking cessation improves treatment outcomes.",
      "Clinical trials are an option for all stages of cervical cancer."
    ]
  },
  {
    "id": "Medical-c8a65fec",
    "source": "Medical",
    "question": "You are a hematology fellow evaluating a 28-year-old patient who presents with painless cervical lymphadenopathy. Based on the clinical practice guideline for Hodgkin lymphoma, compose a detailed diagnostic summary outlining the steps and rationale for confirming the diagnosis and differentiating between classic Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL).",
    "answer": "The initial diagnostic approach to a 28-year-old with painless cervical lymphadenopathy should begin with a thorough health history and physical examination, focusing on lymph node regions and systemic symptoms. Laboratory assessment with blood tests and imaging studies are necessary to evaluate the extent of disease. Definitive diagnosis requires a tissue sample, with excisional lymph node biopsy as the gold standard; core needle biopsy may be considered if excisional biopsy is not feasible. Histopathological analysis is crucial to distinguish between classic Hodgkin lymphoma (characterized by Reed-Sternberg cells) and nodular lymphocyte-predominant Hodgkin lymphoma (characterized by popcorn-shaped cells). Accurate subtyping guides prognosis and treatment planning, as NLPHL can transform into diffuse large B-cell lymphoma, impacting long-term management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Most people are diagnosed between ages 15 to 30 or after age 55.",
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
      "Core needle biopsy may be used for diagnosis in some cases.",
      "Health history and physical exam are part of the diagnostic process.",
      "Blood tests and imaging tests are used in the diagnostic workup.",
      "Classic Hodgkin lymphoma (CHL) is characterized by Reed-Sternberg cells.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is characterized by popcorn-shaped cells.",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
    ]
  },
  {
    "id": "Medical-5d99d529",
    "source": "Medical",
    "question": "Rewrite the guideline facts into a formal referral letter from a primary care physician to a hematologist, summarizing the clinical suspicion of Hodgkin lymphoma and requesting specialist evaluation.",
    "answer": "Dear Hematology Colleague,\n\nI am referring a 32-year-old patient with persistent, painless lymphadenopathy in the cervical and supraclavicular regions. The patient falls within the typical age range for Hodgkin lymphoma onset and has no significant past medical history. Initial workup included health history, physical examination, blood tests, and imaging, all of which indicate lymph node involvement predominantly in the upper body. Given these findings, I am concerned about possible Hodgkin lymphoma. I request your expertise for further diagnostic evaluation, including consideration of excisional lymph node biopsy to confirm the diagnosis and distinguish between classic Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), as subtyping will guide subsequent management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body.",
      "Most people are diagnosed between ages 15 to 30 or after age 55.",
      "Health history and physical exam are part of the diagnostic process.",
      "Blood tests and imaging tests are used in the diagnostic workup.",
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma."
    ]
  },
  {
    "id": "Medical-29982b18",
    "source": "Medical",
    "question": "As a patient recently diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), write a progress note for your oncology visit, summarizing what you have learned about your disease, the diagnostic process, and potential risks.",
    "answer": "Progress Note:\nToday, I discussed my recent diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with my oncologist. I learned that NLPHL is a rare subtype of Hodgkin lymphoma, identified by the presence of popcorn-shaped cells in the lymph node biopsy. My diagnosis was confirmed after an excisional lymph node biopsy, following initial blood tests, imaging, and physical examination. I was informed that while NLPHL is less common than classic Hodgkin lymphoma, it has unique features and can sometimes transform into a more aggressive type, diffuse large B-cell lymphoma (DLBCL). Understanding these details will help guide my treatment and follow-up care.",
    "question_type": "Creative Generation",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma.",
      "NLPHL is characterized by popcorn-shaped cells.",
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
      "Health history and physical exam are part of the diagnostic process.",
      "Blood tests and imaging tests are used in the diagnostic workup.",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
    ]
  },
  {
    "id": "Medical-80542737",
    "source": "Medical",
    "question": "Transform the key points into a structured discharge summary for an adult patient hospitalized for initial workup and diagnosis of Hodgkin lymphoma.",
    "answer": "Discharge Summary:\n\nDiagnosis: Classic Hodgkin lymphoma (CHL)\n\nSummary: The patient, aged 24, was admitted for evaluation of persistent supraclavicular lymphadenopathy. Workup included detailed health history, physical examination, blood tests, and imaging studies, all indicating lymph node involvement in the upper body. Definitive diagnosis was established via excisional lymph node biopsy, which revealed Reed-Sternberg cells, confirming classic Hodgkin lymphoma. The patient was counseled on the nature of the disease, its typical age distribution, and the importance of ongoing hematologic follow-up for treatment planning.",
    "question_type": "Creative Generation",
    "evidence": [
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma.",
      "CHL is characterized by Reed-Sternberg cells.",
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
      "Health history and physical exam are part of the diagnostic process.",
      "Blood tests and imaging tests are used in the diagnostic workup.",
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body.",
      "Most people are diagnosed between ages 15 to 30 or after age 55."
    ]
  },
  {
    "id": "Medical-44f9a6ad",
    "source": "Medical",
    "question": "You are a hepatobiliary surgeon receiving a pathology report for a patient with a suspected intrahepatic bile duct tumor. Based on the provided clinical practice guideline, synthesize a case summary detailing the anatomical structures involved, tumor staging, and potential implications for surgical management.",
    "answer": "The patient presents with a primary intrahepatic bile duct tumor. Histopathological analysis reveals the tumor is confined to the epithelial layer, consistent with a carcinoma in situ (Tis). The bile duct wall is composed of multiple histological layers: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa. The current staging, Tis, indicates the neoplasm remains intraductal without invasion into the lamina propria, muscularis, or surrounding tissue. There is no evidence of spread to nearby blood vessels, liver parenchyma, or structures outside the liver. This early stage may be amenable to local excision with preservation of adjacent tissues, but careful assessment of the serosal boundary is necessary to exclude occult invasion.",
    "question_type": "Creative Generation",
    "evidence": [
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer.",
      "Lamina propria is a connective tissue found under the epithelium.",
      "Muscularis is a soft tissue layer in the bile duct wall.",
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium.",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver."
    ]
  },
  {
    "id": "Medical-e122bd14",
    "source": "Medical",
    "question": "Rewrite the facts about intrahepatic bile duct cancer staging and tumor characteristics into a formal discharge summary for a patient who underwent evaluation for a biliary mass.",
    "answer": "Discharge Summary:\n\nDiagnosis: Intrahepatic bile duct carcinoma in situ (Tis)\n\nHospital Course: The patient was admitted for evaluation of a biliary mass. Imaging and histopathological examination confirmed an intraductal tumor limited to the epithelial layer of the bile duct, without invasion into the lamina propria, muscularis, or perimuscular fibrous tissue. No extension to the serosa or adjacent liver tissue was identified. There was no radiological or intraoperative evidence of tumor spread to blood vessels or structures outside the liver. The tumor is staged as Tis, carcinoma in situ, based on these findings.\n\nPlan: Outpatient follow-up with hepatobiliary surgery and oncology for consideration of localized excision and surveillance.",
    "question_type": "Creative Generation",
    "evidence": [
      "Bile duct cancer staging is based on tumor size and extent of spread.",
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium.",
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer.",
      "Lamina propria is a connective tissue found under the epithelium.",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver."
    ]
  },
  {
    "id": "Medical-d8403485",
    "source": "Medical",
    "question": "As a medical intern, draft a referral letter to a specialized oncology center for a patient with a newly diagnosed primary intrahepatic bile duct tumor. Ensure your letter summarizes relevant anatomical, pathological, and staging details for multidisciplinary evaluation.",
    "answer": "Dear Oncology Colleagues,\n\nI am referring a patient recently diagnosed with a primary intrahepatic bile duct tumor. Pathology reports describe an intraductal neoplasm confined to the epithelial layer, consistent with carcinoma in situ (Tis). The bile duct comprises several histological layers: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa. There is no evidence of invasion into deeper layers or extension to the surrounding liver, blood vessels, or extrahepatic structures. Tumor staging is Tis, indicating early disease suitable for multidisciplinary review and management planning. Please advise on further oncological assessment and treatment options.",
    "question_type": "Creative Generation",
    "evidence": [
      "Intrahepatic bile duct cancer: Stage Tis is defined as a carcinoma in situ, an intraductal tumor confined to the epithelium.",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
      "Bile duct cancer staging is based on tumor size and extent of spread.",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver.",
      "Primary tumor size (cm or mm), spread to blood vessels, spread to liver, and spread to structures outside the liver are key tumor characteristics."
    ]
  },
  {
    "id": "Medical-67cf9d75",
    "source": "Medical",
    "question": "Transform the clinical guideline information into a SOAP (Subjective, Objective, Assessment, Plan) note summarizing the initial evaluation of a patient with suspected bile duct cancer.",
    "answer": "SOAP Note:\n\nSubjective: Patient presents with right upper quadrant discomfort and mild jaundice. No prior history of liver disease.\n\nObjective: Imaging reveals a mass within the intrahepatic bile duct. Biopsy demonstrates an intraductal neoplasm limited to the epithelial layer. No invasion of the lamina propria, muscularis, or perimuscular fibrous tissue observed. No evidence of spread to blood vessels, liver parenchyma, or structures outside the liver.\n\nAssessment: Intrahepatic bile duct carcinoma in situ (Tis), confined to the epithelial layer, without local extension or metastasis.\n\nPlan: Refer to hepatobiliary surgery for consideration of local excision. Schedule further imaging to confirm absence of serosal or vascular involvement. Initiate multidisciplinary tumor board review.",
    "question_type": "Creative Generation",
    "evidence": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium.",
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer.",
      "Lamina propria is a connective tissue found under the epithelium.",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver.",
      "Bile duct cancer staging is based on tumor size and extent of spread."
    ]
  },
  {
    "id": "Medical-f847846c",
    "source": "Medical",
    "question": "You are a hematology fellow evaluating a 56-year-old patient with generalized lymphadenopathy, mild fatigue, and no B symptoms. Laboratory and imaging studies suggest follicular lymphoma. Please synthesize a diagnostic workup plan and discuss how you would determine the grade and guide subsequent management based on the clinical practice guideline.",
    "answer": "For this patient, I would first confirm the diagnosis of follicular lymphoma (FL) using a combination of blood tests, imaging studies, and histopathological evaluation. Specifically, I would obtain a lymph node biopsy, followed by immunophenotyping to identify B-cell lineage markers. Bone marrow aspiration and biopsy are necessary to assess marrow involvement. Imaging (such as CT or PET-CT) would help determine the extent of nodal and extranodal disease. The pathologist would evaluate the lymph node specimen for the proportion of centrocytes and centroblasts, which determines the FL grade (grades 1, 2, 3A, or 3B). This grading is crucial as it guides management: grades 1 and 2 are treated as classic FL, while grade 3B is managed as DLBCL. Furthermore, I would assess for the presence of BCL2 protein overexpression or t(14;18) translocation, which are characteristic of FL. Not all patients require immediate therapy; in the absence of B symptoms and with low disease burden, observation may be appropriate.",
    "question_type": "Creative Generation",
    "evidence": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
      "FL is graded based on the proportion of centrocytes and centroblasts.",
      "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC.",
      "Grade 3B FL is treated as DLBCL.",
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein.",
      "Not all patients with FL require immediate treatment.",
      "The type of cells in FL determines the grade, which guides treatment decisions."
    ]
  },
  {
    "id": "Medical-cabc388f",
    "source": "Medical",
    "question": "Imagine you are a pathologist preparing a diagnostic summary for a lymph node biopsy suspected of follicular lymphoma. Write a pathology report that includes grading, cell type identification, and recommendations for further clinical management based on the guidelines.",
    "answer": "Pathology Report:\n\nSpecimen: Excisional biopsy, left cervical lymph node\n\nMicroscopic Description: The architecture is effaced by neoplastic follicles composed predominantly of small cleaved lymphocytes (centrocytes) with occasional larger non-cleaved cells (centroblasts). The number of centroblasts per high-power field is consistent with Grade 2 follicular lymphoma (classic FL). Immunophenotyping reveals a B-cell phenotype with strong BCL2 protein expression. Cytogenetic analysis demonstrates t(14;18) translocation. No areas of diffuse large B-cell lymphoma are identified.\n\nDiagnosis: Follicular lymphoma, Grade 2 (classic FL), BCL2-positive, t(14;18)-positive\n\nComment: The findings support a diagnosis of classic follicular lymphoma. Clinical correlation is recommended to determine the need for immediate treatment, as not all patients require therapy at diagnosis. Further staging with bone marrow biopsy and imaging studies is advised.",
    "question_type": "Creative Generation",
    "evidence": [
      "FL is graded based on the proportion of centrocytes and centroblasts.",
      "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC.",
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein.",
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
      "The type of cells in FL determines the grade, which guides treatment decisions.",
      "Not all patients with FL require immediate treatment."
    ]
  },
  {
    "id": "Medical-165e8fae",
    "source": "Medical",
    "question": "Rewrite the clinical facts into a comprehensive discharge summary for a patient with pediatric-type follicular lymphoma (PTFL) after excisional biopsy and observation, integrating all relevant diagnostic, pathologic, and management details per the guidelines.",
    "answer": "Discharge Summary\n\nPatient Name: [Redacted]\nMRN: [Redacted]\nAdmission Date: [Date]\nDischarge Date: [Date]\n\nDiagnosis: Pediatric-type follicular lymphoma (PTFL), localized, head and neck\n\nSummary of Hospital Stay: The patient presented with a single enlarged lymph node in the cervical region and minimal symptoms. Excisional lymph node biopsy was performed, and pathology confirmed pediatric-type follicular lymphoma, characterized by follicular proliferation with minimal centroblast presence and absence of t(14;18) translocation. No evidence of bone marrow or extranodal involvement was identified on imaging and marrow studies. The patient did not exhibit B symptoms (fever, night sweats, weight loss) or systemic signs. Given the localized disease and minimal symptoms, no immediate therapy was initiated; the patient will be followed closely with periodic clinical and radiologic assessment.\n\nPlan: Outpatient follow-up in hematology/oncology clinic. No adjuvant therapy required at this time. Education regarding symptom monitoring provided.",
    "question_type": "Creative Generation",
    "evidence": [
      "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms.",
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL.",
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms).",
      "Not all patients with FL require immediate treatment.",
      "The type of cells in FL determines the grade, which guides treatment decisions."
    ]
  },
  {
    "id": "Medical-f9d1c48a",
    "source": "Medical",
    "question": "You are a primary care physician writing a referral letter to hematology-oncology for a 64-year-old with persistent, painless lymphadenopathy and recent onset of night sweats and fatigue. Summarize the clinical findings, initial workup, and rationale for specialist referral using evidence from the guideline.",
    "answer": "Dear Hematology-Oncology Colleagues,\n\nI am referring a 64-year-old patient with a two-month history of persistent, painless lymphadenopathy involving cervical and axillary regions. The patient reports recent onset of night sweats and fatigue but denies fever or significant weight loss. Physical examination reveals multiple enlarged, non-tender lymph nodes. Initial laboratory studies are notable for mild anemia. Given the presence of B symptoms and generalized lymphadenopathy, non-Hodgkin lymphomaspecifically follicular lymphomais suspected. I recommend further evaluation, including excisional lymph node biopsy, bone marrow aspiration, imaging studies, and immunophenotyping, to confirm diagnosis and determine grade, as management is guided by cell type and grade. Thank you for your expert assessment and management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma.",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues.",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms).",
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
      "The type of cells in FL determines the grade, which guides treatment decisions.",
      "Not all patients with FL require immediate treatment."
    ]
  },
  {
    "id": "Medical-2352775b",
    "source": "Medical",
    "question": "Transform the clinical guideline into a public health advisory for primary care providers, highlighting key features of follicular lymphoma, its diagnosis, and referral triggers.",
    "answer": "**Public Health Advisory: Recognizing and Managing Follicular Lymphoma (FL) in Primary Care**\n\nFollicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma that may present as painless lymphadenopathy in nodal or extranodal sites. Classic symptoms include swollen lymph nodes, enlarged spleen, fatigue, night sweats, and weight loss (B symptoms). FL is graded based on the proportion of centrocytes and centroblasts, influencing management decisions. Diagnosis requires a combination of blood tests, bone marrow aspirate and biopsy, imaging, and immunophenotyping. Most cases exhibit BCL2 protein overexpression or t(14;18) translocation. Not all patients require immediate treatment; however, patients with B symptoms, rapidly enlarging nodes, or cytopenias should be referred promptly to hematology-oncology for further evaluation. Early diagnosis and appropriate grading are essential for optimal outcomes.",
    "question_type": "Creative Generation",
    "evidence": [
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma.",
      "FL can present as nodal or extranodal disease.",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms).",
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
      "FL is graded based on the proportion of centrocytes and centroblasts.",
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein.",
      "Not all patients with FL require immediate treatment."
    ]
  },
  {
    "id": "Medical-8df9d4bc",
    "source": "Medical",
    "question": "You are a hepatology specialist preparing a comprehensive case summary for a multidisciplinary tumor board review. The patient is a 48-year-old with cirrhosis and chronic hepatitis B, recently found to have a liver mass on surveillance ultrasound. Summarize the likely diagnosis, relevant risk factors, recommended diagnostic steps, and potential for metastatic disease, referencing the clinical practice guidelines.",
    "answer": "The patient is at high risk for primary liver cancer, specifically hepatocellular carcinoma (HCC), given his underlying cirrhosis and chronic hepatitis B infection. Cirrhosis and hepatitis B are established risk factors for HCC. Surveillance detected a liver mass, which raises suspicion for HCC. The recommended diagnostic approach includes confirmation with imaging tests such as contrast-enhanced MRI or CT, and assessment of alpha-fetoprotein (AFP) levels, as elevated AFP may support the diagnosis. Biopsy may be considered if imaging is inconclusive. Given the nature of liver cancer, there is a risk for metastasis, most commonly to the lung or bone, so staging workup should include evaluation for distant spread.",
    "question_type": "Creative Generation",
    "evidence": [
      "Cirrhosis is a major risk factor for developing liver cancer.",
      "Chronic hepatitis B infection increases the risk of liver cancer.",
      "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer.",
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B.",
      "Liver cancer most often metastasizes to the lung or bone."
    ]
  },
  {
    "id": "Medical-f24b3922",
    "source": "Medical",
    "question": "Imagine you are a primary care physician writing a referral note to a hepatologist for a patient with chronic hepatitis C, abnormal liver enzymes, and a recent ultrasound showing a suspicious liver lesion. Draft a detailed referral letter that includes risk factors, screening rationale, and next diagnostic steps.",
    "answer": "Dear Hepatology Colleague,\n\nI am referring a 55-year-old male with a history of chronic hepatitis C and persistently elevated liver enzymes. He has additional metabolic risk factors, including obesity and features suggestive of non-alcoholic fatty liver disease. Surveillance ultrasound revealed a 2.5 cm hypoechoic lesion in the right hepatic lobe. Given his background of chronic hepatitis C and possible NAFLD, he is at increased risk for primary liver cancer, particularly hepatocellular carcinoma. I have ordered an alpha-fetoprotein (AFP) test and would appreciate your assessment for further imaging (MRI/CT) and management. Biopsy may be needed if imaging is inconclusive.\n\nThank you for your expert evaluation.",
    "question_type": "Creative Generation",
    "evidence": [
      "Chronic hepatitis C infection increases the risk of liver cancer.",
      "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer.",
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B.",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months.",
      "Diagnosis of liver cancer is usually confirmed with imaging tests."
    ]
  },
  {
    "id": "Medical-4dcd1884",
    "source": "Medical",
    "question": "You are a radiology resident tasked with drafting a structured imaging report for a patient with a history of genetic hemochromatosis and new liver mass detected on surveillance. Incorporate relevant risk factors, differential diagnoses, and recommended next steps based on the guidelines.",
    "answer": "Imaging Report:\n\nPatient: 60-year-old male with a history of genetic hemochromatosis, undergoing routine liver cancer surveillance. Recent ultrasound identified a 3 cm mass in the right hepatic lobe. The patient's risk factors include genetic hemochromatosis and possible underlying cirrhosis. Differential diagnoses include hepatocellular carcinoma (most likely), intrahepatic cholangiocarcinoma, and mixed-type tumors. Recommend further evaluation with contrast-enhanced MRI or CT to characterize the lesion, and assessment of alpha-fetoprotein (AFP) levels. Biopsy should be considered if imaging findings are indeterminate.",
    "question_type": "Creative Generation",
    "evidence": [
      "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer.",
      "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer.",
      "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts.",
      "Diagnosis of liver cancer is usually confirmed with imaging tests.",
      "Biopsy may be needed to confirm liver cancer."
    ]
  },
  {
    "id": "Medical-ec347ef8",
    "source": "Medical",
    "question": "Rewrite the core recommendations from the liver cancer guideline as a public health advisory targeted at patients with cirrhosis or chronic hepatitis B. Ensure to include screening frequency, methods, and rationale using evidence from the guideline.",
    "answer": "**Public Health Advisory: Liver Cancer Screening for At-Risk Individuals**\n\nIf you have cirrhosis or chronic hepatitis B, you are at increased risk for developing liver cancer. Early detection improves treatment options and outcomes. We strongly recommend that all individuals with cirrhosis or chronic hepatitis B undergo liver cancer screening with ultrasound and alpha-fetoprotein (AFP) blood tests every 6 months. These tests can identify liver cancer at a stage when it is more treatable. Please speak with your healthcare provider about arranging regular screening.",
    "question_type": "Creative Generation",
    "evidence": [
      "Cirrhosis is a major risk factor for developing liver cancer.",
      "Chronic hepatitis B infection increases the risk of liver cancer.",
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B.",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months.",
      "Early-stage detection of liver cancer improves treatment options and outcomes."
    ]
  },
  {
    "id": "Medical-c780f053",
    "source": "Medical",
    "question": "You are a medical intern asked to write a discharge summary for a patient diagnosed with intrahepatic cholangiocarcinoma following workup for a liver mass. Summarize the diagnosis, underlying risk factors, diagnostic process, and sites of potential metastasis as per the guideline.",
    "answer": "Discharge Summary:\n\nDiagnosis: Intrahepatic cholangiocarcinoma, confirmed following imaging and biopsy of a liver mass. The patient has a history of cirrhosis and primary biliary cholangitis, both recognized risk factors for liver cancer. Diagnosis was established through imaging tests, including ultrasound and MRI, with confirmation via biopsy. The patient has been counseled regarding the risk of metastatic spread, particularly to the lung and bone, and will undergo further staging. Follow-up with oncology and hepatology is arranged.",
    "question_type": "Creative Generation",
    "evidence": [
      "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts.",
      "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer.",
      "Cirrhosis is a major risk factor for developing liver cancer.",
      "Diagnosis of liver cancer is usually confirmed with imaging tests.",
      "Liver cancer most often metastasizes to the lung or bone."
    ]
  },
  {
    "id": "Medical-4cab379f",
    "source": "Medical",
    "question": "You are an endocrinologist evaluating a 45-year-old patient with a newly discovered 2.5 cm thyroid nodule. Construct a stepwise diagnostic and initial management plan, referencing appropriate risk stratification, diagnostic modalities, and treatment recommendations from the guideline.",
    "answer": "As an endocrinologist, my first step would be to conduct a thorough clinical evaluation, including assessment for risk factors such as prior radiation exposure or family history of thyroid cancer. I would order a TSH blood test and a neck ultrasound to characterize the nodules size, echogenicity, margins, and lymph node involvement. Given the nodule is 2.5 cm, I would proceed with a fine-needle aspiration (FNA) biopsy to obtain cytological material. If the FNA indicates malignancy or is indeterminate, molecular testing may be performed to assess for mutations (e.g., BRAF, RET, NTRK fusions) that could aid in diagnosis and treatment planning. If the lesion is confirmed as a papillary or follicular thyroid carcinoma, and it is localized without evidence of invasion or nodal spread, lobectomy would be considered as an initial surgical approach. If there are high-risk features or lymph node involvement, total thyroidectomy with possible neck dissection would be recommended.",
    "question_type": "Creative Generation",
    "evidence": [
      "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules.",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules.",
      "Pathology review determines cancer type and guides treatment.",
      "Molecular tests can help determine malignancy and need for surgery.",
      "Lobectomy is an option for small, low-risk differentiated thyroid cancers.",
      "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers.",
      "Neck dissection is performed if lymph nodes are involved.",
      "Radiation exposure to the head or neck increases risk of thyroid cancer.",
      "Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk."
    ]
  },
  {
    "id": "Medical-32eaeeb1",
    "source": "Medical",
    "question": "Rewrite the evidence-based management of recurrent differentiated thyroid cancer into a formal referral letter from a primary care physician to a tertiary oncology center.",
    "answer": "Dear Oncology Colleague,\n\nI am referring a 58-year-old female with a history of papillary thyroid carcinoma, status post total thyroidectomy and radioactive iodine therapy. She now presents with rising serum thyroglobulin levels and a suspicious cervical lymph node on recent neck ultrasound. Given these findings suggest recurrent disease, I request your expertise for further evaluation and management. \n\nRelevant investigations include physical exam, TSH, Tg, Tg ab blood tests, and neck ultrasound. Imaging with CT or MRI may be warranted for further assessment. According to current guidelines, management options for recurrent, resectable disease include surgical excision. For iodine-avid recurrence, additional RAI therapy may be considered. For unresectable or non-RAI-avid recurrence, external beam radiation therapy or targeted therapy (e.g., lenvatinib, sorafenib, cabozantinib) may be indicated. Biomarker testing for actionable mutations (e.g., BRAF, ALK, NTRK, RET) is recommended in these cases. \n\nThank you for your attention to this complex case.\n\nSincerely,\n[Referring Physician]",
    "question_type": "Creative Generation",
    "evidence": [
      "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound.",
      "Rising thyroglobulin after thyroidectomy may indicate recurrence.",
      "Recurrence detection: Rising thyroglobulin, neck ultrasound, imaging (CT, MRI).",
      "Surgery (if resectable), RAI therapy (if iodine-avid), external beam radiation therapy, targeted therapy, and clinical trial are treatment options for recurrence.",
      "Biomarker testing is recommended for recurrent, advanced, or metastatic cancers not treatable with RAI.",
      "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, TMB-H.",
      "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer."
    ]
  },
  {
    "id": "Medical-bcc6b060",
    "source": "Medical",
    "question": "Imagine you are a medical intern presenting a multidisciplinary case summary for a patient diagnosed with anaplastic thyroid cancer. Summarize the diagnostic findings, genetic considerations, staging, and recommended therapeutic approach.",
    "answer": "The patient is a 68-year-old male presenting with a rapidly enlarging neck mass, hoarseness, and difficulty swallowing. Initial workup included TSH testing and neck ultrasound, which revealed a large, invasive thyroid mass with suspicious cervical lymphadenopathy. Fine-needle aspiration followed by pathology review confirmed anaplastic thyroid cancer. Molecular testing identified a BRAF gene mutation. Imaging with CT scan showed regional lymph node involvement but no distant metastases. Given the aggressive nature of anaplastic thyroid cancer, surgery was deemed not feasible. Current guidelines recommend external beam radiation therapy in combination with chemotherapy as primary treatment. Targeted therapy may be considered if actionable mutations are present. Biomarker testing for other actionable mutations is also advised. The patient was referred for enrollment in a clinical trial for advanced thyroid cancer.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems.",
      "TSH test and neck ultrasound are recommended for evaluation of thyroid nodules.",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules.",
      "Pathology review determines cancer type and guides treatment.",
      "Anaplastic thyroid cancer is the most aggressive and rarest subtype.",
      "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI.",
      "Chemotherapy is rarely effective, mainly used for anaplastic thyroid cancer with radiation.",
      "Biomarker testing is recommended for recurrent, advanced, or metastatic cancers not treatable with RAI.",
      "BRAF gene mutation is an actionable biomarker in anaplastic thyroid cancer.",
      "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer."
    ]
  },
  {
    "id": "Medical-a688bd5b",
    "source": "Medical",
    "question": "Transform the current thyroid cancer surveillance and follow-up strategies into a concise patient discharge summary for a patient who underwent total thyroidectomy for papillary thyroid carcinoma.",
    "answer": "Discharge Summary\n\nDiagnosis: Papillary thyroid carcinoma, status post total thyroidectomy\n\nHospital Course: The patient underwent an uncomplicated total thyroidectomy for papillary thyroid carcinoma. No evidence of lymph node involvement was detected intraoperatively. Postoperative recovery was uneventful.\n\nPlan:\n- Initiate levothyroxine therapy for thyroid hormone replacement.\n- Schedule follow-up in 612 months for neck ultrasound to assess for recurrence.\n- Monitor with periodic physical exams and blood tests, including TSH, thyroglobulin (Tg), and anti-thyroglobulin antibodies (Tg ab).\n- If radioactive iodine (RAI) was administered, consider whole-body RAI scan as indicated.\n- Long-term surveillance will include periodic imaging and laboratory monitoring to detect recurrence.\n\nPatient was educated on symptoms of recurrence and instructed to report any neck swelling, pain, or voice changes.",
    "question_type": "Creative Generation",
    "evidence": [
      "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers.",
      "Thyroid hormone replacement therapy is required after total thyroidectomy.",
      "Levothyroxine is the standard thyroid hormone replacement.",
      "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound.",
      "Neck ultrasound (6-12 months post-op) is recommended.",
      "Whole-body RAI scan (if RAI given) is part of follow-up after total thyroidectomy.",
      "Long-term: periodic physical exams, blood tests, neck ultrasound.",
      "Rising thyroglobulin after thyroidectomy may indicate recurrence."
    ]
  },
  {
    "id": "Medical-900e7337",
    "source": "Medical",
    "question": "Draft a public health advisory summarizing key risk factors, warning symptoms, and early diagnostic recommendations for thyroid cancer based on the guideline.",
    "answer": "**Public Health Advisory: Awareness and Early Detection of Thyroid Cancer**\n\nThyroid cancer incidence is rising, particularly among individuals with prior head or neck radiation exposure and those with a family history of thyroid disease or inherited syndromes (such as FAP, Carney complex, Cowden syndrome, and MEN). Early warning signs include a visible neck lump, neck pain, changes in voice, difficulty breathing, and swallowing problems. While most thyroid nodules are benign, prompt evaluation is crucial. Recommended initial diagnostics include a TSH blood test and neck ultrasound for any suspicious thyroid nodule. Fine-needle aspiration biopsy should be performed for nodules with concerning features. Early diagnosis enables timely treatment, which may include surgery and, for certain subtypes, radioactive iodine therapy. Public awareness of risk factors and symptoms is essential for early intervention.",
    "question_type": "Creative Generation",
    "evidence": [
      "Radiation exposure to the head or neck increases risk of thyroid cancer.",
      "Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk.",
      "Symptoms of large thyroid nodules include visible neck lump, neck pain, voice changes, trouble breathing, and swallowing problems.",
      "Thyroid nodules are often benign but can be the origin of thyroid cancer.",
      "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules.",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules.",
      "Surgery is the main treatment for most thyroid cancers.",
      "RAI therapy is used after total thyroidectomy for differentiated thyroid cancers that take up iodine."
    ]
  },
  {
    "id": "Medical-350bcbcd",
    "source": "Medical",
    "question": "Imagine you are a sarcoma specialist preparing a multidisciplinary case summary for a tumor board meeting. Your patient is a 19-year-old with a newly diagnosed diaphyseal bone lesion. Summarize the key diagnostic steps, relevant biomarkers, genetic testing, staging, and initial treatment considerations as outlined by the clinical practice guidelines.",
    "answer": "Patient is a 19-year-old presenting with a newly diagnosed diaphyseal bone lesion. Initial workup included detailed medical and family history, physical examination, and laboratory evaluation with CBC, CMP, alkaline phosphatase, and LDH. Imaging studies performed were X-ray, MRI, CT scan, and PET scan, all confirming the presence of a destructive diaphyseal lesion. Core needle biopsy was obtained, confirming Ewing sarcoma. Molecular testing identified an EWSR1-FLI1 fusion via PCR. Genetic cancer risk assessment was discussed due to the patient's age and presentation. Staging was performed using the TNM system, including evaluation for nodal and distant metastases. Tumor grade was established histologically. Performance status was evaluated using ECOG criteria to guide treatment planning. The case was reviewed for consideration of fertility preservation prior to initiation of therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1.",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan.",
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk.",
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
      "Tumor grade (G) describes histologic differentiation.",
      "Performance status (ECOG or KPS) is considered in treatment planning.",
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment.",
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation."
    ]
  },
  {
    "id": "Medical-a5356e35",
    "source": "Medical",
    "question": "You are a medical oncologist tasked with drafting a referral letter to a tertiary cancer center for a patient with suspected chondrosarcoma. Transform the clinical findings into a formal referral note, including relevant diagnostics, biomarkers, and potential targeted therapies based on the provided guidelines.",
    "answer": "Dear Colleagues,\n\nI am referring a 54-year-old patient with a cartilage-forming bone lesion, radiographically and histologically consistent with chondrosarcoma. Imaging with X-ray, CT, and MRI revealed a lobulated mass originating in cartilage-forming cells. Core needle biopsy confirmed diagnosis. Laboratory evaluation included alkaline phosphatase, CBC, CMP, and LDH. Next-generation sequencing identified an IDH1 mutation. Staging was performed using the TNM system, and tumor grade was determined histologically. Given the presence of IDH1 mutation, consideration for ivosidenib as a targeted therapy is warranted. The patients ECOG performance status is 1. Fertility preservation has been discussed given the potential impact of systemic therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "Chondrosarcoma starts in cartilage-forming cells.",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan.",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden.",
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib.",
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
      "Tumor grade (G) describes histologic differentiation.",
      "Performance status (ECOG or KPS) is considered in treatment planning.",
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment."
    ]
  },
  {
    "id": "Medical-25bac94b",
    "source": "Medical",
    "question": "Rewrite the clinical recommendations for bone cancer diagnosis and initial evaluation into a structured SOAP (Subjective, Objective, Assessment, Plan) note suitable for inclusion in an oncology clinic chart.",
    "answer": "Subjective: Patient reports persistent, localized bone pain and swelling over several weeks. No significant personal or family history of cancer noted.\n\nObjective: Physical exam reveals tenderness and mild swelling over the metaphyseal region. X-ray and MRI demonstrate a destructive lesion. Laboratory studies show elevated alkaline phosphatase and LDH. Core needle biopsy performed.\n\nAssessment: Primary bone sarcoma (differential includes osteosarcoma, Ewing sarcoma, chondrosarcoma). Tumor grade and histologic subtype pending biopsy results. TNM staging and performance status (ECOG) assessed.\n\nPlan: Complete staging with CT chest and PET scan. Initiate genetic cancer risk and biomarker testing (including IDH1, MSI-H/dMMR, TMB-H). Discuss fertility preservation prior to therapy. Multidisciplinary review planned.",
    "question_type": "Creative Generation",
    "evidence": [
      "Bone sarcomas include osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma, and giant cell tumor of bone.",
      "Osteosarcoma commonly arises in the metaphysis near growth plates.",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan.",
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation.",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden.",
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk.",
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
      "Tumor grade (G) describes histologic differentiation.",
      "Performance status (ECOG or KPS) is considered in treatment planning.",
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment."
    ]
  },
  {
    "id": "Medical-3d413e64",
    "source": "Medical",
    "question": "As a public health officer, draft an advisory for primary care providers on the early recognition, diagnostic workup, and referral process for suspected primary bone cancers, integrating risk factors and the importance of multidisciplinary management.",
    "answer": "Public Health Advisory: Early Detection and Referral of Primary Bone Cancers\n\nPrimary care providers should be vigilant for persistent bone pain, swelling, or unexplained fractures, particularly in adolescents and young adults. Early imaging (X-ray, MRI) is essential for suspicious bone lesions. Diagnostic confirmation requires core needle or surgical biopsy. Laboratory evaluation should include alkaline phosphatase, CBC, CMP, and LDH. Family history of cancer and germline mutations increase risk; consider genetic risk assessment in relevant cases. Staging via the TNM system and tumor grading guide management. Prompt referral to a multidisciplinary sarcoma team is recommended. Discuss fertility preservation prior to initiation of therapy, as some treatments affect reproductive potential.",
    "question_type": "Creative Generation",
    "evidence": [
      "Primary bone cancer originates in bone or cartilage.",
      "Most primary bone cancers are sarcomas.",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan.",
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation.",
      "Family history of cancer and germline mutations increase cancer risk.",
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
      "Tumor grade (G) describes histologic differentiation.",
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment.",
      "Multidisciplinary management is essential in bone sarcoma care."
    ]
  },
  {
    "id": "Medical-fc1f08f3",
    "source": "Medical",
    "question": "You are a clinical intern tasked with creating a concise discharge summary for a patient treated for Stage II osteosarcoma of the distal femur. The summary should include diagnostic methods, staging, laboratory findings, performance status, and follow-up recommendations, as per the guideline.",
    "answer": "Discharge Summary:\n\nDiagnosis: Stage II osteosarcoma of the distal femur.\n\nDiagnostic Workup: Diagnosis confirmed by core needle biopsy. Imaging studies included X-ray, MRI, CT scan, and PET scan, which localized the tumor to the metaphysis of the distal femur. Laboratory evaluation showed elevated alkaline phosphatase and LDH. Tumor grade was G2. Staging performed using the TNM system (T2N0M0). ECOG performance status was 0 at diagnosis.\n\nTreatment: Patient completed surgical resection and adjuvant therapy as per protocol. Fertility preservation was discussed prior to treatment initiation.\n\nFollow-up: Scheduled for surveillance imaging and laboratory monitoring. Monitoring for recurrence, late effects, and consideration of genetic cancer risk testing recommended.",
    "question_type": "Creative Generation",
    "evidence": [
      "Osteosarcoma commonly arises in the metaphysis near growth plates.",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan.",
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation.",
      "Stage is determined by combining T, N, M, and G scores.",
      "Tumor grade (G) describes histologic differentiation.",
      "Performance status (ECOG or KPS) is considered in treatment planning.",
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment.",
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk."
    ]
  },
  {
    "id": "Medical-d446abb7",
    "source": "Medical",
    "question": "You are a head and neck oncology specialist receiving a referral for a 57-year-old patient with a suspicious ulcer on the lateral tongue. Construct a detailed diagnostic and initial staging workflow for this patient, integrating guideline-recommended assessments and justifying each step.",
    "answer": "As a head and neck oncology specialist, my diagnostic and staging approach would include: (1) Performing a thorough clinical examination of the oral cavity and neck, with special attention to the lateral tongue and regional lymph nodes. (2) Ordering imaging studies, including MRI for local tumor extent and depth of invasion (DOI), and a CT scan or PET/CT to assess for regional lymph node involvement and distant metastasis. (3) Arranging a biopsy of the lesion to confirm squamous cell carcinoma histology. (4) If lymphadenopathy is present, recommending fine-needle aspiration (FNA) or core needle biopsy (CNB) of the lymph node to evaluate for metastasis and extranodal extension. (5) Conducting biomarker testing for PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB) to inform potential therapeutic strategies. (6) Assessing the patient's performance status (ECOG) to guide treatment selection. (7) Coordinating dental, speech and swallowing, and nutrition assessments as mouth cancer and its treatment can impact these domains.",
    "question_type": "Creative Generation",
    "evidence": [
      "Mouth cancer can develop in the tongue (front two-thirds).",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer.",
      "Biopsy is required to confirm diagnosis and determine histology.",
      "Fine-needle aspiration (FNA) or core needle biopsy (CNB) is used to assess lymph node involvement.",
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
      "Performance status (ECOG) is considered in treatment selection.",
      "Dental health is affected by head and neck cancer and its treatment.",
      "Speech and swallowing assessment and nutrition assessment are recommended in the diagnostic workup."
    ]
  },
  {
    "id": "Medical-fce3c59a",
    "source": "Medical",
    "question": "Rewrite the essential steps of initial mouth cancer evaluation and staging into a formal SOAP (Subjective, Objective, Assessment, Plan) progress note. Use the facts from the guideline to ensure clinical accuracy.",
    "answer": "**S: (Subjective)**\nPatient reports a persistent sore and changes in the lateral tongue for 3 weeks, with mild discomfort. Denies dysphagia or weight loss. History of tobacco and alcohol use.\n\n**O: (Objective)**\nExam: Ulcerative lesion on lateral tongue (front two-thirds), enlarged ipsilateral submandibular lymph node. Performance status ECOG 1. \nImaging: MRI shows lesion 2.5 cm with depth of invasion 8 mm. CT scan negative for distant metastasis. Panoramic dental x-ray reveals dental health concerns.\nBiopsy: Squamous cell carcinoma confirmed. FNA of lymph node positive for metastasis, no extranodal extension.\nBiomarker testing: Pending.\n\n**A: (Assessment)**\nStage II oral cavity squamous cell carcinoma of the tongue with ipsilateral nodal involvement, history of tobacco and alcohol use, ECOG 1.\n\n**P: (Plan)**\n- Complete biomarker testing (PD-L1, MSI-H/dMMR, TMB)\n- Multidisciplinary tumor board discussion\n- Dental, speech and swallowing, and nutrition assessments\n- Smoking/alcohol cessation counseling\n- Discuss fertility preservation as appropriate\n- Initiate treatment planning based on final staging and patient values.",
    "question_type": "Creative Generation",
    "evidence": [
      "Mouth cancer can develop in the tongue (front two-thirds).",
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer.",
      "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M).",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Biopsy is required to confirm diagnosis and determine histology.",
      "Fine-needle aspiration (FNA) is used for lymph node evaluation.",
      "Performance status (ECOG) is considered in treatment selection.",
      "Tobacco and alcohol use are risk factors for mouth cancer.",
      "Dental health is affected by head and neck cancer and its treatment.",
      "Speech and swallowing assessment and nutrition assessment are part of the diagnostic process.",
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
      "Cancer and its treatment can affect fertility."
    ]
  },
  {
    "id": "Medical-4654807f",
    "source": "Medical",
    "question": "Imagine you are a patient navigator counseling a newly diagnosed mouth cancer patient who is concerned about treatment side effects and fertility. Write an educational summary explaining the diagnostic process, risk factors, potential treatment impacts, and available supportive services, using evidence from the guideline.",
    "answer": "As your patient navigator, I want to guide you through what to expect. Mouth cancer, most often a type called squamous cell carcinoma, can occur in areas like the lips, gums, tongue, and more. Diagnosis involves imaging tests such as CT, MRI, or PET/CT to see the tumor's size and whether it has spread, and a biopsy to confirm the type of cancer. Your history of tobacco and alcohol use are risk factors for mouth cancer, and quitting can improve treatment outcomes. Treatments are planned based on the tumor's location and stage, and may affect dental health as well as speech and swallowing. For patients of reproductive age, we discuss fertility preservation options, as some treatments can impact fertility. We offer dental, speech, and nutrition assessments to support you throughout your care.",
    "question_type": "Creative Generation",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer.",
      "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone.",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Biopsy is required to confirm diagnosis and determine histology.",
      "Tobacco and alcohol use are risk factors for mouth cancer.",
      "Smoking or vaping negatively affects treatment outcomes and increases toxicity.",
      "Treatment planning is based on tumor location and stage.",
      "Dental health is affected by head and neck cancer and its treatment.",
      "Speech and swallowing assessment and nutrition assessment are recommended.",
      "Cancer and its treatment can affect fertility.",
      "Fertility preservation is a consideration in treatment planning."
    ]
  },
  {
    "id": "Medical-afaa48c4",
    "source": "Medical",
    "question": "You are a multidisciplinary tumor board coordinator tasked with drafting a template for a mouth cancer case summary to be used in board meetings. The template must prompt for all critical diagnostic, staging, and supportive care domains as outlined in the guideline.",
    "answer": "**Mouth Cancer Tumor Board Case Summary Template**\n\n1. Patient Demographics: Age, sex, relevant history (e.g., tobacco/alcohol use)\n2. Anatomic Site: Specify location (e.g., tongue, buccal mucosa, etc.)\n3. Symptom Description: Document changes in mouth, tongue, or neck\n4. Diagnostic Imaging: CT/MRI/PET/CT/Ultrasound findings, depth of invasion (DOI)\n5. Histology: Biopsy result (e.g., squamous cell carcinoma)\n6. TNM Staging: Tumor size, depth, nodal involvement, metastasis\n7. Biomarker Results: PD-L1, MSI-H/dMMR, TMB\n8. Performance Status: ECOG score\n9. Dental Assessment: Panoramic dental x-ray, findings\n10. Speech/Swallowing/Nutrition Assessment: Summary\n11. Fertility Considerations: Noted and addressed if relevant\n12. Risk Factors: Smoking, vaping, alcohol use\n13. Treatment Planning: Proposed approach, rationale\n14. Supportive Needs: Smoking/alcohol cessation, dental, speech, and nutritional support",
    "question_type": "Creative Generation",
    "evidence": [
      "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone.",
      "Symptoms may include changes in the mouth, tongue, or neck area.",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer.",
      "Biopsy is required to confirm diagnosis and determine histology.",
      "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M).",
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
      "Performance status (ECOG) is considered in treatment selection.",
      "Dental health is affected by head and neck cancer and its treatment.",
      "Speech and swallowing assessment and nutrition assessment are recommended.",
      "Fertility preservation is a consideration in treatment planning.",
      "Tobacco and alcohol use are risk factors for mouth cancer.",
      "Smoking or vaping negatively affects treatment outcomes and increases toxicity.",
      "Treatment planning is based on tumor location and stage."
    ]
  },
  {
    "id": "Medical-53e61e6b",
    "source": "Medical",
    "question": "Rewrite the mouth cancer practice guideline into a concise discharge summary for a patient who underwent initial evaluation and is pending definitive treatment. Include diagnostic findings, staging, risk factors, and recommendations for next steps.",
    "answer": "**Discharge Summary**\n\nPatient: [Name], [Age/Sex]\nDiagnosis: Squamous cell carcinoma of the oral cavity (tongue, front two-thirds)\n\nSummary:\nThe patient presented with a lesion of the lateral tongue. Imaging (MRI, CT) revealed a 2.2 cm mass with a depth of invasion of 6 mm and no evidence of distant metastasis. Biopsy confirmed squamous cell carcinoma. Fine-needle aspiration of a submandibular lymph node was negative for metastasis. Performance status is ECOG 1. The patient has a history of tobacco and alcohol use. Panoramic dental x-ray identified dental issues requiring management before treatment. Biomarker testing (PD-L1, MSI-H/dMMR, TMB) is pending.\n\nStaging: Stage II (T2N0M0) per TNM classification.\n\nRecommendations:\n- Complete biomarker testing\n- Dental, speech and swallowing, and nutrition assessments\n- Smoking and alcohol cessation support\n- Discuss fertility preservation if relevant\n- Multidisciplinary tumor board review for treatment planning\n\nFollow-up: Outpatient oncology clinic in 1 week.",
    "question_type": "Creative Generation",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer.",
      "Mouth cancer can develop in the tongue (front two-thirds).",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer.",
      "Biopsy is required to confirm diagnosis and determine histology.",
      "Fine-needle aspiration (FNA) is used for lymph node evaluation.",
      "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M).",
      "Performance status (ECOG) is considered in treatment selection.",
      "Tobacco and alcohol use are risk factors for mouth cancer.",
      "Dental health is affected by head and neck cancer and its treatment.",
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
      "Speech and swallowing assessment and nutrition assessment are recommended.",
      "Fertility preservation is a consideration in treatment planning."
    ]
  },
  {
    "id": "Medical-4a6fc716",
    "source": "Medical",
    "question": "You are a gastroenterologist receiving a referral for a 58-year-old patient with suspected stomach cancer. Using the provided clinical practice guideline, compose a detailed diagnostic workup plan, including the rationale for each step and the relevance to staging and treatment selection.",
    "answer": "As a gastroenterologist, my diagnostic workup for a patient with suspected stomach cancer would begin with upper endoscopy to directly visualize the gastric mucosa and obtain biopsies from any suspicious lesions or masses. Histopathological examination will determine if the tumor is an adenocarcinoma and help distinguish between intestinal and diffuse subtypes, influencing further management. Imaging tests, such as CT or MRI, will assess the extent of disease, including invasion into stomach wall layers and potential spread to regional lymph nodes or distant organs like the liver or peritoneum. Biomarker testing on biopsy samples will be performed to identify molecular targets, especially relevant in intestinal-type adenocarcinoma. Genetic risk testing will be offered if there is a family history, as hereditary syndromes may impact treatment planning. This comprehensive approach ensures accurate stagingdistinguishing early-stage (confined to mucosa) from locoregional or metastatic diseaseand guides selection of appropriate therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Most stomach cancers are adenocarcinomas.",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse.",
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy.",
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes.",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs.",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes.",
      "Family history is a risk factor for stomach cancer."
    ]
  },
  {
    "id": "Medical-46f66098",
    "source": "Medical",
    "question": "Imagine you are a multidisciplinary tumor board coordinator tasked with summarizing the key factors that determine the management approach for stomach cancer patients. Provide a structured case summary template integrating anatomical, pathological, and risk factor information as per the guideline.",
    "answer": "Case Summary Template for Stomach Cancer Management:\n\n1. Patient Demographics: Age, sex, relevant history\n2. Anatomical Location: Specify site within stomach (e.g., cardia, fundus, body, antrum, pylorus, esophagogastric junction)\n3. Tumor Histology: Adenocarcinoma (intestinal or diffuse type)\n4. Tumor Stage: Early-stage (confined to mucosa, no lymph node involvement), Locoregional (invasion of other stomach wall layers and/or regional lymph nodes), Metastatic (spread to distant organs such as liver, peritoneum, distant lymph nodes)\n5. Spread Pattern: Local extension (wall layers, lymph nodes) vs distant (liver, peritoneum, pancreas, spleen)\n6. Risk Factors: H. pylori infection, family history\n7. Diagnostic Methods Used: Imaging, endoscopy, biopsy, biomarker testing, genetic risk testing\n8. Symptoms: Presence of ulcer, mass, or other relevant findings\n\nThis structured template ensures all critical factors influencing management are systematically considered.",
    "question_type": "Creative Generation",
    "evidence": [
      "Anatomical Location: [Cardia, Fundus, Body, Antrum, Pylorus, Esophagogastric junction]",
      "Most stomach cancers are adenocarcinomas.",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse.",
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes.",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs.",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes.",
      "Stomach cancer spreads outward through the layers of the stomach wall.",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "H. pylori infection is a risk factor for stomach cancer.",
      "Family history is a risk factor for stomach cancer.",
      "Symptoms can include ulcer or mass formation in the stomach."
    ]
  },
  {
    "id": "Medical-d5faa97f",
    "source": "Medical",
    "question": "Rewrite the clinical guideline information into a formal discharge summary for a patient diagnosed with early-stage intestinal-type stomach adenocarcinoma, specifying the diagnostic findings, risk factors, and recommendations for follow-up.",
    "answer": "Discharge Summary:\n\nDiagnosis: Early-stage intestinal-type stomach adenocarcinoma\n\nFindings:\n- Endoscopy revealed a localized mass in the gastric mucosa; biopsy confirmed adenocarcinoma of intestinal type.\n- Imaging studies showed the lesion was confined to the mucosa with no evidence of lymph node involvement or distant metastasis.\n- Biomarker testing pending; no actionable mutations identified to date.\n- Family history positive for stomach cancer; patient tested for relevant genetic risk factors.\n- H. pylori infection detected and treated.\n\nRecommendations:\n- Regular surveillance endoscopy to monitor for recurrence or new lesions.\n- Continued follow-up with oncology and gastroenterology.\n- Family counseling regarding genetic risk and possible screening.\n- Monitor for symptoms such as ulcer or new mass formation.\n\nPatient is stable and discharged in good condition.",
    "question_type": "Creative Generation",
    "evidence": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes.",
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy.",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Family history is a risk factor for stomach cancer.",
      "H. pylori infection is a risk factor for stomach cancer.",
      "Symptoms can include ulcer or mass formation in the stomach."
    ]
  },
  {
    "id": "Medical-d8e24b59",
    "source": "Medical",
    "question": "As a medical intern, draft a referral note to a genetic counselor for a patient with newly diagnosed diffuse-type stomach adenocarcinoma and a significant family history of gastric cancer. Include relevant clinical and risk factor details from the guideline.",
    "answer": "Referral Note:\n\nTo: Genetic Counseling Service\n\nPatient: [Name], recently diagnosed with diffuse-type stomach adenocarcinoma.\n\nClinical Details:\n- Diagnosis confirmed by biopsy after endoscopy identified scattered cancerous cells consistent with diffuse-type adenocarcinoma.\n- Family history is notable for multiple first-degree relatives with stomach cancer.\n- No evidence of distant metastasis on imaging.\n- Risk factors include positive family history and absence of H. pylori infection.\n\nRationale for Referral:\nGiven the diagnosis of diffuse-type adenocarcinoma and significant familial clustering, evaluation for hereditary cancer syndromes is indicated. Genetic risk testing is recommended to guide patient management and family counseling.",
    "question_type": "Creative Generation",
    "evidence": [
      "Diffuse type adenocarcinoma consists of scattered cells and is less common.",
      "Family history is a risk factor for stomach cancer.",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes.",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse."
    ]
  },
  {
    "id": "Medical-0255e97b",
    "source": "Medical",
    "question": "Transform the core clinical practice facts into a public health advisory warning about stomach cancer, emphasizing risk factors, early detection, and the importance of diagnostic evaluation for at-risk populations.",
    "answer": "**Public Health Advisory: Stomach Cancer Awareness and Early Detection**\n\nStomach cancer is a serious disease arising from the lining of the stomach, with most cases being adenocarcinomas. Individuals with a family history of stomach cancer or infection with H. pylori are at increased risk. Early-stage stomach cancer may not cause symptoms or may present as an ulcer or mass. Early detection is critical, as cancer confined to the stomachs mucosa is more treatable. We urge individuals with risk factors or persistent stomach symptoms to seek medical evaluation, which may include endoscopy, imaging, and biopsy. Genetic risk testing and biomarker analysis may be recommended for those with a family history. Public health efforts should focus on awareness of risk factors, timely diagnosis, and appropriate follow-up.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stomach cancer is a type of cancer that arises in the stomach.",
      "Most stomach cancers are adenocarcinomas.",
      "H. pylori infection is a risk factor for stomach cancer.",
      "Family history is a risk factor for stomach cancer.",
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes.",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing.",
      "Symptoms can include ulcer or mass formation in the stomach."
    ]
  },
  {
    "id": "Medical-50dd4351",
    "source": "Medical",
    "question": "You are a neurosurgeon receiving a referral for a 45-year-old patient with new-onset seizures and an MRI revealing a left frontal lobe mass. Write a detailed diagnostic and initial management plan, referencing relevant classification, diagnostic, and treatment recommendations from the clinical practice guideline.",
    "answer": "Upon receiving this case, my first step would be to perform a comprehensive neurological exam to assess deficits and establish a baseline. The MRI findings suggest a brain mass, so I would recommend a stereotactic or open biopsy to obtain tissue for histological and molecular analysis, including IDH mutation status, which is critical for glioma classification. Based on histology and grade (e.g., low-grade vs. high-grade glioma), further management will be determined. If the tumor is resectable, maximal safe surgical resection should be pursued to reduce tumor burden and provide tissue for definitive diagnosis. Postoperatively, for high-grade gliomas (grades 3 or 4), I would coordinate adjuvant therapy with the neuro-oncology team, including radiation and chemotherapy. The patient's performance status should be evaluated to guide treatment eligibility. Periodic follow-up MRI will be scheduled to monitor for recurrence.",
    "question_type": "Creative Generation",
    "evidence": [
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy.",
      "MRI is the most useful imaging test for identifying glioma.",
      "Biopsy is required for definitive diagnosis and molecular testing.",
      "Gliomas are classified by histology, grade, and biomarkers.",
      "IDH mutation is a biomarker used to classify gliomas.",
      "Surgery may involve resection or biopsy.",
      "High-grade gliomas require additional therapy after surgery.",
      "Performance status is assessed to determine treatment eligibility.",
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence."
    ]
  },
  {
    "id": "Medical-bc869828",
    "source": "Medical",
    "question": "Rewrite the key clinical recommendations for glioma diagnosis and management into a concise discharge summary for a patient who underwent surgery for a grade 4 glioblastoma.",
    "answer": "Discharge Summary:\n\nDiagnosis: Grade 4 glioblastoma (confirmed by histology and molecular testing)\n\nHospital Course: The patient presented with headache and cognitive changes. Neurological exam and MRI revealed a right temporal mass. The patient underwent maximal safe resection. Postoperative recovery was uneventful. Histopathology confirmed grade 4 glioblastoma; IDH mutation was not detected.\n\nTreatment Plan: Given high-grade status, adjuvant radiation therapy and chemotherapy will be initiated. The patients performance status is satisfactory for aggressive therapy. Enrolment in a clinical trial was discussed.\n\nFollow-up: The patient is scheduled for periodic MRI imaging to monitor for recurrence. Outpatient neuro-oncology follow-up arranged.",
    "question_type": "Creative Generation",
    "evidence": [
      "Glioblastoma is the most aggressive subtype of glioma.",
      "Grade 4 gliomas are most commonly glioblastomas.",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy.",
      "Biopsy is required for definitive diagnosis and molecular testing.",
      "High-grade gliomas require additional therapy after surgery.",
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials.",
      "Performance status is assessed to determine treatment eligibility.",
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence."
    ]
  },
  {
    "id": "Medical-8feee92a",
    "source": "Medical",
    "question": "Imagine you are a neuro-oncology fellow preparing a referral note to a radiation oncologist for a patient with a newly diagnosed high-grade oligodendroglioma. Summarize the diagnostic findings, molecular profile, and rationale for radiation therapy.",
    "answer": "Referral Note to Radiation Oncology:\n\nPatient: 52-year-old male with new-onset seizures\n\nDiagnostic Findings: MRI revealed a left frontal lobe mass. Neurological exam showed mild expressive aphasia. Stereotactic biopsy confirmed high-grade oligodendroglioma (grade 3) with positive IDH mutation. Molecular testing supports the diagnosis.\n\nRationale for Radiation Therapy: Following maximal safe resection, high-grade gliomas require adjuvant radiation therapy to reduce recurrence risk. The patients performance status is adequate for combined modality treatment. Please evaluate for initiation of radiation therapy in conjunction with chemotherapy as per current guidelines.\n\nThank you for your collaboration.",
    "question_type": "Creative Generation",
    "evidence": [
      "Gliomas are classified by histology, grade, and biomarkers.",
      "Oligodendroglioma: Grade 2 and Grade 3 are recognized grades.",
      "IDH mutation is a biomarker used to classify gliomas.",
      "High-grade gliomas require additional therapy after surgery.",
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials.",
      "Performance status is assessed to determine treatment eligibility."
    ]
  },
  {
    "id": "Medical-bec7f927",
    "source": "Medical",
    "question": "Transform the clinical guidelines on glioma risk factors, diagnosis, and follow-up into a public health advisory aimed at adult patients and families.",
    "answer": "**Public Health Advisory: Understanding Adult GliomaRisks, Diagnosis, and Lifelong Monitoring**\n\nGliomas are malignant brain tumors developing from glial cells and are more common in adults. Most gliomas are not inherited but arise from non-hereditary mutations. Early symptoms may include headache, seizures, personality or cognitive changes, and vision problems. Diagnosis involves neurological examination, MRI (the preferred imaging method), and biopsy for confirmation and molecular testing. While gliomas are rarely curable, treatments such as surgery, radiation, and chemotherapy can help manage the disease. Lifelong follow-up with periodic MRI imaging is essential to monitor for tumor recurrence. If you experience persistent neurological symptoms, consult your healthcare provider promptly.",
    "question_type": "Creative Generation",
    "evidence": [
      "Glioma is a type of malignant brain tumor.",
      "Gliomas develop from glial cells in the central nervous system.",
      "Gliomas are more common in adults than children.",
      "Most gliomas are not hereditary.",
      "Symptoms of glioma include headache, seizures, fatigue, cognitive changes, personality changes, and vision problems.",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy.",
      "MRI is the most useful imaging test for identifying glioma.",
      "Biopsy is required for definitive diagnosis and molecular testing.",
      "Gliomas are rarely curable but are treatable.",
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence."
    ]
  },
  {
    "id": "Medical-ce7d82e3",
    "source": "Medical",
    "question": "You are a medical intern asked to write a SOAP (Subjective, Objective, Assessment, Plan) progress note for a patient with a low-grade astrocytoma, incorporating guideline-based recommendations for diagnosis, management, and surveillance.",
    "answer": "SOAP Note:\n\nSubjective: Patient reports intermittent headaches and mild fatigue. No new neurological symptoms.\n\nObjective: Neurological exam is stable. MRI shows stable low-grade left temporal astrocytoma. No evidence of progression. Histology and molecular testing confirm low-grade (grade 2) astrocytoma with IDH mutation.\n\nAssessment: 35-year-old female with stable low-grade astrocytoma, no new deficits, and favorable biomarker profile (IDH mutation positive).\n\nPlan: Continue observation with periodic follow-up MRI as per guidelines. No indication for adjuvant therapy at this time. Monitor for symptom progression. Reassess performance status at each visit.",
    "question_type": "Creative Generation",
    "evidence": [
      "Astrocytoma is a common subtype of glioma.",
      "Grades 1 and 2 are low-grade gliomas.",
      "IDH mutation is a biomarker used to classify gliomas.",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy.",
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence.",
      "Performance status is assessed to determine treatment eligibility.",
      "Low-grade gliomas have better prognosis."
    ]
  },
  {
    "id": "Medical-3fc0a01e",
    "source": "Medical",
    "question": "Imagine you are a hematology fellow preparing a referral letter for a patient newly diagnosed with acute myeloid leukemia (AML) to a tertiary care center for consideration of hematopoietic cell transplantation. Summarize the diagnostic work-up, relevant prognostic factors, current treatment status, and supportive care needs.",
    "answer": "Dear Colleagues,\n\nI am referring a 45-year-old patient recently diagnosed with acute myeloid leukemia (AML), confirmed by >20% myeloblasts in bone marrow aspirate and biopsy. Diagnostic work-up included complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and flow cytometry, all supporting AML diagnosis. Molecular and cytogenetic testing revealed FLT3-ITD mutation, an adverse prognostic factor. The patient has completed induction chemotherapy with cytarabine and daunorubicin and is currently in first remission. Performance status is ECOG 1. Supportive care has included transfusions, infection prevention, and management of chemotherapy side effects. Given the high-risk genetic profile and favorable response to induction, hematopoietic cell transplant is being considered. Fertility preservation counseling was performed prior to therapy. Please advise regarding transplant eligibility and further management.",
    "question_type": "Creative Generation",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies.",
      "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA.",
      "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin), and hypomethylating agents (e.g., azacitidine, decitabine).",
      "Hematopoietic cell transplant is considered for eligible patients.",
      "Performance status and general health influence treatment selection.",
      "Supportive care includes transfusions, infection prevention, and management of side effects.",
      "Fertility preservation should be discussed before starting systemic therapy."
    ]
  },
  {
    "id": "Medical-0cd460d0",
    "source": "Medical",
    "question": "You are a clinician asked to create a discharge summary for a patient with newly diagnosed acute promyelocytic leukemia (APL), a subtype of AML, after induction therapy. Include diagnosis, genetic findings, treatment given, complications managed, and follow-up recommendations.",
    "answer": "Discharge Summary:\n\nDiagnosis: Acute promyelocytic leukemia (APL), a subtype of AML, confirmed by bone marrow biopsy showing >20% blasts and identification of PML::RARA fusion gene. \n\nGenetic Findings: Cytogenetic and molecular testing positive for PML::RARA fusion.\n\nTreatment: Induction therapy with chemotherapy and targeted therapy initiated, as per guidelines for APL. Supportive care included transfusions and infection prophylaxis.\n\nComplications: The patient developed thrombocytopenia and neutropenic fever, managed with platelet transfusions and broad-spectrum antibiotics.\n\nFollow-Up Recommendations: Continue consolidation therapy as per protocol. Repeat bone marrow evaluation and molecular testing to assess remission status. Monitor for differentiation syndrome and provide ongoing supportive care.\n\nFertility counseling was completed prior to therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene.",
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies.",
      "Chemotherapy is the standard of care for AML.",
      "Targeted therapies are used for AML with specific genetic alterations, such as ... for PML::RARA.",
      "Supportive care includes transfusions, infection prevention, and management of side effects.",
      "Fertility preservation should be discussed before starting systemic therapy."
    ]
  },
  {
    "id": "Medical-a2771279",
    "source": "Medical",
    "question": "Assume the role of a clinical pathologist and write a detailed report on the laboratory and molecular diagnostic steps necessary to establish an AML diagnosis and subtype, referencing the guidelines recommendations.",
    "answer": "Laboratory and Molecular Diagnostic Report:\n\nA diagnosis of AML requires identification of 20% myeloblasts in bone marrow or blood. The diagnostic process began with complete blood count (CBC), comprehensive metabolic panel (CMP), and lactate dehydrogenase (LDH) to evaluate cytopenias and cell turnover. Bone marrow aspirate and biopsy were performed, with histopathology confirming increased blasts. Flow cytometry and immunophenotyping defined the immunologic profile of the blasts. Cytogenetic analysis (karyotype, FISH) and molecular testing (next-generation sequencing, PCR) were conducted to identify genetic alterations such as FLT3-ITD, inv(16), t(8;21), del(5q), and PML::RARA. These findings are essential for AML subtype classification and to guide therapy.",
    "question_type": "Creative Generation",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies.",
      "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA.",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment.",
      "Bone Marrow Evaluation: bone marrow aspirate, bone marrow biopsy, histopathology.",
      "Molecular and Cytogenetic Testing: karyotype, FISH, next-generation sequencing (NGS), PCR."
    ]
  },
  {
    "id": "Medical-5e1bd01f",
    "source": "Medical",
    "question": "Rewrite the management principles of AML into a public health advisory aimed at primary care providers, focusing on early recognition, risk factors, and referral pathways.",
    "answer": "Public Health Advisory: Early Recognition and Referral for Acute Myeloid Leukemia (AML)\n\nPrimary care providers should maintain high suspicion for AML in patients presenting with unexplained fatigue, frequent infections, bleeding, or easy bruising. Risk factors include family history of leukemia and hereditary predisposition syndromes. Early diagnosis relies on prompt laboratory evaluation, including complete blood count and referral for bone marrow assessment if blasts are detected. Rapid referral to hematology is essential for definitive diagnosis and initiation of therapy. Fertility preservation counseling should be considered before starting systemic treatment. Supportive care, including transfusions and infection prevention, is critical during initial management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of AML include fatigue, infections, bleeding, and bruising.",
      "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML.",
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies.",
      "Fertility preservation should be discussed before starting systemic therapy.",
      "Supportive care includes transfusions, infection prevention, and management of side effects.",
      "Performance status and general health influence treatment selection."
    ]
  },
  {
    "id": "Medical-ee3d898f",
    "source": "Medical",
    "question": "You are a medical intern tasked with drafting a SOAP progress note for a patient with AML who is undergoing induction chemotherapy. Incorporate presenting symptoms, diagnostic findings, genetic risk stratification, therapy administered, and supportive interventions.",
    "answer": "SOAP Progress Note:\n\nSubjective: Patient reports persistent fatigue and new-onset bruising.\n\nObjective: CBC reveals pancytopenia; bone marrow biopsy shows >20% myeloblasts. Flow cytometry confirms myeloid lineage. Molecular testing identifies FLT3-ITD mutation. ECOG performance status is 1.\n\nAssessment: Newly diagnosed AML with adverse genetic risk (FLT3-ITD-positive). Currently receiving induction chemotherapy with cytarabine and daunorubicin.\n\nPlan: Continue induction chemotherapy per protocol. Monitor for infections and bleeding. Provide transfusions as needed. Initiate infection prevention measures. Discuss fertility preservation options and provide ongoing supportive care.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of AML include fatigue, infections, bleeding, and bruising.",
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies.",
      "Common genetic alterations in AML include FLT3-ITD.",
      "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin).",
      "Supportive care includes transfusions, infection prevention, and management of side effects.",
      "Performance status and general health influence treatment selection.",
      "Fertility preservation should be discussed before starting systemic therapy."
    ]
  },
  {
    "id": "Medical-f8205c0e",
    "source": "Medical",
    "question": "You are a gynecologic oncologist seeing a 54-year-old woman newly diagnosed with Stage IIIC high-grade serous ovarian carcinoma. Write a detailed initial management plan, including diagnostic confirmation, surgical approach, adjuvant therapy, genetic testing, and plans for follow-up.",
    "answer": "For this patient with newly diagnosed Stage IIIC high-grade serous ovarian carcinoma, I would first confirm the diagnosis with a review of imaging (CT, MRI, or PET scan), pelvic examination, and histopathologic analysis of biopsy specimens. Surgical staging and maximal cytoreductive surgery (hysterectomy with bilateral salpingo-oophorectomy and debulking of all visible disease) would be performed, as this is the standard initial treatment. Postoperatively, I would recommend adjuvant chemotherapy consisting of paclitaxel and carboplatin, with consideration of adding bevacizumab based on disease burden and comorbidities. Maintenance therapy with a PARP inhibitor, such as olaparib, would be considered, particularly if BRCA mutation or HRD positivity is identified. Therefore, I would order comprehensive genetic testing for BRCA1/2 mutations and other hereditary syndromes for both therapeutic and familial risk assessment. Follow-up would include regular physical and pelvic exams and monitoring of CA-125 levels.",
    "question_type": "Creative Generation",
    "evidence": [
      "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes of epithelial ovarian cancer.",
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers.",
      "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers.",
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages.",
      "Bevacizumab may be added to chemotherapy in some cases.",
      "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment.",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer.",
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers."
    ]
  },
  {
    "id": "Medical-42f6bec1",
    "source": "Medical",
    "question": "Transform the clinical facts for recurrent platinum-resistant epithelial ovarian cancer into a formal oncology referral letter, highlighting diagnostic findings, prior treatments, and rationale for advanced therapies or clinical trial consideration.",
    "answer": "Dear Colleague,\n\nI am referring Ms. Jane Doe, a 62-year-old woman with a history of epithelial ovarian cancer, initially diagnosed as Stage IIIB high-grade serous carcinoma. She underwent primary debulking surgery (hysterectomy and bilateral salpingo-oophorectomy) followed by adjuvant paclitaxel and carboplatin chemotherapy. After an initial remission, she developed symptomatic recurrence within six months of completing platinum therapy, consistent with platinum-resistant disease. Recent imaging (CT and PET scan) confirms multifocal peritoneal disease. Tumor biomarker analysis reveals FR positivity, and BRCA testing is negative. Given her platinum-resistant status, I am seeking your input regarding non-platinum chemotherapy options, consideration for bevacizumab, and the potential for targeted therapy with mirvetuximab soravtansine-gynx. Enrollment in a clinical trial is also under consideration.\n\nSincerely,\nDr. Smith",
    "question_type": "Creative Generation",
    "evidence": [
      "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment.",
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors.",
      "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion.",
      "Clinical trials are recommended for recurrent or persistent ovarian cancer.",
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers.",
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages.",
      "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers."
    ]
  },
  {
    "id": "Medical-f581f48d",
    "source": "Medical",
    "question": "As a medical intern, create a concise SOAP (Subjective, Objective, Assessment, Plan) note for a patient with suspected ovarian cancer, integrating presenting symptoms, diagnostic findings, risk factors, and initial management steps.",
    "answer": "S: Patient reports persistent bloating, pelvic pain, and trouble eating with early satiety for the past two months. She also notes increased urinary urgency. Family history is notable for a mother with breast cancer.\n\nO: Physical exam reveals abdominal distension and tenderness. Pelvic ultrasound shows a complex ovarian mass. CA-125 is elevated. CT scan demonstrates peritoneal implants. No evidence of distant metastases.\n\nA: Suspected advanced epithelial ovarian cancer, likely high-grade serous subtype, in a patient with significant family history (possible BRCA-related risk).\n\nP: Plan includes further diagnostic evaluation with biopsy and referral for genetic testing (BRCA, Lynch syndrome). Surgical staging and cytoreductive surgery are indicated. Initiate multidisciplinary discussion for adjuvant chemotherapy (paclitaxel and carboplatin) and consider maintenance therapy based on biomarker results.",
    "question_type": "Creative Generation",
    "evidence": [
      "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex.",
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers.",
      "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer.",
      "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers.",
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages.",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer."
    ]
  },
  {
    "id": "Medical-cd76440b",
    "source": "Medical",
    "question": "Rewrite the guideline recommendations for post-treatment surveillance of ovarian cancer into a patient-friendly discharge summary, including rationale for each follow-up step.",
    "answer": "Discharge Summary  Ovarian Cancer Post-Treatment Surveillance\n\nYou have completed treatment for ovarian cancer. Your ongoing follow-up care is important to monitor for any signs of recurrence and to support your recovery. Your surveillance plan will include:\n1. Regular physical and pelvic exams to check for any new symptoms or findings.\n2. Blood tests to monitor CA-125 or other tumor markers, which can help detect early signs of recurrence.\n3. Imaging tests (such as ultrasound, CT, or MRI) if there are any concerning symptoms or abnormal exam findings.\n4. Ongoing assessment for side effects of treatment, such as neuropathy or fatigue.\n5. Discussion of any new symptoms, including abdominal pain, bloating, or changes in appetite, as these can signal recurrence.\nThese steps are based on evidence that regular monitoring improves early detection and management of recurrence.",
    "question_type": "Creative Generation",
    "evidence": [
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers.",
      "Imaging (ultrasound, CT, MRI, PET) is used as indicated for diagnosis and follow-up.",
      "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex.",
      "Peripheral neuropathy and fatigue are recognized side effects of treatment.",
      "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment.",
      "Early detection of recurrence can improve management options."
    ]
  },
  {
    "id": "Medical-a3b9f0d4",
    "source": "Medical",
    "question": "Imagine you are a public health official tasked with drafting a community advisory on hereditary ovarian cancer risk. Integrate guideline facts about risk factors, genetic testing, and prevention strategies into your message.",
    "answer": "Community Health Advisory: Hereditary Ovarian Cancer Risk\n\nOvarian cancer is a serious condition that can affect women of all ages. Certain inherited genetic mutations, such as BRCA1, BRCA2, and Lynch syndrome, significantly increase the risk of developing ovarian cancer. All women diagnosed with ovarian cancer are recommended to undergo genetic testing for these mutations, as this information can guide treatment and help family members understand their own risk. Family history of breast or ovarian cancer is also an important risk factor. Early recognition of symptomssuch as persistent bloating, pelvic pain, and changes in eating habitscan lead to earlier diagnosis and better outcomes. If you have a family history of these cancers or are concerned about your risk, please talk to your healthcare provider about genetic counseling and testing.",
    "question_type": "Creative Generation",
    "evidence": [
      "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer.",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer.",
      "Family history is a risk factor for ovarian cancer.",
      "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex.",
      "Early recognition of symptoms can improve diagnosis and outcomes."
    ]
  },
  {
    "id": "Medical-1f9a3a9d",
    "source": "Medical",
    "question": "Imagine you are a hematology fellow asked to write a detailed diagnostic summary for a patient with suspected chronic lymphocytic leukemia (CLL). Your summary should integrate the required laboratory and imaging tests, key biomarkers, risk assessment, and steps to confirm the diagnosis, as per the clinical practice guideline.",
    "answer": "Diagnostic Summary: The patient presents with persistent lymphocytosis and clinical features suggestive of CLL, including swollen glands and fatigue. Initial laboratory evaluation should include a complete blood count (CBC), demonstrating 5,000 monoclonal B lymphocytes per microliter. Flow cytometry is warranted to confirm the immunophenotype of the lymphocytes, assessing for surface markers such as CD20, CD200, and LEF1. Additional biomarker testing with FISH should be performed to identify 17p deletion, and DNA sequencing is indicated for TP53 and IGHV mutations. Karyotype analysis will further evaluate for complex chromosomal abnormalities. Diagnostic imaging with a CT scan is recommended to assess lymph node and organ involvement. Risk assessment should include evaluation of beta-2 microglobulin for disease activity and a thorough review of the patient's age and family history, as these are significant risk factors for CLL. If needed, a lymph node or bone marrow biopsy may be performed to support the diagnosis.",
    "question_type": "Creative Generation",
    "evidence": [
      "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Diagnostic CT scans may be used to assess lymph node involvement and disease extent"
    ]
  },
  {
    "id": "Medical-c8339278",
    "source": "Medical",
    "question": "You are a primary care physician referring a patient with newly diagnosed small lymphocytic lymphoma (SLL) to hematology/oncology. Write a referral note summarizing the clinical findings, diagnostic workup, relevant biomarkers, and rationale for referral, using the recommended guideline framework.",
    "answer": "Referral Note: Patient is a 68-year-old male presenting with painless lymphadenopathy and fatigue. CBC revealed elevated lymphocyte count, and flow cytometry identified a monoclonal B cell population positive for CD20, CD200, and LEF1. Lymph node biopsy confirmed small lymphocytic lymphoma (SLL), a tissue-based equivalent of CLL. FISH analysis detected no 17p deletion, and DNA sequencing for TP53 and IGHV mutations is pending. Beta-2 microglobulin levels are elevated, suggesting increased disease activity. Diagnostic CT scan showed generalized lymphadenopathy without splenomegaly. Due to confirmed SLL diagnosis and need for further staging, prognostic assessment, and treatment planning, referral to hematology/oncology is indicated.",
    "question_type": "Creative Generation",
    "evidence": [
      "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen",
      "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis"
    ]
  },
  {
    "id": "Medical-d5c778d2",
    "source": "Medical",
    "question": "Rewrite the clinical management recommendations for CLL/SLL into a formal discharge summary for a patient who completed initial diagnostic workup and is being managed with watchful waiting. Include key findings, risk factors, follow-up strategy, and supportive care advice.",
    "answer": "Discharge Summary: The patient was evaluated for lymphocytosis and diagnosed with chronic lymphocytic leukemia (CLL) after blood tests showed 5,000 monoclonal B lymphocytes/L and flow cytometry confirmed typical immunophenotype (CD20+, CD200+, LEF1+). Biomarker studies (FISH, TP53/IGHV sequencing, karyotype) did not reveal high-risk features. The patient currently has no B-symptoms, maintains good performance status, and shows no evidence of Richter transformation. Given asymptomatic early-stage disease, a 'watch and wait' approach is recommended. Regular monitoring with CBC, metabolic panel, and physical exams will be scheduled every 36 months. Supportive care includes infection prevention and prompt management of new symptoms. The patient was advised of the importance of follow-up and informed that treatment will be initiated if disease progression or symptoms occur.",
    "question_type": "Creative Generation",
    "evidence": [
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression",
      "Watch and wait, regular monitoring, and supportive care are follow-up strategies",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "Performance status and comprehensive metabolic panel are used in treatment planning",
      "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma"
    ]
  },
  {
    "id": "Medical-d5b7cd3a",
    "source": "Medical",
    "question": "Assume the role of a medical intern tasked with drafting a SOAP (Subjective, Objective, Assessment, Plan) progress note for a patient with established CLL who now reports night sweats and unintentional weight loss. Integrate diagnostic, prognostic, and management elements from the guideline.",
    "answer": "SOAP Note:\nSubjective: Patient reports increased night sweats and unintentional weight loss over the past month. No fever or recurrent infections.\nObjective: Physical exam reveals palpable cervical and axillary lymphadenopathy. CBC shows rising lymphocyte count. Comprehensive metabolic panel is within normal limits. Beta-2 microglobulin is elevated. No evidence of Richter transformation on CT scan.\nAssessment: CLL with new B-symptoms (night sweats, weight loss), elevated lymphocyte count, and rising beta-2 microglobulin, indicating disease progression.\nPlan: Proceed with repeat flow cytometry to assess for immunophenotype changes, FISH to evaluate for 17p deletion, and DNA sequencing for TP53 and IGHV mutations. Consider initiation of oral medications or IV infusions based on risk stratification. Continue supportive care measures and monitor for complications, including Richter transformation.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss",
      "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Treatment options include oral medications, IV infusions, and combination therapies"
    ]
  },
  {
    "id": "Medical-2a322545",
    "source": "Medical",
    "question": "Transform the clinical facts into a patient-facing educational letter explaining CLL/SLL diagnosis, risk factors, necessary tests, and the importance of regular follow-up, using plain language but grounded in guideline evidence.",
    "answer": "Dear Patient,\n\nYou have been diagnosed with chronic lymphocytic leukemia (CLL), a cancer that affects certain white blood cells called B lymphocytes. Sometimes this cancer is found mainly in the lymph nodes and is called small lymphocytic lymphoma (SLL). CLL/SLL is often discovered during routine blood tests, especially in older adults or those with a family history of this condition. To confirm your diagnosis, your doctors used blood tests, including a complete blood count and special tests called flow cytometry to look for markers like CD20, CD200, and LEF1. Additional genetic tests (FISH, DNA sequencing, karyotype) help understand the disease and guide treatment decisions. Most people with early CLL/SLL do not need treatment right away but are closely monitored with regular check-ups and blood tests. Keeping up with follow-up appointments is important to watch for any changes and to manage symptoms if they arise.",
    "question_type": "Creative Generation",
    "evidence": [
      "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes",
      "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen",
      "CLL may be asymptomatic and discovered incidentally on routine blood testing",
      "Risk factors for CLL include older age and family history of CLL",
      "Follow-up strategies include watch and wait, regular monitoring, and supportive care"
    ]
  },
  {
    "id": "Medical-fa8b9196",
    "source": "Medical",
    "question": "Imagine you are an ENT specialist evaluating a new patient presenting with persistent sore throat, difficulty swallowing, and recent voice changes. Using the clinical practice guidelines, synthesize a comprehensive diagnostic workup and initial staging plan for suspected oropharyngeal squamous cell carcinoma, including biomarker and imaging strategies.",
    "answer": "As an ENT specialist, my initial diagnostic approach would begin with a thorough medical history and physical exam, focusing on the oropharynx, tonsils, base of tongue, and lateral/posterior pharyngeal walls. I would assess for risk factors including tobacco, alcohol use, and possible HPV exposure. Next, I would perform endoscopic evaluation (nasolaryngoscopy or panendoscopy) to visualize the tumor and adjacent sites. Biopsy of the suspicious lesion is essential for histopathological confirmation, utilizing endoscopic biopsy or, if lymphadenopathy is present, fine-needle aspiration (FNA) or core needle biopsy (CNB). Biomarker testing for p16 (HPV) status is recommended for all oropharyngeal cancers, as p16 overexpression serves as a surrogate for HPV-mediated disease. Imaging with contrast-enhanced CT scan or MRI of the neck, and PET/CT to evaluate both local extension and distant metastasis (lungs, liver, spine), is critical for accurate staging. Dental health assessment and panoramic dental x-ray (Panorex) should be completed prior to treatment. Staging will use the AJCC TNM system, integrating tumor size, nodal involvement, and distant metastasis.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice.",
      "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue.",
      "Biopsy is required for definitive diagnosis and biomarker testing.",
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer.",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M).",
      "Dental health assessment is important before treatment.",
      "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling."
    ]
  },
  {
    "id": "Medical-6adf6382",
    "source": "Medical",
    "question": "You are a medical oncologist asked to draft a multidisciplinary treatment plan for a patient with newly diagnosed, p16-positive, stage III oropharyngeal squamous cell carcinoma. Integrate details on performance status, biomarker-driven therapy, and required consultations.",
    "answer": "For this patient with stage III, p16-positive oropharyngeal squamous cell carcinoma, I would first confirm the diagnosis with biopsy and p16 immunohistochemistry. I would assess performance status using the ECOG scale, as this will influence eligibility for intensive therapy. Multidisciplinary discussion with radiation oncology, head and neck surgery, and dental services is essential. The recommended approach for fit patients is concurrent chemoradiation, given the advanced stage and favorable HPV/p16 status. Biomarker testing for PD-L1 expression may be considered to guide future immunotherapy options if needed. Dental evaluation and panoramic x-ray should be performed prior to initiating treatment to address potential oral complications. Ongoing surveillance will include imaging follow-up and physical exams.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage III is among the numbered stages in the AJCC TNM staging system.",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer.",
      "Performance status (ECOG) is a prognostic factor considered in treatment planning.",
      "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden.",
      "Multidisciplinary management involving surgery, radiation oncology, and dental assessment is standard.",
      "Dental health assessment is important before treatment.",
      "Imaging follow-up and physical exam are part of surveillance."
    ]
  },
  {
    "id": "Medical-a50184cc",
    "source": "Medical",
    "question": "Rewrite the key recommendations for initial evaluation and diagnosis of throat cancer into a formal referral letter from a primary care physician to an otolaryngologist. Ensure to include relevant risk factors, diagnostic steps, and rationale for specialist referral.",
    "answer": "Dear Otolaryngology Colleague,\n\nI am referring a 56-year-old male with a history of tobacco and alcohol use who presents with a two-month history of sore throat, progressive difficulty swallowing, and recent changes in voice. On exam, there is asymmetry of the tonsillar region and palpable cervical lymphadenopathy. Given his risk factors and concerning symptoms, I am requesting your expertise for further evaluation. The clinical practice guidelines recommend direct visualization via laryngoscopy or endoscopy, biopsy for histologic confirmation, and imaging (CT/MRI and PET/CT) for staging. Biomarker testing, particularly for p16 (HPV) status, is advised for all oropharyngeal cancers. A dental evaluation is also indicated prior to any oncologic therapy. Please advise regarding further diagnostic and management steps.",
    "question_type": "Creative Generation",
    "evidence": [
      "Tobacco and alcohol use are risk factors for head and neck cancers.",
      "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice.",
      "Biopsy is required for definitive diagnosis and biomarker testing.",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer.",
      "Dental health assessment is important before treatment.",
      "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue."
    ]
  },
  {
    "id": "Medical-cf2f3466",
    "source": "Medical",
    "question": "Transform the clinical pathway for diagnosing and staging oropharyngeal squamous cell carcinoma into a structured SOAP (Subjective, Objective, Assessment, Plan) note, incorporating key symptoms, exam findings, diagnostics, and staging elements.",
    "answer": "**Subjective:**\nPatient reports a 3-month history of sore throat, difficulty swallowing, and recent voice changes. Denies weight loss. History of tobacco and alcohol use.\n\n**Objective:**\nPhysical exam reveals ulcerated lesion at the left tonsil extending to the base of tongue. Palpable left cervical lymphadenopathy. Dental exam pending. Imaging (CT neck, PET/CT) shows a 3.5 cm mass in the oropharynx with ipsilateral lymph node involvement. Endoscopic biopsy performed.\n\n**Assessment:**\nLikely oropharyngeal squamous cell carcinoma, risk factors include tobacco, alcohol, and possible HPV exposure. AJCC TNM staging: T2N2M0 (tumor >2 cm and 4 cm, multiple ipsilateral lymph nodes, no distant metastasis). Awaiting p16 (HPV) and PD-L1 biomarker results.\n\n**Plan:**\nComplete dental health assessment and panoramic x-ray prior to treatment. Multidisciplinary discussion for treatment planning. Initiate concurrent chemoradiation pending performance status assessment. Continue surveillance with imaging and physical exams.",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice.",
      "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue.",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging.",
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M).",
      "Biopsy is required for definitive diagnosis and biomarker testing.",
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer.",
      "Dental health assessment is important before treatment.",
      "Performance status (ECOG) is a prognostic factor considered in treatment planning."
    ]
  },
  {
    "id": "Medical-7c30e6dc",
    "source": "Medical",
    "question": "Imagine you are a dermatology consultant receiving a referral for a patient with multiple skin nodules and papules. Compose a detailed case summary for the hematology team, outlining the likely diagnosis, required diagnostic tests, differential considerations, and relevant clinical features based on the guidelines.",
    "answer": "Case Summary: The patient presents with multiple nodules and papules localized to the skin. Primary cutaneous lymphoma (PCL), specifically cutaneous B-cell lymphoma (CBCL), is highly suspected given the presentation and lack of systemic symptoms. CBCL arises from B lymphocytes and is classified as a subtype of non-Hodgkin lymphoma (NHL) manifesting in the skin. Differential diagnoses include other forms of PCL, such as cutaneous T-cell lymphoma (CTCL). To confirm the diagnosis, I recommend a comprehensive workup including a thorough skin exam, blood tests to assess for systemic involvement, imaging tests to rule out extracutaneous disease, and skin biopsy with immunophenotyping to characterize the lymphocyte lineage. Assessment of biomarkers and genetic changes should be performed to further subtype the lymphoma, distinguishing between PCMZL, PCFCL, and PC-DLBCL, leg type. Most primary cutaneous B-cell lymphomas are indolent, but aggressive variants must be ruled out.",
    "question_type": "Creative Generation",
    "evidence": [
      "CBCL appears as nodules or papules under the skin",
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes"
    ]
  },
  {
    "id": "Medical-980656b1",
    "source": "Medical",
    "question": "Rewrite the clinical facts into a formal discharge summary for a patient newly diagnosed with primary cutaneous follicle center lymphoma (PCFCL), ensuring inclusion of presenting symptoms, diagnostic steps, classification, and next steps per guidelines.",
    "answer": "Discharge Summary:\n\nDiagnosis: Primary cutaneous follicle center lymphoma (PCFCL)\n\nPresenting Symptoms: Patient presented with multiple skin nodules and papules. No systemic symptoms or evidence of extracutaneous involvement.\n\nDiagnostic Workup: The diagnostic process included a comprehensive skin exam, blood tests, and imaging studies to assess for systemic disease. Definitive diagnosis was established via skin biopsy, which demonstrated B-cell lineage on immunophenotyping. Additional testing included biomarker and genetic change analysis to confirm the PCFCL subtype.\n\nClassification: PCFCL is a subtype of cutaneous B-cell lymphoma (CBCL), itself a manifestation of primary cutaneous lymphoma (PCL), a form of non-Hodgkin lymphoma originating from B lymphocytes in the skin.\n\nNext Steps: The patient will be referred for hematology-oncology consultation to discuss management options and further surveillance. Most CBCLs are indolent, but ongoing monitoring for disease progression is required.",
    "question_type": "Creative Generation",
    "evidence": [
      "CBCL appears as nodules or papules under the skin",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "CBCL subtypes include primary cutaneous follicle center lymphoma (PCFCL)",
      "Most primary cutaneous B-cell lymphomas are indolent or slow-growing"
    ]
  },
  {
    "id": "Medical-3a2cfb6d",
    "source": "Medical",
    "question": "As a medical intern on the oncology ward, you are asked to prepare a multidisciplinary team (MDT) note summarizing the pathogenesis, diagnostic approach, and clinical classification of cutaneous B-cell lymphomas to educate new team members.",
    "answer": "MDT Educational Note: Cutaneous B-cell lymphomas (CBCL) are a subset of primary cutaneous lymphomas (PCL), which are non-Hodgkin lymphomas that originate in the skin. CBCLs develop from abnormal B lymphocytes, a type of white blood cell involved in immune defense. The pathogenesis involves unregulated growth of these lymphocytes, resulting in disease. CBCL typically presents as nodules or papules confined to the skin. Diagnosis requires a combination of skin examination, blood tests, imaging studies, and confirmatory biopsy with immunophenotyping to determine cell lineage. Further testing for biomarkers and genetic changes aids in precise classification. Major CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type). Most CBCLs are slow-growing, but aggressive variants exist.",
    "question_type": "Creative Generation",
    "evidence": [
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "CBCL develops from abnormal B cells",
      "Lymphocytes are a type of white blood cell that help fight infection",
      "Unregulated growth of lymphocytes can develop into lymphoma",
      "CBCL appears as nodules or papules under the skin",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "Most primary cutaneous B-cell lymphomas are indolent or slow-growing"
    ]
  },
  {
    "id": "Medical-917da89d",
    "source": "Medical",
    "question": "You are a general practitioner drafting a referral letter to dermatology for a patient with persistent skin lesions. Summarize the clinical suspicion, rationale for referral, and suggested workup in the style of a formal referral note, integrating key diagnostic criteria.",
    "answer": "Referral Note:\n\nDear Dermatology Colleague,\n\nI am referring a patient presenting with persistent nodules and papules localized to the skin. Given the chronicity and morphology of the lesions, I am concerned about a possible primary cutaneous lymphoma (PCL), specifically cutaneous B-cell lymphoma (CBCL). CBCL arises from abnormal B lymphocytes and may present as indolent or, less commonly, aggressive disease. To establish a diagnosis, I recommend proceeding with a detailed skin examination, blood tests, and imaging studies as appropriate. A skin biopsy with immunophenotyping should be performed to confirm lymphoid lineage, and additional testing for biomarkers and genetic changes may help classify the subtype (e.g., PCMZL, PCFCL, or PC-DLBCL, leg type). Early identification is essential for optimal management.",
    "question_type": "Creative Generation",
    "evidence": [
      "CBCL appears as nodules or papules under the skin",
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "CBCL develops from abnormal B cells",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)"
    ]
  },
  {
    "id": "Medical-a2ede728",
    "source": "Medical",
    "question": "Transform the guideline information into a patient-friendly educational leaflet explaining what cutaneous B-cell lymphoma is, how it is diagnosed, what symptoms to look for, and the importance of follow-up.",
    "answer": "Patient Information Leaflet: Understanding Cutaneous B-Cell Lymphoma (CBCL)\n\nWhat is CBCL? Cutaneous B-cell lymphoma is a rare cancer that starts in certain white blood cells (B lymphocytes) and affects the skin. It is a type of non-Hodgkin lymphoma that remains in the skin and does not usually spread to other parts of the body.\n\nWhat are the symptoms? CBCL often appears as lumps (nodules) or small bumps (papules) on the skin. These may be painless and grow slowly.\n\nHow is it diagnosed? Your doctor will examine your skin and may order blood tests and imaging scans. The most important step is a skin biopsy, where a small piece of skin is removed and studied. Special laboratory tests (immunophenotyping) and checks for genetic changes help confirm the diagnosis and determine the exact type of lymphoma.\n\nWhy is follow-up important? Most CBCLs grow slowly, but it is important to monitor your condition regularly to catch any changes early. Your healthcare team will guide you through treatment and follow-up visits.\n\nIf you notice new skin lumps or changes, let your doctor know promptly.",
    "question_type": "Creative Generation",
    "evidence": [
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "CBCL appears as nodules or papules under the skin",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "Most primary cutaneous B-cell lymphomas are indolent or slow-growing",
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin"
    ]
  },
  {
    "id": "Medical-cdbc8593",
    "source": "Medical",
    "question": "You are a pediatric hematologist receiving a referral for a 7-year-old newly diagnosed with acute lymphoblastic leukemia (ALL). Write a detailed initial case summary, including diagnostic confirmation, subtype differentiation, risk assessment, and your preliminary treatment plan, citing evidence-based steps from the clinical guideline.",
    "answer": "Case Summary: The patient is a 7-year-old child with a new diagnosis of acute lymphoblastic leukemia (ALL), the most common cancer in children. Diagnostic workup included blood tests and bone marrow aspiration, revealing more than 20% lymphoblasts in the marrow. Subtype analysis is pending to distinguish between B-cell ALL (B-ALL) and T-cell ALL (T-ALL), as B-ALL is more common, but T-ALL may present with an enlarged thymus or breathing problems. Further evaluation includes imaging tests, heart function assessment, and a lumbar puncture to assess CNS involvement. Biomarker and pharmacogenomic testing are ordered to assess for BCR::ABL1 status and other genetic alterations that may influence therapy. All patients with ALL receive steroids and multiagent chemotherapy, with systemic therapy and supportive care as standard. Clinical trial enrollment will be considered, as recommended. The treatment approach will be further tailored once subtype and risk factors are fully established.",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is the most common cancer diagnosed in children",
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "ALL has two main subtypes: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Systemic therapy and supportive care are part of ALL treatment",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management"
    ]
  },
  {
    "id": "Medical-89ee2ffa",
    "source": "Medical",
    "question": "Rewrite the clinical guideline recommendations for pediatric acute lymphoblastic leukemia (ALL) into a formal discharge summary for a child who completed induction therapy. Ensure you include diagnostic findings, risk stratification, subtype, initial therapy, and follow-up recommendations.",
    "answer": "Discharge Summary: Patient: [Name Redacted], Age: 9 years. Diagnosis: B-cell acute lymphoblastic leukemia (B-ALL), confirmed by bone marrow aspirate showing >20% lymphoblasts. Subtype: B-ALL, BCR::ABL1-negative; diagnosed via biomarker and genetic testing. Initial evaluation included blood and bone marrow tests, imaging, cardiac assessment, and lumbar puncture to assess for CNS involvement. Induction therapy consisted of steroids and multiagent chemotherapy per protocol. Supportive care measures were provided throughout therapy. The patient tolerated induction well, with no CNS or testicular involvement detected. Risk assessment was based on age, leukocyte count, and genetic markers. Follow-up: Plan includes initiation of consolidation therapy, ongoing systemic therapy, and continued supportive care. Enrollment in a clinical trial for maintenance phase is being considered. Routine monitoring with blood counts, periodic bone marrow evaluation, and surveillance for relapse or late effects is recommended.",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Systemic therapy and supportive care are part of ALL treatment",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases",
      "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)"
    ]
  },
  {
    "id": "Medical-3f7aae87",
    "source": "Medical",
    "question": "Imagine you are a medical intern presenting a patient with suspected T-cell ALL (T-ALL) to your attending. Construct a problem-based SOAP note (Subjective, Objective, Assessment, Plan), integrating relevant clinical features, diagnostic steps, and guideline-based management.",
    "answer": "SOAP Note:\nSubjective: 10-year-old male presents with shortness of breath and chest fullness. No prior medical history. Parents note rapid onset of symptoms over 2 weeks.\nObjective: Physical exam reveals tachypnea and decreased breath sounds. Chest imaging shows an enlarged mediastinum. CBC demonstrates leukocytosis with circulating lymphoblasts. Bone marrow aspirate pending. \nAssessment: High suspicion for T-cell acute lymphoblastic leukemia (T-ALL) given age, symptoms of breathing difficulty, and imaging findings of enlarged thymus. Awaiting marrow confirmation (>20% lymphoblasts required for diagnosis). \nPlan: Complete diagnostic workup including bone marrow biopsy, blood tests, imaging, heart function evaluation, and lumbar puncture. Initiate steroids and multiagent chemotherapy upon confirmation. Order biomarker/genetic testing (including BCR::ABL1). Engage supportive care team. Consider clinical trial enrollment. Monitor for respiratory compromise due to thymic enlargement.",
    "question_type": "Creative Generation",
    "evidence": [
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Systemic therapy and supportive care are part of ALL treatment",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases"
    ]
  },
  {
    "id": "Medical-deadc13d",
    "source": "Medical",
    "question": "You are a pediatric oncologist drafting a referral letter for a 3-month-old infant with newly diagnosed ALL to a tertiary care center. Summarize the unique considerations for this age group, diagnostic findings, and the rationale for specialized management.",
    "answer": "Referral Letter: Dear Colleagues, I am referring a 3-month-old infant recently diagnosed with acute lymphoblastic leukemia (ALL). Diagnostic workup included blood and bone marrow testing, confirming >20% lymphoblasts. Given the patient's age, this is classified as infant ALL, which requires a distinct treatment approach compared to older children. Subtype analysis is underway, and biomarker/genetic testing is being performed to guide therapy. The infant is currently stable, with no CNS or testicular involvement on imaging and lumbar puncture. As per guidelines, infants with ALL are managed differently due to unique biology and treatment response, necessitating specialized protocols and multidisciplinary care. I recommend consideration for clinical trial enrollment as preferred for this age group. Please see attached records for full diagnostic details.",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Infant ALL (under 12 months) is treated differently than other age groups",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases",
      "ALL most often affects children, adolescents, and young adults (AYAs)"
    ]
  },
  {
    "id": "Medical-f995cb67",
    "source": "Medical",
    "question": "Rewrite the core recommendations from the clinical guideline into a public health advisory for parents and caregivers, focusing on early detection, diagnosis, and standard treatment of childhood ALL.",
    "answer": "Public Health Advisory: Acute lymphoblastic leukemia (ALL) is the most common cancer in children and young people. Early signs can include unexplained fatigue, bruising, or persistent infections. Diagnosis requires blood and bone marrow tests, with further evaluation of the central nervous system and other organs. Most ALL cases are B-cell type, but T-cell types can present with breathing difficulties due to an enlarged thymus. All children with ALL receive steroids and multiagent chemotherapy, with supportive care as part of standard treatment. Genetic and biomarker testing helps tailor therapy. Participation in clinical trials is encouraged to ensure access to the latest treatments. Parents should consult a pediatrician promptly if concerning symptoms arise.",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is the most common cancer diagnosed in children",
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "ALL has two main subtypes: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Systemic therapy and supportive care are part of ALL treatment",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "Clinical trials are preferred for certain B-ALL and T-ALL cases"
    ]
  },
  {
    "id": "Medical-4fa20ee8",
    "source": "Medical",
    "question": "You are a colorectal surgeon preparing a referral letter for a 52-year-old patient recently diagnosed with T1 rectal adenocarcinoma following colonoscopy. Summarize the diagnostic findings, relevant biomarkers, risk factors, and propose initial management, referencing current guideline recommendations.",
    "answer": "Dear Colleague,\n\nI am referring a 52-year-old patient recently diagnosed with T1 rectal adenocarcinoma. The diagnosis was established after colonoscopy revealed an adenomatous polyp in the rectum, confirmed as adenocarcinoma on histology. MRI of the pelvis and endorectal ultrasound (EUS) were performed for local staging, confirming a T1 lesion without evidence of nodal involvement. Blood tests, including CEA, were obtained for baseline monitoring. Genetic testing for mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) is underway, as per guideline recommendations, to assess for Lynch syndrome or other hereditary risks. The patient has no known family history of colorectal cancer or polyposis syndromes. \n\nBased on current guidelines, I recommend endoscopic submucosal dissection (ESD) as a curative option for this T1 lesion, with consideration of transanal local excision if technically feasible. Ongoing surveillance will include flexible sigmoidoscopy every 6 months for 5 years and periodic imaging. Further management will be tailored based on final pathology and biomarker results.\n\nSincerely,\n[Your Name], MD",
    "question_type": "Creative Generation",
    "evidence": [
      "Adenocarcinoma is the most common subtype of rectal cancer",
      "Most rectal cancers start in adenomatous polyps",
      "MRI of the pelvis is recommended for staging rectal cancer",
      "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy",
      "All rectal tumors should be tested for dMMR or MSI-H",
      "CEA blood test is used for monitoring rectal cancer",
      "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors",
      "Transanal local excision is an option for T1 tumors at the end of the rectum",
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging"
    ]
  },
  {
    "id": "Medical-476aa094",
    "source": "Medical",
    "question": "Imagine you are an oncology nurse educator. Prepare a patient-facing discharge summary for a young woman with rectal cancer who has undergone low anterior resection (LAR) and is interested in fertility preservation. Include relevant surgical, surveillance, and fertility guidance from the guidelines.",
    "answer": "Discharge Summary\n\nDiagnosis: Rectal adenocarcinoma\nProcedure: Low anterior resection (LAR)\n\nSummary: You underwent a successful LAR for rectal cancer located in the mid-rectum. Pathology confirmed adenocarcinoma, the most common type of rectal cancer. Your surgery was uneventful, and you are recovering well.\n\nFollow-up and Surveillance: Post-surgery, you will need regular colonoscopies to monitor for recurrence and new polyps, as well as CEA blood tests. Imaging studies such as MRI or CT scans may also be scheduled to check for any signs of cancer returning.\n\nFertility Preservation: Since you expressed interest in future fertility, options such as egg freezing, ovarian tissue banking, and ovarian transposition are available to help preserve your ability to have children. Please discuss these options with your oncology team as soon as possible to plan next steps.\n\nSymptoms to Watch: Report any rectal bleeding, abdominal pain, or changes in bowel habits to your care team.\n\nSincerely,\nThe Oncology Nursing Team",
    "question_type": "Creative Generation",
    "evidence": [
      "Low anterior resection (LAR) is used for tumors in the mid to upper rectum",
      "Adenocarcinoma is the most common subtype of rectal cancer",
      "Colonoscopy is recommended after surgery for surveillance",
      "CEA blood test is used for monitoring rectal cancer",
      "Imaging (EUS or MRI) is recommended for surveillance after treatment",
      "Fertility preservation options include egg freezing, ovarian tissue banking, and ovarian transposition",
      "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain"
    ]
  },
  {
    "id": "Medical-3d15cf50",
    "source": "Medical",
    "question": "You are a multidisciplinary tumor board coordinator. Draft a concise case summary for discussion of a patient with suspected Lynch syndrome and newly diagnosed rectal cancer, integrating genetic risk, diagnostic staging, and recommended biomarker testing.",
    "answer": "Case Summary for Tumor Board\n\nPatient: 45-year-old with newly diagnosed rectal adenocarcinoma and family history suggestive of Lynch syndrome. \n\nKey Points:\n- Diagnosis: Rectal adenocarcinoma identified in an adenomatous polyp on colonoscopy.\n- Risk Factors: Family history significant for early-onset colorectal cancer, raising suspicion for Lynch syndrome.\n- Biomarker Evaluation: Tumor tissue sent for mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) testing as recommended for all rectal tumors. \n- Staging: MRI pelvis and CT chest/abdomen performed for local and distant staging. Endorectal ultrasound (EUS) assessed tumor depth.\n- Management: Treatment options pending staging and molecular results. Genetic counseling advised for Lynch syndrome assessment.\n\nPrepared by: [Your Name], Tumor Board Coordinator",
    "question_type": "Creative Generation",
    "evidence": [
      "Adenocarcinoma is the most common subtype of rectal cancer",
      "Most rectal cancers start in adenomatous polyps",
      "Lynch syndrome is a genetic risk factor for rectal cancer",
      "All rectal tumors should be tested for dMMR or MSI-H",
      "MRI of the pelvis is recommended for staging rectal cancer",
      "CT scan of chest and abdomen is used to detect metastasis",
      "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy",
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
    ]
  },
  {
    "id": "Medical-d1daa403",
    "source": "Medical",
    "question": "Rewrite the clinical facts into a public health advisory about the importance of surveillance and early detection in rectal cancer, highlighting risk factors, symptoms, and preventive strategies.",
    "answer": "**Public Health Advisory: Early Detection and Prevention of Rectal Cancer**\n\nRectal cancer, a type of colorectal cancer, often develops from adenomatous polyps over several years. Individuals with hereditary syndromes such as Lynch syndrome and familial adenomatous polyposis (FAP) are at elevated risk. Early symptoms may include rectal bleeding, abdominal pain, or changes in bowel habits. Regular colonoscopy and polypectomy can remove precancerous polyps and significantly reduce the risk of cancer development. For those who have had local excision or endoscopic submucosal dissection (ESD), ongoing surveillance with flexible sigmoidoscopy and imaging is essential. Early diagnosis and intervention save livestalk to your healthcare provider about your risk and screening options.",
    "question_type": "Creative Generation",
    "evidence": [
      "Rectal cancer is a type of colorectal cancer",
      "Most rectal cancers start in adenomatous polyps",
      "Adenomas can become invasive rectal cancer over many years",
      "Lynch syndrome is a genetic risk factor for rectal cancer",
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
      "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain",
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer",
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging"
    ]
  },
  {
    "id": "Medical-a5e566ed",
    "source": "Medical",
    "question": "As a medical intern, compose a SOAP (Subjective, Objective, Assessment, Plan) note for a patient presenting with rectal bleeding and abdominal pain, found to have a rectal mass on imaging, referencing diagnostic and management guidelines.",
    "answer": "SOAP Note\n\nSubjective: Patient reports several weeks of rectal bleeding, abdominal pain, and recent changes in bowel habits. No significant personal or family history of colorectal cancer noted.\n\nObjective: On examination, mild tenderness in the lower abdomen. Colonoscopy revealed a rectal mass. MRI of the pelvis confirmed a lesion in the lower rectum. CEA blood test elevated. Biopsy confirmed adenocarcinoma.\n\nAssessment: Newly diagnosed rectal adenocarcinoma. Staging underway with CT scan of chest and abdomen to assess for metastasis. Biomarker testing (dMMR/MSI-H) pending.\n\nPlan: Await full staging and biomarker results. Discuss surgical options, including potential for abdominoperineal resection (APR) or chemoradiation, depending on tumor stage and location. Begin genetic counseling if risk factors identified. Schedule multidisciplinary team meeting.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain",
      "Colonoscopy is recommended after surgery for surveillance",
      "MRI of the pelvis is recommended for staging rectal cancer",
      "CEA blood test is used for monitoring rectal cancer",
      "Adenocarcinoma is the most common subtype of rectal cancer",
      "CT scan of chest and abdomen is used to detect metastasis",
      "Abdominoperineal resection (APR) is used for tumors in the lower rectum",
      "Chemoradiation is used for locally advanced rectal cancer",
      "All rectal tumors should be tested for dMMR or MSI-H"
    ]
  },
  {
    "id": "Medical-fbc24d80",
    "source": "Medical",
    "question": "Imagine you are a urology attending preparing a referral letter for a 65-year-old male newly diagnosed with high-grade, muscle-invasive urothelial carcinoma of the bladder. Summarize the diagnostic findings, risk factors, and outline the initial multidisciplinary treatment plan you would recommend, referencing evidence from the provided clinical guidelines.",
    "answer": "Dear Oncology Colleague,\n\nI am referring Mr. John Doe, a 65-year-old male, recently diagnosed with high-grade, muscle-invasive urothelial carcinoma of the bladder (Stage 2). Diagnostic workup included cystoscopy with biopsy confirming high-grade urothelial carcinoma, and imaging (CT and MRI) demonstrating invasion into the detrusor muscle without distant metastasis. Notably, the patient has a significant smoking history and reports intermittent painless hematuria. \n\nGiven the diagnosis, I recommend a multidisciplinary approach involving radical cystectomy as the standard surgical intervention, with consideration for perioperative cisplatin-based chemotherapy (ddMVAC regimen). Preoperative counseling regarding urinary diversion options (ileal conduit, neobladder, or continent cutaneous pouch) is essential. The patient should also be evaluated for potential enrollment in clinical trials and receive supportive care to manage anticipated side effects such as urinary incontinence and fatigue. Ongoing surveillance and follow-up will be critical due to high recurrence risk.\n\nSincerely,\nDr. Smith, Urology",
    "question_type": "Creative Generation",
    "evidence": [
      "Urothelial carcinoma is the most common subtype of bladder cancer.",
      "Cancer grade is classified as low grade (LG) or high grade (HG).",
      "Stages 2, 3, and 4 bladder cancers are muscle-invasive.",
      "Smoking is the greatest risk factor for bladder cancer.",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer.",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC.",
      "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch.",
      "Clinical trials are available at all stages of bladder cancer.",
      "Follow-up and surveillance are required due to high recurrence rates."
    ]
  },
  {
    "id": "Medical-47f26425",
    "source": "Medical",
    "question": "As an oncology nurse educator, draft a comprehensive discharge summary for a patient who underwent radical cystectomy with formation of a neobladder for high-grade, muscle-invasive bladder cancer. Include presenting symptoms, diagnostic steps, treatment course, potential side effects, and follow-up recommendations.",
    "answer": "Discharge Summary\n\nPatient: Jane Smith\nMRN: 123456\nDiagnosis: High-grade, muscle-invasive urothelial carcinoma of the bladder (Stage 3)\n\nPresentation: The patient presented with painless hematuria and increased urinary frequency. \n\nDiagnostic Workup: Evaluation included cystoscopy with biopsy confirming high-grade urothelial carcinoma, urine cytology, and imaging (CT and MRI) showing muscle invasion without distant spread.\n\nHospital Course: The patient underwent radical cystectomy with neobladder construction. Perioperative cisplatin-based chemotherapy (ddMVAC) was administered. The postoperative period was complicated by mild urinary incontinence and fatigue.\n\nPotential Side Effects: The patient was counseled about possible complications including infection, bleeding, urinary incontinence, sexual dysfunction, and fatigue.\n\nFollow-up: Regular cystoscopy, urine cytology, and imaging are scheduled due to the high recurrence rate. The patient was referred for supportive care to address symptoms and side effects, and advised to consider clinical trial enrollment as appropriate.\n\nDischarge Date: [Insert date]\n\nPrepared by: Oncology Nurse Educator",
    "question_type": "Creative Generation",
    "evidence": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer.",
      "Other symptoms include frequent urination, urgency, painful urination, and back pain.",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer.",
      "Urinary diversion procedures include neobladder.",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC.",
      "Common side effects of treatment include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea.",
      "Follow-up and surveillance are required due to high recurrence rates.",
      "Supportive care addresses symptoms and side effects of cancer and its treatment.",
      "Clinical trials are available at all stages of bladder cancer."
    ]
  },
  {
    "id": "Medical-9c29bee8",
    "source": "Medical",
    "question": "You are a medical intern tasked with writing a SOAP (Subjective, Objective, Assessment, Plan) note for a patient presenting with painless hematuria and risk factors for bladder cancer. Incorporate relevant diagnostic and management steps according to the clinical guidelines.",
    "answer": "SOAP Note\n\nSubjective: 58-year-old male presents with several episodes of painless hematuria over the past month. He has a 30-pack-year smoking history and reports mild urinary urgency. No significant family history of cancer.\n\nObjective: Physical exam unremarkable. Urinalysis positive for blood. \n\nAssessment: High suspicion for bladder cancer given classic symptom of painless hematuria and significant smoking history. Differential includes urinary tract infection and nephrolithiasis, but malignancy is prioritized.\n\nPlan:\n- Order cystoscopy, urine cytology, and imaging (CT urogram) for diagnostic confirmation.\n- If nonmuscle-invasive disease (Stage 0 or 1) is confirmed, consider TURBT with intravesical BCG or chemotherapy.\n- If muscle-invasive disease is found, consult urology for possible radical cystectomy and discuss systemic therapy options (cisplatin-based chemotherapy, immunotherapy).\n- Counsel patient on smoking cessation and provide supportive care resources.\n- Schedule regular follow-up and surveillance due to recurrence risk.",
    "question_type": "Creative Generation",
    "evidence": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer.",
      "Smoking is the greatest risk factor for bladder cancer.",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
      "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive.",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer.",
      "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer.",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer.",
      "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy.",
      "Follow-up and surveillance are required due to high recurrence rates.",
      "Supportive care addresses symptoms and side effects of cancer and its treatment."
    ]
  },
  {
    "id": "Medical-0c5272d1",
    "source": "Medical",
    "question": "Rewrite the core clinical recommendations for the management of nonmuscle-invasive bladder cancer (NMIBC) into a concise public health advisory aimed at primary care providers. Highlight risk factors, diagnostic approach, treatment options, and the importance of surveillance.",
    "answer": "**Public Health Advisory: Early Detection and Management of NonMuscle-Invasive Bladder Cancer (NMIBC)**\n\nPrimary care providers should be vigilant for bladder cancer in patients presenting with hematuria, especially those with risk factors such as smoking, age over 55, family history, Lynch syndrome, or chemical exposure. Early diagnosis relies on prompt referral for cystoscopy, urine cytology, and imaging. Most NMIBC cases (Stages 0 and 1) are managed with transurethral resection (TURBT) followed by intravesical therapy (BCG or chemotherapy). Due to high recurrence rates, ongoing surveillance with regular cystoscopy, urine cytology, and biomarker monitoring is essential. Encourage smoking cessation and consider referring eligible patients for clinical trials.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage 0 and Stage 1 bladder cancers are nonmuscle-invasive.",
      "Smoking is the greatest risk factor for bladder cancer.",
      "Other risk factors include age, family history, Lynch syndrome, and chemical exposure.",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
      "TURBT is used for tumor removal in nonmuscle-invasive bladder cancer.",
      "Intravesical therapy (BCG or chemotherapy) is used for nonmuscle-invasive bladder cancer.",
      "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer.",
      "Follow-up and surveillance are required due to high recurrence rates.",
      "Clinical trials are available at all stages of bladder cancer."
    ]
  },
  {
    "id": "Medical-8ddfc9d8",
    "source": "Medical",
    "question": "Imagine you are a patient diagnosed with Stage 4 (metastatic) bladder cancer. Write a detailed email to a cancer support group describing your diagnosis, genetic findings, current treatments, side effects, and follow-up care, grounded in the clinical evidence from the guidelines.",
    "answer": "Subject: My Journey with Metastatic Bladder Cancer\n\nDear Support Group,\n\nI wanted to share my experience after being diagnosed with Stage 4 (metastatic) bladder cancer. My journey began with blood in my urine and back pain. Tests including cystoscopy, biopsy, and imaging (PET/CT) confirmed the cancer had spread beyond the bladder. Genetic tests revealed an FGFR3 mutation, which my oncologist explained could influence my treatment options.\n\nCurrently, I'm receiving systemic therapy, which includes cisplatin-based chemotherapy and immunotherapy with pembrolizumab. My doctor also discussed targeted therapies such as erdafitinib because of my FGFR3 mutation. The treatments have caused fatigue, nausea, and some urinary incontinence, but supportive care services have helped manage these side effects.\n\nMy care team emphasizes the importance of regular imaging and lab tests for surveillance, as well as considering clinical trials for new therapies. I appreciate the support from this group and hope my story helps others facing similar challenges.\n\nSincerely,\nAlex",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage 4 bladder cancer is metastatic and may involve distant organs.",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram).",
      "Genetic alterations such as mutations in FGFR3 are associated with bladder cancer.",
      "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy.",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC.",
      "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab.",
      "Targeted therapies include erdafitinib (Balversa), enfortumab vedotin-ejfv (Padcev), and sacituzumab govitecan-hziy (Trodelvy).",
      "Common side effects of treatment include urinary incontinence, fatigue, and nausea.",
      "Supportive care addresses symptoms and side effects of cancer and its treatment.",
      "Follow-up and surveillance are required due to high recurrence rates.",
      "Clinical trials are available at all stages of bladder cancer."
    ]
  },
  {
    "id": "Medical-fe4d939e",
    "source": "Medical",
    "question": "Imagine you are a urologist writing a referral letter to a multidisciplinary tumor board for a 62-year-old patient recently diagnosed with renal cell carcinoma (RCC) displaying sarcomatoid features and suspected lung metastases. Summarize the case, including diagnostic findings, histology, staging, and key considerations for management.",
    "answer": "Dear Multidisciplinary Tumor Board,\n\nI am referring a 62-year-old male patient recently diagnosed with renal cell carcinoma (RCC). Imaging tests revealed a large renal mass originating in the renal tubules, with histopathologic analysis confirming clear cell RCC (ccRCC) exhibiting sarcomatoid features. Additional imaging identified pulmonary nodules consistent with metastatic disease. Laboratory evaluation included blood and urine tests, and a biopsy confirmed the diagnosis. Biomarker and genetic risk testing are underway. Given the presence of sarcomatoid features, which are associated with more aggressive disease, and evidence of metastasis to the lungs, this case requires input regarding optimal systemic therapy and consideration of clinical trial enrollment. Treatment planning should account for tumor histology, size, location, and metastatic status.",
    "question_type": "Creative Generation",
    "evidence": [
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer.",
      "Clear cell RCC is the most common subtype of RCC.",
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease.",
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain.",
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing.",
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis."
    ]
  },
  {
    "id": "Medical-5242d398",
    "source": "Medical",
    "question": "You are an oncologist tasked with drafting an initial treatment plan for a patient newly diagnosed with non-clear cell RCC (papillary subtype) confined to the kidney, with no evidence of metastasis. Outline your diagnostic confirmation, staging, and treatment strategy.",
    "answer": "For this patient with a new diagnosis of papillary renal cell carcinoma (PRCC) confined to the kidney, I would first confirm the diagnosis using imaging tests (such as CT or MRI), blood and urine tests, and a percutaneous biopsy for histologic subtyping. Biomarker and genetic risk testing would be performed to identify any actionable alterations. Staging would ensure there is no local spread to surrounding fat, blood vessels, lymph nodes, or distant metastasis. Given the localized nature and non-clear cell histology, surgical resection (partial or radical nephrectomy depending on tumor size and location) is the mainstay of treatment. Further management would be determined by final pathology and risk assessment.",
    "question_type": "Creative Generation",
    "evidence": [
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma.",
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing.",
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis.",
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia.",
      "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis."
    ]
  },
  {
    "id": "Medical-fb2edc8f",
    "source": "Medical",
    "question": "Rewrite the clinical facts regarding kidney cancer subtypes, spread, and diagnosis into a structured discharge summary for a patient with newly diagnosed clear cell RCC with local extension but no distant metastasis.",
    "answer": "Discharge Summary:\n\nDiagnosis: Clear cell renal cell carcinoma (ccRCC) with local extension\n\nHospital Course: The patient presented with a renal mass confirmed by imaging tests. Biopsy of the lesion established a diagnosis of clear cell RCC, the most common RCC subtype, originating from renal tubule cells. Staging studies indicated local spread to perirenal fat and regional lymph nodes, but no evidence of distant metastasis to lungs, bones, liver, or brain. Laboratory workup included blood and urine tests, and biomarker as well as genetic risk assessments were initiated. The patient underwent partial nephrectomy, with pathology confirming ccRCC with no sarcomatoid features.\n\nPlan: Outpatient follow-up for ongoing surveillance and consideration of adjuvant therapy based on risk stratification.",
    "question_type": "Creative Generation",
    "evidence": [
      "Clear cell RCC is the most common subtype of RCC.",
      "RCC starts in the cells that line the renal tubules.",
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia.",
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain.",
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing.",
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis."
    ]
  },
  {
    "id": "Medical-8dd14c45",
    "source": "Medical",
    "question": "As a public health official, prepare an advisory summarizing the key risk factors, diagnostic approaches, and importance of early detection for kidney cancer, referencing the main cancer types and common metastatic sites.",
    "answer": "Public Health Advisory: Kidney Cancer Awareness\n\nKidney cancer encompasses several types, most commonly renal cell carcinoma (RCC), which originates in the renal tubules, and urothelial carcinoma, starting in the renal pelvis or ureter. Wilms tumor is the predominant form in young children. Early detection is crucial, as kidney cancer can locally invade surrounding fat, blood vessels, lymph nodes, and adrenal glands, and can metastasize to the lungs, bones, liver, and brain. Diagnosis often requires imaging, blood and urine tests, biopsy, and biomarker/genetic risk assessments. Recognizing risk factors and symptoms, and pursuing timely diagnostic evaluation, can improve outcomes.",
    "question_type": "Creative Generation",
    "evidence": [
      "Renal cell carcinoma (RCC) is the most common type of kidney cancer.",
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter.",
      "Wilms tumor usually occurs in young children and is a distinct kidney cancer type.",
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia.",
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain.",
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing."
    ]
  },
  {
    "id": "Medical-8270fb83",
    "source": "Medical",
    "question": "You are a nephrology fellow tasked with drafting a SOAP (Subjective, Objective, Assessment, Plan) note for a patient presenting with multiple renal masses, focusing on differential diagnosis, workup, and management per guidelines.",
    "answer": "SOAP Note:\n\nSubjective: Patient presents with incidental finding of multiple renal masses on imaging, no symptoms reported.\n\nObjective: CT imaging reveals two lesions, one in each kidney. Blood and urine tests are within normal limits. No evidence of metastasis on chest imaging. Biopsy of both lesions pending.\n\nAssessment: Multiple renal tumors may represent synchronous primary renal cell carcinomas, as per guideline distinction between multiple primaries and metastasis. Differential includes clear cell RCC, papillary RCC, and less commonly, chromophobe RCC or other non-clear cell subtypes. Wilms tumor less likely given adult age.\n\nPlan: Proceed with biopsy of both lesions for histologic classification, initiate biomarker and genetic risk testing, and discuss surgical management options, considering tumor size, location, and patient comorbidities.",
    "question_type": "Creative Generation",
    "evidence": [
      "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis.",
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing.",
      "Clear cell RCC is the most common subtype of RCC.",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma.",
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis.",
      "Wilms tumor usually occurs in young children and is a distinct kidney cancer type."
    ]
  },
  {
    "id": "Medical-6d57a660",
    "source": "Medical",
    "question": "Imagine you are a multidisciplinary tumor board coordinator. Summarize the recommended diagnostic workup and initial management strategy for a patient newly diagnosed with Stage II anal squamous cell carcinoma, integrating risk assessment, staging, and treatment planning.",
    "answer": "For a patient with newly diagnosed Stage II anal squamous cell carcinoma, the diagnostic workup should start with a digital rectal exam (DRE) and high-resolution anoscopy (HRA) to evaluate the primary lesion and surrounding tissues. A biopsy is necessary to confirm the diagnosis histologically. Imaging studies such as CT, MRI, and PET scans are recommended to assess tumor size (>2 cm as per Stage II criteria), evaluate for lymph node involvement, and rule out distant metastasis. HIV testing should be performed, as HIV infection increases the risk and may influence management. Staging is done using the AJCC TNM system. For initial management, concurrent chemoradiation is the standard of care, utilizing IMRT as the preferred radiation technique. Chemotherapy options to be given with radiation include mitomycin plus capecitabine, mitomycin plus 5-FU, or 5-FU plus cisplatin. Multidisciplinary involvement, including medical oncology, radiation oncology, colorectal surgery, and supportive care, is crucial to optimize outcomes and manage side effects.",
    "question_type": "Creative Generation",
    "evidence": [
      "Anal squamous cell carcinoma is the most common subtype of anal cancer.",
      "Stage II: tumor >2 cm, no lymph node or distant spread.",
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy.",
      "Digital rectal exam (DRE), high-resolution anoscopy (HRA), and imaging (CT, MRI, PET) are used for diagnosis and staging.",
      "HIV testing is recommended in patients with anal cancer.",
      "Staging uses the AJCC TNM system.",
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III).",
      "IMRT is the preferred radiation technique for anal cancer.",
      "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin."
    ]
  },
  {
    "id": "Medical-b70d577f",
    "source": "Medical",
    "question": "You are an oncologist writing a referral letter to a fertility specialist for a young adult patient with newly diagnosed Stage III anal cancer who is about to start chemoradiation. The letter must summarize the diagnosis, planned treatment, and the rationale for fertility preservation counseling.",
    "answer": "Dear Fertility Specialist,\n\nI am referring a 32-year-old patient recently diagnosed with Stage III anal squamous cell carcinoma (lymph node involvement, no distant metastasis). The patient is scheduled to begin concurrent chemoradiation, utilizing IMRT and a regimen of mitomycin and capecitabine. Given the high risk of infertility associated with both chemotherapy and pelvic radiation, I am requesting an urgent fertility preservation consultation prior to initiation of treatment. Potential strategies such as sperm banking, egg freezing, ovarian tissue banking, or oophoropexy should be discussed. The patient is highly motivated to preserve future reproductive options. Thank you for your prompt assistance.\n\nSincerely,\nOncologist",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage III: lymph node involvement and/or invasion of nearby organs.",
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III).",
      "IMRT is the preferred radiation technique for anal cancer.",
      "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine.",
      "Radiation and chemotherapy can cause infertility; fertility preservation options should be discussed.",
      "Fertility Preservation: Sperm banking, egg freezing, ovarian tissue banking, oophoropexy."
    ]
  },
  {
    "id": "Medical-8dc3153c",
    "source": "Medical",
    "question": "Transform the following clinical facts into a formal discharge summary for a patient with Stage I perianal squamous cell carcinoma who underwent local excision. Include diagnosis, procedure, pathology, follow-up recommendations, and potential complications.",
    "answer": "Discharge Summary:\n\nDiagnosis: Stage I perianal squamous cell carcinoma (tumor 2 cm, no lymph node or distant spread).\n\nProcedure: Local excision of perianal lesion performed without complication. Surgical margins were negative on pathology.\n\nPathology: Well-differentiated squamous cell carcinoma, tumor size 1.5 cm, negative margins, no lymphovascular invasion.\n\nFollow-up: Surveillance to include digital rectal exam (DRE) and inguinal lymph node exams every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years. Imaging as clinically indicated. Patient advised on symptoms of recurrence (rectal bleeding, anal pain, lump).\n\nPotential Complications: Wound infection, local recurrence, anal pain, and rarely, bowel or urinary dysfunction.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage I: tumor 2 cm, no lymph node or distant spread.",
      "Local excision is an option for some early-stage, low-grade perianal cancers.",
      "Surgical margin: Negative margins desirable for local excision.",
      "Surveillance after treatment includes DRE, lymph node exams, anoscopy, and imaging.",
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus.",
      "Side Effect: Bowel dysfunction, urinary incontinence, anal pain."
    ]
  },
  {
    "id": "Medical-aff81dd6",
    "source": "Medical",
    "question": "Assume the role of a public health official. Draft a community advisory on the prevention, risk factors, and early detection of anal cancer, integrating recommendations for high-risk populations.",
    "answer": "Community Health Advisory: Anal Cancer Prevention and Early Detection\n\nAnal cancer rates are increasing, particularly among individuals with certain risk factors. The strongest risk factor is infection with human papillomavirus (HPV), especially the high-risk HPV16 strain. HIV infection, immunosuppressant use, a history of cervical, vulvar, or vaginal cancer or precancer, and smoking further elevate risk. Individuals with histories of anal dysplasia (AIN, LSIL, HSIL) are also at increased risk. Early symptoms may include rectal bleeding, anal itching, pain, or a lump near the anus. Regular screening with digital rectal exams and anoscopy is recommended for high-risk groups, including those with HIV, immunosuppression, or prior HPV-related cancers. HPV vaccination and smoking cessation are strongly encouraged for prevention. Consult your healthcare provider if you have risk factors or symptoms.",
    "question_type": "Creative Generation",
    "evidence": [
      "HPV infection is the strongest risk factor for anal cancer.",
      "HPV16 is a high-risk strain associated with anal cancer.",
      "HIV infection increases the risk of anal cancer.",
      "Immunosuppressant use increases the risk of anal cancer.",
      "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk.",
      "Anal dysplasia (AIN, LSIL, HSIL) is a precancerous lesion for anal cancer.",
      "Smoking is a risk factor for anal cancer.",
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus.",
      "Digital rectal exam (DRE) and high-resolution anoscopy (HRA) are used for diagnosis and staging."
    ]
  },
  {
    "id": "Medical-841e077a",
    "source": "Medical",
    "question": "You are a medical intern assigned to write a SOAP (Subjective, Objective, Assessment, Plan) note for a patient with metastatic anal cancer who has progressed after first-line chemotherapy and is being considered for immunotherapy. Incorporate relevant symptoms, diagnostics, prior treatments, and next steps.",
    "answer": "SOAP Note:\n\nSubjective: The patient reports persistent anal pain and a palpable mass. Fatigue and intermittent rectal bleeding continue. Symptoms have not improved with prior systemic chemotherapy.\n\nObjective: Imaging (CT and PET) confirms progression of disease with new distant metastases. Physical exam reveals tender anal mass and palpable inguinal lymphadenopathy. Labs within normal limits.\n\nAssessment: Metastatic anal squamous cell carcinoma with progression after first-line chemotherapy (carboplatin and paclitaxel).\n\nPlan: Initiate immunotherapy with nivolumab or pembrolizumab as recommended for metastatic anal cancer post-chemotherapy progression. Continue supportive care for pain and fatigue. Monitor for immune-related adverse events. Recommend clinical trial enrollment if available. Schedule regular imaging for response assessment.",
    "question_type": "Creative Generation",
    "evidence": [
      "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin).",
      "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy.",
      "Common symptoms of anal cancer include rectal bleeding, anal pain, and a lump near the anus.",
      "Imaging (CT, MRI, PET) are used for diagnosis and staging.",
      "Clinical trials are recommended for all patients if available.",
      "Supportive Care: Pain management, fatigue management.",
      "Side Effect: Immune-related adverse events with immunotherapy."
    ]
  },
  {
    "id": "Medical-6a5c7fa6",
    "source": "Medical",
    "question": "You are a pediatric hematologist receiving a referral for a 7-year-old newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). Write a comprehensive initial case summary, including diagnostic confirmation, relevant subtyping, key risk factors, and the preliminary treatment approach based on current clinical guidelines.",
    "answer": "Case Summary:\n\nA 7-year-old child has been referred with a new diagnosis of B-cell acute lymphoblastic leukemia (B-ALL). Diagnosis was confirmed by the presence of >20% lymphoblasts in the bone marrow, as established through blood tests, bone marrow aspirate, and biopsy. Flow cytometry and immunophenotyping identified a B-cell lineage. Genetic and biomarker testing, including BCR::ABL1 status, were performed to further subtype the leukemia and guide therapy.\n\nKey risk factors considered include any underlying genetic syndromes and family history of leukemia. The patient presented with anemia, frequent infections, and enlarged lymph nodes, consistent with common presenting symptoms of ALL.\n\nTreatment will be initiated with steroids and multiagent chemotherapy as per standard protocols. If a BCR::ABL1 fusion is detected, targeted therapy will be added. Fertility preservation options will be discussed prior to commencing cytotoxic therapy. Participation in a clinical trial will be considered if the patient falls into a relevant prognostic subgroup. Ongoing follow-up will include regular blood tests and surveillance for relapse.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow.",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing.",
      "There are two main subtypes of ALL: B-cell ALL (B-ALL) and T-cell ALL (T-ALL).",
      "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement.",
      "Risk factors for ALL include certain genetic syndromes and family history.",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
      "Targeted therapy may be used based on genetic alterations.",
      "Fertility preservation should be considered before treatment.",
      "Follow-up includes regular blood tests and surveillance for relapse."
    ]
  },
  {
    "id": "Medical-3f2e8930",
    "source": "Medical",
    "question": "Transform the clinical practice guideline information into a discharge summary for an adult patient with T-cell ALL who has completed induction chemotherapy. Include the diagnosis, diagnostic work-up, treatment course, complications, and follow-up recommendations.",
    "answer": "Discharge Summary\n\nPatient: [Adult Name], Age: 35\nDiagnosis: T-cell Acute Lymphoblastic Leukemia (T-ALL)\n\nSummary:\nThe patient was diagnosed with T-cell acute lymphoblastic leukemia following evaluation for anemia and recurrent infections. The diagnosis was established through blood tests, bone marrow aspirate and biopsy, and flow cytometry, which confirmed T-cell lymphoid lineage. Imaging studies and lumbar puncture were performed to assess for organ and CNS involvement.\n\nThe patient underwent induction chemotherapy with a multiagent regimen including steroids. No targeted therapy was indicated as no actionable genetic alterations were detected. The treatment course was complicated by transient neutropenic infections, which resolved with supportive care.\n\nAt discharge, the patient is in hematologic remission. The patient has been counseled regarding fertility preservation options for future therapy. Ongoing follow-up will consist of regular blood tests and surveillance for relapse.\n\nRecommendations:\n- Continue follow-up as an outpatient with hematology\n- Monitor for relapse with regular blood counts\n- Consider participation in clinical trials for further therapy if indicated\n",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow.",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture.",
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus.",
      "T-ALL treatment options include chemotherapy and clinical trials.",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
      "Fertility preservation should be considered before treatment.",
      "Follow-up includes regular blood tests and surveillance for relapse."
    ]
  },
  {
    "id": "Medical-b2b22da1",
    "source": "Medical",
    "question": "Imagine you are a primary care physician writing a referral letter to a hematology-oncology specialist for an adolescent with suspected ALL. Summarize key presenting features, initial investigations, risk factors, and the rationale for urgent specialist evaluation.",
    "answer": "Referral Letter\n\nDear Hematology-Oncology Colleague,\n\nI am referring a 15-year-old adolescent presenting with progressive fatigue, pallor, recurrent fevers, and generalized lymphadenopathy. Laboratory evaluation revealed anemia and leukocytosis with circulating blasts. Family history is notable for a first-degree relative with leukemia. The patient also exhibits mild bleeding tendencies.\n\nGiven the constellation of symptoms and laboratory findings, acute lymphoblastic leukemia (ALL) is strongly suspected. Due to the rapid progression and potential for organ involvement, urgent specialist assessment is warranted for confirmatory diagnosis via bone marrow aspirate/biopsy, flow cytometry, and genetic testing. Early initiation of therapy, including multiagent chemotherapy and steroids, is essential for optimal outcomes. Please evaluate at your earliest convenience.\n\nSincerely,\n[Primary Care Physician]",
    "question_type": "Creative Generation",
    "evidence": [
      "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement.",
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow.",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing.",
      "ALL most often affects B cells or T cells.",
      "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults.",
      "Risk factors for ALL include certain genetic syndromes and family history.",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors.",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy."
    ]
  },
  {
    "id": "Medical-a82e0b03",
    "source": "Medical",
    "question": "Rewrite the clinical guidance on ALL into a public health advisory for families with children and adolescents, emphasizing early symptoms, risk factors, and the importance of prompt diagnosis and specialized care.",
    "answer": "Public Health Advisory: Awareness of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents\n\nAcute lymphoblastic leukemia (ALL) is the most common blood cancer in children and adolescents. Families should be alert to early warning signs, including persistent fatigue, frequent infections, unexplained bleeding or bruising, and swelling of lymph nodes. ALL may also involve the bone marrow, blood, lymph nodes, testicles, and central nervous system, leading to a variety of symptoms.\n\nCertain genetic syndromes and a family history of leukemia can increase a child's risk for developing ALL. Diagnosis requires specialized tests, including blood counts, bone marrow examination, and genetic studies. Early recognition and referral to a hematology-oncology specialist are crucial for timely treatment, which typically includes steroids and multiagent chemotherapy. Discussion of fertility preservation before treatment is recommended for affected families.\n\nIf you notice these symptoms in your child or adolescent, consult your healthcare provider promptly.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is a fast-growing blood cancer that starts in lymphocytes.",
      "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults.",
      "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement.",
      "ALL can be found in bone marrow, blood, testicles, and central nervous system.",
      "Risk factors for ALL include certain genetic syndromes and family history.",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing.",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
      "Fertility preservation should be considered before treatment."
    ]
  },
  {
    "id": "Medical-a7cdc968",
    "source": "Medical",
    "question": "You are a clinical trial coordinator drafting an eligibility summary for a new trial in BCR::ABL1-negative B-ALL. List the diagnostic criteria, relevant subtyping, standard therapies, and follow-up requirements for candidate participants, referencing current guidelines.",
    "answer": "Eligibility Summary for BCR::ABL1-negative B-ALL Clinical Trial\n\nEligible participants must have a confirmed diagnosis of B-cell acute lymphoblastic leukemia (B-ALL) with absence of the BCR::ABL1 fusion gene, as determined by bone marrow aspirate/biopsy, flow cytometry, immunophenotyping, and genetic testing. Subtyping confirms B-cell lineage and BCR::ABL1-negative status. Standard therapy involves initial treatment with steroids and multiagent chemotherapy. Fertility preservation strategies should be discussed prior to therapy initiation. Participants must agree to regular follow-up, including periodic blood tests and surveillance for relapse, consistent with current ALL management guidelines.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow.",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing.",
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL.",
      "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL.",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
      "Fertility preservation should be considered before treatment.",
      "Follow-up includes regular blood tests and surveillance for relapse."
    ]
  },
  {
    "id": "Medical-a79ca666",
    "source": "Medical",
    "question": "Imagine you are a medical oncologist receiving a new patient diagnosed with Stage II pancreatic ductal adenocarcinoma (PDAC). Construct an initial management plan including diagnostic confirmation, staging, treatment options, risk assessment, and multidisciplinary coordination, based strictly on the clinical practice guideline.",
    "answer": "As a medical oncologist, my initial management plan for a patient newly diagnosed with Stage II PDAC would involve confirming the diagnosis through histopathologic evaluation obtained via biopsy, supplemented by imaging studies to assess local tumor extent and lymph node involvement. Comprehensive staging would be performed using high-resolution imaging modalities, such as contrast-enhanced CT or MRI, to determine resectability and evaluate for metastasis. I would recommend genetic testing to assess for hereditary cancer syndromes, given their implications for prognosis and family counseling. Treatment options would include surgical resection if the tumor is deemed resectable, followed by adjuvant drug therapy to reduce recurrence risk. Throughout this process, I would coordinate with a multidisciplinary teamincluding surgical and radiation oncologists, radiologists, pathologists, dietitians, genetic counselors, and palliative care providersto ensure optimal patient-centered care and address supportive needs.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes.",
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests.",
      "Imaging is used for staging and determining surgical eligibility in pancreatic cancer.",
      "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer.",
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer.",
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer.",
      "Supportive care is an important part of pancreatic cancer management."
    ]
  },
  {
    "id": "Medical-fd224da5",
    "source": "Medical",
    "question": "You are a genetic counselor seeing a patient with a family history of breast, ovarian, and pancreatic cancers. Draft a formal genetic risk assessment report, summarizing the hereditary syndromes to consider, recommended tests, and implications for pancreatic cancer risk.",
    "answer": "Genetic Risk Assessment Report:\n\nThe patient presents with a significant family history, including relatives affected by breast, ovarian, and pancreatic cancers. This familial pattern raises suspicion for hereditary breast-ovarian cancer syndrome (HBOC), Lynch syndrome, and potentially other syndromes such as Peutz-Jeghers or familial malignant melanoma syndrome (FAMMM). I recommend comprehensive genetic testing to assess for pathogenic mutations associated with these syndromes, including BRCA1/2, mismatch repair genes, and STK11. Identification of a hereditary syndrome would inform not only the patient's risk for pancreatic cancer but also potential screening and preventive strategies for other associated malignancies. Family members may also benefit from cascade testing and personalized risk management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Risk factors for pancreatic cancer include family history of certain cancers.",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer.",
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer.",
      "Family history of breast cancer, ovarian cancer, colorectal cancer, and melanoma are specifically listed as risk factors.",
      "A genetic counselor is part of the multidisciplinary care team in pancreatic cancer.",
      "Screening and prevention recommendations may differ for individuals with hereditary syndromes."
    ]
  },
  {
    "id": "Medical-ba1f5276",
    "source": "Medical",
    "question": "Rewrite the following patient scenario as a formal discharge summary: A patient with Stage IV pancreatic cancer (metastatic to the liver) was admitted for symptom management, received supportive care interventions, and is being discharged to outpatient palliative follow-up.",
    "answer": "Discharge Summary\n\nDiagnosis: Stage IV pancreatic cancer (metastatic to the liver)\n\nHospital Course: The patient was admitted for management of advanced pancreatic cancer symptoms, including jaundice and pain. Supportive care interventions were provided, focusing on symptom relief and quality of life. Multidisciplinary input was obtained from palliative care, dietitian, and mental health providers.\n\nProcedures/Interventions: Symptom-directed medical management, nutritional support, and psychosocial counseling.\n\nDischarge Plan: The patient is stable for discharge with arrangements for outpatient palliative care follow-up. Symptom management, nutritional optimization, and ongoing psychosocial support will continue as part of the comprehensive supportive care plan.",
    "question_type": "Creative Generation",
    "evidence": [
      "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining.",
      "Stage IV pancreatic cancer is metastatic cancer.",
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes).",
      "Supportive care is an important part of pancreatic cancer management.",
      "Palliative care provider and mental health provider are listed as part of the care team.",
      "Supportive care includes symptom management and palliative care.",
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer."
    ]
  },
  {
    "id": "Medical-a02de386",
    "source": "Medical",
    "question": "You are a primary care physician writing a referral letter to a surgical oncologist for a patient with a newly detected pancreatic mass and a history of diabetes and chronic pancreatitis. Summarize the relevant history, risk factors, diagnostic steps taken, and the rationale for surgical evaluation.",
    "answer": "Dear Surgical Oncologist,\n\nI am referring a patient with a recently identified pancreatic mass on imaging. The patients medical history is notable for long-standing diabetes and chronic pancreatitis, both recognized risk factors for pancreatic cancer. Initial workup has included imaging and blood tests, confirming the presence of a suspicious lesion. Given these risk factors and the imaging findings, further evaluation is warranted to determine surgical eligibility. I request your expertise in assessing the patient for possible resection and further management.",
    "question_type": "Creative Generation",
    "evidence": [
      "Risk factors for pancreatic cancer include diabetes and chronic pancreatitis.",
      "Imaging is used for staging and determining surgical eligibility in pancreatic cancer.",
      "Diagnostic methods for pancreatic cancer include imaging and blood tests.",
      "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer.",
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer.",
      "Referral to a surgical oncologist is appropriate for evaluation of surgical options."
    ]
  },
  {
    "id": "Medical-d5eefeeb",
    "source": "Medical",
    "question": "Rewrite the guidelines core facts into a public health advisory for community awareness, emphasizing risk factors, symptoms, and the importance of early diagnosis in pancreatic cancer.",
    "answer": "**Public Health Advisory: Pancreatic Cancer Awareness**\n\nPancreatic cancer is a serious disease that often presents late due to subtle symptoms. Risk factors include smoking, heavy alcohol use, unhealthy diet, exposure to pesticides, diabetes, chronic pancreatitis, and family history of pancreatic, breast, ovarian, colorectal, or melanoma cancers. Certain hereditary syndromes, such as HBOC and Lynch syndrome, further increase risk. Early symptoms, like jaundice (yellowing of the skin or eyes), should prompt prompt medical attention. Early diagnosis and a multidisciplinary care approach improve treatment options and outcomes. If you have risk factors or family history, discuss screening and genetic counseling with your healthcare provider.",
    "question_type": "Creative Generation",
    "evidence": [
      "Pancreatic cancer is a type of cancer that starts in the pancreas.",
      "Risk factors for pancreatic cancer include smoking, heavy alcohol use, unhealthy diet, exposure to pesticides, diabetes, chronic pancreatitis, and family history of certain cancers.",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer.",
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes).",
      "Early diagnosis and multidisciplinary care improve treatment options.",
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer."
    ]
  },
  {
    "id": "Medical-786a5d0e",
    "source": "Medical",
    "question": "You are a urologist seeing a 62-year-old man with an elevated PSA and abnormal digital rectal exam. MRI shows a suspicious lesion confined to the prostate. Biopsy confirms adenocarcinoma with a Gleason score of 3+4=7 (Grade Group 2). No evidence of nodal or distant disease is found. Construct a formal treatment plan, including diagnostic confirmation, risk stratification, and initial management, referencing the clinical guideline.",
    "answer": "As the attending urologist, I would first confirm the diagnosis of prostate adenocarcinoma via transrectal ultrasound-guided biopsy, which has shown a Gleason score of 3+4=7 (Grade Group 2). The MRI has localized the lesion to the prostate without extracapsular extension or nodal involvement. Based on these findings, the patient is classified as having localized, intermediate-risk prostate cancer. Further workup should include molecular biomarker testing to refine risk assessment and guide management. Treatment options discussed should include radical prostatectomy or radiation therapy, both with curative intent, as well as the possibility of active surveillance considering the relatively favorable pathology and patient preference. Multidisciplinary discussion with radiation oncology is recommended. Regular PSA monitoring and follow-up imaging will be scheduled post-treatment.",
    "question_type": "Creative Generation",
    "evidence": [
      "PSA test and digital rectal exam are used for screening and diagnosis.",
      "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease.",
      "Biopsy is required to confirm prostate cancer diagnosis.",
      "Grade Group and Gleason score are used to estimate cancer aggressiveness.",
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment.",
      "Molecular biomarker testing helps assess risk and guide treatment decisions.",
      "Hormone therapy, surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and radiopharmaceuticals are treatment options.",
      "Active surveillance is a management option for low-risk, early-stage prostate cancer.",
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed."
    ]
  },
  {
    "id": "Medical-714cd769",
    "source": "Medical",
    "question": "You are an oncology nurse preparing a discharge summary for a patient recently treated for metastatic prostate cancer with androgen deprivation therapy (ADT) and chemotherapy. Summarize the key clinical findings, treatments administered, and recommended follow-up plan according to the guidelines.",
    "answer": "Discharge Summary:\n\nDiagnosis: Metastatic prostate cancer, confirmed by biopsy and imaging (MRI, CT, bone scan) demonstrating bone metastases. Patient presented with bone pain and elevated PSA levels. \n\nTreatment Course: The patient received androgen deprivation therapy (ADT) with a combination of leuprolide and bicalutamide, alongside docetaxel-based chemotherapy. Genetic testing revealed a BRCA2 mutation, informing the use of targeted agents in future lines. \n\nFollow-Up Recommendations: The patient is to undergo regular PSA monitoring, periodic imaging (bone scan or MRI as indicated), and clinical assessment for symptoms such as bone pain or urinary issues. Molecular biomarker testing will be repeated as needed to guide ongoing therapy. The patient was counseled on symptom monitoring, including bone pain, weight loss, and urinary symptoms, and provided with contact information for palliative care and oncology follow-up.",
    "question_type": "Creative Generation",
    "evidence": [
      "Metastatic prostate cancer has spread to distant organs such as bones, liver, or lungs.",
      "Symptoms of advanced prostate cancer include blood in urine or semen, bone pain, weight loss, and urinary symptoms.",
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment.",
      "LHRH agonist, LHRH antagonist, bicalutamide, and chemotherapy are listed as treatment options for metastatic prostate cancer.",
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer.",
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed.",
      "Molecular biomarker testing helps assess risk and guide treatment decisions."
    ]
  },
  {
    "id": "Medical-c93a242c",
    "source": "Medical",
    "question": "Imagine you are a primary care physician writing a referral letter to a urologist for a 55-year-old Black male with a family history of prostate cancer, elevated PSA, and lower urinary tract symptoms. Include relevant risk factors, initial findings, and the rationale for specialist evaluation, following the clinical practice guideline.",
    "answer": "Dear Urology Colleague,\n\nI am referring a 55-year-old Black male with a significant family history of prostate cancer (father diagnosed at age 60) for further evaluation. He presents with lower urinary tract symptoms including frequent urination and weak urine stream. His recent PSA test returned elevated at 6.8 ng/mL. Digital rectal exam revealed a firm area on the right lobe. Given his age, Black race, family history, and abnormal screening results, he is at increased risk for prostate cancer. I request your assessment for possible prostate biopsy and further workup, including consideration of molecular biomarker and genetic testing as per guidelines. Thank you for your expertise.",
    "question_type": "Creative Generation",
    "evidence": [
      "Age, family history, race, genetic mutations, diet, obesity, and smoking are risk factors for prostate cancer.",
      "PSA test and digital rectal exam are used for screening and diagnosis.",
      "Black race is a recognized risk factor for prostate cancer.",
      "Biopsy is required to confirm prostate cancer diagnosis.",
      "Molecular biomarker testing helps assess risk and guide treatment decisions.",
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer.",
      "Symptoms of advanced prostate cancer include frequent urination, weak urine stream, and trouble urinating."
    ]
  },
  {
    "id": "Medical-bc02cc6c",
    "source": "Medical",
    "question": "Rewrite the key points from the prostate cancer guideline as a public health advisory aimed at men over 50, emphasizing risk factors, early detection, and available treatments.",
    "answer": "**Public Health Advisory: Prostate Cancer Awareness for Men Over 50**\n\nProstate cancer is one of the most common cancers among men. Early stages are often asymptomatic, making screening crucial for early detection. Risk increases with age, family history, Black race, and genetic mutations such as BRCA1 and BRCA2. Lifestyle factors including obesity, smoking, and high-fat diets may also elevate risk. Screening methods include the PSA blood test and digital rectal exam; abnormal results should be evaluated by a healthcare professional. Diagnosis is confirmed with a prostate biopsy and may include imaging such as MRI or ultrasound to determine disease extent. Treatment options vary by stage and risk group, ranging from active surveillance for low-risk cases to surgery, radiation, hormone therapy, and chemotherapy for more advanced disease. Regular follow-up with PSA testing and imaging is important for all men diagnosed with prostate cancer.",
    "question_type": "Creative Generation",
    "evidence": [
      "Age, family history, race, genetic mutations, diet, obesity, and smoking are risk factors for prostate cancer.",
      "Prostate cancer is a disease where cells in the prostate gland grow out of control.",
      "PSA test and digital rectal exam are used for screening and diagnosis.",
      "Localized prostate cancer is early-stage and confined to the prostate.",
      "Biopsy is required to confirm prostate cancer diagnosis.",
      "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease.",
      "Hormone therapy, surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and radiopharmaceuticals are treatment options.",
      "Active surveillance is a management option for low-risk, early-stage prostate cancer.",
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed."
    ]
  },
  {
    "id": "Medical-21fe7d21",
    "source": "Medical",
    "question": "You are a medical intern on the oncology service. Write a SOAP (Subjective, Objective, Assessment, Plan) progress note for a patient with high-risk localized prostate cancer, integrating clinical presentation, diagnostic findings, risk stratification, and next steps based on the guideline.",
    "answer": "SOAP Progress Note:\n\nSubjective: The patient is a 68-year-old male with no significant urinary symptoms but reports occasional blood in urine. No bone pain or weight loss.\n\nObjective: PSA is 14.2 ng/mL. Digital rectal exam reveals a firm nodule on the left prostate. MRI shows a lesion confined to the prostate, no nodal or distant spread. Biopsy confirms adenocarcinoma, Gleason score 4+4=8 (Grade Group 4). No evidence of metastasis on bone scan.\n\nAssessment: High-risk, localized prostate cancer (PSA >10, Gleason 8, organ-confined, no metastasis).\n\nPlan: Recommend molecular biomarker and genetic testing (including BRCA1/2), multidisciplinary discussion for definitive management. Treatment options include radical prostatectomy or radiation therapy plus androgen deprivation therapy. Schedule baseline labs and imaging for follow-up. Patient education and decision support provided.",
    "question_type": "Creative Generation",
    "evidence": [
      "Localized prostate cancer is early-stage and confined to the prostate.",
      "PSA test and digital rectal exam are used for screening and diagnosis.",
      "Biopsy is required to confirm prostate cancer diagnosis.",
      "Grade Group and Gleason score are used to estimate cancer aggressiveness.",
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment.",
      "Molecular biomarker testing helps assess risk and guide treatment decisions.",
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer.",
      "Hormone therapy, surgery, and radiation therapy are treatment options for localized high-risk disease.",
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed."
    ]
  },
  {
    "id": "Medical-ea781222",
    "source": "Medical",
    "question": "Imagine you are an endocrinologist receiving a referral for a 45-year-old patient with an incidentally discovered adrenal mass on CT scan. Draft a detailed diagnostic workup plan, integrating risk assessment for malignancy and hormone excess, as recommended by the guidelines.",
    "answer": "As an endocrinologist, my diagnostic workup for this 45-year-old patient with an adrenal incidentaloma would begin with a thorough clinical assessment for symptoms of hormone excess, such as weight gain, muscle weakness, high blood pressure, or changes in hair distribution. I would order biochemical tests to evaluate for cortisol, aldosterone, and catecholamine excess, including a blood test and 24-hour urine collection. Imaging with MRI or PET/CT would be performed to further characterize the mass and assess for features suggestive of malignancy. Given the patient's age and risk, I would also review family history and consider genetic testing for hereditary syndromes associated with adrenal tumors. If imaging or laboratory findings are suspicious for malignancy or functional tumor, a biopsy may be indicated for definitive diagnosis.",
    "question_type": "Creative Generation",
    "evidence": [
      "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI.",
      "Functional adrenal tumors may produce excess hormones.",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors.",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT.",
      "Certain hereditary syndromes increase the risk of adrenal tumors.",
      "Genetic testing may be performed to identify hereditary risk factors.",
      "Biopsy may be used for diagnosis."
    ]
  },
  {
    "id": "Medical-f5250f06",
    "source": "Medical",
    "question": "You are a medical intern asked to write a referral note to oncology for a pediatric patient (age 4) presenting with abdominal bloating and weight loss. The note should summarize the differential diagnosis, relevant risk factors, and initial investigations, adhering to evidence from the guidelines.",
    "answer": "Referral Note:\n\nPatient: 4-year-old child\nReason for Referral: Evaluation of adrenal mass\n\nSummary: The patient presents with abdominal bloating and unintentional weight loss. Imaging (CT scan) reveals an adrenal mass. Differential diagnosis includes neuroblastoma, adrenocortical carcinoma, and other malignant adrenal tumors. Notably, neuroblastoma is a rare malignant adrenal tumor primarily affecting children under 5. Family history and assessment for hereditary syndromes (e.g., Beckwith-Wiedemann syndrome, Li-Fraumeni syndrome) are being conducted. Initial investigations include CT scan and blood and biochemical tests to assess for hormone excess. Further genetic testing is planned to evaluate for hereditary risk factors.",
    "question_type": "Creative Generation",
    "evidence": [
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5.",
      "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s.",
      "Symptoms of adrenal cancer include abdominal bloating and loss of weight without trying.",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT.",
      "Certain hereditary syndromes increase the risk of adrenal tumors.",
      "Genetic testing may be performed to identify hereditary risk factors.",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors."
    ]
  },
  {
    "id": "Medical-2faf4e34",
    "source": "Medical",
    "question": "Transform the guideline evidence into a structured discharge summary for a patient recently treated for adrenocortical carcinoma (ACC), including presentation, diagnostic process, risk assessment, and follow-up recommendations.",
    "answer": "Discharge Summary:\n\nDiagnosis: Adrenocortical carcinoma (ACC)\n\nPresentation: The patient presented with muscle weakness, pink stretch marks, and recent weight gain. Physical examination and laboratory findings were suggestive of hormone excess.\n\nDiagnostic Process: Initial CT and MRI scans identified a suspicious adrenal mass. Biochemical and blood tests confirmed hypercortisolism. Genetic testing was performed due to a family history of hereditary syndromes. A biopsy of the adrenal mass confirmed ACC.\n\nRisk Assessment: The patient's risk was elevated due to age and family history consistent with hereditary syndromes such as Li-Fraumeni syndrome.\n\nFollow-Up: The patient will undergo regular imaging (MRI/PET-CT) and biochemical monitoring. Genetic counseling is recommended for the patient and family members.",
    "question_type": "Creative Generation",
    "evidence": [
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex.",
      "Adenoma producing excess cortisol causes Cushing syndrome.",
      "Symptoms of adrenal cancer include weight gain, muscle weakness, pink or purple stretch marks.",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT.",
      "Biopsy may be used for diagnosis.",
      "Certain hereditary syndromes increase the risk of adrenal tumors.",
      "Genetic testing may be performed to identify hereditary risk factors."
    ]
  },
  {
    "id": "Medical-7b694381",
    "source": "Medical",
    "question": "Imagine you are a public health officer tasked with drafting a community advisory about the importance of recognizing symptoms and hereditary risk factors for adrenal tumors. Your advisory should integrate at least five key points from the guidelines.",
    "answer": "**Community Health Advisory: Awareness of Adrenal Tumors**\n\nAdrenal tumors, which can be benign or malignant, are sometimes found incidentally during imaging tests. Early recognition of symptoms such as unexplained weight gain or loss, muscle weakness, abdominal bloating, and changes in blood pressure is crucial. Some adrenal tumors produce excess hormones, leading to specific syndromes like Cushing syndrome or high blood pressure. Individuals with a family history of hereditary syndromes (e.g., Li-Fraumeni, MEN 1/2, Lynch syndrome) may be at higher risk. If you or your relatives experience these symptoms or have a relevant family history, consult your healthcare provider for appropriate blood, biochemical, and genetic testing. Early detection and monitoring can improve outcomes.",
    "question_type": "Creative Generation",
    "evidence": [
      "Adrenal tumors can be benign or malignant.",
      "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI.",
      "Functional adrenal tumors may produce excess hormones.",
      "Symptoms of adrenal cancer include weight gain, muscle weakness, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying.",
      "Adenoma producing excess cortisol causes Cushing syndrome.",
      "Certain hereditary syndromes increase the risk of adrenal tumors.",
      "Genetic testing may be performed to identify hereditary risk factors."
    ]
  },
  {
    "id": "Medical-2e1ccbe9",
    "source": "Medical",
    "question": "You are a clinician asked to summarize the key differences in presentation, diagnosis, and risk factors between adrenocortical carcinoma, pheochromocytoma, and neuroblastoma, using evidence from the guidelines.",
    "answer": "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex, most common in children under 5 and adults in their 40s and 50s. It often presents with symptoms of hormone excess such as weight gain, muscle weakness, and stretch marks. Diagnosis involves imaging (CT, MRI, PET), blood and biochemical tests, genetic evaluation, and sometimes biopsy. Hereditary syndromes like Li-Fraumeni and MEN1/2 increase risk. Pheochromocytoma arises from the adrenal medulla, presenting with high blood pressure, headache, rapid heartbeat, and sweating. Diagnosis relies on CT/MRI and biochemical tests. Neuroblastoma mainly affects children under 5, may metastasize to bones, and is diagnosed with imaging and biochemical tests. Family history and hereditary syndromes are important risk factors for all three.",
    "question_type": "Creative Generation",
    "evidence": [
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex.",
      "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s.",
      "Symptoms of adrenal cancer include weight gain, muscle weakness, pink or purple stretch marks.",
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating.",
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5.",
      "Neuroblastoma may metastasize to bones.",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT.",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors.",
      "Certain hereditary syndromes increase the risk of adrenal tumors."
    ]
  },
  {
    "id": "Medical-83c906e0",
    "source": "Medical",
    "question": "You are an oncologist preparing a referral letter for a 45-year-old woman recently diagnosed with Stage II, hormone receptor-positive, HER2-negative invasive ductal carcinoma of the breast. Summarize the diagnostic workup, relevant biomarkers, and outline the initial treatment plan for the receiving multidisciplinary team.",
    "answer": "Dear Multidisciplinary Team,\n\nI am referring a 45-year-old female patient recently diagnosed with Stage II invasive ductal carcinoma of the breast. Diagnostic workup included mammogram and ultrasound, which revealed a suspicious lesion; MRI confirmed tumor extent. Core needle biopsy established the diagnosis and provided tissue for biomarker assessment, which demonstrated estrogen receptor (ER) and progesterone receptor (PR) positivity, and HER2 negativity. Sentinel lymph node biopsy identified limited nodal involvement, consistent with Stage II disease. Blood tests were unremarkable.\n\nGiven the hormone receptor-positive, HER2-negative profile, the initial treatment plan includes breast-conserving surgery (lumpectomy), followed by radiation therapy. Adjuvant endocrine therapy (e.g., tamoxifen or aromatase inhibitor) is planned. Chemotherapy will be considered based on tumor grade and patient risk factors. The patient will be evaluated by fertility preservation specialists prior to systemic therapy, and performance status will be closely monitored throughout treatment.\n\nSincerely,\nDr. Smith",
    "question_type": "Creative Generation",
    "evidence": [
      "Invasive ductal carcinoma is the most common type of invasive breast cancer.",
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests.",
      "Sentinel lymph node biopsy is used to assess lymph node involvement.",
      "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer.",
      "Treatment options include surgery (mastectomy, lumpectomy), radiation therapy, chemotherapy, endocrine therapy, HER2-targeted therapy, immunotherapy, and targeted inhibitors.",
      "Endocrine therapy is used for hormone receptor-positive breast cancer.",
      "Fertility preservation should be discussed before starting treatment.",
      "Performance status is considered in treatment planning."
    ]
  },
  {
    "id": "Medical-d168a555",
    "source": "Medical",
    "question": "Imagine you are a medical intern tasked with writing a discharge summary for a patient with inflammatory breast cancer (IBC) who has completed neoadjuvant systemic therapy and modified radical mastectomy. Structure the summary to include diagnosis, key findings, treatment course, and follow-up recommendations.",
    "answer": "Discharge Summary:\n\nDiagnosis: Stage III inflammatory breast cancer (IBC), ER/PR negative, HER2 positive.\n\nKey Findings: Patient presented with breast swelling, redness, peau dorange, and skin thickening. Imaging (mammogram, ultrasound, MRI) and skin biopsy confirmed IBC. Biomarker analysis revealed HER2 positivity, ER/PR negativity. Sentinel lymph node biopsy was positive for malignancy.\n\nTreatment Course: The patient received neoadjuvant systemic therapy, including chemotherapy and HER2-targeted therapy. This was followed by a modified radical mastectomy. Postoperative recovery was uneventful.\n\nFollow-up Recommendations: Initiate adjuvant radiation therapy and continue HER2-targeted agents as indicated. Schedule regular physical exams and imaging for surveillance. Monitor for recurrence and treatment-related toxicities. Multidisciplinary follow-up is recommended.\n\nSigned,\nMedical Intern",
    "question_type": "Creative Generation",
    "evidence": [
      "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin.",
      "Common symptoms include redness, swelling, peau dorange, and skin thickening.",
      "Diagnosis involves physical exam, medical photographs, mammogram, ultrasound, MRI, CT scan, PET scan, biopsy, skin biopsy, sentinel lymph node biopsy, and blood tests.",
      "Biomarker analysis includes estrogen receptor (ER), progesterone receptor (PR), and HER2 status.",
      "Treatment for IBC includes systemic therapy, chemotherapy, HER2-targeted therapy, immunotherapy, endocrine therapy, surgery (modified radical mastectomy), and radiation therapy.",
      "Follow-up includes imaging, physical exams, and monitoring for recurrence."
    ]
  },
  {
    "id": "Medical-fe801cec",
    "source": "Medical",
    "question": "You are a patient advocate tasked with drafting a public health notice to educate the community about breast cancer risk factors, screening, and the importance of early detection. Your notice should reference clinical evidence and recommended practices.",
    "answer": "Public Health Notice: Protect YourselfKnow the Facts About Breast Cancer\n\nBreast cancer is a carcinoma that starts in the cells of the breast and affects individuals assigned female at birth, particularly those with a family history or BRCA1/2 mutations. Regular screening mammograms are crucial for early detection, even in people without symptoms. If you experience breast lumps, pain, nipple discharge, or skin changes such as redness or swelling, consult your healthcare provider promptly. Early-stage breast cancer is more treatable and has better outcomes. We encourage all eligible individuals to undergo recommended screenings and discuss personal risk factors with their doctor.\n\nIssued by: Community Health Board",
    "question_type": "Creative Generation",
    "evidence": [
      "Breast cancer is a carcinoma that starts in the cells of the breast.",
      "Risk factors include family history, BRCA mutations, and being assigned female at birth.",
      "Screening mammograms are used for early detection in asymptomatic individuals.",
      "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange.",
      "Early detection improves breast cancer outcomes.",
      "If you experience symptoms, consult your healthcare provider promptly."
    ]
  },
  {
    "id": "Medical-9210668e",
    "source": "Medical",
    "question": "Transform the clinical facts on metastatic breast cancer (MBC) into a structured SOAP (Subjective, Objective, Assessment, Plan) progress note for a follow-up visit. Include relevant symptoms, diagnostics, biomarkers, and ongoing management.",
    "answer": "SOAP Progress Note\n\nSubjective: Patient reports persistent bone pain and intermittent shortness of breath. No new neurological symptoms or liver dysfunction.\n\nObjective: Imaging tests (PET scan) confirm metastases to bone and lung. Blood tests within normal limits. Biopsy confirms metastatic breast cancer. Biomarker analysis reveals hormone receptor positivity (ER/PR+) and HER2 negativity. Performance status remains stable.\n\nAssessment: Stage IV metastatic breast cancer with bone and pulmonary involvement, hormone receptor-positive, HER2-negative.\n\nPlan: Continue systemic therapy with endocrine therapy and CDK4/6 inhibitor. Monitor for disease progression with regular imaging and physical exams. Manage bone metastases with bisphosphonates. Provide supportive care for symptom control. Discuss ongoing eligibility for targeted therapies.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs.",
      "Symptoms of MBC include bone pain, shortness of breath, liver dysfunction, and neurological symptoms.",
      "Diagnosis involves imaging tests, biopsy, and blood tests.",
      "Systemic therapy is used for invasive and metastatic breast cancer.",
      "Endocrine therapy is used for hormone receptor-positive breast cancer.",
      "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer.",
      "Follow-up includes imaging, physical exams, and monitoring for recurrence."
    ]
  },
  {
    "id": "Medical-5a1e917c",
    "source": "Medical",
    "question": "Assume the role of a genetic counselor. Prepare a summary for a patient newly found to have a BRCA1 mutation, explaining the implications for breast cancer risk, recommended surveillance, and potential preventive strategies.",
    "answer": "Genetic Counseling Summary:\n\nYou have tested positive for a BRCA1 mutation, which significantly increases your risk of developing breast cancer. Having a BRCA1 mutation is a strong risk factor and may also impact your family members risk. We recommend enhanced surveillance, including annual mammograms and breast MRI starting at an earlier age. Preventive strategies may include risk-reducing medications or prophylactic surgery (such as bilateral mastectomy or oophorectomy). It is important to discuss these options with your oncology and surgical teams. Family members may also wish to consider genetic testing. Ongoing follow-up and support resources are available to you.\n",
    "question_type": "Creative Generation",
    "evidence": [
      "BRCA1 and BRCA2 mutations increase the risk of breast cancer.",
      "Risk factors include family history, BRCA mutations, and being assigned female at birth.",
      "Screening mammograms are used for early detection in asymptomatic individuals.",
      "Bilateral oophorectomy is a surgical option listed under treatments.",
      "Fertility preservation should be discussed before starting treatment.",
      "Follow-up includes imaging, physical exams, and monitoring for recurrence."
    ]
  }
]